Clustering O 1 0.5870838761329651
of O 0 0.006302465219050646
missense O 1 0.9995700716972351
mutations O 1 0.9998262524604797
in O 0 0.003239247016608715
the O 0 0.006614283192902803
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9915754199028015
telangiectasia I-Disease 1 0.9999867677688599
gene O 1 0.9994297623634338
in O 0 0.0027607737574726343
a O 0 0.009575209580361843
sporadic B-Disease 1 0.9946116209030151
T I-Disease 1 0.9999251365661621
- I-Disease 1 0.9008706212043762
cell I-Disease 1 0.9998268485069275
leukaemia I-Disease 1 0.9999786615371704
. O 0 0.011472348123788834

Ataxia B-Disease 1 0.9999924898147583
- I-Disease 1 0.9573171138763428
telangiectasia I-Disease 1 0.9999608993530273
( O 0 0.01210066955536604
A B-Disease 0 0.46476927399635315
- I-Disease 1 0.8854967355728149
T I-Disease 1 0.999903678894043
) O 0 0.003950938582420349
is O 0 0.0015251574805006385
a O 0 0.01365850493311882
recessive B-Disease 1 0.9999994039535522
multi I-Disease 1 0.9984099864959717
- I-Disease 0 0.17460377514362335
system I-Disease 0 0.39176756143569946
disorder I-Disease 1 0.9999878406524658
caused O 0 0.39442917704582214
by O 0 0.005350229796022177
mutations O 1 0.9999808073043823
in O 0 0.001607850892469287
the O 0 0.002792119747027755
ATM O 1 0.9993649125099182
gene O 1 0.9997817873954773
at O 0 0.008092663250863552
11q22 O 1 0.9961807727813721
- O 0 0.0587269552052021
q23 O 1 0.99399733543396
( O 0 0.014112173579633236
ref O 1 0.9927302002906799
. O 0 0.004003199283033609
3 O 0 0.011811518110334873
) O 0 0.0054984427988529205
. O 0 0.004999122116714716

The O 0 0.006613417994230986
risk O 1 0.945369303226471
of O 0 0.0046349819749593735
cancer B-Disease 1 0.9999982118606567
, O 0 0.0033462794963270426
especially O 0 0.010667677968740463
lymphoid B-Disease 1 0.99998939037323
neoplasias I-Disease 1 0.9980003237724304
, O 0 0.002116409596055746
is O 0 0.0016714941011741757
substantially O 0 0.03293281048536301
elevated O 1 0.611470639705658
in O 0 0.002959967590868473
A B-Disease 1 0.9645414352416992
- I-Disease 1 0.9974995255470276
T I-Disease 1 0.9999909400939941
patients O 1 0.9997228980064392
and O 0 0.001589299994520843
has O 0 0.001728591276332736
long O 0 0.004866729024797678
been O 0 0.0018394521903246641
associated O 0 0.010749411769211292
with O 0 0.009297763928771019
chromosomal O 1 0.999998927116394
instability O 1 0.9975887537002563
. O 0 0.008314252831041813

By O 0 0.010115159675478935
analysing O 1 0.932590663433075
tumour B-Disease 1 0.9999932050704956
DNA O 1 0.9986311793327332
from O 0 0.006097313482314348
patients O 1 0.9983023405075073
with O 0 0.005453925579786301
sporadic B-Disease 1 0.9971356391906738
T I-Disease 1 0.9999533891677856
- I-Disease 1 0.6222566366195679
cell I-Disease 1 0.9994051456451416
prolymphocytic I-Disease 1 0.9994432330131531
leukaemia I-Disease 1 0.9999926090240479
( O 0 0.0238560251891613
T B-Disease 1 0.9999408721923828
- I-Disease 1 0.8061243891716003
PLL I-Disease 1 0.9998757839202881
) O 0 0.005235142540186644
, O 0 0.0011450981255620718
a O 0 0.005573261994868517
rare O 0 0.1251714527606964
clonal B-Disease 1 0.9999487400054932
malignancy I-Disease 1 0.9999747276306152
with O 0 0.0026597068645060062
similarities O 0 0.012303544208407402
to O 0 0.001082827802747488
a O 0 0.00800085999071598
mature B-Disease 1 0.9989811778068542
T I-Disease 1 0.9999483823776245
- I-Disease 1 0.8862202167510986
cell I-Disease 1 0.9999260902404785
leukaemia I-Disease 1 0.9999926090240479
seen O 0 0.007018767297267914
in O 0 0.002825335832312703
A B-Disease 1 0.7861686944961548
- I-Disease 1 0.9038355350494385
T I-Disease 1 0.9998252987861633
, O 0 0.0018988476367667317
we O 0 0.0009688238496892154
demonstrate O 0 0.00561496801674366
a O 0 0.003179503371939063
high O 0 0.003694133600220084
frequency O 0 0.02349224127829075
of O 0 0.00219797738827765
ATM O 1 0.9996956586837769
mutations O 1 0.9999772310256958
in O 0 0.00781326461583376
T B-Disease 1 0.9999097585678101
- I-Disease 0 0.25570404529571533
PLL I-Disease 1 0.9992870688438416
. O 0 0.012081106193363667

In O 0 0.00398560194298625
marked O 0 0.009312066249549389
contrast O 0 0.006336714141070843
to O 0 0.00119369151070714
the O 0 0.002856338629499078
ATM O 1 0.9992672801017761
mutation O 1 0.9999840259552002
pattern O 0 0.26428890228271484
in O 0 0.0030752092134207487
A B-Disease 1 0.6888089179992676
- I-Disease 1 0.8995026350021362
T I-Disease 1 0.999839186668396
, O 0 0.0014376472681760788
the O 0 0.0008489236934110522
most O 0 0.001755334553308785
frequent O 0 0.04008834436535835
nucleotide O 1 0.9984357953071594
changes O 0 0.007088694721460342
in O 0 0.0011846444103866816
this O 0 0.003486023982986808
leukaemia B-Disease 1 0.9999910593032837
were O 0 0.005588716361671686
missense O 1 0.999860405921936
mutations O 1 0.9998646974563599
. O 0 0.011119517497718334

These O 0 0.004579577594995499
clustered O 0 0.040018294006586075
in O 0 0.0013779515866190195
the O 0 0.001150142285041511
region O 0 0.0026826306711882353
corresponding O 0 0.008195736445486546
to O 0 0.001140981330536306
the O 0 0.002449673367664218
kinase O 1 0.9999762773513794
domain O 0 0.08064106106758118
, O 0 0.0011688309023156762
which O 0 0.0008762417128309608
is O 0 0.0011797413462772965
highly O 0 0.008464896120131016
conserved O 1 0.5590927004814148
in O 0 0.003661710536107421
ATM O 1 0.9993191957473755
- O 0 0.025770384818315506
related O 0 0.019307253882288933
proteins O 1 0.997951328754425
in O 0 0.003713402897119522
mouse O 1 0.9997081160545349
, O 0 0.00532833905890584
yeast O 1 0.9996069073677063
and O 0 0.00497609656304121
Drosophila O 1 0.9971686005592346
. O 0 0.00912229623645544

The O 0 0.005371146369725466
resulting O 0 0.06457921862602234
amino O 1 0.9952162504196167
- O 0 0.056056853383779526
acid O 1 0.9985101819038391
substitutions O 0 0.06596183776855469
are O 0 0.0012495314003899693
predicted O 0 0.008989684283733368
to O 0 0.0015874365344643593
interfere O 0 0.031965021044015884
with O 0 0.004244026727974415
ATP O 1 0.9980508089065552
binding O 0 0.0732015073299408
or O 0 0.0073403832502663136
substrate O 1 0.9881457090377808
recognition O 0 0.01943395473062992
. O 0 0.005378279369324446

Two O 0 0.0036978384014219046
of O 0 0.0013904261868447065
seventeen O 0 0.04093547165393829
mutated O 1 0.9999816417694092
T B-Disease 1 0.9999003410339355
- I-Disease 0 0.2423485666513443
PLL I-Disease 1 0.9995490908622742
samples O 0 0.0350639782845974
had O 0 0.0025127290282398462
a O 0 0.0034686874132603407
previously O 0 0.0035924124531447887
reported O 0 0.010759791359305382
A B-Disease 0 0.17449328303337097
- I-Disease 1 0.8590319752693176
T I-Disease 1 0.9999339580535889
allele O 1 0.9992954730987549
. O 0 0.009477992542088032

In O 0 0.004324620123952627
contrast O 0 0.011205513030290604
, O 0 0.0016440454637631774
no O 0 0.004343728069216013
mutations O 1 0.999968409538269
were O 0 0.0016574929468333721
detected O 0 0.12791170179843903
in O 0 0.0017766932724043727
the O 0 0.004377660341560841
p53 O 1 0.9999979734420776
gene O 1 0.999929666519165
, O 0 0.002089485991746187
suggesting O 0 0.011666798032820225
that O 0 0.001611690386198461
this O 0 0.005958269350230694
tumour B-Disease 1 0.9999998807907104
suppressor O 1 0.9999959468841553
is O 0 0.0027988555375486612
not O 0 0.0013529041316360235
frequently O 0 0.005654734093695879
altered O 0 0.08444543927907944
in O 0 0.0022135002072900534
this O 0 0.006093953736126423
leukaemia B-Disease 1 0.9999872446060181
. O 0 0.010983482003211975

Occasional O 0 0.10874324291944504
missense O 1 0.9995354413986206
mutations O 1 0.9999395608901978
in O 0 0.0040802787989377975
ATM O 1 0.9508534669876099
were O 0 0.0008108619367703795
also O 0 0.0008027316653169692
found O 0 0.004524132236838341
in O 0 0.004149070009589195
tumour B-Disease 1 0.9999990463256836
DNA O 1 0.9995537400245667
from O 0 0.005029051098972559
patients O 1 0.9994068145751953
with O 0 0.0058130742982029915
B B-Disease 1 0.999229907989502
- I-Disease 0 0.22450897097587585
cell I-Disease 1 0.999286949634552
non I-Disease 0 0.0520547516644001
- I-Disease 1 0.9947994947433472
Hodgkins I-Disease 1 0.9999986886978149
lymphomas I-Disease 1 0.9999932050704956
( O 0 0.01531114149838686
B B-Disease 1 0.99775630235672
- I-Disease 0 0.02817080169916153
NHL I-Disease 0 0.05244229733943939
) O 0 0.002784616779536009
and O 0 0.0009922042954713106
a O 0 0.008609444834291935
B B-Disease 1 0.9978016018867493
- I-Disease 0 0.03503022715449333
NHL I-Disease 1 0.6094533205032349
cell O 1 0.9892732501029968
line O 0 0.01406083069741726
. O 0 0.007046725135296583

The O 0 0.002764433855190873
evidence O 0 0.002843811409547925
of O 0 0.0007552314200438559
a O 0 0.003476302372291684
significant O 0 0.004506976809352636
proportion O 0 0.009585225954651833
of O 0 0.0014419612707570195
loss O 1 0.6292027831077576
- O 0 0.013846897520124912
of O 0 0.0020859960932284594
- O 0 0.031174449250102043
function O 1 0.9730411171913147
mutations O 1 0.9999871253967285
and O 0 0.001163168577477336
a O 0 0.003610787447541952
complete O 0 0.00825346540659666
absence O 0 0.009408758021891117
of O 0 0.0005798396305181086
the O 0 0.0010428816312924027
normal O 0 0.020064253360033035
copy O 0 0.021712860092520714
of O 0 0.0014538696268573403
ATM O 1 0.9825465679168701
in O 0 0.0011358779156580567
the O 0 0.0008902401896193624
majority O 0 0.003908751532435417
of O 0 0.003193181473761797
mutated O 1 0.999990701675415
tumours B-Disease 1 0.9999902248382568
establishes O 1 0.990136444568634
somatic O 1 0.9998470544815063
inactivation O 1 0.9978368878364563
of O 0 0.0012187851825729012
this O 0 0.002145512029528618
gene O 1 0.9998496770858765
in O 0 0.0013263738946989179
the O 0 0.00213832501322031
pathogenesis O 1 0.999976634979248
of O 0 0.0029491938184946775
sporadic B-Disease 1 0.9980958104133606
T I-Disease 1 0.9999785423278809
- I-Disease 1 0.5730535984039307
PLL I-Disease 1 0.9997726082801819
and O 0 0.002214988460764289
suggests O 0 0.011326123960316181
that O 0 0.001942567527294159
ATM O 1 0.9632470011711121
acts O 0 0.005840141326189041
as O 0 0.0023352426942437887
a O 0 0.027997979894280434
tumour B-Disease 1 0.999998927116394
suppressor O 1 0.9999452829360962
. O 0 0.012610524892807007

As O 0 0.004055139143019915
constitutional O 0 0.011228842660784721
DNA O 1 0.9987917542457581
was O 0 0.0024196060840040445
not O 0 0.000877019832842052
available O 0 0.0021308865398168564
, O 0 0.0011473058257251978
a O 0 0.007774225436151028
putative O 1 0.9994497895240784
hereditary O 1 0.999951958656311
predisposition O 1 0.9999676942825317
to O 0 0.007716313935816288
T B-Disease 1 0.9999366998672485
- I-Disease 0 0.07961903512477875
PLL I-Disease 1 0.9994514584541321
will O 0 0.0030252565629780293
require O 0 0.009720105677843094
further O 0 0.003990329802036285
investigation O 0 0.012813563458621502
. O 0 0.002532179467380047
. O 0 0.004816894885152578

Myotonic B-Disease 1 0.9999831914901733
dystrophy I-Disease 1 0.9999983310699463
protein O 1 0.9998155236244202
kinase O 1 0.9998276233673096
is O 0 0.004157907795161009
involved O 0 0.00428733229637146
in O 0 0.0009324681013822556
the O 0 0.0016778780845925212
modulation O 1 0.9857670068740845
of O 0 0.0012625012313947082
the O 0 0.0042841373942792416
Ca2 O 1 0.9999785423278809
+ O 1 0.995411217212677
homeostasis O 1 0.9995328187942505
in O 0 0.00792734045535326
skeletal O 1 0.9999843835830688
muscle O 1 0.9999866485595703
cells O 1 0.9995371103286743
. O 0 0.008503596298396587

Myotonic B-Disease 1 0.9999936819076538
dystrophy I-Disease 1 0.9999991655349731
( O 0 0.05755079537630081
DM B-Disease 1 0.9999923706054688
) O 0 0.0056441184133291245
, O 0 0.0008062684210017323
the O 0 0.0010917250765487552
most O 0 0.00269576464779675
prevalent O 1 0.9994400143623352
muscular B-Disease 1 0.9999983310699463
disorder I-Disease 1 0.9999974966049194
in O 0 0.0035962227266281843
adults O 1 0.8187131881713867
, O 0 0.0016676385421305895
is O 0 0.002240885281935334
caused O 0 0.10710098594427109
by O 0 0.003727659350261092
( O 0 0.007563022430986166
CTG O 1 0.9995957016944885
) O 0 0.007553636562079191
n O 0 0.37081030011177063
- O 0 0.01691070944070816
repeat O 0 0.07029365748167038
expansion O 0 0.00872048083692789
in O 0 0.0011285648215562105
a O 0 0.006781538017094135
gene O 1 0.99958735704422
encoding O 0 0.4589598774909973
a O 0 0.011418946087360382
protein O 1 0.9996380805969238
kinase O 1 0.9998769760131836
( O 0 0.015639126300811768
DM B-Disease 1 0.9999740123748779
protein O 1 0.9998364448547363
kinase O 1 0.9999414682388306
; O 0 0.012911220081150532
DMPK O 1 0.9991422891616821
) O 0 0.0036969236098229885
and O 0 0.0009874737588688731
involves O 0 0.020698141306638718
changes O 0 0.006604308728128672
in O 0 0.0019555643666535616
cytoarchitecture O 1 0.9986467957496643
and O 0 0.004128545988351107
ion O 1 0.9981626868247986
homeostasis O 1 0.9994747042655945
. O 0 0.01213131844997406

To O 0 0.0036969759967178106
obtain O 0 0.009564249776303768
clues O 0 0.01647813990712166
to O 0 0.0010496266186237335
the O 0 0.0010727118933573365
normal O 0 0.020375318825244904
biological O 0 0.02044893614947796
role O 0 0.004202275536954403
of O 0 0.0016001838957890868
DMPK O 1 0.9981958270072937
in O 0 0.0049349660985171795
cellular O 1 0.9999123811721802
ion O 1 0.9994661211967468
homeostasis O 1 0.9999281167984009
, O 0 0.0019494122825562954
we O 0 0.0006650035502389073
have O 0 0.0007638405659236014
compared O 0 0.004536850843578577
the O 0 0.002153587294742465
resting O 1 0.8092610239982605
[ O 1 0.8469206690788269
Ca2 O 1 0.9999877214431763
+ O 1 0.9960334897041321
] O 0 0.05811493471264839
i O 0 0.0034037218429148197
, O 0 0.0010662509594112635
the O 0 0.0015364316059276462
amplitude O 0 0.41858986020088196
and O 0 0.0013732891529798508
shape O 0 0.01589818485081196
of O 0 0.003327041631564498
depolarization O 1 0.9999552965164185
- O 1 0.7525737285614014
induced O 1 0.9998939037322998
Ca2 O 1 0.9999668598175049
+ O 1 0.9983288645744324
transients O 1 0.9955493211746216
, O 0 0.0018308444414287806
and O 0 0.0006678845384158194
the O 0 0.0010168948210775852
content O 0 0.005952928215265274
of O 0 0.0016041449271142483
ATP O 1 0.9989186525344849
- O 0 0.019544770941138268
driven O 0 0.020676635205745697
ion O 1 0.7421073913574219
pumps O 0 0.06673931330442429
in O 0 0.004665904212743044
cultured O 1 0.9989690780639648
skeletal O 1 0.9999790191650391
muscle O 1 0.9999805688858032
cells O 1 0.9985882639884949
of O 0 0.0019053518772125244
wild O 0 0.047418780624866486
- O 0 0.02443535067141056
type O 1 0.7116745114326477
and O 0 0.00321618327870965
DMPK O 1 0.9994924068450928
[ O 1 0.6626085042953491
- O 0 0.3855721354484558
/ O 1 0.9800131916999817
- O 0 0.044822704046964645
] O 1 0.5986801981925964
knockout O 1 0.9992499947547913
mice O 1 0.9993419051170349
. O 0 0.009836768731474876

In O 0 0.008382784202694893
vitro O 1 0.9978081583976746
- O 0 0.05319605767726898
differentiated O 1 0.9970188140869141
DMPK O 1 0.9993249177932739
[ O 1 0.7434803247451782
- O 0 0.33001309633255005
/ O 1 0.9813754558563232
- O 0 0.04244105890393257
] O 0 0.09827406704425812
myotubes O 1 0.9218822121620178
exhibit O 0 0.013191165402531624
a O 0 0.00547165097668767
higher O 0 0.008292751386761665
resting O 0 0.4314626455307007
[ O 1 0.6293396949768066
Ca2 O 1 0.9999570846557617
+ O 1 0.9930167198181152
] O 0 0.03519380837678909
i O 0 0.0023111237678676844
than O 0 0.0013551233569160104
do O 0 0.0034780025016516447
wild O 0 0.04127248749136925
- O 0 0.04169149696826935
type O 1 0.9374586939811707
myotubes O 1 0.9867575168609619
because O 0 0.0031515711452811956
of O 0 0.0006835968233644962
an O 0 0.0016788528300821781
altered O 0 0.30414697527885437
open O 0 0.009445221163332462
probability O 0 0.023885447531938553
of O 0 0.0016380721936002374
voltage O 1 0.9865814447402954
- O 0 0.021642737090587616
dependent O 0 0.050755906850099564
l O 1 0.9968171715736389
- O 0 0.04679720103740692
type O 1 0.9781975150108337
Ca2 O 1 0.9998726844787598
+ O 1 0.9460978507995605
and O 0 0.005134639795869589
Na O 1 0.9961511492729187
+ O 1 0.8800116181373596
channels O 0 0.04312240704894066
. O 0 0.006778416223824024

The O 0 0.010949652642011642
mutant O 1 0.9912368059158325
myotubes O 1 0.9397252798080444
exhibit O 0 0.02102300338447094
smaller O 0 0.010337688960134983
and O 0 0.0023245092015713453
slower O 0 0.46152442693710327
Ca2 O 1 0.9998630285263062
+ O 1 0.9219779372215271
responses O 0 0.027130944654345512
upon O 0 0.005378475412726402
triggering O 1 0.6353157162666321
by O 0 0.005780561827123165
acetylcholine O 1 0.9997418522834778
or O 0 0.004964308347553015
high O 0 0.005674436688423157
external O 0 0.04138879477977753
K O 1 0.9912545680999756
+ O 1 0.883350670337677
. O 0 0.007222464773803949

In O 0 0.004235120955854654
addition O 0 0.0056092990562319756
, O 0 0.0011697029694914818
we O 0 0.0008709949906915426
observed O 0 0.0047155930660665035
that O 0 0.001190087990835309
these O 0 0.003806591033935547
Ca2 O 1 0.9999804496765137
+ O 1 0.9971899390220642
transients O 1 0.9964577555656433
partially O 0 0.04417670518159866
result O 0 0.007760738488286734
from O 0 0.0011569925118237734
an O 0 0.001398736028932035
influx O 0 0.018177365884184837
of O 0 0.0019905855879187584
extracellular O 1 0.9992769360542297
Ca2 O 1 0.9999092817306519
+ O 0 0.37646156549453735
through O 0 0.004309518728405237
the O 0 0.003421573666855693
l O 1 0.9968886971473694
- O 0 0.09263186156749725
type O 1 0.9817708134651184
Ca2 O 1 0.999543309211731
+ O 1 0.8381269574165344
channel O 0 0.04795766994357109
. O 0 0.0077718570828437805

Neither O 0 0.01311986893415451
the O 0 0.0014319091569632292
content O 0 0.007360256277024746
nor O 0 0.004266873933374882
the O 0 0.0008525495650246739
activity O 0 0.006326853297650814
of O 0 0.0025391888339072466
Na O 1 0.9997275471687317
+ O 1 0.996423065662384
/ O 1 0.6456578969955444
K O 1 0.9044883847236633
+ O 1 0.9695920348167419
ATPase O 1 0.996903121471405
and O 0 0.009313466027379036
sarcoplasmic O 1 0.9997238516807556
reticulum O 1 0.9998350143432617
Ca2 O 1 0.9999104738235474
+ O 1 0.9969925880432129
- O 0 0.078202024102211
ATPase O 1 0.9993131160736084
are O 0 0.0025296187959611416
affected O 0 0.01665734499692917
by O 0 0.006278789136558771
DMPK O 1 0.9986212253570557
absence O 0 0.038722313940525055
. O 0 0.007476496044546366

In O 0 0.004547119140625
conclusion O 0 0.010105719789862633
, O 0 0.0011481171241030097
our O 0 0.0015630130656063557
data O 0 0.004808987490832806
suggest O 0 0.007055335212498903
that O 0 0.0020407603587955236
DMPK O 1 0.9990542531013489
is O 0 0.00229822238907218
involved O 0 0.005167421884834766
in O 0 0.0024544098414480686
modulating O 1 0.9994687438011169
the O 0 0.0016501365462318063
initial O 0 0.008840374648571014
events O 0 0.003289617830887437
of O 0 0.001911446452140808
excitation O 1 0.9992972612380981
- O 0 0.03756214678287506
contraction O 1 0.9805311560630798
coupling O 1 0.9891167283058167
in O 0 0.007737935520708561
skeletal O 1 0.9999734163284302
muscle O 1 0.9999629259109497
. O 0 0.005190796218812466
. O 0 0.006002449430525303

Constitutional O 0 0.06379399448633194
RB1 O 1 0.9998016953468323
- O 1 0.9113410115242004
gene O 1 0.9999567270278931
mutations O 1 0.9999734163284302
in O 0 0.006271153688430786
patients O 1 0.9993122816085815
with O 0 0.004664651118218899
isolated O 0 0.36403709650039673
unilateral B-Disease 1 0.9789165258407593
retinoblastoma I-Disease 1 0.9999256134033203
. O 0 0.008791603147983551

In O 0 0.004535275045782328
most O 0 0.0038094529882073402
patients O 1 0.9989407658576965
with O 0 0.004870934411883354
isolated O 0 0.4265833795070648
unilateral B-Disease 1 0.9900688529014587
retinoblastoma I-Disease 1 0.9999954700469971
, O 0 0.00903311837464571
tumor B-Disease 1 0.9999982118606567
development O 0 0.00697077251970768
is O 0 0.0019138302886858582
initiated O 0 0.019336313009262085
by O 0 0.00470843305811286
somatic O 1 0.9998403787612915
inactivation O 1 0.9978797435760498
of O 0 0.0015807969029992819
both O 0 0.0028235253412276506
alleles O 1 0.999624490737915
of O 0 0.001629376201890409
the O 0 0.006673825904726982
RB1 O 1 0.9999821186065674
gene O 1 0.9997382760047913
. O 0 0.009164047427475452

However O 0 0.006009229458868504
, O 0 0.001189659582450986
some O 0 0.0005938128451816738
of O 0 0.0006841886788606644
these O 0 0.002293367637321353
patients O 1 0.9997528195381165
can O 0 0.005896782502532005
transmit O 1 0.9994922876358032
retinoblastoma B-Disease 1 0.9999901056289673
predisposition O 1 0.9998612403869629
to O 0 0.001965493895113468
their O 0 0.0030042389407753944
offspring O 1 0.9964284300804138
. O 0 0.00551557308062911

To O 0 0.00337719963863492
determine O 0 0.005374576430767775
the O 0 0.0013771854573860765
frequency O 0 0.02127486653625965
and O 0 0.0008277932065539062
nature O 0 0.002994330134242773
of O 0 0.0009272594470530748
constitutional O 0 0.025103693827986717
RB1 O 1 0.9999964237213135
- O 1 0.9764527678489685
gene O 1 0.9999886751174927
mutations O 1 0.9999932050704956
in O 0 0.005728874821215868
patients O 1 0.9992086291313171
with O 0 0.004086035303771496
isolated O 0 0.1139330342411995
unilateral B-Disease 1 0.9787499904632568
retinoblastoma I-Disease 1 0.9999662637710571
, O 0 0.0022767314221709967
we O 0 0.0012569304089993238
analyzed O 0 0.025127314031124115
DNA O 1 0.998005211353302
from O 0 0.004156261216849089
peripheral O 1 0.9999431371688843
blood O 1 0.999523401260376
and O 0 0.002357810502871871
from O 0 0.011061604134738445
tumor B-Disease 1 0.9999997615814209
tissue O 1 0.9999634027481079
. O 0 0.007543773390352726

The O 0 0.005811792332679033
analysis O 0 0.01356753334403038
of O 0 0.0034060629550367594
tumors B-Disease 1 0.9999946355819702
from O 0 0.005131041165441275
54 O 0 0.02651026099920273
( O 0 0.006195092108100653
71 O 0 0.030335167422890663
% O 0 0.0069521283730864525
) O 0 0.0026192101649940014
of O 0 0.0012341429246589541
76 O 0 0.03732260316610336
informative O 1 0.5562853813171387
patients O 1 0.9978852868080139
showed O 0 0.009986251592636108
loss O 0 0.020799370482563972
of O 0 0.00132696982473135
constitutional O 0 0.01695138029754162
heterozygosity O 1 0.9998785257339478
( O 0 0.014450297690927982
LOH O 1 0.999687671661377
) O 0 0.006830634083598852
at O 0 0.00636267801746726
intragenic O 1 0.9971886277198792
loci O 1 0.9983969330787659
. O 0 0.010630341246724129

Three O 0 0.003761289408430457
of O 0 0.00195501372218132
13 O 0 0.014720768667757511
uninformative O 1 0.9997205138206482
patients O 1 0.9986059069633484
had O 0 0.004355753306299448
constitutional O 0 0.013895091600716114
deletions O 1 0.9963284134864807
. O 0 0.008769217878580093

For O 0 0.004706962499767542
39 O 0 0.01600768230855465
randomly O 0 0.030019324272871017
selected O 0 0.015962395817041397
tumors B-Disease 1 0.9999920129776001
, O 0 0.0062890322878956795
SSCP O 1 0.9977754950523376
, O 0 0.007661566138267517
hetero O 1 0.9999352693557739
- O 0 0.17640933394432068
duplex O 1 0.9994756579399109
analysis O 0 0.02021058462560177
, O 0 0.002791270613670349
sequencing O 1 0.9982655644416809
, O 0 0.0017907385481521487
and O 0 0.0012533499393612146
Southern O 0 0.007112560328096151
blot O 1 0.9967142343521118
analysis O 0 0.013375809416174889
were O 0 0.0007756009581498802
used O 0 0.002359701320528984
to O 0 0.0024408407043665648
identify O 0 0.13015685975551605
mutations O 1 0.999971866607666
. O 0 0.007273753173649311

Mutations O 1 0.9994385838508606
were O 0 0.004716153256595135
detected O 1 0.5791166424751282
in O 0 0.002375437179580331
21 O 0 0.00930936262011528
( O 0 0.004994695540517569
91 O 0 0.035278815776109695
% O 0 0.005306156352162361
) O 0 0.002352914772927761
of O 0 0.0015050481306388974
23 O 0 0.02656595967710018
tumors B-Disease 1 0.9999979734420776
with O 0 0.013706104829907417
LOH O 1 0.9996451139450073
. O 0 0.011045397259294987

In O 0 0.0068250079639256
6 O 0 0.011158304288983345
( O 0 0.0043714940547943115
38 O 0 0.013680280186235905
% O 0 0.005293926689773798
) O 0 0.0020653032697737217
of O 0 0.0010189509484916925
16 O 0 0.022634092718362808
tumors B-Disease 1 0.9999990463256836
without O 0 0.014093782752752304
LOH O 1 0.9996838569641113
, O 0 0.002502764342352748
one O 0 0.00507585983723402
mutation O 1 0.9999953508377075
was O 0 0.004821290262043476
detected O 1 0.9656715393066406
, O 0 0.0013220410328358412
and O 0 0.0008197805727832019
in O 0 0.0017685637576505542
9 O 0 0.010074172168970108
( O 0 0.004550308454781771
56 O 0 0.014293128624558449
% O 0 0.005386879667639732
) O 0 0.0017504582647234201
of O 0 0.0008353673038072884
the O 0 0.00421652477234602
tumors B-Disease 1 0.9999988079071045
without O 0 0.01932368054986
LOH O 1 0.9997237324714661
, O 0 0.0025027820374816656
both O 0 0.003805913031101227
mutations O 1 0.9999779462814331
were O 0 0.0019208007724955678
found O 0 0.008563765324652195
. O 0 0.005360023584216833

Thus O 0 0.012769143097102642
, O 0 0.001434953766874969
a O 0 0.0028718793764710426
total O 0 0.0018884849268943071
of O 0 0.0010114964097738266
45 O 0 0.011341887526214123
mutations O 1 0.9999747276306152
were O 0 0.0012064833426848054
identified O 0 0.010373854078352451
in O 0 0.0033636875450611115
tumors B-Disease 1 0.9999973773956299
of O 0 0.003444468369707465
36 O 0 0.04701771214604378
patients O 1 0.9988969564437866
. O 0 0.007048761006444693

Thirty O 0 0.030227024108171463
- O 0 0.015036766417324543
nine O 0 0.003789008827880025
of O 0 0.0012725276174023747
the O 0 0.004448918160051107
mutations O 1 0.9999903440475464
- O 0 0.016796739771962166
including O 0 0.0024703615345060825
34 O 0 0.011011010967195034
small O 0 0.010760449804365635
mutations O 1 0.9999815225601196
, O 0 0.002117928583174944
2 O 0 0.005481234285980463
large O 0 0.004802561365067959
structural O 1 0.9582908749580383
alterations O 1 0.9627296328544617
, O 0 0.0016658667009323835
and O 0 0.0017357044853270054
hypermethylation O 1 0.9997580647468567
in O 0 0.003869640873745084
3 O 0 0.15256649255752563
tumors O 1 0.9999995231628418
- O 0 0.016305025666952133
were O 0 0.0009343387791886926
not O 0 0.0016622038092464209
detected O 1 0.5385714769363403
in O 0 0.001104501890949905
the O 0 0.0013829448726028204
corresponding O 0 0.10919078439474106
peripheral O 1 0.9999442100524902
blood O 1 0.9998928308486938
DNA O 1 0.998969554901123
. O 0 0.007957716472446918

In O 0 0.007116117514669895
6 O 0 0.012815451249480247
( O 0 0.004749142564833164
17 O 0 0.007811940740793943
% O 0 0.005265240091830492
) O 0 0.0016555237816646695
of O 0 0.000584326742682606
the O 0 0.001490886672399938
36 O 0 0.022608192637562752
patients O 1 0.9991605281829834
, O 0 0.0017559126717969775
a O 0 0.008862290531396866
mutation O 1 0.9999901056289673
was O 0 0.0035564883146435022
detected O 1 0.6453871726989746
in O 0 0.001546700019389391
constitutional O 0 0.01142729353159666
DNA O 1 0.9998236298561096
, O 0 0.0015138274757191539
and O 0 0.00067445746390149
1 O 0 0.0028723094146698713
of O 0 0.0007115592015907168
these O 0 0.0028589742723852396
mutations O 1 0.999996542930603
is O 0 0.002431753557175398
known O 0 0.003355729393661022
to O 0 0.0009450966026633978
be O 0 0.0011319956975057721
associated O 0 0.007842120714485645
with O 0 0.004174516070634127
reduced O 0 0.08814418315887451
expressivity O 1 0.9993643164634705
. O 0 0.009191748686134815

The O 0 0.0029144054278731346
presence O 0 0.006801196373999119
of O 0 0.0009142525959759951
a O 0 0.005081232637166977
constitutional O 0 0.016285480931401253
mutation O 1 0.9999922513961792
was O 0 0.0028363571036607027
not O 0 0.0013154410989955068
associated O 0 0.006654958240687847
with O 0 0.001661749673075974
an O 0 0.0015522718895226717
early O 0 0.004626339767128229
age O 0 0.006977615412324667
at O 0 0.005354804452508688
treatment O 1 0.9948071837425232
. O 0 0.006837379187345505

In O 0 0.005847883876413107
1 O 0 0.014887799508869648
patient O 1 0.9921565055847168
, O 0 0.006165067199617624
somatic O 1 0.9999206066131592
mosaicism O 1 0.9998531341552734
was O 0 0.003207386936992407
demonstrated O 0 0.008485688827931881
by O 0 0.0024033228401094675
molecular O 1 0.9979678988456726
analysis O 0 0.009529865346848965
of O 0 0.0013812062097713351
DNA O 1 0.9993444085121155
and O 0 0.003310902277007699
RNA O 1 0.9997661709785461
from O 0 0.00833568349480629
peripheral O 1 0.9999288320541382
blood O 1 0.9995691180229187
. O 0 0.007678529713302851

In O 0 0.005637461319565773
2 O 0 0.01838596537709236
patients O 1 0.9957139492034912
without O 0 0.004631872288882732
a O 0 0.007747654337435961
detectable O 1 0.9995191097259521
mutation O 1 0.9999867677688599
in O 0 0.005290951579809189
peripheral O 1 0.9999719858169556
blood O 1 0.9998608827590942
, O 0 0.004727552179247141
mosaicism O 1 0.9999653100967407
was O 0 0.0037633199244737625
suggested O 0 0.007641450501978397
because O 0 0.002483116229996085
1 O 0 0.0025627263821661472
of O 0 0.0007126829586923122
the O 0 0.003127689938992262
patients O 1 0.9998723268508911
showed O 1 0.5471820831298828
multifocal O 1 0.9999995231628418
tumors B-Disease 1 0.9999985694885254
and O 0 0.0015093064866960049
the O 0 0.001023499178700149
other O 0 0.0010810059029608965
later O 0 0.003791569033637643
developed O 0 0.030214577913284302
bilateral B-Disease 0 0.055222637951374054
retinoblastoma I-Disease 1 0.9999057054519653
. O 0 0.011461127549409866

In O 0 0.005083359312266111
conclusion O 0 0.009680332615971565
, O 0 0.0014514162903651595
our O 0 0.0022078845649957657
results O 0 0.008831813931465149
emphasize O 0 0.014423076994717121
that O 0 0.000924613734241575
the O 0 0.0013525066897273064
manifestation O 1 0.6569320559501648
and O 0 0.0023991374764591455
transmissibility O 1 0.9997571110725403
of O 0 0.004357629921287298
retinoblastoma B-Disease 1 0.999982476234436
depend O 0 0.007466068957000971
on O 0 0.0007587774307467043
the O 0 0.0007997611537575722
nature O 0 0.0028764186426997185
of O 0 0.0005572322988882661
the O 0 0.0011822405504062772
first O 0 0.005202105268836021
mutation O 1 0.9999980926513672
, O 0 0.0013647614978253841
its O 0 0.0013478767359629273
time O 0 0.0011950184125453234
in O 0 0.0011953935027122498
development O 0 0.004099872894585133
, O 0 0.00090849056141451
and O 0 0.0005536393728107214
the O 0 0.0006782704731449485
number O 0 0.0011289049871265888
and O 0 0.00074292893987149
types O 0 0.012189309112727642
of O 0 0.00196673721075058
cells O 1 0.9999444484710693
that O 0 0.0013342858292162418
are O 0 0.0011123291915282607
affected O 0 0.020523138344287872
. O 0 0.0030378089286386967
. O 0 0.0054030753672122955

Hereditary B-Disease 1 0.9998675584793091
deficiency I-Disease 1 0.999987006187439
of I-Disease 0 0.001616163644939661
the I-Disease 0 0.0015364133287221193
fifth I-Disease 0 0.009844179265201092
component I-Disease 0 0.025246039032936096
of I-Disease 0 0.0014679295709356666
complement I-Disease 0 0.4220665991306305
in O 0 0.0025318069383502007
man O 0 0.01322336308658123
. O 0 0.006940958555787802

I O 0 0.025960177183151245
. O 0 0.009285368025302887

Clinical O 1 0.9983956217765808
, O 0 0.0067959800362586975
immunochemical O 1 0.996307373046875
, O 0 0.0024683973751962185
and O 0 0.00181225233245641
family O 0 0.014551542699337006
studies O 0 0.020094428211450577
. O 0 0.007054921239614487

The O 0 0.002990420674905181
first O 0 0.002265429822728038
recognized O 0 0.007045093923807144
human O 0 0.011091066524386406
kindred O 1 0.9993588328361511
with O 0 0.009118578396737576
hereditary B-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.9999994039535522
of I-Disease 0 0.0009034140966832638
the I-Disease 0 0.0008913415367715061
fifth I-Disease 0 0.007970579899847507
component I-Disease 0 0.023888597264885902
of I-Disease 0 0.0016753702657297254
complement I-Disease 1 0.9213070869445801
( O 0 0.008365385234355927
C5 O 1 0.9999614953994751
) O 0 0.0043486845679581165
is O 0 0.002543297130614519
described O 0 0.011434567160904408
. O 0 0.006308102980256081

The O 0 0.007158496417105198
proband O 1 0.9609695672988892
, O 0 0.002677647164091468
a O 0 0.007540603633970022
20 O 0 0.009292169474065304
- O 0 0.017703142017126083
year O 0 0.005258108023554087
- O 0 0.016054708510637283
old O 0 0.011199427768588066
black O 0 0.01773275062441826
female O 0 0.0784749761223793
with O 0 0.2844236195087433
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 0.9999997615814209
since O 0 0.008035236969590187
age O 0 0.005862595047801733
11 O 0 0.005748509895056486
, O 0 0.002117054769769311
lacked O 0 0.3097800016403198
serum O 1 0.9999804496765137
hemolytic O 1 0.9999995231628418
complement O 1 0.7860791683197021
activity O 0 0.014592010527849197
, O 0 0.001768176443874836
even O 0 0.0039655836299061775
during O 0 0.009844152256846428
remission O 1 0.9999231100082397
. O 0 0.008625141344964504

C5 O 1 0.9950640797615051
was O 0 0.012887898832559586
undetectable O 1 0.9936425685882568
in O 0 0.003134405240416527
her O 0 0.012398899532854557
serum O 1 0.9996229410171509
by O 0 0.0035678904969245195
both O 0 0.004320284351706505
immunodiffusion O 1 0.9976767897605896
and O 0 0.010832499712705612
hemolytic O 1 0.9999990463256836
assays O 1 0.988375186920166
. O 0 0.010635854676365852

Other O 0 0.003969918005168438
complement O 0 0.04227357357740402
components O 0 0.01317626517266035
were O 0 0.0011399025097489357
normal O 0 0.02107246220111847
during O 0 0.00897863321006298
remission O 1 0.9999686479568481
of O 0 0.008345721289515495
lupus O 1 0.9999998807907104
, O 0 0.0038986504077911377
but O 0 0.004097742959856987
C1 O 1 0.9999343156814575
, O 0 0.005826264154165983
C4 O 1 0.9998676776885986
, O 0 0.007025912869721651
C2 O 1 0.9999251365661621
, O 0 0.003237116849049926
and O 0 0.0032622371800243855
C3 O 1 0.9998623132705688
levels O 0 0.024589039385318756
fell O 0 0.018270418047904968
during O 0 0.01163778081536293
exacerbations O 1 0.9998769760131836
. O 0 0.01100577786564827

A O 0 0.031166700646281242
younger O 0 0.03720724955201149
half O 0 0.011566161178052425
- O 0 0.04096243157982826
sister O 0 0.04567708820104599
, O 0 0.0014414507895708084
who O 0 0.001166225760243833
had O 0 0.001674200058914721
no O 0 0.004732785280793905
underlying O 1 0.9997889399528503
disease O 1 0.9999990463256836
, O 0 0.0016418166924268007
was O 0 0.0013471118872985244
also O 0 0.0009349082829430699
found O 0 0.0034447922371327877
to O 0 0.0014972122153267264
lack O 0 0.019935835152864456
immunochemically O 1 0.9985393285751343
detectable O 1 0.9988808035850525
C5 O 1 0.9991714954376221
. O 0 0.00975267868489027

By O 0 0.03523318096995354
hemolytic O 1 0.9999991655349731
assay O 1 0.9970439076423645
, O 0 0.0029990985058248043
she O 0 0.00260716094635427
exhibited O 0 0.012882011011242867
1 O 0 0.011712410487234592
- O 0 0.015946462750434875
2 O 0 0.006256609223783016
% O 0 0.0025215824134647846
of O 0 0.0006534928688779473
the O 0 0.0017243416514247656
normal O 0 0.4877961277961731
serum O 1 0.9999209642410278
C5 O 1 0.9997090697288513
level O 0 0.0076373545452952385
and O 0 0.001396508770994842
normal O 0 0.022109000012278557
concentrations O 0 0.05986364930868149
of O 0 0.000985229853540659
other O 0 0.0016905440716072917
complement O 0 0.28934967517852783
components O 0 0.028083112090826035
. O 0 0.005331004504114389

C5 O 1 0.998190701007843
levels O 0 0.0176988635212183
of O 0 0.0009813111973926425
other O 0 0.001277647796086967
family O 0 0.006022111512720585
members O 0 0.0014254167908802629
were O 0 0.0007146621937863529
either O 0 0.005677351262420416
normal O 0 0.023417916148900986
or O 0 0.0026147370226681232
approximately O 0 0.0037881231401115656
half O 0 0.006872087717056274
- O 0 0.020462211221456528
normal O 0 0.02514166757464409
, O 0 0.0018262923695147038
consistent O 0 0.011968341656029224
with O 0 0.008321127854287624
autosomal O 1 0.9999994039535522
codominant O 1 0.9979034662246704
inheritance O 1 0.6107112169265747
of O 0 0.0011544241569936275
the O 0 0.003800809383392334
gene O 1 0.9999570846557617
determining O 1 0.9515406489372253
C5 B-Disease 1 0.999994158744812
deficiency I-Disease 1 0.9999984502792358
. O 0 0.015226970426738262

Normal O 1 0.980440080165863
hemolytic O 1 0.9999977350234985
titers O 1 0.9920401573181152
were O 0 0.0019714601803570986
restored O 0 0.008654930628836155
to O 0 0.001241925172507763
both O 0 0.004554200451821089
homozygous O 1 0.9999759197235107
C5 B-Disease 1 0.9999821186065674
- I-Disease 1 0.8105993866920471
deficient I-Disease 1 0.9998887777328491
( O 0 0.01594484969973564
C5D B-Disease 1 0.9997181296348572
) O 0 0.007052927277982235
sera O 0 0.15635667741298676
by O 0 0.0018423820147290826
addition O 0 0.002465616213157773
of O 0 0.0008705370128154755
highly O 0 0.012980847619473934
purified O 1 0.9939026832580566
human O 0 0.037650831043720245
C5 O 1 0.999797523021698
. O 0 0.010829557664692402

In O 0 0.005504656583070755
specific O 0 0.023827452212572098
C5 O 1 0.9999368190765381
titrations O 1 0.9998815059661865
, O 0 0.003601662116125226
however O 0 0.00221004756167531
, O 0 0.000866277317982167
it O 0 0.0008838160429149866
was O 0 0.0013488528784364462
noted O 0 0.002237947890534997
that O 0 0.0010485452366992831
when O 0 0.0018788761226460338
limited O 0 0.003357554553076625
amounts O 0 0.0069794366136193275
of O 0 0.0019148780265823007
C5 O 1 0.9996954202651978
were O 0 0.0019256611121818423
assayed O 1 0.809366762638092
in O 0 0.0013241071719676256
the O 0 0.0010359234875068069
presence O 0 0.00619179243221879
of O 0 0.0012717037461698055
low O 0 0.020700862631201744
dilutions O 1 0.9981837868690491
of O 0 0.0021618157625198364
either O 0 0.01404988206923008
C5D B-Disease 1 0.9998021721839905
serum O 1 0.9996175765991211
, O 0 0.003869254607707262
curving O 0 0.12943224608898163
rather O 0 0.004285712726414204
than O 0 0.0026011283043771982
linear O 1 0.9971523284912109
dose O 1 0.9998778104782104
- O 0 0.02539040520787239
response O 0 0.013780594803392887
plots O 0 0.017931345850229263
were O 0 0.0009909457294270396
consistently O 0 0.005186263006180525
obtained O 0 0.005942159332334995
, O 0 0.0013969963183626533
suggesting O 0 0.01601683348417282
some O 0 0.00338944373652339
inhibitory O 1 0.998036801815033
effect O 0 0.02679060772061348
. O 0 0.006070497911423445

Further O 0 0.013606056571006775
studies O 0 0.01186426728963852
suggested O 0 0.00611912040039897
that O 0 0.0019265887094661593
low O 0 0.019293662160634995
dilutions O 1 0.9946548938751221
of O 0 0.004714098293334246
C5D B-Disease 1 0.9994789958000183
serum O 1 0.9992398023605347
contain O 0 0.02018614485859871
a O 0 0.009034846909344196
factor O 0 0.27193668484687805
( O 0 0.004283708520233631
or O 0 0.004639714024960995
factors O 0 0.027589067816734314
) O 0 0.003285378683358431
interfering O 0 0.04003295302391052
at O 0 0.0017330922419205308
some O 0 0.0009608393302187324
step O 0 0.007518835831433535
in O 0 0.0015827518654987216
the O 0 0.004998566582798958
hemolytic O 1 0.9999996423721313
assay O 1 0.9939649701118469
of O 0 0.004625167232006788
C5 O 1 0.9998886585235596
, O 0 0.0020895495545119047
rather O 0 0.0023262922186404467
than O 0 0.0011341511271893978
a O 0 0.005810469854623079
true O 0 0.021753594279289246
C5 O 1 0.9999724626541138
inhibitor O 1 0.9998970031738281
or O 0 0.014132088981568813
inactivator O 1 0.9756626486778259
. O 0 0.007810690905898809

Of O 0 0.006503681186586618
clinical O 1 0.9970420002937317
interest O 0 0.003660880960524082
are O 0 0.0009427632903680205
( O 0 0.003181884530931711
a O 0 0.004900615196675062
) O 0 0.002003710949793458
the O 0 0.001105360221117735
documentation O 0 0.009592861868441105
of O 0 0.002783294301480055
membranous O 1 0.9999884366989136
glomerulonephritis B-Disease 1 0.9999945163726807
, O 0 0.011708791367709637
vasculitis B-Disease 1 0.9999982118606567
, O 0 0.004253201652318239
and O 0 0.005830500274896622
arthritis B-Disease 1 0.9999997615814209
in O 0 0.002026111353188753
an O 0 0.0017983339494094253
individual O 0 0.007935925386846066
lacking O 1 0.9395084381103516
C5 O 1 0.9999479055404663
( O 0 0.0029188706539571285
and O 0 0.0009413312072865665
its O 0 0.004075038246810436
biologic O 1 0.9999517202377319
functions O 0 0.018693191930651665
) O 0 0.0031451627146452665
, O 0 0.0012366380542516708
and O 0 0.0013695472152903676
( O 0 0.004866149742156267
b O 1 0.9454711079597473
) O 0 0.001999123953282833
a O 0 0.0033870525658130646
remarkable O 0 0.01204760279506445
propensity O 1 0.9971206188201904
to O 0 0.009151673875749111
bacterial B-Disease 1 1.0
infections I-Disease 1 0.9999988079071045
in O 0 0.0022119723726063967
the O 0 0.0029412696603685617
proband O 1 0.9976111650466919
, O 0 0.0023001290392130613
even O 0 0.002203487092629075
during O 0 0.0027696508914232254
periods O 0 0.006286543793976307
of O 0 0.001609350205399096
low O 0 0.04378291592001915
- O 0 0.06376934796571732
dose O 1 0.9974888563156128
or O 0 0.006665087770670652
alternate O 0 0.024768991395831108
- O 0 0.024333884939551353
day O 0 0.013283628039062023
corticosteroid O 1 0.9999502897262573
therapy O 1 0.9995742440223694
. O 0 0.008638327941298485

Other O 0 0.0030355683993548155
observations O 0 0.008770613931119442
indicate O 0 0.008561446331441402
that O 0 0.00117770629003644
the O 0 0.0019212086917832494
C5D B-Disease 1 0.9988833069801331
state O 0 0.0021806485019624233
is O 0 0.001790708745829761
compatible O 0 0.11987288296222687
with O 0 0.0036995504051446915
normal O 1 0.8868278861045837
coagulation O 1 0.9999973773956299
function O 0 0.0405363030731678
and O 0 0.0007582652033306658
the O 0 0.0008131445501931012
capacity O 0 0.0027616405859589577
to O 0 0.0012201680801808834
mount O 0 0.009718773886561394
a O 0 0.016844093799591064
neutrophilic O 1 0.9999649524688721
leukocytosis O 1 0.9996111989021301
during O 0 0.03630738705396652
pyogenic B-Disease 1 0.9999860525131226
infection I-Disease 1 0.999995231628418
. O 0 0.005179550964385271
. O 0 0.006440189201384783

Susceptibility O 1 0.9994410872459412
to O 0 0.026345614343881607
ankylosing B-Disease 1 0.9999958276748657
spondylitis I-Disease 1 0.9999940395355225
in O 0 0.007571957539767027
twins O 1 0.9809158444404602
: O 0 0.0026572211645543575
the O 0 0.0010385004570707679
role O 0 0.004858381114900112
of O 0 0.0019082832150161266
genes O 1 0.9999840259552002
, O 0 0.0060526835732162
HLA O 1 0.9999940395355225
, O 0 0.002078211633488536
and O 0 0.0008787944098003209
the O 0 0.0017624249448999763
environment O 0 0.010979732498526573
. O 0 0.0052030752412974834

OBJECTIVE O 0 0.02167712338268757
To O 0 0.0015587408561259508
determine O 0 0.004583096131682396
the O 0 0.0010310802608728409
relative O 0 0.01105051301419735
effects O 0 0.0688328668475151
of O 0 0.0017273648409172893
genetic O 1 0.9999678134918213
and O 0 0.001521583879366517
environmental O 0 0.008555426262319088
factors O 0 0.018893608823418617
in O 0 0.004459101241081953
susceptibility O 1 0.9999892711639404
to O 0 0.017999209463596344
ankylosing B-Disease 1 0.9999996423721313
spondylitis I-Disease 1 0.9999985694885254
( O 0 0.010954150930047035
AS B-Disease 0 0.007424274459481239
) O 0 0.0058884164318442345
. O 0 0.005310320761054754

METHODS O 0 0.06854894012212753
Twins O 1 0.9749370813369751
with O 0 0.0028067398816347122
AS B-Disease 0 0.0023857017513364553
were O 0 0.0006207874976098537
identified O 0 0.005842629820108414
from O 0 0.001186614972539246
the O 0 0.0011996665270999074
Royal O 0 0.010655687190592289
National O 0 0.008322560228407383
Hospital O 1 0.9991581439971924
for O 0 0.02046142891049385
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999961853027344
database O 1 0.5323789715766907
. O 0 0.007321877870708704

Clinical O 1 0.9968616962432861
and O 0 0.004095848184078932
radiographic O 1 0.9992555975914001
examinations O 0 0.03731932491064072
were O 0 0.0007371728424914181
performed O 0 0.004558449611067772
to O 0 0.0016069143312051892
establish O 0 0.03288397938013077
diagnoses O 1 0.9999709129333496
, O 0 0.0035894010215997696
and O 0 0.005914735142141581
disease O 1 0.9999991655349731
severity O 1 0.998805046081543
was O 0 0.0033111602533608675
assessed O 0 0.012782735750079155
using O 0 0.004910969641059637
a O 0 0.006014606915414333
combination O 0 0.04563353955745697
of O 0 0.0015113221015781164
validated O 0 0.12127850949764252
scoring O 0 0.014933948405086994
systems O 0 0.0372391901910305
. O 0 0.005989543627947569

HLA O 1 0.9995726943016052
typing O 1 0.9729617834091187
for O 0 0.014372759498655796
HLA O 1 0.9999479055404663
- O 0 0.06957447528839111
B27 O 1 0.9938894510269165
, O 0 0.01098975632339716
HLA O 1 0.999984860420227
- O 0 0.059875648468732834
B60 O 1 0.9864819049835205
, O 0 0.003679599380120635
and O 0 0.005333669949322939
HLA O 1 0.9999948740005493
- O 0 0.17904463410377502
DR1 O 1 0.99935382604599
was O 0 0.004661296494305134
performed O 0 0.008853921666741371
by O 0 0.004900808446109295
polymerase O 1 0.9991382360458374
chain O 1 0.6491718888282776
reaction O 0 0.027208393439650536
with O 0 0.0029669615905731916
sequence O 1 0.8013480305671692
- O 0 0.016460847109556198
specific O 0 0.01155238039791584
primers O 1 0.9980382323265076
, O 0 0.0020289712119847536
and O 0 0.0016618232475593686
zygosity O 1 0.993062436580658
was O 0 0.003327353158965707
assessed O 0 0.01877070777118206
using O 0 0.018885089084506035
microsatellite O 1 0.9987633228302002
markers O 1 0.6786458492279053
. O 0 0.007698116824030876

Genetic O 1 0.9991624355316162
and O 0 0.002847441704943776
environmental O 0 0.012064504437148571
variance O 0 0.08667387813329697
components O 0 0.01316908560693264
were O 0 0.0008150804787874222
assessed O 0 0.01043888833373785
with O 0 0.0015182087663561106
the O 0 0.0016582931857556105
program O 0 0.0216086246073246
Mx O 1 0.9995892643928528
, O 0 0.0017530908808112144
using O 0 0.004297715146094561
data O 0 0.004087182693183422
from O 0 0.0012845932506024837
this O 0 0.0008639181032776833
and O 0 0.0008014930062927306
previous O 0 0.004024881403893232
studies O 0 0.008674698881804943
of O 0 0.001508440705947578
twins O 1 0.997042715549469
with O 0 0.0032530585303902626
AS B-Disease 0 0.006063591223210096
. O 0 0.006698896177113056

RESULTS O 0 0.027980156242847443
Six O 0 0.004624552559107542
of O 0 0.0020223469473421574
8 O 0 0.018503647297620773
monozygotic O 1 0.9998677968978882
( O 0 0.01622127555310726
MZ O 1 0.9999542236328125
) O 0 0.00969665590673685
twin O 1 0.6646203994750977
pairs O 0 0.23778781294822693
were O 0 0.004103145562112331
disease O 1 0.9999939203262329
concordant O 1 0.9990806579589844
, O 0 0.0027699603233486414
compared O 0 0.007115860935300589
with O 0 0.0023255818523466587
4 O 0 0.005491826217621565
of O 0 0.0011215220438316464
15 O 0 0.00861393939703703
B27 O 1 0.9970472455024719
- O 0 0.021134136244654655
positive O 0 0.03569438308477402
dizygotic O 1 0.9997425675392151
( O 0 0.011660668067634106
DZ O 1 0.9998924732208252
) O 0 0.00767603050917387
twin O 1 0.8977963924407959
pairs O 0 0.4573223292827606
( O 0 0.004453139845281839
27 O 0 0.009830180555582047
% O 0 0.006848709192126989
) O 0 0.0027854565996676683
and O 0 0.0008427968714386225
4 O 0 0.004371315240859985
of O 0 0.001294408692047
32 O 0 0.023743633180856705
DZ O 1 0.9998472929000854
twin O 1 0.9086411595344543
pairs O 0 0.22011008858680725
overall O 0 0.01560953352600336
( O 0 0.00415663281455636
12 O 0 0.0054862843826413155
. O 0 0.0019077301258221269
5 O 0 0.008026468567550182
% O 0 0.007136559579521418
) O 0 0.004898786079138517
. O 0 0.0043791173957288265

Nonsignificant O 1 0.9745401740074158
increases O 0 0.03291497379541397
in O 0 0.0023685134947299957
similarity O 0 0.14963853359222412
with O 0 0.001941401045769453
regard O 0 0.003590061329305172
to O 0 0.0011015052441507578
age O 0 0.008006060495972633
at O 0 0.018475551158189774
disease O 1 0.9999996423721313
onset O 1 0.9999761581420898
and O 0 0.0010109078139066696
all O 0 0.0006547021912410855
of O 0 0.001086742733605206
the O 0 0.006438075099140406
disease O 1 0.9999991655349731
severity O 1 0.99895179271698
scores O 0 0.017292242497205734
assessed O 0 0.013095708563923836
were O 0 0.000823275069706142
noted O 0 0.00395223731175065
in O 0 0.006972482893615961
disease O 1 0.9999973773956299
- O 1 0.7947384119033813
concordant O 1 0.9996788501739502
MZ O 1 0.9999474287033081
twins O 1 0.9751646518707275
compared O 0 0.01454645674675703
with O 0 0.007418419234454632
concordant O 1 0.9994762539863586
DZ O 1 0.999852180480957
twins O 1 0.9791248440742493
. O 0 0.009936535730957985

HLA O 1 0.9998699426651001
- O 0 0.07296475768089294
B27 O 1 0.9599775075912476
and O 0 0.0032127394806593657
B60 O 1 0.9071189761161804
were O 0 0.0012963555054739118
associated O 0 0.005915441550314426
with O 0 0.0022611271124333143
the O 0 0.004678602330386639
disease O 1 0.9999983310699463
in O 0 0.003519813995808363
probands O 1 0.9996832609176636
, O 0 0.001233681570738554
and O 0 0.0006261132075451314
the O 0 0.0009943789336830378
rate O 0 0.009260178543627262
of O 0 0.003622616408392787
disease O 1 0.9999963045120239
concordance O 1 0.9970169067382812
was O 0 0.003060649847611785
significantly O 0 0.018460916355252266
increased O 0 0.007634388282895088
among O 0 0.005436871200799942
DZ O 1 0.9999641180038452
twin O 1 0.989402174949646
pairs O 0 0.15241888165473938
in O 0 0.001179241924546659
which O 0 0.0010670592309907079
the O 0 0.002345849061384797
co O 1 0.9092143774032593
- O 0 0.024454869329929352
twin O 1 0.8850767612457275
was O 0 0.002442586235702038
positive O 0 0.010129474103450775
for O 0 0.0015195307787507772
both O 0 0.0031038830056786537
B27 O 1 0.9937830567359924
and O 0 0.006265397183597088
DR1 O 1 0.9987697005271912
. O 0 0.013372979126870632

Additive O 1 0.9959219694137573
genetic O 1 0.9993748068809509
effects O 0 0.05300033837556839
were O 0 0.0010454809525981545
estimated O 0 0.003349343780428171
to O 0 0.0013574807671830058
contribute O 0 0.016917401924729347
97 O 0 0.01960672438144684
% O 0 0.0035551416222006083
of O 0 0.0006960522150620818
the O 0 0.0012351031182333827
population O 0 0.004218419082462788
variance O 0 0.2256198674440384
. O 0 0.00568736856803298

CONCLUSION O 0 0.0779537707567215
Susceptibility O 1 0.9995038509368896
to O 0 0.0018300460651516914
AS B-Disease 0 0.002974124625325203
is O 0 0.0017154865199699998
largely O 0 0.004744323901832104
genetically O 1 0.9988248944282532
determined O 0 0.009148803539574146
, O 0 0.0008856347994878888
and O 0 0.0005668532685376704
the O 0 0.001121054170653224
environmental O 0 0.011665241792798042
trigger O 1 0.993297278881073
for O 0 0.0024150407407432795
the O 0 0.004529474303126335
disease O 1 0.9999960660934448
is O 0 0.0033725404646247625
probably O 0 0.010035200044512749
ubiquitous O 1 0.806107223033905
. O 0 0.008224071003496647

HLA O 1 0.9999063014984131
- O 0 0.07901699095964432
B27 O 1 0.8913269639015198
accounts O 0 0.0073126815259456635
for O 0 0.0015059929573908448
a O 0 0.0037949259858578444
minority O 0 0.006882371846586466
of O 0 0.0007196454680524766
the O 0 0.0015952445100992918
overall O 0 0.11282157152891159
genetic O 1 0.99998939037323
susceptibility O 1 0.9999438524246216
to O 0 0.002301796106621623
AS B-Disease 0 0.006056353449821472
. O 0 0.005909749306738377

Cell O 1 0.9983474016189575
cycle O 1 0.7973026633262634
- O 0 0.02596857212483883
dependent O 0 0.0310035590082407
colocalization O 0 0.37157922983169556
of O 0 0.002932544331997633
BARD1 O 1 0.9965299963951111
and O 0 0.008137861266732216
BRCA1 O 1 0.9999971389770508
proteins O 1 0.9923644065856934
in O 0 0.003509179688990116
discrete O 0 0.2513682544231415
nuclear O 0 0.029030118137598038
domains O 0 0.11929171532392502
. O 0 0.006661470979452133

Germ O 1 0.9984651803970337
- O 0 0.038784127682447433
line O 0 0.01637512445449829
mutations O 1 0.9997914433479309
of O 0 0.0017477183137089014
the O 0 0.005307802464812994
BRCA1 O 1 0.9999998807907104
gene O 1 0.9999771118164062
predispose O 1 0.999640703201294
women O 0 0.003984829876571894
to O 0 0.0016460305778309703
early O 0 0.012714614160358906
- O 1 0.9966338276863098
onset O 1 0.9999985694885254
breast B-Disease 1 0.9999992847442627
and I-Disease 0 0.2900274991989136
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
by O 0 0.00411380548030138
compromising O 0 0.14103735983371735
the O 0 0.0029906881973147392
genes O 1 0.9998511075973511
presumptive O 1 0.9985557198524475
function O 0 0.027309447526931763
as O 0 0.0026118929963558912
a O 0 0.03959508240222931
tumor B-Disease 1 0.9999980926513672
suppressor O 1 0.9999351501464844
. O 0 0.011394716799259186

Although O 0 0.005315759219229221
the O 0 0.0028694181237369776
biochemical O 1 0.9975202679634094
properties O 0 0.015578475780785084
of O 0 0.0039398823864758015
BRCA1 O 1 0.9999994039535522
polypeptides O 1 0.9983265995979309
are O 0 0.001299589523114264
not O 0 0.0013222440611571074
understood O 0 0.0098693473264575
, O 0 0.0008995265234261751
their O 0 0.0017468150472268462
expression O 0 0.04782305657863617
pattern O 0 0.05384204164147377
and O 0 0.002163409721106291
subcellular O 1 0.9960373640060425
localization O 1 0.9239106774330139
suggest O 0 0.008855369873344898
a O 0 0.004251331556588411
role O 0 0.00676644267514348
in O 0 0.0041872793808579445
cell O 1 0.9997923970222473
- O 0 0.04473821818828583
cycle O 1 0.8362208604812622
regulation O 0 0.07345767319202423
. O 0 0.007499293889850378

When O 0 0.014040101319551468
resting O 1 0.8891989588737488
cells O 1 0.999377429485321
are O 0 0.0025643627159297466
induced O 1 0.9996650218963623
to O 0 0.0034023874904960394
proliferate O 1 0.9951199293136597
, O 0 0.001372082973830402
the O 0 0.0014686495997011662
steady O 0 0.027805224061012268
- O 0 0.010053972713649273
state O 0 0.001986562740057707
levels O 0 0.009741153568029404
of O 0 0.004178278148174286
BRCA1 O 1 0.999998927116394
increase O 0 0.010967575944960117
in O 0 0.0021399331744760275
late O 0 0.009515014477074146
G1 O 1 0.9999003410339355
and O 0 0.0018564146012067795
reach O 0 0.004279948305338621
a O 0 0.003547229804098606
maximum O 0 0.0068939458578825
during O 0 0.005861004814505577
S O 1 0.8457673192024231
phase O 0 0.06186642497777939
. O 0 0.007384005468338728

Moreover O 0 0.02631111815571785
, O 0 0.0017018100479617715
in O 0 0.0021248196717351675
S O 1 0.8870493769645691
phase O 1 0.7474426627159119
cells O 1 0.9996501207351685
, O 0 0.007232386618852615
BRCA1 O 1 0.9999978542327881
polypeptides O 1 0.99347984790802
are O 0 0.0027427945751696825
hyperphosphorylated O 1 0.9554866552352905
and O 0 0.0028195087797939777
accumulate O 1 0.5666351318359375
into O 0 0.006378727499395609
discrete O 0 0.4408233165740967
subnuclear O 1 0.9922269582748413
foci O 1 0.9964696168899536
termed O 0 0.27959638833999634
" O 0 0.014368964359164238
BRCA1 O 1 0.9999921321868896
nuclear O 0 0.047020114958286285
dots O 1 0.9520748853683472
. O 0 0.007746735122054815

" O 0 0.037990279495716095
BRCA1 O 1 0.9999926090240479
associates O 0 0.1467629075050354
in O 0 0.003460422856733203
vivo O 1 0.9984990358352661
with O 0 0.00329484511166811
a O 0 0.009217867627739906
structurally O 1 0.9857630729675293
related O 0 0.03495568782091141
protein O 1 0.9992244243621826
termed O 1 0.5786402225494385
BARD1 O 1 0.9899975061416626
. O 0 0.009723776951432228

Here O 0 0.004396840464323759
we O 0 0.0013250134652480483
show O 0 0.0023387735709547997
that O 0 0.0008697303710505366
the O 0 0.0016712546348571777
steady O 0 0.03690576180815697
- O 0 0.012862548232078552
state O 0 0.0020787029061466455
levels O 0 0.008798349648714066
of O 0 0.001942236558534205
BARD1 O 1 0.9994889497756958
, O 0 0.0018323611002415419
unlike O 0 0.007438389118760824
those O 0 0.001023564487695694
of O 0 0.0029572530183941126
BRCA1 O 1 0.9999998807907104
, O 0 0.002491811290383339
remain O 0 0.003188684117048979
relatively O 0 0.007136261556297541
constant O 0 0.01467649545520544
during O 0 0.0067051490768790245
cell O 1 0.9996857643127441
cycle O 1 0.9924240112304688
progression O 1 0.9996910095214844
. O 0 0.00744209997355938

However O 0 0.009376060217618942
, O 0 0.003456748090684414
immunostaining O 1 0.9690629243850708
revealed O 0 0.016855958849191666
that O 0 0.0027994129341095686
BARD1 O 1 0.9962538480758667
resides O 0 0.023147357627749443
within O 0 0.008735992945730686
BRCA1 O 1 0.9999970197677612
nuclear O 0 0.034773655235767365
dots O 1 0.8462610244750977
during O 0 0.006023735739290714
S O 0 0.22580288350582123
phase O 0 0.018293997272849083
of O 0 0.0010056166211143136
the O 0 0.002851783996447921
cell O 1 0.9999408721923828
cycle O 1 0.9685227274894714
, O 0 0.0016941814683377743
but O 0 0.0010168144945055246
not O 0 0.0007905244710855186
during O 0 0.0022911415435373783
the O 0 0.004061339423060417
G1 O 1 0.9999309778213501
phase O 0 0.12426694482564926
. O 0 0.00831631664186716

Nevertheless O 0 0.023672495037317276
, O 0 0.005346809979528189
BARD1 O 1 0.994371235370636
polypeptides O 1 0.9903475046157837
are O 0 0.0011851262534037232
found O 0 0.0035579856485128403
exclusively O 0 0.0037266709841787815
in O 0 0.0007515991455875337
the O 0 0.0011716567678377032
nuclear O 0 0.010731830261647701
fractions O 0 0.027645474299788475
of O 0 0.001227214583195746
both O 0 0.004851663019508123
G1 O 1 0.9999910593032837
- O 0 0.027391182258725166
and O 0 0.004156348295509815
S O 1 0.9755699634552002
- O 0 0.052370864897966385
phase O 1 0.7512667775154114
cells O 1 0.9973032474517822
. O 0 0.008528687991201878

Therefore O 0 0.012857578694820404
, O 0 0.0037227903958410025
progression O 1 0.9994773268699646
to O 0 0.0033082596492022276
S O 1 0.9665529727935791
phase O 0 0.058687325567007065
is O 0 0.0017813583835959435
accompanied O 0 0.005569156724959612
by O 0 0.001541788107715547
the O 0 0.001850993256084621
aggregation O 1 0.976498544216156
of O 0 0.001477933838032186
nuclear O 0 0.016578463837504387
BARD1 O 1 0.9933352470397949
polypeptides O 1 0.9841039180755615
into O 0 0.017316527664661407
BRCA1 O 1 0.9999929666519165
nuclear O 0 0.046844784170389175
dots O 1 0.9310511350631714
. O 0 0.007120780646800995

This O 0 0.00902086403220892
cell O 1 0.9967553019523621
cycle O 1 0.8977097868919373
- O 0 0.023777134716510773
dependent O 0 0.028548236936330795
colocalization O 1 0.821288526058197
of O 0 0.0038083200342953205
BARD1 O 1 0.996868908405304
and O 0 0.008129768073558807
BRCA1 O 1 0.9999982118606567
indicates O 0 0.029810210689902306
a O 0 0.005283100064843893
role O 0 0.006437416188418865
for O 0 0.0028000413440167904
BARD1 O 1 0.9967928528785706
in O 0 0.011491903103888035
BRCA1 O 1 0.9999996423721313
- O 1 0.9615783095359802
mediated O 1 0.9997795224189758
tumor B-Disease 1 0.9999865293502808
suppression O 1 0.7415950298309326
. O 0 0.011115171015262604

Ethnic O 0 0.012085163034498692
differences O 0 0.010299969464540482
in O 0 0.0018096346175298095
the O 0 0.004312213510274887
HFE O 1 0.9996569156646729
codon O 1 0.9918666481971741
282 O 1 0.7843846678733826
( O 0 0.02079017646610737
Cys O 1 0.9998279809951782
/ O 1 0.9847518801689148
Tyr O 1 0.9984571933746338
) O 0 0.016777120530605316
polymorphism O 1 0.991449773311615
. O 0 0.009488545358181

Recent O 0 0.01622621715068817
studies O 0 0.009828640148043633
have O 0 0.0012965857749804854
shown O 0 0.006374110467731953
that O 0 0.0055945394560694695
hereditary B-Disease 1 0.9999984502792358
hemochromatosis I-Disease 1 0.9999998807907104
( O 0 0.02952817641198635
HH B-Disease 1 0.9999885559082031
) O 0 0.004970408044755459
is O 0 0.001528052962385118
likely O 0 0.0036426123697310686
to O 0 0.0008449337328784168
be O 0 0.0012808862375095487
caused O 0 0.05511591210961342
by O 0 0.003766097128391266
homozygosity O 1 0.9810466170310974
for O 0 0.0022203337866812944
a O 0 0.008172617293894291
Cys282Tyr O 1 0.9990697503089905
mutation O 1 0.9999649524688721
in O 0 0.0024366758298128843
the O 0 0.004645815119147301
HFE O 1 0.9999865293502808
gene O 1 0.9997321963310242
located O 0 0.008780569769442081
4 O 0 0.012944466434419155
. O 0 0.0076913293451070786

5 O 0 0.03513488918542862
Mb O 1 0.9936720132827759
telomeric O 1 0.9953064322471619
to O 0 0.011727527715265751
HLA O 1 0.9999657869338989
- O 0 0.036040712147951126
A O 0 0.021696316078305244
. O 0 0.007932382635772228

Population O 0 0.0068445648066699505
studies O 0 0.006932099349796772
of O 0 0.0007433344726450741
this O 0 0.001805588137358427
polymorphism O 1 0.9994332194328308
are O 0 0.0016688758041709661
facilitated O 0 0.15253183245658875
by O 0 0.0011497280793264508
the O 0 0.0007303146412596107
fact O 0 0.0017563357250764966
that O 0 0.0008846290875226259
the O 0 0.002277202671393752
Cys282Tyr O 1 0.9996461868286133
mutation O 1 0.9999808073043823
creates O 0 0.04253210499882698
a O 0 0.010873135179281235
Rsal O 1 0.9771206378936768
restriction O 0 0.04082368686795235
site O 0 0.010905222967267036
. O 0 0.005928494967520237

We O 0 0.002680488396435976
have O 0 0.0011344538070261478
studied O 0 0.004274888429790735
the O 0 0.0024414185900241137
codon O 1 0.9945871829986572
282 O 1 0.8576729893684387
( O 0 0.015425361692905426
Cys O 1 0.9998748302459717
/ O 1 0.9933567643165588
Tyr O 1 0.9993510842323303
) O 0 0.0092744966968894
polymorphism O 1 0.9960886240005493
in O 0 0.0020269607193768024
different O 0 0.0022125786636024714
ethnic O 0 0.006027711555361748
groups O 0 0.005876439623534679
. O 0 0.005101996473968029

In O 0 0.004358393140137196
agreement O 0 0.005496213678270578
with O 0 0.0022760340943932533
previous O 0 0.00403235899284482
observations O 0 0.010294245555996895
the O 0 0.0037759316619485617
Tyr O 1 0.9999085664749146
allele O 1 0.999817430973053
appeared O 0 0.006640993058681488
to O 0 0.0011005642591044307
be O 0 0.0012516748392954469
rare O 0 0.017511285841464996
or O 0 0.003593653906136751
absent O 0 0.02573232538998127
in O 0 0.00278817699290812
Asiatic O 1 0.9992509484291077
( O 0 0.004586786963045597
Indian O 0 0.0054416349157691
, O 0 0.0015761356335133314
Chinese O 0 0.003968579228967428
) O 0 0.005096408072859049
populations O 0 0.03391360864043236
. O 0 0.0046472689136862755

The O 0 0.004791088867932558
highest O 0 0.014924566261470318
allele O 1 0.9997900128364563
frequency O 0 0.23540902137756348
( O 0 0.004858238156884909
7 O 0 0.008424290455877781
. O 0 0.002011016709730029
5 O 0 0.006933100987225771
% O 0 0.00575981754809618
) O 0 0.002753690117970109
was O 0 0.0017819181084632874
found O 0 0.0046195113100111485
in O 0 0.002022303408011794
Swedes O 0 0.20533384382724762
. O 0 0.006697413977235556

Saamis O 1 0.9804012179374695
( O 0 0.01062780898064375
2 O 0 0.009918468073010445
% O 0 0.006459078285843134
) O 0 0.003209537360817194
and O 0 0.002011469565331936
Mordvinians O 1 0.9983708262443542
( O 0 0.005473325494676828
1 O 0 0.00696351146325469
. O 0 0.0019234390929341316
8 O 0 0.007143552880734205
% O 0 0.00575479818508029
) O 0 0.002835030434653163
had O 0 0.0022491910494863987
significantly O 0 0.018944095820188522
lower O 0 0.007437917869538069
frequencies O 0 0.020178623497486115
of O 0 0.000966498744674027
the O 0 0.003724563168361783
Tyr O 1 0.9998399019241333
allele O 1 0.9997730851173401
. O 0 0.01100651454180479

Comparisons O 0 0.031335048377513885
with O 0 0.007852342911064625
allele O 1 0.999367892742157
frequencies O 0 0.0412728525698185
based O 0 0.0031931521371006966
on O 0 0.0022159256041049957
prevalence O 1 0.9987668991088867
estimates O 0 0.00894220545887947
of O 0 0.0023847983684390783
HH B-Disease 1 0.9998700618743896
showed O 0 0.008212749846279621
some O 0 0.0012571926927194
disagreements O 0 0.01364679355174303
with O 0 0.001930130529217422
the O 0 0.0026657041162252426
RFLP O 1 0.9999456405639648
data O 0 0.009860442019999027
, O 0 0.0016148891299962997
particularly O 0 0.004156563431024551
in O 0 0.0025172755122184753
Finns O 1 0.6486645936965942
. O 0 0.00735002476722002

The O 0 0.0038243273738771677
newly O 0 0.012428419664502144
described O 0 0.022449254989624023
HFE O 1 0.9998070597648621
marker O 1 0.7373828887939453
provides O 0 0.008394996635615826
a O 0 0.003746048780158162
new O 0 0.002289155498147011
approach O 0 0.004781721159815788
to O 0 0.0006928044022060931
the O 0 0.0013334695249795914
screening O 1 0.8812909126281738
of O 0 0.0029549060855060816
HH B-Disease 1 0.9999717473983765
as O 0 0.002325876383110881
well O 0 0.0014278995804488659
as O 0 0.0011830346193164587
studies O 0 0.00502721406519413
of O 0 0.0005699494504369795
the O 0 0.0011847142595797777
relationship O 0 0.013528304174542427
between O 0 0.0024749054573476315
the O 0 0.004068377427756786
HFE O 1 0.9999885559082031
Tyr O 1 0.9998904466629028
allele O 1 0.9997174143791199
and O 0 0.0026163042057305574
different O 0 0.009546324610710144
disorders O 1 0.9999960660934448
including O 0 0.02223747782409191
cancer B-Disease 1 0.9999935626983643

Autosomal B-Disease 1 0.9999829530715942
dominant I-Disease 1 0.986467719078064
neurohypophyseal I-Disease 1 0.99978107213974
diabetes I-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9999648332595825
associated O 0 0.013785195536911488
with O 0 0.0022269757464528084
a O 0 0.010321583598852158
missense O 1 0.9998329877853394
mutation O 1 0.9999649524688721
encoding O 1 0.9947966933250427
Gly23 O 1 0.9982670545578003
- O 0 0.16039586067199707
- O 0 0.20889998972415924
> O 1 0.9979731440544128
Val O 1 0.9963674545288086
in O 0 0.007153577636927366
neurophysin O 1 0.992957592010498
II O 0 0.06370380520820618
. O 0 0.00848325714468956

Autosomal B-Disease 1 0.9999877214431763
dominant I-Disease 1 0.9841602444648743
neurohypophyseal I-Disease 1 0.9998477697372437
diabetes I-Disease 1 0.9999996423721313
insipidus I-Disease 1 0.9999758005142212
( O 0 0.015051045455038548
ADNDI B-Disease 1 0.9993402361869812
) O 0 0.00408107740804553
is O 0 0.0018184971995651722
an O 0 0.00515518756583333
inherited B-Disease 1 0.9999969005584717
disease I-Disease 1 0.9999995231628418
caused O 1 0.6992742419242859
by O 0 0.004762614145874977
progressive O 1 0.9928213953971863
degeneration O 1 0.9999924898147583
of O 0 0.0015079631702974439
the O 0 0.0026406249962747097
magnocellular O 1 0.9998716115951538
neurons O 1 0.9934921860694885
of O 0 0.0010174481431022286
the O 0 0.0021017033141106367
hypothalamus O 1 0.9995273351669312
leading O 0 0.0074308873154222965
to O 0 0.0018924321047961712
decreased O 0 0.0847826898097992
ability O 0 0.0077017564326524734
to O 0 0.0009623747901059687
produce O 0 0.00707901269197464
the O 0 0.003501283237710595
hormone O 1 0.9995468258857727
arginine O 1 0.9985018968582153
vasopressin O 1 0.9987035989761353
( O 0 0.015399081632494926
AVP O 1 0.9986248016357422
) O 0 0.010308274999260902
. O 0 0.006500575691461563

Affected O 0 0.04241114854812622
individuals O 0 0.005431515630334616
are O 0 0.0009350584005005658
not O 0 0.0024350143503397703
symptomatic O 1 0.9999566078186035
at O 0 0.005228640045970678
birth O 1 0.661412239074707
, O 0 0.0016034671571105719
but O 0 0.001907706493511796
usually O 0 0.008902396075427532
develop O 1 0.9992772936820984
diabetes B-Disease 1 0.9999997615814209
insipidus I-Disease 1 0.9999712705612183
at O 0 0.007617615163326263
1 O 0 0.012449987232685089
- O 0 0.021958651021122932
6 O 0 0.019931158050894737
yr O 1 0.9987621307373047
of O 0 0.0024281484074890614
age O 0 0.009579646401107311
. O 0 0.006643796339631081

The O 0 0.008479386568069458
genetic O 1 0.9998290538787842
locus O 1 0.9983640313148499
of O 0 0.0013370794476941228
the O 0 0.003330661216750741
disease O 1 0.9999839067459106
is O 0 0.002263858914375305
the O 0 0.0032790626864880323
AVP O 1 0.9999220371246338
- O 0 0.15784727036952972
neurophysin O 1 0.9973263740539551
II O 0 0.14840224385261536
( O 0 0.00931803323328495
NPII O 1 0.9992982149124146
) O 0 0.009644868783652782
gene O 1 0.9999561309814453
, O 0 0.0018209231784567237
and O 0 0.0022324733436107635
mutations O 1 0.9999970197677612
that O 0 0.003232616698369384
cause O 1 0.9978237152099609
ADNDI B-Disease 1 0.9994719624519348
have O 0 0.001328473212197423
been O 0 0.0013313287636265159
found O 0 0.0028245311696082354
in O 0 0.00091150141088292
both O 0 0.0009549190872348845
the O 0 0.0016613834304735065
signal O 0 0.07676566392183304
peptide O 1 0.9965757727622986
of O 0 0.0010886597447097301
the O 0 0.003332835389301181
prepro O 1 0.9992183446884155
- O 0 0.2637699544429779
AVP O 1 0.9997510313987732
- O 0 0.08126235753297806
NPII O 1 0.99552321434021
precursor O 1 0.9494560956954956
and O 0 0.002385989995673299
within O 0 0.006612648256123066
NPII O 1 0.9964146614074707
itself O 0 0.01707458309829235
. O 0 0.00611006747931242

An O 0 0.007229117676615715
affected O 0 0.031069915741682053
girl O 0 0.03559642285108566
who O 0 0.0023092092014849186
presented O 0 0.004092181567102671
at O 0 0.0022652940824627876
9 O 0 0.006585212890058756
months O 0 0.003961961250752211
of O 0 0.0009170180419459939
age O 0 0.004034566227346659
and O 0 0.0011948164319619536
her O 0 0.006112086120992899
similarly O 0 0.0423961840569973
affected O 0 0.09045973420143127
younger O 0 0.14965195953845978
brother O 0 0.020398907363414764
and O 0 0.0013623544946312904
father O 0 0.005216477904468775
were O 0 0.0005910872132517397
all O 0 0.0005526127060875297
found O 0 0.0024434379301965237
to O 0 0.0006053694523870945
have O 0 0.0008798085618764162
a O 0 0.004743112716823816
novel O 0 0.03463492915034294
missense O 1 0.9999129772186279
mutation O 1 0.9999819993972778
( O 0 0.01206812635064125
G1758 O 1 0.9994582533836365
- O 1 0.5019913911819458
- O 1 0.5072482228279114
> O 1 0.9995057582855225
T O 1 0.9980008006095886
) O 0 0.006207557395100594
encoding O 0 0.1269391030073166
the O 0 0.002993934554979205
amino O 1 0.9773455858230591
acid O 1 0.997132420539856
substitution O 1 0.9843137264251709
Gly23 O 1 0.9986666440963745
- O 0 0.23605677485466003
- O 0 0.12322601675987244
> O 1 0.997814416885376
Val O 1 0.9920976161956787
within O 0 0.010836649686098099
NPII O 1 0.9960774779319763
. O 0 0.008584028109908104

The O 0 0.011702634394168854
mutation O 1 0.999920129776001
was O 0 0.004426007624715567
confirmed O 0 0.011052211746573448
by O 0 0.004433057736605406
restriction O 0 0.08816232532262802
endonuclease O 1 0.9987286925315857
analysis O 0 0.03453954681754112
. O 0 0.00714273052290082

A O 0 0.05987078696489334
T1 O 1 0.9973868727684021
- O 0 0.036089763045310974
weighted O 0 0.03623761981725693
magnetic O 0 0.05930372327566147
resonance O 1 0.9026316404342651
imaging O 1 0.7764579057693481
of O 0 0.001223691157065332
the O 0 0.0026704624760895967
fathers O 0 0.4199537932872772
pituitary O 1 0.9999853372573853
gland O 1 0.999896764755249
demonstrates O 0 0.03238561376929283
an O 0 0.005640255752950907
attenuated O 1 0.9998997449874878
posterior O 1 0.9999518394470215
pituitary O 1 0.9999642372131348
bright O 0 0.054653722792863846
spot O 0 0.022625211626291275
. O 0 0.006884230300784111

This O 0 0.009051008149981499
mutation O 1 0.999976634979248
may O 0 0.005377707537263632
be O 0 0.0009310352616012096
valuable O 0 0.0045834872871637344
for O 0 0.0012318802764639258
developing O 0 0.00983407162129879
models O 0 0.010012757033109665
of O 0 0.0023055034689605236
dominantly B-Disease 1 0.9996991157531738
inherited I-Disease 1 0.9999550580978394
neurodegeneration I-Disease 1 0.9999970197677612
, O 0 0.001993622398003936
as O 0 0.0009121751063503325
the O 0 0.001201614155434072
early O 0 0.003720289096236229
age O 0 0.004397172946482897
of O 0 0.0025348856579512358
onset O 1 0.999984622001648
of O 0 0.004298490006476641
symptoms O 1 0.9999935626983643
suggests O 0 0.013823417015373707
that O 0 0.0011634690454229712
this O 0 0.003047430654987693
mutation O 1 0.9999971389770508
may O 0 0.004800681956112385
be O 0 0.001169330789707601
particularly O 0 0.005941675044596195
deleterious O 1 0.9973805546760559
to O 0 0.002068806905299425
the O 0 0.0037293010391294956
magnocellular O 1 0.9998979568481445
neuron O 1 0.9996391534805298
. O 0 0.005042353179305792
. O 0 0.004857910796999931

Frequent O 0 0.08428999781608582
inactivation O 1 0.9950213432312012
of O 0 0.0069533102214336395
PTEN O 1 0.9999797344207764
/ O 1 0.917702853679657
MMAC1 O 1 0.9961370825767517
in O 0 0.007128097582608461
primary O 1 0.9986159801483154
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
. O 0 0.011363123543560505

Sporadic B-Disease 1 0.9995243549346924
prostate I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 0.9999997615814209
is O 0 0.002894046949222684
the O 0 0.001009221887215972
most O 0 0.0015126185026019812
common O 0 0.2593681514263153
male B-Disease 1 0.9994447827339172
cancer I-Disease 1 0.9999992847442627
in O 0 0.0014368867268785834
the O 0 0.0010154384654015303
Western O 0 0.0030642091296613216
world O 0 0.0018222323851659894
, O 0 0.00100345176178962
yet O 0 0.0015714054461568594
many O 0 0.00048095008241944015
of O 0 0.00040723156416788697
the O 0 0.0011463958071544766
major O 0 0.00955167319625616
genetic O 1 0.9999414682388306
events O 0 0.004007261712104082
involved O 0 0.004418433178216219
in O 0 0.000835065555293113
the O 0 0.001741123734973371
progression O 1 0.9996320009231567
of O 0 0.0010194819187745452
this O 0 0.0018875020323321223
often O 0 0.012741707265377045
fatal O 1 0.999998927116394
cancer B-Disease 1 0.9999991655349731
remain O 0 0.0030003790743649006
to O 0 0.0009548318339511752
be O 0 0.002176262205466628
elucidated O 1 0.995707631111145
. O 0 0.005651718471199274

Numerous O 0 0.029954995959997177
cytogenetic O 1 0.9992223978042603
and O 0 0.005864749196916819
allelotype O 1 0.9933619499206543
studies O 0 0.013641749508678913
have O 0 0.0020349931437522173
reported O 0 0.008843141607940197
frequent O 0 0.025205550715327263
loss O 0 0.02342107892036438
of O 0 0.002164426725357771
heterozygosity O 1 0.9987674951553345
on O 0 0.00535705778747797
chromosomal O 1 0.9999926090240479
arm O 1 0.9681409001350403
10q O 1 0.9944726824760437
in O 0 0.008390000090003014
sporadic B-Disease 1 0.9998794794082642
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
. O 0 0.013971157371997833

Deletion O 1 0.9977241158485413
mapping O 0 0.11102750152349472
studies O 0 0.010548517107963562
have O 0 0.0015567900845780969
unambiguously O 0 0.07630622386932373
identified O 0 0.010345938615500927
a O 0 0.0035012182779610157
region O 0 0.002487372839823365
of O 0 0.00224484084174037
chromosome O 1 0.9999983310699463
10q23 O 1 0.9948727488517761
to O 0 0.0011461911490187049
be O 0 0.0007412293343804777
the O 0 0.0012563385535031557
minimal O 0 0.027797574177384377
area O 0 0.002309948904439807
of O 0 0.001748523092828691
loss O 0 0.1272234469652176
. O 0 0.00776815926656127

A O 0 0.0219547338783741
new O 0 0.01784886233508587
tumor B-Disease 1 0.9999972581863403
suppressor O 1 0.9999849796295166
gene O 1 0.9998327493667603
, O 0 0.012715211138129234
PTEN O 1 0.999993085861206
/ O 1 0.9951713681221008
MMAC1 O 1 0.9983324408531189
, O 0 0.00288812885992229
was O 0 0.0027744737453758717
isolated O 0 0.034657735377550125
recently O 0 0.006291777361184359
at O 0 0.0014008891303092241
this O 0 0.0008251497056335211
region O 0 0.002613488817587495
of O 0 0.0025100947823375463
chromosome O 1 0.9999983310699463
10q23 O 1 0.9969180822372437
and O 0 0.001215127995237708
found O 0 0.00279438984580338
to O 0 0.001089793280698359
be O 0 0.0015953241381794214
inactivated O 1 0.960832953453064
by O 0 0.004613887052983046
mutation O 1 0.9999656677246094
in O 0 0.003939657937735319
three O 0 0.14020249247550964
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 1 0.9996650218963623
lines O 0 0.02777715027332306
. O 0 0.006975570693612099

We O 0 0.00732409255579114
screened O 0 0.05305261164903641
80 O 0 0.059712719172239304
prostate B-Disease 1 0.9999997615814209
tumors I-Disease 1 0.9999954700469971
by O 0 0.00929761491715908
microsatellite O 1 0.9998194575309753
analysis O 0 0.01324805524200201
and O 0 0.0013846238143742085
found O 0 0.014134548604488373
chromosome O 1 0.9999923706054688
10q23 O 1 0.9927694797515869
to O 0 0.0014880528906360269
be O 0 0.0012645646929740906
deleted O 0 0.04707995057106018
in O 0 0.0026637602131813765
23 O 0 0.010301885195076466
cases O 0 0.01357233989983797
. O 0 0.006809156853705645

We O 0 0.003545357845723629
then O 0 0.0023802085779607296
proceeded O 0 0.009910689666867256
with O 0 0.0025702931452542543
sequence O 0 0.04319286346435547
analysis O 0 0.00877652782946825
of O 0 0.000772980391047895
the O 0 0.0017190228682011366
entire O 0 0.02664848603308201
PTEN O 1 0.9999831914901733
/ O 1 0.9868713617324829
MMAC1 O 1 0.9989181756973267
coding O 1 0.9967221617698669
region O 0 0.0057290890254080296
and O 0 0.0014384201494976878
tested O 0 0.026900017634034157
for O 0 0.0030612971168011427
homozygous O 1 0.9997851252555847
deletion O 1 0.9991211295127869
with O 0 0.004086457192897797
new O 0 0.004705982282757759
intragenic O 1 0.9974477291107178
markers O 1 0.6100237965583801
in O 0 0.0012662742519751191
these O 0 0.0014288251986727118
23 O 0 0.008219623006880283
cases O 0 0.010070748627185822
with O 0 0.00525227515026927
10q23 O 1 0.9966758489608765
loss O 0 0.048800885677337646
of O 0 0.00408029044046998
heterozygosity O 1 0.9990583062171936
. O 0 0.008896652609109879

The O 0 0.0036018621176481247
identification O 0 0.013650277629494667
of O 0 0.0006668700953014195
the O 0 0.0012994707794860005
second O 0 0.009152361191809177
mutational O 1 0.9999457597732544
event O 0 0.00939672626554966
in O 0 0.0014113802462816238
10 O 0 0.0034054741263389587
( O 0 0.0033979020081460476
43 O 0 0.015093568712472916
% O 0 0.008328725583851337
) O 0 0.014071443118155003
tumors B-Disease 1 0.9999986886978149
establishes O 1 0.9981471300125122
PTEN O 1 0.9999880790710449
/ O 1 0.9607044458389282
MMAC1 O 1 0.9861225485801697
as O 0 0.002087077358737588
a O 0 0.004700272344052792
main O 0 0.006863331887871027
inactivation O 1 0.9985535740852356
target O 0 0.009950858540832996
of O 0 0.0014916323125362396
10q O 1 0.9957706332206726
loss O 0 0.14470966160297394
in O 0 0.008026452735066414
sporadic B-Disease 1 0.9999358654022217
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.0057020243257284164
. O 0 0.00623110868036747

Risk O 1 0.8986884951591492
reversals O 0 0.33430829644203186
in O 0 0.00449885381385684
predictive O 1 0.998925507068634
testing O 1 0.6427735686302185
for O 0 0.013813084922730923
Huntington B-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999972581863403
. O 0 0.009554971940815449

The O 0 0.003430265700444579
first O 0 0.004345696419477463
predictive O 1 0.9962989687919617
testing O 0 0.36972811818122864
for O 0 0.009686692617833614
Huntington B-Disease 1 0.9999978542327881
disease I-Disease 1 0.9999986886978149
( O 0 0.010882142931222916
HD B-Disease 1 0.999230146408081
) O 0 0.0037913473788648844
was O 0 0.0015071111265569925
based O 0 0.0019750932697206736
on O 0 0.0009045272599905729
analysis O 0 0.008869858458638191
of O 0 0.0016496683238074183
linked O 1 0.970210611820221
polymorphic O 1 0.9999039173126221
DNA O 1 0.9996426105499268
markers O 0 0.45583492517471313
to O 0 0.0014975143130868673
estimate O 0 0.005674764979630709
the O 0 0.0016237213276326656
likelihood O 0 0.037583593279123306
of O 0 0.0015567295486107469
inheriting O 1 0.9882034659385681
the O 0 0.004917132202535868
mutation O 1 0.9999872446060181
for O 0 0.004861713387072086
HD B-Disease 1 0.9915663599967957
. O 0 0.007174972910434008

Limits O 0 0.010623903945088387
to O 0 0.001819466706365347
accuracy O 0 0.012343247421085835
included O 0 0.004438798408955336
recombination O 1 0.9992233514785767
between O 0 0.0022513375151902437
the O 0 0.0022956044413149357
DNA O 1 0.999600350856781
markers O 1 0.5034512281417847
and O 0 0.001054366584867239
the O 0 0.0028689736500382423
mutation O 1 0.9999948740005493
, O 0 0.003586922073736787
pedigree O 1 0.995093584060669
structure O 0 0.01386487390846014
, O 0 0.000894156692083925
and O 0 0.0008823153912089765
whether O 0 0.004760296083986759
DNA O 1 0.9995253086090088
samples O 0 0.02084098756313324
were O 0 0.0008939944091252983
available O 0 0.002491735853254795
from O 0 0.0017175553366541862
family O 0 0.0075758639723062515
members O 0 0.0033398198429495096
. O 0 0.005276746582239866

With O 0 0.0059485845267772675
direct O 0 0.009733124636113644
tests O 0 0.012055255472660065
for O 0 0.0011412356980144978
the O 0 0.002831718884408474
HD B-Disease 1 0.9999293088912964
mutation O 1 0.9999911785125732
, O 0 0.0016932380385696888
we O 0 0.0006529344245791435
have O 0 0.0007687126635573804
assessed O 0 0.007577570620924234
the O 0 0.001017591217532754
accuracy O 0 0.008428223431110382
of O 0 0.0008576750406064093
results O 0 0.0077779595740139484
obtained O 0 0.0057547325268387794
by O 0 0.003127948846668005
linkage O 1 0.998808741569519
approaches O 0 0.026888610795140266
when O 0 0.003280440578237176
requested O 0 0.004344749264419079
to O 0 0.0011625654296949506
do O 0 0.0018615812296047807
so O 0 0.0012308411533012986
by O 0 0.0013025704538449645
the O 0 0.0016402102774009109
test O 0 0.02014818973839283
individuals O 0 0.00721063744276762
. O 0 0.005637694150209427

For O 0 0.004086163826286793
six O 0 0.0036697466857731342
such O 0 0.0024022965226322412
individuals O 0 0.00418132496997714
, O 0 0.001072471379302442
there O 0 0.0009907352505251765
was O 0 0.0016021523624658585
significant O 0 0.006865497212857008
disparity O 1 0.6505376100540161
between O 0 0.0028691308107227087
the O 0 0.0025368479546159506
tests O 0 0.0369865745306015
. O 0 0.006170980166643858

Three O 0 0.005288733635097742
went O 0 0.003825694089755416
from O 0 0.002030431292951107
a O 0 0.006990641355514526
decreased O 1 0.7995303869247437
risk O 1 0.9112151861190796
to O 0 0.0010842964984476566
an O 0 0.001938992878422141
increased O 0 0.02556515485048294
risk O 1 0.9987046718597412
, O 0 0.0011720542097464204
while O 0 0.0012990084942430258
in O 0 0.0009803537977859378
another O 0 0.0033957231789827347
three O 0 0.0017540032276883721
the O 0 0.0025962749496102333
risk O 1 0.9795743227005005
was O 0 0.004498422611504793
decreased O 0 0.3269103765487671
. O 0 0.006531580816954374

Knowledge O 0 0.011439355090260506
of O 0 0.000986795756034553
the O 0 0.0015308294678106904
potential O 0 0.014864885248243809
reasons O 0 0.003753662109375
for O 0 0.0008128249901346862
these O 0 0.0008713419665582478
changes O 0 0.004945556167513132
in O 0 0.0009390473715029657
results O 0 0.008425808511674404
and O 0 0.0006906350026838481
impact O 0 0.00605024304240942
of O 0 0.0007937605259940028
these O 0 0.0024361913092434406
risk O 1 0.9982584118843079
reversals O 1 0.9844616055488586
on O 0 0.0015679700300097466
both O 0 0.0037584458477795124
patients O 1 0.9998040795326233
and O 0 0.0010289615020155907
the O 0 0.0019711721688508987
counseling O 1 0.9974299073219299
team O 0 0.00378714082762599
can O 0 0.0026377432513982058
assist O 0 0.008518564514815807
in O 0 0.000817823747638613
the O 0 0.0009418133995495737
development O 0 0.003103285562247038
of O 0 0.0010404241038486362
strategies O 0 0.23766854405403137
for O 0 0.0013293472584336996
the O 0 0.0027970990631729364
prevention O 1 0.9995266199111938
and O 0 0.0013579463120549917
, O 0 0.0010456388117745519
where O 0 0.0014082626439630985
necessary O 0 0.004556641448289156
, O 0 0.001457368372939527
management O 0 0.01112449448555708
of O 0 0.001080450601875782
a O 0 0.009111342951655388
risk O 1 0.9850497841835022
reversal O 0 0.16049037873744965
in O 0 0.0014116753591224551
any O 0 0.003430255688726902
predictive O 1 0.9997803568840027
testing O 0 0.38219234347343445
program O 0 0.013868412934243679
. O 0 0.0024046609178185463
. O 0 0.004399262368679047

A O 0 0.021768081933259964
novel O 0 0.023583151400089264
common O 0 0.028506888076663017
missense O 1 0.9999431371688843
mutation O 1 0.9999836683273315
G301C O 1 0.930494487285614
in O 0 0.001914121792651713
the O 0 0.002900677267462015
N O 1 0.9867059588432312
- O 0 0.06308059394359589
acetylgalactosamine O 1 0.9981856942176819
- O 0 0.03195924311876297
6 O 0 0.021793978288769722
- O 0 0.14122958481311798
sulfate O 1 0.9997724890708923
sulfatase O 1 0.9998231530189514
gene O 1 0.999442994594574
in O 0 0.009055991657078266
mucopolysaccharidosis B-Disease 1 0.9968122839927673
IVA I-Disease 1 0.9979610443115234
. O 0 0.01502806693315506

Mucopolysaccharidosis B-Disease 1 0.9947643280029297
IVA I-Disease 1 0.9988678693771362
( O 0 0.014357967302203178
MPS B-Disease 1 0.8106174468994141
IVA I-Disease 1 0.9999468326568604
) O 0 0.004941125400364399
is O 0 0.0020759038161486387
an O 0 0.0070405988954007626
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 0.999980092048645
storage I-Disease 1 0.9742030501365662
disorder I-Disease 1 0.9999885559082031
caused O 0 0.04172923415899277
by O 0 0.002103000646457076
a O 0 0.012239690870046616
genetic B-Disease 1 0.9999969005584717
defect I-Disease 1 0.999863862991333
in O 0 0.004231685772538185
N O 1 0.9879748821258545
- O 0 0.04644891247153282
acetylgalactosamine O 1 0.9982917904853821
- O 0 0.03513927012681961
6 O 0 0.02294374816119671
- O 0 0.29353630542755127
sulfate O 1 0.9998621940612793
sulfatase O 1 0.9998143315315247
( O 0 0.017401760444045067
GALNS O 1 0.9964333772659302
) O 0 0.008166933432221413
. O 0 0.005323782563209534

In O 0 0.00454918947070837
previous O 0 0.007210344076156616
studies O 0 0.011574732139706612
, O 0 0.0010215655202046037
we O 0 0.0006565945805050433
have O 0 0.0007659919210709631
found O 0 0.0029659532010555267
two O 0 0.00220970599912107
common O 0 0.36945396661758423
mutations O 1 0.9999957084655762
in O 0 0.003671102924272418
Caucasians O 1 0.9990699887275696
and O 0 0.0018552230903878808
Japanese O 0 0.00650280574336648
, O 0 0.0019013797864317894
respectively O 0 0.008148765191435814
. O 0 0.005707297939807177

To O 0 0.00471509201452136
characterize O 0 0.06617757678031921
the O 0 0.0061032637022435665
mutational O 1 0.9997761845588684
spectrum O 0 0.04785683751106262
in O 0 0.0013080922653898597
various O 0 0.0011503800051286817
ethnic O 0 0.004159464035183191
groups O 0 0.003890281543135643
, O 0 0.002992312191054225
mutations O 1 0.9999880790710449
in O 0 0.0016722438158467412
the O 0 0.002756615402176976
GALNS O 1 0.9997130036354065
gene O 1 0.9997873902320862
in O 0 0.003501507919281721
Colombian O 0 0.14847545325756073
MPS B-Disease 1 0.97061687707901
IVA I-Disease 1 0.9999924898147583
patients O 1 0.9991655349731445
were O 0 0.0014981541316956282
investigated O 0 0.01962634176015854
, O 0 0.0013111545704305172
and O 0 0.0021133411210030317
genetic O 1 0.9999450445175171
backgrounds O 0 0.008481396362185478
were O 0 0.0007587098516523838
extensively O 0 0.007856460288167
analyzed O 0 0.01542271301150322
to O 0 0.0013509477721527219
identify O 0 0.01302390918135643
racial O 0 0.009482281282544136
origin O 0 0.005945610348135233
, O 0 0.0008965812157839537
based O 0 0.0019354165997356176
on O 0 0.0022296695969998837
mitochondrial O 1 0.9999450445175171
DNA O 1 0.9996235370635986
( O 0 0.009830078110098839
mtDNA O 1 0.9997733235359192
) O 0 0.008172960951924324
lineages O 1 0.9966700673103333
. O 0 0.00720281433314085

Three O 0 0.009413345716893673
novel O 0 0.044705990701913834
missense O 1 0.9999499320983887
mutations O 1 0.9999872446060181
never O 0 0.006443756632506847
identified O 0 0.007928229868412018
previously O 0 0.0022311946377158165
in O 0 0.0009045475162565708
other O 0 0.0011362426448613405
populations O 0 0.0203543808311224
and O 0 0.0010860468028113246
found O 0 0.004604184068739414
in O 0 0.0013286839239299297
16 O 0 0.004298573359847069
out O 0 0.0020694774575531483
of O 0 0.0012168317334726453
19 O 0 0.010402951389551163
Colombian O 0 0.04993005469441414
MPS B-Disease 1 0.6007570028305054
IVA I-Disease 1 0.9999374151229858
unrelated O 1 0.9915299415588379
alleles O 1 0.9997631907463074
account O 0 0.007954281754791737
for O 0 0.0030384634155780077
84 O 0 0.03206987679004669
. O 0 0.007672555278986692

2 O 0 0.012169654481112957
% O 0 0.004313074052333832
of O 0 0.0009137234301306307
the O 0 0.00298582692630589
alleles O 1 0.999832034111023
in O 0 0.002140024909749627
this O 0 0.0018046224722638726
study O 0 0.011495261453092098
. O 0 0.005345557350665331

The O 0 0.008376823738217354
G301C O 1 0.8463453650474548
and O 0 0.005587773397564888
S162F O 1 0.9981518387794495
mutations O 1 0.999913215637207
account O 0 0.006607212591916323
for O 0 0.0023682434111833572
68 O 0 0.02863580733537674
. O 0 0.007377514615654945

4 O 0 0.020309846848249435
% O 0 0.008139400742948055
and O 0 0.002001367509365082
10 O 0 0.0059331608936190605
. O 0 0.006857507396489382

5 O 0 0.010302804410457611
% O 0 0.004869127180427313
of O 0 0.002912673866376281
mutations O 1 0.9999967813491821
, O 0 0.0021720747463405132
respectively O 0 0.0046105701476335526
, O 0 0.0012792166089639068
whereas O 0 0.0095365634188056
the O 0 0.0014887339202687144
remaining O 0 0.00783261377364397
F69V O 1 0.9990737438201904
is O 0 0.002190629718825221
limited O 0 0.0036685350351035595
to O 0 0.0012701927917078137
a O 0 0.006512356922030449
single O 0 0.024053752422332764
allele O 1 0.9991509914398193
. O 0 0.008782013319432735

The O 0 0.007595754694193602
skewed O 1 0.8472015857696533
prevalence O 1 0.9921626448631287
of O 0 0.0026181803550571203
G301C O 1 0.9868811368942261
in O 0 0.0015887574991211295
only O 0 0.0019375731935724616
Colombian O 1 0.6741988062858582
patients O 1 0.999471127986908
and O 0 0.0033115351106971502
haplotype O 1 0.9999526739120483
analysis O 0 0.012947862036526203
by O 0 0.0023028759751468897
restriction O 0 0.03444437310099602
fragment O 1 0.8120480179786682
length O 0 0.02066449448466301
polymorphisms O 1 0.9996103644371033
in O 0 0.0016938371118158102
the O 0 0.0030131912790238857
GALNS O 1 0.999782383441925
gene O 1 0.9999055862426758
suggest O 0 0.010421961545944214
that O 0 0.002120545133948326
G301C O 1 0.9920387268066406
originated O 0 0.01776191219687462
from O 0 0.002035284647718072
a O 0 0.00656435452401638
common O 0 0.020126689225435257
ancestor O 1 0.6628595590591431
. O 0 0.006311152130365372

Investigation O 0 0.02193884178996086
of O 0 0.0013242779532447457
the O 0 0.002736176596954465
genetic O 1 0.9998595714569092
background O 0 0.011084478348493576
by O 0 0.0014021184761077166
means O 0 0.003476720070466399
of O 0 0.0018120644381269813
mtDNA O 1 0.9999270439147949
lineages O 1 0.9990897178649902
indicate O 0 0.008894839324057102
that O 0 0.0007247103494592011
all O 0 0.000612288189586252
our O 0 0.004552321974188089
patients O 1 0.9996761083602905
are O 0 0.0012541512260213494
probably O 0 0.004435826558619738
of O 0 0.0009887856431305408
native O 0 0.00518744857981801
American O 0 0.010004233568906784
descent O 0 0.10500318557024002

Low O 0 0.02752767689526081
frequency O 0 0.031359173357486725
of O 0 0.006295299157500267
BRCA1 O 1 0.9999991655349731
germline O 1 0.99998939037323
mutations O 1 0.9999386072158813
in O 0 0.0028973566368222237
45 O 0 0.011791658587753773
German O 1 0.9460409879684448
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999855756759644
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
families O 0 0.017317654564976692
. O 0 0.007566953543573618

In O 0 0.003477308200672269
this O 0 0.001435495214536786
study O 0 0.004673457238823175
we O 0 0.0010842776391655207
investigated O 0 0.014202790334820747
45 O 0 0.013043674640357494
German O 1 0.8483546376228333
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999755620956421
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
families O 0 0.009478341788053513
for O 0 0.005584536585956812
germline O 1 0.9999935626983643
mutations O 1 0.9999606609344482
in O 0 0.0031271132174879313
the O 0 0.006875541061162949
BRCA1 O 1 0.9999995231628418
gene O 1 0.9997310042381287
. O 0 0.010486132465302944

We O 0 0.0030456387903541327
identified O 0 0.01036685612052679
four O 0 0.0073297107592225075
germline O 1 0.9999871253967285
mutations O 1 0.9999480247497559
in O 0 0.003385398304089904
three O 0 0.019068017601966858
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
families O 0 0.004925669636577368
and O 0 0.0008657267899252474
in O 0 0.0016512947622686625
one O 0 0.0895381048321724
breast B-Disease 1 1.0
- I-Disease 1 0.9999825954437256
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 0.0245298333466053
. O 0 0.0013456124579533935
among O 0 0.0011544229928404093
these O 0 0.0006734105991199613
were O 0 0.0005848382716067135
one O 0 0.004677251446992159
frameshift O 1 0.9999961853027344
mutation O 1 0.9999890327453613
, O 0 0.002053703647106886
one O 0 0.002752272179350257
nonsense O 1 0.9858761429786682
mutation O 1 0.9999915361404419
, O 0 0.0017284408677369356
one O 0 0.0019035727018490434
novel O 0 0.023046592250466347
splice O 1 0.999637246131897
site O 0 0.025191180408000946
mutation O 1 0.9999884366989136
, O 0 0.0020130204502493143
and O 0 0.0013421188341453671
one O 0 0.005840877071022987
missense O 1 0.9999197721481323
mutation O 1 0.9999183416366577
. O 0 0.011209084652364254

The O 0 0.01183249056339264
missense O 1 0.9998145699501038
mutation O 1 0.999957799911499
was O 0 0.003671513171866536
also O 0 0.001335254404693842
found O 0 0.005142030771821737
in O 0 0.002185045974329114
2 O 0 0.012487223371863365
. O 0 0.0061471955850720406

8 O 0 0.012377709150314331
% O 0 0.004040671046823263
of O 0 0.0007430079276673496
the O 0 0.0011253110133111477
general O 0 0.0024440400302410126
population O 0 0.0026338675525039434
, O 0 0.0013425042852759361
suggesting O 0 0.012588432990014553
that O 0 0.0010340858716517687
it O 0 0.001082054222933948
is O 0 0.002139198360964656
not O 0 0.005463304929435253
disease O 1 0.9999959468841553
associated O 0 0.02356541156768799
. O 0 0.006244066637009382

The O 0 0.0042380099184811115
average O 0 0.006882202811539173
age O 0 0.006617122329771519
of O 0 0.00493581360206008
disease O 1 0.9999996423721313
onset O 1 0.9999315738677979
in O 0 0.0017192878294736147
those O 0 0.0015976432478055358
families O 0 0.009910094551742077
harbouring O 1 0.9993663430213928
causative O 1 0.999955415725708
mutations O 1 0.9999350309371948
was O 0 0.003988226410001516
between O 0 0.0035380558110773563
32 O 0 0.014377814717590809
. O 0 0.005013356450945139

3 O 0 0.019683964550495148
and O 0 0.0032608527690172195
37 O 0 0.01962842233479023
. O 0 0.006401003338396549

4 O 0 0.019152993336319923
years O 0 0.003505719592794776
, O 0 0.0015765377320349216
whereas O 0 0.009134143590927124
the O 0 0.0014620270812883973
family O 0 0.010405799373984337
harbouring O 1 0.9655339121818542
the O 0 0.005410481244325638
missense O 1 0.9999663829803467
mutation O 1 0.999971866607666
had O 0 0.003651954000815749
an O 0 0.0014798863558098674
average O 0 0.004360102582722902
age O 0 0.004580968990921974
of O 0 0.0025159588549286127
onset O 1 0.9998225569725037
of O 0 0.002568963449448347
51 O 0 0.02985086478292942
. O 0 0.006590036675333977

2 O 0 0.01821046881377697
years O 0 0.004607505165040493
. O 0 0.006490827072411776

These O 0 0.0035813183058053255
findings O 0 0.008505976758897305
show O 0 0.003767294343560934
that O 0 0.004404776263982058
BRCA1 O 1 0.9999988079071045
is O 0 0.004162886179983616
implicated O 1 0.6578996777534485
in O 0 0.0012560687027871609
a O 0 0.0034718469250947237
small O 0 0.003681293921545148
fraction O 0 0.022425085306167603
of O 0 0.007407570723444223
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999876022338867
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 0 0.0067711141891777515
suggesting O 0 0.011436539702117443
the O 0 0.0013087434927001595
involvement O 0 0.01213434711098671
of O 0 0.0012751355534419417
another O 0 0.01715400628745556
susceptibility O 1 0.999997615814209
gene O 1 0.9999744892120361
( O 0 0.008719475008547306
s O 0 0.20144768059253693
) O 0 0.011647558771073818

Paternal O 1 0.984636664390564
transmission O 1 0.9949705004692078
of O 0 0.022792873904109
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999971389770508
dystrophy I-Disease 1 0.999997615814209
. O 0 0.019657162949442863

We O 0 0.0028744034934788942
report O 0 0.0026828323025256395
a O 0 0.004180619493126869
rare O 0 0.014177355915307999
case O 0 0.005920945666730404
of O 0 0.003003633115440607
paternally O 1 0.9999231100082397
transmitted O 1 0.9999756813049316
congenital B-Disease 1 1.0
myotonic I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999997615814209
( O 0 0.040734708309173584
DM B-Disease 1 0.9999830722808838
) O 0 0.012430363334715366
. O 0 0.006567900534719229

The O 0 0.006983601488173008
proband O 1 0.8657229542732239
is O 0 0.002852556062862277
a O 0 0.006122006569057703
23 O 0 0.007554709445685148
year O 0 0.0030043970327824354
old O 0 0.010709194466471672
, O 0 0.004769942723214626
mentally B-Disease 1 0.9995021820068359
retarded I-Disease 1 0.9994786381721497
male O 1 0.6661226749420166
who O 0 0.01045813038945198
suffers O 1 0.9999397993087769
severe O 1 0.9996967315673828
muscular B-Disease 1 0.9999600648880005
weakness I-Disease 1 0.9949277639389038
. O 0 0.010078362189233303

He O 0 0.004167144652456045
presented O 0 0.006279014982283115
with O 0 0.008951033465564251
respiratory O 1 0.999992847442627
and O 0 0.004036992322653532
feeding O 1 0.7599830627441406
difficulties O 0 0.026200009509921074
at O 0 0.005015184171497822
birth O 1 0.5545333623886108
. O 0 0.007223121356219053

His O 0 0.010464769788086414
two O 0 0.008169814944267273
sibs O 1 0.9996328353881836
suffer O 1 0.956447184085846
from O 0 0.008042870089411736
childhood O 1 0.9990264177322388
onset O 1 0.9999903440475464
DM B-Disease 1 0.999969482421875
. O 0 0.01384825725108385

Their O 0 0.007028441410511732
late O 0 0.007644603960216045
father O 0 0.007113705389201641
had O 0 0.0017570004565641284
the O 0 0.0016956336330622435
adult O 0 0.32396379113197327
type O 0 0.37474343180656433
of O 0 0.0043646711856126785
DM B-Disease 1 0.9999920129776001
, O 0 0.0037598477210849524
with O 0 0.005387563724070787
onset O 1 0.9998552799224854
around O 0 0.004284906666725874
30 O 0 0.006256389897316694
years O 0 0.0035990532487630844
. O 0 0.005813093390315771

Only O 0 0.002920211525633931
six O 0 0.003093183506280184
other O 0 0.0011683735065162182
cases O 0 0.005005940794944763
of O 0 0.001705535571090877
paternal O 1 0.9992266893386841
transmission O 1 0.9995502829551697
of O 0 0.009810743853449821
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999895095825195
have O 0 0.003093285020440817
been O 0 0.002284098183736205
reported O 0 0.010709538124501705
recently O 0 0.011754876933991909
. O 0 0.005366606637835503

We O 0 0.003486606990918517
review O 0 0.004446639679372311
the O 0 0.0017852128949016333
sex O 0 0.02387429215013981
related O 0 0.014335683546960354
effects O 0 0.04010973870754242
on O 0 0.0031908852979540825
transmission O 1 0.9987348914146423
of O 0 0.012834389694035053
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999388456344604
. O 0 0.014327826909720898

Decreased O 0 0.35630348324775696
fertility O 1 0.8384396433830261
of O 0 0.0021004213485866785
males O 0 0.03945097327232361
with O 0 0.006053688004612923
adult O 1 0.9967194199562073
onset O 1 0.999991774559021
DM B-Disease 1 0.9999871253967285
and O 0 0.0036699348129332066
contraction O 1 0.6893813610076904
of O 0 0.0008257612935267389
the O 0 0.0011211150558665395
repeat O 0 0.21070566773414612
upon O 0 0.003372614271938801
male O 1 0.8240264058113098
transmission O 1 0.9997243285179138
contribute O 0 0.013749288395047188
to O 0 0.0009384552831761539
the O 0 0.001129915937781334
almost O 0 0.0032961268443614244
absent O 0 0.03521550074219704
occurrence O 0 0.048542603850364685
of O 0 0.001913511659950018
paternal O 1 0.9968804121017456
transmission O 1 0.9991612434387207
of O 0 0.012064391747117043
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999386072158813
. O 0 0.016515811905264854

Also O 0 0.0036033447831869125
the O 0 0.0018903932068496943
fathers O 0 0.013537827879190445
of O 0 0.0010433302959427238
the O 0 0.0020742074120789766
reported O 0 0.016989003866910934
congenitally O 1 0.9996240139007568
affected O 0 0.03450166434049606
children O 0 0.008703170344233513
showed O 0 0.008433233015239239
, O 0 0.0011924783466383815
on O 0 0.0010151125025004148
average O 0 0.005115170031785965
, O 0 0.0022450138349086046
shorter O 0 0.4532827138900757
CTG O 1 0.9985613226890564
repeat O 1 0.6289455890655518
lengths O 0 0.045675404369831085
and O 0 0.0013346237828955054
hence O 0 0.01766369119286537
less O 0 0.009313073940575123
severe O 1 0.999944806098938
clinical O 1 0.9999895095825195
symptoms O 1 0.9999573230743408
than O 0 0.001798428245820105
the O 0 0.001968210097402334
mothers O 0 0.11486219614744186
of O 0 0.0015851514181122184
children O 0 0.014712070114910603
with O 0 0.09073348343372345
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999563694000244
. O 0 0.012476050294935703

We O 0 0.003592325607314706
conclude O 0 0.014121146872639656
that O 0 0.0023221480660140514
paternal O 1 0.9942767024040222
transmission O 1 0.99785977602005
of O 0 0.00859792996197939
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999920129776001
is O 0 0.004342670552432537
rare O 0 0.015783369541168213
and O 0 0.001767994835972786
preferentially O 1 0.9871546030044556
occurs O 0 0.06029847636818886
with O 0 0.005550780333578587
onset O 1 0.9999027252197266
of O 0 0.004786097910255194
DM B-Disease 1 0.999988317489624
past O 0 0.006223043892532587
30 O 0 0.00475609116256237
years O 0 0.001840800978243351
in O 0 0.0012516183778643608
the O 0 0.0018794751958921552
father O 0 0.00998165737837553
. O 0 0.0032476766500622034
. O 0 0.005097641609609127

The O 0 0.02112058363854885
RB1 O 1 0.9998612403869629
gene O 1 0.9999302625656128
mutation O 1 0.9998923540115356
in O 0 0.0027470525819808245
a O 0 0.00714566046372056
child O 0 0.02697630226612091
with O 0 0.013421617448329926
ectopic B-Disease 1 0.9999985694885254
intracranial I-Disease 1 0.9999943971633911
retinoblastoma I-Disease 1 0.9998877048492432
. O 0 0.011171276681125164

The O 0 0.01778361201286316
RB1 O 1 0.9999264478683472
gene O 1 0.9999760389328003
mutation O 1 0.9999798536300659
was O 0 0.003190266666933894
investigated O 0 0.01278473436832428
in O 0 0.0014012587489560246
a O 0 0.00420742854475975
child O 0 0.024949923157691956
with O 0 0.01227995939552784
ectopic B-Disease 1 0.999998927116394
intracranial I-Disease 1 0.9999949932098389
retinoblastoma I-Disease 1 0.9999547004699707
using O 0 0.017358070239424706
DNA O 1 0.9993402361869812
obtained O 0 0.0046721710823476315
from O 0 0.000926524749957025
both O 0 0.0010441297199577093
the O 0 0.002274423372000456
pineal B-Disease 1 0.9998107552528381
and I-Disease 0 0.007765516638755798
retinal I-Disease 1 0.9999995231628418
tumours I-Disease 1 0.999990701675415
of O 0 0.0020306818187236786
the O 0 0.0036905850283801556
patient O 1 0.9997066855430603
. O 0 0.007356390357017517

A O 0 0.02689807303249836
nonsense O 1 0.5934947729110718
mutation O 1 0.9996993541717529
in O 0 0.004845267161726952
exon O 1 0.9948659539222717
17 O 0 0.017017841339111328
( O 0 0.007317889481782913
codon O 1 0.9968019723892212
556 O 0 0.44133955240249634
) O 0 0.003117175307124853
of O 0 0.0011167145567014813
the O 0 0.005257698707282543
RB1 O 1 0.9999938011169434
gene O 1 0.999861478805542
was O 0 0.003195358207449317
found O 0 0.003758529666811228
to O 0 0.000881012761965394
be O 0 0.0008054962963797152
present O 0 0.0029669529758393764
homozygously O 1 0.9792065620422363
in O 0 0.001251336419954896
both O 0 0.0015407900791615248
the O 0 0.00359616638161242
retinal B-Disease 1 0.9999936819076538
and I-Disease 0 0.002433731220662594
the I-Disease 0 0.006479079369455576
pineal I-Disease 1 0.9999644756317139
tumours I-Disease 1 0.9999896287918091
. O 0 0.010642017237842083

The O 0 0.0041664461605250835
same O 0 0.008507790975272655
mutation O 1 0.9999536275863647
was O 0 0.0021595859434455633
present O 0 0.0029742249753326178
heterozygously O 1 0.9869632124900818
in O 0 0.0010499436175450683
the O 0 0.0018281136872246861
DNA O 1 0.9992615580558777
from O 0 0.0012921341694891453
the O 0 0.0010374790290370584
constitutional O 0 0.008340789936482906
cells O 1 0.9992788434028625
of O 0 0.0010947224218398333
the O 0 0.0029943659901618958
patient O 1 0.9997709393501282
, O 0 0.002081185346469283
proving O 0 0.03663092479109764
it O 0 0.0009667574195191264
to O 0 0.0008339384221471846
be O 0 0.0009911837987601757
of O 0 0.0026041113305836916
germline O 1 0.9999223947525024
origin O 0 0.016840917989611626
. O 0 0.006028597243130207

The O 0 0.004968205466866493
initial O 0 0.036329541355371475
mutation O 1 0.9999783039093018
was O 0 0.0032537481747567654
shown O 0 0.00452413922175765
to O 0 0.0010044077644124627
have O 0 0.0009720770758576691
occurred O 0 0.006566385738551617
in O 0 0.0010382848558947444
the O 0 0.0028447310905903578
paternally O 1 0.9983816146850586
derived O 1 0.8111289739608765
RB1 O 1 0.9999579191207886
allele O 1 0.999453604221344
. O 0 0.012768970802426338

The O 0 0.013198541477322578
mutation O 1 0.999976396560669
is O 0 0.0025126258842647076
in O 0 0.0010400926694273949
an O 0 0.0012439050478860736
area O 0 0.0016037861350923777
of O 0 0.0006914946716278791
the O 0 0.002336822682991624
gene O 1 0.9997965693473816
that O 0 0.0019139159703627229
encodes O 1 0.9950605034828186
the O 0 0.004529018420726061
protein O 1 0.9999178647994995
- O 0 0.028898900374770164
binding O 0 0.071958027780056
region O 0 0.004284292459487915
known O 0 0.002972590969875455
as O 0 0.0009785756701603532
the O 0 0.0017739192117005587
pocket O 1 0.9953569769859314
region O 0 0.0039984071627259254
and O 0 0.0008711884147487581
has O 0 0.0013399343006312847
been O 0 0.0020419445354491472
detected O 1 0.8349192142486572
in O 0 0.001277487725019455
other O 0 0.0011647141072899103
cases O 0 0.008560148067772388
of O 0 0.004002313129603863
retinoblastoma B-Disease 1 0.9999836683273315
. O 0 0.005191992502659559
. O 0 0.006166753824800253

Low O 0 0.026130646467208862
levels O 0 0.013744085095822811
of O 0 0.00277752080000937
beta O 1 0.9932730197906494
hexosaminidase O 1 0.9798570275306702
A O 0 0.01035693846642971
in O 0 0.002823165850713849
healthy O 1 0.8470509648323059
individuals O 0 0.004898706451058388
with O 0 0.004349722992628813
apparent O 1 0.9977898597717285
deficiency O 1 0.999997615814209
of O 0 0.0016699574189260602
this O 0 0.003485952503979206
enzyme O 1 0.9996706247329712
. O 0 0.007918749004602432

Appreciable O 1 0.9603438377380371
beta O 1 0.9669660925865173
hexosaminidase O 1 0.9435655474662781
A O 0 0.015220507979393005
( O 0 0.005824099760502577
hex O 1 0.761091411113739
A O 0 0.013075792230665684
) O 0 0.0033037159591913223
activity O 0 0.0071443780325353146
has O 0 0.0014818832278251648
been O 0 0.0018924445612356067
detected O 0 0.4124965965747833
in O 0 0.0037827452179044485
cultured O 1 0.9997966885566711
skin O 1 0.9999946355819702
fibroblasts O 1 0.9999572038650513
and O 0 0.013615909963846207
melanoma B-Disease 1 1.0
tissue O 1 0.9999881982803345
from O 0 0.005030373111367226
healthy O 1 0.9748299717903137
individuals O 0 0.004170079715549946
previously O 0 0.0036633589770644903
reported O 0 0.005535138305276632
as O 0 0.00206026085652411
having O 0 0.010729492641985416
deficiency B-Disease 1 0.9999984502792358
of I-Disease 0 0.0017706073122099042
hex I-Disease 1 0.9595827460289001
A I-Disease 0 0.009374735876917839
activity O 0 0.009667221456766129
indistinguishable O 0 0.27063652873039246
from O 0 0.0012564348289743066
that O 0 0.0009046579361893237
of O 0 0.001643231837078929
patients O 1 0.9999411106109619
with O 0 0.0583866685628891
Tay B-Disease 1 0.9999997615814209
- I-Disease 1 0.9995495676994324
Sachs I-Disease 1 0.9999959468841553
disease I-Disease 1 0.9999964237213135
( O 0 0.016719412058591843
TSD B-Disease 1 0.9999361038208008
) O 0 0.009689890779554844
. O 0 0.006553076207637787

Identification O 0 0.04846997559070587
and O 0 0.004006200470030308
quantitation O 1 0.9915050864219666
of O 0 0.0026621923316270113
hex O 1 0.7548688650131226
A O 0 0.012104375287890434
, O 0 0.0020782086066901684
amounting O 0 0.020627716556191444
to O 0 0.0022855231072753668
3 O 0 0.011387919075787067
. O 0 0.007137677166610956

5 O 0 0.0240474920719862
% O 0 0.01574799418449402
- O 0 0.02771337702870369
6 O 0 0.015740064904093742
. O 0 0.007443080190569162

9 O 0 0.013765042647719383
% O 0 0.00396479107439518
of O 0 0.000980053679086268
total O 0 0.005231841001659632
beta O 1 0.9969964027404785
hexosaminidase O 1 0.9957531690597534
activity O 0 0.012439105659723282
, O 0 0.001270129345357418
has O 0 0.0010794650297611952
been O 0 0.0011704855132848024
obtained O 0 0.004727482795715332
by O 0 0.00420219823718071
cellulose O 1 0.9992904663085938
acetate O 1 0.9987404942512512
gel O 1 0.9995287656784058
electrophoresis O 1 0.9992693066596985
, O 0 0.006838603876531124
DEAE O 1 0.9989870190620422
- O 0 0.05786716565489769
cellulose O 1 0.9992294311523438
ion O 1 0.9910336136817932
- O 0 0.032912712544202805
exchange O 0 0.015096573159098625
chromatography O 1 0.994721531867981
, O 0 0.0055977157317101955
radial O 1 0.9998151659965515
immunodiffusion O 1 0.9960712194442749
, O 0 0.002855412196367979
and O 0 0.0027948736678808928
radioimmunoassay O 1 0.9960069060325623
. O 0 0.009287126362323761

Previous O 0 0.013844051398336887
family O 0 0.013652217574417591
studies O 0 0.009664760902523994
suggested O 0 0.006085814908146858
that O 0 0.0010107875568792224
these O 0 0.0012233899906277657
individuals O 0 0.0039217653684318066
may O 0 0.0030722282826900482
be O 0 0.001094262464903295
compound O 0 0.20132744312286377
heterozygotes O 1 0.9988768696784973
for O 0 0.0011671414831653237
the O 0 0.0015112664550542831
common O 0 0.030313357710838318
mutant O 1 0.9999526739120483
TSD B-Disease 1 0.9999843835830688
gene O 1 0.9997485280036926
and O 0 0.001757866470143199
a O 0 0.005743402522057295
rare O 0 0.029872216284275055
( O 0 0.005944829899817705
allelic O 1 0.999707043170929
) O 0 0.009713961742818356
mutant O 1 0.9997206330299377
gene O 1 0.9998403787612915
. O 0 0.009616915136575699

Thus O 0 0.011241083033382893
, O 0 0.0012838103575631976
the O 0 0.0018448092741891742
postulated O 1 0.6785960793495178
rate O 0 0.021082671359181404
mutant O 1 0.9998469352722168
gene O 1 0.9998929500579834
appears O 0 0.011646515689790249
to O 0 0.0011918495874851942
code O 0 0.009184906259179115
for O 0 0.0010893987491726875
the O 0 0.0011878404766321182
expression O 0 0.02077983133494854
of O 0 0.0010127322748303413
low O 0 0.008824060671031475
amounts O 0 0.008762235753238201
of O 0 0.0015609546098858118
hex O 1 0.928484320640564
A O 0 0.015498342923820019
. O 0 0.005568699445575476

Heterozygotes O 1 0.984645664691925
for O 0 0.002674458082765341
the O 0 0.0024423329159617424
rare O 0 0.102669358253479
mutant O 1 0.9994640946388245
may O 0 0.007184309884905815
be O 0 0.0018015570240095258
indistinguishable O 0 0.22248011827468872
from O 0 0.003796118078753352
heterozygotes O 1 0.9982450008392334
for O 0 0.0015202283393591642
the O 0 0.0019147705752402544
common O 0 0.13293233513832092
TSD B-Disease 1 0.9999361038208008
mutant O 1 0.9986335635185242
. O 0 0.012817242182791233

However O 0 0.006645889021456242
, O 0 0.0017962969141080976
direct O 0 0.009912789799273014
visualization O 1 0.5740591287612915
and O 0 0.0024264187086373568
quantitation O 1 0.9979287385940552
of O 0 0.001956253545358777
hex O 1 0.7645189762115479
A O 0 0.007671767845749855
by O 0 0.0014754567528143525
the O 0 0.001140064443461597
methods O 0 0.008871439844369888
described O 0 0.008059372194111347
may O 0 0.00578473974019289
prevent O 0 0.12177185714244843
false O 0 0.021045666188001633
- O 0 0.030410656705498695
positive O 1 0.7347998023033142
prenatal O 1 0.9999958276748657
diagnosis O 1 0.9999222755432129
of O 0 0.004435127135366201
TSD B-Disease 1 0.9999299049377441
in O 0 0.004793672356754541
fetuses O 1 0.9995700716972351
having O 0 0.004285712726414204
the O 0 0.001543008373118937
incomplete O 0 0.033492956310510635
hex B-Disease 1 0.9614943265914917
A I-Disease 0 0.05209316685795784
deficiency I-Disease 1 0.9999904632568359
of O 0 0.0014739892212674022
the O 0 0.0021849730983376503
type O 1 0.9076665639877319
described O 0 0.005769090726971626
in O 0 0.0010573132894933224
the O 0 0.0014000835362821817
four O 0 0.004900817293673754
healthy O 1 0.922426164150238
individuals O 0 0.0163295716047287

The O 0 0.02158268541097641
tumor B-Disease 1 0.9999970197677612
suppressor O 1 0.9999896287918091
gene O 1 0.9999600648880005
Smad4 O 1 0.9996040463447571
/ O 1 0.9270662665367126
Dpc4 O 1 0.9828672409057617
is O 0 0.0023102322593331337
required O 0 0.004596437327563763
for O 0 0.0025687608867883682
gastrulation O 1 0.9989670515060425
and O 0 0.0021189656108617783
later O 0 0.003031582571566105
for O 0 0.002884411718696356
anterior O 1 0.9996415376663208
development O 0 0.004840930458158255
of O 0 0.001030385959893465
the O 0 0.0042093913070857525
mouse O 1 0.9999059438705444
embryo O 1 0.9988816380500793
. O 0 0.009179193526506424

Mutations O 1 0.9996514320373535
in O 0 0.003430774202570319
the O 0 0.004143699072301388
SMAD4 O 1 0.9997230172157288
/ O 1 0.9964469075202942
DPC4 O 1 0.9998655319213867
tumor B-Disease 1 0.9999992847442627
suppressor O 1 0.9999909400939941
gene O 1 0.9998321533203125
, O 0 0.0020719405729323626
a O 0 0.003856141585856676
key O 0 0.006402483209967613
signal O 0 0.03830152750015259
transducer O 1 0.9949594736099243
in O 0 0.0015928561333566904
most O 0 0.002737569622695446
TGFbeta O 1 0.9997714161872864
- O 0 0.04754257574677467
related O 0 0.05914565920829773
pathways O 1 0.9999547004699707
, O 0 0.0015199597692117095
are O 0 0.0007076665642671287
involved O 0 0.004032987169921398
in O 0 0.0009892563102766871
50 O 0 0.0038058138452470303
% O 0 0.005754121579229832
of O 0 0.0066039953380823135
pancreatic B-Disease 1 0.9999998807907104
cancers I-Disease 1 0.999997615814209
. O 0 0.009966312907636166

Homozygous O 1 0.9965421557426453
Smad4 O 1 0.9955412745475769
mutant O 1 0.9993894100189209
mice O 1 0.9999064207077026
die O 1 0.8253391981124878
before O 0 0.00447004335001111
day O 0 0.003228329587727785
7 O 0 0.011388177052140236
. O 0 0.00612296350300312

5 O 0 0.014925896190106869
of O 0 0.003985240589827299
embryogenesis O 1 0.9893873929977417
. O 0 0.012574572116136551

Mutant O 1 0.9926002621650696
embryos O 0 0.4501565098762512
have O 0 0.003139579202979803
reduced O 0 0.017385663464665413
size O 0 0.009429659694433212
, O 0 0.0020700544118881226
fail O 0 0.030477941036224365
to O 0 0.002245725365355611
gastrulate O 1 0.9937042593955994
or O 0 0.0044889128766953945
express O 0 0.014832650311291218
a O 0 0.011252048425376415
mesodermal O 1 0.9997953772544861
marker O 1 0.7937710881233215
, O 0 0.002130563836544752
and O 0 0.0011973908403888345
show O 0 0.008813704364001751
abnormal O 1 0.9998058676719666
visceral O 1 0.998846173286438
endoderm O 1 0.998227059841156
development O 0 0.013984795659780502
. O 0 0.00561569444835186

Growth B-Disease 0 0.3697347640991211
retardation I-Disease 1 0.9981038570404053
of O 0 0.0020209266804158688
the O 0 0.0043436503037810326
Smad4 O 1 0.999154806137085
- O 0 0.3009680211544037
deficient O 1 0.9989462494850159
embryos O 1 0.8554710745811462
results O 0 0.012524234130978584
from O 0 0.0032154922373592854
reduced O 0 0.05231313407421112
cell O 1 0.9995383024215698
proliferation O 1 0.7087663412094116
rather O 0 0.0032891363371163607
than O 0 0.0022067376412451267
increased O 0 0.02004706673324108
apoptosis O 1 0.999911904335022
. O 0 0.008351149037480354

Aggregation O 1 0.6029850840568542
of O 0 0.006458472926169634
mutant O 1 0.9979390501976013
Smad4 O 1 0.9985602498054504
ES O 1 0.9981573224067688
cells O 1 0.9982925057411194
with O 0 0.005155947990715504
wild O 0 0.032780569046735764
- O 0 0.03092191368341446
type O 1 0.7375698685646057
tetraploid O 1 0.9982668161392212
morulae O 1 0.9774128794670105
rescues O 0 0.43806347250938416
the O 0 0.007905274629592896
gastrulation B-Disease 1 0.9994202852249146
defect I-Disease 1 0.9991371035575867
. O 0 0.010750208050012589

These O 0 0.003674166975542903
results O 0 0.011661207303404808
indicate O 0 0.010803074575960636
that O 0 0.0021449632477015257
Smad4 O 1 0.9965996146202087
is O 0 0.0018232353031635284
initially O 0 0.0036989457439631224
required O 0 0.002963123144581914
for O 0 0.0007540513179264963
the O 0 0.0015389630571007729
differentiation O 1 0.9985927939414978
of O 0 0.0010645468719303608
the O 0 0.0028102637734264135
visceral O 1 0.9992881417274475
endoderm O 1 0.9987404942512512
and O 0 0.0012243470409885049
that O 0 0.0010321233421564102
the O 0 0.0027446786407381296
gastrulation B-Disease 1 0.9998310804367065
defect I-Disease 1 0.9997287392616272
in O 0 0.0019115271279588342
the O 0 0.002512838691473007
epiblast O 1 0.9996930360794067
is O 0 0.0028852124232798815
secondary O 0 0.025406967848539352
and O 0 0.0016576192574575543
non O 0 0.01362826768308878
- O 0 0.10284208506345749
cell O 1 0.9979853630065918
autonomous O 0 0.018160223960876465
. O 0 0.006370185408741236

Rescued O 0 0.13054752349853516
embryos O 1 0.5766017436981201
show O 0 0.019543131813406944
severe O 1 0.9976997971534729
anterior O 1 0.9998753070831299
truncations O 1 0.9992963075637817
, O 0 0.00267776963301003
indicating O 0 0.019114209339022636
a O 0 0.0038816803134977818
second O 0 0.0038138527888804674
important O 0 0.0024598015006631613
role O 0 0.005958684254437685
for O 0 0.0029644600581377745
Smad4 O 1 0.991817057132721
in O 0 0.006282223388552666
anterior O 1 0.9998413324356079
patterning O 1 0.9994691014289856
during O 0 0.014735314063727856
embryogenesis O 1 0.9970189332962036
. O 0 0.009279882535338402

Prevalence O 1 0.9847301840782166
of O 0 0.0058277565985918045
p16 O 1 0.9992244243621826
and O 0 0.006466861814260483
CDK4 O 1 0.999565064907074
germline O 1 0.9999734163284302
mutations O 1 0.9998921155929565
in O 0 0.006490446161478758
48 O 1 0.7272483706474304
melanoma B-Disease 1 0.9999998807907104
- O 0 0.3399542570114136
prone O 1 0.9338001608848572
families O 0 0.0081900330260396
in O 0 0.0025838271249085665
France O 0 0.01068897731602192
. O 0 0.006417382042855024

The O 0 0.009309929795563221
French O 1 0.5888709425926208
Familial B-Disease 1 0.9999995231628418
Melanoma I-Disease 1 0.9999996423721313
Study O 0 0.027583327144384384
Group O 0 0.010978044010698795
. O 0 0.005394349340349436

Germline O 1 0.9999306201934814
mutations O 1 0.9995957016944885
in O 0 0.0023053139448165894
the O 0 0.00312467641197145
p16 O 1 0.9999200105667114
and O 0 0.0036531216464936733
CDK4 O 1 0.9996080994606018
genes O 1 0.9995470643043518
have O 0 0.0017093144124373794
been O 0 0.0013506871182471514
reported O 0 0.004458107985556126
in O 0 0.0009280647500418127
a O 0 0.004405660089105368
subset O 1 0.927698016166687
of O 0 0.00485330680385232
melanoma B-Disease 1 0.9999998807907104
pedigrees O 1 0.9993799924850464
, O 0 0.0018959344597533345
but O 0 0.001271420274861157
their O 0 0.0027040510904043913
prevalence O 1 0.999922513961792
is O 0 0.0022135600447654724
not O 0 0.0011973731452599168
well O 0 0.0020080874674022198
known O 0 0.007366606499999762
. O 0 0.0050811623223125935

We O 0 0.0030485319439321756
searched O 0 0.010000528767704964
for O 0 0.0017130873166024685
such O 0 0.004972039721906185
germline O 1 0.9999896287918091
mutations O 1 0.9999454021453857
in O 0 0.0035095498897135258
48 O 0 0.022591449320316315
French O 1 0.9577523469924927
melanoma B-Disease 1 0.9999998807907104
- O 1 0.6800745129585266
prone O 1 0.9779110550880432
families O 0 0.005653916392475367
selected O 0 0.003435622900724411
according O 0 0.0015139903407543898
to O 0 0.0008604619652032852
two O 0 0.0015158599708229303
major O 0 0.005652053747326136
criteria O 0 0.009135810658335686
families O 0 0.004234922118484974
with O 0 0.002125029917806387
at O 0 0.0016474277945235372
least O 0 0.0024631593842059374
three O 0 0.0018796068616211414
affected O 0 0.011121593415737152
members O 0 0.002492401748895645
( O 0 0.005451043136417866
n O 1 0.7607255578041077
= O 0 0.11583859473466873
20 O 0 0.006183641031384468
) O 0 0.002860343549400568
or O 0 0.002682283753529191
families O 0 0.0035433887969702482
with O 0 0.0018064765026792884
two O 0 0.0019552286248654127
affected O 0 0.013610657304525375
members O 0 0.0013770845253020525
, O 0 0.0007845096406526864
one O 0 0.0008910074247978628
of O 0 0.0006211829022504389
them O 0 0.0015038978308439255
affected O 0 0.012122688814997673
before O 0 0.0015256627229973674
the O 0 0.0009622661746107042
age O 0 0.003244539722800255
of O 0 0.0009535317658446729
50 O 0 0.006164791993796825
( O 0 0.0061838929541409016
n O 1 0.7157210111618042
= O 1 0.6557495594024658
28 O 0 0.011968950740993023
) O 0 0.0032901931554079056
, O 0 0.0010515813482925296
and O 0 0.0007992542232386768
one O 0 0.002244755392894149
additional O 0 0.008230837993323803
minor O 0 0.13811556994915009
criterion O 0 0.22892414033412933
. O 0 0.007290360983461142

Sixteen O 0 0.02576928399503231
different O 0 0.011895759031176567
p16 O 1 0.9998785257339478
germline O 1 0.9999804496765137
mutations O 1 0.9999589920043945
were O 0 0.001619892311282456
found O 0 0.003771641757339239
in O 0 0.001242677797563374
21 O 0 0.00686243548989296
families O 0 0.004471541848033667
, O 0 0.0011244580382481217
while O 0 0.0017045586137101054
one O 0 0.005479248706251383
germline O 1 0.9999984502792358
mutation O 1 0.9999946355819702
, O 0 0.004545736126601696
Arg24His O 1 0.998088538646698
, O 0 0.0017813838785514235
was O 0 0.0024074569810181856
detected O 0 0.2452457845211029
in O 0 0.0014032397884875536
the O 0 0.003746894421055913
CDK4 O 1 0.999848484992981
gene O 1 0.9997897744178772
. O 0 0.0093926303088665

The O 0 0.00520204147323966
frequency O 0 0.029869085177779198
of O 0 0.004224629141390324
p16 O 1 0.9999531507492065
gene O 1 0.9999730587005615
mutation O 1 0.9999336004257202
in O 0 0.0016627878649160266
our O 0 0.0024517669808119535
sample O 0 0.020687613636255264
( O 0 0.004593410063534975
44 O 0 0.013379346579313278
% O 0 0.00628278311342001
) O 0 0.0026508343871682882
is O 0 0.001079039415344596
among O 0 0.0012358915992081165
the O 0 0.0010679353727027774
highest O 0 0.00459493650123477
rates O 0 0.012804604135453701
yet O 0 0.003238893114030361
reported O 0 0.004580323584377766
and O 0 0.000834612175822258
the O 0 0.0025900269392877817
CDK4 O 1 0.9999337196350098
mutation O 1 0.9999868869781494
is O 0 0.0013947556726634502
the O 0 0.0011542999418452382
second O 0 0.011016485281288624
mutation O 1 0.9999969005584717
detected O 1 0.9253210425376892
in O 0 0.0016779068391770124
this O 0 0.002758047077804804
gene O 1 0.9998338222503662
worldwide O 0 0.026574956253170967
. O 0 0.006406276486814022

In O 0 0.0055119870230555534
summary O 0 0.019919080659747124
, O 0 0.0016152168391272426
our O 0 0.002191321924328804
results O 0 0.008205116726458073
show O 0 0.0037854344118386507
frequent O 0 0.020826108753681183
involvement O 0 0.0132762985303998
of O 0 0.001004312071017921
the O 0 0.004257014021277428
p16 O 1 0.9999785423278809
gene O 1 0.999866247177124
in O 0 0.01623888686299324
familial B-Disease 1 0.9999990463256836
melanoma I-Disease 1 0.9999996423721313
and O 0 0.0021768680308014154
confirm O 0 0.00863046757876873
the O 0 0.001326075871475041
role O 0 0.004352080635726452
of O 0 0.0008009173325262964
the O 0 0.0028230261523276567
CDK4 O 1 0.9995898604393005
gene O 1 0.9997647404670715
as O 0 0.004020415246486664
a O 0 0.07546620070934296
melanoma B-Disease 1 0.9999998807907104
- O 1 0.9531840682029724
predisposing O 1 0.999969482421875
gene O 1 0.9998940229415894
. O 0 0.004994486924260855
. O 0 0.005899916402995586

Progression O 1 0.9959402084350586
of O 0 0.005776255391538143
somatic O 1 0.9994675517082214
CTG O 1 0.9976981282234192
repeat O 0 0.19804908335208893
length O 0 0.020047219470143318
heterogeneity O 1 0.9845439791679382
in O 0 0.0017100322293117642
the O 0 0.0035985400900244713
blood O 1 0.9999384880065918
cells O 1 0.9997524619102478
of O 0 0.012702396139502525
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.999853253364563
. O 0 0.009718530811369419

The O 0 0.008138308301568031
genetic O 1 0.9935990571975708
basis O 0 0.00752189289778471
of O 0 0.007669313810765743
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
( O 0 0.035597220063209534
DM B-Disease 1 0.9999948740005493
) O 0 0.0045322529040277
is O 0 0.0011122534051537514
the O 0 0.0008488447056151927
expansion O 0 0.00593462074175477
of O 0 0.0007439574110321701
an O 0 0.002716337563470006
unstable O 1 0.9969411492347717
CTG O 1 0.9993778467178345
repeat O 0 0.13242340087890625
in O 0 0.0015162201598286629
the O 0 0.001829777960665524
34 O 0 0.015562206506729126
UTR O 1 0.8784418106079102
of O 0 0.0018025081371888518
the O 0 0.005709741730242968
DM B-Disease 1 0.9999632835388184
protein O 1 0.9998131394386292
kinase O 1 0.9999202489852905
gene O 1 0.9994499087333679
on O 0 0.00624013552442193
chromosome O 1 0.9999309778213501
19 O 0 0.01862558349967003
. O 0 0.005622947588562965

One O 0 0.0033412643242627382
of O 0 0.0007874220027588308
the O 0 0.0011194577673450112
principal O 0 0.005620297510176897
features O 0 0.0041917250491678715
of O 0 0.001092709368094802
the O 0 0.005838485434651375
DM B-Disease 1 0.9999970197677612
mutation O 1 0.9999905824661255
is O 0 0.0023427812848240137
an O 0 0.001750430092215538
extraordinarily O 0 0.04194182530045509
high O 0 0.0036602236796170473
level O 0 0.0026391714345663786
of O 0 0.0023289432283490896
somatic O 1 0.9999784231185913
mosaicism O 1 0.9999738931655884
, O 0 0.0026048868894577026
due O 0 0.0038348177913576365
to O 0 0.0009499783627688885
an O 0 0.0013467937242239714
extremely O 0 0.008973815478384495
high O 0 0.004524707794189453
degree O 0 0.007577535230666399
of O 0 0.0022466809023171663
somatic O 1 0.9999662637710571
instability O 1 0.946003258228302
both O 0 0.001526553649455309
within O 0 0.001964324852451682
and O 0 0.0007366710342466831
between O 0 0.0021500885486602783
different O 0 0.004743983969092369
tissues O 1 0.9998430013656616
. O 0 0.008236713707447052

This O 0 0.0075735487043857574
instability O 1 0.8677554726600647
appears O 0 0.013409877195954323
to O 0 0.0011853629257529974
be O 0 0.001229765941388905
biased O 0 0.017009083181619644
towards O 0 0.003116077743470669
further O 0 0.0028685969300568104
expansion O 0 0.007875596173107624
and O 0 0.0009799032704904675
continuous O 0 0.019668366760015488
throughout O 0 0.0016774899559095502
the O 0 0.0009165237424895167
life O 0 0.0028445441275835037
of O 0 0.0007071825675666332
an O 0 0.001316166715696454
individual O 0 0.0049238745123147964
, O 0 0.0010638609528541565
features O 0 0.004055398982018232
that O 0 0.0008682241314090788
could O 0 0.0019058662001043558
be O 0 0.000887095055077225
associated O 0 0.005519503727555275
with O 0 0.0015609657857567072
the O 0 0.0016575261252000928
progressive O 0 0.10968337208032608
nature O 0 0.005552143789827824
of O 0 0.001306624268181622
the O 0 0.006111208815127611
disease O 1 0.9999914169311523
. O 0 0.010233400389552116

Although O 0 0.008549360558390617
increasing O 0 0.011445282958447933
measured O 0 0.025158192962408066
allele O 1 0.9995187520980835
size O 0 0.013329117558896542
between O 0 0.00739970663562417
patients O 1 0.9989134073257446
clearly O 0 0.008400087244808674
correlates O 1 0.9472194910049438
with O 0 0.002207865472882986
an O 0 0.0018092599930241704
increased O 0 0.014892925508320332
severity O 1 0.9979984164237976
of O 0 0.004222848452627659
symptoms O 1 0.9999884366989136
and O 0 0.0011009853333234787
an O 0 0.0011671086540445685
earlier O 0 0.0035060876980423927
age O 0 0.004605915397405624
of O 0 0.0029126987792551517
onset O 1 0.9999923706054688
, O 0 0.0016325667966157198
this O 0 0.00170793232973665
correlation O 1 0.9959261417388916
is O 0 0.001294957473874092
not O 0 0.000943889026530087
precise O 0 0.014284800738096237
and O 0 0.0014684231719002128
measured O 0 0.027050308883190155
allele O 1 0.9999428987503052
length O 0 0.01427309587597847
cannot O 0 0.0031608338467776775
be O 0 0.000795909611042589
used O 0 0.0019604037515819073
as O 0 0.0010046111419796944
an O 0 0.0014348250115290284
accurate O 0 0.01490030251443386
predictor O 1 0.9969649910926819
of O 0 0.0015485221520066261
age O 0 0.005468838848173618
of O 0 0.0036346239503473043
onset O 1 0.9999575614929199
. O 0 0.008987327106297016

In O 0 0.0038766057696193457
order O 0 0.0032807025127112865
to O 0 0.0012203498044982553
further O 0 0.0037412219680845737
characterize O 0 0.05223840847611427
the O 0 0.0027219478506594896
dynamics O 0 0.25415387749671936
of O 0 0.005114808678627014
DM B-Disease 1 0.99998939037323
CTG O 1 0.9993569254875183
repeat O 1 0.9936873316764832
somatic O 1 0.9998693466186523
instability O 1 0.9919360876083374
, O 0 0.0015746902208775282
we O 0 0.0007324376492761075
have O 0 0.0009775124490261078
studied O 0 0.006921531166881323
repeat O 0 0.3049118220806122
length O 0 0.012030473910272121
changes O 0 0.005089591722935438
over O 0 0.0012175367446616292
time O 0 0.001585646765306592
in O 0 0.0033027566969394684
111 O 1 0.9986521601676941
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.9996404647827148
with O 0 0.0044411043636500835
varying O 0 0.03079817444086075
clinical O 1 0.999907374382019
severity O 1 0.9965344667434692
and O 0 0.0033661052584648132
CTG O 1 0.9996718168258667
repeat O 0 0.34060922265052795
size O 0 0.008490756154060364
over O 0 0.0015512531390413642
time O 0 0.001953896600753069
intervals O 0 0.021178752183914185
of O 0 0.0017236408311873674
1 O 0 0.012279525399208069
- O 0 0.019828354939818382
7 O 0 0.013323655351996422
years O 0 0.004052409436553717
. O 0 0.006305616814643145

We O 0 0.002721671247854829
have O 0 0.0010006169322878122
found O 0 0.003305071033537388
a O 0 0.004282512702047825
direct O 0 0.01246088556945324
progression O 1 0.9995459914207458
of O 0 0.0008180345757864416
the O 0 0.0012648934498429298
size O 0 0.01225073542445898
heterogeneity O 1 0.9974029660224915
over O 0 0.0021113159600645304
time O 0 0.00169945671223104
related O 0 0.006289365701377392
to O 0 0.0016646997537463903
initial O 0 0.027520153671503067
CTG O 1 0.9995132684707642
repeat O 1 0.6479095220565796
size O 0 0.007480733562260866
and O 0 0.0008177863201126456
the O 0 0.0011625150218605995
time O 0 0.0023771915584802628
interval O 0 0.3136148154735565
and O 0 0.0012001431314274669
always O 0 0.002327467780560255
biased O 0 0.017316428944468498
towards O 0 0.00342793227173388
further O 0 0.0038039337377995253
expansion O 0 0.015103296376764774
. O 0 0.005173924844712019

Attempts O 0 0.026029150933027267
to O 0 0.002554452745243907
mathematically O 0 0.041044682264328
model O 0 0.00995064340531826
the O 0 0.001865578698925674
dynamics O 1 0.6434623003005981
have O 0 0.001293074805289507
proved O 0 0.0075454371981322765
only O 0 0.0013694609515368938
partially O 0 0.025158986449241638
successful O 0 0.010015774518251419
suggesting O 0 0.00968764815479517
that O 0 0.0007003038772381842
individual O 0 0.003407853888347745
specific O 0 0.011663037352263927
genetic O 1 0.99997878074646
and O 0 0.0024808531161397696
/ O 1 0.972200870513916
or O 0 0.004496416077017784
environmental O 0 0.010339387692511082
factors O 0 0.013436134904623032
also O 0 0.0011641473975032568
play O 0 0.0024113261606544256
a O 0 0.004439506214112043
role O 0 0.006997980643063784
in O 0 0.004248966928571463
somatic O 1 0.9999487400054932
mosaicism O 1 0.9998525381088257
. O 0 0.005418764427304268
. O 0 0.005128548946231604

Aspartylglucosaminuria B-Disease 1 0.9590347409248352
among O 0 0.008272762410342693
Palestinian O 0 0.016804702579975128
Arabs O 0 0.0187781173735857
. O 0 0.0071778129786252975

Aspartylglucosaminuria B-Disease 1 0.998100221157074
( O 0 0.02736901119351387
AGU B-Disease 1 0.9999611377716064
) O 0 0.004939415026456118
is O 0 0.001534114358946681
a O 0 0.006608257535845041
rare O 0 0.2197946012020111
disorder B-Disease 1 0.9998786449432373
of I-Disease 0 0.003079951973631978
glycoprotein I-Disease 1 0.9999651908874512
metabolism I-Disease 1 0.9999568462371826
caused O 0 0.10349273681640625
by O 0 0.0022566518746316433
the O 0 0.0032451024744659662
deficiency B-Disease 1 0.9999977350234985
of I-Disease 0 0.0013826248468831182
the I-Disease 0 0.003611520165577531
lysosomal I-Disease 1 0.9999773502349854
enzyme I-Disease 1 0.9999215602874756
aspartylglucosaminidase I-Disease 1 0.9962806105613708
( O 0 0.012161471880972385
AGA O 1 0.9981916546821594
) O 0 0.006943900603801012
. O 0 0.006123454309999943

AGU B-Disease 1 0.9996129870414734
is O 0 0.00991609413176775
inherited O 1 0.8531310558319092
as O 0 0.0029778426978737116
an O 0 0.00860228855162859
autosomal O 1 1.0
recessive O 1 0.9999997615814209
trait O 1 0.9997995495796204
and O 0 0.00205431436188519
occurs O 0 0.05554124712944031
with O 0 0.0022410249803215265
a O 0 0.0050699301064014435
high O 0 0.00571223022416234
frequency O 0 0.03397535905241966
in O 0 0.0015561745967715979
Finland O 0 0.007610988803207874
because O 0 0.0022205791901797056
of O 0 0.0007774430559948087
a O 0 0.007300748489797115
founder O 0 0.03324204310774803
effect O 0 0.02163480408489704
. O 0 0.0065530212596058846

While O 0 0.006119824945926666
very O 0 0.004448734689503908
few O 0 0.005878794007003307
patients O 1 0.9995821118354797
with O 0 0.00889664888381958
AGU B-Disease 1 0.9999773502349854
have O 0 0.0022842404432594776
been O 0 0.0018453309312462807
reported O 0 0.00612171646207571
from O 0 0.002386597217991948
non O 0 0.010655838996171951
- O 0 0.01456809975206852
Finnish O 0 0.027963390573859215
origin O 0 0.006698483135551214
, O 0 0.0013728576013818383
we O 0 0.0027844232972711325
diagnosed O 1 0.9999923706054688
the O 0 0.004956178832799196
disorder O 1 0.9999933242797852
in O 0 0.003060706192627549
8 O 0 0.01659083552658558
patients O 1 0.99933260679245
originating O 0 0.036443114280700684
from O 0 0.0025719772092998028
3 O 0 0.011860278435051441
unrelated O 1 0.8887221813201904
families O 0 0.005818996578454971
, O 0 0.0009302349062636495
all O 0 0.0008365641697309911
Palestinian O 0 0.007529966998845339
Arabs O 0 0.006567732896655798
from O 0 0.001502289087511599
the O 0 0.0011977917747572064
region O 0 0.0027394755743443966
of O 0 0.0012772863265126944
Jerusalem O 0 0.009995812550187111
. O 0 0.005365242250263691

The O 0 0.012024938128888607
clinical O 1 0.999691367149353
diagnosis O 1 0.9999454021453857
of O 0 0.005761702079325914
AGU B-Disease 1 0.9999808073043823
is O 0 0.004193515051156282
often O 0 0.0033607683144509792
difficult O 0 0.005499877035617828
, O 0 0.0010274089872837067
in O 0 0.0009118893067352474
particular O 0 0.0035526948049664497
early O 0 0.0029359327163547277
in O 0 0.0007918366463854909
the O 0 0.0009834816446527839
course O 0 0.0045875380747020245
of O 0 0.0008132665534503758
the O 0 0.004752950742840767
disease O 1 0.9999991655349731
, O 0 0.0014870966551825404
and O 0 0.0005391211016103625
most O 0 0.0006277815555222332
of O 0 0.0006764227873645723
the O 0 0.0031261725816875696
patients O 1 0.9999819993972778
are O 0 0.003493532072752714
diagnosed O 1 0.9999942779541016
after O 0 0.0050356280989944935
the O 0 0.0013857041485607624
age O 0 0.004043122287839651
of O 0 0.0013470896519720554
5 O 0 0.0081709586083889
years O 0 0.0037687637377530336
. O 0 0.004604953341186047

However O 0 0.008258286863565445
, O 0 0.0017325908411294222
since O 0 0.003246872453019023
these O 0 0.0035507166758179665
patients O 1 0.9997574687004089
excrete O 1 0.9993529915809631
early O 0 0.00466105667874217
large O 0 0.002910065930336714
amounts O 0 0.006590608041733503
of O 0 0.001361373346298933
aspartylglucosamine O 1 0.9926542043685913
in O 0 0.00290723517537117
urine O 1 0.9996329545974731
, O 0 0.0036786035634577274
biochemical O 1 0.9998669624328613
screening O 1 0.907228946685791
is O 0 0.0019527615513652563
easy O 0 0.0082405349239707
by O 0 0.004677576012909412
urine O 1 0.9996494054794312
chromatography O 1 0.9976654052734375
. O 0 0.0035530778113752604
. O 0 0.004785644356161356

Detection O 0 0.4075852930545807
of O 0 0.00416774395853281
heterozygous O 1 0.9994533658027649
carriers O 0 0.055127307772636414
of O 0 0.001406155526638031
the O 0 0.006272490601986647
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9917324781417847
telangiectasia I-Disease 1 0.9999933242797852
( O 0 0.012192076072096825
ATM O 1 0.9973410964012146
) O 0 0.007525545544922352
gene O 1 0.9995512366294861
by O 0 0.0070104640908539295
G2 O 1 0.9997524619102478
phase O 0 0.4421049952507019
chromosomal O 1 0.999942421913147
radiosensitivity O 1 0.9223633408546448
of O 0 0.004680969286710024
peripheral O 1 0.9999748468399048
blood O 1 0.9999552965164185
lymphocytes O 1 0.9999288320541382
. O 0 0.009899643249809742

In O 0 0.02438761480152607
ataxia B-Disease 1 0.9999953508377075
- I-Disease 1 0.9679709076881409
telangiectasia I-Disease 1 0.9999747276306152
( O 0 0.012136949226260185
A B-Disease 1 0.6018581986427307
- I-Disease 1 0.980363667011261
T I-Disease 1 0.9999815225601196
) O 0 0.010299216955900192
patients O 1 0.9992501139640808
, O 0 0.0030597855802625418
mutations O 1 0.9999847412109375
in O 0 0.0014818748459219933
a O 0 0.004433840978890657
single O 0 0.037336334586143494
gene O 1 0.9999791383743286
, O 0 0.0027348955627530813
ATM O 1 0.9977295994758606
, O 0 0.0014729102840647101
result O 0 0.006256846245378256
in O 0 0.002001300686970353
an O 0 0.014949431642889977
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
that O 0 0.00192910002078861
embraces O 0 0.028571639209985733
a O 0 0.004193318076431751
variety O 0 0.004357495345175266
of O 0 0.0016787818167358637
clinical O 1 0.9995972514152527
features O 0 0.006458239629864693
and O 0 0.001824387931264937
manifests O 1 0.9868211150169373
extreme O 0 0.038888413459062576
radiosensitivity O 1 0.9942804574966431
and O 0 0.0015453362138941884
a O 0 0.004924870561808348
strong O 0 0.007343966979533434
pre O 0 0.3583866059780121
- O 0 0.036370933055877686
disposition O 1 0.561009407043457
to O 0 0.007348928600549698
malignancy B-Disease 1 0.999925971031189
. O 0 0.010471674613654613

Heterozygotes O 1 0.9774086475372314
for O 0 0.0028496342711150646
the O 0 0.0032132372725754976
ATM O 1 0.9991158843040466
gene O 1 0.9997561573982239
have O 0 0.0020729643292725086
no O 0 0.0031455543357878923
clinical O 1 0.9947288632392883
expression O 0 0.015745848417282104
of O 0 0.001257693744264543
A B-Disease 1 0.665140688419342
- I-Disease 1 0.9619107246398926
T I-Disease 1 0.9999443292617798
but O 0 0.0028414418920874596
may O 0 0.006073550786823034
be O 0 0.0056222910061478615
cancer B-Disease 1 0.9999992847442627
prone O 1 0.9480646848678589
with O 0 0.0029502594843506813
a O 0 0.00702087115496397
moderate O 0 0.016581682488322258
increase O 0 0.006368984933942556
in O 0 0.0015683791134506464
in O 0 0.004047631286084652
vitro O 1 0.9994587302207947
radiosensitivity O 1 0.9927565455436707
. O 0 0.010916847735643387

We O 0 0.003549507586285472
performed O 0 0.006971311755478382
a O 0 0.0098906634375453
blind O 1 0.7065826058387756
chromosomal O 1 0.9999446868896484
analysis O 0 0.024327687919139862
on O 0 0.004462976008653641
G2 O 1 0.9999428987503052
- O 0 0.053574781864881516
phase O 0 0.49810877442359924
lymphocytes O 1 0.9998195767402649
from O 0 0.002689444227144122
7 O 0 0.009859804064035416
unrelated O 1 0.9769129753112793
A B-Disease 1 0.8212117552757263
- I-Disease 1 0.9954328536987305
T I-Disease 1 0.9999901056289673
patients O 1 0.9988706707954407
, O 0 0.002031744224950671
13 O 0 0.00885852612555027
obligate O 1 0.9961403012275696
A B-Disease 0 0.40571802854537964
- I-Disease 1 0.9498766660690308
T I-Disease 1 0.9999725818634033
heterozygotes O 1 0.9997465014457703
( O 0 0.004158577416092157
parents O 0 0.004494147375226021
of O 0 0.0007877230527810752
the O 0 0.003939167596399784
patients O 1 0.9999831914901733
) O 0 0.0037857124116271734
, O 0 0.000990979839116335
and O 0 0.000817903142888099
14 O 0 0.0052829342894256115
normal O 0 0.01932414248585701
controls O 0 0.0185722503811121
following O 0 0.009475468657910824
X O 1 0.994647204875946
- O 0 0.03559672459959984
irradiation O 1 0.9832367300987244
with O 0 0.005327268037945032
1 O 0 0.012305021286010742
Gy O 1 0.9956973791122437
in O 0 0.001834808150306344
order O 0 0.0025284448638558388
to O 0 0.0012208092957735062
evaluate O 0 0.01753913052380085
this O 0 0.002582559362053871
cytogenetic O 1 0.9998730421066284
method O 0 0.01550345215946436
as O 0 0.0013324939645826817
a O 0 0.004515509586781263
tool O 0 0.018436653539538383
for O 0 0.0027551394887268543
detection O 1 0.6868197917938232
of O 0 0.003582007484510541
ATM O 1 0.9979366064071655
carriers O 1 0.5896121859550476
. O 0 0.007515442091971636

Both O 0 0.008504304103553295
A B-Disease 0 0.05659758672118187
- I-Disease 1 0.8438741564750671
T I-Disease 1 0.9999001026153564
homozygotes O 1 0.998554527759552
and O 0 0.004984700586646795
heterozygotes O 1 0.9974623918533325
showed O 0 0.011220759712159634
significantly O 0 0.023277509957551956
increased O 0 0.007929091341793537
levels O 0 0.009692160412669182
of O 0 0.0027339395601302385
radiation O 1 0.9999383687973022
- O 1 0.9184966683387756
induced O 1 0.9999635219573975
chromatid O 1 0.9999481439590454
damage O 1 0.5174462199211121
relative O 0 0.009523016400635242
to O 0 0.0008030299795791507
that O 0 0.0007763558533042669
of O 0 0.0014071293408051133
normal O 0 0.08407867699861526
controls O 0 0.03027273528277874
. O 0 0.006554113235324621

These O 0 0.003317819908261299
results O 0 0.007454713806509972
show O 0 0.0025127704720944166
that O 0 0.00100738147739321
the O 0 0.003473939374089241
G2 O 1 0.9999758005142212
- O 0 0.037719856947660446
phase O 1 0.6925229430198669
chromosomal O 1 0.9999877214431763
radiosensitivity O 1 0.9988114833831787
assay O 1 0.9964814186096191
can O 0 0.0029050465673208237
be O 0 0.0007467580144293606
used O 0 0.0016258801333606243
for O 0 0.0007049482082948089
the O 0 0.0013217257801443338
detection O 1 0.9642329812049866
of O 0 0.0018316234927624464
A B-Disease 1 0.6476544141769409
- I-Disease 1 0.9117757678031921
T I-Disease 1 0.9999358654022217
heterozygotes O 1 0.9980613589286804
. O 0 0.010984444990754128

In O 0 0.004437342751771212
combination O 0 0.04473567381501198
with O 0 0.004948410205543041
molecular O 1 0.9999247789382935
genetic O 1 0.9999562501907349
analyses O 0 0.05261823907494545
, O 0 0.0011024499544873834
this O 0 0.0011058493983000517
test O 0 0.01744154468178749
may O 0 0.0032221563160419464
be O 0 0.0004242433060426265
of O 0 0.00044101427192799747
value O 0 0.001584855723194778
in O 0 0.0008513294160366058
studies O 0 0.008527570404112339
of O 0 0.0023421940859407187
familial B-Disease 1 0.9999960660934448
and I-Disease 0 0.004201256204396486
sporadic I-Disease 1 0.9979523420333862
cancers I-Disease 1 0.9999961853027344
aimed O 0 0.015173450112342834
at O 0 0.0020354939624667168
determination O 0 0.005858902353793383
of O 0 0.0005377336638048291
the O 0 0.0011589752975851297
potential O 0 0.014840939082205296
involvement O 0 0.013467795215547085
of O 0 0.0024041791912168264
ATM O 1 0.9997996687889099
mutations O 1 0.9999847412109375
in O 0 0.012921702116727829
tumor B-Disease 1 0.9999997615814209
risk O 1 0.9988104104995728
or O 0 0.005263787228614092
development O 0 0.006083562504500151
. O 0 0.00259458483196795
. O 0 0.004602076485753059

Ataxia B-Disease 1 0.9999967813491821
- I-Disease 1 0.9829482436180115
telangiectasia I-Disease 1 0.9999586343765259
: O 0 0.009621012955904007
identification O 0 0.020002905279397964
and O 0 0.001895436435006559
detection O 1 0.9369031190872192
of O 0 0.0015734904445707798
founder O 0 0.09414149820804596
- O 0 0.02456551231443882
effect O 0 0.032597336918115616
mutations O 1 0.999967098236084
in O 0 0.0017142025753855705
the O 0 0.002553845290094614
ATM O 1 0.9996753931045532
gene O 1 0.9998219609260559
in O 0 0.002140255179256201
ethnic O 0 0.008848275989294052
populations O 0 0.03779502213001251
. O 0 0.006989579182118177

To O 0 0.0029833107255399227
facilitate O 0 0.01586454175412655
the O 0 0.0014760743360966444
evaluation O 0 0.016438273712992668
of O 0 0.0016742191510275006
ATM O 1 0.9994646906852722
heterozygotes O 1 0.9987105131149292
for O 0 0.003586638020351529
susceptibility O 1 0.9999401569366455
to O 0 0.0018695963080972433
other O 0 0.0038316952995955944
diseases O 1 0.9999971389770508
, O 0 0.001425928552635014
such O 0 0.0028112675063312054
as O 0 0.05449232459068298
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.0018542952602729201
we O 0 0.0007974476902745664
have O 0 0.0009028839413076639
attempted O 0 0.008282125927507877
to O 0 0.0008332958095706999
define O 0 0.006552449893206358
the O 0 0.0008149698260240257
most O 0 0.0013909339904785156
common O 0 0.2900135815143585
mutations O 1 0.9999960660934448
and O 0 0.0008301909547299147
their O 0 0.0015092045068740845
frequencies O 0 0.03998136147856712
in O 0 0.007703880313783884
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.986454427242279
telangiectasia I-Disease 1 0.9999781847000122
( O 0 0.011487794108688831
A B-Disease 0 0.4203130900859833
- I-Disease 1 0.8367888331413269
T I-Disease 1 0.9998879432678223
) O 0 0.01193108782172203
homozygotes O 1 0.9990047812461853
from O 0 0.0026377683971077204
10 O 0 0.003707307390868664
ethnic O 0 0.007944341748952866
populations O 0 0.03749068081378937
. O 0 0.007547816261649132

Both O 0 0.011751720681786537
genomic O 1 0.9997584223747253
mutations O 1 0.999933123588562
and O 0 0.002142853569239378
their O 0 0.0019719668198376894
effects O 0 0.03868741914629936
on O 0 0.0028522179927676916
cDNA O 1 0.9916841983795166
were O 0 0.003867759369313717
characterized O 0 0.05592287331819534
. O 0 0.007340931799262762

Protein O 1 0.9984979629516602
- O 0 0.06373297423124313
truncation O 1 0.9884272217750549
testing O 0 0.029411040246486664
of O 0 0.0008927465532906353
the O 0 0.0011238540755584836
entire O 0 0.013116258196532726
ATM O 1 0.9962762594223022
cDNA O 1 0.9940510392189026
detected O 1 0.7876452803611755
92 O 0 0.03901845961809158
( O 0 0.005266005173325539
66 O 0 0.02139914408326149
% O 0 0.007687066216021776
) O 0 0.007257120683789253
truncating O 1 0.9987333416938782
mutations O 1 0.999829888343811
in O 0 0.003486217465251684
140 O 0 0.028970904648303986
mutant O 1 0.9992116689682007
alleles O 1 0.9997835755348206
screened O 0 0.06347150355577469
. O 0 0.006832136306911707

The O 0 0.007355951704084873
haplotyping O 1 0.9418580532073975
of O 0 0.0032977720256894827
patients O 1 0.9989548921585083
with O 0 0.003489789320155978
identical O 1 0.9248977303504944
mutations O 1 0.9999949932098389
indicates O 0 0.016909364610910416
that O 0 0.000894431839697063
almost O 0 0.001330280676484108
all O 0 0.0004982955288141966
of O 0 0.0005178264691494405
these O 0 0.0008124374435283244
represent O 0 0.0027559574227780104
common O 0 0.018396247178316116
ancestry O 0 0.17102110385894775
and O 0 0.0008329568663612008
that O 0 0.0009139794856309891
very O 0 0.0020614543464034796
few O 0 0.00371992657892406
spontaneously O 1 0.9932895302772522
recurring O 1 0.9986685514450073
ATM O 1 0.9996730089187622
mutations O 1 0.9999697208404541
exist O 0 0.011008326895534992
. O 0 0.004272489808499813

Assays O 1 0.8220841884613037
requiring O 0 0.04087374731898308
minimal O 0 0.027301955968141556
amounts O 0 0.008726113475859165
of O 0 0.002652294933795929
genomic O 1 0.9999306201934814
DNA O 1 0.9975824356079102
were O 0 0.0011126577155664563
designed O 0 0.003795912256464362
to O 0 0.0008544135489501059
allow O 0 0.005665280390530825
rapid O 1 0.5552084445953369
screening O 1 0.6612866520881653
for O 0 0.0018571517430245876
common O 0 0.01328215841203928
ethnic O 0 0.015709038823843002
mutations O 1 0.9999619722366333
. O 0 0.008581256493926048

These O 0 0.006176744122058153
rapid O 0 0.08190987259149551
assays O 1 0.9891133308410645
detected O 1 0.9927940368652344
mutations O 1 0.9999127388000488
in O 0 0.00255685206502676
76 O 0 0.019032303243875504
% O 0 0.0033695257734507322
of O 0 0.0015592463314533234
Costa O 0 0.12148584425449371
Rican O 1 0.895005464553833
patients O 1 0.9998741149902344
( O 0 0.006490123458206654
3 O 0 0.00981022510677576
) O 0 0.0028588830027729273
, O 0 0.0008638703147880733
50 O 0 0.0025209158193320036
% O 0 0.0027368441224098206
of O 0 0.0012947809882462025
Norwegian O 0 0.13545118272304535
patients O 1 0.9999293088912964
( O 0 0.0057868873700499535
1 O 0 0.007645393256098032
) O 0 0.002741863252595067
, O 0 0.0009141096961684525
25 O 0 0.0023128013126552105
% O 0 0.0031886582728475332
of O 0 0.0014211904490366578
Polish O 0 0.3197215497493744
patients O 1 0.9998948574066162
( O 0 0.005289373453706503
4 O 0 0.009241176769137383
) O 0 0.0027720762882381678
, O 0 0.0009579298784956336
and O 0 0.0007762773893773556
14 O 0 0.003972113132476807
% O 0 0.003212844720110297
of O 0 0.0014368676347658038
Italian O 1 0.8190576434135437
patients O 1 0.9999711513519287
( O 0 0.005513620562851429
1 O 0 0.009933051653206348
) O 0 0.0029530408792197704
, O 0 0.0008439773810096085
as O 0 0.0007857669843360782
well O 0 0.0008125450694933534
as O 0 0.0010747285559773445
in O 0 0.002397705800831318
patients O 1 0.9994480013847351
of O 0 0.0021443283185362816
Amish O 1 0.9946907162666321
/ O 1 0.9685254096984863
Mennonite O 1 0.5595111846923828
and O 0 0.0018661478534340858
Irish O 0 0.01969168335199356
English O 0 0.006015359424054623
backgrounds O 0 0.017914878204464912
. O 0 0.005880713928490877

Additional O 0 0.026092587038874626
mutations O 1 0.9995287656784058
were O 0 0.0018695740727707744
observed O 0 0.008946415036916733
in O 0 0.0013386860955506563
Japanese O 0 0.005838828627020121
, O 0 0.001825103652663529
Utah O 0 0.017860865220427513
Mormon O 0 0.035971399396657944
, O 0 0.0018486143089830875
and O 0 0.0013969163410365582
African O 0 0.014791285619139671
American O 0 0.014312980696558952
patients O 1 0.9996875524520874
. O 0 0.007341787219047546

These O 0 0.00506669282913208
assays O 1 0.6587910652160645
should O 0 0.0029937922954559326
facilitate O 0 0.020851626992225647
screening O 0 0.1853320598602295
for O 0 0.003063769079744816
A B-Disease 0 0.21248824894428253
- I-Disease 1 0.9052467942237854
T I-Disease 1 0.9999662637710571
heterozygotes O 1 0.999203622341156
in O 0 0.0018313184846192598
the O 0 0.001979552675038576
populations O 0 0.034607142210006714
studied O 0 0.009836249053478241
. O 0 0.002706371946260333
. O 0 0.005453664343804121

The O 0 0.010199706070125103
von B-Disease 1 0.9901946187019348
Hippel I-Disease 1 0.9998347759246826
- I-Disease 1 0.9851208925247192
Lindau I-Disease 1 0.9999812841415405
tumor I-Disease 1 0.9999986886978149
suppressor O 1 0.9999815225601196
gene O 1 0.9997723698616028
is O 0 0.0023277446161955595
required O 0 0.0036443795543164015
for O 0 0.002419521799311042
cell O 1 0.9983406066894531
cycle O 0 0.43458783626556396
exit O 0 0.033732667565345764
upon O 0 0.00758148031309247
serum O 1 0.9991185069084167
withdrawal O 0 0.05600391700863838
. O 0 0.006974933203309774

The O 0 0.007246245630085468
inactivation O 1 0.9901871681213379
of O 0 0.0015411106869578362
the O 0 0.003921156283468008
von B-Disease 1 0.9984872341156006
Hippel I-Disease 1 0.9999216794967651
- I-Disease 1 0.7276148796081543
Lindau I-Disease 1 0.9997754693031311
( I-Disease 0 0.01627141609787941
VHL I-Disease 1 0.999984860420227
) I-Disease 0 0.02194300666451454
tumor I-Disease 1 0.9999988079071045
suppressor O 1 0.9999939203262329
gene O 1 0.9999721050262451
predisposes O 1 0.999847412109375
affected O 0 0.0187591090798378
individuals O 0 0.0025173474568873644
to O 0 0.0007075034664012492
the O 0 0.0019164544064551592
human O 1 0.9799321293830872
VHL B-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
and O 0 0.001823455560952425
is O 0 0.0015600483166053891
associated O 0 0.006511940620839596
with O 0 0.004244623705744743
sporadic B-Disease 1 0.9995079040527344
renal I-Disease 1 1.0
cell I-Disease 1 0.9999874830245972
carcinomas I-Disease 1 0.9999985694885254
( O 0 0.015714474022388458
RCC B-Disease 1 0.9999250173568726
) O 0 0.0063332258723676205
and O 0 0.0038368026725947857
brain B-Disease 1 0.9999462366104126
hemangioblastomas I-Disease 1 0.9895930290222168
. O 0 0.010232904925942421

VHL O 1 0.9995008707046509
- O 0 0.06662636250257492
negative O 0 0.059797342866659164
786 O 1 0.994932234287262
- O 0 0.059353798627853394
0 O 0 0.1283065378665924
RCC B-Disease 1 0.9997811913490295
cells O 1 0.9984984397888184
are O 0 0.001800841884687543
tumorigenic O 1 0.9308329820632935
in O 0 0.002744663041085005
nude O 1 0.9875664710998535
mice O 1 0.9999573230743408
which O 0 0.0021348129957914352
is O 0 0.0018563970224931836
suppressed O 0 0.03410741686820984
by O 0 0.002239607274532318
the O 0 0.002221209928393364
reintroduction O 1 0.9897650480270386
of O 0 0.00756709324195981
VHL B-Disease 1 0.9999350309371948
. O 0 0.01356918178498745

Remarkably O 0 0.08792822808027267
, O 0 0.002172649372369051
this O 0 0.0017949542962014675
occurs O 0 0.05602874979376793
without O 0 0.004281104076653719
affecting O 0 0.02558957040309906
the O 0 0.001391208847053349
growth O 0 0.009135019965469837
rate O 0 0.007989154197275639
and O 0 0.002107025124132633
cell O 1 0.9998451471328735
cycle O 1 0.8020563721656799
profile O 0 0.02331821247935295
of O 0 0.0008936781086958945
these O 0 0.002529775258153677
cells O 1 0.9997352957725525
in O 0 0.0019972468726336956
culture O 0 0.008071106858551502
. O 0 0.0053349449299275875

The O 0 0.014624099247157574
786 O 1 0.9888089299201965
- O 0 0.04985847324132919
0 O 0 0.04074868559837341
cell O 1 0.9983431100845337
line O 0 0.0065095997415483
, O 0 0.0010525655234232545
like O 0 0.004399014171212912
many O 0 0.005663084331899881
cancer B-Disease 1 0.9999998807907104
cells O 1 0.9999738931655884
, O 0 0.0016111840959638357
fails O 0 0.023103466257452965
to O 0 0.0013133817119523883
exit O 0 0.0225263312458992
the O 0 0.0028882843907922506
cell O 1 0.9976746439933777
cycle O 0 0.34017613530158997
upon O 0 0.011325451545417309
serum O 1 0.999362051486969
withdrawal O 0 0.05916532874107361
. O 0 0.00808950886130333

Here O 0 0.004517008550465107
, O 0 0.0016577241476625204
it O 0 0.0011722494382411242
is O 0 0.0012752795591950417
shown O 0 0.004642962943762541
that O 0 0.0014522721758112311
reintroduction O 1 0.8551220297813416
of O 0 0.0008948722388595343
the O 0 0.0018306630663573742
wild O 0 0.040278054773807526
- O 0 0.08257979154586792
type O 1 0.994300365447998
VHL B-Disease 1 0.9999783039093018
gene O 1 0.9998098015785217
restores O 0 0.46469253301620483
the O 0 0.002119756303727627
ability O 0 0.009093760512769222
of O 0 0.0033119136933237314
VHL O 1 0.9999954700469971
- O 0 0.18594323098659515
negative O 1 0.8695159554481506
RCC B-Disease 1 0.9999918937683105
cancer I-Disease 1 0.9999979734420776
cells O 1 0.9986706972122192
to O 0 0.0014524533180519938
exit O 0 0.025495460256934166
the O 0 0.0031227371655404568
cell O 1 0.9991937279701233
cycle O 0 0.097963348031044
and O 0 0.0017597348196431994
enter O 0 0.0303427092730999
G0 O 1 0.9998681545257568
/ O 1 0.8812128305435181
quiescence O 1 0.992274820804596
in O 0 0.0054558818228542805
low O 0 0.040151387453079224
serum O 1 0.9966508746147156
. O 0 0.011598032899200916

Both O 0 0.021861804649233818
VHL O 1 0.9999409914016724
- O 0 0.037884894758462906
positive O 0 0.0182801466435194
and O 0 0.004672760609537363
VHL O 1 0.9999912977218628
- O 0 0.0407865010201931
negative O 0 0.12558579444885254
RCC B-Disease 1 0.9997997879981995
cells O 1 0.9983599781990051
exit O 0 0.031468648463487625
the O 0 0.003734233323484659
cell O 1 0.9977826476097107
cycle O 0 0.17362573742866516
by O 0 0.005057667847722769
contact O 0 0.2004101723432541
inhibition O 1 0.9993374943733215
. O 0 0.009129471145570278

The O 0 0.014287231490015984
cyclin O 1 0.9995197057723999
- O 0 0.043659791350364685
dependent O 0 0.08619170635938644
kinase O 1 0.9999372959136963
inhibitor O 1 0.9998408555984497
, O 0 0.008630961179733276
p27 O 1 0.9992407560348511
, O 0 0.0044669462367892265
accumulates O 1 0.8702400922775269
upon O 0 0.008621382527053356
serum O 1 0.999830961227417
withdrawal O 0 0.26458677649497986
, O 0 0.0011065939906984568
only O 0 0.0007570371381007135
in O 0 0.0005979970446787775
the O 0 0.001159458770416677
presence O 0 0.008075485937297344
of O 0 0.0025235668290406466
VHL B-Disease 1 0.9999947547912598
, O 0 0.002151694381609559
as O 0 0.0014080381952226162
a O 0 0.0038544407580047846
result O 0 0.005425967276096344
of O 0 0.0007073263986967504
the O 0 0.0013369704829528928
stabilization O 0 0.03763444721698761
of O 0 0.0011876937933266163
the O 0 0.003697799751535058
protein O 1 0.9992572665214539
. O 0 0.008697805926203728

We O 0 0.0040105655789375305
propose O 0 0.017369426786899567
that O 0 0.0011337477480992675
the O 0 0.001281163888052106
loss O 0 0.018284715712070465
of O 0 0.0015665151877328753
wild O 0 0.17899014055728912
- O 0 0.22353512048721313
type O 1 0.9990099668502808
VHL B-Disease 1 0.9999955892562866
gene O 1 0.9998598098754883
results O 0 0.01046232134103775
in O 0 0.0012222229270264506
a O 0 0.0037203598767518997
specific O 0 0.009464679285883904
cellular O 1 0.9997298121452332
defect O 1 0.999607503414154
in O 0 0.005486039910465479
serum O 1 0.9998568296432495
- O 0 0.02758917026221752
dependent O 0 0.028833599761128426
growth O 0 0.02205771394073963
control O 0 0.018200289458036423
, O 0 0.0012312387116253376
which O 0 0.0014368458651006222
may O 0 0.00913065392524004
initiate O 1 0.9971994161605835
tumor B-Disease 1 0.9999938011169434
formation O 0 0.17374204099178314
. O 0 0.006393383722752333

This O 0 0.0040605035610497
is O 0 0.00275201047770679
corrected O 0 0.12322487682104111
by O 0 0.0015720692463219166
the O 0 0.0017503900453448296
reintroduction O 1 0.9835736751556396
of O 0 0.0016223813872784376
wild O 0 0.06334078311920166
- O 0 0.07459273189306259
type O 1 0.9920755624771118
VHL B-Disease 1 0.9999619722366333
, O 0 0.007496118079870939
implicating O 1 0.9971171617507935
VHL B-Disease 1 0.9999598264694214
as O 0 0.0016071712598204613
the O 0 0.0013569352449849248
first O 0 0.008520650677382946
tumor B-Disease 1 0.9999992847442627
suppressor O 1 0.9999786615371704
involved O 0 0.009370994754135609
in O 0 0.0011330212000757456
the O 0 0.0012239154893904924
regulation O 0 0.02574492059648037
of O 0 0.002621512161567807
cell O 1 0.9997822642326355
cycle O 1 0.9333137273788452
exit O 0 0.3855926990509033
, O 0 0.0014272747794166207
which O 0 0.000975997478235513
is O 0 0.001236998476088047
consistent O 0 0.00773930549621582
with O 0 0.0015897932462394238
its O 0 0.003073738422244787
gatekeeper O 1 0.9995378255844116
function O 0 0.03225274756550789
in O 0 0.001841313554905355
the O 0 0.00550060672685504
kidney O 1 0.9999994039535522
. O 0 0.0042809983715415
. O 0 0.005458158906549215

Piebaldism B-Disease 1 0.9920468330383301
with O 0 0.018961282446980476
deafness B-Disease 1 0.9999924898147583
: O 0 0.012151050381362438
molecular O 1 0.996222734451294
evidence O 0 0.003889269195497036
for O 0 0.0013600831152871251
an O 0 0.0031018562149256468
expanded O 0 0.051659874618053436
syndrome O 1 0.9999982118606567
. O 0 0.011179538443684578

In O 0 0.00420542573556304
a O 0 0.005319605115801096
South O 0 0.003419779008254409
African O 0 0.01065332442522049
girl O 0 0.02504081092774868
of O 0 0.002251570811495185
Xhosa O 1 0.9993125200271606
stock O 0 0.0316617526113987
with O 0 0.0063986326567828655
severe O 1 0.9980888962745667
piebaldism B-Disease 1 0.9940775632858276
and O 0 0.004983636550605297
profound O 1 0.9987195730209351
congenital O 1 1.0
sensorineural B-Disease 1 0.999998927116394
deafness I-Disease 1 0.9999978542327881
we O 0 0.0031314638908952475
identified O 0 0.009594306349754333
a O 0 0.005856097675859928
novel O 0 0.025843871757388115
missense O 1 0.9994773268699646
substitution O 0 0.1657317876815796
at O 0 0.0024269658606499434
a O 0 0.00397904310375452
highly O 0 0.008768360130488873
conserved O 1 0.5117934942245483
residue O 0 0.2336321771144867
in O 0 0.0014217915013432503
the O 0 0.0024444363079965115
intracellular O 1 0.9998787641525269
kinase O 1 0.9998466968536377
domain O 0 0.025110509246587753
of O 0 0.0009873182279989123
the O 0 0.00290175573900342
KIT O 1 0.9974991679191589
proto O 1 0.999261200428009
- O 1 0.846457302570343
oncogene O 1 0.9999415874481201
, O 0 0.007369270548224449
R796G O 1 0.9629201889038086
. O 0 0.00945636723190546

Though O 0 0.021272417157888412
auditory B-Disease 1 0.9979296922683716
anomalies I-Disease 1 0.9888558983802795
have O 0 0.001890042214654386
been O 0 0.0014860180672258139
observed O 0 0.0077865575440227985
in O 0 0.0027786591090261936
mice O 1 0.9999722242355347
with O 0 0.004680671263486147
dominant O 1 0.6302998661994934
white O 0 0.032229404896497726
spotting O 1 0.9996317625045776
( O 0 0.011975566856563091
W O 1 0.9993220567703247
) O 0 0.004172882996499538
due O 0 0.004087116569280624
to O 0 0.003143847221508622
KIT O 1 0.9995111227035522
mutations O 1 0.999994158744812
, O 0 0.009227452799677849
deafness B-Disease 1 0.9999992847442627
is O 0 0.0030398895032703876
not O 0 0.0013291042996570468
typical O 0 0.011634566821157932
in O 0 0.0023452388122677803
human O 0 0.0242314375936985
piebaldism B-Disease 1 0.9946228265762329
. O 0 0.008796262554824352

Thus O 0 0.011379493400454521
, O 0 0.0015012415824458003
the O 0 0.0018900611903518438
occurrence O 0 0.27452027797698975
of O 0 0.0050228675827383995
sensorineural B-Disease 1 0.9999984502792358
deafness I-Disease 1 0.9999990463256836
in O 0 0.002994553418830037
this O 0 0.003113457001745701
patient O 1 0.9989890456199646
extends O 0 0.022905174642801285
considerably O 0 0.019904591143131256
the O 0 0.002147048246115446
phenotypic O 1 0.9887818694114685
range O 0 0.00486215204000473
of O 0 0.0015154347056522965
piebaldism B-Disease 1 0.9937730431556702
due O 0 0.0055948891676962376
to O 0 0.002815959509462118
KIT O 1 0.9995300769805908
gene O 1 0.999984622001648
mutation O 1 0.9999692440032959
in O 0 0.00281723216176033
humans O 0 0.181624174118042
and O 0 0.0019755710382014513
tightens O 1 0.9987636804580688
the O 0 0.004328101873397827
clinical O 1 0.9992566704750061
similarity O 1 0.7011100649833679
between O 0 0.004045511595904827
piebaldism B-Disease 1 0.9934883117675781
and O 0 0.0008397870697081089
the O 0 0.0008157809497788548
various O 0 0.0015021301805973053
forms O 0 0.011900248937308788
of O 0 0.007915106602013111
Waardenburg B-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999992847442627
. O 0 0.005392026621848345
. O 0 0.006127132568508387

Cycloheximide O 1 0.9793647527694702
facilitates O 0 0.1907469630241394
the O 0 0.0020208305213600397
identification O 0 0.013680272735655308
of O 0 0.00164604012388736
aberrant O 1 0.9977685213088989
transcripts O 0 0.05764385685324669
resulting O 0 0.025416499003767967
from O 0 0.0018649182748049498
a O 0 0.005292035639286041
novel O 0 0.03090573102235794
splice O 1 0.9997523427009583
- O 0 0.026842202991247177
site O 0 0.014315295964479446
mutation O 1 0.9999487400054932
in O 0 0.004226210527122021
COL17A1 O 1 0.9962382316589355
in O 0 0.003086474258452654
a O 0 0.009742855094373226
patient O 1 0.9984470009803772
with O 0 0.008018286898732185
generalized O 1 0.9998331069946289
atrophic B-Disease 1 0.9999815225601196
benign I-Disease 1 0.9999203681945801
epidermolysis I-Disease 1 0.9999674558639526
bullosa I-Disease 1 0.9998874664306641
. O 0 0.015899794176220894

Patients O 1 0.994053065776825
with O 0 0.013830895535647869
generalized O 1 0.9998258948326111
atrophic B-Disease 1 0.9999837875366211
benign I-Disease 1 0.9999185800552368
epidermolysis I-Disease 1 0.9999949932098389
bullosa I-Disease 1 0.999909520149231
often O 0 0.00811546016484499
show O 0 0.005892082117497921
decreased O 0 0.035464972257614136
expression O 0 0.022290663793683052
of O 0 0.0021041096188127995
type O 1 0.9962121248245239
XVII O 1 0.9998984336853027
collagen O 1 0.9999685287475586
, O 0 0.0030730462167412043
a O 0 0.007957568392157555
transmembrane O 1 0.9982303977012634
hemidesmosomal O 1 0.9934485554695129
protein O 1 0.9971731901168823
encoded O 0 0.128692165017128
by O 0 0.007106198463588953
COL17A1 O 1 0.9888027310371399
. O 0 0.010033206082880497

This O 0 0.003288466949015856
report O 0 0.0023135694209486246
documents O 0 0.0026574688963592052
a O 0 0.006008731201291084
novel O 0 0.02906735986471176
splice O 1 0.9996631145477295
- O 0 0.027409138157963753
site O 0 0.015186624601483345
mutation O 1 0.9999425411224365
in O 0 0.0041886609978973866
COL17A1 O 1 0.9954801797866821
in O 0 0.002240495989099145
a O 0 0.008612061850726604
patient O 1 0.9972425699234009
with O 0 0.008022547699511051
generalized O 1 0.9999206066131592
atrophic B-Disease 1 0.9999899864196777
benign I-Disease 1 0.9999734163284302
epidermolysis I-Disease 1 0.9999967813491821
bullosa I-Disease 1 0.999977707862854
, O 0 0.003984689712524414
and O 0 0.0012766161235049367
applies O 0 0.008671857416629791
a O 0 0.003690418554469943
new O 0 0.002056361408904195
methodology O 0 0.016577327623963356
to O 0 0.001186099019832909
define O 0 0.009407985024154186
and O 0 0.0011967784957960248
characterize O 0 0.07791158556938171
the O 0 0.002396453870460391
resulting O 0 0.22603391110897064
mRNA O 1 0.9939274787902832
splice O 1 0.9986680746078491
variants O 1 0.8965628743171692
. O 0 0.008560750633478165

Mutational O 1 0.9939588308334351
analysis O 0 0.022433722391724586
of O 0 0.0024363119155168533
COL17A1 O 1 0.9879729747772217
identified O 0 0.017664585262537003
a O 0 0.011786893010139465
maternally O 1 0.998802661895752
inherited O 1 0.9996628761291504
G O 1 0.9994552731513977
- O 0 0.022975966334342957
to O 0 0.004373686388134956
- O 0 0.25558850169181824
T O 1 0.9996887445449829
transversion O 1 0.9684974551200867
at O 0 0.0031081587076187134
the O 0 0.0024300571531057358
- O 0 0.013624981977045536
1 O 0 0.005464561283588409
position O 0 0.002882655244320631
of O 0 0.002232795115560293
exon O 1 0.9983469247817993
32 O 0 0.022515958175063133
. O 0 0.006322680972516537

This O 0 0.009290528483688831
acceptor O 1 0.9979877471923828
splice O 1 0.9990804195404053
- O 0 0.03553859889507294
site O 0 0.016622694209218025
mutation O 1 0.9998762607574463
led O 0 0.00538749760016799
to O 0 0.0009249132708646357
the O 0 0.0012978499289602041
formation O 0 0.02663634531199932
of O 0 0.001960028661414981
aberrant O 1 0.9992173910140991
transcripts O 0 0.034685008227825165
present O 0 0.0031336660031229258
at O 0 0.0028216089121997356
extremely O 0 0.015446675941348076
low O 0 0.021320896223187447
levels O 0 0.02334102801978588
. O 0 0.007136117201298475

Based O 0 0.007451993878930807
on O 0 0.0014224970946088433
our O 0 0.0021561793982982635
recent O 0 0.004131986293941736
finding O 0 0.009435594081878662
that O 0 0.002589558716863394
cycloheximide O 1 0.9916394352912903
stabilized O 1 0.9906829595565796
mutant O 1 0.9986451268196106
COL17A1 O 1 0.9885713458061218
transcripts O 0 0.03859178349375725
in O 0 0.004547773394733667
keratinocytes O 1 0.997671902179718
homozygous O 1 0.9980514049530029
for O 0 0.00324118766002357
a O 0 0.014652070589363575
frameshift O 1 0.9999947547912598
mutation O 1 0.9999868869781494
, O 0 0.0017858935752883554
the O 0 0.001202919753268361
effects O 0 0.02560407668352127
of O 0 0.0007650093757547438
the O 0 0.0030998606234788895
splice O 1 0.9999630451202393
- O 0 0.02403925731778145
site O 0 0.013755680061876774
mutation O 1 0.9997826218605042
on O 0 0.0042625656351447105
splicing O 1 0.9981831908226013
of O 0 0.0030258691404014826
COL17A1 O 1 0.992983341217041
transcripts O 0 0.030390825122594833
were O 0 0.0013544487301260233
determined O 0 0.006262434646487236
using O 0 0.009934420697391033
reverse O 1 0.7166170477867126
transcriptase O 1 0.9997832179069519
polymerase O 1 0.9994326233863831
chain O 0 0.2972913384437561
reaction O 0 0.020725661888718605
of O 0 0.000983355799689889
total O 0 0.005767629947513342
RNA O 1 0.9994181394577026
from O 0 0.0052084168419241905
keratinocytes O 1 0.9986489415168762
incubated O 1 0.6789961457252502
for O 0 0.003120638895779848
2 O 0 0.010140830650925636
. O 0 0.0060475715436041355

5 O 0 0.027442561462521553
h O 0 0.17814353108406067
in O 0 0.0016973682213574648
the O 0 0.0016490432899445295
presence O 0 0.009425904601812363
or O 0 0.0033741933293640614
absence O 0 0.014055020175874233
of O 0 0.0014202941674739122
10 O 0 0.00788273848593235
microg O 1 0.9950414299964905
cycloheximide O 1 0.9794759154319763
per O 0 0.012286640703678131
ml O 1 0.990346372127533
. O 0 0.009321467950940132

Using O 0 0.015500112436711788
this O 0 0.0024701368529349566
approach O 0 0.010025433264672756
, O 0 0.0015545993810519576
an O 0 0.004819647874683142
abnormally O 1 0.9992724061012268
spliced O 1 0.9995580315589905
transcript O 1 0.9208143949508667
was O 0 0.0036690786946564913
identified O 0 0.007956144399940968
that O 0 0.0008628486539237201
contains O 0 0.0035165860317647457
an O 0 0.001254955306649208
extra O 0 0.009211167693138123
264 O 0 0.04700784012675285
bases O 0 0.010538768023252487
upstream O 0 0.035495828837156296
from O 0 0.004341914318501949
exon O 1 0.9982219338417053
32 O 0 0.012582230381667614
, O 0 0.0017855229089036584
resulting O 0 0.027959046885371208
in O 0 0.0016985435504466295
a O 0 0.010324152186512947
premature O 1 0.9989138841629028
termination O 1 0.991084098815918
codon O 1 0.9823586344718933
27 O 0 0.017724573612213135
bp O 0 0.06596627086400986
downstream O 0 0.04247426614165306
from O 0 0.0021497264970093966
the O 0 0.0028324839659035206
cryptic O 1 0.998297393321991
splice O 1 0.9986916184425354
site O 0 0.015626585111021996
. O 0 0.007332459557801485

Three O 0 0.005327414721250534
other O 0 0.004112754482775927
splice O 1 0.9998148083686829
variants O 1 0.9874695539474487
, O 0 0.002037141239270568
including O 0 0.0017559519037604332
one O 0 0.0016451181145384908
derived O 0 0.012303468771278858
from O 0 0.0011886263964697719
the O 0 0.0015474712708964944
skipping O 1 0.6839142441749573
of O 0 0.0033110312651842833
exon O 1 0.9991770386695862
32 O 0 0.016418863087892532
, O 0 0.001327072735875845
were O 0 0.0006915734265930951
also O 0 0.0016485361848026514
identified O 0 0.015563009306788445
. O 0 0.006848662625998259

These O 0 0.0035047056153416634
results O 0 0.00897260196506977
indicate O 0 0.00640728697180748
the O 0 0.0014572662767022848
usefulness O 0 0.2003287971019745
of O 0 0.0025356453843414783
cycloheximide O 1 0.9997637867927551
treatment O 1 0.9030477404594421
in O 0 0.0021591309923678637
evaluating O 0 0.03174367547035217
the O 0 0.0027745163533836603
abnormal O 1 0.9987521171569824
processing O 0 0.011201519519090652
of O 0 0.0015203680377453566
mRNA O 1 0.9919130802154541
due O 0 0.005237122997641563
to O 0 0.002410438610240817
splice O 1 0.9999368190765381
- O 0 0.02875913493335247
site O 0 0.015458029694855213
mutations O 1 0.9999932050704956
, O 0 0.0027599928434938192
because O 0 0.004717218689620495
( O 0 0.003857414936646819
i O 0 0.004195570480078459
) O 0 0.007414164952933788
aberrant O 1 0.9986006617546082
splicing O 1 0.9978723526000977
often O 0 0.0052259876392781734
generates O 0 0.027576791122555733
a O 0 0.012434307485818863
premature O 1 0.9985330104827881
termination O 1 0.9983635544776917
codon O 1 0.9980886578559875
, O 0 0.003222901141270995
( O 0 0.004655653610825539
ii O 0 0.018157200887799263
) O 0 0.003579365089535713
transcripts O 0 0.0272553451359272
with O 0 0.005059839691966772
premature O 1 0.9995212554931641
termination O 1 0.9992125034332275
codons O 1 0.9989219903945923
can O 0 0.005296470131725073
occur O 0 0.015841851010918617
at O 0 0.0026601748540997505
low O 0 0.0129619762301445
or O 0 0.0074776639230549335
undetectable O 1 0.9979562759399414
levels O 0 0.016871483996510506
due O 0 0.004959956742823124
to O 0 0.002123838057741523
nonsense O 1 0.5931711196899414
- O 0 0.040398091077804565
mediated O 1 0.9950587749481201
mRNA O 1 0.9948476552963257
decay O 1 0.949042558670044
, O 0 0.0021759087685495615
and O 0 0.0013026058441028
( O 0 0.006114079616963863
iii O 1 0.9084432125091553
) O 0 0.0025391587987542152
the O 0 0.001007542829029262
levels O 0 0.0058935158886015415
of O 0 0.0005522343562915921
these O 0 0.0012868193443864584
transcripts O 0 0.03585507720708847
can O 0 0.002525896765291691
be O 0 0.001079918583855033
increased O 0 0.006434095092117786
by O 0 0.004836001433432102
cycloheximide O 1 0.9823097586631775
. O 0 0.008918102830648422

A O 0 0.045377884060144424
deletion O 1 0.9993964433670044
mutation O 1 0.9999089241027832
in O 0 0.005311903078109026
COL17A1 O 1 0.9962509274482727
in O 0 0.0018261855002492666
five O 0 0.0029754426795989275
Austrian O 0 0.04770609363913536
families O 0 0.005817686207592487
with O 0 0.008125819265842438
generalized O 1 0.9998582601547241
atrophic B-Disease 1 0.9999843835830688
benign I-Disease 1 0.9999504089355469
epidermolysis I-Disease 1 0.9999918937683105
bullosa I-Disease 1 0.999923586845398
represents O 0 0.02515464834868908
propagation O 0 0.06181280314922333
of O 0 0.0012661705259233713
an O 0 0.003472078125923872
ancestral O 1 0.8588704466819763
allele O 1 0.999636173248291
. O 0 0.009967733174562454

Patients O 1 0.9952641725540161
with O 0 0.014470540918409824
generalized O 1 0.9998132586479187
atrophic B-Disease 1 0.9999891519546509
benign I-Disease 1 0.9999707937240601
epidermolysis I-Disease 1 0.9999969005584717
bullosa I-Disease 1 0.9999790191650391
, O 0 0.004055202938616276
a O 0 0.005988152697682381
usually O 0 0.005787921603769064
nonlethal O 1 0.8699386715888977
form O 0 0.010960077866911888
of O 0 0.00403671944513917
junctional B-Disease 1 0.9999825954437256
epidermolysis I-Disease 1 0.999994158744812
bullosa I-Disease 1 0.9999606609344482
, O 0 0.004151953384280205
have O 0 0.0025753250811249018
generalized O 1 0.9989234805107117
blistering B-Disease 1 0.9782751798629761
, O 0 0.0077853454276919365
nail B-Disease 1 0.9999727010726929
dystrophy I-Disease 1 0.9999990463256836
, O 0 0.010348447598516941
patchy B-Disease 1 0.9999078512191772
alopecia I-Disease 1 0.9999974966049194
, O 0 0.005875362083315849
and O 0 0.0055437409318983555
dental B-Disease 1 0.9999741315841675
abnormalities I-Disease 1 0.999984622001648
. O 0 0.010351446457207203

Skin B-Disease 1 0.9999549388885498
fragility I-Disease 1 0.9987768530845642
in O 0 0.0026455300394445658
most O 0 0.001902381656691432
cases O 0 0.008187719620764256
is O 0 0.0013681481359526515
due O 0 0.003934712149202824
to O 0 0.0021103904582560062
mutations O 1 0.9999693632125854
in O 0 0.0014486904256045818
the O 0 0.0027678851038217545
gene O 1 0.9999467134475708
encoding O 1 0.9967748522758484
type O 1 0.9848639369010925
XVII O 1 0.9997935891151428
collagen O 1 0.9999865293502808
( O 0 0.01748529262840748
COL17A1 O 1 0.997922956943512
) O 0 0.008143898099660873
. O 0 0.007399300578981638

Recently O 0 0.02039201930165291
, O 0 0.0017614210955798626
we O 0 0.0010664622532203794
reported O 0 0.0046115415170788765
five O 0 0.0027943234890699387
Austrian O 0 0.03725353255867958
families O 0 0.007019126322120428
with O 0 0.0066636232659220695
generalized O 1 0.9999265670776367
atrophic B-Disease 1 0.999988317489624
benign I-Disease 1 0.9999450445175171
epidermolysis I-Disease 1 0.9999936819076538
bullosa I-Disease 1 0.9999388456344604
who O 0 0.004360326565802097
share O 0 0.005452053155750036
the O 0 0.0019193376647308469
same O 0 0.008120397105813026
COL17A1 O 1 0.9994674324989319
mutation O 1 0.9999377727508545
. O 0 0.010685352608561516

Affected O 0 0.03794995695352554
individuals O 0 0.005884247366338968
in O 0 0.0011887566652148962
three O 0 0.001779968268238008
families O 0 0.004500045906752348
are O 0 0.001942824455909431
homozygous O 1 0.999925971031189
for O 0 0.003376589622348547
4003delTC O 1 0.9990174770355225
, O 0 0.0024869649205356836
whereas O 0 0.01321232970803976
those O 0 0.001022543990984559
in O 0 0.000882389722391963
two O 0 0.0015384495491161942
others O 0 0.0027293958701193333
are O 0 0.0014801373472437263
compound O 0 0.2608395218849182
heterozygotes O 1 0.9988804459571838
. O 0 0.007011801470071077

To O 0 0.0033447197638452053
determine O 0 0.006274245213717222
if O 0 0.0018969252705574036
the O 0 0.0014729879330843687
occurrence O 0 0.21848970651626587
of O 0 0.0018603260396048427
4003delTC O 1 0.9970963001251221
in O 0 0.0015322610270231962
these O 0 0.001979512395337224
unrelated O 1 0.505692720413208
families O 0 0.007329238578677177
signifies O 0 0.21716581284999847
propagation O 0 0.08346531540155411
of O 0 0.001086054602637887
an O 0 0.0023251064121723175
ancestral O 1 0.7787230014801025
allele O 1 0.999618411064148
or O 0 0.005363400559872389
a O 0 0.01191398873925209
mutational O 1 0.9999263286590576
hot O 0 0.02745860442519188
spot O 0 0.017040204256772995
, O 0 0.0032432430889457464
haplotypes O 1 0.9996411800384521
were O 0 0.0014705851208418608
determined O 0 0.006730908993631601
for O 0 0.0026810746639966965
polymorphisms O 1 0.999610960483551
both O 0 0.0019340458093211055
within O 0 0.0023343563079833984
and O 0 0.0026536346413195133
flanking O 1 0.9963312745094299
COL17A1 O 1 0.9980595707893372
. O 0 0.009348577819764614

Five O 0 0.0157298743724823
intragenic O 1 0.9887863397598267
polymorphisms O 1 0.9980879426002502
were O 0 0.0015992962289601564
chosen O 0 0.003560123033821583
based O 0 0.002719246782362461
on O 0 0.001315386383794248
their O 0 0.00363595737144351
informativeness O 1 0.9973426461219788
. O 0 0.01008222158998251

One O 0 0.003770525800064206
of O 0 0.0009494532132521272
these O 0 0.0010504259262233973
, O 0 0.0009661607909947634
not O 0 0.0009113055421039462
previously O 0 0.0030043842270970345
reported O 0 0.006562594324350357
, O 0 0.001408836804330349
was O 0 0.0026870586443692446
2988 O 1 0.9874882698059082
A O 0 0.015045391395688057
or O 0 0.00632886728271842
C O 0 0.4969480037689209
that O 0 0.002065496752038598
introduces O 0 0.034670181572437286
a O 0 0.004771602340042591
new O 0 0.0033935322426259518
restriction O 0 0.023508258163928986
site O 0 0.005583154037594795
for O 0 0.003136958461254835
Eco0109 O 1 0.992163896560669
I O 0 0.011203601956367493
. O 0 0.005938079208135605

All O 0 0.0023960741236805916
the O 0 0.0037958603352308273
4003delTC O 1 0.9982762336730957
alleles O 1 0.999749481678009
showed O 0 0.007511146366596222
the O 0 0.001344197546131909
same O 0 0.005534083116799593
haplotype O 1 0.9999226331710815
for O 0 0.001771962852217257
these O 0 0.0013442040653899312
five O 0 0.005802036728709936
polymorphic O 1 0.999858021736145
markers O 1 0.8843217492103577
. O 0 0.008004141971468925

Fourteen O 0 0.060614969581365585
microsatellite O 1 0.9992621541023254
polymorphisms O 1 0.9981243014335632
were O 0 0.001515197567641735
selected O 0 0.002960786921903491
based O 0 0.0017631037626415491
on O 0 0.0008066072477959096
their O 0 0.0018273217137902975
high O 0 0.00852193683385849
heterozygosity O 1 0.9990653395652771
and O 0 0.001098913373425603
their O 0 0.0012194825103506446
location O 0 0.00487211300060153
within O 0 0.00555914081633091
10q23 O 1 0.9947434663772583
- O 0 0.04379354044795036
q25 O 1 0.9745029211044312
near O 0 0.02847868949174881
COL17A1 O 1 0.9865258932113647
. O 0 0.009929066523909569

Three O 0 0.005859479773789644
families O 0 0.008603443391621113
shared O 0 0.021757381036877632
microsatellite O 1 0.9998717308044434
polymorphisms O 1 0.9995579123497009
covering O 0 0.011516688391566277
at O 0 0.002685553627088666
most O 0 0.0018737155478447676
19 O 0 0.012009818106889725
cM O 0 0.25326666235923767
, O 0 0.001733135897666216
whereas O 0 0.010981699451804161
the O 0 0.0012227228144183755
others O 0 0.002868056995794177
shared O 0 0.007248029112815857
smaller O 0 0.009937817230820656
regions O 0 0.006200448609888554
consistent O 0 0.01109247375279665
with O 0 0.003313890192657709
cross O 0 0.018934858962893486
- O 0 0.013192139565944672
over O 0 0.0018103058682754636
events O 0 0.003112313337624073
during O 0 0.0024399254471063614
passage O 0 0.0067936633713543415
of O 0 0.0010016689775511622
this O 0 0.0029552967753261328
mutation O 1 0.9999701976776123
through O 0 0.0061669605784118176
several O 0 0.002658389275893569
generations O 0 0.020363030955195427
. O 0 0.005554661620408297

These O 0 0.0042104944586753845
results O 0 0.010917129926383495
indicate O 0 0.010819091461598873
that O 0 0.0026010118890553713
4003delTC O 1 0.9975090026855469
occurs O 0 0.027964234352111816
on O 0 0.0012482674792408943
a O 0 0.004342895466834307
single O 0 0.013835460878908634
ancestral O 1 0.8511403799057007
allele O 1 0.9998478889465332
. O 0 0.00500886794179678
. O 0 0.00541398162022233

The O 0 0.014673275873064995
haptoglobin O 1 0.9973114728927612
- O 0 0.38317736983299255
gene O 1 0.9997667670249939
deletion O 1 0.9981433153152466
responsible O 0 0.019683828577399254
for O 0 0.004774447530508041
anhaptoglobinemia B-Disease 1 0.9639818072319031
. O 0 0.009515754878520966

We O 0 0.0024791883770376444
have O 0 0.0010856587905436754
found O 0 0.003762531094253063
an O 0 0.0032310481183230877
allelic O 1 0.9993270635604858
deletion O 1 0.9972214698791504
of O 0 0.001485896296799183
the O 0 0.003207076108083129
haptoglobin O 1 0.9996645450592041
( O 0 0.009668353013694286
Hp O 1 0.9938780665397644
) O 0 0.009212023578584194
gene O 1 0.9996201992034912
from O 0 0.0019450838444754481
an O 0 0.0014364916132763028
individual O 0 0.006128293927758932
with O 0 0.005141344852745533
anhaptoglobinemia B-Disease 1 0.9901443719863892
. O 0 0.009177545085549355

The O 0 0.008245938457548618
Hp O 1 0.9815923571586609
gene O 1 0.9994224309921265
cluster O 0 0.10793530195951462
consists O 0 0.005924264434725046
of O 0 0.0020985454320907593
coding O 1 0.9973938465118408
regions O 0 0.005868987645953894
of O 0 0.000677781121339649
the O 0 0.0019089600536972284
alpha O 1 0.8789563179016113
chain O 1 0.5667139887809753
and O 0 0.002068866742774844
beta O 1 0.9867368340492249
chain O 0 0.03549356386065483
of O 0 0.0008702998165972531
the O 0 0.0033298982307314873
haptoglobin O 1 0.9998894929885864
gene O 1 0.9999850988388062
( O 0 0.008948259055614471
Hp O 1 0.9892421364784241
) O 0 0.002876630751416087
and O 0 0.00047032831935212016
of O 0 0.0005044421995989978
the O 0 0.001614962238818407
alpha O 1 0.9677960872650146
chain O 1 0.6612499952316284
and O 0 0.0022279296535998583
beta O 1 0.9966821074485779
chain O 0 0.04460863396525383
of O 0 0.0007719223503954709
the O 0 0.0028730183839797974
haptoglobin O 1 0.9993938207626343
- O 0 0.04644181206822395
related O 0 0.1326487809419632
gene O 1 0.9999723434448242
( O 0 0.012554693967103958
Hpr O 1 0.9999227523803711
) O 0 0.004477999173104763
, O 0 0.0011798065388575196
in O 0 0.0016886329976841807
tandem O 1 0.9715320467948914
from O 0 0.0018463225569576025
the O 0 0.0013917634496465325
5 O 0 0.00754943024367094
side O 0 0.007245429325848818
. O 0 0.005694162100553513

Southern O 0 0.02211756445467472
blot O 1 0.9766101837158203
and O 0 0.006175429560244083
PCR O 1 0.9992766976356506
analyses O 0 0.0371638759970665
have O 0 0.0015595699660480022
indicated O 0 0.0053703440353274345
that O 0 0.0004799196613021195
the O 0 0.0007652511121705174
individual O 0 0.003969582263380289
with O 0 0.00344243086874485
anhaptoglobinemia B-Disease 1 0.9966443777084351
was O 0 0.0032684202305972576
homozygous O 1 0.9992877840995789
for O 0 0.001735611935146153
the O 0 0.002987621584907174
gene O 1 0.999987006187439
deletion O 1 0.9997541308403015
and O 0 0.0010041971690952778
that O 0 0.000731723615899682
the O 0 0.0029078407678753138
gene O 1 0.999991774559021
deletion O 1 0.9997318387031555
was O 0 0.0021595507860183716
included O 0 0.0018628493417054415
at O 0 0.001695606973953545
least O 0 0.002888054819777608
from O 0 0.0013984250836074352
the O 0 0.00164209702052176
promoter O 1 0.9815149903297424
region O 0 0.004203264135867357
of O 0 0.0015072396490722895
Hp O 1 0.9239439368247986
to O 0 0.00406262930482626
Hpr O 1 0.9996381998062134
alpha O 1 0.5604874491691589
but O 0 0.0018383939750492573
not O 0 0.0011416585184633732
to O 0 0.0034751922357827425
Hpr O 1 0.9997827410697937
beta O 1 0.9969369173049927
( O 0 0.00880192220211029
Hpdel O 1 0.9950750470161438
) O 0 0.006715548690408468
. O 0 0.004933565855026245

In O 0 0.005131883081048727
addition O 0 0.005277212243527174
, O 0 0.0011968372855335474
we O 0 0.0008460632525384426
found O 0 0.0033859352115541697
seven O 0 0.0026003934908658266
individuals O 0 0.00400141067802906
with O 0 0.003437317907810211
hypohaptoglobinemia B-Disease 1 0.9960237741470337
in O 0 0.001771517563611269
three O 0 0.0021656001918017864
families O 0 0.004947124049067497
, O 0 0.0009624609956517816
and O 0 0.0008344833040609956
the O 0 0.0021236813627183437
genotypes O 1 0.9996569156646729
of O 0 0.0010044622467830777
six O 0 0.0018892049556598067
of O 0 0.0005422053509391844
the O 0 0.0009445511386729777
seven O 0 0.0023645530454814434
individuals O 0 0.0028245123103260994
were O 0 0.0005504652508534491
found O 0 0.003102201269939542
to O 0 0.001075842883437872
be O 0 0.0028518126346170902
Hp2 O 1 0.9991733431816101
/ O 1 0.9771489500999451
Hpdel O 1 0.9954106211662292
. O 0 0.008115652948617935

The O 0 0.00802514050155878
phenotypes O 1 0.9995436072349548
and O 0 0.004481572192162275
genotypes O 1 0.9999065399169922
in O 0 0.0015004348242655396
one O 0 0.00114941387437284
of O 0 0.0006165180820971727
these O 0 0.0010128789581358433
three O 0 0.0017337440513074398
families O 0 0.0037315129302442074
showed O 0 0.004401602316647768
the O 0 0.0012171899434179068
father O 0 0.00559014780446887
to O 0 0.0011756320018321276
be O 0 0.0021447499748319387
hypohaptoglobinemic B-Disease 1 0.9983661770820618
( O 0 0.007368597202003002
Hp2 O 1 0.999053418636322
) O 0 0.0048393430188298225
and O 0 0.0032089147716760635
Hp2 O 1 0.9998176693916321
/ O 1 0.9936612844467163
Hpdel O 1 0.9958595633506775
, O 0 0.0015523848123848438
the O 0 0.0015111370012164116
mother O 0 0.009260192513465881
to O 0 0.0013068363768979907
be O 0 0.002165637444704771
Hp2 O 1 0.9990461468696594
- O 0 0.017805924639105797
1 O 0 0.007163683418184519
and O 0 0.0031948282849043608
Hp1 O 1 0.9998898506164551
/ O 1 0.992384672164917
Hp2 O 1 0.9971576929092407
, O 0 0.0012959704035893083
one O 0 0.0008419047808274627
of O 0 0.00046964394277893007
the O 0 0.0008791277650743723
two O 0 0.0014521463308483362
children O 0 0.00431599747389555
to O 0 0.0010924385860562325
be O 0 0.0021007321774959564
hypohaptoglobinemic B-Disease 1 0.9986242055892944
( O 0 0.007121583446860313
Hp2 O 1 0.9992817044258118
) O 0 0.0038321795873343945
and O 0 0.002424192149192095
Hp2 O 1 0.9997809529304504
/ O 1 0.9958075284957886
Hpdel O 1 0.9984702467918396
, O 0 0.0016866454388946295
and O 0 0.0007005234947428107
the O 0 0.0009535566787235439
other O 0 0.0012829166371375322
child O 0 0.010227356106042862
to O 0 0.001216692617163062
be O 0 0.001803313149139285
Hp1 O 1 0.9933683276176453
and O 0 0.0038656634278595448
Hp1 O 1 0.9998359680175781
/ O 1 0.992853581905365
Hpdel O 1 0.9977545142173767
, O 0 0.0018384954892098904
showing O 0 0.00704771326854825
an O 0 0.002363801933825016
anomalous O 1 0.9853044152259827
inheritance O 1 0.9609230160713196
of O 0 0.0028889242094010115
Hp O 1 0.9985442161560059
phenotypes O 1 0.9999046325683594
in O 0 0.001953356433659792
the O 0 0.0020358816254884005
child O 0 0.02535373531281948
with O 0 0.006795258726924658
Hp1 O 1 0.9938079714775085
. O 0 0.009351229295134544

The O 0 0.012791857123374939
Hp2 O 1 0.997703492641449
/ O 1 0.9504720568656921
Hpdel O 1 0.9934126734733582
individuals O 0 0.007293281611055136
had O 0 0.0020121911074966192
an O 0 0.001703714020550251
extremely O 0 0.010381639935076237
low O 0 0.008735539391636848
level O 0 0.002893502125516534
of O 0 0.001270183129236102
Hp O 1 0.9932001233100891
( O 0 0.004775688983500004
mean O 0 0.018727310001850128
+ O 1 0.9986739158630371
/ O 1 0.9752193689346313
- O 0 0.07516039162874222
SD O 1 0.998036801815033
= O 0 0.15326210856437683
0 O 0 0.026373114436864853
. O 0 0.005738595966249704
049 O 1 0.9997695088386536
+ O 1 0.9971436858177185
/ O 1 0.7859033942222595
- O 0 0.02098870649933815
0 O 0 0.025328120216727257
. O 0 0.004889007192105055
043 O 1 0.9990795850753784
mg O 1 0.9997058510780334
/ O 1 0.992388129234314
ml O 1 0.9991055130958557
; O 0 0.009673523716628551
n O 1 0.6294522285461426
= O 0 0.3238912522792816
6 O 0 0.01027652807533741
) O 0 0.0034230244345963
, O 0 0.0011432376923039556
compared O 0 0.004873007535934448
with O 0 0.0013693280052393675
the O 0 0.0011636323761194944
level O 0 0.004423092119395733
( O 0 0.003126768162474036
1 O 0 0.004889227915555239
. O 0 0.001796661177650094
64 O 0 0.023467693477869034
+ O 1 0.9979811310768127
/ O 1 0.8916517496109009
- O 0 0.01975938305258751
1 O 0 0.0071258568204939365
. O 0 0.0035663496237248182
07 O 1 0.9809679388999939
mg O 1 0.9997374415397644
/ O 1 0.9942065477371216
ml O 1 0.998749852180481
) O 0 0.005231072194874287
obtained O 0 0.004983352031558752
from O 0 0.0018697468331083655
52 O 0 0.01931597851216793
healthy O 1 0.6049882769584656
volunteers O 0 0.01759493350982666
having O 0 0.012725853361189365
phenotype O 1 0.9999945163726807
Hp2 O 1 0.9965408444404602
, O 0 0.0021596259903162718
whereas O 0 0.010077595710754395
the O 0 0.0031326685566455126
serum O 1 0.9999141693115234
Hp O 1 0.9249041676521301
level O 0 0.0036927827168256044
of O 0 0.0005681225447915494
an O 0 0.0013600753154605627
individual O 0 0.004529259633272886
with O 0 0.004793635569512844
Hp1 O 1 0.9998247027397156
/ O 1 0.9908381104469299
Hpdel O 1 0.9944161176681519
was O 0 0.006250996608287096
0 O 0 0.02599211409687996
. O 0 0.00597074581310153

50 O 0 0.03170578554272652
mg O 1 0.9997124075889587
/ O 1 0.9943475127220154
ml O 1 0.998603880405426
, O 0 0.0020030939485877752
which O 0 0.0010005391668528318
was O 0 0.0013171597383916378
approximately O 0 0.0024461906868964434
half O 0 0.0021597298327833414
the O 0 0.000842986861243844
level O 0 0.0026453386526554823
of O 0 0.0011882696999236941
Hp O 1 0.8508330583572388
in O 0 0.002383879851549864
control O 0 0.018507255241274834
sera O 0 0.11111035943031311
from O 0 0.002020919928327203
the O 0 0.0039565665647387505
Hp1 O 1 0.9997817873954773
phenotype O 1 0.9999938011169434
( O 0 0.006658849306404591
1 O 0 0.005565344356000423
. O 0 0.001959744840860367
26 O 0 0.014254223555326462
+ O 1 0.9982773065567017
/ O 1 0.8786949515342712
- O 0 0.021743355318903923
0 O 0 0.019564317539334297
. O 0 0.0033031378407031298
33 O 0 0.027006657794117928
mg O 1 0.9995054006576538
/ O 1 0.9805541038513184
ml O 1 0.9985960125923157
; O 0 0.010289358906447887
n O 0 0.4028972387313843
= O 0 0.32238447666168213
9 O 0 0.009511306881904602
) O 0 0.0027746891137212515
, O 0 0.0010079555213451385
showing O 0 0.008067423477768898
a O 0 0.018070684745907784
gene O 1 0.9999812841415405
- O 0 0.12394122034311295
dosage O 1 0.9988179802894592
effect O 0 0.02816867269575596
. O 0 0.006134326569736004

The O 0 0.0045753647573292255
other O 0 0.004773600026965141
allele O 1 0.999896764755249
( O 0 0.010056587867438793
Hp2 O 1 0.9982683658599854
) O 0 0.0026382501237094402
of O 0 0.000788649485912174
individuals O 0 0.004447944462299347
with O 0 0.005214042495936155
Hp2 O 1 0.9998621940612793
/ O 1 0.9946039319038391
Hpdel O 1 0.9979442954063416
was O 0 0.0027281916700303555
found O 0 0.0037124166265130043
to O 0 0.0008646032074466348
have O 0 0.0009081434109248221
, O 0 0.000759652117267251
in O 0 0.0007861354970373213
all O 0 0.0011280784383416176
exons O 1 0.9993763566017151
, O 0 0.0020496079232543707
no O 0 0.005033896770328283
mutation O 1 0.9999897480010986
, O 0 0.001836798619478941
by O 0 0.003726481692865491
DNA O 1 0.9992781281471252
sequencing O 1 0.9892717599868774
. O 0 0.00919618271291256

On O 0 0.002996541792526841
the O 0 0.0012329872697591782
basis O 0 0.002064142841845751
of O 0 0.000591663527302444
the O 0 0.000954442482907325
present O 0 0.0028485155198723078
study O 0 0.005670690909028053
, O 0 0.0009389552869834006
the O 0 0.0014753190334886312
mechanism O 0 0.0601918026804924
of O 0 0.0016608014702796936
anhaptoglobinemia B-Disease 1 0.9951876401901245
and O 0 0.0010273633524775505
the O 0 0.0016220803372561932
mechanism O 0 0.040812477469444275
of O 0 0.0019046601373702288
anomalous O 1 0.9953067898750305
inheritance O 1 0.9403777718544006
of O 0 0.0030695509631186724
Hp O 1 0.9989272952079773
phenotypes O 1 0.9998860359191895
were O 0 0.0015137273585423827
well O 0 0.002536045853048563
explained O 0 0.013144951313734055
. O 0 0.005402222275733948

However O 0 0.006144620478153229
, O 0 0.0015934249386191368
the O 0 0.002003859728574753
mechanism O 0 0.14493633806705475
of O 0 0.002189754508435726
hypohaptoglobinemia B-Disease 1 0.9919185042381287
remains O 0 0.01152636669576168
unknown O 0 0.03390130773186684

ATM O 1 0.9852521419525146
mutations O 1 0.9997499585151672
and O 0 0.005194658413529396
phenotypes O 1 0.9998125433921814
in O 0 0.013842333108186722
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9920281767845154
telangiectasia I-Disease 1 0.9999792575836182
families O 0 0.00803240854293108
in O 0 0.0012086544884368777
the O 0 0.0013588913716375828
British O 0 0.00700005516409874
Isles O 0 0.15340456366539001
: O 0 0.003738422179594636
expression O 0 0.01755312643945217
of O 0 0.0019141974626109004
mutant O 1 0.9998238682746887
ATM O 1 0.9904110431671143
and O 0 0.0010334316175431013
the O 0 0.0018453177763149142
risk O 1 0.9937798380851746
of O 0 0.005839420948177576
leukemia B-Disease 1 1.0
, O 0 0.0401882641017437
lymphoma B-Disease 1 1.0
, O 0 0.00577474944293499
and O 0 0.018143439665436745
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
. O 0 0.008825412951409817

We O 0 0.003418620442971587
report O 0 0.002543789567425847
the O 0 0.00169078866019845
spectrum O 0 0.02394763007760048
of O 0 0.0016106301918625832
59 O 0 0.03515169024467468
ATM O 1 0.9986603260040283
mutations O 1 0.9999299049377441
observed O 0 0.019390875473618507
in O 0 0.006704733241349459
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9865676164627075
telangiectasia I-Disease 1 0.9999860525131226
( O 0 0.011011986993253231
A B-Disease 1 0.807303249835968
- I-Disease 1 0.9916478395462036
T I-Disease 1 0.9999864101409912
) O 0 0.012126388028264046
patients O 1 0.9992188215255737
in O 0 0.001484135864302516
the O 0 0.001971115591004491
British O 0 0.011060157790780067
Isles O 0 0.10587016493082047
. O 0 0.006910210009664297

Of O 0 0.00412707170471549
51 O 0 0.04746811091899872
ATM O 1 0.9992227554321289
mutations O 1 0.9999793767929077
identified O 0 0.013300856575369835
in O 0 0.0013623563572764397
families O 0 0.0038155391812324524
native O 0 0.0026117293164134026
to O 0 0.00085661985212937
the O 0 0.0011386820115149021
British O 0 0.008038322441279888
Isles O 0 0.18757182359695435
, O 0 0.0014591285726055503
11 O 0 0.004120694939047098
were O 0 0.0014242674224078655
founder O 1 0.8045734763145447
mutations O 1 0.9999961853027344
, O 0 0.001752724521793425
and O 0 0.0009347407030873001
2 O 0 0.003944936208426952
of O 0 0.0006436429102905095
these O 0 0.0010186468716710806
11 O 0 0.005311582703143358
conferred O 0 0.01874295249581337
a O 0 0.011390695348381996
milder O 1 0.9998019337654114
clinical O 1 0.9999802112579346
phenotype O 1 0.9999935626983643
with O 0 0.0021668642293661833
respect O 0 0.0023856654297560453
to O 0 0.001243858365342021
both O 0 0.006297650281339884
cerebellar B-Disease 1 0.9999967813491821
degeneration I-Disease 1 0.9999966621398926
and O 0 0.0047238473780453205
cellular O 1 0.9987103939056396
features O 0 0.013669623993337154
. O 0 0.00619894452393055

We O 0 0.0034510658588260412
report O 0 0.002553164027631283
, O 0 0.0009469470824114978
in O 0 0.0009927337523549795
two O 0 0.002715256530791521
A B-Disease 1 0.5433462262153625
- I-Disease 1 0.7721747159957886
T I-Disease 1 0.9997560381889343
families O 0 0.006376491393893957
, O 0 0.0013787958305329084
an O 0 0.0031028559897094965
ATM O 1 0.9992473125457764
mutation O 1 0.9999849796295166
( O 0 0.009653352200984955
7271T O 1 0.9994187355041504
- O 1 0.5178565979003906
- O 1 0.7088232636451721
> O 1 0.9998034834861755
G O 1 0.9996013045310974
) O 0 0.003745113033801317
that O 0 0.001128501957282424
may O 0 0.00328130298294127
be O 0 0.0008219534647651017
associated O 0 0.004747037775814533
with O 0 0.001113643404096365
an O 0 0.0012583043426275253
increased O 0 0.011381817981600761
risk O 1 0.997190535068512
of O 0 0.005995610728859901
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
in O 0 0.0020369524136185646
both O 0 0.0036456333473324776
homozygotes O 1 0.999883770942688
and O 0 0.0040969946421682835
heterozygotes O 1 0.9998606443405151
( O 0 0.005569932516664267
relative O 0 0.023148180916905403
risk O 1 0.9663380980491638
12 O 0 0.005421806126832962
. O 0 0.0021405729930847883
7 O 0 0.01076288241893053
; O 0 0.008404958061873913
P O 1 0.9958018660545349
= O 1 0.5223643183708191
. O 0 0.007103797513991594
0025 O 1 0.9998263716697693
) O 0 0.004834768828004599
, O 0 0.001074130297638476
although O 0 0.0015704227844253182
there O 0 0.0007020790362730622
is O 0 0.0009302286780439317
a O 0 0.0038479501381516457
less O 0 0.005978062748908997
severe O 1 0.9995101690292358
A B-Disease 1 0.9140932559967041
- I-Disease 1 0.9955127835273743
T I-Disease 1 0.9999940395355225
phenotype O 1 0.9999909400939941
in O 0 0.0016350967343896627
terms O 0 0.0015896465629339218
of O 0 0.0006058824947103858
the O 0 0.0014099751133471727
degree O 0 0.011073132045567036
of O 0 0.00420440174639225
cerebellar B-Disease 1 0.9999970197677612
degeneration I-Disease 1 0.9999972581863403
. O 0 0.011038560420274734

This O 0 0.010889501310884953
mutation O 1 0.9999345541000366
( O 0 0.013663729652762413
7271T O 1 0.9989703893661499
- O 1 0.6123359203338623
- O 1 0.6263014674186707
> O 1 0.9996954202651978
G O 1 0.9992669224739075
) O 0 0.0032428239937871695
also O 0 0.0010736857075244188
allows O 0 0.0072424462996423244
expression O 0 0.014929081313312054
of O 0 0.0009128315723501146
full O 0 0.005590714979916811
- O 0 0.014131572097539902
length O 0 0.021902188658714294
ATM O 1 0.9982376098632812
protein O 1 0.9992187023162842
at O 0 0.0022865671198815107
a O 0 0.003685561940073967
level O 0 0.0039952886290848255
comparable O 0 0.016337476670742035
with O 0 0.0015405649319291115
that O 0 0.0010514004388824105
in O 0 0.002546371426433325
unaffected O 1 0.991104781627655
individuals O 0 0.008862295188009739
. O 0 0.00524081289768219

In O 0 0.004193232394754887
addition O 0 0.0044613732025027275
, O 0 0.001154199242591858
we O 0 0.0006273192702792585
have O 0 0.0008219808805733919
studied O 0 0.004455717280507088
18 O 0 0.006514735519886017
A B-Disease 1 0.9061870574951172
- I-Disease 1 0.9985508322715759
T I-Disease 1 0.9999984502792358
patients O 1 0.999893307685852
, O 0 0.0020644001197069883
in O 0 0.0013448167592287064
15 O 0 0.0037237920332700014
families O 0 0.0036669597029685974
, O 0 0.0014236464630812407
who O 0 0.003115409752354026
developed O 1 0.9982398748397827
leukemia B-Disease 1 1.0
, O 0 0.013815977610647678
lymphoma B-Disease 1 0.9999998807907104
, O 0 0.00559834111481905
preleukemic O 1 0.9997255206108093
T O 1 0.9999732971191406
- O 1 0.7623618841171265
cell O 1 0.9998103976249695
proliferation O 1 0.9814444780349731
, O 0 0.0044132424518466
or O 1 0.5492630004882812
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.003466665279120207
mostly O 0 0.0024591435212641954
in O 0 0.002970639616250992
childhood O 1 0.9314577579498291
. O 0 0.00843837857246399

A O 0 0.014829684048891068
wide O 0 0.008993108756840229
variety O 0 0.005533052142709494
of O 0 0.0021795504726469517
ATM O 1 0.9997308850288391
mutation O 1 0.9999927282333374
types O 0 0.020285185426473618
, O 0 0.001533815753646195
including O 0 0.0049920473247766495
missense O 1 0.9999821186065674
mutations O 1 0.9999896287918091
and O 0 0.0019260580884292722
in O 0 0.0020956662483513355
- O 0 0.02396347187459469
frame O 0 0.322660356760025
deletions O 1 0.999387264251709
, O 0 0.0013225891161710024
were O 0 0.000605907931458205
seen O 0 0.003275867784395814
in O 0 0.0016008340753614902
these O 0 0.003952978644520044
patients O 1 0.9993903636932373
. O 0 0.007504675537347794

We O 0 0.0026340356562286615
also O 0 0.0009254219476133585
show O 0 0.002140991622582078
that O 0 0.0009887362830340862
25 O 0 0.0023296878207474947
% O 0 0.0023601939901709557
of O 0 0.0005727637908421457
all O 0 0.0012336657382547855
A B-Disease 1 0.8072742819786072
- I-Disease 1 0.9848653078079224
T I-Disease 1 0.9999856948852539
patients O 1 0.9988627433776855
carried O 0 0.008436663076281548
in O 0 0.002251132857054472
- O 0 0.01694217137992382
frame O 0 0.04620657116174698
deletions O 1 0.9976861476898193
or O 0 0.013984795659780502
missense O 1 0.9999876022338867
mutations O 1 0.9999934434890747
, O 0 0.001472405274398625
many O 0 0.0004481382784433663
of O 0 0.0005538755794987082
which O 0 0.0008385141263715923
were O 0 0.0005251261754892766
also O 0 0.0011275014840066433
associated O 0 0.0055602118372917175
with O 0 0.0016654640203341842
expression O 0 0.019702838733792305
of O 0 0.0023216931149363518
mutant O 1 0.9998372793197632
ATM O 1 0.9985536932945251
protein O 1 0.9976790547370911
. O 0 0.008603491820394993

The O 0 0.011600788682699203
DMPK O 1 0.9944933652877808
gene O 1 0.9982463121414185
of O 0 0.005041970871388912
severely O 1 0.9866034984588623
affected O 1 0.9954811334609985
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.9998952150344849
is O 0 0.006258735433220863
hypermethylated O 1 0.9985138773918152
proximal O 1 0.9996194839477539
to O 0 0.001333027146756649
the O 0 0.0012834679801017046
largely O 0 0.005087884608656168
expanded O 0 0.01613464206457138
CTG O 1 0.9981093406677246
repeat O 1 0.527742326259613
. O 0 0.007162472698837519

Using O 0 0.033612143248319626
methylation O 1 0.9952926635742188
- O 0 0.024569770321249962
sensitive O 0 0.020378440618515015
restriction O 0 0.12107180058956146
enzymes O 1 0.9985781908035278
, O 0 0.00151561398524791
we O 0 0.0011326882522553205
characterized O 0 0.02017168328166008
the O 0 0.002854044083505869
methylation O 1 0.9994410872459412
pattern O 0 0.037418682128190994
on O 0 0.0011280665639787912
the O 0 0.0012700416846200824
5 O 0 0.004464120604097843
side O 0 0.0026863152161240578
of O 0 0.000666945765260607
the O 0 0.0022950691636651754
CTG O 1 0.9996317625045776
repeat O 0 0.14745503664016724
in O 0 0.0014893017942085862
the O 0 0.003057216526940465
DMPK O 1 0.9997829794883728
gene O 1 0.9997411370277405
of O 0 0.00184679648373276
normal O 0 0.03288701921701431
individuals O 0 0.0036671217530965805
and O 0 0.000981988268904388
of O 0 0.002281723776832223
patients O 1 0.9999364614486694
affected O 0 0.3061780631542206
with O 0 0.04141760990023613
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999995231628418
, O 0 0.0038001590874046087
showing O 0 0.010573331266641617
expansions O 0 0.03415089100599289
of O 0 0.0011232777033001184
the O 0 0.003692605532705784
repetitive O 1 0.9974748492240906
sequence O 0 0.20636148750782013
. O 0 0.00901894923299551

The O 0 0.011062536388635635
gene O 1 0.999457061290741
segment O 0 0.044583480805158615
analyzed O 0 0.02562030963599682
corresponds O 0 0.012188205495476723
to O 0 0.0012001694412901998
the O 0 0.0031974108424037695
genomic O 1 0.9998327493667603
SacI O 1 0.9980661273002625
- O 0 0.03693627938628197
HindIII O 1 0.9619154930114746
fragment O 0 0.32797467708587646
carrying O 0 0.025963226333260536
exons O 1 0.9879124760627747
11 O 0 0.0239130686968565
- O 0 0.022385092452168465
15 O 0 0.010653330013155937
. O 0 0.006766356527805328

There O 0 0.003127821022644639
is O 0 0.0035637447144836187
constitutive O 1 0.9632675647735596
methylation O 1 0.9919044375419617
in O 0 0.005225501488894224
intron O 1 0.9997263550758362
12 O 0 0.007493162993341684
at O 0 0.0024314909242093563
restriction O 0 0.017444806173443794
sites O 0 0.0032306092325598
of O 0 0.0016263097058981657
SacII O 1 0.9974187612533569
and O 0 0.0033661280758678913
HhaI O 1 0.9985550045967102
, O 0 0.004385803826153278
localized O 1 0.9989945292472839
1 O 0 0.008955213241279125
, O 0 0.0028847737703472376
159 O 1 0.5280600190162659
- O 0 0.02307954430580139
1 O 0 0.00753519544377923
, O 0 0.0022013946436345577
232 O 0 0.05367507040500641
bp O 0 0.06224823743104935
upstream O 0 0.028551332652568817
of O 0 0.0011029468150809407
the O 0 0.003182238433510065
CTG O 1 0.9998548030853271
repeat O 1 0.9675131440162659
, O 0 0.0023648152127861977
whereas O 0 0.013157613575458527
most O 0 0.0013546717818826437
, O 0 0.0012171765556558967
if O 0 0.0018069623038172722
not O 0 0.0006705587729811668
all O 0 0.000489416706841439
, O 0 0.0006158251198939979
of O 0 0.0004917176556773484
the O 0 0.0007755658007226884
other O 0 0.0008080847910605371
sites O 0 0.002970254048705101
of O 0 0.0016883581411093473
SacII O 1 0.999230146408081
, O 0 0.003710812423378229
HhaI O 1 0.998795747756958
, O 0 0.0019853783305734396
and O 0 0.001960732974112034
HpaII O 1 0.9980592131614685
in O 0 0.0015060288133099675
this O 0 0.0010905618546530604
region O 0 0.0027958599384874105
are O 0 0.0015373110072687268
unmethylated O 1 0.9996470212936401
, O 0 0.0016913135768845677
in O 0 0.0017861912492662668
normal O 0 0.15051208436489105
individuals O 0 0.0035369868855923414
and O 0 0.0005629209917970002
most O 0 0.0006750040920451283
of O 0 0.0007363214972428977
the O 0 0.0035342650953680277
patients O 1 0.9998383522033691
. O 0 0.006430997047573328

In O 0 0.004041068721562624
a O 0 0.003984650131314993
number O 0 0.0011944494908675551
of O 0 0.001006386592052877
young O 0 0.0072806766256690025
and O 0 0.0028008657973259687
severely O 1 0.998670220375061
affected O 1 0.9842661619186401
patients O 1 0.9999315738677979
, O 0 0.0015992046101018786
however O 0 0.00184836785774678
, O 0 0.001109798438847065
complete O 0 0.011330279521644115
methylation O 1 0.9966748952865601
of O 0 0.0007467224495485425
these O 0 0.0009708529687486589
restriction O 0 0.02027108520269394
sites O 0 0.0032945494167506695
was O 0 0.0012462888844311237
found O 0 0.0035651824437081814
in O 0 0.001317264512181282
the O 0 0.004341683350503445
mutated O 1 0.9999791383743286
allele O 1 0.9997637867927551
. O 0 0.008999418467283249

In O 0 0.00261663063429296
most O 0 0.001018789247609675
of O 0 0.0008817148627713323
these O 0 0.002373539609834552
patients O 1 0.9998196959495544
, O 0 0.001458389451727271
the O 0 0.0023079761303961277
onset O 1 0.9999204874038696
of O 0 0.00140999851282686
the O 0 0.0062903850339353085
disease O 1 0.9999983310699463
was O 0 0.017483867704868317
congenital O 1 0.9999998807907104
. O 0 0.010116152465343475

Preliminary O 0 0.022372564300894737
in O 0 0.005805236753076315
vivo O 1 0.9990993738174438
footprinting O 1 0.9995148181915283
data O 0 0.007147595752030611
gave O 0 0.003569038351997733
evidence O 0 0.002452143467962742
for O 0 0.002765125362202525
protein O 1 0.9999191761016846
- O 0 0.15904809534549713
DNA O 1 0.9996399879455566
contact O 0 0.019886497408151627
in O 0 0.001964982133358717
normal O 0 0.07551886886358261
genes O 1 0.9990567564964294
at O 0 0.0026878127828240395
an O 0 0.0031956303864717484
Sp1 O 1 0.9998505115509033
consensus O 0 0.012654339894652367
binding O 0 0.026277486234903336
site O 0 0.004435354843735695
upstream O 0 0.017668960615992546
of O 0 0.0007433824939653277
the O 0 0.0023847552947700024
CTG O 1 0.999819815158844
repeat O 1 0.7148178815841675
and O 0 0.0009967614896595478
for O 0 0.0010009696707129478
a O 0 0.0035556971561163664
significant O 0 0.005086475517600775
reduction O 0 0.014271815307438374
of O 0 0.0005124456365592778
this O 0 0.0008118752157315612
interaction O 0 0.01958254911005497
in O 0 0.0020485909190028906
cells O 1 0.9996337890625
with O 0 0.0026644773315638304
a O 0 0.010370377451181412
hypermethylated O 1 0.9993934631347656
DMPK O 1 0.9996602535247803
gene O 1 0.9997290968894958
. O 0 0.004609388764947653
. O 0 0.0049492367543280125

The O 0 0.02080499939620495
hemochromatosis B-Disease 1 0.999983549118042
gene O 1 0.999481737613678
product O 0 0.02082167938351631
complexes O 0 0.05692863091826439
with O 0 0.0019661562982946634
the O 0 0.0034134602174162865
transferrin O 1 0.9998424053192139
receptor O 1 0.9993849992752075
and O 0 0.0031408972572535276
lowers O 1 0.9784844517707825
its O 0 0.004370971117168665
affinity O 1 0.8356873393058777
for O 0 0.0037934137508273125
ligand O 1 0.996801495552063
binding O 0 0.07876736670732498
. O 0 0.0069431280717253685

We O 0 0.0056411512196063995
recently O 0 0.009840168990194798
reported O 0 0.00673614302650094
the O 0 0.0022298872936517
positional O 1 0.9943814873695374
cloning O 1 0.8746393918991089
of O 0 0.0011183887254446745
a O 0 0.004263533744961023
candidate O 0 0.01527365855872631
gene O 1 0.9998462200164795
for O 0 0.009258175268769264
hereditary B-Disease 1 0.9999918937683105
hemochromatosis I-Disease 1 0.9999988079071045
called O 0 0.04521055519580841
HFE O 1 0.9996005892753601
. O 0 0.013737887144088745

The O 0 0.009791528806090355
gene O 1 0.9999121427536011
product O 0 0.016790669411420822
, O 0 0.0014196266420185566
a O 0 0.003481167135760188
member O 0 0.0016514062881469727
of O 0 0.0005333927692845464
the O 0 0.0015372013440355659
major O 0 0.012667234055697918
histocompatibility O 1 0.99996018409729
complex O 0 0.0278435330837965
class O 0 0.024798862636089325
I O 0 0.01096806675195694
- O 0 0.0179500300437212
like O 0 0.0067574214190244675
family O 0 0.008679402060806751
, O 0 0.00128338357899338
was O 0 0.0013741932343691587
found O 0 0.002723365556448698
to O 0 0.0008397406782023609
have O 0 0.0010499355848878622
a O 0 0.009830384515225887
mutation O 1 0.9999927282333374
, O 0 0.00672888895496726
Cys O 1 0.9999024868011475
- O 0 0.05001657456159592
282 O 1 0.9885327816009521
- O 0 0.2992572486400604
- O 0 0.14869153499603271
> O 1 0.9994308352470398
Tyr O 1 0.9996084570884705
( O 0 0.012273778207600117
C282Y O 1 0.9984447360038757
) O 0 0.004181831143796444
, O 0 0.0013232952915132046
in O 0 0.0011850573355332017
85 O 0 0.011953741312026978
% O 0 0.004857012070715427
of O 0 0.0031205052509903908
patient O 1 0.9988817572593689
chromosomes O 1 0.9982435703277588
. O 0 0.008488228544592857

This O 0 0.010625788010656834
mutation O 1 0.9998321533203125
eliminates O 1 0.7226327061653137
the O 0 0.0021811393089592457
ability O 0 0.010080709122121334
of O 0 0.002678138669580221
HFE O 1 0.9996620416641235
to O 0 0.0032642658334225416
associate O 0 0.013897750526666641
with O 0 0.004913680255413055
beta2 O 1 0.9991033673286438
- O 0 0.06994780153036118
microglobulin O 1 0.9969074130058289
( O 0 0.009669129736721516
beta2m O 1 0.9940494298934937
) O 0 0.004986280109733343
and O 0 0.0031257071532309055
prevents O 1 0.9989784955978394
cell O 1 0.9995074272155762
- O 0 0.023614417761564255
surface O 0 0.024810098111629486
expression O 0 0.04636186361312866
. O 0 0.006232002750039101

A O 0 0.01860486902296543
second O 0 0.015989352017641068
mutation O 1 0.999975323677063
that O 0 0.0023171843495219946
has O 0 0.00137107796035707
no O 0 0.00205292459577322
effect O 0 0.008546258322894573
on O 0 0.002156648086383939
beta2m O 1 0.9976751208305359
association O 0 0.010323917493224144
, O 0 0.0037180643994361162
H63D O 1 0.9993853569030762
, O 0 0.002168192295357585
was O 0 0.0012970477109774947
found O 0 0.0034181298688054085
in O 0 0.0009137478191405535
eight O 0 0.001893407665193081
out O 0 0.0014961246633902192
of O 0 0.0010351001983508468
nine O 0 0.011130213737487793
patients O 1 0.9998874664306641
heterozygous O 1 0.9996204376220703
for O 0 0.0019801424350589514
the O 0 0.003580298740416765
C282Y O 1 0.9966048002243042
mutant O 1 0.9977806210517883
. O 0 0.010282198898494244

In O 0 0.003962988965213299
this O 0 0.0019441397162154317
report O 0 0.0030887287575751543
, O 0 0.0010353022953495383
we O 0 0.0009550583781674504
demonstrate O 0 0.007191686891019344
in O 0 0.0024994949344545603
cultured O 1 0.9785830974578857
293 O 1 0.9829832315444946
cells O 1 0.9993939399719238
overexpressing O 1 0.9995513558387756
wild O 0 0.05011552572250366
- O 0 0.024807928130030632
type O 0 0.0920199528336525
or O 0 0.008689472451806068
mutant O 1 0.9997875094413757
HFE O 1 0.999944806098938
proteins O 1 0.9919901490211487
that O 0 0.001003734301775694
both O 0 0.0009241948137059808
the O 0 0.0014356409665197134
wild O 0 0.0613098107278347
- O 0 0.022939493879675865
type O 0 0.20629914104938507
and O 0 0.0035262703895568848
H63D O 1 0.999468982219696
HFE O 1 0.9998557567596436
proteins O 1 0.9905099272727966
form O 0 0.014287037774920464
stable O 0 0.05021722614765167
complexes O 0 0.05233689770102501
with O 0 0.002119616139680147
the O 0 0.0035284562036395073
transferrin O 1 0.9998369216918945
receptor O 1 0.9997846484184265
( O 0 0.014136163517832756
TfR O 1 0.9995304346084595
) O 0 0.006848993711173534
. O 0 0.00521804578602314

The O 0 0.009865028783679008
C282Y O 1 0.9939182996749878
mutation O 1 0.9998914003372192
nearly O 0 0.00962325744330883
completely O 0 0.01714899018406868
prevents O 1 0.7455649375915527
the O 0 0.001118435407988727
association O 0 0.002344416920095682
of O 0 0.0006186668178997934
the O 0 0.0024916904512792826
mutant O 1 0.9998424053192139
HFE O 1 0.9999566078186035
protein O 1 0.998145341873169
with O 0 0.0038337816949933767
the O 0 0.004049117676913738
TfR O 1 0.9992780089378357
. O 0 0.007140922825783491

Studies O 0 0.023623639717698097
on O 0 0.006202464457601309
cell O 1 0.9994762539863586
- O 0 0.03663033992052078
associated O 0 0.023779984563589096
transferrin O 1 0.9958072900772095
at O 0 0.005422125104814768
37 O 0 0.018491990864276886
degrees O 0 0.015215533785521984
C O 1 0.7262477874755859
suggest O 0 0.007005794905126095
that O 0 0.000976849696598947
the O 0 0.002120246412232518
overexpressed O 1 0.9996730089187622
wild O 0 0.03710266202688217
- O 0 0.03249520808458328
type O 1 0.9756532311439514
HFE O 1 0.9999333620071411
protein O 1 0.9986987113952637
decreases O 0 0.04625704884529114
the O 0 0.002197548747062683
affinity O 0 0.16402004659175873
of O 0 0.0010834282729774714
the O 0 0.0028178358916193247
TfR O 1 0.9993382096290588
for O 0 0.006589490454643965
transferrin O 1 0.9990614056587219
. O 0 0.008986881002783775

The O 0 0.011895165778696537
overexpressed O 1 0.9980740547180176
H63D O 1 0.9993224143981934
protein O 1 0.9997039437294006
does O 0 0.005754552781581879
not O 0 0.0008929009782150388
have O 0 0.0008049429743550718
this O 0 0.0012968007940798998
effect O 0 0.00980063620954752
, O 0 0.0011621220037341118
providing O 0 0.004558571148663759
the O 0 0.0007737519918009639
first O 0 0.0015923975734040141
direct O 0 0.006102701649069786
evidence O 0 0.002330716699361801
for O 0 0.0010705430759117007
a O 0 0.004971813410520554
functional O 1 0.6527199745178223
consequence O 0 0.019681913778185844
of O 0 0.0011030003661289811
the O 0 0.004116021562367678
H63D O 1 0.9997982382774353
mutation O 1 0.999954104423523
. O 0 0.010629899799823761

Addition O 0 0.008394720032811165
of O 0 0.0024237309116870165
soluble O 1 0.9984914064407349
wild O 0 0.08096574246883392
- O 0 0.05521206930279732
type O 1 0.9870167374610901
HFE O 1 0.999930739402771
/ O 1 0.9118779897689819
beta2m O 1 0.991925060749054
heterodimers O 1 0.9982759952545166
to O 0 0.004239740781486034
cultured O 1 0.9984951019287109
cells O 1 0.9991241097450256
also O 0 0.0021786303259432316
decreased O 0 0.02708890102803707
the O 0 0.0019256600644439459
apparent O 0 0.08705661445856094
affinity O 1 0.5902277231216431
of O 0 0.0010952783050015569
the O 0 0.0021620914340019226
TfR O 1 0.9993613362312317
for O 0 0.0015256430488079786
its O 0 0.003003546269610524
ligand O 1 0.9975311160087585
under O 0 0.003332477528601885
steady O 0 0.03405967727303505
- O 0 0.012090095318853855
state O 0 0.00216701440513134
conditions O 0 0.00784508790820837
, O 0 0.0011567148612812161
both O 0 0.001347454497590661
in O 0 0.002527380594983697
293 O 1 0.9956775307655334
cells O 1 0.9994514584541321
and O 0 0.0019413658883422613
in O 0 0.005011106841266155
HeLa O 1 0.9999767541885376
cells O 1 0.9991146922111511
. O 0 0.007689375430345535

Furthermore O 0 0.03209669142961502
, O 0 0.0025652104523032904
at O 0 0.003449878888204694
4 O 0 0.010204979218542576
degrees O 0 0.013414174318313599
C O 1 0.5954277515411377
, O 0 0.0011290631955489516
the O 0 0.001089997822418809
added O 0 0.004926113411784172
soluble O 1 0.9976904392242432
complex O 0 0.013997596688568592
of O 0 0.003172049531713128
HFE O 1 0.9999841451644897
/ O 1 0.9574570655822754
beta2m O 1 0.9892488718032837
inhibited O 1 0.9783555269241333
binding O 0 0.02651224657893181
of O 0 0.001590190688148141
transferrin O 1 0.9990023970603943
to O 0 0.006616022437810898
HeLa O 1 0.9999220371246338
cell O 1 0.9986889958381653
TfR O 1 0.9975574016571045
in O 0 0.002143791876733303
a O 0 0.007877458818256855
concentration O 0 0.4850301444530487
- O 0 0.025257868692278862
dependent O 0 0.02921673096716404
manner O 0 0.019742904230952263
. O 0 0.006570527330040932

Scatchard O 1 0.7488992214202881
plots O 0 0.02516697533428669
of O 0 0.0009879532735794783
these O 0 0.0009276203927583992
data O 0 0.003895466448739171
indicate O 0 0.006087485235184431
that O 0 0.0007257163524627686
the O 0 0.0009977990994229913
added O 0 0.006027042865753174
heterodimer O 1 0.999607503414154
substantially O 0 0.03678483888506889
reduced O 0 0.011522526852786541
the O 0 0.002032618271186948
affinity O 1 0.6727190017700195
of O 0 0.0030203014612197876
TfR O 1 0.9992344379425049
for O 0 0.006193908862769604
transferrin O 1 0.9987598657608032
. O 0 0.010089343413710594

These O 0 0.003284306265413761
results O 0 0.008030623197555542
establish O 0 0.009519688785076141
a O 0 0.007515586446970701
molecular O 1 0.9951480031013489
link O 0 0.09106019139289856
between O 0 0.005301570054143667
HFE O 1 0.999929666519165
and O 0 0.0012721786042675376
a O 0 0.0040371110662817955
key O 0 0.009908962994813919
protein O 1 0.9996466636657715
involved O 0 0.007236435078084469
in O 0 0.0016839121235534549
iron O 0 0.07380151003599167
transport O 0 0.013894385658204556
, O 0 0.0013529774732887745
the O 0 0.002590957097709179
TfR O 1 0.9999287128448486
, O 0 0.001587300794199109
and O 0 0.0008476735674776137
raise O 0 0.006194387562572956
the O 0 0.0012462587328627706
possibility O 0 0.008468786254525185
that O 0 0.0015703950775787234
alterations O 1 0.8630903363227844
in O 0 0.001178105128929019
this O 0 0.0017670273082330823
regulatory O 1 0.9917818307876587
mechanism O 1 0.9767001271247864
may O 0 0.004115876741707325
play O 0 0.0021296730265021324
a O 0 0.0030824257992208004
role O 0 0.004011904820799828
in O 0 0.0010558124631643295
the O 0 0.002917839912697673
pathogenesis O 1 0.9999897480010986
of O 0 0.007040024735033512
hereditary B-Disease 1 0.9999990463256836
hemochromatosis I-Disease 1 0.9999991655349731
. O 0 0.008608818054199219
. O 0 0.007669118698686361

Genomic O 1 0.9967982172966003
organization O 0 0.0071450951509177685
of O 0 0.0011076860828325152
the O 0 0.004428327549248934
UBE3A O 1 0.9999518394470215
/ O 1 0.9949553608894348
E6 O 1 0.9997864365577698
- O 0 0.07345032691955566
AP O 0 0.31485578417778015
gene O 1 0.9995885491371155
and O 0 0.0028943715151399374
related O 0 0.03144901245832443
pseudogenes O 1 0.9982337951660156
. O 0 0.00902941357344389

The O 0 0.015365845523774624
UBE3A O 1 0.9989833235740662
gene O 1 0.9982916712760925
encodes O 1 0.8957569599151611
the O 0 0.005613636691123247
E6 O 1 0.999242901802063
- O 0 0.038621604442596436
AP O 0 0.05899098888039589
ubiquitin O 1 0.9974343180656433
- O 0 0.07942064106464386
protein O 1 0.9991133809089661
ligase O 1 0.9766085147857666
and O 0 0.001878707087598741
has O 0 0.0014718839665874839
recently O 0 0.004452078603208065
been O 0 0.001001775381155312
shown O 0 0.002909549977630377
to O 0 0.0008438210934400558
be O 0 0.002372246002778411
mutated O 1 0.9999817609786987
in O 0 0.1238393783569336
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9998099207878113
who O 0 0.0032867658883333206
lack O 0 0.02733667381107807
15q11 O 1 0.9990788698196411
- O 0 0.04616871476173401
q13 O 1 0.9952488541603088
deletions O 1 0.9960632920265198
or O 0 0.014846705831587315
chromosome O 1 0.9998403787612915
15 O 0 0.024298865348100662
paternal O 1 0.9938681721687317
uniparental B-Disease 1 0.999832272529602
disomy I-Disease 1 0.9778372049331665
. O 0 0.010422940365970135

Previous O 0 0.031919632107019424
UBE3A O 1 0.9986695051193237
cDNA O 1 0.9876185655593872
analysis O 0 0.022242339327931404
has O 0 0.0022128482814878225
shown O 0 0.006372546311467886
a O 0 0.008744223043322563
coding O 1 0.996191143989563
region O 0 0.0040851859375834465
of O 0 0.0008970435010269284
approximately O 0 0.0053190323524177074
2 O 0 0.01119356881827116
. O 0 0.005325146019458771

6 O 0 0.027336478233337402
kb O 0 0.3504559099674225
and O 0 0.0022988019045442343
a O 0 0.008265119045972824
3 O 0 0.016924390569329262
- O 0 0.029788702726364136
untranslated O 1 0.98993319272995
region O 0 0.009372331202030182
( O 0 0.007233862765133381
UTR O 1 0.9949507713317871
) O 0 0.0042757089249789715
of O 0 0.002011324046179652
< O 1 0.994590163230896
50 O 0 0.009638930670917034
bp O 0 0.06599036604166031
, O 0 0.002409105421975255
whereas O 0 0.01099647581577301
Northern O 0 0.0038866503164172173
analysis O 0 0.01083112508058548
has O 0 0.0015783589333295822
indicated O 0 0.012258017435669899
mRNA O 1 0.9577026963233948
sizes O 0 0.011953200213611126
of O 0 0.001566393068060279
5 O 0 0.012281132861971855
- O 0 0.01944979652762413
8 O 0 0.01812114752829075
kb O 1 0.9632100462913513
. O 0 0.009814027696847916

We O 0 0.0028270799666643143
have O 0 0.0013374022673815489
analyzed O 0 0.019464030861854553
additional O 0 0.008531833067536354
cDNA O 1 0.9980605244636536
clones O 1 0.9967924952507019
and O 0 0.0014928095042705536
provide O 0 0.0031516775488853455
evidence O 0 0.002454826608300209
for O 0 0.0009548580273985863
an O 0 0.0018120212480425835
additional O 0 0.007589941378682852
0 O 0 0.02350163832306862
. O 0 0.005660579074174166

5 O 0 0.024040525779128075
kb O 0 0.2582577168941498
of O 0 0.003165831556543708
5 O 0 0.013891080394387245
- O 0 0.02730761654675007
UTR O 1 0.9944339394569397
and O 0 0.004790970589965582
> O 1 0.9911971092224121
2 O 0 0.01236956287175417
kb O 1 0.7012196779251099
of O 0 0.0025296597741544247
3 O 0 0.017680924385786057
- O 0 0.035929374396800995
UTR O 1 0.9843189120292664
. O 0 0.009513530880212784

We O 0 0.002885302994400263
have O 0 0.0013538425555452704
established O 0 0.0025782722514122725
the O 0 0.0023964205756783485
genomic O 1 0.9996473789215088
organization O 0 0.0062738643027842045
of O 0 0.002188092330470681
UBE3A O 1 0.9996590614318848
and O 0 0.0014196984702721238
the O 0 0.0017992901848629117
sequence O 0 0.04764358699321747
of O 0 0.0044747754000127316
intron O 1 0.9999467134475708
- O 0 0.13458263874053955
exon O 1 0.9967580437660217
borders O 0 0.028182851150631905
. O 0 0.007882492616772652

We O 0 0.003108859295025468
have O 0 0.0010767566272988915
also O 0 0.00110719446092844
mapped O 0 0.018191063776612282
two O 0 0.0023840463254600763
highly O 0 0.014815235510468483
homologous O 1 0.9995680451393127
processed O 0 0.04137668386101723
pseudogenes O 1 0.9980447292327881
, O 0 0.005097083281725645
UBE3AP1 O 1 0.9965271353721619
and O 0 0.0036795225460082293
UBE3AP2 O 1 0.998672604560852
, O 0 0.001888538128696382
to O 0 0.0026387725956737995
chromosomes O 1 0.9991212487220764
2 O 0 0.007589693646878004
and O 0 0.001212641946040094
21 O 0 0.00665773032233119
, O 0 0.00135239795781672
respectively O 0 0.0038227110635489225
, O 0 0.0009700300870463252
and O 0 0.0007234300137497485
determined O 0 0.006705180741846561
their O 0 0.003824451006948948
genomic O 1 0.9998539686203003
organization O 0 0.011863820254802704
. O 0 0.006336888298392296

These O 0 0.004203012213110924
results O 0 0.010009100660681725
will O 0 0.0012228678679093719
form O 0 0.005185418296605349
the O 0 0.0008218266302719712
basis O 0 0.0019943700172007084
for O 0 0.0009877589764073491
studies O 0 0.005843968130648136
of O 0 0.0017898372607305646
mutation O 1 0.9999895095825195
and O 0 0.003940110560506582
imprinting O 1 0.999524712562561
of O 0 0.005619913339614868
UBE3A O 1 0.9995993971824646
. O 0 0.012396294623613358

Mutation O 1 0.9997478127479553
spectrum O 0 0.08073287457227707
and O 0 0.00645121606066823
genotype O 1 0.9999747276306152
- O 1 0.7106594443321228
phenotype O 1 0.9999874830245972
analyses O 0 0.07610808312892914
in O 0 0.006210791412740946
Cowden B-Disease 1 0.9999927282333374
disease I-Disease 1 0.9999929666519165
and O 0 0.005745199508965015
Bannayan B-Disease 1 0.9998488426208496
- I-Disease 1 0.9955049157142639
Zonana I-Disease 1 0.999983549118042
syndrome I-Disease 1 0.999997615814209
, O 0 0.005058896262198687
two O 0 0.010224808007478714
hamartoma B-Disease 1 0.9999916553497314
syndromes I-Disease 1 0.9999963045120239
with O 0 0.018180860206484795
germline O 1 0.9999953508377075
PTEN O 1 0.999966025352478
mutation O 1 0.999954104423523
. O 0 0.010029219090938568

The O 0 0.02582184039056301
tumour B-Disease 1 0.9999960660934448
suppressor O 1 0.9999803304672241
gene O 1 0.9999774694442749
PTEN O 1 0.9999182224273682
, O 0 0.0034014517441391945
which O 0 0.0011511039920151234
maps O 0 0.009006151929497719
to O 0 0.00326616526581347
10q23 O 1 0.981788158416748
. O 0 0.009052226319909096

3 O 0 0.013499914668500423
and O 0 0.0024586853105574846
encodes O 1 0.8632848262786865
a O 0 0.009942828677594662
403 O 0 0.11802741140127182
amino O 1 0.9647581577301025
acid O 1 0.9843733310699463
dual O 0 0.046266790479421616
specificity O 1 0.8539444208145142
phosphatase O 1 0.9994654059410095
( O 0 0.010137964971363544
protein O 1 0.999229907989502
tyrosine O 1 0.9996294975280762
phosphatase O 1 0.9999539852142334
; O 0 0.013184619136154652
PTPase O 1 0.9990098476409912
) O 0 0.004404227714985609
, O 0 0.001069611287675798
was O 0 0.0016762143932282925
shown O 0 0.006463577970862389
recently O 0 0.004954815376549959
to O 0 0.0009705736883915961
play O 0 0.002407768275588751
a O 0 0.004954157397150993
broad O 0 0.01119389571249485
role O 0 0.006489756982773542
in O 0 0.0019482705974951386
human O 0 0.0946052297949791
malignancy B-Disease 1 0.9999890327453613
. O 0 0.009402253665030003

Somatic O 1 0.9995478987693787
PTEN O 1 0.9998482465744019
deletions O 1 0.9884529709815979
and O 0 0.005760404746979475
mutations O 1 0.9999064207077026
were O 0 0.0012061961460858583
observed O 0 0.008844691328704357
in O 0 0.0026668147183954716
sporadic B-Disease 1 0.9990342855453491
breast I-Disease 1 0.9999978542327881
, I-Disease 0 0.008465160615742207
brain I-Disease 1 0.9999953508377075
, I-Disease 0 0.010303796268999577
prostate I-Disease 1 0.9999998807907104
and I-Disease 0 0.11003175377845764
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 1 0.9998440742492676
lines O 0 0.01289350539445877
and O 0 0.0006914343684911728
in O 0 0.0007824879139661789
several O 0 0.0016967712435871363
primary O 1 0.5873602032661438
tumours B-Disease 1 0.9999973773956299
such O 0 0.0036963948514312506
as O 0 0.009370087645947933
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.9999997615814209
, O 0 0.2817622423171997
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.08534029871225357
thyroid B-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999948740005493
. O 0 0.01025504618883133

In O 0 0.004381188191473484
addition O 0 0.006320746149867773
, O 0 0.004284687340259552
PTEN O 1 0.9999566078186035
was O 0 0.0030020871199667454
identified O 0 0.006903762463480234
as O 0 0.0010514491004869342
the O 0 0.0030583327170461416
susceptibility O 1 0.9999865293502808
gene O 1 0.9997907280921936
for O 0 0.0027730599977076054
two O 0 0.0105553874745965
hamartoma B-Disease 1 0.9999988079071045
syndromes I-Disease 1 0.9999998807907104
Cowden B-Disease 1 0.9999980926513672
disease I-Disease 1 0.9999955892562866
( O 0 0.007538692094385624
CD B-Disease 0 0.26954495906829834
; O 0 0.00918805692344904
MIM O 1 0.9999182224273682
158350 O 1 0.9942606687545776
) O 0 0.004652972333133221
and O 0 0.0023945451248437166
Bannayan B-Disease 1 0.9991409778594971
- I-Disease 1 0.5181992053985596
Zonana I-Disease 1 0.9996523857116699
( I-Disease 0 0.013017562218010426
BZS I-Disease 1 0.996060311794281
) I-Disease 0 0.007862391881644726
or I-Disease 0 0.010813850909471512
Ruvalcaba I-Disease 1 0.9998102784156799
- I-Disease 0 0.1199059784412384
Riley I-Disease 1 0.9806647300720215
- I-Disease 1 0.5975802540779114
Smith I-Disease 1 0.9842660427093506
syndrome I-Disease 1 0.999998927116394
( O 0 0.0190233513712883
MIM O 1 0.999819815158844
153480 O 1 0.9927493333816528
) O 0 0.00883629359304905
. O 0 0.006486090831458569

Constitutive O 1 0.9554480314254761
DNA O 1 0.9881537556648254
from O 0 0.004315325524657965
37 O 0 0.014522824436426163
CD B-Disease 0 0.024641597643494606
families O 0 0.004790363367646933
and O 0 0.0013446700759232044
seven O 0 0.006040317937731743
BZS B-Disease 1 0.9986086487770081
families O 0 0.006565151270478964
was O 0 0.0024314955808222294
screened O 0 0.03292122110724449
for O 0 0.007448824122548103
germline O 1 0.999985933303833
PTEN O 1 0.9999536275863647
mutations O 1 0.999790608882904
. O 0 0.011358420364558697

PTEN O 1 0.9998015761375427
mutations O 1 0.9998294115066528
were O 0 0.002247441094368696
identified O 0 0.008045291528105736
in O 0 0.0012988792732357979
30 O 0 0.002987624378874898
of O 0 0.0014243542682379484
37 O 0 0.014836610294878483
( O 0 0.004851736593991518
81 O 0 0.02731887623667717
% O 0 0.00823140237480402
) O 0 0.00363508821465075
CD B-Disease 0 0.022892843931913376
families O 0 0.00469184061512351
, O 0 0.0012923046015203
including O 0 0.0032154740765690804
missense O 1 0.9998123049736023
and O 0 0.001973737496882677
nonsense O 0 0.06720886379480362
point O 0 0.008086837828159332
mutations O 1 0.9999889135360718
, O 0 0.0037698382511734962
deletions O 1 0.9974592328071594
, O 0 0.0033834227360785007
insertions O 1 0.9983781576156616
, O 0 0.0022109602577984333
a O 0 0.008848300203680992
deletion O 1 0.999876856803894
/ O 1 0.9123075604438782
insertion O 1 0.9938023090362549
and O 0 0.003480050712823868
splice O 1 0.9993135929107666
site O 0 0.026093272492289543
mutations O 1 0.9999489784240723
. O 0 0.007318994030356407

These O 0 0.009067500941455364
mutations O 1 0.9998890161514282
were O 0 0.0016061324859037995
scattered O 0 0.005929871927946806
over O 0 0.001071085105650127
the O 0 0.0010203010169789195
entire O 0 0.007406778167933226
length O 0 0.01169529091566801
of O 0 0.0028239847160875797
PTEN O 1 0.9999960660934448
, O 0 0.0017804191447794437
with O 0 0.0013306487817317247
the O 0 0.0009346713195554912
exception O 0 0.005011449102312326
of O 0 0.000598598038777709
the O 0 0.0009054517722688615
first O 0 0.001879420829936862
, O 0 0.0010616998188197613
fourth O 0 0.007463447283953428
and O 0 0.0014226250350475311
last O 0 0.007395061198621988
exons O 1 0.9986526966094971
. O 0 0.007782141212373972

A O 0 0.018505705520510674
hot O 0 0.020920848473906517
spot O 0 0.017297307029366493
for O 0 0.006014184560626745
PTEN O 1 0.9999891519546509
mutation O 1 0.999983549118042
in O 0 0.0027206900995224714
CD B-Disease 0 0.027380064129829407
was O 0 0.0023098611272871494
identified O 0 0.008205353282392025
in O 0 0.002590780844911933
exon O 1 0.9994494318962097
5 O 0 0.005275940056890249
that O 0 0.0007539011421613395
contains O 0 0.0033206059597432613
the O 0 0.0019534931052476168
PTPase O 1 0.9971666932106018
core O 0 0.028131024911999702
motif O 1 0.9804012179374695
, O 0 0.0016252268105745316
with O 0 0.00216055940836668
13 O 0 0.004005709663033485
of O 0 0.0009713498293422163
30 O 0 0.004723553545773029
( O 0 0.003188347676768899
43 O 0 0.013381650671362877
% O 0 0.005660542286932468
) O 0 0.004367046989500523
CD B-Disease 1 0.8149212002754211
mutations O 1 0.9999892711639404
identified O 0 0.010780182667076588
in O 0 0.0014843236422166228
this O 0 0.0029643981251865625
exon O 1 0.9979398846626282
. O 0 0.008891540579497814

Seven O 0 0.007361412979662418
of O 0 0.0019348410423845053
30 O 0 0.0058643571101129055
( O 0 0.003787615802139044
23 O 0 0.008801635354757309
% O 0 0.005755253601819277
) O 0 0.0017722244374454021
were O 0 0.0004329000075813383
within O 0 0.0012527446961030364
the O 0 0.0011146145407110453
core O 0 0.02013520337641239
motif O 1 0.9943283200263977
, O 0 0.0012774267233908176
the O 0 0.0011697175214067101
majority O 0 0.006211957428604364
( O 0 0.0025808229111135006
five O 0 0.0014935452491044998
of O 0 0.0006893056561239064
seven O 0 0.002832747995853424
) O 0 0.0017514635110273957
of O 0 0.0005214550765231252
which O 0 0.0011284438660368323
were O 0 0.002517678076401353
missense O 1 0.9999878406524658
mutations O 1 0.9999918937683105
, O 0 0.0020265376660972834
possibly O 0 0.009481287561357021
pointing O 0 0.008221038617193699
to O 0 0.0008829065482132137
the O 0 0.0014373576268553734
functional O 0 0.19515110552310944
significance O 0 0.005073187407106161
of O 0 0.000736495538149029
this O 0 0.0015058007556945086
region O 0 0.005331391002982855
. O 0 0.005114917643368244

Germline O 1 0.9999018907546997
PTEN O 1 0.9999597072601318
mutations O 1 0.9999078512191772
were O 0 0.002005668357014656
identified O 0 0.008252847008407116
in O 0 0.00101324706338346
four O 0 0.0013528938870877028
of O 0 0.0007904419326223433
seven O 0 0.0035989610478281975
( O 0 0.004476689733564854
57 O 0 0.01841406151652336
% O 0 0.00819472037255764
) O 0 0.007665671873837709
BZS B-Disease 1 0.9981854557991028
families O 0 0.011128470301628113
studied O 0 0.009659088216722012
. O 0 0.005314841400831938

Interestingly O 0 0.3312029540538788
, O 0 0.00270715169608593
none O 0 0.003538654185831547
of O 0 0.0007894825539551675
these O 0 0.002747125690802932
mutations O 1 0.9999861717224121
was O 0 0.0033851666375994682
observed O 0 0.007712813094258308
in O 0 0.001213770010508597
the O 0 0.0025284085422754288
PTPase O 1 0.9901207685470581
core O 0 0.04029063880443573
motif O 1 0.959509551525116
. O 0 0.008670147508382797

It O 0 0.0038611399941146374
is O 0 0.0018906766781583428
also O 0 0.0013780072331428528
worthy O 0 0.015548662282526493
of O 0 0.000874316378030926
note O 0 0.00899029616266489
that O 0 0.0008926091832108796
a O 0 0.0029317273292690516
single O 0 0.009014144539833069
nonsense O 0 0.09263850003480911
point O 0 0.011018709279596806
mutation O 1 0.9999938011169434
, O 0 0.003979375585913658
R233X O 1 0.9986497759819031
, O 0 0.0014409242430701852
was O 0 0.00132791418582201
observed O 0 0.0052832853980362415
in O 0 0.00111728860065341
the O 0 0.0032790000550448895
germline O 1 0.9999938011169434
DNA O 1 0.9990968704223633
from O 0 0.002113137859851122
two O 0 0.002710276748985052
unrelated O 1 0.893281102180481
CD B-Disease 0 0.03487316519021988
families O 0 0.004676368087530136
and O 0 0.0014916380168870091
one O 0 0.005592497065663338
BZS B-Disease 1 0.9990197420120239
family O 0 0.021877756342291832
. O 0 0.007416432723402977

Genotype O 1 0.9998747110366821
- O 1 0.9464893341064453
phenotype O 1 0.9999816417694092
studies O 0 0.012440165504813194
were O 0 0.0007578852819278836
not O 0 0.0010082694934681058
performed O 0 0.003834408475086093
on O 0 0.0007126606069505215
this O 0 0.0011509136529639363
small O 0 0.0038135771173983812
group O 0 0.005067219492048025
of O 0 0.002833546604961157
BZS B-Disease 1 0.9987841248512268
families O 0 0.013587716035544872
. O 0 0.007203302811831236

However O 0 0.009771392680704594
, O 0 0.007514079101383686
genotype O 1 0.9999279975891113
- O 1 0.5452000498771667
phenotype O 1 0.9999545812606812
analysis O 0 0.03284319490194321
inthe O 1 0.9889946579933167
group O 0 0.006948514841496944
of O 0 0.0012615107698366046
CD B-Disease 0 0.032281335443258286
families O 0 0.005631042178720236
revealed O 0 0.009651405736804008
two O 0 0.0014784251106902957
possible O 0 0.005215209908783436
associations O 0 0.008426089771091938
worthy O 0 0.024126900359988213
of O 0 0.0015156693989410996
follow O 0 0.010662954300642014
- O 0 0.012347597628831863
up O 0 0.003261443693190813
in O 0 0.001730227842926979
independent O 0 0.007035433314740658
analyses O 0 0.04866798594594002
. O 0 0.006681682541966438

The O 0 0.003395154606550932
first O 0 0.002372372429817915
was O 0 0.001962329028174281
an O 0 0.0017100726254284382
association O 0 0.004555451683700085
noted O 0 0.0022005015052855015
in O 0 0.0009551848634146154
the O 0 0.0010973842581734061
group O 0 0.003953763749450445
of O 0 0.001039480441249907
CD B-Disease 0 0.12623636424541473
families O 0 0.008876828476786613
with O 0 0.02688615396618843
breast B-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999904632568359
. O 0 0.008775778114795685

A O 0 0.031997255980968475
correlation O 1 0.5602465271949768
was O 0 0.0032387853134423494
observed O 0 0.00805732887238264
between O 0 0.0019959365017712116
the O 0 0.0015150114195421338
presence O 0 0.014960836619138718
/ O 1 0.5241856575012207
absence O 0 0.010189048014581203
of O 0 0.0011393434833735228
a O 0 0.015857500955462456
PTEN O 1 0.9999972581863403
mutation O 1 0.9999681711196899
and O 0 0.0011559525737538934
the O 0 0.0014600652502849698
type O 1 0.5796139240264893
of O 0 0.00414128927513957
breast O 1 0.9999980926513672
involvement O 0 0.24151846766471863
( O 0 0.007606513798236847
unaffected O 1 0.9966358542442322
versus O 1 0.9397983551025391
benign O 1 0.9998388290405273
versus O 1 0.9947836995124817
malignant O 1 0.9999978542327881
) O 0 0.008952818810939789
. O 0 0.005801005754619837

Specifically O 0 0.01662006601691246
and O 0 0.001381825772114098
more O 0 0.0012248229468241334
directly O 0 0.004265950992703438
, O 0 0.0015036400873214006
an O 0 0.0018523469334468246
association O 0 0.004331039264798164
was O 0 0.0016504216473549604
also O 0 0.001247681095264852
observed O 0 0.007292584050446749
between O 0 0.0014059478417038918
the O 0 0.0007709474884904921
presence O 0 0.0039984965696930885
of O 0 0.0010786066995933652
a O 0 0.01813635043799877
PTEN O 1 0.9999954700469971
mutation O 1 0.999997615814209
and O 0 0.04664047434926033
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999771118164062
. O 0 0.0112864188849926

Secondly O 0 0.48063716292381287
, O 0 0.0019803924951702356
there O 0 0.0011460421374067664
appeared O 0 0.003147138748317957
to O 0 0.0007949715945869684
be O 0 0.0008562546572647989
an O 0 0.0020099757239222527
interdependent O 1 0.9862328767776489
association O 0 0.005404602736234665
between O 0 0.006469625514000654
mutations O 1 0.9999827146530151
upstream O 0 0.04196486994624138
and O 0 0.0010541542433202267
within O 0 0.001762327621690929
the O 0 0.001968945609405637
PTPase O 1 0.9971501231193542
core O 0 0.026953283697366714
motif O 1 0.9697709679603577
, O 0 0.0012506726197898388
the O 0 0.0010559245711192489
core O 0 0.01592552475631237
motif O 1 0.9553118944168091
containing O 0 0.007323381956666708
the O 0 0.0007842107443138957
majority O 0 0.003259075805544853
of O 0 0.002328422386199236
missense O 1 0.9999958276748657
mutations O 1 0.9999972581863403
, O 0 0.0015665980754420161
and O 0 0.0006231771549209952
the O 0 0.0012850580969825387
involvement O 0 0.012121790088713169
of O 0 0.0007604688289575279
all O 0 0.0011190504301339388
major O 0 0.011590679176151752
organ O 1 0.9987635612487793
systems O 0 0.11504605412483215
( O 0 0.0029762748163193464
central O 0 0.0045887683518230915
nervous O 1 0.9995490908622742
system O 0 0.02556048519909382
, O 0 0.0070071956142783165
thyroid O 1 0.9999996423721313
, O 0 0.011811528354883194
breast O 1 0.9999996423721313
, O 0 0.009539807215332985
skin O 1 0.9999979734420776
and O 0 0.014736691489815712
gastrointestinal O 1 0.9999997615814209
tract O 1 0.9999678134918213
) O 0 0.007754069287329912
. O 0 0.004943525418639183

However O 0 0.0070336745120584965
, O 0 0.0012817539973184466
these O 0 0.0011056524235755205
observations O 0 0.0060502998530864716
would O 0 0.0014268020167946815
need O 0 0.0025873417034745216
to O 0 0.000883032800629735
be O 0 0.001064819167368114
confirmed O 0 0.005721806548535824
by O 0 0.0015086834318935871
studying O 0 0.004563688766211271
a O 0 0.003607441671192646
larger O 0 0.005288779269903898
number O 0 0.0012510777451097965
of O 0 0.0011179285356774926
CD B-Disease 0 0.0575132854282856
families O 0 0.00910347979515791
. O 0 0.005617902148514986

Molecular O 1 0.9992191791534424
defects O 1 0.9994658827781677
leading O 0 0.008139531128108501
to O 0 0.0012872508959844708
human O 0 0.008512808009982109
complement B-Disease 1 0.8692269921302795
component I-Disease 1 0.995448648929596
C6 I-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999991655349731
in O 0 0.0025446293875575066
an O 0 0.002988894237205386
African O 0 0.018939049914479256
- O 0 0.020871601998806
American O 0 0.008817587047815323
family O 0 0.014974161051213741
. O 0 0.006541551556438208

Complement B-Disease 1 0.5077095031738281
component I-Disease 1 0.9855421781539917
C6 I-Disease 1 0.999997615814209
deficiency I-Disease 1 0.9999990463256836
( O 0 0.016004353761672974
C6D B-Disease 1 0.9986681938171387
) O 0 0.006205277983099222
was O 0 0.004668287932872772
diagnosed O 1 0.9999727010726929
in O 0 0.0021426251623779535
a O 0 0.006858296226710081
16 O 0 0.01065072137862444
- O 0 0.01908862590789795
year O 0 0.005846057087182999
- O 0 0.01557599101215601
old O 0 0.010138184763491154
African O 0 0.013807649724185467
- O 0 0.01492924802005291
American O 0 0.006889050360769033
male O 0 0.13153275847434998
with O 0 0.030803639441728592
meningococcal B-Disease 1 0.9999998807907104
meningitis I-Disease 1 0.9999985694885254
. O 0 0.01381676271557808

The O 0 0.011363674886524677
patients O 1 0.9996674060821533
father O 0 0.009189984761178493
and O 0 0.0012200826313346624
two O 0 0.0026876989286392927
brothers O 0 0.022954894229769707
also O 0 0.0016059076879173517
had O 0 0.0047762286849319935
C6D B-Disease 1 0.999573290348053
, O 0 0.0019680322147905827
but O 0 0.0013154455227777362
gave O 0 0.0032990211620926857
no O 0 0.0015838833060115576
history O 0 0.0020756025332957506
of O 0 0.0032149741891771555
meningitis B-Disease 1 0.9999996423721313
or O 0 0.006387488450855017
other O 0 0.005486333277076483
neisserial B-Disease 1 0.9999055862426758
infection I-Disease 1 0.9999901056289673
. O 0 0.010534770786762238

By O 0 0.006508431397378445
using O 0 0.014792097732424736
exon O 1 0.9961345195770264
- O 0 0.027814118191599846
specific O 0 0.01651945151388645
polymerase O 1 0.9992355108261108
chain O 1 0.742318868637085
reaction O 0 0.05225014686584473
( O 0 0.008349601179361343
PCR O 1 0.9996547698974609
) O 0 0.008871606551110744
/ O 0 0.15582086145877838
single O 0 0.015004596672952175
- O 0 0.03292680159211159
strand O 1 0.9956884980201721
conformation O 1 0.9924254417419434
polymorphism O 1 0.993423581123352
as O 0 0.0025790168438106775
a O 0 0.00805266946554184
screening O 0 0.3148280382156372
step O 0 0.011526455171406269
and O 0 0.0021996451541781425
nucleotide O 1 0.99394690990448
sequencing O 1 0.8371267914772034
of O 0 0.0019110181601718068
target O 0 0.020136002451181412
exons O 1 0.9983671307563782
, O 0 0.0016471289563924074
we O 0 0.0009305390412919223
determined O 0 0.004890633746981621
that O 0 0.0007483598892576993
the O 0 0.0014807393308728933
proband O 1 0.9891353845596313
was O 0 0.0021693501621484756
a O 0 0.006809898652136326
compound O 0 0.08884391188621521
heterozygote O 1 0.9980683922767639
for O 0 0.0026156350504606962
two O 0 0.009000335820019245
C6 O 1 0.9999737739562988
gene O 1 0.9999289512634277
mutations O 1 0.9998612403869629
. O 0 0.010511052794754505

The O 0 0.003508584573864937
first O 0 0.0031401582527905703
, O 0 0.0027967083733528852
1195delC O 1 0.9767850041389465
located O 0 0.004985142964869738
in O 0 0.002694398630410433
exon O 1 0.9994198083877563
7 O 0 0.010028254240751266
, O 0 0.00117790256626904
is O 0 0.001241084886714816
a O 0 0.006003296934068203
novel O 0 0.3982604444026947
mutation O 1 0.999994158744812
, O 0 0.0015487566124647856
while O 0 0.0011256813304498792
the O 0 0.0009512142860330641
second O 0 0.004360046237707138
, O 0 0.0025951722636818886
1936delG O 1 0.9974461793899536
in O 0 0.0038951742462813854
exon O 1 0.9994447827339172
12 O 0 0.007547358982264996
, O 0 0.0014061621623113751
has O 0 0.0012021533912047744
been O 0 0.0015981344040483236
described O 0 0.005554450675845146
before O 0 0.002026679925620556
to O 0 0.0020518512465059757
cause O 1 0.9978724718093872
C6D B-Disease 1 0.9992467164993286
in O 0 0.001998803112655878
an O 0 0.0027752260211855173
unrelated O 1 0.9253260493278503
African O 0 0.021041961386799812
- O 0 0.02336283214390278
American O 0 0.006843336392194033
individual O 0 0.008595910854637623
. O 0 0.006078740581870079

Both O 0 0.01589631848037243
mutations O 1 0.9998728036880493
result O 0 0.01653016172349453
in O 0 0.00413995236158371
premature O 1 0.9993313550949097
termination O 1 0.994273841381073
codons O 1 0.9883447885513306
and O 0 0.006200924515724182
C6 O 1 0.9998887777328491
null O 1 0.9913303852081299
alleles O 1 0.9995075464248657
. O 0 0.009482120163738728

Allele O 1 0.9996206760406494
- O 0 0.03852655366063118
specific O 0 0.019131679087877274
PCR O 1 0.9988928437232971
indicated O 0 0.010477161034941673
that O 0 0.0011443087132647634
the O 0 0.001697246334515512
probands O 1 0.9772630333900452
two O 0 0.0037627601996064186
brothers O 0 0.021907510235905647
also O 0 0.002586167771369219
inherited O 1 0.9058370590209961
the O 0 0.002962693339213729
1195delC O 1 0.9995537400245667
mutation O 1 0.9999724626541138
from O 0 0.002934555523097515
their O 0 0.003018223447725177
heterozygous O 1 0.9998887777328491
mother O 0 0.015432750806212425
and O 0 0.0011661362368613482
the O 0 0.0024618429597467184
1936delG O 1 0.9998466968536377
mutation O 1 0.9999799728393555
from O 0 0.0024991442915052176
their O 0 0.0038546875584870577
homozygous O 1 0.9999072551727295
father O 0 0.013926252722740173
. O 0 0.0033958246931433678
. O 0 0.005734279286116362

PAX6 O 1 0.999423623085022
mutations O 1 0.9996153116226196
reviewed O 0 0.03776172548532486
. O 0 0.007905249483883381

Mutations O 1 0.9997511506080627
in O 0 0.007192790042608976
PAX6 O 1 0.9998791217803955
are O 0 0.0014797102194279432
responsible O 0 0.00636314507573843
for O 0 0.0015842695720493793
human O 0 0.01875210553407669
aniridia B-Disease 1 0.9998652935028076
and O 0 0.001128418487496674
have O 0 0.0007235893863253295
also O 0 0.0007668151520192623
been O 0 0.001157847000285983
found O 0 0.004131726920604706
in O 0 0.0028375238180160522
patients O 1 0.9998470544815063
with O 0 0.005556480959057808
Peters B-Disease 1 0.9991494417190552
anomaly I-Disease 1 0.9997709393501282
, O 0 0.003354068147018552
with O 0 0.0486353375017643
congenital B-Disease 1 1.0
cataracts I-Disease 1 0.9999997615814209
, O 0 0.0033345192205160856
with O 0 0.00986911915242672
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9987726807594299
keratitis I-Disease 1 0.999996542930603
, O 0 0.0021945752669125795
and O 0 0.001148100709542632
with O 0 0.004385137930512428
isolated B-Disease 1 0.9477711915969849
foveal I-Disease 1 0.9998152852058411
hypoplasia I-Disease 1 0.999957799911499
. O 0 0.01169267762452364

No O 0 0.011136396788060665
locus O 1 0.9905419945716858
other O 0 0.002747993217781186
than O 0 0.004775031935423613
chromosome O 1 0.9999929666519165
11p13 O 1 0.9935890436172485
has O 0 0.00273145898245275
been O 0 0.002729837317019701
implicated O 0 0.4883171617984772
in O 0 0.0037091237027198076
aniridia B-Disease 1 0.9993869066238403
, O 0 0.002518638502806425
and O 0 0.0033227659296244383
PAX6 O 1 0.9999829530715942
is O 0 0.0027913313824683428
clearly O 0 0.003248521126806736
the O 0 0.0014606618788093328
major O 0 0.005937127862125635
, O 0 0.001329673221334815
if O 0 0.001959826098755002
not O 0 0.0008243972552008927
only O 0 0.0011683988850563765
, O 0 0.0032295065466314554
gene O 1 0.9999346733093262
responsible O 0 0.01782001554965973
. O 0 0.006489579100161791

Twenty O 0 0.03288799896836281
- O 0 0.019581185653805733
eight O 0 0.00490987254306674
percent O 0 0.0036053324583917856
of O 0 0.0016481924103572965
identified O 0 0.04631676897406578
PAX6 O 1 0.9999406337738037
mutations O 1 0.9999597072601318
are O 0 0.004964096006006002
C O 1 0.9974691867828369
- O 0 0.11143005639314651
T O 1 0.9964569211006165
changes O 0 0.01363497506827116
at O 0 0.005143867339938879
CpG O 1 0.9994707703590393
dinucleotides O 1 0.9882912039756775
, O 0 0.0020973007194697857
20 O 0 0.003161052707582712
% O 0 0.003828322049230337
are O 0 0.0018395510269328952
splicing O 1 0.9999504089355469
errors O 1 0.8298880457878113
, O 0 0.00120849150698632
and O 0 0.0006815330707468092
more O 0 0.0007646519225090742
than O 0 0.001140819862484932
30 O 0 0.003301960648968816
% O 0 0.003381023183465004
are O 0 0.0019123333040624857
deletion O 1 0.9996774196624756
or O 0 0.009450322948396206
insertion O 1 0.9950651526451111
events O 0 0.00972715299576521
. O 0 0.0051069799810647964

There O 0 0.0032212284859269857
is O 0 0.0017780994530767202
a O 0 0.005961969960480928
noticeably O 1 0.5902097225189209
elevated O 1 0.6556810736656189
level O 0 0.003375630360096693
of O 0 0.001719490042887628
mutation O 1 0.9999896287918091
in O 0 0.0014362261863425374
the O 0 0.0017615803517401218
paired O 1 0.9918272495269775
domain O 0 0.09968307614326477
compared O 0 0.005869963672012091
with O 0 0.0017782136565074325
the O 0 0.001062937662936747
rest O 0 0.0031335530802607536
of O 0 0.0009874470997601748
the O 0 0.003887115977704525
gene O 1 0.9999221563339233
. O 0 0.00787076074630022

Increased O 0 0.04651321470737457
mutation O 1 0.9997928738594055
in O 0 0.0026785198133438826
the O 0 0.0028238031081855297
homeodomain O 1 0.9996495246887207
is O 0 0.0025974567979574203
accounted O 0 0.009418941102921963
for O 0 0.0010404965141788125
by O 0 0.0015720189549028873
the O 0 0.0034946012310683727
hypermutable O 1 0.9949264526367188
CpG O 1 0.9972021579742432
dinucleotide O 1 0.9609184861183167
in O 0 0.006303808186203241
codon O 1 0.9815690517425537
240 O 0 0.03824463486671448
. O 0 0.006516795139759779

Very O 0 0.006014309823513031
nearly O 0 0.005721279885619879
all O 0 0.0030852272175252438
mutations O 1 0.9999815225601196
appear O 0 0.008523238822817802
to O 0 0.001809862907975912
cause O 1 0.9746048450469971
loss O 0 0.021233702078461647
of O 0 0.0009233746095560491
function O 0 0.012576454319059849
of O 0 0.000668949622195214
the O 0 0.0020326259545981884
mutant O 1 0.9999749660491943
allele O 1 0.9999679327011108
, O 0 0.00201292778365314
and O 0 0.0007134780753403902
more O 0 0.0008086131419986486
than O 0 0.0014874180778861046
80 O 0 0.004623378627002239
% O 0 0.0038904647808521986
of O 0 0.0017609423957765102
exonic O 1 0.9928626418113708
substitutions O 0 0.11396017670631409
result O 0 0.008666600100696087
in O 0 0.0026035194750875235
nonsense O 1 0.8650528788566589
codons O 1 0.9970933198928833
. O 0 0.007574473507702351

In O 0 0.005893034860491753
a O 0 0.01399764884263277
gene O 1 0.9996587038040161
with O 0 0.0037679190281778574
such O 0 0.002631769049912691
extraordinarily O 0 0.04283320903778076
high O 0 0.006813972722738981
sequence O 0 0.052871860563755035
conservation O 0 0.01242306549102068
throughout O 0 0.0028076660819351673
evolution O 0 0.021652286872267723
, O 0 0.0009955400601029396
there O 0 0.0007537890924140811
are O 0 0.0010558697395026684
presumed O 0 0.27467599511146545
undiscovered O 1 0.9967734217643738
missense O 1 0.9999799728393555
mutations O 1 0.9999896287918091
, O 0 0.0016743019223213196
these O 0 0.0008489292813464999
are O 0 0.0011132842628285289
hypothesized O 1 0.9921197891235352
to O 0 0.001074036117643118
exist O 0 0.0036679008044302464
in O 0 0.0009554546559229493
as O 0 0.0021648872643709183
- O 0 0.015078957192599773
yet O 0 0.006308799609541893
unidentified O 1 0.7624638080596924
phenotypes O 1 0.9998774528503418
. O 0 0.004741904325783253
. O 0 0.005705825984477997

Genetic O 1 0.9991779923439026
heterogeneity O 1 0.9882434010505676
and O 0 0.004249767865985632
penetrance O 1 0.9992597699165344
analysis O 0 0.010281006805598736
of O 0 0.0009500767337158322
the O 0 0.0033943308517336845
BRCA1 O 1 0.9999988079071045
and O 0 0.009864671155810356
BRCA2 O 1 0.9999995231628418
genes O 1 0.9999302625656128
in O 0 0.018913909792900085
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999964237213135
families O 0 0.014382896013557911
. O 0 0.006077700760215521

The O 0 0.04483029991388321
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999995231628418
Linkage O 1 0.999148964881897
Consortium O 1 0.826933741569519
. O 0 0.008517631329596043

The O 0 0.003101702779531479
contribution O 0 0.006727069616317749
of O 0 0.003825759282335639
BRCA1 O 1 0.9999984502792358
and O 0 0.00836930237710476
BRCA2 O 1 0.9999988079071045
to O 0 0.012687526643276215
inherited B-Disease 1 0.9999974966049194
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
was O 0 0.003895712783560157
assessed O 0 0.012936062179505825
by O 0 0.0034128648694604635
linkage O 1 0.997786283493042
and O 0 0.004322903696447611
mutation O 1 0.9999887943267822
analysis O 0 0.016156502068042755
in O 0 0.001971912570297718
237 O 1 0.5666105151176453
families O 0 0.005831779912114143
, O 0 0.0009604005026631057
each O 0 0.0011437992798164487
with O 0 0.00120659195818007
at O 0 0.0010892592836171389
least O 0 0.0019170920131728053
four O 0 0.0016294948291033506
cases O 0 0.00853455625474453
of O 0 0.006075373850762844
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
, O 0 0.001186524168588221
collected O 0 0.002434762893244624
by O 0 0.0028290769550949335
the O 0 0.013136480003595352
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999995231628418
Linkage O 1 0.9995892643928528
Consortium O 1 0.7771153450012207
. O 0 0.0074617136269807816

Families O 0 0.011109700426459312
were O 0 0.0008512026397511363
included O 0 0.001929162535816431
without O 0 0.0032483043614774942
regard O 0 0.003193383105099201
to O 0 0.0006997177260927856
the O 0 0.0014040031237527728
occurrence O 1 0.6526283621788025
of O 0 0.0057077715173363686
ovarian B-Disease 1 0.9999996423721313
or I-Disease 0 0.009565378539264202
other I-Disease 0 0.007421052549034357
cancers I-Disease 1 0.9999984502792358
. O 0 0.008727326057851315

Overall O 0 0.03595096245408058
, O 0 0.00656618969514966
disease O 1 0.9999856948852539
was O 0 0.00384579598903656
linked O 0 0.4234471321105957
to O 0 0.0036050141789019108
BRCA1 O 1 0.9999994039535522
in O 0 0.0019355409312993288
an O 0 0.0014006837736815214
estimated O 0 0.005004634615033865
52 O 0 0.010722312144935131
% O 0 0.0035326469223946333
of O 0 0.0010010430123656988
families O 0 0.004245306830853224
, O 0 0.0011850529117509723
to O 0 0.0034349451307207346
BRCA2 O 1 0.9999983310699463
in O 0 0.0024976921267807484
32 O 0 0.007783028297126293
% O 0 0.003918676171451807
of O 0 0.0011539602419361472
families O 0 0.004656793549656868
, O 0 0.0010170236928388476
and O 0 0.0006339721730910242
to O 0 0.001283914316445589
neither O 0 0.017305567860603333
gene O 1 0.9999442100524902
in O 0 0.002167382510378957
16 O 0 0.006144020706415176
% O 0 0.006090139504522085
( O 0 0.0033373890910297632
95 O 0 0.010323503986001015
% O 0 0.005414839368313551
confidence O 0 0.010506843216717243
interval O 1 0.8075058460235596
[ O 0 0.25239238142967224
CI O 1 0.9995653033256531
] O 0 0.06525280326604843
6 O 0 0.009733282029628754
% O 0 0.009283903054893017
- O 0 0.01752062514424324
28 O 0 0.011154432781040668
% O 0 0.0069413334131240845
) O 0 0.003480436047539115
, O 0 0.0015009420458227396
suggesting O 0 0.01539104338735342
other O 0 0.004598787520080805
predisposition O 1 0.9999738931655884
genes O 1 0.9992746710777283
. O 0 0.007315436843782663

The O 0 0.004530459176748991
majority O 0 0.009111549705266953
( O 0 0.004576744046062231
81 O 0 0.022729596123099327
% O 0 0.0044425297528505325
) O 0 0.0020389051642268896
of O 0 0.0010030469857156277
the O 0 0.008103770203888416
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999276399612427
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.006378733087331057
were O 0 0.0007795436540618539
due O 0 0.004974810406565666
to O 0 0.0037731616757810116
BRCA1 O 1 0.9999997615814209
, O 0 0.002514834515750408
with O 0 0.0014876447385177016
most O 0 0.0011248709633946419
others O 0 0.003601129399612546
( O 0 0.003587959101423621
14 O 0 0.0062792799435555935
% O 0 0.005459758918732405
) O 0 0.0027608354575932026
due O 0 0.005088107194751501
to O 0 0.006254234816879034
BRCA2 O 1 0.9999946355819702
. O 0 0.010316562838852406

Conversely O 0 0.3283887803554535
, O 0 0.0018382043344900012
the O 0 0.0010012196144089103
majority O 0 0.0029795223381370306
of O 0 0.0008543007425032556
families O 0 0.004435988143086433
with O 0 0.002690943656489253
male B-Disease 0 0.04229462891817093
and I-Disease 0 0.0028528175316751003
female I-Disease 1 0.9992627501487732
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
were O 0 0.0012747066793963313
due O 0 0.005503168795257807
to O 0 0.005433244630694389
BRCA2 O 1 0.9999995231628418
( O 0 0.009460728615522385
76 O 0 0.03447294607758522
% O 0 0.009717618115246296
) O 0 0.005504461470991373
. O 0 0.005337202455848455

The O 0 0.004295044112950563
largest O 0 0.009481010027229786
proportion O 0 0.020644061267375946
( O 0 0.005124482326209545
67 O 0 0.027153009548783302
% O 0 0.006909999996423721
) O 0 0.0019239105749875307
of O 0 0.0007117062923498452
families O 0 0.004316624253988266
due O 0 0.003632358741015196
to O 0 0.0009273062460124493
other O 0 0.0016032038256525993
genes O 1 0.9997913241386414
was O 0 0.001996486447751522
found O 0 0.002990014385432005
in O 0 0.0010203905403614044
families O 0 0.0032618229743093252
with O 0 0.001683513750322163
four O 0 0.001745365560054779
or O 0 0.002016996266320348
five O 0 0.001877111615613103
cases O 0 0.005781372543424368
of O 0 0.0018447847105562687
female O 1 0.9994701743125916
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999982118606567
only O 0 0.00461408169940114
. O 0 0.006444633472710848

These O 0 0.0035527250729501247
estimates O 0 0.006061913445591927
were O 0 0.0006308456650003791
not O 0 0.0015058423159644008
substantially O 0 0.04036339372396469
affected O 0 0.015382533892989159
either O 0 0.004253997001796961
by O 0 0.0018390382174402475
changing O 0 0.007375133223831654
the O 0 0.0018604472279548645
assumed O 0 0.021770603954792023
penetrance O 1 0.9997215867042542
model O 0 0.01998830959200859
for O 0 0.005212979391217232
BRCA1 O 1 0.999998927116394
or O 0 0.005737553350627422
by O 0 0.0019109852146357298
including O 0 0.002424192149192095
or O 0 0.0050972686149179935
excluding O 0 0.22001634538173676
BRCA1 O 1 0.9999997615814209
mutation O 1 0.9999755620956421
data O 0 0.013501260429620743
. O 0 0.005940399598330259

Among O 0 0.004253868013620377
those O 0 0.001583044184371829
families O 0 0.005902414675801992
with O 0 0.007918168790638447
disease O 1 0.9999971389770508
due O 0 0.007013007532805204
to O 0 0.0036902574356645346
BRCA1 O 1 0.9999996423721313
that O 0 0.001771304290741682
were O 0 0.0009469497599638999
tested O 0 0.02874310314655304
by O 0 0.0011766102397814393
one O 0 0.0009995602304115891
of O 0 0.0006214366876520216
the O 0 0.0013520237989723682
standard O 0 0.025693612173199654
screening O 1 0.711930513381958
methods O 0 0.013186585158109665
, O 0 0.003121211426332593
mutations O 1 0.9999736547470093
were O 0 0.001770724426023662
detected O 0 0.45118823647499084
in O 0 0.0012318246299400926
the O 0 0.0019856516737490892
coding O 1 0.998789370059967
sequence O 0 0.07983323931694031
or O 0 0.006829302292317152
splice O 1 0.9987962245941162
sites O 0 0.00561694148927927
in O 0 0.001024268800392747
an O 0 0.0014505678554996848
estimated O 0 0.00679893558844924
63 O 0 0.019747048616409302
% O 0 0.005792711861431599
( O 0 0.003625183366239071
95 O 0 0.013036737218499184
% O 0 0.009655495174229145
CI O 1 0.9988627433776855
51 O 0 0.028923526406288147
% O 0 0.01114310510456562
- O 0 0.021689873188734055
77 O 0 0.03395573049783707
% O 0 0.010360624641180038
) O 0 0.005743089132010937
. O 0 0.005910671316087246

The O 0 0.003678877605125308
estimated O 0 0.007692515384405851
sensitivity O 0 0.044844262301921844
was O 0 0.0024348916485905647
identical O 0 0.01781461574137211
for O 0 0.0017320120241492987
direct O 0 0.012173290364444256
sequencing O 1 0.9946016073226929
and O 0 0.0018886448815464973
other O 0 0.0017789840931072831
techniques O 0 0.021067926660180092
. O 0 0.005922091193497181

The O 0 0.009933022782206535
penetrance O 1 0.9968770742416382
of O 0 0.008776984177529812
BRCA2 O 1 0.9999978542327881
was O 0 0.0035644967574626207
estimated O 0 0.004053313750773668
by O 0 0.002043369458988309
maximizing O 0 0.05386392027139664
the O 0 0.002509295241907239
LOD O 1 0.9953711628913879
score O 0 0.00700550340116024
in O 0 0.005585131701081991
BRCA2 O 1 0.9999998807907104
- O 1 0.9791034460067749
mutation O 1 0.9999889135360718
families O 0 0.007461639121174812
, O 0 0.0008661137544550002
over O 0 0.0010002589551731944
all O 0 0.001021979725919664
possible O 0 0.014351672492921352
penetrance O 1 0.9997171759605408
functions O 0 0.015282195061445236
. O 0 0.005475116427987814

The O 0 0.0034288866445422173
estimated O 0 0.007896249182522297
cumulative O 0 0.19373738765716553
risk O 1 0.9441556930541992
of O 0 0.00830766186118126
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999973773956299
reached O 0 0.005405686795711517
28 O 0 0.007386738434433937
% O 0 0.005214594304561615
( O 0 0.0035059782676398754
95 O 0 0.014359350316226482
% O 0 0.010121999308466911
CI O 1 0.9987173080444336
9 O 0 0.012740401551127434
% O 0 0.009439223445951939
- O 0 0.015937523916363716
44 O 0 0.016420487314462662
% O 0 0.0073112729005515575
) O 0 0.003024666802957654
by O 0 0.0018998546293005347
age O 0 0.005005788989365101
50 O 0 0.003538483055308461
years O 0 0.0015979543095454574
and O 0 0.0011633194517344236
84 O 0 0.022233061492443085
% O 0 0.006192872766405344
( O 0 0.0034862724132835865
95 O 0 0.012648412957787514
% O 0 0.009606761857867241
CI O 1 0.9968780279159546
43 O 0 0.01986950822174549
% O 0 0.009529445320367813
- O 0 0.01831597462296486
95 O 0 0.017810385674238205
% O 0 0.007609868887811899
) O 0 0.003394115949049592
by O 0 0.0020883430261164904
age O 0 0.0055637056939303875
70 O 0 0.008222079835832119
years O 0 0.004094922915101051
. O 0 0.005332212429493666

The O 0 0.012247850187122822
corresponding O 1 0.9929600358009338
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
risks O 1 0.7136024236679077
were O 0 0.002442364115267992
0 O 0 0.028730804100632668
. O 0 0.006024198140949011

4 O 0 0.01873348467051983
% O 0 0.008221151307225227
( O 0 0.00489874416962266
95 O 0 0.01648964360356331
% O 0 0.011584741994738579
CI O 1 0.9976958632469177
0 O 0 0.031368326395750046
% O 0 0.010537057183682919
- O 0 0.01872067339718342
1 O 0 0.009753460995852947
% O 0 0.007022260222584009
) O 0 0.0030155987478792667
by O 0 0.0018451684154570103
age O 0 0.00491135660558939
50 O 0 0.003839582670480013
years O 0 0.0017535864608362317
and O 0 0.0012479507131502032
27 O 0 0.009906642138957977
% O 0 0.0060840812511742115
( O 0 0.00381132448092103
95 O 0 0.015949605032801628
% O 0 0.012397181242704391
CI O 1 0.9991238713264465
0 O 0 0.029404345899820328
% O 0 0.009762938134372234
- O 0 0.017814692109823227
47 O 0 0.019102659076452255
% O 0 0.006916508078575134
) O 0 0.002956198761239648
by O 0 0.0022061499767005444
age O 0 0.0063665020279586315
70 O 0 0.008965849876403809
years O 0 0.004009753931313753
. O 0 0.005765748675912619

The O 0 0.006026914343237877
lifetime O 0 0.06566224247217178
risk O 1 0.9903355836868286
of O 0 0.008739763870835304
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
appears O 0 0.016251444816589355
similar O 0 0.0037956831511110067
to O 0 0.0007426079828292131
the O 0 0.0014353749575093389
risk O 1 0.997016191482544
in O 0 0.006568485405296087
BRCA1 O 1 1.0
carriers O 1 0.9991718530654907
, O 0 0.0016218246892094612
but O 0 0.0009165756637230515
there O 0 0.0006601067143492401
was O 0 0.0008406413835473359
some O 0 0.000745437282603234
suggestion O 0 0.007018206175416708
of O 0 0.0007127610733732581
a O 0 0.004708973690867424
lower O 0 0.013147427700459957
risk O 1 0.9910057783126831
in O 0 0.009041743353009224
BRCA2 O 1 0.9999995231628418
carriers O 1 0.9979314804077148
< O 1 0.9948176741600037
50 O 0 0.005782474763691425
years O 0 0.0018963865004479885
of O 0 0.001307935337536037
age O 0 0.00962710753083229
. O 0 0.005995497107505798

Eye B-Disease 1 0.9636436700820923
movement I-Disease 0 0.031917914748191833
abnormalities I-Disease 1 0.9999896287918091
correlate O 1 0.94681715965271
with O 0 0.006285465322434902
genotype O 1 0.9998658895492554
in O 0 0.0078880051150918
autosomal O 1 0.9999991655349731
dominant O 1 0.9978629946708679
cerebellar B-Disease 1 0.9999973773956299
ataxia I-Disease 1 0.9999982118606567
type I-Disease 1 0.9628250002861023
I I-Disease 0 0.012489157728850842
. O 0 0.00763041852042079

We O 0 0.005866653751581907
compared O 0 0.0165557861328125
horizontal O 1 0.9309341907501221
eye O 1 0.9648284316062927
movements O 0 0.017217455431818962
( O 0 0.005253640469163656
visually O 0 0.14722885191440582
guided O 0 0.03682735189795494
saccades O 1 0.99955815076828
, O 0 0.00499372836202383
antisaccades O 1 0.9954102635383606
, O 0 0.0017423382960259914
and O 0 0.0016996468184515834
smooth O 1 0.8824012279510498
pursuit O 0 0.2858869135379791
) O 0 0.0027736469637602568
in O 0 0.0014693106058984995
control O 0 0.013942449353635311
subjects O 0 0.008530923165380955
( O 0 0.0055418359115719795
n O 1 0.8365774750709534
= O 1 0.5174762010574341
14 O 0 0.007490068208426237
) O 0 0.003082488663494587
and O 0 0.0020006978884339333
patients O 1 0.9994630217552185
with O 0 0.0021119758021086454
three O 0 0.0017852358287200332
forms O 0 0.006843268871307373
of O 0 0.0027856098022311926
autosomal O 1 0.9999994039535522
dominant O 1 0.9878491759300232
cerebellar B-Disease 1 0.9999849796295166
ataxias I-Disease 1 0.9989601373672485
type I-Disease 1 0.9580471515655518
I I-Disease 0 0.02493940480053425
spinocerebellar B-Disease 1 0.9999948740005493
ataxias I-Disease 1 0.9962877035140991
1 I-Disease 0 0.006905584130436182
and I-Disease 0 0.0015572757693007588
2 I-Disease 0 0.008134478703141212
( O 0 0.006085044238716364
SCA1 B-Disease 1 0.9993622899055481
, O 0 0.0034515513107180595
n O 0 0.1617237627506256
= O 0 0.07416874170303345
11 O 0 0.009983796626329422
; O 0 0.006288668140769005
SCA2 B-Disease 1 0.9975282549858093
, O 0 0.0033444405999034643
n O 0 0.17898139357566833
= O 0 0.06766518205404282
10 O 0 0.004040924832224846
) O 0 0.002910184906795621
and O 0 0.002347141969949007
SCA3 B-Disease 1 0.9998612403869629
/ O 1 0.993053138256073
Machado B-Disease 1 0.9989151954650879
- I-Disease 0 0.34085699915885925
Joseph I-Disease 1 0.9537591934204102
disease I-Disease 1 0.9999958276748657
( O 0 0.012445826083421707
MJD B-Disease 1 0.999796450138092
) O 0 0.007801905740052462
( O 0 0.007086563389748335
n O 0 0.46249285340309143
= O 0 0.0997195914387703
16 O 0 0.009172516874969006
) O 0 0.005149030592292547
. O 0 0.004856267478317022

In O 0 0.010287834331393242
SCA1 B-Disease 1 0.9909770488739014
, O 0 0.007508768234401941
saccade O 1 0.9963627457618713
amplitude O 1 0.6712612509727478
was O 0 0.003650267841294408
significantly O 0 0.02696027234196663
increased O 0 0.009607083164155483
, O 0 0.001971299760043621
resulting O 0 0.03612571209669113
in O 0 0.003992547281086445
hypermetria B-Disease 1 0.9931529760360718
. O 0 0.008993053808808327

The O 0 0.006455392111092806
smooth O 0 0.08163536339998245
pursuit O 0 0.044225651770830154
gain O 0 0.01494701486080885
was O 0 0.0038268892094492912
decreased O 0 0.11795474588871002
. O 0 0.007878223434090614

In O 0 0.010629869997501373
SCA2 B-Disease 1 0.9937111139297485
, O 0 0.006596401799470186
saccade O 1 0.9955317974090576
velocity O 0 0.07604635506868362
was O 0 0.007006548345088959
markedly O 1 0.8863475918769836
decreased O 0 0.193045973777771
. O 0 0.006695044692605734

The O 0 0.00347902555949986
percentage O 0 0.007279501296579838
of O 0 0.0012215512106195092
errors O 0 0.08741259574890137
in O 0 0.0032232378143817186
antisaccades O 1 0.9916834831237793
was O 0 0.003558066673576832
greatly O 0 0.010891334153711796
increased O 0 0.007086073514074087
and O 0 0.001002047793008387
was O 0 0.002685281913727522
significantly O 0 0.14773254096508026
correlated O 1 0.9569119811058044
with O 0 0.0036946444306522608
age O 0 0.010573700070381165
at O 0 0.018101753666996956
disease O 1 0.9999985694885254
onset O 1 0.9999494552612305
. O 0 0.011448634788393974

In O 0 0.0034076902084052563
addition O 0 0.004639702849090099
, O 0 0.001431564218364656
a O 0 0.006163578014820814
correlation O 1 0.9476456642150879
between O 0 0.004943004343658686
smooth O 1 0.7109711766242981
pursuit O 0 0.04576569050550461
gain O 0 0.007658122573047876
and O 0 0.000711107044480741
the O 0 0.0007887696847319603
number O 0 0.0014034596970304847
of O 0 0.002392366761341691
trinucleotide O 1 0.9997592568397522
repeats O 1 0.7037556767463684
was O 0 0.003364947158843279
found O 0 0.0075997705571353436
. O 0 0.00553181441500783

In O 0 0.01102471724152565
SCA3 B-Disease 1 0.9968819618225098
, O 0 0.005745303351432085
gaze B-Disease 1 0.7311527132987976
- I-Disease 0 0.05110657215118408
evoked I-Disease 1 0.9761705994606018
nystagmus I-Disease 1 0.9999067783355713
was O 0 0.0037108331453055143
often O 0 0.0021147653460502625
present O 0 0.0018236447358503938
as O 0 0.0012983116321265697
was O 0 0.003958478104323149
saccade O 1 0.9997519850730896
hypometria O 1 0.9902091026306152
and O 0 0.002423166297376156
smooth O 1 0.6824460625648499
pursuit O 0 0.04074139520525932
gain O 0 0.010660463944077492
was O 0 0.004385975189507008
markedly O 1 0.8996913433074951
decreased O 0 0.2521892786026001
. O 0 0.006208534352481365

Three O 0 0.006724657956510782
major O 0 0.006523837335407734
criteria O 0 0.011950801126658916
, O 0 0.003999854438006878
saccade O 1 0.9984439015388489
amplitude O 1 0.7692160606384277
, O 0 0.005527209956198931
saccade O 1 0.9991515874862671
velocity O 0 0.0932067334651947
, O 0 0.0016587289283052087
and O 0 0.0008852732717059553
presence O 0 0.006978818215429783
of O 0 0.0019146676640957594
gaze B-Disease 1 0.9651429057121277
- I-Disease 0 0.0504913255572319
evoked I-Disease 1 0.9730907678604126
nystagmus I-Disease 1 0.9998613595962524
, O 0 0.0022270625922828913
permitted O 0 0.0033700333442538977
the O 0 0.00188035040628165
correct O 0 0.03303326666355133
assignment O 0 0.014509742148220539
of O 0 0.0008846863638609648
90 O 0 0.00556519627571106
% O 0 0.0029814394656568766
of O 0 0.0008356291218660772
the O 0 0.0029465812258422375
SCA1 B-Disease 1 0.9993630051612854
, O 0 0.0019081804202869534
90 O 0 0.004831823520362377
% O 0 0.0028709755279123783
of O 0 0.0006056631100364029
the O 0 0.0023626687470823526
SCA2 B-Disease 1 0.9996322393417358
, O 0 0.0015568207018077374
and O 0 0.0011035831412300467
93 O 0 0.014641725458204746
% O 0 0.0029852192383259535
of O 0 0.0008252594852820039
the O 0 0.0025455018039792776
patients O 1 0.9996980428695679
with O 0 0.004734249785542488
SCA3 B-Disease 1 0.9985931515693665
to O 0 0.001265872735530138
their O 0 0.0023606957402080297
genetically O 1 0.9996458292007446
confirmed O 0 0.379252552986145
patient O 1 0.9998863935470581
group O 0 0.007240945007652044
and O 0 0.0009979825699701905
, O 0 0.0013331795344129205
therefore O 0 0.003436292288824916
, O 0 0.0013114878674969077
may O 0 0.004883574787527323
help O 0 0.008352302014827728
orient O 0 0.07011349499225616
diagnoses O 1 0.9997829794883728
of O 0 0.003121588146314025
SCA1 B-Disease 1 0.9997596144676208
, O 0 0.004583004862070084
SCA2 B-Disease 1 0.9995059967041016
, O 0 0.002068356843665242
and O 0 0.0018249698914587498
SCA3 B-Disease 1 0.9993382096290588
at O 0 0.0043298364616930485
early O 0 0.007554083596915007
clinical O 1 0.997479259967804
stages O 0 0.02683664672076702
of O 0 0.0012785180006176233
the O 0 0.005346688441932201
diseases O 1 0.9999988079071045
. O 0 0.003440648317337036
. O 0 0.004981735721230507

Genetic O 1 0.9951093792915344
basis O 0 0.005517049226909876
and O 0 0.002147182822227478
molecular O 1 0.9987338185310364
mechanism O 1 0.9151604771614075
for O 0 0.00946137122809887
idiopathic B-Disease 1 0.9999996423721313
ventricular I-Disease 1 0.9999955892562866
fibrillation I-Disease 1 0.9999905824661255
. O 0 0.012696720659732819

Ventricular B-Disease 1 0.9999833106994629
fibrillation I-Disease 1 0.9999971389770508
causes O 1 0.9941251277923584
more O 0 0.0018273897003382444
than O 0 0.0015442997682839632
300 O 0 0.005676882807165384
, O 0 0.0020630951039493084
000 O 0 0.03034588135778904
sudden O 1 0.9969409108161926
deaths O 0 0.10504317283630371
each O 0 0.0024033912923187017
year O 0 0.002140279859304428
in O 0 0.001178044592961669
the O 0 0.001976987347006798
USA O 0 0.03305383771657944
alone O 0 0.010509228333830833
. O 0 0.005881397519260645

In O 0 0.004203622695058584
approximately O 0 0.007109200116246939
5 O 0 0.01224483922123909
- O 0 0.011703720316290855
12 O 0 0.004577144049108028
% O 0 0.0035182673018425703
of O 0 0.0008612772217020392
these O 0 0.0015928676584735513
cases O 0 0.008107822388410568
, O 0 0.0009291353053413332
there O 0 0.0007570061716251075
are O 0 0.0005660677561536431
no O 0 0.003647561650723219
demonstrable O 1 0.9999692440032959
cardiac O 1 0.9999972581863403
or O 0 0.007840428501367569
non O 0 0.08226419985294342
- O 1 0.9972956776618958
cardiac O 1 0.9999997615814209
causes O 1 0.997040331363678
to O 0 0.0012608591932803392
account O 0 0.0023922089021652937
for O 0 0.0008181137382052839
the O 0 0.0012970607494935393
episode O 0 0.01842254213988781
, O 0 0.001239880220964551
which O 0 0.0008589660283178091
is O 0 0.0010125571861863136
therefore O 0 0.0035034469328820705
classified O 0 0.016949297860264778
as O 0 0.007636082358658314
idiopathic B-Disease 1 0.9999998807907104
ventricular I-Disease 1 0.9999988079071045
fibrillation I-Disease 1 0.9999996423721313
( O 0 0.025656314566731453
IVF B-Disease 1 0.999982476234436
) O 0 0.008815928362309933
. O 0 0.005902556702494621

A O 0 0.016709521412849426
distinct O 0 0.01910959742963314
group O 0 0.006786823272705078
of O 0 0.004159620031714439
IVF B-Disease 1 0.9999991655349731
patients O 1 0.9998420476913452
has O 0 0.0019069439731538296
been O 0 0.001178447506390512
found O 0 0.0025945331435650587
to O 0 0.0007460232591256499
present O 0 0.0019149337895214558
with O 0 0.002063756575807929
a O 0 0.006404934450984001
characteristic O 1 0.9059439301490784
electrocardiographic O 1 0.9979704022407532
pattern O 1 0.6246283054351807
. O 0 0.00721912132576108

Because O 0 0.005748019088059664
of O 0 0.0007526749977841973
the O 0 0.0010844437638297677
small O 0 0.0035541937686502934
size O 0 0.004684605170041323
of O 0 0.0006464857142418623
most O 0 0.0016035041771829128
pedigrees O 1 0.9927535653114319
and O 0 0.0009781700791791081
the O 0 0.001505051739513874
high O 0 0.006659780163317919
incidence O 1 0.9994608759880066
of O 0 0.0024946255143731833
sudden B-Disease 1 0.999278724193573
death I-Disease 0 0.054937634617090225
, O 0 0.0011977928224951029
however O 0 0.0017374014714732766
, O 0 0.0022170899901539087
molecular O 1 0.9999083280563354
genetic O 1 0.9998461008071899
studies O 0 0.009925869293510914
of O 0 0.0020764137152582407
IVF B-Disease 1 0.999994158744812
have O 0 0.001814690069295466
not O 0 0.0009120299946516752
yet O 0 0.002539888257160783
been O 0 0.0018561444012448192
done O 0 0.0062106940895318985
. O 0 0.004784849472343922

Because O 0 0.03487253934144974
IVF B-Disease 1 0.9999699592590332
causes O 1 0.9998602867126465
cardiac O 1 0.999998927116394
rhythm O 1 0.9994020462036133
disturbance O 1 0.9973565340042114
, O 0 0.00189823133405298
we O 0 0.001162768225185573
investigated O 0 0.013088117353618145
whether O 0 0.005453095305711031
malfunction O 1 0.9982128143310547
of O 0 0.002026919275522232
ion O 1 0.9573044180870056
channels O 0 0.027396883815526962
could O 0 0.005214557982981205
cause O 1 0.8502523303031921
the O 0 0.004671638831496239
disorder O 1 0.9999805688858032
by O 0 0.003396271727979183
studying O 0 0.012513687834143639
mutations O 1 0.9999558925628662
in O 0 0.002079219790175557
the O 0 0.004750021733343601
cardiac O 1 0.9999977350234985
sodium O 1 0.99947589635849
channel O 0 0.21402700245380402
gene O 1 0.9996167421340942
SCN5A O 1 0.9898489117622375
. O 0 0.01063805166631937

We O 0 0.002986387349665165
have O 0 0.0011137606343254447
now O 0 0.0016969329444691539
identified O 0 0.010164767503738403
a O 0 0.008091560564935207
missense O 1 0.9999179840087891
mutation O 1 0.999941349029541
, O 0 0.0027301094960421324
a O 0 0.009269720874726772
splice O 1 0.9999338388442993
- O 1 0.7264652848243713
donor O 1 0.9997676014900208
mutation O 1 0.9999872446060181
, O 0 0.001878981594927609
and O 0 0.0011504956055432558
a O 0 0.011623133905231953
frameshift O 1 0.9999951124191284
mutation O 1 0.9999743700027466
in O 0 0.002128866733983159
the O 0 0.0024080625735223293
coding O 1 0.999271810054779
region O 0 0.0052338289096951485
of O 0 0.0016239841934293509
SCN5A O 1 0.9963083863258362
in O 0 0.0029799174517393112
three O 0 0.008582048118114471
IVF B-Disease 1 0.9999191761016846
families O 0 0.01592681184411049
. O 0 0.007296845316886902

We O 0 0.00290652341209352
show O 0 0.0031576198525726795
that O 0 0.0023847827687859535
sodium O 1 0.9913893342018127
channels O 0 0.022255461663007736
with O 0 0.0019305335590615869
the O 0 0.003238135250285268
missense O 1 0.9999531507492065
mutation O 1 0.9999731779098511
recover O 0 0.16353894770145416
from O 0 0.004617985803633928
inactivation O 1 0.9993379712104797
more O 0 0.0019703111611306667
rapidly O 0 0.015534182079136372
than O 0 0.0020964546129107475
normal O 0 0.01585593819618225
and O 0 0.0008261891780421138
that O 0 0.0008668345981277525
the O 0 0.0035395356826484203
frameshift O 1 0.9999973773956299
mutation O 1 0.9999957084655762
causes O 1 0.9637910723686218
the O 0 0.0028318993281573057
sodium O 1 0.9989033937454224
channel O 0 0.01830958016216755
to O 0 0.0013251352356746793
be O 0 0.00159744534175843
non O 0 0.012280276976525784
- O 0 0.02698705904185772
functional O 1 0.6582987904548645
. O 0 0.007343510631471872

Our O 0 0.006758461240679026
results O 0 0.010953199118375778
indicate O 0 0.007769860792905092
that O 0 0.0023738942109048367
mutations O 1 0.9999573230743408
in O 0 0.00628982437774539
cardiac O 1 0.9999964237213135
ion O 1 0.9984197616577148
- O 0 0.025835208594799042
channel O 0 0.04499424621462822
genes O 1 0.9986714124679565
contribute O 0 0.011438336223363876
to O 0 0.0009505682392045856
the O 0 0.002028467133641243
risk O 1 0.8315122127532959
of O 0 0.001983282156288624
developing O 1 0.8990336656570435
IVF B-Disease 1 0.999984622001648
. O 0 0.00454801507294178
. O 0 0.00522206723690033

Molecular O 1 0.9961397051811218
heterogeneity O 1 0.9892467856407166
in O 0 0.006600543390959501
mucopolysaccharidosis B-Disease 1 0.9981060028076172
IVA I-Disease 1 0.9996564388275146
in O 0 0.0021449674386531115
Australia O 0 0.0021086069755256176
and O 0 0.0008715611766092479
Northern O 0 0.0034813855309039354
Ireland O 0 0.005256033036857843
: O 0 0.002505028387531638
nine O 0 0.004208566155284643
novel O 0 0.05828637257218361
mutations O 1 0.999982476234436
including O 0 0.005494352430105209
T312S O 1 0.9961226582527161
, O 0 0.0020649859216064215
a O 0 0.005519846919924021
common O 0 0.022384874522686005
allele O 1 0.9997020363807678
that O 0 0.002835399704053998
confers O 1 0.9829388856887817
a O 0 0.015837466344237328
mild O 1 0.9988862872123718
phenotype O 1 0.9999725818634033
. O 0 0.008613258600234985

Mucopolysaccharidosis B-Disease 1 0.9957520961761475
IVA I-Disease 1 0.9994731545448303
( O 0 0.015229901298880577
MPS B-Disease 1 0.7773364782333374
IVA I-Disease 1 0.9999505281448364
) O 0 0.004431997425854206
is O 0 0.0021378002129495144
an O 0 0.006866105366498232
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 0.9999996423721313
lysosomal I-Disease 1 0.9999867677688599
storage I-Disease 1 0.9646487832069397
disorder I-Disease 1 0.9999730587005615
caused O 0 0.05733473598957062
by O 0 0.0028784300666302443
a O 0 0.011837359517812729
genetic B-Disease 1 0.9999922513961792
defect I-Disease 1 0.9999557733535767
in O 0 0.004147870000451803
N O 1 0.98541659116745
- O 0 0.055884797126054764
acetylgalactosamine O 1 0.9983314871788025
- O 0 0.03196266293525696
6 O 0 0.024069922044873238
- O 0 0.226786807179451
sulfate O 1 0.9998425245285034
sulfatase O 1 0.9997362494468689
( O 0 0.01855861023068428
GALNS O 1 0.9950953722000122
) O 0 0.008226665668189526
. O 0 0.005441863089799881

Previous O 0 0.013731274753808975
studies O 0 0.01198436040431261
of O 0 0.002744721481576562
patients O 1 0.9987095594406128
from O 0 0.0028711557388305664
a O 0 0.00654554320499301
British O 0 0.013170351274311543
- O 0 0.020283425226807594
Irish O 0 0.017412085086107254
population O 0 0.0024386190343648195
showed O 0 0.003956959117203951
that O 0 0.0009616172756068408
the O 0 0.0025728067848831415
I113F O 1 0.9997485280036926
mutation O 1 0.9999939203262329
is O 0 0.0018217067699879408
the O 0 0.0008829087018966675
most O 0 0.0011153086088597775
common O 0 0.009875672869384289
single O 0 0.01958591863512993
mutation O 1 0.999980092048645
among O 0 0.007602108642458916
MPS B-Disease 1 0.988385796546936
IVA I-Disease 1 0.9999951124191284
patients O 1 0.9997432827949524
and O 0 0.0017012745374813676
produces O 0 0.059860214591026306
a O 0 0.016583997756242752
severe O 1 0.9996380805969238
clinical O 1 0.9999431371688843
phenotype O 1 0.9999799728393555
. O 0 0.009143954142928123

We O 0 0.0048945313319563866
studied O 0 0.013312628492712975
mutations O 1 0.9998706579208374
in O 0 0.0018816090887412429
the O 0 0.0029287778306752443
GALNS O 1 0.9994543194770813
gene O 1 0.9995844960212708
from O 0 0.0029759774915874004
23 O 0 0.007511132396757603
additional O 0 0.008267753757536411
MPS B-Disease 1 0.9849435091018677
IVA I-Disease 1 0.9999983310699463
patients O 1 0.9999185800552368
( O 0 0.004767193458974361
15 O 0 0.0036340802907943726
from O 0 0.0016639588866382837
Australia O 0 0.0021395892836153507
, O 0 0.0011889050947502255
8 O 0 0.00498445937409997
from O 0 0.001764440443366766
Northern O 0 0.004463588818907738
Ireland O 0 0.007468182593584061
) O 0 0.0024162083864212036
, O 0 0.0009149275138042867
with O 0 0.0016011036932468414
various O 0 0.004121329635381699
clinical O 1 0.9999619722366333
phenotypes O 1 0.9999899864196777
( O 0 0.008519318886101246
severe O 1 0.999607264995575
, O 0 0.0015915068797767162
16 O 0 0.006713691167533398
cases O 0 0.012851260602474213
; O 0 0.004677442368119955
intermediate O 1 0.6738685369491577
, O 0 0.0018415257800370455
4 O 0 0.009800219908356667
cases O 0 0.03808629512786865
; O 0 0.009227893315255642
mild O 1 0.9989184141159058
, O 0 0.0024538130965083838
3 O 0 0.012911900877952576
cases O 0 0.016913533210754395
) O 0 0.005000594537705183
. O 0 0.004573575686663389

We O 0 0.0027237776666879654
found O 0 0.003959369380027056
two O 0 0.0025089264381676912
common O 0 0.05459420010447502
mutations O 1 0.9999904632568359
that O 0 0.0014353543519973755
together O 0 0.002386394189670682
accounted O 0 0.008410018868744373
for O 0 0.0012003249721601605
32 O 0 0.007687337696552277
% O 0 0.0026768764946609735
of O 0 0.0005003086989745498
the O 0 0.0013690829509869218
44 O 0 0.014885623008012772
unrelated O 1 0.9916226267814636
alleles O 1 0.9999107122421265
in O 0 0.002536328276619315
these O 0 0.0039986502379179
patients O 1 0.9997145533561707
. O 0 0.007537324912846088

One O 0 0.004086608067154884
is O 0 0.0017902698600664735
the O 0 0.0029723194893449545
T312S O 1 0.9996281862258911
mutation O 1 0.9999830722808838
, O 0 0.0021478135604411364
a O 0 0.005089111626148224
novel O 0 0.050924964249134064
mutation O 1 0.9999821186065674
found O 0 0.006630293559283018
exclusively O 0 0.006692464463412762
in O 0 0.004321586806327105
milder O 1 0.9997081160545349
patients O 1 0.9995617270469666
. O 0 0.008794782683253288

The O 0 0.0034712115302681923
other O 0 0.0013234690995886922
is O 0 0.0012516748392954469
the O 0 0.0010579938534647226
previously O 0 0.0032374432776123285
described O 0 0.009657666087150574
I113F O 1 0.9893431663513184
that O 0 0.0018778821686282754
produces O 0 0.032013945281505585
a O 0 0.01648741029202938
severe O 1 0.9994670748710632
phenotype O 1 0.9999812841415405
. O 0 0.011174173094332218

The O 0 0.006997076794505119
I113F O 1 0.9165464639663696
and O 0 0.005119566805660725
T312S O 1 0.9974174499511719
mutations O 1 0.9999691247940063
accounted O 0 0.018004603683948517
for O 0 0.002137864474207163
8 O 0 0.008255267515778542
( O 0 0.003618494840338826
18 O 0 0.005046790931373835
% O 0 0.005970451049506664
) O 0 0.0033700047060847282
and O 0 0.0012818651739507914
6 O 0 0.007890935987234116
( O 0 0.003335055196657777
14 O 0 0.005860371980816126
% O 0 0.004647886846214533
) O 0 0.0021962705068290234
of O 0 0.001020870404317975
44 O 0 0.016146045178174973
unrelated O 1 0.9958052635192871
alleles O 1 0.9999626874923706
, O 0 0.003122965805232525
respectively O 0 0.006930481176823378
. O 0 0.005846487358212471

The O 0 0.003879392985254526
relatively O 0 0.010549941100180149
high O 0 0.009253531694412231
residual O 1 0.9927419424057007
GALNS O 1 0.9980835914611816
activity O 0 0.014210770837962627
seen O 0 0.004309244453907013
when O 0 0.0022913641296327114
the O 0 0.002855913480743766
T312S O 1 0.9938915967941284
mutant O 1 0.9989383816719055
cDNA O 1 0.990105926990509
is O 0 0.00517032528296113
overexpressed O 1 0.9981060028076172
in O 0 0.004813042469322681
mutant O 1 0.9998815059661865
cells O 1 0.9991010427474976
provides O 0 0.007590167690068483
an O 0 0.0011456372449174523
explanation O 0 0.009599986486136913
for O 0 0.0013490313431248069
the O 0 0.003769100410863757
mild O 1 0.9998084902763367
phenotype O 1 0.9999970197677612
in O 0 0.005555430427193642
patients O 1 0.9991777539253235
with O 0 0.0032577316742390394
this O 0 0.004077104385942221
mutation O 1 0.9999887943267822
. O 0 0.007848035544157028

The O 0 0.0046060290187597275
distribution O 0 0.012925862334668636
and O 0 0.0011422047391533852
relative O 0 0.008281801827251911
frequencies O 0 0.018156616017222404
of O 0 0.000642390048597008
the O 0 0.0018029295606538653
I113F O 1 0.9954701662063599
and O 0 0.004261998925358057
T312S O 1 0.9997432827949524
mutations O 1 0.9999830722808838
in O 0 0.0017923529958352447
Australia O 0 0.002238271525129676
corresponded O 0 0.016682004556059837
to O 0 0.0008752744761295617
those O 0 0.0009566383087076247
observed O 0 0.006557634565979242
in O 0 0.0010601014364510775
Northern O 0 0.0032070849556475878
Ireland O 0 0.00445070955902338
and O 0 0.000654320465400815
are O 0 0.000531447643879801
unique O 0 0.0028874811250716448
to O 0 0.0005554786184802651
these O 0 0.0007385865319520235
two O 0 0.0016973192105069757
populations O 0 0.11410465091466904
, O 0 0.0011498919920995831
suggesting O 0 0.012461019679903984
that O 0 0.0012362695997580886
both O 0 0.002897498197853565
mutations O 1 0.9999966621398926
were O 0 0.0011459504021331668
probably O 0 0.004454858601093292
introduced O 0 0.004565896932035685
to O 0 0.0008800341165624559
Australia O 0 0.002275079255923629
by O 0 0.0022198206279426813
Irish O 0 0.015246129594743252
migrants O 0 0.008822957053780556
during O 0 0.0024945351760834455
the O 0 0.001463314751163125
19th O 0 0.006266510114073753
century O 0 0.005812297109514475
. O 0 0.006073784548789263

Haplotype O 1 0.9974633455276489
analysis O 0 0.025157678872346878
using O 0 0.009099176153540611
6 O 0 0.011353886686265469
RFLPs O 1 0.9853177666664124
provides O 0 0.007794445846229792
additional O 0 0.0026137151289731264
data O 0 0.003006554674357176
that O 0 0.0009278047946281731
the O 0 0.0023729887325316668
I113F O 1 0.9990736246109009
mutation O 1 0.9999606609344482
originated O 0 0.02350160852074623
from O 0 0.00207397248595953
a O 0 0.006564547773450613
common O 0 0.02266322821378708
ancestor O 1 0.6801031827926636
. O 0 0.00719448272138834

The O 0 0.003584338119253516
other O 0 0.002125977538526058
9 O 0 0.010312976315617561
novel O 0 0.08428773283958435
mutations O 1 0.9999927282333374
identified O 0 0.011548125185072422
in O 0 0.001014089328236878
these O 0 0.0019225795986130834
23 O 0 0.014490677043795586
patients O 1 0.9988380074501038
were O 0 0.000840802036691457
each O 0 0.001471968018449843
limited O 0 0.003433950012549758
to O 0 0.001123912399634719
a O 0 0.005399870686233044
single O 0 0.012602927163243294
family O 0 0.015926891937851906
. O 0 0.007210829295217991

These O 0 0.0031895721331238747
data O 0 0.00439641484990716
provide O 0 0.0032945272978395224
further O 0 0.002376046497374773
evidence O 0 0.0023445661645382643
for O 0 0.001479522092267871
extensive O 0 0.020413747057318687
allelic O 1 0.9991014003753662
heterogeneity O 1 0.9946972131729126
in O 0 0.004182784352451563
MPS B-Disease 0 0.29142385721206665
IVA I-Disease 1 0.9998610019683838
in O 0 0.0031938168685883284
British O 0 0.01385276485234499
- O 0 0.07682690024375916
Irish O 1 0.7919700145721436
patients O 1 0.9996719360351562
and O 0 0.0010691166389733553
provide O 0 0.002887880662456155
evidence O 0 0.002095006639137864
for O 0 0.0010098711354658008
their O 0 0.0020400399807840586
transmission O 1 0.9978212118148804
to O 0 0.0013357863062992692
Australia O 0 0.0022081027273088694
by O 0 0.002461834577843547
British O 0 0.011460755951702595
- O 0 0.02500859834253788
Irish O 0 0.028285199776291847
migrants O 0 0.014110442250967026
. O 0 0.003256514435634017
. O 0 0.005233143921941519

Identification O 0 0.029044518247246742
of O 0 0.0021560511086136103
constitutional O 0 0.023448288440704346
WT1 O 1 0.9999876022338867
mutations O 1 0.9999843835830688
, O 0 0.0033205458894371986
in O 0 0.0028862443286925554
patients O 1 0.9994644522666931
with O 0 0.005749333184212446
isolated O 1 0.9966243505477905
diffuse B-Disease 1 0.9999966621398926
mesangial I-Disease 1 0.9999996423721313
sclerosis I-Disease 1 0.9999998807907104
, O 0 0.0025266835000365973
and O 0 0.0010584918782114983
analysis O 0 0.010511265136301517
of O 0 0.002850452670827508
genotype O 1 0.9999954700469971
/ O 1 0.998106837272644
phenotype O 1 0.9999899864196777
correlations O 1 0.9845743775367737
by O 0 0.002057309029623866
use O 0 0.001942883594892919
of O 0 0.0009611478890292346
a O 0 0.009418593719601631
computerized O 1 0.9986036419868469
mutation O 1 0.999970555305481
database O 0 0.07058613747358322
. O 0 0.006548936944454908

Constitutional O 0 0.02874360792338848
mutations O 1 0.9987509250640869
of O 0 0.0016226727748289704
the O 0 0.0046517751179635525
WT1 O 1 0.999984860420227
gene O 1 0.9996587038040161
, O 0 0.0034021176397800446
encoding O 1 0.9083446264266968
a O 0 0.010996387340128422
zinc O 1 0.9983249306678772
- O 0 0.04202369973063469
finger O 1 0.9919425249099731
transcription O 1 0.9996119141578674
factor O 0 0.038074664771556854
involved O 0 0.007855557836592197
in O 0 0.004924636799842119
renal O 1 0.9999998807907104
and O 0 0.004506394267082214
gonadal O 1 0.9999955892562866
development O 0 0.007159330416470766
, O 0 0.0009597788448445499
are O 0 0.0005804392858408391
found O 0 0.002593531273305416
in O 0 0.00100712850689888
most O 0 0.0025215179193764925
patients O 1 0.9998613595962524
with O 0 0.008171186782419682
Denys B-Disease 1 0.9999786615371704
- I-Disease 1 0.992065966129303
Drash I-Disease 1 0.9999767541885376
syndrome I-Disease 1 0.9999997615814209
( O 0 0.018763208761811256
DDS B-Disease 1 0.9999810457229614
) O 0 0.005793790798634291
, O 0 0.0021914741955697536
or O 0 0.01644998975098133
diffuse B-Disease 1 0.999993085861206
mesangial I-Disease 1 0.9999992847442627
sclerosis I-Disease 1 1.0
( O 0 0.023320844396948814
DMS B-Disease 1 0.9999785423278809
) O 0 0.005659379530698061
associated O 0 0.0072496081702411175
with O 0 0.003166105365380645
pseudohermaphroditism B-Disease 1 0.9989380240440369
and O 0 0.0034299460239708424
/ O 1 0.9826183319091797
or O 0 0.06973492354154587
Wilms B-Disease 1 0.9999994039535522
tumor I-Disease 1 0.9999980926513672
( O 0 0.01809353567659855
WT B-Disease 1 0.9999037981033325
) O 0 0.008967265486717224
. O 0 0.00578929902985692

Most O 0 0.01056526880711317
mutations O 1 0.999943733215332
in O 0 0.00921813677996397
DDS B-Disease 1 0.9999902248382568
patients O 1 0.9995388984680176
lie O 0 0.015064346604049206
in O 0 0.003373292274773121
exon O 1 0.9985698461532593
8 O 0 0.010875617153942585
or O 0 0.006832439452409744
exon O 1 0.9920637011528015
9 O 0 0.010585755109786987
, O 0 0.002876260317862034
encoding O 1 0.9954162836074829
zinc O 1 0.9982746839523315
finger O 1 0.964328408241272
2 O 0 0.012669524177908897
or O 0 0.007988795638084412
zinc O 1 0.9990479350090027
finger O 1 0.992801308631897
3 O 0 0.009646745398640633
, O 0 0.0016556846676394343
respectively O 0 0.003550406778231263
, O 0 0.0009885365143418312
with O 0 0.0017557272221893072
a O 0 0.005400761961936951
hot O 0 0.019004760310053825
spot O 0 0.01579013466835022
( O 0 0.007232325617223978
R394W O 1 0.9945928454399109
) O 0 0.004456039052456617
in O 0 0.003142774570733309
exon O 1 0.9992165565490723
9 O 0 0.017359867691993713
. O 0 0.005996935069561005

We O 0 0.003993552178144455
analyzed O 0 0.018458928912878036
a O 0 0.004108327440917492
series O 0 0.005731224548071623
of O 0 0.0014376259641721845
24 O 0 0.015303803607821465
patients O 1 0.9996949434280396
, O 0 0.0012482027523219585
10 O 0 0.0029352810233831406
with O 0 0.003951152320951223
isolated B-Disease 1 0.9587512016296387
DMS I-Disease 1 0.9999681711196899
( O 0 0.016888273879885674
IDMS B-Disease 1 0.999983549118042
) O 0 0.005882649682462215
, O 0 0.0015281299129128456
10 O 0 0.0037687027361243963
with O 0 0.00621455442160368
DDS B-Disease 1 0.9999575614929199
, O 0 0.00211515580303967
and O 0 0.0011347823310643435
4 O 0 0.007577958051115274
with O 0 0.007095661945641041
urogenital B-Disease 1 0.9999902248382568
abnormalities I-Disease 1 0.9999970197677612
and O 0 0.004981286823749542
/ O 1 0.9574886560440063
or O 0 0.015405896119773388
WT B-Disease 1 0.9994714856147766
. O 0 0.010314212180674076

We O 0 0.005345719400793314
report O 0 0.011312718503177166
WT1 O 1 0.9998347759246826
heterozygous O 1 0.999795138835907
mutations O 1 0.9999569654464722
in O 0 0.004535812418907881
16 O 0 0.01652570627629757
patients O 1 0.9997877478599548
, O 0 0.00213967589661479
4 O 0 0.00492542190477252
of O 0 0.0009501073509454727
whom O 0 0.0032292907126247883
presented O 0 0.005277867894619703
with O 0 0.008817716501653194
IDMS B-Disease 1 0.9999189376831055
. O 0 0.009971346706151962

One O 0 0.006390503607690334
male O 0 0.02284814789891243
and O 0 0.0013093367451801896
two O 0 0.0030255026649683714
female O 1 0.5764467716217041
IDMS B-Disease 1 0.9999958276748657
patients O 1 0.9990946054458618
with O 0 0.013652937486767769
WT1 O 1 0.9999901056289673
mutations O 1 0.999988317489624
underwent O 1 0.9990410208702087
normal O 1 0.5102336406707764
puberty O 1 0.998933732509613
. O 0 0.011203051544725895

Two O 0 0.01543541718274355
mutations O 1 0.9999266862869263
associated O 0 0.0186531413346529
with O 0 0.005885887425392866
IDMS B-Disease 1 0.9999558925628662
are O 0 0.0013665615115314722
different O 0 0.0014828925486654043
from O 0 0.0012144353240728378
those O 0 0.0016108633717522025
described O 0 0.010857006534934044
in O 0 0.007583779748529196
DDS B-Disease 1 0.9999886751174927
patients O 1 0.9990085959434509
. O 0 0.009092526510357857

No O 0 0.023787058889865875
WT1 O 1 0.9998890161514282
mutations O 1 0.9998732805252075
were O 0 0.0024837933015078306
detected O 0 0.14125235378742218
in O 0 0.0009289316367357969
the O 0 0.0008616055129095912
six O 0 0.0035889269784092903
other O 0 0.005144475493580103
IDMS B-Disease 1 0.9999988079071045
patients O 1 0.9998792409896851
, O 0 0.0024825530126690865
suggesting O 0 0.04725001007318497
genetic O 1 0.9998925924301147
heterogeneity O 1 0.9954825639724731
of O 0 0.001718314248137176
this O 0 0.0059279161505401134
disease O 1 0.999995231628418
. O 0 0.00852317363023758

We O 0 0.007387424353510141
analyzed O 0 0.08216749131679535
genotype O 1 0.9999064207077026
/ O 1 0.996180534362793
phenotype O 1 0.9999853372573853
correlations O 1 0.9938232898712158
, O 0 0.0016781985759735107
on O 0 0.0006485979538410902
the O 0 0.0006115486612543464
basis O 0 0.001732486067339778
of O 0 0.00041550741298124194
the O 0 0.0007861625053919852
constitution O 0 0.0023582084104418755
of O 0 0.0011083235731348395
a O 0 0.013688459992408752
WT1 O 1 0.9999858140945435
mutation O 1 0.9999445676803589
database O 0 0.03185879811644554
of O 0 0.0015865692403167486
84 O 0 0.0883779525756836
germ O 1 0.9998635053634644
- O 0 0.036124300211668015
line O 0 0.024064864963293076
mutations O 1 0.9999855756759644
, O 0 0.0014708386734127998
to O 0 0.0010323371971026063
compare O 0 0.013055955991148949
the O 0 0.0009613052825443447
distribution O 0 0.009805371053516865
and O 0 0.0010512513108551502
type O 0 0.48959338665008545
of O 0 0.0023854938335716724
mutations O 1 0.999998927116394
, O 0 0.0014309234684333205
according O 0 0.0010941301006823778
to O 0 0.0008980676648207009
the O 0 0.0015452919760718942
different O 0 0.006772203370928764
symptoms O 1 0.9999483823776245
. O 0 0.007554179988801479

This O 0 0.006072408519685268
demonstrated O 0 0.02338551916182041
( O 0 0.005221349187195301
1 O 0 0.006878775544464588
) O 0 0.0024997435975819826
the O 0 0.0011271036928519607
association O 0 0.004496755078434944
between O 0 0.0058152819983661175
mutations O 1 0.9999899864196777
in O 0 0.0035266494378447533
exons O 1 0.9993390440940857
8 O 0 0.006501469295471907
and O 0 0.0011106827296316624
9 O 0 0.008550138212740421
and O 0 0.003945717588067055
DMS B-Disease 1 0.9999926090240479
; O 0 0.007401724811643362
( O 0 0.004470272455364466
2 O 0 0.00765874981880188
) O 0 0.0032462936360388994
among O 0 0.004812400788068771
patients O 1 0.9996254444122314
with O 0 0.0072194053791463375
DMS B-Disease 1 0.9999538660049438
, O 0 0.0022349790669977665
a O 0 0.004465737845748663
higher O 0 0.005696398206055164
frequency O 0 0.027114875614643097
of O 0 0.001869417610578239
exon O 1 0.9985378980636597
8 O 0 0.02301216311752796
mutations O 1 0.9999634027481079
among O 0 0.004227887839078903
46 O 0 0.015722719952464104
, O 0 0.0048927320167422295
XY O 1 0.9999750852584839
patients O 1 0.9989442229270935
with O 0 0.004686804488301277
female O 0 0.19160196185112
phenotype O 1 0.9999860525131226
than O 0 0.0024610417895019054
among O 0 0.00295951752923429
46 O 0 0.01615842804312706
, O 0 0.0065455655567348
XY O 1 0.99998939037323
patients O 1 0.9987596273422241
with O 0 0.003957771230489016
sexual O 0 0.01805860549211502
ambiguity O 0 0.07941889762878418
or O 0 0.007925349287688732
male O 1 0.9909369349479675
phenotype O 1 0.999998927116394
; O 0 0.006108255125582218
and O 0 0.0015372730558738112
( O 0 0.003997127525508404
3 O 0 0.007795794866979122
) O 0 0.0026882984675467014
statistically O 0 0.01646019145846367
significant O 0 0.004213370382785797
evidence O 0 0.0031052641570568085
that O 0 0.002501169452443719
mutations O 1 0.9999653100967407
in O 0 0.0030891161877661943
exons O 1 0.9982252717018127
8 O 0 0.007007928099483252
and O 0 0.0014581381110474467
9 O 0 0.008575530722737312
preferentially O 1 0.8222063779830933
affect O 0 0.0294113140553236
amino O 1 0.9948517680168152
acids O 1 0.9901955723762512
with O 0 0.0018429531482979655
different O 0 0.0019488881807774305
functions O 0 0.008727573789656162
. O 0 0.0024343703407794237
. O 0 0.005158861633390188

The O 0 0.014285316690802574
185delAG O 1 0.9983515739440918
BRCA1 O 1 0.9999979734420776
mutation O 1 0.9999574422836304
originated O 0 0.0285370871424675
before O 0 0.002468869322910905
the O 0 0.0015393205685541034
dispersion O 1 0.8035345077514648
of O 0 0.000826792442239821
Jews O 0 0.0022698738612234592
in O 0 0.000880866777151823
the O 0 0.001146269147284329
diaspora O 0 0.02150101028382778
and O 0 0.0010276613757014275
is O 0 0.0013225083239376545
not O 0 0.0010975489858537912
limited O 0 0.004248098935931921
to O 0 0.002723338780924678
Ashkenazim O 1 0.9836915731430054
. O 0 0.006525184493511915

The O 0 0.00912709441035986
185delAG O 1 0.9947715401649475
mutation O 1 0.9998873472213745
in O 0 0.01041589118540287
BRCA1 O 1 0.9999974966049194
is O 0 0.005855242721736431
detected O 0 0.34518444538116455
in O 0 0.002368691610172391
Ashkenazi O 1 0.8846448659896851
Jews O 0 0.0027679430786520243
both O 0 0.001466798479668796
in O 0 0.004118562676012516
familial B-Disease 1 0.9999998807907104
breast I-Disease 1 0.9999996423721313
and I-Disease 1 0.786928117275238
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.0017369945999234915
in O 0 0.001102731446735561
the O 0 0.001245264895260334
general O 0 0.003302632598206401
population O 0 0.004185216035693884
. O 0 0.005425209179520607

All O 0 0.005191944073885679
tested O 0 0.2672176957130432
Ashkenazi O 1 0.9975320100784302
mutation O 1 0.9999744892120361
carriers O 1 0.5414160490036011
share O 0 0.00643613887950778
the O 0 0.0013286239700391889
same O 0 0.005139725282788277
allelic O 1 0.9986704587936401
pattern O 0 0.061919957399368286
at O 0 0.0036230189725756645
the O 0 0.006258370354771614
BRCA1 O 1 0.9999992847442627
locus O 1 0.9996137022972107
. O 0 0.011187712661921978

Our O 0 0.005943113472312689
previous O 0 0.004800360184162855
study O 0 0.0056826891377568245
showed O 0 0.0047474028542637825
that O 0 0.0011734896106645465
this O 0 0.0023089710157364607
Ashkenazi O 1 0.9995156526565552
mutation O 1 0.9999886751174927
also O 0 0.0027545737102627754
occurs O 0 0.05636582151055336
in O 0 0.0011025886051356792
Iraqi O 0 0.004008239135146141
Jews O 0 0.002642288338392973
with O 0 0.0019316761754453182
a O 0 0.006270937155932188
similar O 0 0.018736617639660835
allelic O 1 0.9994465708732605
pattern O 0 0.4620511829853058
. O 0 0.008812117390334606

We O 0 0.0041085476987063885
extended O 0 0.005589469335973263
our O 0 0.0025046600494533777
analysis O 0 0.00924435630440712
to O 0 0.0010177784133702517
other O 0 0.0016057846369221807
non O 0 0.010872585698962212
- O 0 0.030594762414693832
Ashkenazi O 1 0.9745061993598938
subsets O 0 0.38323596119880676
354 O 0 0.06282269209623337
of O 0 0.0017976176459342241
Moroccan O 0 0.03421394154429436
origin O 0 0.007868096232414246
, O 0 0.0014640124281868339
200 O 0 0.006390221416950226
Yemenites O 1 0.9905447959899902
and O 0 0.0015370403416454792
150 O 0 0.005407912656664848
Iranian O 0 0.005287906154990196
Jews O 0 0.00565249053761363
. O 0 0.005170575808733702

Heteroduplex O 1 0.8992013335227966
analysis O 0 0.03215956315398216
complemented O 0 0.038126155734062195
by O 0 0.0029946404974907637
direct O 0 0.014321573078632355
DNA O 1 0.9954368472099304
sequencing O 1 0.9345718026161194
of O 0 0.0041758110746741295
abnormally O 1 0.998161256313324
migrating O 0 0.2993314266204834
bands O 0 0.014930259436368942
were O 0 0.001774295000359416
employed O 0 0.01045540627092123
. O 0 0.006889860145747662

Four O 0 0.005981225520372391
of O 0 0.0018229227280244231
Moroccan O 0 0.03934497386217117
origin O 0 0.012033326551318169
( O 0 0.004215347580611706
1 O 0 0.006628999952226877
. O 0 0.0016417197184637189
1 O 0 0.005663967691361904
% O 0 0.005422303918749094
) O 0 0.0025799074210226536
and O 0 0.0006722236867062747
none O 0 0.0029929468873888254
of O 0 0.0006986091029830277
the O 0 0.0021867109462618828
Yemenites O 1 0.9983475208282471
or O 0 0.004318434279412031
Iranians O 0 0.006217850372195244
was O 0 0.0014498000964522362
a O 0 0.0048649790696799755
carrier O 0 0.04668695479631424
of O 0 0.0013525099493563175
the O 0 0.004005026537925005
185delAG O 1 0.9993385672569275
mutation O 1 0.9999709129333496
. O 0 0.009028278291225433

BRCA1 O 1 0.9999902248382568
allelic O 1 0.9977680444717407
patterns O 0 0.0381791852414608
were O 0 0.001050376333296299
determined O 0 0.004986214451491833
for O 0 0.000799702072981745
four O 0 0.0013544460525736213
of O 0 0.000571373151615262
these O 0 0.0008799876668490469
individuals O 0 0.0028969240374863148
and O 0 0.0006416679825633764
for O 0 0.0008720600162632763
12 O 0 0.003200552659109235
additional O 0 0.004954947158694267
non O 0 0.010492556728422642
- O 0 0.034653130918741226
Ashkenazi O 1 0.9984037280082703
185delAG O 1 0.9992524981498718
mutation O 1 0.9999738931655884
carriers O 1 0.7579978704452515
who O 0 0.0039690653793513775
had O 0 0.020474720746278763
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999735355377197
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999984502792358
. O 0 0.013255326077342033

Six O 0 0.014832909218966961
non O 0 0.020957624539732933
- O 0 0.03635454177856445
Ashkenazi O 1 0.9747655391693115
individuals O 0 0.004549036733806133
shared O 0 0.005217244382947683
the O 0 0.0017266825307160616
common O 0 0.05558141693472862
Ashkenazi O 1 0.9993582367897034
haplotype O 1 0.9999781847000122
, O 0 0.00196070852689445
four O 0 0.0018709109863266349
had O 0 0.0016950519056990743
a O 0 0.004229235462844372
closely O 0 0.008094818331301212
related O 0 0.015754705294966698
pattern O 1 0.839116632938385
, O 0 0.0009680294897407293
and O 0 0.0006258520297706127
the O 0 0.0010466889943927526
rest O 0 0.006220537703484297
( O 0 0.005421819165349007
n O 1 0.8835558295249939
= O 1 0.5529643297195435
6 O 0 0.006988533306866884
) O 0 0.001939263311214745
displayed O 0 0.004113330505788326
a O 0 0.0066864630207419395
distinct O 0 0.47396984696388245
BRCA1 O 1 0.9999984502792358
allelic O 1 0.9993667006492615
pattern O 0 0.45454680919647217
. O 0 0.008477920666337013

We O 0 0.003660149173811078
conclude O 0 0.014515361748635769
that O 0 0.0012687293346971273
the O 0 0.003585971426218748
185delAG O 1 0.9998496770858765
BRCA1 O 1 0.9999998807907104
mutation O 1 0.9999972581863403
occurs O 0 0.08505050092935562
in O 0 0.001187139074318111
some O 0 0.0015653400914743543
non O 0 0.012434367090463638
- O 0 0.04597528278827667
Ashkenazi O 1 0.9965805411338806
populations O 0 0.027913639321923256
at O 0 0.003089286619797349
rates O 0 0.013548542745411396
comparable O 0 0.013730376027524471
with O 0 0.001578424358740449
that O 0 0.0010987939313054085
of O 0 0.002421723445877433
Ashkenazim O 1 0.9934932589530945
. O 0 0.00937963929027319

The O 0 0.002543932292610407
majority O 0 0.0038204616867005825
of O 0 0.001336345449090004
Jewish O 0 0.014026702381670475
185delAG O 1 0.999788224697113
mutation O 1 0.9999959468841553
carriers O 1 0.7846941351890564
have O 0 0.001174180768430233
a O 0 0.004603476729243994
common O 0 0.02321479097008705
allelic O 1 0.9998581409454346
pattern O 1 0.5815590620040894
, O 0 0.0017652401002123952
supporting O 0 0.005575757008045912
the O 0 0.001956481719389558
founder O 0 0.03467493876814842
effect O 0 0.015565597452223301
notion O 0 0.010832669213414192
, O 0 0.0010989560978487134
but O 0 0.001049673999659717
dating O 0 0.008124501444399357
the O 0 0.0029357890598475933
mutations O 1 0.9999861717224121
origin O 0 0.00636775977909565
to O 0 0.0009078182629309595
an O 0 0.0012745083076879382
earlier O 0 0.002918243408203125
date O 0 0.003532136557623744
than O 0 0.0013535530306398869
currently O 0 0.0022727835457772017
estimated O 0 0.006878481712192297
. O 0 0.004964920226484537

However O 0 0.006281707901507616
, O 0 0.0014270676765590906
the O 0 0.0011186550837010145
different O 0 0.003592701395973563
allelic O 1 0.9989412426948547
pattern O 0 0.051663126796483994
at O 0 0.003437293227761984
the O 0 0.0065949708223342896
BRCA1 O 1 0.9999996423721313
locus O 1 0.9996114373207092
even O 0 0.0029229619540274143
in O 0 0.0008725866209715605
some O 0 0.0014562883879989386
Jewish O 0 0.016819680109620094
mutation O 1 0.9999982118606567
carriers O 1 0.992798924446106
, O 0 0.001669637975282967
might O 0 0.004389724228531122
suggest O 0 0.005061877891421318
that O 0 0.00077851238893345
the O 0 0.002957085845991969
mutation O 1 0.9999936819076538
arose O 0 0.0392758771777153
independently O 0 0.012423141859471798
. O 0 0.002434222027659416
. O 0 0.004234580788761377

Crystal O 0 0.0745449960231781
structure O 0 0.011180766858160496
of O 0 0.0011365911923348904
the O 0 0.00617951899766922
hemochromatosis B-Disease 1 0.9999964237213135
protein O 1 0.9998231530189514
HFE O 1 0.9996652603149414
and O 0 0.0025136086624115705
characterization O 0 0.035792894661426544
of O 0 0.0008684277418069541
its O 0 0.002078692428767681
interaction O 0 0.029125230386853218
with O 0 0.006469785235822201
transferrin O 1 0.9996638298034668
receptor O 1 0.9988744854927063
. O 0 0.007691635750234127

HFE O 1 0.9978621602058411
is O 0 0.005450057797133923
an O 0 0.006057771388441324
MHC O 1 0.9999594688415527
- O 0 0.03620074316859245
related O 0 0.024190867319703102
protein O 1 0.9993265867233276
that O 0 0.0016188918380066752
is O 0 0.0020604077726602554
mutated O 1 0.9997664093971252
in O 0 0.0015141252661123872
the O 0 0.002281604567542672
iron B-Disease 1 0.9891669750213623
- I-Disease 1 0.9939572811126709
overload I-Disease 1 0.9999895095825195
disease I-Disease 1 0.9999986886978149
hereditary B-Disease 1 0.999994158744812
hemochromatosis I-Disease 1 0.9999967813491821
. O 0 0.015637841075658798

HFE O 1 0.996304988861084
binds O 1 0.7480300664901733
to O 0 0.008564409799873829
transferrin O 1 0.9986419081687927
receptor O 1 0.9993158578872681
( O 0 0.013047032058238983
TfR O 1 0.999626636505127
) O 0 0.0040406519547104836
and O 0 0.0016590164741501212
reduces O 0 0.33806127309799194
its O 0 0.0035192370414733887
affinity O 1 0.7754968404769897
for O 0 0.002592421369627118
iron O 0 0.11934206634759903
- O 0 0.02147183194756508
loaded O 0 0.03494642674922943
transferrin O 1 0.9956468939781189
, O 0 0.005909265018999577
implicating O 1 0.989513635635376
HFE O 1 0.9995582699775696
in O 0 0.007597729098051786
iron O 1 0.5039490461349487
metabolism O 1 0.9994567036628723
. O 0 0.010771033354103565

The O 0 0.00785998534411192
2 O 0 0.016043925657868385
. O 0 0.007128563243895769

6 O 0 0.017649110406637192
A O 0 0.014722947031259537
crystal O 0 0.039435870945453644
structure O 0 0.012702442705631256
of O 0 0.002443634206429124
HFE O 1 0.9998199343681335
reveals O 0 0.025137757882475853
the O 0 0.0013233317295089364
locations O 0 0.0059366049244999886
of O 0 0.004642709158360958
hemochromatosis B-Disease 1 0.9999996423721313
mutations O 1 0.9999910593032837
and O 0 0.0019010414835065603
a O 0 0.007076880428940058
patch O 1 0.9970843195915222
of O 0 0.0020889821462333202
histidines O 1 0.9957233667373657
that O 0 0.00130069546867162
could O 0 0.0017726141959428787
be O 0 0.0011189780198037624
involved O 0 0.0057790158316493034
in O 0 0.004236549139022827
pH O 1 0.9999439716339111
- O 0 0.034446507692337036
dependent O 0 0.03448203206062317
interactions O 0 0.17094439268112183
. O 0 0.007082927506417036

We O 0 0.0027748604770749807
also O 0 0.001346489996649325
demonstrate O 0 0.007801184896379709
that O 0 0.0032397473696619272
soluble O 1 0.9996812343597412
TfR O 1 0.9980698227882385
and O 0 0.006205208133906126
HFE O 1 0.9999234676361084
bind O 1 0.9914474487304688
tightly O 0 0.02842860296368599
at O 0 0.001699728425592184
the O 0 0.0012337426887825131
basic O 0 0.01016814075410366
pH O 1 0.9981966614723206
of O 0 0.000945600972045213
the O 0 0.002820731606334448
cell O 1 0.9998664855957031
surface O 0 0.019642380997538567
, O 0 0.0013957568444311619
but O 0 0.0009266257984563708
not O 0 0.0008360396604984999
at O 0 0.0014511889312416315
the O 0 0.001958452630788088
acidic O 1 0.998794674873352
pH O 1 0.9982099533081055
of O 0 0.00490571279078722
intracellular O 1 0.999657392501831
vesicles O 1 0.9972788691520691
. O 0 0.01030971109867096

TfR O 1 0.9965487122535706
HFE O 1 0.999261200428009
stoichiometry O 1 0.9930490255355835
( O 0 0.010106254369020462
2 O 0 0.009521505795419216
1 O 0 0.007748769596219063
) O 0 0.0038847867399454117
differs O 0 0.023586586117744446
from O 0 0.004293777979910374
TfR O 1 0.9995081424713135
transferrin O 1 0.9992377758026123
stoichiometry O 1 0.996431827545166
( O 0 0.0070149763487279415
2 O 0 0.009161390364170074
2 O 0 0.008900424465537071
) O 0 0.0033176057040691376
, O 0 0.0013893613358959556
implying O 0 0.029257794842123985
a O 0 0.0035410630516707897
different O 0 0.0019311835058033466
mode O 0 0.01861944980919361
of O 0 0.0009716710192151368
binding O 0 0.04537880793213844
for O 0 0.003032489214092493
HFE O 1 0.9998873472213745
and O 0 0.0038948894944041967
transferrin O 1 0.9992327690124512
to O 0 0.0056294165551662445
TfR O 1 0.9993891716003418
, O 0 0.0022905422374606133
consistent O 0 0.009273934178054333
with O 0 0.0015718184877187014
our O 0 0.002137614181265235
demonstration O 0 0.011135295033454895
that O 0 0.004078457597643137
HFE O 1 0.9999167919158936
, O 0 0.005652543157339096
transferrin O 1 0.9991325736045837
, O 0 0.002067048102617264
and O 0 0.002486237557604909
TfR O 1 0.9996837377548218
form O 0 0.011487348936498165
a O 0 0.006995181553065777
ternary O 1 0.9928795695304871
complex O 0 0.023315170779824257
. O 0 0.0060307979583740234

Identification O 0 0.030501756817102432
of O 0 0.0013269545743241906
three O 0 0.0030924249440431595
novel O 0 0.09466266632080078
mutations O 1 0.9999580383300781
and O 0 0.00166638707742095
a O 0 0.004328042734414339
high O 0 0.0039574215188622475
frequency O 0 0.019374268129467964
of O 0 0.0006666053086519241
the O 0 0.002724674064666033
Arg778Leu O 1 0.999631404876709
mutation O 1 0.9999932050704956
in O 0 0.0037189763970673084
Korean O 0 0.04900823533535004
patients O 1 0.9997560381889343
with O 0 0.008965265937149525
Wilson B-Disease 1 0.9974653720855713
disease I-Disease 1 0.9999856948852539
. O 0 0.009354285895824432

Four O 0 0.02612954005599022
mutations O 1 0.9999771118164062
- O 0 0.20979249477386475
- O 0 0.08091969043016434
R778L O 1 0.9869909882545471
, O 0 0.004888471215963364
A874V O 1 0.9815183281898499
, O 0 0.004820648115128279
L1083F O 1 0.992182195186615
, O 0 0.0022067101672291756
and O 0 0.0034471077378839254
2304delC O 1 0.9997640252113342
- O 0 0.043074287474155426
- O 0 0.013096324168145657
in O 0 0.0013834761921316385
the O 0 0.0019091288559138775
copper O 0 0.04872317239642143
- O 0 0.02094341441988945
transporting O 0 0.058725692331790924
enzyme O 1 0.9990782737731934
, O 0 0.005569056142121553
P O 1 0.9845511317253113
- O 0 0.043246157467365265
type O 1 0.9742912650108337
ATPase O 1 0.9998735189437866
( O 0 0.012425827793776989
ATP7B O 1 0.9996538162231445
) O 0 0.004560704808682203
, O 0 0.0008845018455758691
were O 0 0.0005846178391948342
identified O 0 0.0077842408791184425
in O 0 0.001931481179781258
Korean O 0 0.10561693459749222
Patients O 1 0.9999234676361084
with O 0 0.00830161850899458
Wilson B-Disease 1 0.9959954023361206
disease I-Disease 1 0.9999750852584839
. O 0 0.007970967330038548

Arg778Leu O 1 0.989346444606781
, O 0 0.003174281446263194
the O 0 0.0014242625329643488
most O 0 0.0011684068012982607
frequently O 0 0.005616384092718363
reported O 0 0.013295626267790794
mutation O 1 0.9999561309814453
of O 0 0.0010279194684699178
this O 0 0.0023336790036410093
enzyme O 1 0.9999634027481079
, O 0 0.0015732544707134366
was O 0 0.0013445971999317408
found O 0 0.0034661453682929277
in O 0 0.000902131199836731
six O 0 0.0023428681306540966
of O 0 0.0009489440126344562
eight O 0 0.007446102797985077
unrelated O 1 0.9981564879417419
patients O 1 0.999731719493866
studied O 0 0.008134929463267326
, O 0 0.0015761511167511344
an O 0 0.0033617662265896797
allele O 1 0.9998836517333984
frequency O 0 0.0430196113884449
of O 0 0.001710177748464048
37 O 0 0.017253851518034935
. O 0 0.0063210129737854

5 O 0 0.0170906912535429
% O 0 0.0068920752964913845
, O 0 0.001280113123357296
which O 0 0.0010371764656156301
is O 0 0.0015996706206351519
considerably O 0 0.02512008510529995
higher O 0 0.0035524482373148203
than O 0 0.0010541881201788783
those O 0 0.0009269034489989281
in O 0 0.0009418062400072813
other O 0 0.0018230121349915862
Asian O 0 0.019745830446481705
populations O 0 0.0838550254702568
. O 0 0.006084161810576916

The O 0 0.00373856071382761
novel O 0 0.014034194871783257
single O 0 0.015399486757814884
nucleotide O 1 0.9991911053657532
deletion O 1 0.9994511008262634
, O 0 0.005220051389187574
2304delC O 1 0.9960280656814575
, O 0 0.0019764858298003674
was O 0 0.0018063309835270047
found O 0 0.0040915850549936295
in O 0 0.001892539206892252
one O 0 0.005235222168266773
patient O 1 0.998506486415863
. O 0 0.008213072083890438

Since O 0 0.009734610095620155
a O 0 0.013695736415684223
mutation O 1 0.9994400143623352
at O 0 0.009591140784323215
cDNA O 1 0.9923670887947083
nucleotide O 1 0.9988831877708435
2302 O 1 0.9997666478157043
( O 0 0.013007584027945995
2302insC O 1 0.9962312579154968
) O 0 0.004883213900029659
had O 0 0.001771381008438766
been O 0 0.0014640206936746836
previously O 0 0.003626371966674924
described O 0 0.006377693731337786
, O 0 0.0009097474394366145
this O 0 0.0008294073631986976
region O 0 0.001748133567161858
of O 0 0.0006160892662592232
the O 0 0.002830594778060913
ATP7B O 1 0.9999185800552368
gene O 1 0.9999558925628662
may O 0 0.006116120144724846
be O 0 0.0018218213226646185
susceptible O 1 0.9995450377464294
to O 0 0.004316163249313831
gene O 1 0.9999666213989258
rearrangements O 1 0.9998360872268677
causing O 1 0.9978694915771484
Wilson B-Disease 1 0.9925695061683655
disease I-Disease 1 0.9999648332595825
. O 0 0.009430354461073875

Disruption O 0 0.12028228491544724
of O 0 0.005035391543060541
splicing O 1 0.9987378716468811
regulated O 0 0.03634198009967804
by O 0 0.0030504874885082245
a O 0 0.011217322200536728
CUG O 1 0.997403085231781
- O 0 0.036568451672792435
binding O 0 0.25747406482696533
protein O 1 0.9987096786499023
in O 0 0.0175034049898386
myotonic B-Disease 1 0.9999979734420776
dystrophy I-Disease 1 0.9999967813491821
. O 0 0.015500657260417938

Myotonic B-Disease 1 0.9999945163726807
dystrophy I-Disease 1 0.999998927116394
( O 0 0.04401184991002083
DM B-Disease 1 0.9999767541885376
) O 0 0.007917075417935848
is O 0 0.002995056565850973
caused O 0 0.02823420986533165
by O 0 0.002581500681117177
a O 0 0.008910268545150757
CTG O 1 0.9977403879165649
expansion O 0 0.014482052065432072
in O 0 0.00119470723439008
the O 0 0.0018730313749983907
3 O 0 0.010670386254787445
untranslated O 1 0.9244351387023926
region O 0 0.003346844110637903
of O 0 0.0012035007821395993
the O 0 0.0053600105457007885
DM B-Disease 1 0.9999938011169434
gene O 1 0.9998231530189514
. O 0 0.009561309590935707

One O 0 0.0041694664396345615
model O 0 0.016185255721211433
of O 0 0.005861802492290735
DM B-Disease 1 0.9999974966049194
pathogenesis O 1 0.9999861717224121
suggests O 0 0.023396652191877365
that O 0 0.002720415825024247
RNAs O 1 0.9960015416145325
from O 0 0.0016521643847227097
the O 0 0.0012999039608985186
expanded O 0 0.009704241529107094
allele O 1 0.9992662072181702
create O 0 0.011319872923195362
a O 0 0.006288817618042231
gain O 0 0.013928432017564774
- O 0 0.011517200618982315
of O 0 0.002195285400375724
- O 0 0.035058315843343735
function O 1 0.8879803419113159
mutation O 1 0.9999589920043945
by O 0 0.0020895397756248713
the O 0 0.0014986186288297176
inappropriate O 0 0.024756601080298424
binding O 0 0.02597845159471035
of O 0 0.0015183824580162764
proteins O 1 0.9910153746604919
to O 0 0.001542494515888393
the O 0 0.0031514239963144064
CUG O 1 0.9984898567199707
repeats O 1 0.807566225528717
. O 0 0.010123523883521557

Data O 0 0.01187085546553135
presented O 0 0.004734499379992485
here O 0 0.0014686075737699866
indicate O 0 0.0057275439612567425
that O 0 0.000840325781609863
the O 0 0.0016522904625162482
conserved O 1 0.9435831308364868
heterogeneous O 1 0.9754109382629395
nuclear O 0 0.03114004246890545
ribonucleoprotein O 1 0.9982640147209167
, O 0 0.004440941847860813
CUG O 1 0.9958580136299133
- O 0 0.029961686581373215
binding O 0 0.4289242625236511
protein O 1 0.9991664886474609
( O 0 0.011289392597973347
CUG O 1 0.9996522665023804
- O 0 0.08491256088018417
BP O 1 0.9778622388839722
) O 0 0.004761414602398872
, O 0 0.0014716217992827296
may O 0 0.004794807638972998
mediate O 1 0.647227942943573
the O 0 0.0038195960223674774
trans O 1 0.9990634322166443
- O 0 0.022038862109184265
dominant O 0 0.038054514676332474
effect O 0 0.008917862549424171
of O 0 0.001023116521537304
the O 0 0.0033262968063354492
RNA O 1 0.9997994303703308
. O 0 0.009718659333884716

CUG O 1 0.9957420229911804
- O 0 0.053602032363414764
BP O 0 0.42765891551971436
was O 0 0.00319717382080853
found O 0 0.0035121506080031395
to O 0 0.0016381440218538046
bind O 1 0.5587825775146484
to O 0 0.001081242342479527
the O 0 0.002016995334997773
human O 0 0.24862806499004364
cardiac O 1 0.9999991655349731
troponin O 1 0.9999880790710449
T O 1 0.9997683167457581
( O 0 0.011812835931777954
cTNT O 1 0.9790812134742737
) O 0 0.006776570342481136
pre O 0 0.05194726958870888
- O 0 0.03320224955677986
messenger O 1 0.9936515092849731
RNA O 1 0.9977777600288391
and O 0 0.0029293617699295282
regulate O 0 0.043027061969041824
its O 0 0.0045004067942500114
alternative O 0 0.04005065932869911
splicing O 1 0.9982333183288574
. O 0 0.011086035519838333

Splicing O 1 0.9829084873199463
of O 0 0.005519689526408911
cTNT O 1 0.9506418108940125
was O 0 0.006089544855058193
disrupted O 0 0.16027633845806122
in O 0 0.010366229340434074
DM B-Disease 1 0.9999929666519165
striated O 1 0.9999864101409912
muscle O 1 0.9998866319656372
and O 0 0.0016630355967208743
in O 0 0.002177896909415722
normal O 1 0.6421273946762085
cells O 1 0.9994896650314331
expressing O 0 0.016920147463679314
transcripts O 0 0.02624768763780594
that O 0 0.0019663115963339806
contain O 0 0.026538429781794548
CUG O 1 0.9969068169593811
repeats O 1 0.6889883279800415
. O 0 0.009257848374545574

Altered O 0 0.07484186440706253
expression O 0 0.025486882776021957
of O 0 0.002597824903205037
genes O 1 0.9988228678703308
regulated O 0 0.07065985351800919
posttranscriptionally O 1 0.9893991947174072
by O 0 0.007199566345661879
CUG O 1 0.9995642304420471
- O 0 0.04291193559765816
BP O 0 0.4942178428173065
therefore O 0 0.005588213447481394
may O 0 0.004624241031706333
contribute O 0 0.01345186959952116
to O 0 0.006009209435433149
DM B-Disease 1 0.999991774559021
pathogenesis O 1 0.9999877214431763
. O 0 0.004872783087193966
. O 0 0.004965909756720066

Identification O 0 0.026984963566064835
of O 0 0.0012532329419627786
a O 0 0.005573124624788761
novel O 0 0.022722145542502403
nonsense O 1 0.8825015425682068
mutation O 1 0.9999622106552124
and O 0 0.002033126074820757
a O 0 0.008206378668546677
missense O 1 0.9993329644203186
substitution O 0 0.11620549857616425
in O 0 0.0017941327532753348
the O 0 0.003563852980732918
vasopressin O 1 0.9997017979621887
- O 0 0.1285196989774704
neurophysin O 1 0.9972768425941467
II O 1 0.817445695400238
gene O 1 0.9995478987693787
in O 0 0.0017078161472454667
two O 0 0.0021844743750989437
Spanish O 0 0.015326131135225296
kindreds O 1 0.9988885521888733
with O 0 0.01566547155380249
familial B-Disease 1 0.9999979734420776
neurohypophyseal I-Disease 1 0.9999090433120728
diabetes I-Disease 1 0.999998927116394
insipidus I-Disease 1 0.9998713731765747
. O 0 0.01860564388334751

Familial B-Disease 1 0.9999819993972778
neurohypophyseal I-Disease 1 0.9998770952224731
diabetes I-Disease 1 0.9999997615814209
insipidus I-Disease 1 0.9999880790710449
( O 0 0.018312061205506325
FNDI B-Disease 1 0.9998133778572083
) O 0 0.004122888203710318
is O 0 0.0016560156363993883
an O 0 0.005573583766818047
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9992621541023254
disease I-Disease 1 0.9999972581863403
caused O 1 0.9404394626617432
by O 0 0.007610333152115345
deficiency O 1 0.9999980926513672
in O 0 0.002665682462975383
the O 0 0.004938957281410694
antidiuretic O 1 0.9998067021369934
hormone O 1 0.9995773434638977
arginine O 1 0.9982612729072571
vasopressin O 1 0.9981597065925598
( O 0 0.012390142306685448
AVP O 1 0.9978995323181152
) O 0 0.006387254688888788
encoded O 0 0.05085097625851631
by O 0 0.001962656155228615
the O 0 0.002972902962937951
AVP O 1 0.9995394945144653
- O 0 0.06919408589601517
neurophysin O 1 0.9963739514350891
II O 0 0.19140984117984772
( O 0 0.012508515268564224
AVP O 1 0.9997431635856628
- O 0 0.14187178015708923
NPII O 1 0.9986698627471924
) O 0 0.011118578724563122
gene O 1 0.9993351101875305
on O 0 0.006025494541972876
chromosome O 1 0.9999630451202393
20p13 O 1 0.9820453524589539
. O 0 0.010594888590276241

In O 0 0.00430653803050518
this O 0 0.002082524821162224
study O 0 0.007049485109746456
, O 0 0.0012279651127755642
we O 0 0.0008657054277136922
analyzed O 0 0.01340379100292921
two O 0 0.0018121652537956834
families O 0 0.0044278334826231
with O 0 0.003964683506637812
FNDI B-Disease 1 0.9991357922554016
using O 0 0.007655612658709288
direct O 0 0.011992143467068672
automated O 0 0.1777055263519287
fluorescent O 1 0.9878151416778564
, O 0 0.0026306852232664824
solid O 0 0.016169346868991852
phase O 0 0.031267762184143066
, O 0 0.0016718640690669417
single O 0 0.01130826584994793
- O 0 0.017763426527380943
stranded O 0 0.2119193822145462
DNA O 1 0.9962687492370605
sequencing O 1 0.8750672936439514
of O 0 0.0041451905854046345
PCR O 1 0.9993091821670532
- O 0 0.04668009653687477
amplified O 1 0.9893353581428528
AVP O 1 0.9993547797203064
- O 0 0.11344072967767715
NPII O 1 0.9970172643661499
DNA O 1 0.9968293309211731
. O 0 0.010729734785854816

In O 0 0.0030736627522855997
one O 0 0.00146861607208848
of O 0 0.0007507432019338012
the O 0 0.0014677067520096898
families O 0 0.006784637924283743
, O 0 0.0018302970565855503
affected O 0 0.01472281664609909
individuals O 0 0.0034845154732465744
presented O 0 0.0034931902773678303
a O 0 0.005054486449807882
novel O 0 0.0211054515093565
nonsense O 1 0.9504287838935852
mutation O 1 0.9999586343765259
in O 0 0.004182148724794388
exon O 1 0.9988718628883362
3 O 0 0.0054906620644032955
of O 0 0.0006407400360330939
the O 0 0.002104892861098051
gene O 1 0.999969482421875
, O 0 0.0015627036336809397
consisting O 0 0.004291118122637272
in O 0 0.0011579247657209635
a O 0 0.007117505185306072
G O 1 0.9985974431037903
to O 0 0.003966431133449078
T O 1 0.9990060925483704
transition O 0 0.025893257930874825
at O 0 0.005743015557527542
nucleotide O 1 0.9992092251777649
2101 O 1 0.9962174296379089
, O 0 0.00195421208627522
which O 0 0.0014483567792922258
produces O 0 0.019107038155198097
a O 0 0.005312134977430105
stop O 0 0.010656792670488358
signal O 0 0.029117558151483536
in O 0 0.0030237813480198383
codon O 1 0.9888880848884583
82 O 0 0.03343169018626213
( O 0 0.012242105789482594
Glu O 1 0.9998791217803955
) O 0 0.005917006637901068
of O 0 0.00349428947083652
NPII O 1 0.9920051693916321
. O 0 0.009741461835801601

The O 0 0.012133040465414524
premature O 1 0.9968908429145813
termination O 1 0.9929612278938293
eliminates O 1 0.6541928648948669
part O 0 0.0024111748207360506
of O 0 0.0009439258137717843
the O 0 0.0030839750543236732
C O 1 0.9983179569244385
- O 0 0.024065157398581505
terminal O 1 0.6975941061973572
domain O 0 0.02731705829501152
of O 0 0.0021434002555906773
NPII O 1 0.9985059499740601
, O 0 0.0014764313818886876
including O 0 0.0017895338824018836
a O 0 0.007539145182818174
cysteine O 1 0.998451828956604
residue O 1 0.9302830696105957
in O 0 0.0014449565205723047
position O 0 0.0032290818635374308
85 O 0 0.01278995256870985
, O 0 0.001113944104872644
which O 0 0.0009430408827029169
could O 0 0.0016199604142457247
be O 0 0.0009152683196589351
involved O 0 0.00429186038672924
in O 0 0.0009542932966724038
the O 0 0.0014761368511244655
correct O 0 0.05560040846467018
folding O 1 0.6956437230110168
of O 0 0.001527909655123949
the O 0 0.004225082695484161
prohormone O 1 0.9990755319595337
. O 0 0.011221913620829582

In O 0 0.002934485673904419
the O 0 0.001562911900691688
second O 0 0.005946597084403038
family O 0 0.009021320380270481
, O 0 0.0016283915610983968
a O 0 0.007384385913610458
G279A O 1 0.9896386861801147
substitution O 1 0.6602891683578491
at O 0 0.0034690466709434986
position O 0 0.005427843891084194
- O 0 0.012635741382837296
1 O 0 0.0036701965145766735
of O 0 0.0006996731390245259
the O 0 0.0018348972080275416
signal O 0 0.47559332847595215
peptide O 1 0.9995301961898804
was O 0 0.003228092100471258
observed O 0 0.007446310482919216
in O 0 0.0010219091782346368
all O 0 0.0011208320502191782
affected O 0 0.02210404723882675
individuals O 0 0.008789305575191975
. O 0 0.005403910297900438

This O 0 0.012183948419988155
missense O 1 0.9998693466186523
mutation O 1 0.9999756813049316
, O 0 0.0027637742459774017
which O 0 0.0022976745385676622
replaces O 1 0.9734426736831665
Ala O 1 0.9975233674049377
with O 0 0.010805261321365833
Thr O 1 0.9999493360519409
, O 0 0.00280554685741663
is O 0 0.0018535947892814875
frequent O 0 0.023741979151964188
among O 0 0.009647729806602001
FNDI B-Disease 1 0.9999772310256958
patients O 1 0.9997913241386414
and O 0 0.0014697479782626033
is O 0 0.0014991636853665113
thought O 0 0.004908919334411621
to O 0 0.0010832666885107756
reduce O 0 0.01302394736558199
the O 0 0.00150487688370049
efficiency O 0 0.01666574366390705
of O 0 0.0023323434870690107
cleavage O 1 0.9994418025016785
by O 0 0.00546209467574954
signal O 0 0.18749815225601196
peptidases O 1 0.9900143146514893
. O 0 0.005238918587565422
. O 0 0.005914721172302961

Genetic O 1 0.996356725692749
heterogeneity O 1 0.965099036693573
of O 0 0.0045950692147016525
Saethre B-Disease 1 0.9997114539146423
- I-Disease 1 0.9885590672492981
Chotzen I-Disease 1 0.9999496936798096
syndrome I-Disease 1 0.9999994039535522
, O 0 0.003312298096716404
due O 0 0.005282501690089703
to O 0 0.002292078919708729
TWIST O 1 0.9877364039421082
and O 0 0.005792936775833368
FGFR O 1 0.9997401833534241
mutations O 1 0.9999401569366455
. O 0 0.010203366167843342

Thirty O 0 0.046061720699071884
- O 0 0.02247544191777706
two O 0 0.005435071885585785
unrelated O 1 0.9899943470954895
patients O 1 0.998572587966919
with O 0 0.0023717086296528578
features O 0 0.005392410326749086
of O 0 0.0023920678067952394
Saethre B-Disease 1 0.9999293088912964
- I-Disease 1 0.9781249761581421
Chotzen I-Disease 1 0.9999622106552124
syndrome I-Disease 1 0.9999994039535522
, O 0 0.00280809891410172
a O 0 0.008350277319550514
common O 1 0.6570190787315369
autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.840086042881012
condition I-Disease 1 0.8198723196983337
of O 0 0.0031569250859320164
craniosynostosis B-Disease 1 0.9999970197677612
and O 0 0.005491896532475948
limb B-Disease 1 0.9999971389770508
anomalies I-Disease 1 0.9995716214179993
, O 0 0.0014407673152163625
were O 0 0.0009341914555989206
screened O 0 0.0328218899667263
for O 0 0.003887721337378025
mutations O 1 0.999985933303833
in O 0 0.0033661245834082365
TWIST O 1 0.9956343770027161
, O 0 0.004548904486000538
FGFR2 O 1 0.9994884729385376
, O 0 0.0027198235038667917
and O 0 0.0028884790372103453
FGFR3 O 1 0.9966005682945251
. O 0 0.008676682598888874

Nine O 0 0.013274893164634705
novel O 0 0.016887569800019264
and O 0 0.0014430348528549075
three O 0 0.005252564325928688
recurrent O 1 0.999925971031189
TWIST O 1 0.9992640614509583
mutations O 1 0.9999750852584839
were O 0 0.001564059522934258
found O 0 0.004248389508575201
in O 0 0.0017026023706421256
12 O 0 0.0069643659517169
families O 0 0.008324192836880684
. O 0 0.005946400109678507

Seven O 0 0.010470311157405376
families O 0 0.005770047195255756
were O 0 0.0008425394771620631
found O 0 0.0029324188362807035
to O 0 0.0008368051494471729
have O 0 0.00103287142701447
the O 0 0.0031898911111056805
FGFR3 O 1 0.9996261596679688
P250R O 1 0.99982750415802
mutation O 1 0.9999922513961792
, O 0 0.0019835331477224827
and O 0 0.0008521873969584703
one O 0 0.0013657354284077883
individual O 0 0.0038692145608365536
was O 0 0.0015098957810550928
found O 0 0.00281808921135962
to O 0 0.0008146550389938056
have O 0 0.0011495562503114343
an O 0 0.00375345372594893
FGFR2 O 1 0.9991094470024109
VV269 O 1 0.9975250363349915
- O 0 0.040912214666604996
270 O 0 0.09195618331432343
deletion O 1 0.9945642948150635
. O 0 0.012378356419503689

To O 0 0.0031756460666656494
date O 0 0.004327099304646254
, O 0 0.0014113951474428177
our O 0 0.003078164765611291
detection O 1 0.9643211960792542
rate O 0 0.008463330566883087
for O 0 0.0022767249029129744
TWIST O 1 0.9901798963546753
or O 0 0.00883036945015192
FGFR O 1 0.9998946189880371
mutations O 1 0.9999841451644897
is O 0 0.003060299204662442
68 O 0 0.014739011414349079
% O 0 0.0035126276779919863
in O 0 0.001229540561325848
our O 0 0.0053029912523925304
Saethre B-Disease 1 0.999816358089447
- I-Disease 1 0.9958527088165283
Chotzen I-Disease 1 0.999995231628418
syndrome I-Disease 1 1.0
patients O 1 0.9999284744262695
, O 0 0.0013567479327321053
including O 0 0.001580465817824006
our O 0 0.0022636004723608494
five O 0 0.005228764843195677
patients O 1 0.9996034502983093
elsewhere O 0 0.0077834343537688255
reported O 0 0.007692988961935043
with O 0 0.005502005107700825
TWIST O 1 0.9990216493606567
mutations O 1 0.9999669790267944
. O 0 0.010388731025159359

More O 0 0.0026919571682810783
than O 0 0.0019968589767813683
35 O 0 0.00696686003357172
different O 0 0.005192672833800316
TWIST O 1 0.9988215565681458
mutations O 1 0.9999823570251465
are O 0 0.0012735890923067927
now O 0 0.0017117373645305634
known O 0 0.003620257368311286
in O 0 0.0009126993827521801
the O 0 0.0015556300058960915
literature O 0 0.008817166090011597
. O 0 0.006352403666824102

The O 0 0.0026099788956344128
most O 0 0.002142543438822031
common O 0 0.018059447407722473
phenotypic O 1 0.9990214109420776
features O 0 0.007893022149801254
, O 0 0.0012103042099624872
present O 0 0.002139072399586439
in O 0 0.0008396606426686049
more O 0 0.0008330698474310338
than O 0 0.0009470440563745797
a O 0 0.0030177095904946327
third O 0 0.002986063715070486
of O 0 0.0009654402965679765
our O 0 0.004630729090422392
patients O 1 0.9994357228279114
with O 0 0.006537412293255329
TWIST O 1 0.999284565448761
mutations O 1 0.9999837875366211
, O 0 0.0022204353008419275
are O 0 0.002095297444611788
coronal B-Disease 1 0.9994090795516968
synostosis I-Disease 1 0.9969557523727417
, O 0 0.003781659761443734
brachycephaly B-Disease 1 0.9947031140327454
, O 0 0.00369802163913846
low B-Disease 0 0.10194634646177292
frontal I-Disease 1 0.9999567270278931
hairline I-Disease 1 0.99998939037323
, O 0 0.009332628920674324
facial B-Disease 1 0.9999655485153198
asymmetry I-Disease 1 0.9997677206993103
, O 0 0.00977514497935772
ptosis B-Disease 1 0.9999960660934448
, O 0 0.007167425472289324
hypertelorism B-Disease 1 0.9997033476829529
, O 0 0.0032522145193070173
broad B-Disease 0 0.01519920863211155
great I-Disease 0 0.007963338866829872
toes I-Disease 1 0.9914023280143738
, O 0 0.0022968591656535864
and O 0 0.0026009576395154
clinodactyly B-Disease 1 0.9968955516815186
. O 0 0.008606983348727226

Significant O 0 0.030742738395929337
intra O 1 0.91778165102005
- O 0 0.022038020193576813
and O 0 0.00317138759419322
interfamilial O 1 0.9968118071556091
phenotypic O 1 0.9994170665740967
variability O 1 0.9894298911094666
is O 0 0.0016464391956105828
present O 0 0.0015589098911732435
for O 0 0.001160656102001667
either O 0 0.008315479382872581
TWIST O 1 0.9982129335403442
mutations O 1 0.9999860525131226
or O 0 0.013176711276173592
FGFR O 1 0.9997606873512268
mutations O 1 0.999942421913147
. O 0 0.010057338513433933

The O 0 0.004625174216926098
overlap O 0 0.07990404218435287
in O 0 0.003342445008456707
clinical O 1 0.99906986951828
features O 0 0.005098538473248482
and O 0 0.0007113510509952903
the O 0 0.0011061454424634576
presence O 0 0.006841619033366442
, O 0 0.0007778920698910952
in O 0 0.000670101959258318
the O 0 0.0009055379778146744
same O 0 0.004062560386955738
genes O 1 0.9994713664054871
, O 0 0.0013145023258402944
of O 0 0.0017691253451630473
mutations O 1 0.9999914169311523
for O 0 0.0014471489703282714
more O 0 0.0008313926518894732
than O 0 0.001252341433428228
one O 0 0.003359115682542324
craniosynostotic B-Disease 1 0.9996885061264038
condition I-Disease 1 0.9973875880241394
- O 0 0.012348009273409843
such O 0 0.0023361784406006336
as O 0 0.003444391069933772
Saethre B-Disease 1 0.9995073080062866
- I-Disease 0 0.07585886120796204
Chotzen I-Disease 1 0.9922289252281189
, I-Disease 0 0.004552983213216066
Crouzon I-Disease 1 0.9934123158454895
, I-Disease 0 0.0032924520783126354
and I-Disease 0 0.005179218482226133
Pfeiffer I-Disease 1 0.9999932050704956
syndromes I-Disease 1 0.9999996423721313
- O 0 0.018128879368305206
support O 0 0.0037493458949029446
the O 0 0.0017927376320585608
hypothesis O 1 0.7489113211631775
that O 0 0.0028958143666386604
TWIST O 1 0.9149664044380188
and O 0 0.00202590087428689
FGFRs O 1 0.9940813183784485
are O 0 0.0009923393372446299
components O 0 0.00791771151125431
of O 0 0.0004641548730432987
the O 0 0.0008489519241265953
same O 0 0.004293215461075306
molecular O 1 0.9999188184738159
pathway O 1 0.9995948672294617
involved O 0 0.005772414151579142
in O 0 0.0009944087360054255
the O 0 0.001780258840881288
modulation O 1 0.9973019361495972
of O 0 0.0033351436723023653
craniofacial O 1 0.9999972581863403
and O 0 0.005176067817956209
limb O 1 0.9999836683273315
development O 0 0.0074446541257202625
in O 0 0.0024026301689445972
humans O 1 0.9237295389175415
. O 0 0.003102111630141735
. O 0 0.005906430538743734

Mutation O 1 0.9996280670166016
analysis O 0 0.02088545449078083
of O 0 0.004273167345672846
UBE3A O 1 0.9999469518661499
in O 0 0.20670676231384277
Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 1 0.9997431635856628
. O 0 0.010911715216934681

Angelman B-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999996423721313
( O 0 0.00973478052765131
AS B-Disease 0 0.004847860895097256
) O 0 0.003405350958928466
is O 0 0.002357527846470475
caused O 0 0.043238330632448196
by O 0 0.00836258102208376
chromosome O 1 0.9999898672103882
15q11 O 1 0.9978514909744263
- O 0 0.0367048904299736
q13 O 1 0.9912136197090149
deletions O 1 0.9907744526863098
of O 0 0.00276000052690506
maternal O 1 0.991532027721405
origin O 0 0.008772077970206738
, O 0 0.0014963105786591768
by O 0 0.004619123414158821
paternal O 1 0.9987590312957764
uniparental B-Disease 1 0.9999735355377197
disomy I-Disease 1 0.9992098808288574
( O 0 0.015296151861548424
UPD B-Disease 1 0.9999624490737915
) O 0 0.0057652294635772705
15 O 0 0.004513311665505171
, O 0 0.0013875344302505255
by O 0 0.005592234432697296
imprinting O 1 0.9999866485595703
defects O 1 0.9999659061431885
, O 0 0.0018401341512799263
and O 0 0.0009032401721924543
by O 0 0.003838847391307354
mutations O 1 0.9999889135360718
in O 0 0.0021347040310502052
the O 0 0.004747014958411455
UBE3A O 1 0.9999618530273438
gene O 1 0.999839186668396
. O 0 0.00939145963639021

UBE3A O 1 0.9920111298561096
encodes O 1 0.8543357849121094
a O 0 0.019771642982959747
ubiquitin O 1 0.9929634928703308
- O 0 0.05838100612163544
protein O 1 0.9972789883613586
ligase O 1 0.7478026747703552
and O 0 0.00275926454924047
shows O 0 0.016132039949297905
brain O 1 0.9999769926071167
- O 0 0.029650678858160973
specific O 0 0.018784763291478157
imprinting O 1 0.9991297125816345
. O 0 0.010991368442773819

Here O 0 0.003914492670446634
we O 0 0.0022790636867284775
describe O 0 0.02403251640498638
UBE3A O 1 0.9997318387031555
coding O 1 0.9992884397506714
- O 0 0.03393883630633354
region O 0 0.016634788364171982
mutations O 1 0.9999854564666748
detected O 1 0.928007185459137
by O 0 0.005260462872684002
SSCP O 1 0.9986798167228699
analysis O 0 0.017017697915434837
in O 0 0.0017909100279211998
13 O 0 0.005476027261465788
AS B-Disease 0 0.004236500710248947
individuals O 0 0.006221265997737646
or O 0 0.004718047101050615
families O 0 0.008862677030265331
. O 0 0.006890173070132732

Two O 0 0.006809223908931017
identical O 0 0.036101777106523514
de O 0 0.035143714398145676
novo O 1 0.9410734176635742
5 O 0 0.017840782180428505
- O 0 0.026924481615424156
bp O 0 0.12480969727039337
duplications O 1 0.9942269325256348
in O 0 0.005555158946663141
exon O 1 0.9954535961151123
16 O 0 0.0077793290838599205
were O 0 0.001301953918300569
found O 0 0.007636974565684795
. O 0 0.0057989624328911304

Among O 0 0.0035031770821660757
the O 0 0.001274413662031293
other O 0 0.0011344191152602434
11 O 0 0.005975963547825813
unique O 0 0.015338556841015816
mutations O 1 0.9999934434890747
, O 0 0.002005769871175289
8 O 0 0.004285598639398813
were O 0 0.0007467198884114623
small O 0 0.005201996769756079
deletions O 1 0.9986403584480286
or O 0 0.00867279153317213
insertions O 1 0.9981228709220886
predicted O 0 0.01602930575609207
to O 0 0.0029463558457791805
cause O 1 0.9951812624931335
frameshifts O 1 0.9975316524505615
, O 0 0.002192077925428748
1 O 0 0.005060466472059488
was O 0 0.002101332414895296
a O 0 0.009028227999806404
mutation O 1 0.9999386072158813
to O 0 0.0013002173509448767
a O 0 0.00445577222853899
stop O 0 0.016797615215182304
codon O 1 0.9929553866386414
, O 0 0.002165383892133832
1 O 0 0.0038833178114145994
was O 0 0.001639771624468267
a O 0 0.009064974263310432
missense O 1 0.9999828338623047
mutation O 1 0.9999953508377075
, O 0 0.0026406378019601107
and O 0 0.001143479603342712
1 O 0 0.004920642822980881
was O 0 0.0019147521816194057
predicted O 0 0.010091658681631088
to O 0 0.0018019283888861537
cause O 1 0.8644126653671265
insertion O 1 0.9947517514228821
of O 0 0.0011149643687531352
an O 0 0.0027036487590521574
isoleucine O 1 0.9987618923187256
in O 0 0.0017433505272492766
the O 0 0.001921456540003419
hect O 1 0.9794552326202393
domain O 0 0.019752338528633118
of O 0 0.0009363733697682619
the O 0 0.0038215420208871365
UBE3A O 1 0.9999620914459229
protein O 1 0.9996969699859619
, O 0 0.0015278552891686559
which O 0 0.0010209010215476155
functions O 0 0.006074734032154083
in O 0 0.002812872175127268
E2 O 1 0.9998201727867126
binding O 0 0.0437149852514267
and O 0 0.0023531278129667044
ubiquitin O 1 0.9982922673225403
transfer O 0 0.018024589866399765
. O 0 0.004871329292654991

Eight O 0 0.005277166608721018
of O 0 0.0008670288370922208
the O 0 0.0018968133954331279
cases O 0 0.01053199265152216
were O 0 0.002652716124430299
familial O 1 0.9999933242797852
, O 0 0.0019243748392909765
and O 0 0.0009589178371243179
five O 0 0.0020561530254781246
were O 0 0.0019464034121483564
sporadic O 0 0.23542606830596924
. O 0 0.007281973026692867

In O 0 0.004214059095829725
two O 0 0.007657535839825869
familial O 1 0.9999972581863403
cases O 0 0.012784769758582115
and O 0 0.00108197086956352
one O 0 0.0020953223574906588
sporadic O 0 0.4719729423522949
case O 0 0.007440874353051186
, O 0 0.003126705763861537
mosaicism O 1 0.9998630285263062
for O 0 0.008595000021159649
UBE3A O 1 0.9999829530715942
mutations O 1 0.9999887943267822
was O 0 0.004972817841917276
detected O 1 0.6177933812141418
in O 0 0.0013258781982585788
the O 0 0.001193324220366776
mother O 0 0.00816806498914957
of O 0 0.0008185550686903298
three O 0 0.0021799877285957336
AS B-Disease 0 0.005273778922855854
sons O 0 0.21575626730918884
, O 0 0.0010012624552473426
in O 0 0.0008104186272248626
the O 0 0.0018441200954839587
maternal O 1 0.9994276165962219
grandfather O 0 0.01990017294883728
of O 0 0.0008607025956735015
two O 0 0.0015607845271006227
AS B-Disease 0 0.002630622824653983
first O 0 0.0035439212806522846
cousins O 1 0.9622023701667786
, O 0 0.0014741233317181468
and O 0 0.0008454258204437792
in O 0 0.0009643706725910306
the O 0 0.0013670769985765219
mother O 0 0.009115545079112053
of O 0 0.0008338338229805231
an O 0 0.0021437539253383875
AS B-Disease 0 0.006642062682658434
daughter O 0 0.171993687748909
. O 0 0.008012251928448677

The O 0 0.0049248612485826015
frequencies O 0 0.027142642065882683
with O 0 0.0018734104232862592
which O 0 0.0012303335824981332
we O 0 0.001978892832994461
detected O 1 0.9967935681343079
mutations O 1 0.9999511241912842
were O 0 0.0019964268431067467
5 O 0 0.008225051686167717
( O 0 0.003468779381364584
14 O 0 0.005734777078032494
% O 0 0.0048396047204732895
) O 0 0.0017224251059815288
of O 0 0.0007665791199542582
35 O 0 0.005593900103121996
in O 0 0.0020242889877408743
sporadic O 1 0.9382746815681458
cases O 0 0.011114181019365788
and O 0 0.0015590088441967964
8 O 0 0.007567365188151598
( O 0 0.0029876232147216797
80 O 0 0.005715752020478249
% O 0 0.004761130083352327
) O 0 0.001729945419356227
of O 0 0.0006210248684510589
10 O 0 0.0035970755852758884
in O 0 0.004753465298563242
familial O 1 0.9999984502792358
cases O 0 0.022774910554289818
. O 0 0.0031999635975807905
. O 0 0.005472914781421423

The O 0 0.020622199401259422
hemochromatosis B-Disease 1 0.9999703168869019
845 O 1 0.9981308579444885
G O 1 0.9993991851806641
- O 0 0.16061580181121826
- O 0 0.04713937267661095
> O 1 0.9884359836578369
A O 0 0.010421189479529858
and O 0 0.0019349608337506652
187 O 0 0.1451633721590042
C O 1 0.9918255805969238
- O 0 0.06445558369159698
- O 0 0.12486375123262405
> O 1 0.9993870258331299
G O 1 0.9997732043266296
mutations O 1 0.999991774559021
: O 0 0.009896773844957352
prevalence O 1 0.999194324016571
in O 0 0.0022883715573698282
non O 0 0.013434447348117828
- O 0 0.06845933198928833
Caucasian O 1 0.9983087778091431
populations O 0 0.11146680265665054
. O 0 0.006850824225693941

Hemochromatosis B-Disease 1 0.9999598264694214
, O 0 0.004174456465989351
the O 0 0.004401443991810083
inherited B-Disease 1 0.9999833106994629
disorder I-Disease 1 0.9999921321868896
of I-Disease 0 0.002627769485116005
iron I-Disease 1 0.9831030368804932
metabolism I-Disease 1 0.9999817609786987
, O 0 0.002502258401364088
leads O 0 0.0860549733042717
, O 0 0.0019272518111392856
if O 0 0.006239715497940779
untreated O 1 0.9998496770858765
, O 0 0.0019682045094668865
to O 0 0.0024796496145427227
progressive O 1 0.7633068561553955
iron B-Disease 1 0.9535050988197327
overload I-Disease 1 0.9995294809341431
and O 0 0.006134012248367071
premature B-Disease 1 0.999025821685791
death I-Disease 0 0.03736192733049393
. O 0 0.008636380545794964

The O 0 0.020497895777225494
hemochromatosis B-Disease 1 0.9999983310699463
gene O 1 0.9999406337738037
, O 0 0.008890322409570217
HFE O 1 0.9999771118164062
, O 0 0.0031615998595952988
recently O 0 0.006446489132940769
has O 0 0.0012229656567797065
been O 0 0.0016638307133689523
identified O 0 0.009005931206047535
, O 0 0.0009339083917438984
and O 0 0.000950797984842211
characterization O 0 0.21076953411102295
of O 0 0.000676248746458441
this O 0 0.0023661083541810513
gene O 1 0.9999808073043823
has O 0 0.001711827120743692
shown O 0 0.003887488506734371
that O 0 0.0007451936835423112
it O 0 0.0007306735496968031
contains O 0 0.0038747284561395645
two O 0 0.0033743069507181644
mutations O 1 0.9999784231185913
that O 0 0.001563318190164864
result O 0 0.005835958756506443
in O 0 0.002193982247263193
amino O 1 0.9939858913421631
acid O 1 0.996382474899292
substitutions O 0 0.13481850922107697
- O 0 0.0334872305393219
cDNA O 1 0.9799805283546448
nucleotides O 1 0.9867588877677917
845 O 1 0.9938784241676331
G O 1 0.9981722831726074
- O 0 0.09196902811527252
- O 0 0.045301783829927444
> O 1 0.9936317801475525
A O 0 0.015815110877156258
( O 0 0.006138999480754137
C282Y O 1 0.9941790103912354
) O 0 0.0033052596263587475
and O 0 0.0015113537665456533
187 O 0 0.26133933663368225
C O 1 0.9970086216926575
- O 0 0.2243763655424118
- O 0 0.4269310534000397
> O 1 0.9995348453521729
G O 1 0.9990285634994507
( O 0 0.012236005626618862
H63D O 1 0.9987826943397522
) O 0 0.006715513300150633
. O 0 0.004914477933198214

Although O 0 0.027531586587429047
hemochromatosis B-Disease 1 0.9999799728393555
is O 0 0.0045983754098415375
common O 0 0.01077479962259531
in O 0 0.0024855483788996935
Caucasians O 1 0.9973113536834717
, O 0 0.004527227953076363
affecting O 1 0.9752434492111206
> O 1 0.9996728897094727
= O 1 0.6447027325630188
1 O 0 0.012924328446388245
/ O 0 0.04817097261548042
300 O 0 0.004957171622663736
individuals O 0 0.002848429838195443
of O 0 0.0006221661460585892
northern O 0 0.002498988527804613
European O 0 0.0036458014510571957
origin O 0 0.005613703280687332
, O 0 0.0008866226999089122
it O 0 0.0008190851658582687
has O 0 0.0010394160635769367
not O 0 0.0009713007602840662
been O 0 0.001222077989950776
recognized O 0 0.005231049377471209
in O 0 0.0012569292448461056
other O 0 0.0020084152929484844
populations O 0 0.04860232025384903
. O 0 0.006456468719989061

The O 0 0.003871565917506814
present O 0 0.0032707510981708765
study O 0 0.0066509065218269825
used O 0 0.007146431598812342
PCR O 1 0.9964345693588257
and O 0 0.0024359943345189095
restriction O 0 0.1175796166062355
- O 0 0.08984003961086273
enzyme O 1 0.9998852014541626
digestion O 1 0.9983471632003784
to O 0 0.002196452347561717
analyze O 0 0.01781129650771618
the O 0 0.0013259932165965438
frequency O 0 0.018248962238430977
of O 0 0.0008859956287778914
the O 0 0.003437611972913146
845 O 1 0.9995936751365662
G O 1 0.9998700618743896
- O 0 0.15071448683738708
- O 0 0.052201494574546814
> O 1 0.9952467083930969
A O 0 0.009404887445271015
and O 0 0.0022218322847038507
187 O 0 0.10373465716838837
C O 1 0.9928306937217712
- O 0 0.10764728486537933
- O 0 0.13651606440544128
> O 1 0.9991090893745422
G O 1 0.9992276430130005
mutations O 1 0.9999642372131348
in O 0 0.007344432175159454
HLA O 1 0.9999752044677734
- O 0 0.03458944335579872
typed O 0 0.2881819009780884
samples O 0 0.028494568541646004
from O 0 0.0029908374417573214
non O 0 0.015436969697475433
- O 0 0.04569969326257706
Caucasian O 1 0.9982191920280457
populations O 0 0.02572985552251339
, O 0 0.001506034517660737
comprising O 0 0.004805098287761211
Australian O 0 0.008242799900472164
Aboriginal O 0 0.024676257744431496
, O 0 0.0017471519531682134
Chinese O 0 0.003049039514735341
, O 0 0.001611838350072503
and O 0 0.0017445924459025264
Pacific O 0 0.023364311084151268
Islanders O 0 0.06398696452379227
. O 0 0.008955518715083599

Results O 0 0.02100873365998268
showed O 0 0.007305250037461519
that O 0 0.0014668075600638986
the O 0 0.00337403011508286
845 O 1 0.9989973902702332
G O 1 0.9998063445091248
- O 0 0.200330451130867
- O 0 0.0812753438949585
> O 1 0.998767614364624
A O 0 0.027701519429683685
mutation O 1 0.999975323677063
was O 0 0.0020331640262156725
present O 0 0.0018724503461271524
in O 0 0.0012310920283198357
these O 0 0.0019561380613595247
populations O 0 0.03412167727947235
( O 0 0.007901305332779884
allele O 1 0.9998886585235596
frequency O 0 0.10001665353775024
0 O 0 0.01816387102007866
. O 0 0.002188298385590315
32 O 0 0.009998607449233532
% O 0 0.007149974815547466
) O 0 0.0030198898166418076
, O 0 0.0010850747348740697
and O 0 0.0008741298806853592
, O 0 0.0016134805046021938
furthermore O 0 0.01782793551683426
, O 0 0.001254740171134472
it O 0 0.0010227701859548688
was O 0 0.0012125496286898851
always O 0 0.0018539937445893884
seen O 0 0.0030439686961472034
in O 0 0.001420560060068965
conjunction O 0 0.10922272503376007
with O 0 0.007769058458507061
HLA O 1 0.9999970197677612
haplotypes O 1 0.9999374151229858
common O 0 0.01819724589586258
in O 0 0.0023742872290313244
Caucasians O 1 0.9992988109588623
, O 0 0.0019112788140773773
suggesting O 0 0.016236472874879837
that O 0 0.003888027975335717
845 O 1 0.9991670846939087
G O 1 0.9999089241027832
- O 1 0.6185664534568787
- O 0 0.2416565716266632
> O 1 0.9989045858383179
A O 0 0.015309199690818787
may O 0 0.0038988206069916487
have O 0 0.0007484357920475304
been O 0 0.001174140372313559
introduced O 0 0.005260108970105648
into O 0 0.0027785194106400013
these O 0 0.0018544410122558475
populations O 0 0.022050945088267326
by O 0 0.007022752892225981
Caucasian O 1 0.9983653426170349
admixture O 1 0.9994603991508484
. O 0 0.00929692480713129

187 O 0 0.28285127878189087
C O 1 0.9922685027122498
- O 0 0.36049291491508484
- O 0 0.22279611229896545
> O 1 0.9984923601150513
G O 1 0.9869634509086609
was O 0 0.00241259066388011
present O 0 0.002280989196151495
at O 0 0.0021738135255873203
an O 0 0.0034176979679614305
allele O 1 0.9997469782829285
frequency O 0 0.038837820291519165
of O 0 0.0016107943374663591
2 O 0 0.009014586918056011
. O 0 0.0053170653991401196

68 O 0 0.0515553317964077
% O 0 0.006040889769792557
in O 0 0.001013349392451346
the O 0 0.001256032264791429
two O 0 0.0029167369939386845
populations O 0 0.03348447009921074
analyzed O 0 0.03155020624399185
( O 0 0.003522339975461364
Australian O 0 0.007676320616155863
Aboriginal O 0 0.017426500096917152
and O 0 0.001550756162032485
Chinese O 0 0.0043387096375226974
) O 0 0.00532175786793232
. O 0 0.004870772361755371

In O 0 0.002305293921381235
the O 0 0.0013328221393749118
Australian O 0 0.007517177611589432
Aboriginal O 0 0.019185397773981094
samples O 0 0.02731521986424923
, O 0 0.002821446629241109
187 O 0 0.39578574895858765
C O 1 0.998141884803772
- O 1 0.5601669549942017
- O 1 0.550822377204895
> O 1 0.9996918439865112
G O 1 0.9977477192878723
was O 0 0.002030599396675825
found O 0 0.003126144176349044
to O 0 0.0008644626941531897
be O 0 0.0012732307659462094
associated O 0 0.00817790161818266
with O 0 0.006983991712331772
HLA O 1 0.9999954700469971
haplotypes O 1 0.9999556541442871
common O 0 0.018282391130924225
in O 0 0.0029915242921561003
Caucasians O 1 0.9997298121452332
, O 0 0.0021283996757119894
suggesting O 0 0.014913718216121197
that O 0 0.0008638748549856246
it O 0 0.0008169731590896845
was O 0 0.0011981819989159703
introduced O 0 0.006756295450031757
by O 0 0.0026078347582370043
recent O 0 0.011157888919115067
admixture O 1 0.9996476173400879
. O 0 0.007637484930455685

In O 0 0.003177181351929903
the O 0 0.001151973265223205
Chinese O 0 0.0033145942725241184
samples O 0 0.023740040138363838
analyzed O 0 0.025724560022354126
, O 0 0.0033088636118918657
187 O 0 0.11045084148645401
C O 1 0.9948987364768982
- O 0 0.36829644441604614
- O 1 0.6291414499282837
> O 1 0.9996471405029297
G O 1 0.9957982897758484
was O 0 0.002378930104896426
present O 0 0.002044372959062457
in O 0 0.00115033402107656
association O 0 0.0037813307717442513
with O 0 0.0018689121352508664
a O 0 0.003832070389762521
wide O 0 0.005072508938610554
variety O 0 0.004571498371660709
of O 0 0.002859265310689807
HLA O 1 0.9999988079071045
haplotypes O 1 0.9999381303787231
, O 0 0.001842946163378656
showing O 0 0.006024432834237814
this O 0 0.002609740477055311
mutation O 1 0.9999855756759644
to O 0 0.0013016210868954659
be O 0 0.0010594497434794903
widespread O 0 0.009721821174025536
and O 0 0.001022043521516025
likely O 0 0.004507336299866438
to O 0 0.0016334669198840857
predate O 1 0.7568608522415161
the O 0 0.0014804797247052193
more O 0 0.0024710288271307945
genetically O 1 0.9886685013771057
restricted O 0 0.027525443583726883
845 O 1 0.9977768063545227
G O 1 0.9996800422668457
- O 0 0.1864084005355835
- O 0 0.060130923986434937
> O 1 0.995657205581665
A O 0 0.03280511498451233
mutation O 1 0.9998835325241089
. O 0 0.008905288763344288

Genotype O 1 0.9997708201408386
- O 0 0.49243631958961487
phenotype O 1 0.9999173879623413
correlations O 1 0.9843961000442505
in O 0 0.012246008962392807
attenuated B-Disease 1 0.9999759197235107
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999986886978149
coli I-Disease 1 0.9999712705612183
. O 0 0.019857995212078094

Germ O 1 0.9991816878318787
- O 0 0.03378760814666748
line O 0 0.018105706200003624
mutations O 1 0.9997519850730896
of O 0 0.002348437439650297
the O 0 0.006893302779644728
tumor B-Disease 1 0.9999992847442627
suppressor O 1 0.9999829530715942
APC O 1 0.9985779523849487
are O 0 0.0026521156542003155
implicated O 1 0.8105646967887878
in O 0 0.008201117627322674
attenuated B-Disease 1 0.9999949932098389
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999973773956299
( O 0 0.02506522461771965
AAPC B-Disease 1 0.9998979568481445
) O 0 0.0054641468450427055
, O 0 0.001183643820695579
a O 0 0.00706898421049118
variant O 1 0.999160647392273
of O 0 0.009930106811225414
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999994039535522
( O 0 0.0343921035528183
FAP B-Disease 1 0.9999510049819946
) O 0 0.009251752868294716
. O 0 0.006679631769657135

AAPC B-Disease 1 0.9986758828163147
is O 0 0.005777566693723202
recognized O 0 0.005967463832348585
by O 0 0.0016539280768483877
the O 0 0.0015102726174518466
occurrence O 0 0.08698610216379166
of O 0 0.002155495807528496
< O 1 0.9973490238189697
100 O 0 0.012265600264072418
colonic B-Disease 1 0.9999865293502808
adenomas I-Disease 1 0.9999724626541138
and O 0 0.0015051313675940037
a O 0 0.004972721450030804
later O 0 0.0068182568065822124
onset O 1 0.9999285936355591
of O 0 0.021736541762948036
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.007786760106682777
age O 0 0.014926291070878506
> O 1 0.99852055311203
40 O 0 0.008582919836044312
years O 0 0.0035813930444419384
) O 0 0.005080477800220251
. O 0 0.005577034316956997

The O 0 0.003367078024893999
aim O 0 0.011527389287948608
of O 0 0.0008075586520135403
this O 0 0.001001511001959443
study O 0 0.004889069590717554
was O 0 0.0014281288022175431
to O 0 0.002039741026237607
assess O 0 0.1643272489309311
genotype O 1 0.9999785423278809
- O 1 0.8252078890800476
phenotype O 1 0.9999887943267822
correlations O 1 0.9918752312660217
in O 0 0.006558666937053204
AAPC B-Disease 1 0.9997151494026184
families O 0 0.016274331137537956
. O 0 0.007980240508913994

By O 0 0.01608610525727272
protein O 1 0.9974750876426697
- O 0 0.04147576540708542
truncation O 1 0.9954620003700256
test O 0 0.031296566128730774
( O 0 0.006904782727360725
PTT O 1 0.9688008427619934
) O 0 0.0063437591306865215
assay O 1 0.9867621064186096
, O 0 0.001038325484842062
the O 0 0.0009094882989302278
entire O 0 0.00930057093501091
coding O 1 0.9989470839500427
region O 0 0.0024857386015355587
of O 0 0.0006091766408644617
the O 0 0.0029826743993908167
APC B-Disease 1 0.9999896287918091
gene O 1 0.9999479055404663
was O 0 0.004074686206877232
screened O 0 0.024669623002409935
in O 0 0.002097482094541192
affected O 0 0.01604858599603176
individuals O 0 0.004938750993460417
from O 0 0.0033631757833063602
11 O 0 0.021077638491988182
AAPC B-Disease 1 0.9999680519104004
kindreds O 1 0.9996203184127808
, O 0 0.0020082786213606596
and O 0 0.0007771030650474131
their O 0 0.0020421163644641638
phenotypic O 1 0.9983888864517212
differences O 0 0.011258878745138645
were O 0 0.0014167878543958068
examined O 0 0.04054805636405945
. O 0 0.006492033135145903

Five O 0 0.011141439899802208
novel O 0 0.04043439030647278
germ O 1 0.9993932247161865
- O 0 0.030604444444179535
line O 0 0.023082664236426353
APC B-Disease 1 0.9999146461486816
mutations O 1 0.9999121427536011
were O 0 0.0017050080932676792
identified O 0 0.008052129298448563
in O 0 0.001609139610081911
seven O 0 0.00760517455637455
kindreds O 1 0.9982557892799377
. O 0 0.009452678263187408

Mutations O 1 0.9998175501823425
were O 0 0.001617359695956111
located O 0 0.0025189584121108055
in O 0 0.0010434212163090706
three O 0 0.001355105428956449
different O 0 0.001582867931574583
regions O 0 0.0031377130653709173
of O 0 0.0007763787871226668
the O 0 0.0037913869600743055
APC B-Disease 1 0.9999953508377075
gene O 1 0.99998939037323
( O 0 0.005446822848170996
1 O 0 0.007259205915033817
) O 0 0.002408328466117382
at O 0 0.0012546948855742812
the O 0 0.0010519139468669891
5 O 0 0.005017920397222042
end O 0 0.004296367987990379
spanning O 0 0.028994668275117874
exons O 1 0.9989736080169678
4 O 0 0.008661508560180664
and O 0 0.001539859571494162
5 O 0 0.00659980857744813
, O 0 0.0017472858307883143
( O 0 0.0037675537168979645
2 O 0 0.006480405572801828
) O 0 0.0021877519320696592
within O 0 0.0035034334287047386
exon O 1 0.9995434880256653
9 O 0 0.009861028753221035
, O 0 0.001524854451417923
and O 0 0.0012662657536566257
( O 0 0.003925041761249304
3 O 0 0.008193425834178925
) O 0 0.0021050190553069115
at O 0 0.0012238952331244946
the O 0 0.0015109269879758358
3 O 0 0.01249715406447649
distal O 1 0.9998136162757874
end O 0 0.0036005412694066763
of O 0 0.0009120195172727108
the O 0 0.0037779412232339382
gene O 1 0.9998524188995361
. O 0 0.00893409550189972

Variability O 1 0.8971402645111084
in O 0 0.0014140608254820108
the O 0 0.000936087453737855
number O 0 0.001989024458453059
of O 0 0.0061951796524226665
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999961853027344
was O 0 0.003724651876837015
most O 0 0.0018428810872137547
apparent O 0 0.10058559477329254
in O 0 0.0013664672151207924
individuals O 0 0.0041259960271418095
with O 0 0.004549127537757158
mutations O 1 0.9999971389770508
in O 0 0.0015920721925795078
region O 0 0.004001845605671406
1 O 0 0.004785912577062845
, O 0 0.0011619317810982466
and O 0 0.0016954680904746056
upper O 1 0.9709835052490234
- O 1 0.9944255352020264
gastrointestinal O 1 0.9999994039535522
manifestations O 1 0.8864433169364929
were O 0 0.0014529528561979532
more O 0 0.0025655936915427446
severe O 1 0.9967644214630127
in O 0 0.0016970071010291576
them O 0 0.0019446708029136062
. O 0 0.005826176144182682

In O 0 0.0039713699370622635
individuals O 0 0.00601011561229825
with O 0 0.0055888015776872635
mutations O 1 0.99998939037323
in O 0 0.001729196053929627
either O 0 0.005028568673878908
region O 0 0.0037145516835153103
2 O 0 0.005920187570154667
or O 0 0.0031641165260225534
region O 0 0.0036602255422621965
3 O 0 0.005165125709027052
, O 0 0.0007357568247243762
the O 0 0.0009013733360916376
average O 0 0.003387248609215021
number O 0 0.001542542828246951
of O 0 0.0025970367714762688
adenomas B-Disease 1 0.9999762773513794
tended O 0 0.015200166963040829
to O 0 0.0011717090383172035
be O 0 0.0010435286676511168
lower O 0 0.004467196762561798
than O 0 0.0009563991334289312
those O 0 0.0008281123009510338
in O 0 0.0009611853747628629
individuals O 0 0.004189960192888975
with O 0 0.005412007682025433
mutations O 1 0.9999967813491821
in O 0 0.002652326598763466
region O 0 0.0045910971239209175
1 O 0 0.005289616994559765
, O 0 0.0012575184227898717
although O 0 0.0025874353013932705
age O 0 0.006438401993364096
at O 0 0.007252868730574846
diagnosis O 1 0.9999784231185913
was O 0 0.00337696704082191
similar O 0 0.011546861380338669
. O 0 0.005672191269695759

In O 0 0.005828598979860544
all O 0 0.0051260581240057945
AAPC B-Disease 1 0.9997943043708801
kindreds O 1 0.9954042434692383
, O 0 0.0030235571321099997
a O 0 0.0052591231651604176
predominance O 1 0.84755939245224
of O 0 0.001756784738972783
right O 0 0.016512032598257065
- O 1 0.8183961510658264
sided O 1 0.9997807145118713
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999946355819702
and O 0 0.01999443769454956
rectal B-Disease 1 0.9999988079071045
polyp I-Disease 1 0.9999879598617554
sparing O 1 0.9843355417251587
was O 0 0.0065948935225605965
observed O 0 0.017130693420767784
. O 0 0.006584442686289549

No O 0 0.017779290676116943
desmoid B-Disease 1 0.9993448853492737
tumors I-Disease 1 0.9999878406524658
were O 0 0.001628640340641141
found O 0 0.004523239564150572
in O 0 0.001441198168322444
these O 0 0.003067225916311145
kindreds O 1 0.9990763664245605
. O 0 0.008124709129333496

Our O 0 0.005674432031810284
data O 0 0.006595624145120382
suggest O 0 0.007795640267431736
that O 0 0.0011005002306774259
, O 0 0.001232756651006639
in O 0 0.003604392521083355
AAPC B-Disease 1 0.9999781847000122
families O 0 0.006519604939967394
, O 0 0.0007255763048306108
the O 0 0.0007092187297530472
location O 0 0.002235645893961191
of O 0 0.0007267395267263055
the O 0 0.004055085591971874
APC B-Disease 1 0.9999938011169434
mutation O 1 0.999997615814209
may O 0 0.008227420970797539
partially O 0 0.033464863896369934
predict O 0 0.024292802438139915
specific O 0 0.010069874115288258
phenotypic O 1 0.9952712655067444
expression O 0 0.06079436466097832
. O 0 0.006960581056773663

This O 0 0.003876199247315526
should O 0 0.002088753506541252
help O 0 0.004419472999870777
in O 0 0.0008095799712464213
the O 0 0.0008235552231781185
design O 0 0.0056492057628929615
of O 0 0.001784590887837112
tailored O 1 0.9986458420753479
clinical O 1 0.999983549118042
- O 0 0.0634835809469223
management O 0 0.03256858140230179
protocols O 0 0.17449167370796204
in O 0 0.0010001532500609756
this O 0 0.0013879203470423818
subset O 1 0.9238357543945312
of O 0 0.005399402230978012
FAP B-Disease 1 0.9999980926513672
patients O 1 0.999893307685852
. O 0 0.003714766586199403
. O 0 0.006168012972921133

Wilms B-Disease 1 0.9998317956924438
' I-Disease 0 0.18585237860679626
tumor I-Disease 1 0.9999591112136841
1 O 0 0.01133141852915287
and O 0 0.0026968109887093306
Dax O 1 0.9451701045036316
- O 0 0.020225737243890762
1 O 0 0.011189606972038746
modulate O 1 0.9920138716697693
the O 0 0.004459439776837826
orphan O 1 0.9958529472351074
nuclear O 0 0.04480494558811188
receptor O 1 0.9997590184211731
SF O 1 0.9992855191230774
- O 0 0.0249329824000597
1 O 0 0.00635289354249835
in O 0 0.0021007005125284195
sex O 0 0.04562247171998024
- O 0 0.018090745434165
specific O 0 0.014461057260632515
gene O 1 0.9999163150787354
expression O 0 0.05504230409860611
. O 0 0.006415612529963255

Products O 0 0.018417609855532646
of O 0 0.003544008359313011
steroidogenic O 1 0.9997698664665222
factor O 0 0.14596565067768097
1 O 0 0.012002305127680302
( O 0 0.008900566957890987
SF O 1 0.9995372295379639
- O 0 0.025608785450458527
1 O 0 0.008214578963816166
) O 0 0.004309291485697031
and O 0 0.004538075532764196
Wilms B-Disease 1 0.9999986886978149
tumor I-Disease 1 0.9999973773956299
1 O 0 0.013058745302259922
( O 0 0.010086366906762123
WT1 O 1 0.9999730587005615
) O 0 0.00817178562283516
genes O 1 0.9982380867004395
are O 0 0.001008475199341774
essential O 0 0.006340008694678545
for O 0 0.002408016938716173
mammalian O 1 0.9998844861984253
gonadogenesis O 1 0.9876262545585632
prior O 0 0.005807623267173767
to O 0 0.002239072462543845
sexual O 0 0.0423562228679657
differentiation O 1 0.9993875026702881
. O 0 0.007059211377054453

In O 0 0.009289948269724846
males O 0 0.050259850919246674
, O 0 0.006117641925811768
SF O 1 0.9996402263641357
- O 0 0.026334969326853752
1 O 0 0.008386392146348953
participates O 0 0.05304451286792755
in O 0 0.002035134704783559
sexual O 0 0.014136328361928463
development O 0 0.004956016782671213
by O 0 0.002886395202949643
regulating O 0 0.12305156141519547
expression O 0 0.02220389060676098
of O 0 0.0010422712657600641
the O 0 0.004231771919876337
polypeptide O 1 0.9998117089271545
hormone O 1 0.9998303651809692
Mullerian O 1 0.9999362230300903
inhibiting O 1 0.9998161196708679
substance O 1 0.9893990755081177
( O 0 0.013863320462405682
MIS O 1 0.9998225569725037
) O 0 0.00816372036933899
. O 0 0.0052111498080194

Here O 0 0.004594502970576286
, O 0 0.001394057646393776
we O 0 0.0008057054365053773
show O 0 0.003294928465038538
that O 0 0.005276195704936981
WT1 O 1 0.9999704360961914
- O 0 0.36707812547683716
KTS O 1 0.9993038177490234
isoforms O 1 0.9882146120071411
associate O 0 0.02172181010246277
and O 0 0.0033754922915250063
synergize O 1 0.9993194341659546
with O 0 0.010537728667259216
SF O 1 0.9997970461845398
- O 0 0.024258609861135483
1 O 0 0.006123166996985674
to O 0 0.0024434251245111227
promote O 0 0.018771620467305183
MIS O 1 0.9996383190155029
expression O 0 0.06281028687953949
. O 0 0.007656282279640436

In O 0 0.005968869663774967
contrast O 0 0.017769502475857735
, O 0 0.008531736209988594
WT1 O 1 0.9999469518661499
missense O 1 0.9999663829803467
mutations O 1 0.9999688863754272
, O 0 0.0028660111129283905
associated O 0 0.008178815245628357
with O 0 0.002538082655519247
male B-Disease 0 0.2552720308303833
pseudohermaphroditism I-Disease 1 0.998664379119873
in O 0 0.006686438340693712
Denys B-Disease 1 0.9999430179595947
- I-Disease 1 0.9886065125465393
Drash I-Disease 1 0.9999338388442993
syndrome I-Disease 1 0.9999990463256836
, O 0 0.003847988788038492
fail O 0 0.03360302001237869
to O 0 0.0034571753349155188
synergize O 1 0.9995928406715393
with O 0 0.011707770638167858
SF O 1 0.9995738863945007
- O 0 0.03512375429272652
1 O 0 0.014828632585704327
. O 0 0.006911728531122208

Additionally O 0 0.02393520623445511
, O 0 0.002531563863158226
the O 0 0.0031616194173693657
X O 1 0.9944165945053101
- O 0 0.04380881041288376
linked O 0 0.11538557708263397
, O 0 0.002360752085223794
candidate O 0 0.017245175316929817
dosage O 1 0.9991363883018494
- O 0 0.023465748876333237
sensitive O 0 0.02050398662686348
sex O 0 0.08189515024423599
- O 0 0.03625364229083061
reversal O 1 0.9931278228759766
gene O 1 0.9998981952667236
, O 0 0.005075992085039616
Dax O 1 0.9936783909797668
- O 0 0.02445807494223118
1 O 0 0.00902603566646576
, O 0 0.0034703456331044436
antagonizes O 1 0.9978959560394287
synergy O 1 0.9937707781791687
between O 0 0.011763360351324081
SF O 1 0.9997836947441101
- O 0 0.025311915203928947
1 O 0 0.00890291016548872
and O 0 0.0040393914096057415
WT1 O 1 0.999980092048645
, O 0 0.002227683551609516
most O 0 0.0010271016508340836
likely O 0 0.004349865484982729
through O 0 0.002733469009399414
a O 0 0.0039377110078930855
direct O 0 0.010816652327775955
interaction O 0 0.061386588960886
with O 0 0.008164693601429462
SF O 1 0.9996497631072998
- O 0 0.0353398472070694
1 O 0 0.013562111184000969
. O 0 0.006832060869783163

We O 0 0.004708870314061642
propose O 0 0.025446057319641113
that O 0 0.004778627306222916
WT1 O 1 0.999848484992981
and O 0 0.004587474744766951
Dax O 1 0.9905171990394592
- O 0 0.02568032778799534
1 O 0 0.011879348196089268
functionally O 1 0.9752377271652222
oppose O 0 0.008793635293841362
each O 0 0.0013872372219339013
other O 0 0.0007310147630050778
in O 0 0.002232599537819624
testis O 1 0.9999057054519653
development O 0 0.0077004628255963326
by O 0 0.0056573860347270966
modulating O 1 0.9999241828918457
SF O 1 0.9995859265327454
- O 0 0.04923436418175697
1 O 0 0.0210428386926651
- O 0 0.05193672329187393
mediated O 1 0.9953548908233643
transactivation O 1 0.9983748197555542
. O 0 0.004706037696450949
. O 0 0.005081264302134514

A O 0 0.036190856248140335
mouse O 1 0.9833975434303284
model O 0 0.027700040489435196
for O 0 0.012340678833425045
Prader B-Disease 1 0.9999799728393555
- I-Disease 1 0.9952965378761292
Willi I-Disease 1 0.9999927282333374
syndrome I-Disease 1 0.9999994039535522
imprinting O 1 0.9999346733093262
- O 0 0.05916391685605049
centre O 0 0.03573215752840042
mutations O 1 0.9999616146087646
. O 0 0.01198536530137062

Imprinting O 1 0.9957349300384521
in O 0 0.0033135844860225916
the O 0 0.0036069483030587435
15q11 O 1 0.9969215989112854
- O 0 0.04287419840693474
q13 O 1 0.9740477204322815
region O 0 0.007154339924454689
involves O 0 0.021664416417479515
an O 0 0.003821922931820154
imprinting O 1 0.9998390674591064
centre O 0 0.019830865785479546
( O 0 0.007957701571285725
IC O 1 0.9996321201324463
) O 0 0.0042869336903095245
, O 0 0.001350714243017137
mapping O 0 0.03305589407682419
in O 0 0.0009470309596508741
part O 0 0.0017552090575918555
to O 0 0.0009455496910959482
the O 0 0.0017972949426621199
promoter O 1 0.9604253768920898
and O 0 0.001072264974936843
first O 0 0.0037053143605589867
exon O 1 0.9985981583595276
of O 0 0.0035364117939025164
SNRPN O 1 0.9981169700622559
. O 0 0.008519957773387432

Deletion O 1 0.9810051321983337
of O 0 0.0025541731156408787
this O 0 0.003484507091343403
IC O 1 0.9942289590835571
abolishes O 1 0.9579388499259949
local O 0 0.009828008711338043
paternally O 1 0.995974600315094
derived O 0 0.07994171977043152
gene O 1 0.9995644688606262
expression O 0 0.024109438061714172
and O 0 0.0012122701155021787
results O 0 0.012336947955191135
in O 0 0.006815919186919928
Prader B-Disease 1 0.999998927116394
- I-Disease 1 0.9991450309753418
Willi I-Disease 1 0.9999982118606567
syndrome I-Disease 1 0.9999998807907104
( O 0 0.025112880393862724
PWS B-Disease 1 0.9999734163284302
) O 0 0.010147342458367348
. O 0 0.006113030947744846

We O 0 0.0028121445793658495
have O 0 0.0010874152649194002
created O 0 0.004869021009653807
two O 0 0.005166845861822367
deletion O 1 0.9999485015869141
mutations O 1 0.9999821186065674
in O 0 0.004670042544603348
mice O 1 0.9998247027397156
to O 0 0.002683043945580721
understand O 0 0.016979601234197617
PWS B-Disease 1 0.9999444484710693
and O 0 0.0014776826137676835
the O 0 0.0017250410746783018
mechanism O 0 0.11097792536020279
of O 0 0.0011188575299456716
this O 0 0.002845488488674164
IC O 1 0.9967235922813416
. O 0 0.009445883333683014

Mice O 1 0.9989619255065918
harbouring O 1 0.7027188539505005
an O 0 0.008282474242150784
intragenic O 1 0.9903590083122253
deletion O 1 0.9975528120994568
in O 0 0.005530114285647869
Snrpn O 1 0.9913057684898376
are O 0 0.0027742565143853426
phenotypically O 1 0.9993237257003784
normal O 0 0.026779206469655037
, O 0 0.0016391603276133537
suggesting O 0 0.013948999345302582
that O 0 0.002311456948518753
mutations O 1 0.9999821186065674
of O 0 0.0022656810469925404
SNRPN O 1 0.9990967512130737
are O 0 0.0010107307462021708
not O 0 0.0009060527663677931
sufficient O 0 0.006824904587119818
to O 0 0.004406858701258898
induce O 1 0.9996139407157898
PWS B-Disease 1 0.9998713731765747
. O 0 0.012369261123239994

Mice O 1 0.9972699284553528
with O 0 0.004729574080556631
a O 0 0.005257285200059414
larger O 0 0.014963986352086067
deletion O 1 0.9996108412742615
involving O 0 0.019908079877495766
both O 0 0.002791154896840453
Snrpn O 1 0.9808093309402466
and O 0 0.001176488003693521
the O 0 0.0031955877784639597
putative O 1 0.9999226331710815
PWS O 1 0.9999908208847046
- O 0 0.11229527741670609
IC O 1 0.9955360889434814
lack O 0 0.01438942737877369
expression O 0 0.015921281650662422
of O 0 0.0008249965030699968
the O 0 0.002772287465631962
imprinted O 1 0.999718964099884
genes O 1 0.9998520612716675
Zfp127 O 1 0.998043417930603
( O 0 0.007693549618124962
mouse O 1 0.9991176724433899
homologue O 1 0.9984809756278992
of O 0 0.004734393209218979
ZNF127 O 1 0.9994820952415466
) O 0 0.0047126710414886475
, O 0 0.0027738253120332956
Ndn O 1 0.9998366832733154
and O 0 0.002982968930155039
Ipw O 1 0.9993581175804138
, O 0 0.002083652885630727
and O 0 0.0011630578665062785
manifest O 0 0.04790507256984711
several O 0 0.004674444440752268
phenotypes O 1 0.99988853931427
common O 0 0.015491907484829426
to O 0 0.005851053632795811
PWS B-Disease 1 0.9999767541885376
infants O 1 0.9994433522224426
. O 0 0.008943693712353706

These O 0 0.0027380746323615313
data O 0 0.004349731374531984
demonstrate O 0 0.005588376894593239
that O 0 0.0008076283265836537
both O 0 0.0009829767514020205
the O 0 0.0009229070856235921
position O 0 0.0019046764355152845
of O 0 0.0006938205915503204
the O 0 0.0022706319577991962
IC O 1 0.9993041753768921
and O 0 0.0013695040252059698
its O 0 0.001494100084528327
role O 0 0.004732715431600809
in O 0 0.0007781804888509214
the O 0 0.0011576843680813909
coordinate O 0 0.028282329440116882
expression O 0 0.02017214335501194
of O 0 0.0013647556770592928
genes O 1 0.9995357990264893
is O 0 0.0024438665714114904
conserved O 1 0.9507231712341309
between O 0 0.004663743078708649
mouse O 1 0.9998107552528381
and O 0 0.0015190953854471445
human O 0 0.008994213305413723
, O 0 0.0010016594314947724
and O 0 0.0007689243066124618
indicate O 0 0.0069439304061234
that O 0 0.0008448661537840962
the O 0 0.0016502857906743884
mouse O 1 0.9998495578765869
is O 0 0.0018890316132456064
a O 0 0.003883613273501396
suitable O 0 0.01496940664947033
model O 0 0.011730649508535862
system O 0 0.009395110420882702
in O 0 0.0008294519502669573
which O 0 0.0007316633709706366
to O 0 0.0008490627515129745
investigate O 0 0.006264722440391779
the O 0 0.0018800185061991215
molecular O 1 0.9989994168281555
mechanisms O 0 0.2864069938659668
of O 0 0.0021150957327336073
imprinting O 1 0.9999626874923706
in O 0 0.0015585101209580898
this O 0 0.001008506864309311
region O 0 0.0020541599951684475
of O 0 0.0007668033940717578
the O 0 0.0029851198196411133
genome O 1 0.9998107552528381
. O 0 0.0037095604930073023
. O 0 0.0052487486973404884

Mutations O 1 0.9987180233001709
of O 0 0.0017166759353131056
the O 0 0.0033464194275438786
ATM O 1 0.9991459846496582
gene O 1 0.9998569488525391
detected O 1 0.5087915062904358
in O 0 0.00248351669870317
Japanese O 0 0.07693790644407272
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9993414282798767
telangiectasia I-Disease 1 0.9999992847442627
patients O 1 0.9998724460601807
: O 0 0.0036881067790091038
possible O 0 0.0070937746204435825
preponderance O 1 0.7187041640281677
of O 0 0.0008639406296424568
the O 0 0.0012618033215403557
two O 0 0.003724857233464718
founder O 1 0.5798807144165039
mutations O 1 0.999976396560669
4612del165 O 1 0.9938341379165649
and O 0 0.004335526376962662
7883del5 O 1 0.9879570603370667
. O 0 0.009328722953796387

The O 0 0.010226435028016567
ATM O 1 0.9783263206481934
( O 0 0.010094191879034042
A O 0 0.14950083196163177
- O 1 0.5415096879005432
T O 1 0.9998173117637634
, O 0 0.006883992347866297
mutated O 1 0.9999405145645142
) O 0 0.010979453101754189
gene O 1 0.9993578791618347
on O 0 0.003542239312082529
human O 0 0.026083508506417274
chromosome O 1 0.99997878074646
11q22 O 1 0.9823779463768005
. O 0 0.009138867259025574

3 O 0 0.014544024132192135
has O 0 0.002367801498621702
recently O 0 0.005321825388818979
been O 0 0.0016293908702209592
identified O 0 0.007000894285738468
as O 0 0.000966376275755465
the O 0 0.0019167617429047823
gene O 1 0.9999740123748779
responsible O 0 0.006989598739892244
for O 0 0.000987492618151009
the O 0 0.002238448243588209
human O 1 0.9822248816490173
recessive B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9945317506790161
telangiectasia I-Disease 1 0.9999927282333374
( O 0 0.011148571036756039
A B-Disease 1 0.7442198395729065
- I-Disease 1 0.9368723630905151
T I-Disease 1 0.9998891353607178
) O 0 0.008453480899333954
. O 0 0.005918610841035843

In O 0 0.003555755130946636
order O 0 0.0030608023516833782
to O 0 0.0011304181534796953
define O 0 0.007268556393682957
the O 0 0.0014819552889093757
types O 0 0.015682613477110863
of O 0 0.004825586918741465
disease O 1 0.9999991655349731
- O 0 0.2087692767381668
causing O 1 0.9943612813949585
ATM O 1 0.9992650151252747
mutations O 1 0.9998972415924072
in O 0 0.0021003985311836004
Japanese O 0 0.007733854465186596
A B-Disease 1 0.900561511516571
- I-Disease 1 0.9966075420379639
T I-Disease 1 0.9999953508377075
patients O 1 0.9996856451034546
as O 0 0.0016966776456683874
well O 0 0.0010337736457586288
as O 0 0.0008182703168131411
to O 0 0.0009975110879167914
look O 0 0.004552283324301243
for O 0 0.0017755191074684262
possible O 0 0.013483446091413498
mutational O 1 0.9999055862426758
hotspots O 1 0.9744315147399902
, O 0 0.004017201252281666
reverse O 1 0.833842396736145
- O 0 0.0326634906232357
transcribed O 1 0.9862998127937317
RNA O 1 0.9992814660072327
derived O 0 0.020257774740457535
from O 0 0.0019468098180368543
ten O 0 0.006125184707343578
patients O 1 0.9989370703697205
belonging O 0 0.010888772085309029
to O 0 0.0010078821796923876
eight O 0 0.003518005134537816
unrelated O 0 0.26963353157043457
Japanese O 0 0.010749796405434608
A B-Disease 0 0.4428270161151886
- I-Disease 1 0.8216893076896667
T I-Disease 1 0.9998074173927307
families O 0 0.006298422813415527
was O 0 0.0022311934735625982
analyzed O 0 0.02280842512845993
for O 0 0.003481911728158593
mutations O 1 0.9999386072158813
by O 0 0.002055268967524171
the O 0 0.0020783047657459974
restriction O 0 0.1489572376012802
endonuclease O 1 0.9991029500961304
fingerprinting O 1 0.7357503771781921
method O 0 0.03100101836025715
. O 0 0.007235955446958542

As O 0 0.004262835253030062
has O 0 0.002031597075983882
been O 0 0.002087473403662443
reported O 0 0.006786492187529802
by O 0 0.0022433942649513483
others O 0 0.004189017228782177
, O 0 0.0032272650860249996
mutations O 1 0.9999817609786987
that O 0 0.0018358913948759437
lead O 0 0.01119620818644762
to O 0 0.0027169305831193924
exon O 1 0.9980511665344238
skipping O 1 0.8128846883773804
or O 0 0.011723741888999939
premature O 1 0.9992830157279968
protein O 1 0.9993628859519958
truncation O 1 0.9924299120903015
were O 0 0.0012834630906581879
also O 0 0.0015457834815606475
predominant O 0 0.02659059688448906
in O 0 0.0019331650109961629
our O 0 0.005361167248338461
mutants O 1 0.9888461232185364
. O 0 0.008739938028156757

Six O 0 0.009098147973418236
different O 0 0.00566169572994113
mutations O 1 0.9999816417694092
were O 0 0.0014181857695803046
identified O 0 0.007602188736200333
on O 0 0.0009557487792335451
12 O 0 0.002673771232366562
of O 0 0.0006844729068689048
the O 0 0.0016782087041065097
16 O 0 0.01616159826517105
alleles O 1 0.999911904335022
examined O 0 0.061055056750774384
. O 0 0.00600191717967391

Four O 0 0.005684559233486652
were O 0 0.0022345157340168953
deletions O 1 0.9962144494056702
involving O 0 0.021899878978729248
a O 0 0.0065864394418895245
loss O 0 0.016515515744686127
of O 0 0.0009618756594136357
a O 0 0.004865920636802912
single O 0 0.01984061859548092
exon O 1 0.9989330172538757
exon O 1 0.9987242817878723
7 O 0 0.014069419354200363
, O 0 0.00387777341529727
exon O 1 0.9974104762077332
16 O 0 0.009007016196846962
, O 0 0.003452117322012782
exon O 1 0.997000515460968
33 O 0 0.023062290623784065
or O 0 0.010813898406922817
exon O 1 0.996353030204773
35 O 0 0.019341766834259033
. O 0 0.006769170518964529

The O 0 0.0035065212287008762
others O 0 0.0034165028482675552
were O 0 0.0012517821742221713
minute O 0 0.016343824565410614
deletions O 1 0.997427761554718
, O 0 0.004147399216890335
4649delA O 1 0.985675036907196
in O 0 0.004480869974941015
exon O 1 0.9982749223709106
33 O 0 0.017811963334679604
and O 0 0.0024706830736249685
7883del5 O 1 0.9846577048301697
in O 0 0.005217531695961952
exon O 1 0.9958898425102234
55 O 0 0.028935804963111877
. O 0 0.007590634748339653

The O 0 0.012364321388304234
mutations O 1 0.99997878074646
4612del165 O 1 0.9927708506584167
and O 0 0.003047559643164277
7883del5 O 1 0.9869804978370667
were O 0 0.0010296705877408385
found O 0 0.003945504315197468
in O 0 0.0009548535454086959
more O 0 0.0008229449158534408
than O 0 0.0012175192823633552
two O 0 0.0026352033019065857
unrelated O 1 0.9429240822792053
families O 0 0.008076594211161137
; O 0 0.0038912964519113302
44 O 0 0.010922971181571484
% O 0 0.0071084327064454556
( O 0 0.0032711767125874758
7 O 0 0.005116893909871578
of O 0 0.0008873363840393722
16 O 0 0.005201895721256733
) O 0 0.0015483277384191751
of O 0 0.0005298180039972067
the O 0 0.0018820336554199457
mutant O 1 0.9999271631240845
alleles O 1 0.9999139308929443
had O 0 0.0025843509938567877
one O 0 0.0009177675819955766
of O 0 0.00047858842299319804
the O 0 0.0012276293709874153
two O 0 0.005246912129223347
mutations O 1 0.9999856948852539
. O 0 0.00739272590726614

The O 0 0.010021033696830273
4612del165 O 1 0.9985477328300476
mutations O 1 0.9999384880065918
in O 0 0.002263697562739253
three O 0 0.0016752738738432527
different O 0 0.0020099757239222527
families O 0 0.0028523807413876057
were O 0 0.000627027009613812
all O 0 0.0007421793416142464
ascribed O 0 0.0269769374281168
to O 0 0.0008661353494971991
the O 0 0.0015110514359548688
same O 0 0.008369848132133484
T O 1 0.9999659061431885
- O 0 0.18353970348834991
- O 0 0.04841439053416252
> O 1 0.9919400811195374
A O 0 0.012667383067309856
substitution O 0 0.06188304349780083
at O 0 0.002521475777029991
the O 0 0.002976858988404274
splice O 1 0.9996720552444458
donor O 1 0.8532285690307617
site O 0 0.007966316305100918
in O 0 0.004835950210690498
intron O 1 0.9998607635498047
33 O 0 0.030058253556489944
. O 0 0.007012698799371719

Microsatellite O 1 0.9959802627563477
genotyping O 1 0.9891576766967773
around O 0 0.00433834083378315
the O 0 0.0030357246287167072
ATM O 1 0.9971991777420044
locus O 1 0.9988749623298645
also O 0 0.002656361786648631
indicated O 0 0.007083337288349867
that O 0 0.0009739389643073082
a O 0 0.00488901836797595
common O 0 0.03517201915383339
haplotype O 1 0.9999440908432007
was O 0 0.002092285780236125
shared O 0 0.004353963304311037
by O 0 0.001373341423459351
the O 0 0.0024316830094903708
mutant O 1 0.9998588562011719
alleles O 1 0.9998015761375427
in O 0 0.00329331262037158
both O 0 0.006329162046313286
mutations O 1 0.9999805688858032
. O 0 0.007997892796993256

This O 0 0.004490877967327833
suggests O 0 0.011135262437164783
that O 0 0.0009568826062604785
these O 0 0.0008461478864774108
two O 0 0.0025432342663407326
founder O 1 0.8342773914337158
mutations O 1 0.999994158744812
may O 0 0.006005522795021534
be O 0 0.0014633028768002987
predominant O 0 0.022444434463977814
among O 0 0.0030882633291184902
Japanese O 0 0.010424858890473843
ATM O 1 0.9974149465560913
mutant O 1 0.9993062019348145
alleles O 1 0.9995623230934143
. O 0 0.009995339438319206

W474C O 1 0.855540931224823
amino O 1 0.9620306491851807
acid O 1 0.9958835244178772
substitution O 1 0.855401873588562
affects O 1 0.6112553477287292
early O 0 0.004374018404632807
processing O 0 0.00827513076364994
of O 0 0.0007388455560430884
the O 0 0.0019213404739275575
alpha O 1 0.9152694344520569
- O 0 0.02637205459177494
subunit O 1 0.9843616485595703
of O 0 0.003494874108582735
beta O 1 0.9988686442375183
- O 0 0.038088325411081314
hexosaminidase O 1 0.9954671859741211
A O 0 0.009745239280164242
and O 0 0.0011846444103866816
is O 0 0.0016782936872914433
associated O 0 0.009517264552414417
with O 0 0.0082573052495718
subacute O 1 0.9999942779541016
G B-Disease 1 0.9996516704559326
( I-Disease 0 0.010809236206114292
M2 I-Disease 1 0.9987034797668457
) I-Disease 0 0.009362950921058655
gangliosidosis I-Disease 1 0.9410544037818909
. O 0 0.007984866388142109

Mutations O 1 0.9997267127037048
in O 0 0.0033040798734873533
the O 0 0.006513769738376141
HEXA O 1 0.999984860420227
gene O 1 0.9997082352638245
, O 0 0.003452765289694071
encoding O 0 0.3976823091506958
the O 0 0.003533069510012865
alpha O 0 0.4934852719306946
- O 0 0.02793758362531662
subunit O 1 0.9585889577865601
of O 0 0.003697831416502595
beta O 1 0.9960741996765137
- O 0 0.03502858057618141
hexosaminidase O 1 0.984176754951477
A O 0 0.017616095021367073
( O 0 0.006718965247273445
Hex O 1 0.9445621967315674
A O 0 0.01400174293667078
) O 0 0.0027299344073981047
, O 0 0.0008264104253612459
that O 0 0.0008563569863326848
abolish O 0 0.03252611309289932
Hex O 0 0.3975234627723694
A O 0 0.01334433350712061
enzyme O 1 0.9996976852416992
activity O 0 0.030263496562838554
cause O 1 0.9996359348297119
Tay B-Disease 1 0.9999982118606567
- I-Disease 1 0.9985937476158142
Sachs I-Disease 1 0.999993085861206
disease I-Disease 1 0.9999979734420776
( O 0 0.01288405992090702
TSD B-Disease 1 0.9999796152114868
) O 0 0.0037094512954354286
, O 0 0.0012317734071984887
the O 0 0.0031719347462058067
fatal O 1 0.999967098236084
infantile B-Disease 1 0.9999649524688721
form I-Disease 0 0.01483927946537733
of I-Disease 0 0.0032145630102604628
G I-Disease 1 0.9996079802513123
( I-Disease 0 0.010279186069965363
M2 I-Disease 1 0.9994451403617859
) I-Disease 0 0.008062029257416725
gangliosidosis I-Disease 1 0.9964753985404968
, I-Disease 0 0.003338245674967766
Type I-Disease 1 0.6468151807785034
1 I-Disease 0 0.01160927303135395
. O 0 0.0056839496828615665

Less O 0 0.022684186697006226
severe O 1 0.9938219785690308
, O 0 0.007458528038114309
subacute O 1 0.99998939037323
( O 0 0.01723604090511799
juvenile O 1 0.9999113082885742
- O 1 0.9429661631584167
onset O 1 0.999967098236084
) O 0 0.005536962766200304
and O 0 0.004402643069624901
chronic O 1 0.9999963045120239
( O 0 0.009201528504490852
adult O 1 0.9970958232879639
- O 1 0.9644976258277893
onset O 1 0.9999679327011108
) O 0 0.0067799570970237255
variants O 1 0.9951980710029602
are O 0 0.0011979240225628018
characterized O 0 0.06418762356042862
by O 0 0.0020239718724042177
a O 0 0.0045846495777368546
broad O 0 0.016619527712464333
spectrum O 0 0.09688100963830948
of O 0 0.0023369716946035624
clinical O 1 0.9999535083770752
manifestations O 1 0.9645897746086121
and O 0 0.0010057894978672266
are O 0 0.0007609820459038019
associated O 0 0.006353853736072779
with O 0 0.0028495260048657656
residual O 1 0.8799809217453003
levels O 0 0.008753837086260319
of O 0 0.001186251756735146
Hex O 1 0.9444626569747925
A O 0 0.0215691439807415
enzyme O 1 0.9996743202209473
activity O 0 0.019154757261276245
. O 0 0.005712113808840513

We O 0 0.003585862461477518
identified O 0 0.01241268590092659
a O 0 0.01324168685823679
1422 O 1 0.9992449283599854
G O 1 0.9992982149124146
- O 0 0.2579059898853302
- O 0 0.14957131445407867
> O 1 0.9981964230537415
C O 1 0.739496111869812
( O 0 0.007611020468175411
amino O 1 0.9955869913101196
acid O 1 0.9989782571792603
W474C O 1 0.9890936613082886
) O 0 0.006102904677391052
substitution O 0 0.18866066634655
in O 0 0.0012345868162810802
the O 0 0.0009320625686086714
first O 0 0.0016666980227455497
position O 0 0.0023513371124863625
of O 0 0.0016248038737103343
exon O 1 0.9975312948226929
13 O 0 0.008390866219997406
of O 0 0.0025855235289782286
HEXA O 1 0.9998472929000854
of O 0 0.0023823061492294073
a O 0 0.008024327456951141
non O 0 0.01100802980363369
- O 0 0.017952751368284225
Jewish O 0 0.012765123508870602
proband O 1 0.9674931764602661
who O 0 0.003676146734505892
manifested O 1 0.6809099316596985
a O 0 0.01938602887094021
subacute O 1 0.9999672174453735
variant O 1 0.9974415302276611
of O 0 0.004072943702340126
G B-Disease 1 0.9996125102043152
( I-Disease 0 0.008671860210597515
M2 I-Disease 1 0.999099850654602
) I-Disease 0 0.009518519975244999
gangliosidosis I-Disease 1 0.9744871854782104
. O 0 0.008678832091391087

On O 0 0.0025332607328891754
the O 0 0.0020518319215625525
second O 0 0.011540746316313744
maternally O 1 0.9997978806495667
inherited O 1 0.9997498393058777
allele O 1 0.9999072551727295
, O 0 0.0015016574179753661
we O 0 0.0008068509050644934
identified O 0 0.005676691886037588
the O 0 0.0019577895291149616
common O 1 0.9564027190208435
infantile O 1 0.9999995231628418
disease O 1 0.9999994039535522
- O 0 0.24433499574661255
causing O 1 0.9844502806663513
4 O 0 0.01670883782207966
- O 0 0.028291281312704086
bp O 0 0.33223578333854675
insertion O 1 0.9958880543708801
, O 0 0.007011977955698967
+ O 1 0.9962393045425415
TATC O 1 0.9982208609580994
1278 O 1 0.9973946809768677
, O 0 0.0030888020992279053
in O 0 0.0037291916087269783
exon O 1 0.9961448907852173
11 O 0 0.014721184968948364
. O 0 0.008356395177543163

Pulse O 1 0.9913434982299805
- O 0 0.04305567592382431
chase O 0 0.18136946856975555
analysis O 0 0.01788577437400818
using O 0 0.014184516854584217
proband O 1 0.9952493906021118
fibroblasts O 1 0.9992241859436035
revealed O 0 0.016984960064291954
that O 0 0.0014057375956326723
the O 0 0.0025689024478197098
W474C O 1 0.9953927993774414
- O 0 0.021266944706439972
containing O 0 0.023299431428313255
alpha O 1 0.8966975212097168
- O 0 0.03807475417852402
subunit O 1 0.9973524808883667
precursor O 1 0.9608062505722046
was O 0 0.003268774366006255
normally O 0 0.010565999895334244
synthesized O 1 0.9873680472373962
, O 0 0.0016093787271529436
but O 0 0.0010639566462486982
not O 0 0.0014033907791599631
phosphorylated O 1 0.9955978989601135
or O 0 0.006719010882079601
secreted O 1 0.998008668422699
, O 0 0.001218171906657517
and O 0 0.0007640127441845834
the O 0 0.0022651676554232836
mature O 1 0.980323314666748
lysosomal O 1 0.9999432563781738
alpha O 1 0.9869582056999207
- O 0 0.03996756300330162
subunit O 1 0.9975824356079102
was O 0 0.0029607703909277916
not O 0 0.0028569712303578854
detected O 1 0.8288384079933167
. O 0 0.00718105211853981

When O 0 0.007853822782635689
the O 0 0.003629340324550867
W474C O 1 0.9937843084335327
- O 0 0.021312134340405464
containing O 0 0.023754406720399857
alpha O 1 0.7331339120864868
- O 0 0.03045554831624031
subunit O 1 0.994046688079834
was O 0 0.007638218812644482
transiently O 1 0.9988406300544739
co O 0 0.21040333807468414
- O 0 0.013414704240858555
expressed O 0 0.0037300330586731434
with O 0 0.0015983855118975043
the O 0 0.002687569707632065
beta O 1 0.9988093376159668
- O 0 0.025938035920262337
subunit O 1 0.9858844876289368
to O 0 0.0020678944420069456
produce O 0 0.010242490097880363
Hex O 1 0.6353597640991211
A O 0 0.013926821760833263
( O 0 0.006483875680714846
alphabeta O 1 0.9951443076133728
) O 0 0.004460776224732399
in O 0 0.003272281028330326
COS O 1 0.99980229139328
- O 0 0.028777949512004852
7 O 0 0.01675352267920971
cells O 1 0.9989445805549622
, O 0 0.0013146188575774431
the O 0 0.0019800595473498106
mature O 1 0.917236864566803
alpha O 1 0.9758063554763794
- O 0 0.043414149433374405
subunit O 1 0.9981416463851929
was O 0 0.002947166794911027
present O 0 0.0025396307464689016
, O 0 0.000982565339654684
but O 0 0.0008419448276981711
its O 0 0.0013075878378003836
level O 0 0.0029823228251188993
was O 0 0.0014347585383802652
much O 0 0.0019525198731571436
lower O 0 0.005246879532933235
than O 0 0.000969058251939714
that O 0 0.0009092898108065128
from O 0 0.0019836891442537308
normal O 0 0.08467355370521545
alpha O 1 0.9933547973632812
- O 0 0.11862671375274658
subunit O 1 0.9995229244232178
transfections O 1 0.9936854243278503
, O 0 0.0023480127565562725
although O 0 0.002172828884795308
higher O 0 0.0032337522134184837
than O 0 0.0008478807285428047
in O 0 0.0010646411683410406
those O 0 0.002535102656111121
cells O 1 0.9999064207077026
transfected O 1 0.9996912479400635
with O 0 0.003422931768000126
an O 0 0.003016870468854904
alpha O 1 0.9852685332298279
- O 0 0.04086417704820633
subunit O 1 0.9963125586509705
associated O 0 0.02050795592367649
with O 0 0.013647562824189663
infantile O 1 0.9999698400497437
TSD B-Disease 1 0.999638557434082
. O 0 0.01344041433185339

Furthermore O 0 0.030449219048023224
, O 0 0.0013180609093979
the O 0 0.0015700019430369139
precursor O 1 0.9778621196746826
level O 0 0.0027636948507279158
of O 0 0.000611745985224843
the O 0 0.002219941932708025
W474C O 1 0.998181939125061
alpha O 1 0.9853818416595459
- O 0 0.04315590485930443
subunit O 1 0.9958744645118713
was O 0 0.002949691377580166
found O 0 0.004283311776816845
to O 0 0.0018062862800434232
accumulate O 1 0.9272747039794922
in O 0 0.0018053225940093398
comparison O 0 0.007156740874052048
to O 0 0.0010129068978130817
the O 0 0.0014195307157933712
normal O 0 0.028705628588795662
alpha O 1 0.9778850674629211
- O 0 0.05012449622154236
subunit O 1 0.9981953501701355
precursor O 1 0.971832811832428
levels O 0 0.021643994376063347
. O 0 0.006462011020630598

We O 0 0.003669074969366193
conclude O 0 0.014872267842292786
that O 0 0.0013208442833274603
the O 0 0.004515404812991619
1422 O 1 0.999679684638977
G O 1 0.999715268611908
- O 0 0.41164544224739075
- O 0 0.412566602230072
> O 1 0.9996546506881714
C O 1 0.9951617121696472
mutation O 1 0.999930739402771
is O 0 0.0020061552058905363
the O 0 0.0015067768981680274
cause O 0 0.09218517690896988
of O 0 0.0012609100667759776
Hex B-Disease 1 0.9883922934532166
A I-Disease 0 0.26752355694770813
enzyme I-Disease 1 0.9999977350234985
deficiency I-Disease 1 0.9999983310699463
in O 0 0.0029785181395709515
the O 0 0.0034664166159927845
proband O 1 0.9898672103881836
. O 0 0.008587499149143696

The O 0 0.005835107062011957
resulting O 0 0.0659540519118309
W474C O 1 0.9376956820487976
substitution O 0 0.25365734100341797
clearly O 0 0.009392409585416317
interferes O 1 0.9710501432418823
with O 0 0.004624983295798302
alpha O 1 0.970770001411438
- O 0 0.047431446611881256
subunit O 1 0.9979999661445618
processing O 0 0.023031918331980705
, O 0 0.0015210508136078715
but O 0 0.0010822820477187634
because O 0 0.0018858371768146753
the O 0 0.0011559888953343034
base O 0 0.008322611451148987
substitution O 1 0.9876532554626465
falls O 0 0.014860117807984352
at O 0 0.0016009178943932056
the O 0 0.000774902815464884
first O 0 0.0015428101178258657
position O 0 0.002224713796749711
of O 0 0.0016507329419255257
exon O 1 0.9987142086029053
13 O 0 0.009210724383592606
, O 0 0.0034371400251984596
aberrant O 1 0.9997994303703308
splicing O 1 0.9998905658721924
may O 0 0.004619357641786337
also O 0 0.0010917427716776729
contribute O 0 0.007365061901509762
to O 0 0.0015964587219059467
Hex B-Disease 1 0.9943287968635559
A I-Disease 0 0.1916934847831726
deficiency I-Disease 1 0.9999982118606567
in O 0 0.002897006692364812
this O 0 0.002507273107767105
proband O 1 0.9948569536209106
. O 0 0.003769800765439868
. O 0 0.005534254014492035

Two O 0 0.009828797541558743
frequent O 0 0.06896854192018509
missense O 1 0.9997102618217468
mutations O 1 0.999955415725708
in O 0 0.013277984224259853
Pendred B-Disease 1 0.9999691247940063
syndrome I-Disease 1 0.9999992847442627
. O 0 0.01402610819786787

Pendred B-Disease 1 0.9999034404754639
syndrome I-Disease 1 0.9999988079071045
is O 0 0.008473540656268597
an O 0 0.021600976586341858
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 0.9999995231628418
characterized O 1 0.7567113041877747
by O 0 0.00385403074324131
early O 0 0.012133514508605003
childhood O 1 0.9993494153022766
deafness B-Disease 1 0.9999979734420776
and O 0 0.011156037449836731
goiter B-Disease 1 0.9999881982803345
. O 0 0.0128247095271945

A O 0 0.01720532588660717
century O 0 0.004109970759600401
after O 0 0.003456366714090109
its O 0 0.0019060474587604403
recognition O 0 0.009573224931955338
as O 0 0.002526252530515194
a O 0 0.03213564679026604
syndrome O 1 0.9999996423721313
by O 0 0.005277362186461687
Vaughan O 1 0.8868682384490967
Pendred O 1 0.997086226940155
, O 0 0.0028226340655237436
the O 0 0.00709147471934557
disease O 1 0.9999994039535522
gene O 1 0.9999908208847046
( O 0 0.012856338173151016
PDS O 1 0.9995357990264893
) O 0 0.003962928894907236
was O 0 0.0018336470238864422
mapped O 0 0.023177891969680786
to O 0 0.006348256953060627
chromosome O 1 0.9999817609786987
7q22 O 1 0.9966944456100464
- O 0 0.05217239633202553
q31 O 1 0.9781322479248047
. O 0 0.012767924927175045

1 O 0 0.014353095553815365
and O 0 0.0018858228577300906
, O 0 0.0017069854075089097
recently O 0 0.005845735780894756
, O 0 0.0009602105710655451
found O 0 0.0026973967906087637
to O 0 0.0011976039968430996
encode O 0 0.33096158504486084
a O 0 0.012582057155668736
putative O 1 0.9993768334388733
sulfate O 1 0.9997517466545105
transporter O 1 0.9993332028388977
. O 0 0.010698964819312096

We O 0 0.004320226609706879
performed O 0 0.015946852043271065
mutation O 1 0.9999396800994873
analysis O 0 0.011178390122950077
of O 0 0.0007265751482918859
the O 0 0.0028601926751434803
PDS B-Disease 1 0.9999674558639526
gene O 1 0.9999750852584839
in O 0 0.005816787481307983
patients O 1 0.9989326596260071
from O 0 0.002620152197778225
14 O 0 0.00923216249793768
Pendred B-Disease 1 0.9962396621704102
families O 0 0.00925028882920742
originating O 0 0.028844662010669708
from O 0 0.0016477885656058788
seven O 0 0.0023399407509714365
countries O 0 0.0008205855847336352
and O 0 0.0010591794271022081
identified O 0 0.010570358484983444
all O 0 0.0035654501989483833
mutations O 1 0.9999692440032959
. O 0 0.008163504302501678

The O 0 0.008918032050132751
mutations O 1 0.9998313188552856
include O 0 0.004919318947941065
three O 0 0.001957816071808338
single O 0 0.007935257628560066
base O 0 0.010966752655804157
deletions O 1 0.997853696346283
, O 0 0.0019206026336178184
one O 0 0.0030689758714288473
splice O 1 0.9989513158798218
site O 0 0.018195204436779022
mutation O 1 0.9999336004257202
and O 0 0.002742090029641986
10 O 0 0.009431752376258373
missense O 1 0.999915361404419
mutations O 1 0.9999054670333862
. O 0 0.0096126152202487

One O 0 0.014994092285633087
missense O 1 0.9998437166213989
mutation O 1 0.9999834299087524
( O 0 0.011475096456706524
L236P O 1 0.9979640245437622
) O 0 0.003662337316200137
was O 0 0.0012661638902500272
found O 0 0.002786346711218357
in O 0 0.0013505455572158098
a O 0 0.00750120310112834
homozygous O 1 0.9995063543319702
state O 0 0.0022589582949876785
in O 0 0.0012471069348976016
two O 0 0.0032227938063442707
consanguineous O 1 0.9996300935745239
families O 0 0.007346793543547392
and O 0 0.0011330890702083707
in O 0 0.0014172681840136647
a O 0 0.008945569396018982
heterozygous O 1 0.9996606111526489
state O 0 0.0016596493078395724
in O 0 0.0010244045406579971
five O 0 0.00231437967158854
additional O 0 0.006200416479259729
non O 0 0.012961666099727154
- O 0 0.06539679318666458
consanguineous O 1 0.999067485332489
families O 0 0.01346015464514494
. O 0 0.005700685549527407

Another O 0 0.03496891260147095
missense O 1 0.9996871948242188
mutation O 1 0.9999604225158691
( O 0 0.01293149683624506
T416P O 1 0.9971398115158081
) O 0 0.003976371604949236
was O 0 0.0017560363048687577
found O 0 0.003670341335237026
in O 0 0.0013790978118777275
a O 0 0.008334320038557053
homozygous O 1 0.999728262424469
state O 0 0.002350511960685253
in O 0 0.0011565589811652899
one O 0 0.0018148886738345027
family O 0 0.007031570188701153
and O 0 0.0009888375643640757
in O 0 0.0013287834590300918
a O 0 0.00866738986223936
heterozygous O 1 0.9996294975280762
state O 0 0.00237109512090683
in O 0 0.0013561639934778214
four O 0 0.0036309906281530857
families O 0 0.008234517648816109
. O 0 0.005250013433396816

Pendred B-Disease 1 0.9989977478981018
patients O 1 0.9951809644699097
in O 0 0.0022350142244249582
three O 0 0.003087886143475771
non O 0 0.013744362629950047
- O 0 0.0661722794175148
consanguineous O 1 0.9994598031044006
families O 0 0.005467010661959648
were O 0 0.0007597483927384019
shown O 0 0.004420596174895763
to O 0 0.0009812084026634693
be O 0 0.001675941632129252
compound O 0 0.0727071762084961
heterozygotes O 1 0.9980589747428894
for O 0 0.004155472386628389
L236P O 1 0.9885898232460022
and O 0 0.0034166621044278145
T416P O 1 0.9906332492828369
. O 0 0.007928304374217987

In O 0 0.0031644233968108892
total O 0 0.002891430864110589
, O 0 0.0011890239547938108
one O 0 0.0013326671905815601
or O 0 0.0020241502206772566
both O 0 0.0008902946137823164
of O 0 0.000684652419295162
these O 0 0.002902168082073331
mutations O 1 0.9999880790710449
were O 0 0.0011685792123898864
found O 0 0.0032436191104352474
in O 0 0.0009588095708750188
nine O 0 0.0024721291847527027
of O 0 0.0007685569580644369
the O 0 0.0013837490696460009
14 O 0 0.006682233419269323
families O 0 0.008160206489264965
analyzed O 0 0.04145289212465286
. O 0 0.005262499209493399

The O 0 0.003660788992419839
identification O 0 0.01585005410015583
of O 0 0.00093494524480775
two O 0 0.0025786464102566242
frequent O 0 0.37012574076652527
PDS B-Disease 1 0.9999117851257324
mutations O 1 0.9999654293060303
will O 0 0.0017572647193446755
facilitate O 0 0.01123114489018917
the O 0 0.002728343242779374
molecular O 1 0.9999533891677856
diagnosis O 1 0.999984622001648
of O 0 0.006786080542951822
Pendred B-Disease 1 0.9999903440475464
syndrome I-Disease 1 0.9999994039535522
. O 0 0.013490201905369759

Insertional O 1 0.9923712015151978
mutation O 1 0.9994727969169617
by O 0 0.009146949276328087
transposable O 1 0.9978147745132446
element O 0 0.0318400040268898
, O 0 0.0029612949583679438
L1 O 1 0.9997836947441101
, O 0 0.0018033870728686452
in O 0 0.0013634454226121306
the O 0 0.005630694795399904
DMD B-Disease 1 0.9999992847442627
gene O 1 0.9999021291732788
results O 0 0.012661962769925594
in O 0 0.0033177444711327553
X B-Disease 1 0.9988017082214355
- I-Disease 0 0.4449063539505005
linked I-Disease 1 0.9943547248840332
dilated I-Disease 1 0.999920129776001
cardiomyopathy I-Disease 1 0.9999916553497314
. O 0 0.014505691826343536

X B-Disease 1 0.9062245488166809
- I-Disease 0 0.11781782656908035
linked I-Disease 1 0.9921863079071045
dilated I-Disease 1 0.9999308586120605
cardiomyopathy I-Disease 1 0.9999980926513672
( O 0 0.012082943692803383
XLDCM B-Disease 1 0.9992648959159851
) O 0 0.003540948498994112
is O 0 0.0014370091957971454
a O 0 0.008875515311956406
clinical O 1 0.9999477863311768
phenotype O 1 0.9999912977218628
of O 0 0.00261583155952394
dystrophinopathy B-Disease 1 0.9985492825508118
which O 0 0.0019042885396629572
is O 0 0.0022427206858992577
characterized O 0 0.07584678381681442
by O 0 0.004776584915816784
preferential O 1 0.9934925436973572
myocardial B-Disease 1 0.999993085861206
involvement I-Disease 0 0.03935769572854042
without O 0 0.0043714833445847034
any O 0 0.003851746441796422
overt O 1 0.9131300449371338
clinical O 1 0.9981379508972168
signs O 0 0.02096182480454445
of O 0 0.005089947022497654
skeletal B-Disease 1 0.9999977350234985
myopathy I-Disease 1 0.9999979734420776
. O 0 0.01511654444038868

To O 0 0.003988298587501049
date O 0 0.003944458439946175
, O 0 0.0012837027898058295
several O 0 0.0033586923964321613
mutations O 1 0.9999754428863525
in O 0 0.0025420007295906544
the O 0 0.00794919952750206
Duchenne B-Disease 1 0.9999991655349731
muscular I-Disease 1 0.9999972581863403
dystrophy I-Disease 1 0.9999998807907104
gene O 1 0.9999918937683105
, O 0 0.012995792552828789
DMD O 1 0.9999979734420776
, O 0 0.0024562235921621323
have O 0 0.0009069995139725506
been O 0 0.0012465020408853889
identified O 0 0.010706598870456219
in O 0 0.0038452460430562496
patients O 1 0.9997754693031311
with O 0 0.005258696619421244
XLDCM B-Disease 1 0.9998539686203003
, O 0 0.0016350912628695369
but O 0 0.0013572480529546738
a O 0 0.007343469653278589
pathogenic O 1 0.9994428753852844
correlation O 0 0.41134586930274963
of O 0 0.0009928424842655659
these O 0 0.002483072690665722
cardiospecific O 1 0.9995027780532837
mutations O 1 0.9999908208847046
in O 0 0.0069799222983419895
DMD O 1 0.9999955892562866
with O 0 0.0033741870429366827
the O 0 0.0036069038324058056
XLDCM B-Disease 1 0.9999701976776123
phenotype O 1 0.9999949932098389
has O 0 0.0025813065003603697
remained O 0 0.0023991947527974844
to O 0 0.0012969395611435175
be O 0 0.002255552913993597
elucidated O 1 0.9936363697052002
. O 0 0.007520799990743399

We O 0 0.0033896658569574356
report O 0 0.001964427763596177
here O 0 0.0007789966184645891
the O 0 0.0009302344406023622
identification O 0 0.011680583469569683
of O 0 0.0008183974423445761
a O 0 0.0040166135877370834
unique O 0 0.008739454671740532
de O 0 0.027848422527313232
novo O 1 0.9959468245506287
L1 O 1 0.9991123080253601
insertion O 1 0.9901511669158936
in O 0 0.0021508908830583096
the O 0 0.0035895989276468754
muscle O 1 0.9999566078186035
exon O 1 0.9994214773178101
1 O 0 0.010482816956937313
in O 0 0.0042715370655059814
DMD O 1 0.9999969005584717
in O 0 0.0031625365372747183
three O 0 0.006516510620713234
XLDCM B-Disease 1 0.9999470710754395
patients O 1 0.9991508722305298
from O 0 0.0027687973342835903
two O 0 0.0029695271514356136
unrelated O 0 0.4267188608646393
Japanese O 0 0.009210466407239437
families O 0 0.010635457932949066
. O 0 0.006358962040394545

The O 0 0.008488701656460762
insertion O 1 0.9867665767669678
was O 0 0.004301311448216438
a O 0 0.006767711602151394
5 O 0 0.012850173749029636
- O 0 0.019873932003974915
truncated O 1 0.7579068541526794
form O 0 0.007928473874926567
of O 0 0.0012776282383129
human O 0 0.017389249056577682
L1 O 1 0.999739944934845
inversely O 1 0.7757770419120789
integrated O 0 0.029474684968590736
in O 0 0.0013909359695389867
the O 0 0.0019973532762378454
5 O 0 0.01188020408153534
- O 0 0.021982012316584587
untranslated O 1 0.9689934253692627
region O 0 0.004737832583487034
in O 0 0.0012973189586773515
the O 0 0.0036280956119298935
muscle O 1 0.9999865293502808
exon O 1 0.9997875094413757
1 O 0 0.008745520375669003
, O 0 0.0012884580064564943
which O 0 0.0011066502192988992
affected O 0 0.0091015063226223
the O 0 0.002310302807018161
transcription O 1 0.9996819496154785
or O 0 0.0026759514585137367
the O 0 0.0009537271107546985
stability O 0 0.0077337599359452724
of O 0 0.0007361973403021693
the O 0 0.002907515736296773
muscle O 1 0.9999579191207886
form O 0 0.008940701372921467
of O 0 0.00225254287943244
dystrophin O 1 0.9999951124191284
transcripts O 0 0.22103670239448547
but O 0 0.0013892686692997813
not O 0 0.0006821195711381733
that O 0 0.000491635175421834
of O 0 0.0005194969708099961
the O 0 0.0026379916816949844
brain O 1 0.9999798536300659
or O 0 0.01455111987888813
Purkinje O 1 0.9999960660934448
cell O 1 0.999927282333374
form O 0 0.014196798205375671
, O 0 0.0011824234388768673
probably O 0 0.00483662961050868
due O 0 0.003284609178081155
to O 0 0.0007351519889198244
its O 0 0.0012762636179104447
unique O 0 0.004324355162680149
site O 0 0.003409410361200571
of O 0 0.0015627183020114899
integration O 0 0.033875517547130585
. O 0 0.0060412827879190445

We O 0 0.00485706003382802
speculate O 0 0.02402341738343239
that O 0 0.0013546273112297058
this O 0 0.0017380790086463094
insertion O 1 0.9541670083999634
of O 0 0.0014064668212085962
an O 0 0.003047700272873044
L1 O 1 0.9999030828475952
sequence O 0 0.3961682915687561
in O 0 0.006143286824226379
DMD O 1 0.9999992847442627
is O 0 0.003335465444251895
responsible O 0 0.005719777662307024
for O 0 0.000814292929135263
some O 0 0.0006122452323324978
of O 0 0.0004729599168058485
the O 0 0.0007580088567920029
population O 0 0.0017643764149397612
of O 0 0.0011430035810917616
Japanese O 0 0.014105580747127533
patients O 1 0.9997342228889465
with O 0 0.007060614880174398
XLDCM B-Disease 1 0.9990861415863037
. O 0 0.003906375728547573
. O 0 0.005093724932521582

Severe O 1 0.9863355159759521
early O 0 0.02694118395447731
- O 1 0.959417998790741
onset O 1 0.9999914169311523
obesity B-Disease 1 0.9999938011169434
, O 0 0.012078379280865192
adrenal B-Disease 1 0.9999986886978149
insufficiency I-Disease 1 0.9999923706054688
and O 0 0.004541539121419191
red O 1 0.7354910373687744
hair O 1 0.999906063079834
pigmentation O 1 0.9999897480010986
caused O 1 0.6177957057952881
by O 0 0.009079848416149616
POMC O 1 0.9999761581420898
mutations O 1 0.9999555349349976
in O 0 0.005335577297955751
humans O 1 0.5456888675689697
. O 0 0.006095565389841795

Sequential O 1 0.750263512134552
cleavage O 1 0.9847588539123535
of O 0 0.001809223904274404
the O 0 0.0028983072843402624
precursor O 1 0.9936442375183105
protein O 1 0.9990618824958801
pre O 0 0.14808794856071472
- O 0 0.02657904103398323
pro O 0 0.032017603516578674
- O 0 0.039664193987846375
opiomelanocortin O 1 0.9930439591407776
( O 0 0.015483553521335125
POMC O 1 0.9997922778129578
) O 0 0.005753261968493462
generates O 0 0.024462318047881126
the O 0 0.004132886417210102
melanocortin O 1 0.9990395903587341
peptides O 1 0.995608389377594
adrenocorticotrophin O 1 0.9919561147689819
( O 0 0.011504721827805042
ACTH O 1 0.9998544454574585
) O 0 0.005087161436676979
, O 0 0.004271743819117546
melanocyte O 1 0.9999270439147949
- O 0 0.06270678341388702
stimulating O 1 0.9958795309066772
hormones O 1 0.9996850490570068
( O 0 0.014191738329827785
MSH O 1 0.9999680519104004
) O 0 0.006766099948436022
alpha O 1 0.6417887806892395
, O 0 0.0026118175592273474
beta O 1 0.995557963848114
and O 0 0.0019237357191741467
gamma O 1 0.9726808667182922
as O 0 0.0016261130804196
well O 0 0.0011542181018739939
as O 0 0.001349766505882144
the O 0 0.0030815245117992163
opioid O 1 0.9998242259025574
- O 0 0.1360645592212677
receptor O 1 0.9994768500328064
ligand O 1 0.9985186457633972
beta O 1 0.9957360029220581
- O 0 0.10047885030508041
endorphin O 1 0.9979768395423889
. O 0 0.015180377289652824

While O 0 0.004679983016103506
a O 0 0.004226906690746546
few O 0 0.0020997771061956882
cases O 0 0.0051689958199858665
of O 0 0.0017410385189577937
isolated O 1 0.9952163696289062
ACTH B-Disease 1 0.9999966621398926
deficiency I-Disease 1 0.9999992847442627
have O 0 0.0018415764207020402
been O 0 0.0020705312490463257
reported O 0 0.011389799416065216
( O 0 0.010600843466818333
OMIM O 1 0.9999895095825195
201400 O 1 0.9985789060592651
) O 0 0.003977969288825989
, O 0 0.0013643422862514853
an O 0 0.004179669078439474
inherited O 1 0.9999042749404907
POMC O 1 0.9999948740005493
defect O 1 0.9998297691345215
has O 0 0.0027552968822419643
not O 0 0.0010764249600470066
been O 0 0.0015038677956908941
described O 0 0.006144591607153416
so O 0 0.0025532501749694347
far O 0 0.004221877548843622
. O 0 0.005239653866738081

Recent O 0 0.017007935792207718
studies O 0 0.01152121927589178
in O 0 0.0026332801207900047
animal O 0 0.03319964557886124
models O 0 0.023575013503432274
elucidated O 1 0.9874007105827332
a O 0 0.005017615854740143
central O 0 0.0026785475201904774
role O 0 0.005001710262149572
of O 0 0.0018198468023911119
alpha O 1 0.9909033179283142
- O 0 0.3881511092185974
MSH O 1 0.9998149275779724
in O 0 0.0024600622709840536
the O 0 0.0017117634415626526
regulation O 0 0.0206929761916399
of O 0 0.001188470283523202
food O 0 0.009864315390586853
intake O 1 0.8147408962249756
by O 0 0.003306197701022029
activation O 1 0.9964306950569153
of O 0 0.0008518975228071213
the O 0 0.0035650639329105616
brain O 1 0.9999921321868896
melanocortin O 1 0.9999440908432007
- O 0 0.03362255170941353
4 O 0 0.018691914156079292
- O 0 0.06103489175438881
receptor O 1 0.9997223019599915
( O 0 0.0162382610142231
MC4 O 1 0.9999397993087769
- O 0 0.13875168561935425
R O 1 0.8342007994651794
; O 0 0.008106652647256851
refs O 1 0.961770236492157
3 O 0 0.02238050475716591
- O 0 0.018755730241537094
5 O 0 0.00860602781176567
) O 0 0.0021696847397834063
and O 0 0.0005505993030965328
the O 0 0.0011306044179946184
linkage O 1 0.9931318163871765
of O 0 0.0013097877381369472
human O 0 0.033658843487501144
obesity B-Disease 1 0.9999876022338867
to O 0 0.005107032600790262
chromosome O 1 0.9999899864196777
2 O 0 0.006524238735437393
in O 0 0.0011483305133879185
close O 0 0.003615973750129342
proximity O 0 0.013040144927799702
to O 0 0.0010274212108924985
the O 0 0.00379711901769042
POMC O 1 0.9999904632568359
locus O 1 0.999866247177124
, O 0 0.002339184982702136
led O 0 0.003310225671157241
to O 0 0.0009463219903409481
the O 0 0.0010702197905629873
proposal O 0 0.005058169364929199
of O 0 0.0007669890183024108
an O 0 0.0013948942068964243
association O 0 0.005175289697945118
of O 0 0.0029609021730720997
POMC O 1 0.9999611377716064
with O 0 0.006765179801732302
human O 0 0.14477884769439697
obesity B-Disease 1 0.9999760389328003
. O 0 0.012290241196751595

The O 0 0.005215334240347147
dual O 0 0.03208334743976593
role O 0 0.007851912640035152
of O 0 0.0024054867681115866
alpha O 1 0.9944924116134644
- O 0 0.14258894324302673
MSH O 1 0.9996745586395264
in O 0 0.005720778834074736
regulating O 0 0.1343090832233429
food O 0 0.01524381060153246
intake O 1 0.5928099155426025
and O 0 0.0033596584107726812
influencing O 1 0.9627161622047424
hair O 1 0.9998753070831299
pigmentation O 1 0.9999911785125732
predicts O 0 0.1536804437637329
that O 0 0.0012553175911307335
the O 0 0.003170555690303445
phenotype O 1 0.9999961853027344
associated O 0 0.010923712514340878
with O 0 0.0023864645045250654
a O 0 0.008268225938081741
defect O 1 0.9997876286506653
in O 0 0.004631080664694309
POMC O 1 0.9999696016311646
function O 0 0.02948407270014286
would O 0 0.002611329313367605
include O 0 0.011515343561768532
obesity B-Disease 1 0.9999880790710449
, O 0 0.0035409568808972836
alteration O 1 0.9963222742080688
in O 0 0.006652232259511948
pigmentation O 1 0.9999884366989136
and O 0 0.011603823862969875
ACTH B-Disease 1 0.9999815225601196
deficiency I-Disease 1 0.9999984502792358
. O 0 0.010051158256828785

The O 0 0.003687456948682666
observation O 0 0.01201715786010027
of O 0 0.001204031752422452
these O 0 0.003298983909189701
symptoms O 1 0.9999583959579468
in O 0 0.0019218368688598275
two O 0 0.003323198528960347
probands O 1 0.9968507885932922
prompted O 0 0.02295106090605259
us O 0 0.0025571438018232584
to O 0 0.0010703320149332285
search O 0 0.010114194825291634
for O 0 0.0032688272185623646
mutations O 1 0.999904990196228
within O 0 0.003676363732665777
their O 0 0.005777276586741209
POMC O 1 0.9999375343322754
genes O 1 0.9982262253761292
. O 0 0.009117853827774525

Patient O 1 0.9967616200447083
1 O 0 0.009279623627662659
was O 0 0.0017755563603714108
found O 0 0.002868184121325612
to O 0 0.0008119077538140118
be O 0 0.0008342511719092727
a O 0 0.004662428982555866
compound O 0 0.08664859086275101
heterozygote O 1 0.9991586208343506
for O 0 0.0019390354864299297
two O 0 0.00381577480584383
mutations O 1 0.9999796152114868
in O 0 0.005467863287776709
exon O 1 0.9992874264717102
3 O 0 0.01514801848679781
( O 0 0.007101758383214474
G7013T O 1 0.996977686882019
, O 0 0.004786734934896231
C7133delta O 1 0.9969332218170166
) O 0 0.0034902901388704777
which O 0 0.0013544332468882203
interfere O 0 0.028786974027752876
with O 0 0.0020359279587864876
appropriate O 0 0.008399034850299358
synthesis O 1 0.9795962572097778
of O 0 0.0026698994915932417
ACTH O 1 0.9994840621948242
and O 0 0.0042460463009774685
alpha O 1 0.9938588738441467
- O 0 0.34353792667388916
MSH O 1 0.999497652053833
. O 0 0.015948552638292313

Patient O 1 0.9909421801567078
2 O 0 0.011289876885712147
was O 0 0.003752090036869049
homozygous O 1 0.9989792704582214
for O 0 0.002760369563475251
a O 0 0.010340769775211811
mutation O 1 0.9999743700027466
in O 0 0.005226742010563612
exon O 1 0.9987626075744629
2 O 0 0.014199032448232174
( O 0 0.00644712196663022
C3804A O 1 0.9952141046524048
) O 0 0.004842729773372412
which O 0 0.0037151069846004248
abolishes O 1 0.9986920952796936
POMC O 1 0.9994138479232788
translation O 0 0.04009048640727997
. O 0 0.008324013091623783

These O 0 0.003736309241503477
findings O 0 0.008376317098736763
represent O 0 0.001926541212014854
the O 0 0.0007491993601433933
first O 0 0.0010702116414904594
examples O 0 0.0035093980841338634
of O 0 0.0010098181664943695
a O 0 0.010387676768004894
genetic B-Disease 1 0.9999942779541016
defect I-Disease 1 0.9998144507408142
within O 0 0.004301111213862896
the O 0 0.00460030697286129
POMC O 1 0.9999953508377075
gene O 1 0.9998667240142822
and O 0 0.0014090012991800904
define O 0 0.009890701621770859
a O 0 0.00486263632774353
new O 0 0.010632484219968319
monogenic B-Disease 1 0.9999920129776001
endocrine I-Disease 1 0.999998927116394
disorder I-Disease 1 0.9999856948852539
resulting O 0 0.07193221151828766
in O 0 0.0022656430955976248
early O 0 0.013604623265564442
- O 1 0.9930478930473328
onset O 1 0.9999954700469971
obesity B-Disease 1 0.9999964237213135
, O 0 0.012308962643146515
adrenal B-Disease 1 0.9999957084655762
insufficiency I-Disease 1 0.9999849796295166
and O 0 0.004668402951210737
red O 1 0.8901621103286743
hair O 1 0.9998958110809326
pigmentation O 1 0.9999865293502808
. O 0 0.005012138746678829
. O 0 0.006391097325831652

A O 0 0.020561564713716507
European O 0 0.0110216299071908
multicenter O 1 0.9945026636123657
study O 0 0.010195605456829071
of O 0 0.0029697264544665813
phenylalanine B-Disease 1 0.9999428987503052
hydroxylase I-Disease 1 0.9999896287918091
deficiency I-Disease 1 0.9999994039535522
: O 0 0.005986004136502743
classification O 0 0.03612595796585083
of O 0 0.0013895694864913821
105 O 0 0.04945801571011543
mutations O 1 0.999980092048645
and O 0 0.0012931233504787087
a O 0 0.0036535088438540697
general O 0 0.0024207904934883118
system O 0 0.01170860230922699
for O 0 0.00467583118006587
genotype O 1 0.999968409538269
- O 0 0.02516777254641056
based O 0 0.006530423648655415
prediction O 0 0.061448290944099426
of O 0 0.005031986627727747
metabolic O 1 0.9999949932098389
phenotype O 1 0.9999678134918213
. O 0 0.009472576901316643

Phenylketonuria B-Disease 1 0.9999302625656128
( O 0 0.03466099873185158
PKU B-Disease 1 0.9999938011169434
) O 0 0.00722234882414341
and O 0 0.002798595931380987
mild B-Disease 1 0.9991658926010132
hyperphenylalaninemia I-Disease 1 0.9997937083244324
( O 0 0.012854618020355701
MHP B-Disease 1 0.9999814033508301
) O 0 0.0050646355375647545
are O 0 0.0030430848710238934
allelic B-Disease 1 0.9999756813049316
disorders I-Disease 1 0.9999959468841553
caused O 1 0.5199170112609863
by O 0 0.005030241794884205
mutations O 1 0.9999654293060303
in O 0 0.0013986974954605103
the O 0 0.002983540529385209
gene O 1 0.9998799562454224
encoding O 1 0.9949393272399902
phenylalanine O 1 0.9992239475250244
hydroxylase O 1 0.9995855689048767
( O 0 0.02450357750058174
PAH O 1 0.9999574422836304
) O 0 0.010627618059515953
. O 0 0.007649380713701248

Previous O 0 0.012255264446139336
studies O 0 0.009773953817784786
have O 0 0.0009941230528056622
suggested O 0 0.003327114274725318
that O 0 0.0006945133209228516
the O 0 0.0011627787025645375
highly O 0 0.014905018731951714
variable O 1 0.9949523210525513
metabolic O 1 0.9999849796295166
phenotypes O 1 0.9998186230659485
of O 0 0.011268697679042816
PAH B-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999986886978149
correlate O 1 0.9933196306228638
with O 0 0.016832543537020683
PAH O 1 0.9999933242797852
genotypes O 1 0.99920254945755
. O 0 0.012107957154512405

We O 0 0.002981982659548521
identified O 0 0.009192313067615032
both O 0 0.0037473905831575394
causative O 1 0.9999750852584839
mutations O 1 0.9999856948852539
in O 0 0.005334312561899424
686 O 1 0.9997432827949524
patients O 1 0.9984707236289978
from O 0 0.002590424846857786
seven O 0 0.0036556723061949015
European O 0 0.00789550319314003
centers O 0 0.017344459891319275
. O 0 0.006078236270695925

On O 0 0.00235721911303699
the O 0 0.0010957898339256644
basis O 0 0.0017925174906849861
of O 0 0.00053531548473984
the O 0 0.0015802469570189714
phenotypic O 1 0.9959160685539246
characteristics O 0 0.015469797886908054
of O 0 0.00184836785774678
297 O 1 0.9935916066169739
functionally O 1 0.9998059868812561
hemizygous O 1 0.999795138835907
patients O 1 0.9993138313293457
, O 0 0.0016351022059097886
105 O 0 0.007806126028299332
of O 0 0.0007895081653259695
the O 0 0.002914232201874256
mutations O 1 0.999988317489624
were O 0 0.0011738042812794447
assigned O 0 0.004719363059848547
to O 0 0.0007901550852693617
one O 0 0.0009510258096270263
of O 0 0.0006838985136710107
four O 0 0.0029765008948743343
arbitrary O 0 0.03146521374583244
phenotype O 1 0.9999866485595703
categories O 0 0.02169199101626873
. O 0 0.006235816515982151

We O 0 0.003528093919157982
proposed O 0 0.006084977649152279
and O 0 0.0013346868799999356
tested O 0 0.027560625225305557
a O 0 0.00527080288156867
simple O 0 0.010494238696992397
model O 0 0.008838699199259281
for O 0 0.001956709660589695
correlation O 1 0.9475114941596985
between O 0 0.007107268553227186
genotype O 1 0.9998505115509033
and O 0 0.0036076477263122797
phenotypic O 1 0.9973002076148987
outcome O 0 0.028428299352526665
. O 0 0.006450051907449961

The O 0 0.004804081749171019
observed O 0 0.02714448794722557
phenotype O 1 0.9999825954437256
matched O 0 0.07458193600177765
the O 0 0.001994179328903556
predicted O 0 0.1402510404586792
phenotype O 1 0.9999922513961792
in O 0 0.0022328533232212067
79 O 0 0.016197163611650467
% O 0 0.0026724033523350954
of O 0 0.0006696394411846995
the O 0 0.0015240547945722938
cases O 0 0.013542107306420803
, O 0 0.0009792817290872335
and O 0 0.0006509740487672389
in O 0 0.0008082072017714381
only O 0 0.0010845600627362728
5 O 0 0.004168412648141384
of O 0 0.0017439729999750853
184 O 1 0.9703819155693054
patients O 1 0.9989699125289917
was O 0 0.0018979458836838603
the O 0 0.001673992839641869
observed O 0 0.0393279604613781
phenotype O 1 0.9999877214431763
more O 0 0.0016462275525555015
than O 0 0.0011574334930628538
one O 0 0.0017204585019499063
category O 0 0.01487611886113882
away O 0 0.004235920961946249
from O 0 0.0018312808824703097
that O 0 0.0014808070845901966
expected O 0 0.0035779050085693598
. O 0 0.004670687951147556

Among O 0 0.004707196727395058
the O 0 0.0015056459233164787
seven O 0 0.003140810877084732
contributing O 0 0.019330309703946114
centers O 0 0.012804554775357246
, O 0 0.0008718536118976772
the O 0 0.0011626722989603877
proportion O 0 0.01128701027482748
of O 0 0.0023432595189660788
patients O 1 0.9997057318687439
for O 0 0.0015757018700242043
whom O 0 0.002626679837703705
the O 0 0.0016178725054487586
observed O 0 0.2509115934371948
phenotype O 1 0.9999949932098389
did O 0 0.0029660789296031
not O 0 0.0008541722199879587
match O 0 0.0034292093478143215
the O 0 0.001610850333236158
predicted O 0 0.04160526767373085
phenotype O 1 0.9999903440475464
was O 0 0.003015657188370824
4 O 0 0.007833636365830898
% O 0 0.006853860802948475
- O 0 0.013026006519794464
23 O 0 0.008180980570614338
% O 0 0.007620834745466709
( O 0 0.008703234605491161
P O 1 0.9983680844306946
< O 1 0.9978004097938538
. O 0 0.006109230220317841
0001 O 1 0.9989319443702698
) O 0 0.003960253670811653
, O 0 0.0012458348646759987
suggesting O 0 0.010472039692103863
that O 0 0.0010360418818891048
differences O 0 0.0055935014970600605
in O 0 0.0008905355352908373
methods O 0 0.005705463699996471
used O 0 0.0025502899661660194
for O 0 0.0037776788230985403
mutation O 1 0.9999971389770508
detection O 1 0.999504566192627
or O 0 0.012325014919042587
phenotype O 1 0.9999977350234985
classification O 1 0.924176037311554
may O 0 0.004231027327477932
account O 0 0.002217404544353485
for O 0 0.0009131756378337741
a O 0 0.0033401947002857924
considerable O 0 0.00610525393858552
proportion O 0 0.011036296375095844
of O 0 0.003323501441627741
genotype O 1 0.9999946355819702
- O 1 0.8947324752807617
phenotype O 1 0.9999487400054932
inconsistencies O 1 0.8035219311714172
. O 0 0.010226333513855934

Our O 0 0.005449917633086443
data O 0 0.004206608049571514
indicate O 0 0.006403013598173857
that O 0 0.0016540209762752056
the O 0 0.005485717672854662
PAH O 1 0.999997615814209
- O 1 0.9573562145233154
mutation O 1 0.9999929666519165
genotype O 1 0.9998528957366943
is O 0 0.001972042955458164
the O 0 0.0008222711621783674
main O 0 0.0031829236540943384
determinant O 1 0.9857368469238281
of O 0 0.004084289539605379
metabolic O 1 0.9999985694885254
phenotype O 1 0.9999945163726807
in O 0 0.0028311116620898247
most O 0 0.0040687439031898975
patients O 1 0.9998397827148438
with O 0 0.08316778391599655
PAH B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999980926513672
. O 0 0.011018043383955956

In O 0 0.003248525783419609
the O 0 0.001599347684532404
present O 0 0.0033243042416870594
study O 0 0.006023290567100048
, O 0 0.000896371144335717
the O 0 0.0011883355909958482
classification O 0 0.08230689913034439
of O 0 0.002337080892175436
105 O 1 0.7767804265022278
PAH O 1 0.9999983310699463
mutations O 1 0.9999892711639404
may O 0 0.006034566089510918
allow O 0 0.003571912180632353
the O 0 0.0013097566552460194
prediction O 0 0.02823791280388832
of O 0 0.0006986446678638458
the O 0 0.0023917299695312977
biochemical O 1 0.9999673366546631
phenotype O 1 0.9999946355819702
in O 0 0.0042502316646277905
> O 1 0.9992438554763794
10 O 0 0.0038956478238105774
, O 0 0.0018565604696050286
000 O 0 0.03471323847770691
genotypes O 1 0.9998984336853027
, O 0 0.002099722856655717
which O 0 0.001409352757036686
may O 0 0.003367891302332282
be O 0 0.0008074036450125277
useful O 0 0.005536784417927265
for O 0 0.0008862687973305583
the O 0 0.0012701160740107298
management O 0 0.014497733674943447
of O 0 0.0019378212746232748
hyperphenylalaninemia B-Disease 1 0.9993695616722107
in O 0 0.006223923061043024
newborns O 1 0.9995742440223694
. O 0 0.008024858310818672

Somatic O 1 0.9954625964164734
instability O 0 0.08875592797994614
of O 0 0.001818573335185647
the O 0 0.003034633817151189
CTG O 1 0.9974560141563416
repeat O 0 0.23215901851654053
in O 0 0.004386657848954201
mice O 1 0.9999440908432007
transgenic O 1 0.9969925880432129
for O 0 0.0031868992373347282
the O 0 0.00833030603826046
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
region O 0 0.008522319607436657
is O 0 0.0022037578746676445
age O 0 0.006310243159532547
dependent O 0 0.017036857083439827
but O 0 0.001168360118754208
not O 0 0.0012414425145834684
correlated O 1 0.7588711380958557
to O 0 0.000874665507581085
the O 0 0.0014094662619754672
relative O 0 0.01713905856013298
intertissue O 1 0.998815655708313
transcription O 1 0.9992450475692749
levels O 0 0.0206038486212492
and O 0 0.003905481891706586
proliferative O 1 0.999934196472168
capacities O 0 0.040803711861371994
. O 0 0.0064812093041837215

A O 0 0.03438310697674751
( O 0 0.01204066351056099
CTG O 1 0.9945764541625977
) O 0 0.009010864421725273
nexpansion O 1 0.5766879320144653
in O 0 0.0017414785688742995
the O 0 0.0019869343377649784
3 O 0 0.015212304890155792
- O 0 0.026771249249577522
untranslated O 1 0.9900065660476685
region O 0 0.00843085814267397
( O 0 0.006075517274439335
UTR O 1 0.9945764541625977
) O 0 0.002739962888881564
of O 0 0.0007855712319724262
the O 0 0.004260861314833164
DM O 1 0.9999853372573853
protein O 1 0.9998574256896973
kinase O 1 0.9999755620956421
gene O 1 0.9999575614929199
( O 0 0.010228250175714493
DMPK O 1 0.9980120658874512
) O 0 0.0039188554510474205
is O 0 0.0017884890548884869
responsible O 0 0.009373053908348083
for O 0 0.005648063961416483
causing O 1 0.9996826648712158
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999997615814209
( O 0 0.04704858735203743
DM B-Disease 1 0.9999748468399048
) O 0 0.011838837526738644
. O 0 0.006868879310786724

Major O 0 0.03464595600962639
instability O 1 0.9220601320266724
, O 0 0.0020991216879338026
with O 0 0.0021226853132247925
very O 0 0.00234232097864151
large O 0 0.004051851108670235
expansions O 0 0.09480210393667221
between O 0 0.0027051186189055443
generations O 0 0.009863384068012238
and O 0 0.0009552735718898475
high O 0 0.0030193773563951254
levels O 0 0.009359731338918209
of O 0 0.002689771819859743
somatic O 1 0.9999876022338867
mosaicism O 1 0.9999648332595825
, O 0 0.0029083536937832832
is O 0 0.0019627793226391077
observed O 0 0.013418479822576046
in O 0 0.005108618177473545
patients O 1 0.9993481040000916
. O 0 0.00854919571429491

There O 0 0.0036575591657310724
is O 0 0.001909450744278729
a O 0 0.005034520290791988
good O 0 0.006638681516051292
correlation O 1 0.860789954662323
between O 0 0.004113859962671995
repeat O 1 0.79561448097229
size O 0 0.012211653403937817
( O 0 0.0029291484970599413
at O 0 0.0016395373968407512
least O 0 0.0030130052473396063
in O 0 0.0024598168674856424
leucocytes O 1 0.9993583559989929
) O 0 0.0068345628678798676
, O 0 0.004184055607765913
clinical O 1 0.9999575614929199
severity O 1 0.9973821043968201
and O 0 0.0014667839277535677
age O 0 0.00558784743770957
of O 0 0.00343146244995296
onset O 1 0.9999393224716187
. O 0 0.009664377197623253

The O 0 0.010710366070270538
trinucleotide O 1 0.9948630928993225
repeat O 1 0.6869246363639832
instability O 1 0.8851711750030518
mechanisms O 1 0.8811383247375488
involved O 0 0.009031625464558601
in O 0 0.00345096574164927
DM B-Disease 1 0.9999861717224121
and O 0 0.0017733982531353831
other O 0 0.0018730242736637592
human O 1 0.6932127475738525
genetic B-Disease 1 0.9999997615814209
diseases I-Disease 1 0.9999985694885254
are O 0 0.0019944619853049517
unknown O 0 0.018365364521741867
. O 0 0.005008708219975233

We O 0 0.005417811684310436
studied O 0 0.013467686250805855
somatic O 1 0.9997320771217346
instability O 1 0.5100311040878296
by O 0 0.0024345603305846453
measuring O 0 0.017008725553750992
the O 0 0.0035922336392104626
CTG O 1 0.9994397759437561
repeat O 1 0.743860125541687
length O 0 0.010308747179806232
at O 0 0.0014775960007682443
several O 0 0.0014690972166135907
ages O 0 0.006379065569490194
in O 0 0.0009695413173176348
various O 0 0.0021629435941576958
tissues O 1 0.9994100332260132
of O 0 0.0026520818937569857
transgenic O 1 0.999890923500061
mice O 1 0.9997537732124329
carrying O 0 0.013213473372161388
a O 0 0.009535248391330242
( O 0 0.0075166975148022175
CTG O 1 0.9993368983268738
) O 0 0.006873871199786663
55expansion O 1 0.900185763835907
surrounded O 0 0.010463599115610123
by O 0 0.002354949712753296
45 O 0 0.007591220084577799
kb O 0 0.45103007555007935
of O 0 0.0010380870662629604
the O 0 0.002279489068314433
human O 0 0.05217284336686134
DM B-Disease 1 0.9999748468399048
region O 0 0.008359437808394432
, O 0 0.001435500686056912
using O 0 0.007257051765918732
small O 0 0.007355398032814264
- O 0 0.02387334406375885
pool O 0 0.08515126258134842
PCR O 1 0.9957464337348938
. O 0 0.011179095134139061

These O 0 0.010574394837021828
mice O 1 0.9995983242988586
have O 0 0.0020818382035940886
been O 0 0.0013477555476129055
shown O 0 0.004249156452715397
to O 0 0.0012712078168988228
reproduce O 0 0.3672904670238495
the O 0 0.0021919028367847204
intergenerational O 1 0.9994446635246277
and O 0 0.002981293248012662
somatic O 1 0.9999051094055176
instability O 0 0.24227717518806458
of O 0 0.001162035739980638
the O 0 0.001999861327931285
55 O 0 0.022323541343212128
CTG O 1 0.9994205236434937
repeat O 0 0.37247443199157715
suggesting O 0 0.013793781399726868
that O 0 0.001217287266626954
surrounding O 0 0.008281989023089409
sequences O 0 0.1280696988105774
and O 0 0.000875134370289743
the O 0 0.0020638226997107267
chromatin O 1 0.9994961023330688
environment O 0 0.007336270995438099
are O 0 0.0009415868553332984
involved O 0 0.005894778296351433
in O 0 0.0031407454516738653
instability O 1 0.9867421984672546
mechanisms O 1 0.9332839250564575
. O 0 0.006983333732932806

As O 0 0.0045788646675646305
observed O 0 0.008887163363397121
in O 0 0.0008605553302913904
some O 0 0.0005249710520729423
of O 0 0.0005886696162633598
the O 0 0.002255392028018832
tissues O 1 0.9999518394470215
of O 0 0.006858737673610449
DM B-Disease 1 0.9999997615814209
patients O 1 0.9999233484268188
, O 0 0.0017411644803360105
there O 0 0.0009041270823217928
is O 0 0.0011322577483952045
a O 0 0.004148839972913265
tendency O 0 0.04060635343194008
for O 0 0.002245415700599551
repeat O 0 0.22608575224876404
length O 0 0.010746338404715061
and O 0 0.002991605317220092
somatic O 1 0.9999690055847168
mosaicism O 1 0.9998682737350464
to O 0 0.0024853800423443317
increase O 0 0.0048240553587675095
with O 0 0.0015900378348305821
the O 0 0.0011752694845199585
age O 0 0.0034644438419491053
of O 0 0.0009401965071447194
the O 0 0.003366058925166726
mouse O 1 0.9997994303703308
. O 0 0.008324623107910156

Furthermore O 0 0.031962934881448746
, O 0 0.001747508649714291
we O 0 0.0011601941660046577
observed O 0 0.006830479484051466
no O 0 0.0029933368787169456
correlation O 0 0.36338934302330017
between O 0 0.0022753593511879444
the O 0 0.00330847199074924
somatic O 1 0.9999508857727051
mutation O 1 0.9999755620956421
rate O 0 0.015848588198423386
and O 0 0.0037036193534731865
tissue O 1 0.9999759197235107
proliferation O 1 0.9389339685440063
capacity O 0 0.00901684071868658
. O 0 0.0048207868821918964

The O 0 0.010430486872792244
somatic O 1 0.9998018145561218
mutation O 1 0.99996018409729
rates O 0 0.015114222653210163
in O 0 0.0014047634322196245
different O 0 0.0039558750577270985
tissues O 1 0.9999053478240967
were O 0 0.000849180098157376
also O 0 0.000931137299630791
not O 0 0.0012992274714633822
correlated O 1 0.6802620887756348
to O 0 0.0008869028533808887
the O 0 0.0012941915774717927
relative O 0 0.015790041536092758
inter O 0 0.35329216718673706
- O 0 0.09677974879741669
tissue O 1 0.9998049139976501
difference O 0 0.011782295070588589
in O 0 0.0017589728813618422
transcriptional O 1 0.9989092350006104
levels O 0 0.006833018735051155
of O 0 0.0004851197882089764
the O 0 0.0010778279975056648
three O 0 0.004076701123267412
genes O 1 0.99992835521698
( O 0 0.008112958632409573
DMAHP O 1 0.9994788765907288
, O 0 0.0036914919037371874
DMPK O 1 0.9979425072669983
and O 0 0.0021922749001532793
59 O 0 0.02017417922616005
) O 0 0.0029058437794446945
surrounding O 0 0.005563513375818729
the O 0 0.002347930334508419
repeat O 1 0.7892792820930481
. O 0 0.0031806251499801874
. O 0 0.004736794158816338

A O 0 0.025351474061608315
novel O 0 0.04415813460946083
missense O 1 0.9999017715454102
mutation O 1 0.9999758005142212
in O 0 0.006402428261935711
patients O 1 0.9990610480308533
from O 0 0.00339137832634151
a O 0 0.014931458048522472
retinoblastoma B-Disease 1 0.9999767541885376
pedigree O 1 0.9916062355041504
showing O 0 0.00933683943003416
only O 0 0.0025021489709615707
mild O 1 0.9643583297729492
expression O 0 0.020753880962729454
of O 0 0.001481036888435483
the O 0 0.007321576122194529
tumor B-Disease 1 0.9999995231628418
phenotype O 1 0.999974250793457
. O 0 0.011013545095920563

We O 0 0.0026950340252369642
have O 0 0.0010347842471674085
used O 0 0.0030762942042201757
single O 0 0.012979932129383087
strand O 1 0.9972434043884277
conformation O 1 0.9974435567855835
polymorphism O 1 0.9963905215263367
analysis O 0 0.01307034119963646
to O 0 0.0012838310794904828
study O 0 0.0036855232901871204
the O 0 0.0014240428572520614
27 O 0 0.010883190669119358
exons O 1 0.9713404774665833
of O 0 0.00132878462318331
the O 0 0.004552188329398632
RB1 O 1 0.9999949932098389
gene O 1 0.9999350309371948
in O 0 0.0020874158944934607
individuals O 0 0.0036480766721069813
from O 0 0.0019812406972050667
a O 0 0.005662632640451193
family O 0 0.010908149182796478
showing O 0 0.01700877957046032
mild O 1 0.9906987547874451
expression O 0 0.02790290117263794
of O 0 0.0014657470164820552
the O 0 0.006532712839543819
retinoblastoma B-Disease 1 0.9999973773956299
phenotype O 1 0.9999864101409912
. O 0 0.008386360481381416

In O 0 0.00371892680414021
this O 0 0.0021001326385885477
family O 0 0.01070259977132082
affected O 0 0.015855833888053894
individuals O 0 0.00772231025621295
developed O 0 0.2121775895357132
unilateral B-Disease 1 0.9975820779800415
tumors I-Disease 1 0.9999990463256836
and O 0 0.0021540739107877016
, O 0 0.0010562929091975093
as O 0 0.0012015718966722488
a O 0 0.0037268002051860094
result O 0 0.0062340800650417805
of O 0 0.0018498095450922847
linkage O 1 0.9983890056610107
analysis O 0 0.018925946205854416
, O 0 0.003145736875012517
unaffected O 1 0.9995478987693787
mutation O 1 0.9999964237213135
carriers O 1 0.8870470523834229
were O 0 0.0008037986699491739
also O 0 0.0010798875009641051
identified O 0 0.006493974477052689
within O 0 0.002263307571411133
the O 0 0.002851353259757161
pedigree O 1 0.9939124584197998
. O 0 0.007898355834186077

A O 0 0.01715255156159401
single O 0 0.010822352953255177
band O 0 0.011548325419425964
shift O 0 0.018689464777708054
using O 0 0.013413215056061745
SSCP O 1 0.998439610004425
was O 0 0.0029730189125984907
identified O 0 0.009495161473751068
in O 0 0.0024649782571941614
exon O 1 0.9988914132118225
21 O 0 0.007731480523943901
which O 0 0.0011712478008121252
resulted O 0 0.009236708283424377
in O 0 0.0014671434182673693
a O 0 0.00997224636375904
missense O 1 0.9997541308403015
mutation O 1 0.9997636675834656
converting O 0 0.05183006823062897
a O 0 0.020139500498771667
cys O 1 0.999715268611908
- O 0 0.15720915794372559
- O 0 0.08766207098960876
> O 1 0.9981009364128113
arg O 1 0.9878820180892944
at O 0 0.007668072823435068
nucleotide O 1 0.9919945001602173
position O 0 0.0049079107120633125
28 O 0 0.005742506589740515
in O 0 0.0013146419078111649
the O 0 0.0034265443682670593
exon O 1 0.9961850047111511
. O 0 0.009143514558672905

The O 0 0.009206712245941162
mutation O 1 0.9997376799583435
destroyed O 0 0.016335362568497658
an O 0 0.003801412181928754
NdeI O 1 0.9849350452423096
restriction O 0 0.11657398194074631
enzyme O 1 0.9989135265350342
site O 0 0.01428898423910141
. O 0 0.0066236634738743305

Analysis O 0 0.02110249362885952
of O 0 0.0010811681859195232
all O 0 0.0008331445278599858
family O 0 0.005421726033091545
members O 0 0.0013019514735788107
demonstrated O 0 0.005575822666287422
that O 0 0.0007933793822303414
the O 0 0.002712009474635124
missense O 1 0.9999921321868896
mutation O 1 0.9999972581863403
co O 1 0.7995427846908569
- O 0 0.018453367054462433
segregated O 0 0.10704884678125381
with O 0 0.007086704485118389
patients O 1 0.9999089241027832
with O 0 0.01865307427942753
tumors B-Disease 1 0.9999998807907104
or O 0 0.005184258334338665
who O 0 0.0013533938908949494
, O 0 0.0009111693361774087
as O 0 0.0010542223462834954
a O 0 0.0036111664958298206
result O 0 0.006244945339858532
of O 0 0.001324727782048285
linkage O 1 0.9992826581001282
analysis O 0 0.015443638898432255
had O 0 0.001540325814858079
been O 0 0.0013351235538721085
predicted O 0 0.007603389210999012
to O 0 0.0010004224022850394
carry O 0 0.006858734413981438
the O 0 0.004236862529069185
predisposing O 1 0.9999704360961914
mutation O 1 0.9999359846115112
. O 0 0.009585756808519363

These O 0 0.003296532202512026
observations O 0 0.007357567083090544
point O 0 0.0023887360002845526
to O 0 0.0008878294611349702
another O 0 0.003288595238700509
region O 0 0.0018913253443315625
of O 0 0.0007851999835111201
the O 0 0.003840469289571047
RB1 O 1 0.9999953508377075
gene O 1 0.9999161958694458
where O 0 0.005450115073472261
mutations O 1 0.9999372959136963
only O 0 0.00156141456682235
modify O 0 0.03861656039953232
the O 0 0.001121116103604436
function O 0 0.011211506091058254
of O 0 0.0007223071297630668
the O 0 0.0033575051929801702
gene O 1 0.9999788999557495
and O 0 0.001418334781192243
raise O 0 0.006931912153959274
important O 0 0.0015548341907560825
questions O 0 0.002775569213554263
for O 0 0.002671154448762536
genetic O 1 0.9999852180480957
counseling O 1 0.9920367002487183
in O 0 0.0014449224108830094
families O 0 0.003778425743803382
with O 0 0.0023183091543614864
these O 0 0.00224760128185153
distinctive O 1 0.9536192417144775
phenotypes O 1 0.9999618530273438
. O 0 0.004218630027025938
. O 0 0.004500133451074362

Maternal B-Disease 1 0.9737359881401062
disomy I-Disease 1 0.9817991852760315
and O 0 0.01358415000140667
Prader B-Disease 1 0.9999943971633911
- I-Disease 1 0.9964385032653809
Willi I-Disease 1 0.9999885559082031
syndrome I-Disease 1 0.999997615814209
consistent O 0 0.025361929088830948
with O 0 0.0070278225466609
gamete O 1 0.9999144077301025
complementation O 1 0.9998775720596313
in O 0 0.002304543973878026
a O 0 0.003867768682539463
case O 0 0.0056068687699735165
of O 0 0.0029089634772390127
familial O 1 0.9999985694885254
translocation O 1 0.9999885559082031
( O 0 0.006376147270202637
3 O 0 0.009292630478739738
; O 0 0.004004298243671656
15 O 0 0.0053514475002884865
) O 0 0.003773131174966693
( O 0 0.006267668213695288
p25 O 1 0.9998680353164673
; O 0 0.008887923322618008
q11 O 1 0.9939259886741638
. O 0 0.0035367547534406185
2 O 0 0.009426819160580635
) O 0 0.005160489119589329
. O 0 0.0062639364041388035

Maternal B-Disease 1 0.9906145334243774
uniparental I-Disease 1 0.9997894167900085
disomy I-Disease 1 0.9930204749107361
( I-Disease 0 0.01917777769267559
UPD I-Disease 1 0.9998624324798584
) I-Disease 0 0.006156792398542166
for I-Disease 0 0.003787409048527479
chromosome I-Disease 1 0.9999862909317017
15 I-Disease 0 0.005013280548155308
is O 0 0.0013927308609709144
responsible O 0 0.005898389499634504
for O 0 0.0010128653375431895
an O 0 0.001267950632609427
estimated O 0 0.003768069203943014
30 O 0 0.0028621326200664043
% O 0 0.0026467519346624613
of O 0 0.000817802210804075
cases O 0 0.00623660022392869
of O 0 0.003851651679724455
Prader B-Disease 1 0.9999991655349731
- I-Disease 1 0.999262273311615
Willi I-Disease 1 0.9999980926513672
syndrome I-Disease 1 0.9999995231628418
( O 0 0.028680233284831047
PWS B-Disease 1 0.9999707937240601
) O 0 0.008827978745102882
. O 0 0.006095447111874819

We O 0 0.00319619826041162
report O 0 0.00210289447568357
on O 0 0.0008045886643230915
an O 0 0.001504015177488327
unusual O 0 0.009303017519414425
case O 0 0.00462047616019845
of O 0 0.0017671433743089437
maternal B-Disease 1 0.9987393021583557
disomy I-Disease 1 0.9982376098632812
15 I-Disease 0 0.007186973001807928
in O 0 0.004395185969769955
PWS B-Disease 1 0.9999935626983643
that O 0 0.0021888273768126965
is O 0 0.0012691746233031154
most O 0 0.0011450119782239199
consistent O 0 0.009122581221163273
with O 0 0.0023643947206437588
adjacent O 0 0.019411582499742508
- O 0 0.013607656583189964
1 O 0 0.007113166153430939
segregation O 0 0.02417946606874466
of O 0 0.001523445243947208
a O 0 0.011642180383205414
paternal O 1 0.9996960163116455
t O 1 0.9995700716972351
( O 0 0.0059928265400230885
3 O 0 0.009544918313622475
; O 0 0.003973099868744612
15 O 0 0.005663970485329628
) O 0 0.004247510340064764
( O 0 0.006218301132321358
p25 O 1 0.9999027252197266
; O 0 0.008233916945755482
q11 O 1 0.9946871995925903
. O 0 0.0023604959715157747
2 O 0 0.005633803550153971
) O 0 0.002230293583124876
with O 0 0.001993892714381218
simultaneous O 0 0.31742268800735474
maternal O 1 0.9985793828964233
meiotic O 1 0.9999034404754639
nondisjunction O 1 0.9882797002792358
for O 0 0.007060942705720663
chromosome O 1 0.9998499155044556
15 O 0 0.011711184866726398
. O 0 0.0054951682686805725

The O 0 0.010978871956467628
patient O 1 0.9981814622879028
( O 0 0.01245496142655611
J O 1 0.9999641180038452
. O 0 0.005940382368862629
B O 1 0.9964309930801392
. O 0 0.002300218679010868
) O 0 0.0024477653205394745
, O 0 0.0011042251717299223
a O 0 0.006794878747314215
17 O 0 0.013802697882056236
- O 0 0.020508456975221634
year O 0 0.005284606013447046
- O 0 0.016978902742266655
old O 0 0.013220787048339844
white O 0 0.015327928587794304
male O 0 0.05139286816120148
with O 0 0.007962153293192387
PWS B-Disease 1 0.9999939203262329
, O 0 0.002730896696448326
was O 0 0.0016356442356482148
found O 0 0.002985037863254547
to O 0 0.0009500563028268516
have O 0 0.0012396251549944282
47 O 0 0.01601896807551384
chromosomes O 1 0.996585488319397
with O 0 0.0034652212634682655
a O 0 0.008632765151560307
supernumerary O 1 0.998822033405304
, O 0 0.005813143216073513
paternal O 1 0.9986408352851868
der O 1 0.9200445413589478
( O 0 0.005781317595392466
15 O 0 0.00588284432888031
) O 0 0.002349380636587739
consisting O 0 0.0035828296095132828
of O 0 0.0006473683170042932
the O 0 0.001715581282041967
short O 0 0.011986810714006424
arm O 1 0.8380937576293945
and O 0 0.0011050048051401973
the O 0 0.0029550548642873764
proximal O 1 0.9999122619628906
long O 0 0.017477571964263916
arm O 1 0.5216954350471497
of O 0 0.00407837051898241
chromosome O 1 0.9999901056289673
15 O 0 0.007012336514890194
, O 0 0.0019118955824524164
and O 0 0.0035915335174649954
distal O 1 0.9999812841415405
chromosome O 1 0.9999823570251465
arm O 1 0.9804961085319519
3p O 1 0.9953930377960205
. O 0 0.011715170927345753

The O 0 0.01111894566565752
t O 1 0.9989525079727173
( O 0 0.008040501736104488
3 O 0 0.01194888073951006
; O 0 0.004359647165983915
15 O 0 0.005198819562792778
) O 0 0.002501619281247258
was O 0 0.0012253911700099707
present O 0 0.0015532958786934614
in O 0 0.0008025668212212622
the O 0 0.0013840727042406797
balanced O 0 0.01778685301542282
state O 0 0.0015573329292237759
in O 0 0.00157563213724643
the O 0 0.003741650376468897
patients O 1 0.9998341798782349
father O 0 0.009266081266105175
and O 0 0.0015346702421084046
a O 0 0.008547846227884293
sister O 0 0.066828653216362
. O 0 0.006810137070715427

Fluorescent O 1 0.9527456164360046
in O 0 0.00783393532037735
situ O 1 0.9963433146476746
hybridization O 1 0.9917381405830383
analysis O 0 0.017876194790005684
demonstrated O 0 0.009106333367526531
that O 0 0.0011750791454687715
the O 0 0.0030880242120474577
PWS B-Disease 1 0.9999833106994629
critical O 0 0.016425341367721558
region O 0 0.003794181626290083
resided O 0 0.008483875542879105
on O 0 0.0009594808798283339
the O 0 0.0026157782413065434
derivative O 1 0.9997816681861877
chromosome O 1 0.9999933242797852
3 O 0 0.007538338657468557
and O 0 0.0007584557752124965
that O 0 0.000800074078142643
there O 0 0.000777641253080219
was O 0 0.0012944708578288555
no O 0 0.002931649098172784
deletion O 1 0.9985077977180481
of O 0 0.0014840628718957305
the O 0 0.0037161395885050297
PWS B-Disease 1 0.9999818801879883
region O 0 0.005118352361023426
on O 0 0.001024743658490479
the O 0 0.0016082902438938618
normal O 0 0.02051042765378952
pair O 0 0.013284632936120033
of O 0 0.0019937946926802397
15s O 1 0.9956563711166382
present O 0 0.005666851997375488
in O 0 0.004744968377053738
J O 1 0.9995108842849731
. O 0 0.008964121341705322

B O 1 0.7897557020187378
. O 0 0.012522141449153423

Methylation O 1 0.9717806577682495
analysis O 0 0.02601345255970955
at O 0 0.005455622915178537
exon O 1 0.988121509552002
alpha O 0 0.05681019276380539
of O 0 0.0008593028760515153
the O 0 0.0010927633848041296
small O 0 0.0054054586216807365
nuclear O 0 0.025082793086767197
ribonucleoprotein O 1 0.9995304346084595
- O 0 0.029234327375888824
associated O 0 0.024264786392450333
polypeptide O 1 0.9997261166572571
N O 1 0.7801390886306763
( O 0 0.007994413375854492
SNRPN O 1 0.998773992061615
) O 0 0.008694559335708618
gene O 1 0.9994742274284363
showed O 0 0.007621563505381346
a O 0 0.005827430170029402
pattern O 0 0.32970374822616577
characteristic O 0 0.03506584092974663
of O 0 0.0005525736487470567
only O 0 0.0009871775982901454
the O 0 0.0025785702746361494
maternal O 1 0.9997307658195496
chromosome O 1 0.9999850988388062
15 O 0 0.008637303486466408
in O 0 0.004700241144746542
J O 1 0.9992799162864685
. O 0 0.010852445848286152

B O 1 0.692307710647583
. O 0 0.012638724409043789

Maternal B-Disease 1 0.9943333864212036
disomy I-Disease 1 0.9488470554351807
was O 0 0.004063331987708807
confirmed O 0 0.010495898313820362
by O 0 0.005317592062056065
polymerase O 1 0.9998089671134949
chain O 1 0.7835721373558044
reaction O 0 0.033732324838638306
analysis O 0 0.012059525586664677
of O 0 0.0028817548882216215
microsatellite O 1 0.9998679161071777
repeats O 0 0.2825199067592621
at O 0 0.0023399353958666325
the O 0 0.0026037869974970818
gamma O 1 0.9932576417922974
- O 0 0.043636124581098557
aminobutyric O 1 0.9945704340934753
acid O 1 0.999004065990448
receptor O 1 0.9992682337760925
beta3 O 1 0.9887688159942627
subunit O 1 0.9967764019966125
( O 0 0.013104499317705631
GABRB3 O 1 0.996253252029419
) O 0 0.013135187327861786
locus O 1 0.9978129863739014
. O 0 0.009314988739788532

A O 0 0.03616241738200188
niece O 1 0.9898346066474915
( O 0 0.01029951311647892
B O 1 0.9925472140312195
. O 0 0.005020995158702135
B O 1 0.989969789981842
. O 0 0.0018655456369742751
) O 0 0.0020196125842630863
with O 0 0.0017894880147650838
45 O 0 0.00806840043514967
chromosomes O 1 0.9982483386993408
and O 0 0.0010967348935082555
the O 0 0.002076289150863886
derivative O 1 0.9952577948570251
3 O 0 0.008012626320123672
but O 0 0.0012581305345520377
without O 0 0.0025702298153191805
the O 0 0.002337707905098796
der O 1 0.6846730709075928
( O 0 0.0046641346998512745
15 O 0 0.004608959890902042
) O 0 0.0028193723410367966
demonstrated O 0 0.01208066288381815
a O 0 0.010969837196171284
phenotype O 1 0.9999942779541016
consistent O 0 0.01571810245513916
with O 0 0.0018401946872472763
that O 0 0.0011814124882221222
reported O 0 0.00592674920335412
for O 0 0.0026623732410371304
haploinsufficiency O 1 0.9811134338378906
of O 0 0.004757355432957411
distal O 1 0.9999052286148071
3 O 0 0.024225275963544846
p O 1 0.724273145198822
. O 0 0.0070837996900081635

Uniparental B-Disease 1 0.9998026490211487
disomy I-Disease 1 0.9940347075462341
associated O 0 0.01874026469886303
with O 0 0.005065604113042355
unbalanced O 1 0.8002536296844482
segregation O 0 0.04539886862039566
of O 0 0.0018855446251109242
non O 0 0.016205130144953728
- O 0 0.07824689894914627
Robertsonian O 1 0.9992177486419678
translocations O 1 0.9998549222946167
has O 0 0.002855123020708561
been O 0 0.0020209422800689936
reported O 0 0.007325104437768459
previously O 0 0.0035314972046762705
but O 0 0.0013608080334961414
has O 0 0.0012904917821288109
not O 0 0.000914036005269736
, O 0 0.0006840360583737493
to O 0 0.0007443070062436163
our O 0 0.0017657552380114794
knowledge O 0 0.004930023103952408
, O 0 0.0010837409645318985
been O 0 0.001488385139964521
observed O 0 0.007018239237368107
in O 0 0.0010671806521713734
a O 0 0.004545796662569046
case O 0 0.006172278895974159
of O 0 0.003767408663406968
PWS B-Disease 1 0.9999576807022095
. O 0 0.010445648804306984

Furthermore O 0 0.03353412076830864
, O 0 0.001728075323626399
our O 0 0.0021032278891652822
findings O 0 0.01029855478554964
are O 0 0.0008885115385055542
best O 0 0.0027618242893368006
interpreted O 0 0.007619324140250683
as O 0 0.001703461050055921
true O 0 0.014644211158156395
gamete O 1 0.9996817111968994
complementation O 1 0.9998229146003723
resulting O 0 0.053804751485586166
in O 0 0.005223623476922512
maternal B-Disease 1 0.9995143413543701
UPD I-Disease 1 0.9999027252197266
15 I-Disease 0 0.01428921241313219
and O 0 0.006939249578863382
PWS B-Disease 1 0.9997288584709167

Schwartz B-Disease 1 0.9825989007949829
- I-Disease 1 0.7513653635978699
Jampel I-Disease 1 0.9998884201049805
syndrome I-Disease 1 0.9999992847442627
type I-Disease 1 0.5336672067642212
2 I-Disease 0 0.0076029435731470585
and O 0 0.0035425000824034214
Stuve B-Disease 1 0.9997922778129578
- I-Disease 1 0.9952527284622192
Wiedemann I-Disease 1 0.9999876022338867
syndrome I-Disease 1 0.9999995231628418
: O 0 0.005673320032656193
a O 0 0.00635131448507309
case O 0 0.006628378294408321
for O 0 0.0017316400771960616
" O 0 0.005738908890634775
lumping O 1 0.9738147854804993
" O 0 0.007532072719186544
. O 0 0.0058865295723080635

Recent O 0 0.014886652119457722
studies O 0 0.010644141584634781
demonstrated O 0 0.007582039572298527
the O 0 0.0008648751536384225
existence O 0 0.0029586313758045435
of O 0 0.0007996640633791685
a O 0 0.006645622197538614
genetically O 1 0.9993534684181213
distinct O 0 0.03215339034795761
, O 0 0.0015128158265724778
usually O 0 0.004985092673450708
lethal O 1 0.9794358015060425
form O 0 0.005347013007849455
of O 0 0.0007072563166730106
the O 0 0.003031934378668666
Schwartz B-Disease 1 0.9991844296455383
- I-Disease 1 0.974162757396698
Jampel I-Disease 1 0.9999443292617798
syndrome I-Disease 1 0.9999996423721313
( O 0 0.022112445905804634
SJS B-Disease 1 0.9999818801879883
) O 0 0.0045227063819766045
of O 0 0.0027702422812581062
myotonia B-Disease 1 0.9999830722808838
and O 0 0.006787359248846769
skeletal B-Disease 1 0.9999963045120239
dysplasia I-Disease 1 0.9999998807907104
, O 0 0.0021672495640814304
which O 0 0.0011433998588472605
we O 0 0.001799890655092895
called O 0 0.024487227201461792
SJS B-Disease 1 0.9999849796295166
type I-Disease 1 0.7352871298789978
2 I-Disease 0 0.013080697506666183
. O 0 0.005602946504950523

This O 0 0.011563957668840885
disorder O 1 0.9999406337738037
is O 0 0.0028111180290579796
reminiscent O 0 0.021566016599535942
of O 0 0.0011554438387975097
another O 0 0.007586828898638487
rare O 1 0.5192946791648865
condition O 1 0.8253910541534424
, O 0 0.0011904019629582763
the O 0 0.0029260790906846523
Stuve B-Disease 1 0.9999469518661499
- I-Disease 1 0.9981435537338257
Wiedemann I-Disease 1 0.9999945163726807
syndrome I-Disease 1 0.9999997615814209
( O 0 0.01993853785097599
SWS B-Disease 1 0.9999767541885376
) O 0 0.0052739339880645275
, O 0 0.0009206772083416581
which O 0 0.0010123314568772912
comprises O 0 0.0056658959947526455
campomelia B-Disease 1 0.9894798398017883
at O 0 0.003013019450008869
birth O 0 0.3469097912311554
with O 0 0.008914055302739143
skeletal B-Disease 1 0.9999988079071045
dysplasia I-Disease 1 0.9999998807907104
, O 0 0.0076386453583836555
contractures B-Disease 1 0.9999891519546509
, O 0 0.002811805112287402
and O 0 0.0015559270977973938
early B-Disease 0 0.0074377586133778095
death I-Disease 0 0.027691062539815903
. O 0 0.007549037225544453

To O 0 0.004255188629031181
test O 0 0.013099419884383678
for O 0 0.0020027344580739737
possible O 0 0.010329117067158222
nosologic O 1 0.9915156364440918
identity O 0 0.020280567929148674
between O 0 0.0034670510794967413
these O 0 0.004628979600965977
disorders O 1 0.9999985694885254
, O 0 0.0016168724978342652
we O 0 0.0008898425148800015
reviewed O 0 0.004384434316307306
the O 0 0.0009807858150452375
literature O 0 0.0037846234627068043
and O 0 0.0009484816109761596
obtained O 0 0.00572636304423213
a O 0 0.00400807149708271
follow O 0 0.00919751264154911
- O 0 0.008526142686605453
up O 0 0.0016487928805872798
of O 0 0.0005448235897347331
the O 0 0.000780203496105969
only O 0 0.0010411106050014496
two O 0 0.0026139402762055397
surviving O 1 0.9932745695114136
patients O 1 0.9997864365577698
, O 0 0.0014800188364461064
one O 0 0.0023145778104662895
with O 0 0.01045575737953186
SJS B-Disease 1 0.9999969005584717
type I-Disease 1 0.9085566401481628
2 I-Disease 0 0.00806391704827547
at O 0 0.002360143233090639
age O 0 0.004392413422465324
10 O 0 0.0027148511726409197
years O 0 0.0014757062308490276
and O 0 0.0009552148403599858
another O 0 0.006373391952365637
with O 0 0.00694691576063633
SWS B-Disease 1 0.9999492168426514
at O 0 0.005570609122514725
age O 0 0.00740966759622097
7 O 0 0.010312674567103386
years O 0 0.003460327396169305
. O 0 0.004997428506612778

Patients O 1 0.9989209175109863
reported O 0 0.010226896964013577
as O 0 0.0016326910117641091
having O 0 0.006444279104471207
either O 0 0.05252883955836296
neonatal O 1 0.9999991655349731
SJS B-Disease 1 0.9999579191207886
or O 0 0.018788501620292664
SWS B-Disease 1 0.9997250437736511
presented O 0 0.0065230028703808784
a O 0 0.005074578803032637
combination O 0 0.035149846225976944
of O 0 0.0011486242292448878
a O 0 0.009925231337547302
severe O 1 0.9982843995094299
, O 0 0.00865093432366848
prenatal O 1 0.9999970197677612
- O 1 0.9978804588317871
onset O 1 0.9999970197677612
neuromuscular B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999905824661255
( O 0 0.008295504376292229
with O 0 0.012520118616521358
congenital B-Disease 1 0.9999998807907104
joint I-Disease 1 0.9977772831916809
contractures I-Disease 1 0.999996542930603
, O 0 0.011041424237191677
respiratory O 1 0.9999983310699463
and O 0 0.0027881411369889975
feeding O 1 0.9880826473236084
difficulties O 0 0.05353968217968941
, O 0 0.002544473158195615
tendency O 1 0.6152163743972778
to O 0 0.00573057821020484
hyperthermia B-Disease 1 0.999983549118042
, O 0 0.0023713083937764168
and O 0 0.0016967318952083588
frequent O 0 0.042923394590616226
death O 0 0.02227170579135418
in O 0 0.00405326159670949
infancy O 1 0.998289167881012
) O 0 0.003590115811675787
with O 0 0.0018445511814206839
a O 0 0.006524329073727131
distinct O 0 0.04642956703901291
campomelic B-Disease 1 0.9974126219749451
- I-Disease 0 0.1827993541955948
metaphyseal I-Disease 1 0.9991868138313293
skeletal I-Disease 1 0.9999759197235107
dysplasia I-Disease 1 0.999997615814209
. O 0 0.011789523996412754

The O 0 0.0032188300974667072
similarity O 0 0.03164961561560631
of O 0 0.0009365415317006409
the O 0 0.0021887251641601324
clinical O 1 0.9997627139091492
and O 0 0.002622445812448859
radiographic O 1 0.9999094009399414
findings O 0 0.0142167117446661
is O 0 0.0013216446386650205
so O 0 0.0017666529165580869
extensive O 0 0.007855857722461224
that O 0 0.0011606320040300488
these O 0 0.0035794165451079607
disorders O 1 0.9999988079071045
appear O 0 0.0067246039398014545
to O 0 0.0008368841954506934
be O 0 0.000799437693785876
a O 0 0.003937512636184692
single O 0 0.011184915900230408
entity O 0 0.027301451191306114
. O 0 0.005289140623062849

The O 0 0.005660275928676128
follow O 0 0.013338143937289715
- O 0 0.014546184800565243
up O 0 0.0037854467518627644
observation O 0 0.012902605347335339
of O 0 0.0008372694137506187
an O 0 0.0015566739020869136
identical O 0 0.01936209946870804
and O 0 0.0007921563228592277
unique O 0 0.0053011709824204445
pattern O 0 0.037947338074445724
of O 0 0.0019351018127053976
progressive O 1 0.9997431635856628
bone B-Disease 1 0.9999997615814209
dysplasia I-Disease 1 0.9999996423721313
in O 0 0.001973671605810523
the O 0 0.0014274163404479623
two O 0 0.004607176873832941
patients O 1 0.9999532699584961
( O 0 0.0033633934799581766
one O 0 0.002162605756893754
with O 0 0.009675795212388039
SJS B-Disease 1 0.9999983310699463
type I-Disease 1 0.9265474081039429
2 I-Disease 0 0.006675324402749538
, O 0 0.0009678550995886326
one O 0 0.0020228135399520397
with O 0 0.006162493955343962
SWS B-Disease 1 0.999951958656311
) O 0 0.006491011939942837
surviving O 0 0.03068610280752182
beyond O 0 0.011510785669088364
infancy O 1 0.9952037334442139
adds O 0 0.02136208862066269
to O 0 0.0009697704226709902
the O 0 0.0010530861327424645
evidence O 0 0.002629694528877735
in O 0 0.0012072576209902763
favor O 0 0.00593649223446846
of O 0 0.001465418259613216
identity O 0 0.03222036361694336
. O 0 0.005569161847233772

The O 0 0.005317892879247665
hypothesis O 0 0.10052594542503357
that O 0 0.004733010195195675
SWS B-Disease 1 0.9998525381088257
and O 0 0.011707477271556854
SJS B-Disease 1 0.9999934434890747
type I-Disease 1 0.7300989627838135
2 I-Disease 0 0.004848564974963665
are O 0 0.0005174825782887638
the O 0 0.0010396229336038232
same O 0 0.006654205732047558
disorder O 1 0.9999951124191284
should O 0 0.001461063977330923
be O 0 0.001153566176071763
testable O 1 0.6211696863174438
by O 0 0.003952969331294298
molecular O 1 0.9987571239471436
methods O 0 0.013743405230343342
. O 0 0.0026979525573551655
. O 0 0.004619344603270292

A O 0 0.02769264578819275
mouse O 1 0.9889804124832153
model O 0 0.014512729831039906
of O 0 0.003956397529691458
severe O 1 0.9998979568481445
von B-Disease 1 0.9999842643737793
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999990463256836
: O 0 0.013727759942412376
defects O 1 0.9999783039093018
in O 0 0.006844131276011467
hemostasis O 1 0.9999772310256958
and O 0 0.013959373347461224
thrombosis B-Disease 1 0.9999985694885254
. O 0 0.010933000594377518

von B-Disease 1 0.9916284084320068
Willebrand I-Disease 1 0.9999418258666992
factor I-Disease 0 0.3878213167190552
( I-Disease 0 0.014482603408396244
vWf I-Disease 1 0.9997486472129822
) I-Disease 0 0.044354017823934555
deficiency I-Disease 1 0.9999994039535522
causes O 1 0.999893307685852
severe O 1 0.9999313354492188
von B-Disease 1 0.9999721050262451
Willebrand I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999972581863403
in O 0 0.005954928696155548
humans O 1 0.8641202449798584
. O 0 0.007033201865851879

We O 0 0.004165051504969597
generated O 0 0.012186931446194649
a O 0 0.008396978490054607
mouse O 1 0.9994633793830872
model O 0 0.013538960367441177
for O 0 0.0020539588294923306
this O 0 0.003822209546342492
disease O 1 0.9999513626098633
by O 0 0.0034250144381076097
using O 0 0.016286658123135567
gene O 1 0.9997689127922058
targeting O 0 0.05132810026407242
. O 0 0.007309580687433481

vWf B-Disease 1 0.9986825585365295
- I-Disease 1 0.7752723693847656
deficient I-Disease 1 0.9997057318687439
mice O 1 0.999542236328125
appeared O 0 0.015453502535820007
normal O 0 0.03301788866519928
at O 0 0.004601772408932447
birth O 1 0.8938553333282471
; O 0 0.0027315483894199133
they O 0 0.0007452534046024084
were O 0 0.0009348583989776671
viable O 0 0.12328089028596878
and O 0 0.0020365084055811167
fertile O 0 0.12732836604118347
. O 0 0.007346041966229677

Neither O 0 0.049264486879110336
vWf O 1 0.9953674077987671
nor O 0 0.041256070137023926
vWf O 1 0.998672604560852
propolypeptide O 1 0.9893634915351868
( O 0 0.017305389046669006
von B-Disease 1 0.9990342855453491
Willebrand I-Disease 1 0.999998927116394
antigen O 1 0.9999772310256958
II O 0 0.12099152058362961
) O 0 0.0032505085691809654
were O 0 0.0012058939319103956
detectable O 1 0.9747700691223145
in O 0 0.0032868969719856977
plasma O 1 0.9985595345497131
, O 0 0.00523579865694046
platelets O 1 0.9999784231185913
, O 0 0.0023864032700657845
or O 0 0.00913558155298233
endothelial O 1 0.999993085861206
cells O 1 0.9968945980072021
of O 0 0.0011459733359515667
the O 0 0.0038847168907523155
homozygous O 1 0.9999163150787354
mutant O 1 0.9998757839202881
mice O 1 0.9998015761375427
. O 0 0.011534574441611767

The O 0 0.01066527422517538
mutant O 1 0.9991675615310669
mice O 1 0.9998329877853394
exhibited O 0 0.07513206452131271
defects O 1 0.9998703002929688
in O 0 0.005527146626263857
hemostasis O 1 0.999913215637207
with O 0 0.0035030303988605738
a O 0 0.006501555442810059
highly O 0 0.026869267225265503
prolonged O 1 0.9996950626373291
bleeding O 1 0.9999760389328003
time O 0 0.003858862677589059
and O 0 0.002959508914500475
spontaneous O 1 0.9997513890266418
bleeding O 1 0.9999862909317017
events O 0 0.005902243312448263
in O 0 0.0014003636315464973
approximately O 0 0.003871413180604577
10 O 0 0.0036812431644648314
% O 0 0.004452776163816452
of O 0 0.002926678629592061
neonates O 1 0.9994915723800659
. O 0 0.009897974319756031

As O 0 0.0031451000832021236
in O 0 0.0013570510782301426
the O 0 0.0024831481277942657
human O 1 0.6505110263824463
disease O 1 0.9999958276748657
, O 0 0.0016616882057860494
the O 0 0.0019634277559816837
factor O 1 0.8402966260910034
VIII O 1 0.9964088797569275
level O 0 0.004707214888185263
in O 0 0.001189562026411295
these O 0 0.0029428109992295504
mice O 1 0.9999722242355347
was O 0 0.0028751720674335957
reduced O 0 0.014566839672625065
strongly O 0 0.004036319442093372
as O 0 0.0011584487510845065
a O 0 0.004089152906090021
result O 0 0.005773052107542753
of O 0 0.0006276093772612512
the O 0 0.0009733852348290384
lack O 0 0.006543527822941542
of O 0 0.0010800964664667845
protection O 0 0.011210703290998936
provided O 0 0.005897170398384333
by O 0 0.006373181007802486
vWf O 1 0.9993645548820496
. O 0 0.012592796236276627

Defective O 1 0.9997544884681702
thrombosis B-Disease 1 0.9999920129776001
in O 0 0.010530338622629642
mutant O 1 0.9998432397842407
mice O 1 0.999944806098938
was O 0 0.0035972753539681435
also O 0 0.0014063870767131448
evident O 0 0.008733442053198814
in O 0 0.0009878634009510279
an O 0 0.0013933024602010846
in O 0 0.0026029834989458323
vivo O 1 0.99937903881073
model O 0 0.01927998848259449
of O 0 0.007329829037189484
vascular B-Disease 1 0.9999998807907104
injury I-Disease 1 0.9993857145309448
. O 0 0.010711034759879112

In O 0 0.0041865454986691475
this O 0 0.0019730040803551674
model O 0 0.010696840472519398
, O 0 0.0012439870042726398
the O 0 0.0023597143590450287
exteriorized O 1 0.9971674084663391
mesentery O 1 0.9991433620452881
was O 0 0.00672230776399374
superfused O 1 0.9285961389541626
with O 0 0.008267207071185112
ferric O 1 0.9998633861541748
chloride O 1 0.9991515874862671
and O 0 0.001093382015824318
the O 0 0.001781271887011826
accumulation O 1 0.8728170394897461
of O 0 0.0030277338810265064
fluorescently O 1 0.9995002746582031
labeled O 1 0.9237395524978638
platelets O 1 0.9998605251312256
was O 0 0.003519902704283595
observed O 0 0.011730578728020191
by O 0 0.004731041844934225
intravital O 1 0.9956704378128052
microscopy O 1 0.7930312156677246
. O 0 0.008412361145019531

We O 0 0.0038527052383869886
conclude O 0 0.01320558600127697
that O 0 0.001362290931865573
these O 0 0.0021260736975818872
mice O 1 0.9999148845672607
very O 0 0.004177091643214226
closely O 0 0.012153785675764084
mimic O 1 0.9994188547134399
severe O 1 0.9991100430488586
human O 1 0.8619112372398376
von B-Disease 1 0.9999886751174927
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999994039535522
and O 0 0.0015557181322947145
will O 0 0.0008458137745037675
be O 0 0.0006862554582767189
very O 0 0.0015592921990901232
useful O 0 0.00586656155064702
for O 0 0.0009102147305384278
investigating O 0 0.0055711534805595875
the O 0 0.0010149504523724318
role O 0 0.005274403840303421
of O 0 0.0019415036076679826
vWf O 1 0.9998518228530884
in O 0 0.003115229308605194
normal O 1 0.5976428389549255
physiology O 1 0.9993324875831604
and O 0 0.0019151634769514203
in O 0 0.005154016427695751
disease O 1 0.9999986886978149
models O 0 0.028021089732646942
. O 0 0.0030368908774107695
. O 0 0.005184656009078026

Oral O 1 0.959955632686615
contraceptives O 1 0.9902652502059937
and O 0 0.0015173114370554686
the O 0 0.002158333547413349
risk O 1 0.9429455995559692
of O 0 0.006276564206928015
hereditary B-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.011325771920382977

Hereditary B-Disease 1 0.9999899864196777
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999995231628418
Clinical O 1 0.999808132648468
Study O 0 0.02029142901301384
Group O 0 0.011602544225752354
. O 0 0.00640341779217124

BACKGROUND O 0 0.033912207931280136
Women O 0 0.007451419252902269
with O 0 0.006060982123017311
mutations O 1 0.9999804496765137
in O 0 0.0018984139896929264
either O 0 0.004223143216222525
the O 0 0.0043620034120976925
BRCA1 O 1 0.9999983310699463
or O 0 0.006671373266726732
the O 0 0.00531798554584384
BRCA2 O 1 0.9999994039535522
gene O 1 0.9999001026153564
have O 0 0.0019821752794086933
a O 0 0.004626651294529438
high O 0 0.006934117991477251
lifetime O 0 0.27416548132896423
risk O 1 0.99671870470047
of O 0 0.015077200718224049
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
. O 0 0.010204487480223179

Oral O 1 0.7078341841697693
contraceptives O 1 0.988121509552002
protect O 0 0.03769592568278313
against O 0 0.3749406933784485
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.003238077275454998
general O 0 0.0033432436175644398
, O 0 0.001214227289892733
but O 0 0.001297240611165762
it O 0 0.001022085314616561
is O 0 0.0013020043261349201
not O 0 0.0009301024256274104
known O 0 0.002860655076801777
whether O 0 0.001979613909497857
they O 0 0.0005060869152657688
also O 0 0.0007206583395600319
protect O 0 0.007553919684141874
against O 0 0.004155558999627829
hereditary B-Disease 1 0.9999406337738037
forms I-Disease 0 0.03340364992618561
of I-Disease 0 0.016132492572069168
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.011608096770942211

METHODS O 0 0.02922721765935421
We O 0 0.0029862229712307453
enrolled O 0 0.022656584158539772
207 O 0 0.4296268820762634
women O 0 0.00972708873450756
with O 0 0.020355530083179474
hereditary B-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
and O 0 0.0029197961557656527
161 O 0 0.030581966042518616
of O 0 0.0009138605673797429
their O 0 0.001802332466468215
sisters O 0 0.016016915440559387
as O 0 0.0015023633604869246
controls O 0 0.013698719441890717
in O 0 0.0013283214066177607
a O 0 0.0062935687601566315
case O 0 0.013924313709139824
- O 0 0.02441086806356907
control O 0 0.02427837811410427
study O 0 0.014500909484922886
. O 0 0.006043977569788694

All O 0 0.0022378754802048206
the O 0 0.003120643086731434
patients O 1 0.9935401082038879
carried O 0 0.00943092443048954
a O 0 0.012599249370396137
pathogenic O 1 0.9999096393585205
mutation O 1 0.9999628067016602
in O 0 0.0033882097341120243
either O 0 0.020283792167901993
BRCA1 O 1 0.9999985694885254
( O 0 0.007502871565520763
179 O 0 0.0661989226937294
women O 0 0.006408498622477055
) O 0 0.004739596042782068
or O 0 0.014012320898473263
BRCA2 O 1 0.9999996423721313
( O 0 0.0067355274222791195
28 O 0 0.010066590271890163
women O 0 0.007732380647212267
) O 0 0.006008822470903397
. O 0 0.005502542946487665

The O 0 0.005049128085374832
control O 0 0.015289832837879658
women O 0 0.0032367075327783823
were O 0 0.0009487984352745116
enrolled O 0 0.015842804685235023
regardless O 0 0.005190262105315924
of O 0 0.000934230163693428
whether O 0 0.0030081388540565968
or O 0 0.002705254824832082
not O 0 0.0008302747155539691
they O 0 0.0008930719341151416
had O 0 0.0023616966791450977
either O 0 0.01391439326107502
mutation O 1 0.9999837875366211
. O 0 0.008646727539598942

Lifetime O 0 0.06972063332796097
histories O 0 0.036534618586301804
of O 0 0.003521749284118414
oral O 1 0.9944822788238525
- O 1 0.5167797207832336
contraceptive O 1 0.9998854398727417
use O 0 0.005451373755931854
were O 0 0.0009769871830940247
obtained O 0 0.005872833076864481
by O 0 0.0027511047665029764
interview O 0 0.008930059149861336
or O 0 0.003329161088913679
by O 0 0.001782656996510923
written O 0 0.003102643648162484
questionnaire O 0 0.04513878747820854
and O 0 0.0007908104453235865
were O 0 0.0006509175873361528
compared O 0 0.007494467776268721
between O 0 0.005700359120965004
patients O 1 0.9999406337738037
and O 0 0.0014730124967172742
control O 0 0.028020203113555908
women O 0 0.005254939664155245
, O 0 0.0016968263080343604
after O 0 0.005042606499046087
adjustment O 0 0.03554894030094147
for O 0 0.001499728299677372
year O 0 0.0018220830243080854
of O 0 0.0013284656452015042
birth O 1 0.5530738234519958
and O 0 0.0024355901405215263
parity O 1 0.5154895186424255
. O 0 0.007158947177231312

RESULTS O 0 0.02527519129216671
The O 0 0.0025381045415997505
adjusted O 0 0.014478164725005627
odds O 0 0.040023308247327805
ratio O 0 0.2331826537847519
for O 0 0.03862475976347923
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 0.014500736258924007
with O 0 0.0017188754864037037
any O 0 0.001590719330124557
past O 0 0.0015781966503709555
use O 0 0.002646225970238447
of O 0 0.0015469113131985068
oral O 1 0.9970259070396423
contraceptives O 1 0.9990776777267456
was O 0 0.005930026061832905
0 O 0 0.028638871386647224
. O 0 0.006779816932976246

5 O 0 0.023355184122920036
( O 0 0.006428961642086506
95 O 0 0.01295358408242464
percent O 0 0.005469717551022768
confidence O 0 0.01333013828843832
interval O 0 0.40774333477020264
, O 0 0.002171717118471861
0 O 0 0.0160265751183033
. O 0 0.002077598823234439
3 O 0 0.0051653217524290085
to O 0 0.001829845947213471
0 O 0 0.01812797039747238
. O 0 0.002517982153221965
8 O 0 0.009522611275315285
) O 0 0.005386827979236841
. O 0 0.004751024767756462

The O 0 0.009281200356781483
risk O 1 0.9828724265098572
decreased O 0 0.048442695289850235
with O 0 0.0028060339391231537
increasing O 0 0.0076332357712090015
duration O 0 0.018123693764209747
of O 0 0.0009432564838789403
use O 0 0.006170123349875212
( O 0 0.0060775186866521835
P O 1 0.8880887031555176
for O 0 0.0021430461201816797
trend O 0 0.022142354398965836
, O 0 0.0042847017757594585
< O 1 0.9984679818153381
0 O 0 0.025449302047491074
. O 0 0.004318688064813614
001 O 1 0.9972500205039978
) O 0 0.003955630585551262
; O 0 0.002288675168529153
use O 0 0.00246530887670815
for O 0 0.0011010215384885669
six O 0 0.0027668667025864124
or O 0 0.002403056249022484
more O 0 0.0011069561587646604
years O 0 0.0016546816332265735
was O 0 0.0018322826363146305
associated O 0 0.006854137871414423
with O 0 0.0018858450930565596
a O 0 0.004924263339489698
60 O 0 0.0056402613408863544
percent O 0 0.006170667242258787
reduction O 0 0.09561088681221008
in O 0 0.004244925454258919
risk O 1 0.9891147613525391
. O 0 0.006821518763899803

Oral O 1 0.9803522825241089
- O 0 0.05923258885741234
contraceptive O 1 0.9983377456665039
use O 0 0.008744565770030022
protected O 0 0.02012450061738491
against O 0 0.1999834179878235
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
both O 0 0.002114705042913556
for O 0 0.0015796872321516275
carriers O 0 0.04342858865857124
of O 0 0.0011354618472978473
the O 0 0.00549208652228117
BRCA1 O 1 1.0
mutation O 1 0.999995231628418
( O 0 0.006586610339581966
odds O 0 0.04652632772922516
ratio O 0 0.04027682542800903
, O 0 0.00277989124879241
0 O 0 0.01843259669840336
. O 0 0.002499077934771776
5 O 0 0.007088272366672754
; O 0 0.0030283646192401648
95 O 0 0.009181630797684193
percent O 0 0.0044446177780628204
confidence O 0 0.011067681014537811
interval O 1 0.659522533416748
, O 0 0.0020368320401757956
0 O 0 0.01839270070195198
. O 0 0.0016364229377359152
3 O 0 0.005034474655985832
to O 0 0.0016720829298719764
0 O 0 0.016172047704458237
. O 0 0.0018545424100011587
9 O 0 0.007151362486183643
) O 0 0.002094109309837222
and O 0 0.0006517568253912032
for O 0 0.0011947196908295155
carriers O 0 0.03724709153175354
of O 0 0.001080365153029561
the O 0 0.006161389406770468
BRCA2 O 1 0.9999998807907104
mutation O 1 0.9999948740005493
( O 0 0.006952773779630661
odds O 0 0.08670638501644135
ratio O 0 0.05729968473315239
, O 0 0.0023754131980240345
0 O 0 0.018512379378080368
. O 0 0.0022358843125402927
4 O 0 0.007146390620619059
; O 0 0.0035017323680222034
95 O 0 0.01018216460943222
percent O 0 0.005040195770561695
confidence O 0 0.0129406051710248
interval O 1 0.5815134048461914
, O 0 0.002161659300327301
0 O 0 0.01483514066785574
. O 0 0.001577316434122622
2 O 0 0.004404233768582344
to O 0 0.0013237446546554565
1 O 0 0.005924256052821875
. O 0 0.0021826685406267643
1 O 0 0.007779398467391729
) O 0 0.0046011172235012054
. O 0 0.004995031747967005

CONCLUSIONS O 0 0.05394390970468521
Oral O 1 0.9801415205001831
- O 0 0.2817138135433197
contraceptive O 1 0.9998012185096741
use O 0 0.007360158953815699
may O 0 0.004046218935400248
reduce O 0 0.014707026071846485
the O 0 0.002670345362275839
risk O 1 0.998371422290802
of O 0 0.011955047026276588
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
in O 0 0.0022218069061636925
women O 0 0.0040968796238303185
with O 0 0.0063837431371212006
pathogenic O 1 0.9999816417694092
mutations O 1 0.9999632835388184
in O 0 0.002101522171869874
the O 0 0.005183040630072355
BRCA1 O 1 0.999998927116394
or O 0 0.06444540619850159
BRCA2 O 1 0.9999980926513672
gene O 1 0.9994396567344666

A O 0 0.016419781371951103
Japanese O 0 0.00789025891572237
family O 0 0.010407528840005398
with O 0 0.0067758201621472836
adrenoleukodystrophy B-Disease 1 0.9999909400939941
with O 0 0.0036871677730232477
a O 0 0.008491977117955685
codon O 1 0.9945729374885559
291 O 1 0.9360480308532715
deletion O 1 0.9997269511222839
: O 0 0.00463408837094903
a O 0 0.008621683344244957
clinical O 1 0.9991625547409058
, O 0 0.0034389058127999306
biochemical O 1 0.9998416900634766
, O 0 0.003823606064543128
pathological O 1 0.9997367262840271
, O 0 0.0024978513829410076
and O 0 0.0027374105993658304
genetic O 1 0.9999344348907471
report O 0 0.006929398514330387
. O 0 0.005759746767580509

We O 0 0.0032574182841926813
report O 0 0.002943724626675248
a O 0 0.003904706798493862
Japanese O 0 0.006583911832422018
family O 0 0.012723780237138271
with O 0 0.013253379613161087
adrenoleukodystrophy B-Disease 1 0.9999978542327881
( O 0 0.03446062281727791
ALD B-Disease 1 0.9999966621398926
) O 0 0.0048821154050529
with O 0 0.0017926284344866872
a O 0 0.003545857733115554
three O 0 0.002025415189564228
base O 0 0.008785870857536793
pair O 0 0.044889919459819794
deletion O 1 0.99953293800354
( O 0 0.008696979843080044
delGAG O 1 0.9971352815628052
291 O 1 0.9159753918647766
) O 0 0.0036555491387844086
in O 0 0.0020135848317295313
the O 0 0.007009189575910568
ALD B-Disease 1 0.9999970197677612
gene O 1 0.9995960593223572
. O 0 0.010411989875137806

A O 0 0.01425403356552124
variety O 0 0.006855503655970097
of O 0 0.0023892587050795555
phenotypes O 1 0.9999198913574219
were O 0 0.0013344535836949944
observed O 0 0.007936072535812855
within O 0 0.0023765075020492077
this O 0 0.001569403219036758
family O 0 0.011781217530369759
. O 0 0.007307576946914196

While O 0 0.004871412646025419
the O 0 0.0036640844773501158
proband O 1 0.9986644983291626
( O 0 0.013560828752815723
patient O 1 0.999823272228241
1 O 0 0.009376831352710724
) O 0 0.0026243748143315315
was O 0 0.0017569995252415538
classified O 0 0.01077974122017622
as O 0 0.0009987957309931517
having O 0 0.002871870994567871
a O 0 0.0047380393370985985
rare O 0 0.019962666556239128
intermediate O 0 0.4616132378578186
type O 0 0.053424715995788574
of O 0 0.0018126853974536061
adult O 1 0.9580580592155457
cerebral O 1 0.9999668598175049
and O 0 0.004112822934985161
cerebello O 1 0.9998989105224609
- O 1 0.9923622608184814
brain O 1 0.9999939203262329
stem O 1 0.9987474679946899
forms O 0 0.0123353386297822
, O 0 0.0015520723536610603
his O 0 0.0040186746045947075
younger O 0 0.39192408323287964
brother O 0 0.12557712197303772
( O 0 0.010715157724916935
patient O 1 0.9988036155700684
2 O 0 0.009418381378054619
) O 0 0.0035019484348595142
and O 0 0.0021909165661782026
nephew O 1 0.9913232326507568
( O 0 0.011560083366930485
patient O 1 0.9996836185455322
3 O 0 0.010379543527960777
) O 0 0.0026022307574748993
had O 0 0.00204011844471097
a O 0 0.01171511597931385
childhood O 1 0.9990369081497192
ALD B-Disease 1 0.9999955892562866
type O 1 0.8582617044448853
. O 0 0.0072286841459572315

Another O 0 0.02409151755273342
nephew O 1 0.8760926127433777
( O 0 0.01565004698932171
patient O 1 0.9972990155220032
4 O 0 0.011435644701123238
) O 0 0.0034470963291823864
of O 0 0.00226937816478312
patient O 1 0.9997578263282776
1 O 0 0.005760388448834419
was O 0 0.0016802519094198942
classified O 0 0.010114787146449089
as O 0 0.0015609664842486382
having O 0 0.003863330464810133
an O 0 0.0037141437642276287
adolescent O 1 0.9995549321174622
form O 0 0.02102040685713291
. O 0 0.00613967701792717

The O 0 0.007060347590595484
tau O 1 0.9147133231163025
level O 0 0.004785405937582254
in O 0 0.001600731979124248
the O 0 0.005085607524961233
cerebrospinal O 1 0.9999914169311523
fluid O 1 0.9996652603149414
( O 0 0.014387541450560093
CSF O 1 0.9999725818634033
) O 0 0.0058762673288583755
in O 0 0.00336079066619277
patient O 1 0.9996428489685059
1 O 0 0.006176559254527092
was O 0 0.0013150011654943228
as O 0 0.0010223077842965722
high O 0 0.0027065183967351913
as O 0 0.0008163412567228079
that O 0 0.0008759228512644768
of O 0 0.0024333258625119925
patients O 1 0.9999778270721436
with O 0 0.3089100122451782
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999984502792358
( O 0 0.009620426222682
AD B-Disease 0 0.17834018170833588
) O 0 0.006343693006783724
. O 0 0.0053614117205142975

His O 0 0.022224148735404015
brain O 1 0.9992585778236389
magnetic O 0 0.08023151010274887
resonance O 1 0.9760825634002686
image O 0 0.044070690870285034
( O 0 0.009476060047745705
MRI O 1 0.9998370409011841
) O 0 0.0053277029655873775
showed O 0 0.013496548868715763
abnormalities B-Disease 1 0.9999792575836182
in I-Disease 0 0.0011934752110391855
the I-Disease 0 0.0017312048003077507
bilateral I-Disease 0 0.03401432931423187
cerebellar I-Disease 1 0.999983549118042
hemispheres I-Disease 1 0.9971007704734802
and O 0 0.0085457693785429
brain O 1 0.9999988079071045
stem O 1 0.99934321641922
, O 0 0.0017634411342442036
but O 0 0.0010814735433086753
not O 0 0.0007366717327386141
in O 0 0.0010672741336748004
the O 0 0.0038127347361296415
cerebral O 1 0.9999972581863403
white O 0 0.018181201070547104
matter O 0 0.0044943904504179955
, O 0 0.0010763171594589949
where O 0 0.0012789900647476315
marked O 0 0.00788972619920969
reductions O 0 0.015737168490886688
of O 0 0.0008482977864332497
the O 0 0.0040590157732367516
cerebral O 1 0.9999939203262329
blood O 1 0.9997828602790833
flow O 0 0.026808228343725204
and O 0 0.002325214445590973
oxygen O 1 0.9994157552719116
metabolism O 1 0.9997926354408264
were O 0 0.0011254454730078578
clearly O 0 0.0043410626240074635
demonstrated O 0 0.009385982528328896
by O 0 0.005030564032495022
positron O 1 0.9997122883796692
emission O 1 0.963860809803009
tomography O 1 0.9989190101623535
( O 0 0.013727463781833649
PET O 1 0.9958180785179138
) O 0 0.007255657110363245
. O 0 0.005281344521790743

In O 0 0.012541200965642929
patients O 1 0.9991251826286316
2 O 0 0.008494852110743523
and O 0 0.0016118884086608887
3 O 0 0.006181695964187384
, O 0 0.0011066830484196544
the O 0 0.0015969632659107447
autopsy O 1 0.980069637298584
findings O 0 0.0110864182934165
showed O 0 0.008676834404468536
massive O 0 0.2116919457912445
demyelination B-Disease 1 0.9999493360519409
of I-Disease 0 0.0018182349158450961
the I-Disease 0 0.004537838976830244
cerebral I-Disease 1 0.9999892711639404
white I-Disease 0 0.013944403268396854
matter I-Disease 0 0.00444856146350503
with O 0 0.0032418007031083107
sparing O 1 0.736396312713623
of O 0 0.000915560987778008
the O 0 0.002816081279888749
U O 1 0.9979427456855774
- O 1 0.618067741394043
fibers O 1 0.999474823474884
, O 0 0.0028460435569286346
compatible O 0 0.04101761057972908
with O 0 0.0016530620632693172
the O 0 0.0013129065046086907
findings O 0 0.010009926743805408
of O 0 0.0033377856016159058
childhood O 1 0.9987421631813049
ALD B-Disease 1 0.9999923706054688
. O 0 0.013276366516947746

Oleic O 1 0.9818338751792908
and O 0 0.00946086272597313
erucic O 1 0.9991517066955566
acids O 1 0.9947670698165894
( O 0 0.0073135471902787685
Lorenzos O 1 0.9964213371276855
Oil O 0 0.008452086709439754
) O 0 0.001991900149732828
were O 0 0.0008108114707283676
administered O 0 0.01999632455408573
to O 0 0.0029147339519113302
patients O 1 0.9999130964279175
1 O 0 0.006737123243510723
and O 0 0.0014600965660065413
4 O 0 0.005742455366998911
, O 0 0.0010488104308024049
but O 0 0.0011537437094375491
sufficient O 0 0.010151960887014866
effectiveness O 0 0.29106205701828003
was O 0 0.002085084095597267
not O 0 0.0015504196053370833
obtained O 0 0.007672036997973919
. O 0 0.0057273078709840775

The O 0 0.003397978376597166
findings O 0 0.010744727216660976
in O 0 0.0012222869554534554
this O 0 0.0010863085044547915
family O 0 0.007520226761698723
suggest O 0 0.00763693917542696
that O 0 0.0017554496880620718
delGAG291 O 1 0.9985318183898926
is O 0 0.0014380571665242314
part O 0 0.0011572249932214618
of O 0 0.0005371202132664621
the O 0 0.0016655019717290998
cause O 1 0.6502876877784729
of O 0 0.0015249473508447409
Japanese O 0 0.021188143640756607
ALD B-Disease 1 0.9999915361404419
with O 0 0.008456272073090076
phenotypic O 1 0.9983592629432678
variations O 0 0.05107003450393677
. O 0 0.0071982028894126415

Moreover O 0 0.03640337660908699
, O 0 0.0016780467703938484
although O 0 0.0016293569933623075
the O 0 0.0009809663752093911
scale O 0 0.007115470245480537
of O 0 0.000609898183029145
the O 0 0.0011088685132563114
study O 0 0.0072863660752773285
is O 0 0.0015901715960353613
limited O 0 0.004150073044002056
, O 0 0.0008301517809741199
there O 0 0.000835662183817476
is O 0 0.0012118499726057053
a O 0 0.0035756581928581
possibility O 0 0.008923698216676712
that O 0 0.0016002891352400184
PET O 1 0.9976365566253662
can O 0 0.0048139928840100765
detect O 1 0.8674731254577637
an O 0 0.004473399370908737
insidious B-Disease 1 0.9998866319656372
lesion I-Disease 1 0.9999911785125732
which O 0 0.002155683934688568
is O 0 0.0030799140222370625
undetectable O 1 0.9988616704940796
by O 0 0.00465006660670042
computed O 1 0.9807890057563782
tomogram O 1 0.9986552000045776
( O 0 0.012415222823619843
CT O 1 0.9999740123748779
) O 0 0.0069206696934998035
or O 0 0.007400050293654203
MRI O 1 0.9999462366104126
analysis O 0 0.019674647599458694
, O 0 0.0011026777792721987
and O 0 0.0006599745829589665
that O 0 0.0006628050468862057
the O 0 0.001023182412609458
higher O 0 0.003970788791775703
level O 0 0.002717224881052971
of O 0 0.0012330655008554459
tau O 1 0.9940816760063171
reflects O 0 0.006778576876968145
the O 0 0.0009876597905531526
process O 0 0.0052625443786382675
of O 0 0.003214449854567647
neuronal B-Disease 1 0.9999957084655762
degeneration I-Disease 1 0.9999960660934448
in O 0 0.013601437211036682
ALD B-Disease 1 0.9999872446060181
. O 0 0.014139744453132153

Lorenzos O 1 0.9742942452430725
Oil O 0 0.011200368404388428
should O 0 0.0021988018415868282
be O 0 0.0009453613893128932
given O 0 0.0015569080132991076
in O 0 0.0008197312708944082
the O 0 0.00159920915029943
early O 0 0.0065065775997936726
stage O 0 0.02986270561814308
. O 0 0.00319710117764771
. O 0 0.005248674191534519

Nonsense O 1 0.9185875654220581
mutation O 1 0.9997928738594055
in O 0 0.006314639467746019
exon O 1 0.9951531887054443
4 O 0 0.0066320812329649925
of O 0 0.0011692296247929335
human O 0 0.010644663125276566
complement O 1 0.994034469127655
C9 O 1 0.9999867677688599
gene O 1 0.9998868703842163
is O 0 0.0018930716905742884
the O 0 0.0011335539165884256
major O 0 0.006182123441249132
cause O 0 0.2969815731048584
of O 0 0.0012342609697952867
Japanese O 0 0.009516767226159573
complement B-Disease 1 0.9971561431884766
C9 I-Disease 1 0.9999899864196777
deficiency I-Disease 1 0.999996542930603
. O 0 0.01213855016976595

Deficiency B-Disease 1 0.9999476671218872
of I-Disease 0 0.0020313281565904617
the I-Disease 0 0.0016603879630565643
ninth I-Disease 0 0.015079468488693237
component I-Disease 0 0.018562473356723785
of I-Disease 0 0.0011865133419632912
human I-Disease 0 0.00933596957474947
complement I-Disease 1 0.9284304976463318
( O 0 0.009394227527081966
C9 O 1 0.9999853372573853
) O 0 0.0035923051182180643
is O 0 0.0008700950420461595
the O 0 0.0006390041089616716
most O 0 0.0015069935470819473
common O 0 0.11013266444206238
complement B-Disease 1 0.9998821020126343
deficiency I-Disease 1 0.9999998807907104
in O 0 0.0020498342346400023
Japan O 0 0.002918604062870145
but O 0 0.0012175169540569186
is O 0 0.0017807971453294158
rare O 0 0.018310055136680603
in O 0 0.0012117356527596712
other O 0 0.0011590409558266401
countries O 0 0.0018110194941982627
. O 0 0.004813862964510918

We O 0 0.0032079708762466908
studied O 0 0.004713340196758509
the O 0 0.0018258698983117938
molecular O 1 0.9954783320426941
basis O 0 0.0038841518107801676
of O 0 0.0032373694702982903
C9 B-Disease 1 0.9999969005584717
deficiency I-Disease 1 0.9999977350234985
in O 0 0.00204036314971745
four O 0 0.0029439625795930624
Japanese O 0 0.019667545333504677
C9 B-Disease 1 0.9999935626983643
- I-Disease 1 0.9927272796630859
deficient I-Disease 1 0.9999794960021973
patients O 1 0.9994426369667053
who O 0 0.0030150427483022213
had O 0 0.004170361440628767
suffered O 1 0.9952694773674011
from O 0 0.024436578154563904
meningococcal B-Disease 1 0.9999997615814209
meningitis I-Disease 1 0.9999970197677612
. O 0 0.014901855029165745

Direct O 0 0.026612546294927597
sequencing O 0 0.43317851424217224
of O 0 0.0036624502390623093
amplified O 1 0.8884006142616272
C9 O 1 0.9993808269500732
cDNA O 1 0.981537938117981
and O 0 0.0043797846883535385
DNA O 1 0.9969643950462341
revealed O 0 0.014857590198516846
a O 0 0.0065778144635260105
nonsense O 0 0.05369848757982254
substitution O 1 0.7212797403335571
( O 0 0.010282641276717186
CGA O 1 0.9919919371604919
- O 0 0.2654368579387665
- O 0 0.3634274899959564
> O 1 0.9995504021644592
TGA O 1 0.9995558857917786
) O 0 0.005788248032331467
at O 0 0.0036534862592816353
codon O 1 0.9776468873023987
95 O 0 0.012777832336723804
in O 0 0.002825032453984022
exon O 1 0.9974836707115173
4 O 0 0.007562138605862856
in O 0 0.0008523156284354627
the O 0 0.0014161127619445324
four O 0 0.01110534742474556
C9 B-Disease 1 0.9999886751174927
- I-Disease 1 0.78444904088974
deficient I-Disease 1 0.9995368719100952
individuals O 0 0.010815260000526905
. O 0 0.006827510427683592

An O 0 0.013314655981957912
allele O 1 0.9982232451438904
- O 0 0.030036229640245438
specific O 0 0.02029438503086567
polymerase O 1 0.9994168281555176
chain O 1 0.8638303279876709
reaction O 0 0.06565383076667786
system O 0 0.012614823877811432
designed O 0 0.006335516460239887
to O 0 0.0018172761192545295
detect O 1 0.7364821434020996
exclusively O 0 0.0038969970773905516
only O 0 0.0006595998420380056
one O 0 0.00074508145917207
of O 0 0.0004730857035610825
the O 0 0.0009243455133400857
normal O 0 0.01978858932852745
and O 0 0.0019583567045629025
mutant O 1 0.9999654293060303
alleles O 1 0.9999690055847168
indicated O 0 0.010943209752440453
that O 0 0.0007407512166537344
all O 0 0.0005085884477011859
the O 0 0.001291679684072733
four O 0 0.004580547567456961
patients O 1 0.9992139339447021
were O 0 0.001601499505341053
homozygous O 1 0.9997157454490662
for O 0 0.0017350692069157958
the O 0 0.0027495448011904955
mutation O 1 0.9999872446060181
in O 0 0.004279706161469221
exon O 1 0.999421238899231
4 O 0 0.007280673366039991
and O 0 0.0007207617163658142
that O 0 0.0005828622379340231
the O 0 0.0010547428391873837
parents O 0 0.006188222672790289
of O 0 0.0021491271909326315
patient O 1 0.9995843768119812
2 O 0 0.007116871420294046
were O 0 0.0024288876447826624
heterozygous O 1 0.9993422627449036
. O 0 0.007845896296203136

The O 0 0.005622325465083122
common O 0 0.03220713511109352
mutation O 1 0.9999030828475952
at O 0 0.006904769688844681
codon O 1 0.9813168048858643
95 O 0 0.015591863542795181
in O 0 0.0029269419610500336
exon O 1 0.9986067414283752
4 O 0 0.010075589641928673
might O 0 0.00491263996809721
be O 0 0.0010224850848317146
responsible O 0 0.004818635061383247
for O 0 0.0010629071621224284
most O 0 0.002022075466811657
Japanese O 0 0.026996679604053497
C9 B-Disease 1 0.9999972581863403
deficiency I-Disease 1 0.9999991655349731
. O 0 0.005751863121986389
. O 0 0.006546921096742153

BRCA1 O 1 0.9999347925186157
required O 0 0.012725025415420532
for O 0 0.004821700043976307
transcription O 1 0.9993574023246765
- O 0 0.025448964908719063
coupled O 0 0.06415756046772003
repair O 1 0.8677878379821777
of O 0 0.004727616906166077
oxidative O 1 0.999975323677063
DNA O 1 0.9996888637542725
damage O 0 0.44634222984313965
. O 0 0.008089565671980381

The O 0 0.0169602632522583
breast B-Disease 1 0.999990701675415
and I-Disease 0 0.1753820925951004
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
susceptibility O 1 0.999984622001648
gene O 1 0.9999704360961914
BRCA1 O 1 0.9999922513961792
encodes O 1 0.9921777844429016
a O 0 0.015661561861634254
zinc O 1 0.9981721639633179
finger O 1 0.9842700958251953
protein O 1 0.9950460195541382
of O 0 0.0022669113241136074
unknown O 0 0.017015008255839348
function O 0 0.043334513902664185
. O 0 0.005818657577037811

Association O 0 0.008225565776228905
of O 0 0.0011563166044652462
the O 0 0.004578884225338697
BRCA1 O 1 0.9999978542327881
protein O 1 0.9976484179496765
with O 0 0.002292103134095669
the O 0 0.002504713600501418
DNA O 1 0.9997518658638
repair O 1 0.9985737800598145
protein O 1 0.9998148083686829
Rad51 O 1 0.9998413324356079
and O 0 0.0019634237978607416
changes O 0 0.005091352388262749
in O 0 0.0008830685983411968
the O 0 0.001704537426121533
phosphorylation O 1 0.9934357404708862
and O 0 0.0021506124176084995
cellular O 1 0.9977964162826538
localization O 0 0.47070491313934326
of O 0 0.000877190672326833
the O 0 0.00216355687007308
protein O 1 0.9996498823165894
after O 0 0.00838008988648653
exposure O 1 0.9718429446220398
to O 0 0.003665735013782978
DNA O 1 0.9998555183410645
- O 0 0.037170130759477615
damaging O 0 0.4052028954029083
agents O 0 0.01182799693197012
are O 0 0.000797176850028336
consistent O 0 0.008183605968952179
with O 0 0.0018421192653477192
a O 0 0.005113151855766773
role O 0 0.007194265257567167
for O 0 0.005137105006724596
BRCA1 O 1 0.9999985694885254
in O 0 0.0075031486339867115
DNA O 1 0.9998155236244202
repair O 1 0.9890580773353577
. O 0 0.007213789038360119

Here O 0 0.003949055448174477
, O 0 0.0013513112207874656
it O 0 0.0010695658857002854
is O 0 0.0013609564630314708
shown O 0 0.006227866746485233
that O 0 0.003094613319262862
mouse O 1 0.9998600482940674
embryonic O 1 0.9997250437736511
stem O 1 0.9991336464881897
cells O 1 0.9998266100883484
deficient B-Disease 1 0.9995855689048767
in I-Disease 0 0.007489185314625502
BRCA1 I-Disease 1 0.9999988079071045
are O 0 0.003550877096131444
defective O 1 0.9998103976249695
in O 0 0.0012828215258195996
the O 0 0.0010966372210532427
ability O 0 0.005891783628612757
to O 0 0.0009399948758073151
carry O 0 0.006547814235091209
out O 0 0.005569280590862036
transcription O 1 0.9997608065605164
- O 0 0.02247719280421734
coupled O 0 0.24596628546714783
repair O 1 0.8221508264541626
of O 0 0.003438299521803856
oxidative O 1 0.9999948740005493
DNA O 1 0.9999747276306152
damage O 1 0.834884762763977
, O 0 0.001434018835425377
and O 0 0.0007941429503262043
are O 0 0.0016618856461718678
hypersensitive O 1 0.9983826875686646
to O 0 0.004486220423132181
ionizing O 1 0.9987226128578186
radiation O 1 0.9892753958702087
and O 0 0.0036544997710734606
hydrogen O 1 0.9945876598358154
peroxide O 1 0.998344898223877
. O 0 0.011481361463665962

These O 0 0.003458996070548892
results O 0 0.010116850025951862
suggest O 0 0.010222197510302067
that O 0 0.005183778237551451
BRCA1 O 1 0.9999994039535522
participates O 1 0.770973265171051
, O 0 0.0017434657784178853
directly O 0 0.00410801125690341
or O 0 0.0038012077566236258
indirectly O 0 0.019837096333503723
, O 0 0.0015257884515449405
in O 0 0.002777916844934225
transcription O 1 0.9999222755432129
- O 0 0.02625310607254505
coupled O 0 0.06619089096784592
repair O 1 0.7352297306060791
of O 0 0.004005684982985258
oxidative O 1 0.9999862909317017
DNA O 1 0.9999130964279175
damage O 1 0.609130859375
. O 0 0.0030062871519476175
. O 0 0.005524869542568922

Truncation O 1 0.998127281665802
mutations O 1 0.9994246959686279
in O 0 0.0027798726223409176
the O 0 0.0029725045897066593
transactivation O 1 0.9979674220085144
region O 0 0.006268488243222237
of O 0 0.002974985633045435
PAX6 O 1 0.9999175071716309
result O 0 0.015497585758566856
in O 0 0.002719081239774823
dominant O 1 0.6352495551109314
- O 0 0.031805381178855896
negative O 0 0.04783713072538376
mutants O 1 0.9883557558059692
. O 0 0.009590809233486652

PAX6 O 1 0.9972482323646545
is O 0 0.005201762076467276
a O 0 0.009656082838773727
transcription O 1 0.9962106943130493
factor O 0 0.025098642334342003
with O 0 0.0023356559686362743
two O 0 0.0038622149731963873
DNA O 1 0.9998282194137573
- O 0 0.020938223227858543
binding O 0 0.07774654030799866
domains O 1 0.6150856018066406
( O 0 0.005504030268639326
paired O 1 0.8758989572525024
box O 0 0.028911873698234558
and O 0 0.0038484251126646996
homeobox O 1 0.9999854564666748
) O 0 0.003969953861087561
and O 0 0.0011517648817971349
a O 0 0.008991884998977184
proline O 1 0.9986615180969238
- O 0 0.07051598280668259
serine O 1 0.9987094402313232
- O 0 0.07194948196411133
threonine O 1 0.9979445338249207
( O 0 0.015462006442248821
PST O 1 0.9977061748504639
) O 0 0.009417365305125713
- O 0 0.020834555849432945
rich O 0 0.028186380863189697
transactivation O 1 0.9963253140449524
domain O 0 0.06985662132501602
. O 0 0.00748929800465703

PAX6 O 1 0.999471127986908
regulates O 1 0.9912021160125732
eye O 1 0.9566482901573181
development O 0 0.007292238995432854
in O 0 0.0021173974964767694
animals O 0 0.013330616056919098
ranging O 0 0.008985105901956558
from O 0 0.003620463889092207
jellyfish O 1 0.9980839490890503
to O 0 0.00457350118085742
Drosophila O 1 0.9971277117729187
to O 0 0.003664843738079071
humans O 0 0.19617697596549988
. O 0 0.00563138909637928

Heterozygous O 1 0.9989011287689209
mutations O 1 0.9993564486503601
in O 0 0.0023475203197449446
the O 0 0.002125341212376952
human O 0 0.02946239523589611
PAX6 O 1 0.9999785423278809
gene O 1 0.9998742341995239
result O 0 0.009964139200747013
in O 0 0.001284708036109805
various O 0 0.0031446488574147224
phenotypes O 1 0.9999544620513916
, O 0 0.002017742255702615
including O 0 0.004946704022586346
aniridia B-Disease 1 0.999294638633728
, O 0 0.0054343705996870995
Peters B-Disease 1 0.993198573589325
anomaly I-Disease 1 0.9997078776359558
, O 0 0.012533862143754959
autosomal B-Disease 1 0.9999991655349731
dominant I-Disease 1 0.9969205856323242
keratitis I-Disease 1 0.9999873638153076
, O 0 0.003743309061974287
and O 0 0.004548041149973869
familial B-Disease 1 0.9999973773956299
foveal I-Disease 1 0.9998700618743896
dysplasia I-Disease 1 0.9999988079071045
. O 0 0.013484198600053787

It O 0 0.0031977342441678047
is O 0 0.0016185167478397489
believed O 0 0.003151280339807272
that O 0 0.0009855602402240038
the O 0 0.002698209136724472
mutated O 1 0.9999668598175049
allele O 1 0.9990822076797485
of O 0 0.0035878275521099567
PAX6 O 1 0.9998301267623901
produces O 0 0.02968466840684414
an O 0 0.003132526995614171
inactive O 1 0.9540421366691589
protein O 1 0.9990192651748657
and O 0 0.0032707401551306248
aniridia B-Disease 1 0.9989209175109863
is O 0 0.0033977115526795387
caused O 0 0.08598706126213074
due O 0 0.006116997916251421
to O 0 0.003378644585609436
genetic O 1 0.9999598264694214
haploinsufficiency O 1 0.990760862827301
. O 0 0.008192143402993679

However O 0 0.0061835357919335365
, O 0 0.0016137717757374048
several O 0 0.004414853639900684
truncation O 1 0.9998705387115479
mutations O 1 0.9999740123748779
have O 0 0.001574664725922048
been O 0 0.0012539493618533015
found O 0 0.00295697757974267
to O 0 0.0011441834503784776
occur O 0 0.01554868370294571
in O 0 0.0011278012534603477
the O 0 0.0027803971897810698
C O 1 0.9988952279090881
- O 0 0.024724015966057777
terminal O 0 0.09949943423271179
half O 0 0.0044506145641207695
of O 0 0.0027013367507606745
PAX6 O 1 0.9999874830245972
in O 0 0.006068518850952387
patients O 1 0.9996688365936279
with O 0 0.004565270151942968
Aniridia B-Disease 1 0.9995877146720886
resulting O 0 0.03142537176609039
in O 0 0.0022618283983319998
mutant O 1 0.9995916485786438
proteins O 1 0.9858368635177612
that O 0 0.0012142936466261744
retain O 0 0.009819929488003254
the O 0 0.0027069151401519775
DNA O 1 0.9998399019241333
- O 0 0.03091045841574669
binding O 0 0.3972918689250946
domains O 1 0.6977912783622742
but O 0 0.0015644237864762545
have O 0 0.001094814040698111
lost O 0 0.004246219992637634
most O 0 0.0008268506499007344
of O 0 0.0008119951817207038
the O 0 0.0032364644575864077
transactivation O 1 0.9993564486503601
domain O 0 0.07304661720991135
. O 0 0.00907264743000269

It O 0 0.004329006187617779
is O 0 0.0015234678285196424
not O 0 0.0009050199296325445
clear O 0 0.003135664388537407
whether O 0 0.0023760588373988867
such O 0 0.0027757936622947454
mutants O 1 0.9961642026901245
really O 0 0.009564741514623165
behave O 0 0.054849494248628616
as O 0 0.002566523617133498
loss O 1 0.5977513194084167
- O 0 0.013610908761620522
of O 0 0.0019647025037556887
- O 0 0.026604846119880676
function O 0 0.4662910997867584
mutants O 1 0.9959016442298889
as O 0 0.002943288302049041
predicted O 0 0.01603977009654045
by O 0 0.005355035420507193
haploinsufficiency O 1 0.9871838688850403
. O 0 0.009249571710824966

Contrary O 0 0.013462865725159645
to O 0 0.0014457795768976212
this O 0 0.0013850483810529113
theory O 0 0.009231648407876492
, O 0 0.0008884831913746893
our O 0 0.001207025838084519
data O 0 0.00347145926207304
showed O 0 0.0037125435192137957
that O 0 0.0009602031786926091
these O 0 0.001564695849083364
mutants O 1 0.9963770508766174
are O 0 0.0022660891991108656
dominant O 1 0.5385767221450806
- O 0 0.01795942895114422
negative O 0 0.01718149334192276
in O 0 0.003812778741121292
transient O 1 0.9994754195213318
transfection O 1 0.9998899698257446
assays O 1 0.9925336837768555
when O 0 0.0029798427131026983
they O 0 0.0007391233812086284
are O 0 0.0011424592230468988
coexpressed O 1 0.9937683343887329
with O 0 0.004381995182484388
wild O 0 0.07521001994609833
- O 0 0.05784613639116287
type O 1 0.980574369430542
PAX6 O 1 0.9995468258857727
. O 0 0.01377994567155838

We O 0 0.002877931809052825
found O 0 0.003172856057062745
that O 0 0.0008914227364584804
the O 0 0.0018464862369000912
dominant O 1 0.8665791153907776
- O 0 0.025872278958559036
negative O 0 0.03334175795316696
effects O 1 0.6005551815032959
result O 0 0.007033395115286112
from O 0 0.0012778424425050616
the O 0 0.0019405753118917346
enhanced O 1 0.7824544906616211
DNA O 1 0.9995371103286743
binding O 0 0.04384853318333626
ability O 0 0.007006040308624506
of O 0 0.0008761774515733123
these O 0 0.0025696821976453066
mutants O 1 0.9976050853729248
. O 0 0.007080631330609322

Kinetic O 0 0.11429855972528458
studies O 0 0.011664257384836674
of O 0 0.0016267899191007018
binding O 0 0.04243999347090721
and O 0 0.00268758786842227
dissociation O 1 0.9992971420288086
revealed O 0 0.011098328046500683
that O 0 0.0009136630105786026
various O 0 0.002375091426074505
truncation O 1 0.9989894032478333
mutants O 1 0.990314781665802
have O 0 0.0026539035607129335
3 O 0 0.012767083011567593
- O 0 0.020485591143369675
5 O 0 0.012646133080124855
- O 0 0.017438188195228577
fold O 0 0.03500980883836746
higher O 0 0.007439987268298864
affinity O 0 0.22536055743694305
to O 0 0.0011309394612908363
various O 0 0.003241409547626972
DNA O 1 0.9999080896377563
- O 0 0.018985485658049583
binding O 0 0.039495985954999924
sites O 0 0.0040194266475737095
when O 0 0.002189293270930648
compared O 0 0.0051204729825258255
with O 0 0.0016629621386528015
the O 0 0.0020052045583724976
wild O 0 0.25079765915870667
- O 0 0.22634565830230713
type O 1 0.9868163466453552
PAX6 O 1 0.9995517134666443
. O 0 0.012882797978818417

These O 0 0.004086089786142111
results O 0 0.009330974891781807
provide O 0 0.00411407882347703
a O 0 0.004061626736074686
new O 0 0.002719779498875141
insight O 0 0.027207104489207268
into O 0 0.0024766013957560062
the O 0 0.0012906964402645826
role O 0 0.005192060023546219
of O 0 0.0023073272313922644
mutant O 1 0.9998520612716675
PAX6 O 1 0.999921441078186
in O 0 0.006179423071444035
causing O 1 0.993168830871582
aniridia B-Disease 1 0.9990655779838562
. O 0 0.004650401882827282
. O 0 0.005893831141293049

Reversal O 0 0.17052143812179565
of O 0 0.006674624979496002
severe O 1 0.9998553991317749
hypertrophic B-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 0.9999982118606567
and O 0 0.0037317858077585697
excellent O 0 0.019611235707998276
neuropsychologic O 1 0.9963663816452026
outcome O 0 0.015043179504573345
in O 0 0.0015700743533670902
very B-Disease 0 0.004533832427114248
- I-Disease 0 0.018565697595477104
long I-Disease 0 0.014513425529003143
- I-Disease 0 0.03347180411219597
chain I-Disease 1 0.9810338020324707
acyl I-Disease 1 0.999617338180542
- I-Disease 0 0.07523408532142639
coenzyme I-Disease 1 0.9992594122886658
A I-Disease 0 0.27135929465293884
dehydrogenase I-Disease 1 0.9999878406524658
deficiency I-Disease 1 0.9999926090240479
. O 0 0.01189925242215395

Very B-Disease 0 0.01788729801774025
- I-Disease 0 0.03316114470362663
long I-Disease 0 0.021416906267404556
- I-Disease 0 0.04195495322346687
chain I-Disease 1 0.9831321835517883
acyl I-Disease 1 0.9993934631347656
- I-Disease 0 0.05329953506588936
coenzyme I-Disease 1 0.9981010556221008
A I-Disease 0 0.035601887851953506
dehydrogenase I-Disease 1 0.9999077320098877
( I-Disease 0 0.013895824551582336
VLCAD I-Disease 1 0.9994340538978577
) I-Disease 0 0.01925257220864296
deficiency I-Disease 1 0.999996542930603
is O 0 0.003053669584915042
a O 0 0.009797901846468449
disorder O 1 0.9999083280563354
of O 0 0.003562195925042033
fatty O 1 0.9999517202377319
acid O 1 0.9998220801353455
beta O 1 0.9983420372009277
oxidation O 1 0.9991050362586975
that O 0 0.0019564377143979073
reportedly O 0 0.0057890466414391994
has O 0 0.0011186603223904967
high O 0 0.0032641973812133074
rates O 0 0.009780707769095898
of O 0 0.0021764817647635937
morbidity O 1 0.9999778270721436
and O 0 0.004252465907484293
mortality O 1 0.9980282187461853
. O 0 0.006924005225300789

We O 0 0.003410828299820423
describe O 0 0.008324962109327316
the O 0 0.0012883879244327545
outcome O 0 0.007505578454583883
of O 0 0.0008589561912231147
a O 0 0.007035613525658846
5 O 0 0.013084471225738525
- O 0 0.01810785010457039
year O 0 0.005839802790433168
- O 0 0.016232365742325783
old O 0 0.01275988481938839
girl O 0 0.10791058093309402
with O 0 0.01405437383800745
VLCAD B-Disease 1 0.9999943971633911
deficiency I-Disease 1 0.9999997615814209
who O 0 0.003637018147855997
was O 0 0.0017787961987778544
first O 0 0.002233471954241395
seen O 0 0.004787870217114687
at O 0 0.002606344176456332
5 O 0 0.005443801172077656
months O 0 0.003374488325789571
of O 0 0.0007916386821307242
age O 0 0.006392919924110174
with O 0 0.00866132415831089
severe O 1 0.9999784231185913
hypertrophic B-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 0.9999994039535522
, O 0 0.011969064362347126
hepatomegaly B-Disease 1 0.999982476234436
, O 0 0.013087970204651356
encephalopathy B-Disease 1 0.9999970197677612
, O 0 0.0048402706161141396
and O 0 0.004471919499337673
hypotonia B-Disease 1 0.9998377561569214
. O 0 0.009479133412241936

Biochemical O 1 0.9951565265655518
studies O 0 0.031551238149404526
indicated O 0 0.05591431260108948
VLCAD B-Disease 1 0.999975323677063
deficiency I-Disease 1 0.9999996423721313
caused O 0 0.45893594622612
by O 0 0.0029644968453794718
a O 0 0.007836341857910156
stable O 0 0.052735332399606705
yet O 0 0.00759869534522295
inactive O 1 0.9030141830444336
enzyme O 1 0.9990272521972656
. O 0 0.009069082327187061

Molecular O 1 0.9975109100341797
genetic O 1 0.9980633854866028
analysis O 0 0.014329485595226288
of O 0 0.001589690218679607
her O 0 0.011922013014554977
VLCAD O 1 0.9997977614402771
gene O 1 0.999853253364563
revealed O 0 0.020433323457837105
a O 0 0.009926042519509792
T1372C O 1 0.9889795780181885
( O 0 0.008342402055859566
F458L O 1 0.9907625317573547
) O 0 0.012235834263265133
missense O 1 0.999874472618103
mutation O 1 0.9998565912246704
and O 0 0.003165943082422018
a O 0 0.013309020549058914
1668 O 1 0.9966996312141418
ACAG O 1 0.9955421090126038
1669 O 1 0.9746317863464355
splice O 1 0.9974310994148254
site O 0 0.038236960768699646
mutation O 1 0.9997954964637756
. O 0 0.011516852304339409

After O 0 0.013842848129570484
initial O 0 0.02395114302635193
treatment O 1 0.8390051126480103
with O 0 0.006811820436269045
intravenous O 1 0.9999774694442749
glucose O 1 0.9999361038208008
and O 0 0.004602738190442324
carnitine O 1 0.9999680519104004
, O 0 0.002690221881493926
the O 0 0.0028882157057523727
patient O 1 0.9987040758132935
has O 0 0.002712265122681856
thrived O 0 0.021288573741912842
on O 0 0.0013453137362375855
a O 0 0.006984263192862272
low O 0 0.02603219635784626
- O 0 0.03773084282875061
fat O 1 0.9924216866493225
diet O 1 0.8345326781272888
supplemented O 0 0.040877390652894974
with O 0 0.003967260010540485
medium O 0 0.023780517280101776
- O 0 0.02660483866930008
chain O 1 0.9481669068336487
triglyceride O 1 0.9989041090011597
oil O 0 0.009532222524285316
and O 0 0.00370139442384243
carnitine O 1 0.9997585415840149
and O 0 0.005094111431390047
avoidance O 1 0.9932112693786621
of O 0 0.003916674293577671
fasting O 0 0.3114529550075531
. O 0 0.008497025817632675

Her O 0 0.06849117577075958
ventricular O 1 0.9999617338180542
hypertrophy O 1 0.9999624490737915
resolved O 0 0.035875070840120316
significantly O 0 0.024230608716607094
over O 0 0.0020788873080164194
1 O 0 0.006133233197033405
year O 0 0.0022917301394045353
, O 0 0.0014069604221731424
and O 0 0.0026302000042051077
cognitively O 1 0.9996106028556824
, O 0 0.0023161200806498528
she O 0 0.0018583090277388692
is O 0 0.0011262766784057021
in O 0 0.0009844604646787047
the O 0 0.001783613464795053
superior O 0 0.01846305839717388
range O 0 0.004633593838661909
for O 0 0.001942632021382451
age O 0 0.007877646014094353
. O 0 0.005557496566325426

Clinical O 1 0.9893151521682739
recognition O 0 0.019905585795640945
of O 0 0.005523195955902338
VLCAD B-Disease 1 0.9999936819076538
deficiency I-Disease 1 0.9999997615814209
is O 0 0.0037161661311984062
important O 0 0.0021463700104504824
because O 0 0.0022911897394806147
it O 0 0.0008264954085461795
is O 0 0.0008603036403656006
one O 0 0.0008384602842852473
of O 0 0.0005211879615671933
the O 0 0.0009047747007571161
few O 0 0.0027212570421397686
directly O 0 0.01227572001516819
treatable O 1 0.999997615814209
causes O 1 0.9981619715690613
of O 0 0.004665691405534744
cardiomyopathy B-Disease 1 0.9999996423721313
in O 0 0.004149538930505514
children O 0 0.010640657506883144
. O 0 0.0030684799421578646
. O 0 0.005062079522758722

Cloning O 1 0.8069656491279602
of O 0 0.0019177693175151944
a O 0 0.005440825130790472
novel O 0 0.010180626064538956
member O 0 0.001872487016953528
of O 0 0.0006046975613571703
the O 0 0.0015084693441167474
low O 0 0.020423850044608116
- O 0 0.029308907687664032
density O 0 0.3692053258419037
lipoprotein O 1 0.9999456405639648
receptor O 1 0.9997100234031677
family O 0 0.02188488095998764
. O 0 0.006079826969653368

A O 0 0.03820730000734329
gene O 1 0.9971106052398682
encoding O 0 0.46232882142066956
a O 0 0.008902636356651783
novel O 0 0.025288529694080353
transmembrane O 1 0.9993534684181213
protein O 1 0.9979414343833923
was O 0 0.0028575314208865166
identified O 0 0.00765209598466754
by O 0 0.0028800510335713625
DNA O 1 0.9976915121078491
sequence O 0 0.03838333114981651
analysis O 0 0.008612224832177162
within O 0 0.0019400137243792415
the O 0 0.0031564917881041765
insulin B-Disease 1 0.9999935626983643
- I-Disease 1 0.8786443471908569
dependent I-Disease 1 0.9975932240486145
diabetes I-Disease 1 1.0
mellitus I-Disease 1 0.9999988079071045
( O 0 0.013684630393981934
IDDM B-Disease 1 0.998323380947113
) O 0 0.008996440097689629
locus O 1 0.9996243715286255
IDDM4 O 1 0.9929730892181396
on O 0 0.010611320845782757
chromosome O 1 0.9999336004257202
11q13 O 1 0.9816126823425293
. O 0 0.008781573735177517

Based O 0 0.005975294858217239
on O 0 0.001278465730138123
its O 0 0.0044730957597494125
chromosomal O 1 0.9999842643737793
position O 0 0.004207780584692955
, O 0 0.001177268335595727
this O 0 0.0022233573254197836
gene O 1 0.999972939491272
is O 0 0.0021652395371347666
a O 0 0.003407321171835065
candidate O 0 0.007575749419629574
for O 0 0.0030022356659173965
conferring O 1 0.9925639033317566
susceptibility O 1 0.9999586343765259
to O 0 0.014575508423149586
diabetes B-Disease 1 0.9999978542327881
. O 0 0.010968822054564953

The O 0 0.011988448910415173
gene O 1 0.999228835105896
, O 0 0.0038191897328943014
termed O 0 0.09222657978534698
low O 0 0.022737668827176094
- O 0 0.024389438331127167
density O 0 0.07423408329486847
lipoprotein O 1 0.9999377727508545
receptor O 1 0.9995362758636475
related O 0 0.04970062896609306
protein O 1 0.9994572997093201
5 O 0 0.013066601939499378
( O 0 0.006029233802109957
LRP5 O 1 0.9987486600875854
) O 0 0.003250208916142583
, O 0 0.0014664081390947104
encodes O 1 0.9675731658935547
a O 0 0.008208909071981907
protein O 1 0.9936362504959106
of O 0 0.0020457229111343622
1615 O 1 0.9595537781715393
amino O 1 0.9930499792098999
acids O 1 0.86786288022995
that O 0 0.0009556999430060387
contains O 0 0.005049000959843397
conserved O 1 0.7140841484069824
modules O 0 0.028968388214707375
which O 0 0.0008380164508707821
are O 0 0.0006573826540261507
characteristic O 0 0.017641132697463036
of O 0 0.0006046025082468987
the O 0 0.0016362913884222507
low O 0 0.020601468160748482
- O 0 0.02473929151892662
density O 0 0.31069880723953247
lipoprotein O 1 0.9999799728393555
( O 0 0.01953502744436264
LDL O 1 0.999988317489624
) O 0 0.013852844014763832
receptor O 1 0.9997965693473816
family O 0 0.02086762711405754
. O 0 0.0071827624924480915

These O 0 0.003983798902481794
modules O 0 0.03252565860748291
include O 0 0.004431393463164568
a O 0 0.007770823780447245
putative O 1 0.9914970993995667
signal O 0 0.06679345667362213
peptide O 1 0.9950476884841919
for O 0 0.0033434866927564144
protein O 1 0.9963268637657166
export O 0 0.0076730456203222275
, O 0 0.0017308619571849704
four O 0 0.005788343958556652
epidermal O 1 0.9999309778213501
growth O 0 0.02899356000125408
factor O 0 0.11520203202962875
( O 0 0.010499563999474049
EGF O 1 0.9998830556869507
) O 0 0.006618288345634937
repeats O 0 0.1760929822921753
with O 0 0.0036893899086862803
associated O 0 0.015002368949353695
spacer O 1 0.9992177486419678
domains O 1 0.5475481748580933
, O 0 0.002171431900933385
three O 0 0.007756667677313089
LDL O 1 0.9999947547912598
- O 1 0.7464282512664795
receptor O 1 0.9998455047607422
( O 0 0.011214377358555794
LDLR O 1 0.9993178844451904
) O 0 0.005392196122556925
repeats O 0 0.2566000521183014
, O 0 0.001259040436707437
a O 0 0.004324411042034626
single O 0 0.012155995704233646
transmembrane O 1 0.9970093369483948
spanning O 0 0.029960136860609055
domain O 0 0.035865362733602524
, O 0 0.001177137135528028
and O 0 0.0009071817621588707
a O 0 0.009296081960201263
cytoplasmic O 1 0.9994862079620361
domain O 0 0.068022221326828
. O 0 0.006516504567116499

The O 0 0.005606736056506634
encoded O 0 0.4665127098560333
protein O 1 0.9975433349609375
has O 0 0.0018971628742292523
a O 0 0.003076575929298997
unique O 0 0.00497103575617075
organization O 0 0.004057997837662697
of O 0 0.002045193687081337
EGF O 1 0.9999068975448608
and O 0 0.004371705465018749
LDLR O 1 0.9997405409812927
repeats O 1 0.990653932094574
; O 0 0.004128647968173027
therefore O 0 0.004107258748263121
, O 0 0.0021070833317935467
LRP5 O 1 0.9986987113952637
likely O 0 0.007907051593065262
represents O 0 0.005646292120218277
a O 0 0.0036189609672874212
new O 0 0.002088014967739582
category O 0 0.007762853987514973
of O 0 0.0009687241399660707
the O 0 0.0040034581907093525
LDLR O 1 0.9986487030982971
family O 0 0.021979179233312607
. O 0 0.007602303754538298

Both O 0 0.005322673823684454
human O 0 0.009797142818570137
and O 0 0.003379381727427244
mouse O 1 0.9998679161071777
LRP5 O 1 0.9990405440330505
cDNAs O 1 0.9862750768661499
have O 0 0.0017623183084651828
been O 0 0.0015447740443050861
isolated O 0 0.015969032421708107
and O 0 0.0007029949920251966
the O 0 0.001538830460049212
encoded O 1 0.9783468246459961
mature O 1 0.6137428879737854
proteins O 1 0.9891358613967896
are O 0 0.0009923828765749931
95 O 0 0.009162966161966324
% O 0 0.004772557877004147
identical O 0 0.025361090898513794
, O 0 0.001304609701037407
indicating O 0 0.016595426946878433
a O 0 0.004834316670894623
high O 0 0.004231605678796768
degree O 0 0.007732388097792864
of O 0 0.0014933854108676314
evolutionary O 1 0.9954635500907898
conservation O 0 0.015859145671129227
. O 0 0.002731278771534562
. O 0 0.004847375676035881

The O 0 0.011704355478286743
APC B-Disease 1 0.9985601305961609
variants O 1 0.9707478880882263
I1307K O 1 0.9723153710365295
and O 0 0.0033734608441591263
E1317Q O 1 0.9485318660736084
are O 0 0.0019078553887084126
associated O 0 0.017182715237140656
with O 0 0.3432624042034149
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.003093718783929944
but O 0 0.0013402028707787395
not O 0 0.0009608841501176357
always O 0 0.0015596240991726518
with O 0 0.0018382050329819322
a O 0 0.0058706677518785
family O 0 0.00883640255779028
history O 0 0.004720790311694145
. O 0 0.006053501274436712

Classical O 0 0.3514518737792969
familial B-Disease 1 0.9999964237213135
adenomatous I-Disease 1 0.9999988079071045
polyposis I-Disease 1 0.9999983310699463
( O 0 0.03127991780638695
FAP B-Disease 1 0.9999127388000488
) O 0 0.004712322261184454
is O 0 0.0015831446507945657
a O 0 0.00549705047160387
high O 0 0.010291769169270992
- O 1 0.7290045022964478
penetrance O 1 0.9999908208847046
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.999081015586853
disease I-Disease 1 0.9999923706054688
that O 0 0.0033288132399320602
predisposes O 1 0.9996693134307861
to O 0 0.0013743279268965125
hundreds O 0 0.00336021208204329
or O 0 0.0022410377860069275
thousands O 0 0.00498997000977397
of O 0 0.00884927436709404
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999991655349731
and I-Disease 0 0.012450315058231354
carcinoma I-Disease 1 0.9999998807907104
and O 0 0.0020800211932510138
that O 0 0.001340861665084958
results O 0 0.0067145973443984985
from O 0 0.0035179900005459785
truncating O 1 0.9995937943458557
mutations O 1 0.9999659061431885
in O 0 0.0026272672694176435
the O 0 0.00487170135602355
APC B-Disease 1 0.9999306201934814
gene O 1 0.9994288086891174
. O 0 0.011118804104626179

A O 0 0.03118683397769928
variant O 1 0.9402065873146057
of O 0 0.005234768148511648
FAP B-Disease 1 0.9999192953109741
is O 0 0.015457929112017155
attenuated B-Disease 1 0.9999867677688599
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999966621398926
, O 0 0.0031446574721485376
which O 0 0.0010973680764436722
results O 0 0.00784093327820301
from O 0 0.005167534574866295
germ O 1 0.9998841285705566
- O 0 0.0334031768143177
line O 0 0.01941528171300888
mutations O 1 0.9999641180038452
in O 0 0.00200544111430645
the O 0 0.0017776333261281252
5 O 0 0.005573446396738291
and O 0 0.0011075943475589156
3 O 0 0.005133061669766903
regions O 0 0.004058603197336197
of O 0 0.0009048143401741982
the O 0 0.0039334725588560104
APC B-Disease 1 0.9999309778213501
gene O 1 0.9996728897094727
. O 0 0.009934908710420132

Attenuated B-Disease 1 0.9998819828033447
adenomatous I-Disease 1 0.9999986886978149
polyposis I-Disease 1 0.9999991655349731
coli I-Disease 1 0.9999984502792358
patients O 1 0.9988320469856262
have O 0 0.0020859078504145145
" O 0 0.0038537997752428055
multiple O 1 0.8066896796226501
" O 0 0.4221247136592865
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999988079071045
( O 0 0.006887367460876703
typically O 0 0.005712639074772596
fewer O 0 0.006023190449923277
than O 0 0.0014509339816868305
100 O 0 0.003084699623286724
) O 0 0.003030291525647044
without O 0 0.0029061269015073776
the O 0 0.0026561750564724207
florid O 1 0.9993957281112671
phenotype O 1 0.999958872795105
of O 0 0.0026247717905789614
classical O 0 0.03281562775373459
FAP B-Disease 1 0.9999001026153564
. O 0 0.01160211768001318

Another O 0 0.013113178312778473
group O 0 0.005961436312645674
of O 0 0.001942463917657733
patients O 1 0.9996745586395264
with O 0 0.004291071556508541
multiple O 1 0.9868820309638977
adenomas B-Disease 1 0.9999750852584839
has O 0 0.0026504904963076115
no O 0 0.003947029821574688
mutations O 1 0.999929666519165
in O 0 0.0018059131689369678
the O 0 0.003997689578682184
APC B-Disease 1 0.9999804496765137
gene O 1 0.9999399185180664
, O 0 0.0020922247786074877
and O 0 0.0010653432691469789
their O 0 0.00427430821582675
phenotype O 1 0.9999958276748657
probably O 0 0.007483382243663073
results O 0 0.007603030186146498
from O 0 0.0020294287241995335
variation O 0 0.20020729303359985
at O 0 0.0022911634296178818
a O 0 0.008869845420122147
locus O 1 0.9999493360519409
, O 0 0.0025893545243889093
or O 0 0.006544340401887894
loci O 1 0.9999650716781616
, O 0 0.0016943418886512518
elsewhere O 0 0.003949036821722984
in O 0 0.000948057568166405
the O 0 0.0030489941127598286
genome O 1 0.9996349811553955
. O 0 0.008418923243880272

Recently O 0 0.0238401647657156
, O 0 0.0019458688329905272
however O 0 0.0018407220486551523
, O 0 0.0013690026244148612
a O 0 0.009197334758937359
missense O 1 0.9996662139892578
variant O 1 0.9972158670425415
of O 0 0.004476092755794525
APC B-Disease 1 0.9998971223831177
( O 0 0.011781484819948673
I1307K O 1 0.999091386795044
) O 0 0.0036464184522628784
was O 0 0.0014542607823386788
described O 0 0.0049813007935881615
that O 0 0.0012901335721835494
confers O 1 0.7923952341079712
an O 0 0.0018106711795553565
increased O 0 0.012404464185237885
risk O 1 0.9979046583175659
of O 0 0.01141215581446886
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999998807907104
, O 0 0.0029425830580294132
including O 0 0.004158274736255407
multiple O 1 0.996454119682312
adenomas B-Disease 1 0.999993085861206
, O 0 0.0029840385541319847
in O 0 0.003673039609566331
Ashkenazim O 1 0.989510715007782
. O 0 0.00919758714735508

We O 0 0.00265869521535933
have O 0 0.0013011222472414374
studied O 0 0.003916382323950529
a O 0 0.0028652071487158537
set O 0 0.0013900845078751445
of O 0 0.0013444049982354045
164 O 1 0.9251128435134888
patients O 1 0.9989097118377686
with O 0 0.006763674784451723
multiple O 1 0.9997876286506653
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999990463256836
and I-Disease 0 0.004711352288722992
/ I-Disease 1 0.9952847361564636
or I-Disease 0 0.01754254661500454
carcinoma I-Disease 1 0.9999997615814209
and O 0 0.002942001214250922
analyzed O 0 0.10877878963947296
codons O 1 0.9982321858406067
1263 O 1 0.9974626302719116
- O 0 0.06758420914411545
1377 O 1 0.9898537993431091
( O 0 0.013054132461547852
exon O 1 0.9988083839416504
15G O 1 0.9942384958267212
) O 0 0.0038952447939664125
of O 0 0.0008067971793934703
the O 0 0.003271699184551835
APC B-Disease 1 0.9997890591621399
gene O 1 0.9998146891593933
for O 0 0.0073920441791415215
germ O 1 0.9996908903121948
- O 0 0.027536066249012947
line O 0 0.019241197034716606
variants O 1 0.9613661766052246
. O 0 0.009391228668391705

Three O 0 0.014895571395754814
patients O 1 0.9935977458953857
with O 0 0.002166981576010585
the O 0 0.0026734559796750546
I1307K O 1 0.9995613694190979
allele O 1 0.9998342990875244
were O 0 0.002532604383304715
detected O 1 0.8862950205802917
, O 0 0.0013595819473266602
each O 0 0.0012982366606593132
of O 0 0.001690046745352447
Ashkenazi O 1 0.9898968935012817
descent O 0 0.04779950529336929
. O 0 0.006603451445698738

Four O 0 0.014412683434784412
patients O 1 0.997988224029541
had O 0 0.0037145938258618116
a O 0 0.01121944934129715
germ O 1 0.9994375109672546
- O 0 0.023624984547495842
line O 0 0.01459356676787138
E1317Q O 1 0.9957231283187866
missense O 1 0.9997819066047668
variant O 1 0.9965053796768188
of O 0 0.0036117518320679665
APC O 1 0.9997859597206116
that O 0 0.0017616339027881622
was O 0 0.0013794031692668796
not O 0 0.0007843931089155376
present O 0 0.0022420850582420826
in O 0 0.001823446131311357
controls O 0 0.054857105016708374
; O 0 0.0026053579058498144
one O 0 0.0010905858362093568
of O 0 0.0005934263463132083
these O 0 0.0009112143306992948
individuals O 0 0.0033619392197579145
had O 0 0.0015665232203900814
an O 0 0.0016806712374091148
unusually O 0 0.02161368913948536
large O 0 0.0025739925913512707
number O 0 0.001311535481363535
of O 0 0.0021319431252777576
metaplastic B-Disease 1 0.9995231628417969
polyps I-Disease 1 0.9999237060546875
of I-Disease 0 0.002276086248457432
the I-Disease 0 0.003560562850907445
colorectum I-Disease 1 0.991407036781311
. O 0 0.009259557351469994

There O 0 0.0030361544340848923
is O 0 0.001525310450233519
increasing O 0 0.004614344798028469
evidence O 0 0.0023622370790690184
that O 0 0.0007172590121626854
there O 0 0.0015427309554070234
exist O 0 0.013096700422465801
germ O 1 0.9997702240943909
- O 0 0.019632620736956596
line O 0 0.008699661120772362
variants O 0 0.1193997785449028
of O 0 0.001051205676048994
the O 0 0.003329433035105467
APC B-Disease 1 0.9999735355377197
gene O 1 0.9998623132705688
that O 0 0.003271438181400299
predispose O 1 0.999441921710968
to O 0 0.0007120251539163291
the O 0 0.0007339702569879591
development O 0 0.0029369029216468334
of O 0 0.002018873579800129
multiple O 1 0.9999417066574097
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999994039535522
and I-Disease 0 0.01800880767405033
carcinoma I-Disease 1 1.0
, O 0 0.002966296160593629
but O 0 0.001370199490338564
without O 0 0.002051307586953044
the O 0 0.002497188514098525
florid O 1 0.9994961023330688
phenotype O 1 0.9999380111694336
of O 0 0.0023818800691515207
classical O 0 0.037631358951330185
FAP B-Disease 1 0.9999881982803345
, O 0 0.0020490020979195833
and O 0 0.0009178681648336351
possibly O 0 0.007792104035615921
with O 0 0.0016072363359853625
importance O 0 0.0054701692424714565
for O 0 0.10237658023834229
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9989985823631287
in O 0 0.0012281570816412568
the O 0 0.0012029301142320037
general O 0 0.00264119915664196
population O 0 0.0030123258475214243
. O 0 0.002734628738835454
. O 0 0.005367377772927284

Genomic O 1 0.9960545301437378
structure O 0 0.012363475747406483
of O 0 0.0010054426966235042
the O 0 0.002091512084007263
human O 1 0.7094036936759949
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999908208847046
diarrhea I-Disease 1 0.999998927116394
( O 0 0.02577923610806465
CLD B-Disease 1 0.999972939491272
) O 0 0.017489036545157433
gene O 1 0.9995699524879456
. O 0 0.008913743309676647

Congenital B-Disease 1 0.9999997615814209
chloride I-Disease 1 0.9999815225601196
diarrhea I-Disease 1 0.9999992847442627
( O 0 0.023696839809417725
CLD B-Disease 1 0.9999881982803345
) O 0 0.005411812569946051
is O 0 0.001965258037671447
caused O 0 0.03327292576432228
by O 0 0.004592252895236015
mutations O 1 0.9999792575836182
in O 0 0.0020882405806332827
a O 0 0.007842001505196095
gene O 1 0.9997962117195129
which O 0 0.003187890164554119
encodes O 1 0.994562566280365
an O 0 0.011935067363083363
intestinal O 1 0.9999946355819702
anion O 1 0.9997097849845886
transporter O 1 0.999083399772644
. O 0 0.010236328467726707

We O 0 0.003996598068624735
report O 0 0.0022593119647353888
here O 0 0.000820488203316927
the O 0 0.0013864657375961542
complete O 0 0.015640918165445328
genomic O 1 0.9996639490127563
organization O 0 0.004318717401474714
of O 0 0.0006046557682566345
the O 0 0.0016215620562434196
human O 0 0.11692120134830475
CLD B-Disease 1 0.9999750852584839
gene O 1 0.9999058246612549
which O 0 0.003029359970241785
spans O 0 0.024712396785616875
approximately O 0 0.008283775299787521
39kb O 1 0.9905655384063721
, O 0 0.00165061024017632
and O 0 0.0010986337438225746
comprises O 0 0.00740851741284132
21 O 0 0.014658475294709206
exons O 1 0.9922447800636292
. O 0 0.00914415717124939

All O 0 0.009336186572909355
exon O 1 0.9979918003082275
/ O 1 0.8157381415367126
intron O 1 0.9977141618728638
boundaries O 0 0.008272571489214897
conform O 0 0.013017506338655949
to O 0 0.0012781356927007437
the O 0 0.0037877170834690332
GT O 1 0.9999184608459473
/ O 1 0.9961851239204407
AG O 1 0.999330997467041
rule O 0 0.018194232136011124
. O 0 0.007132941856980324

An O 0 0.005074602551758289
analysis O 0 0.00914366077631712
of O 0 0.001049950486049056
the O 0 0.0028864156920462847
putative O 1 0.9994043111801147
promoter O 1 0.9600681662559509
region O 0 0.005967330187559128
sequence O 0 0.030070200562477112
shows O 0 0.004209263250231743
a O 0 0.008968448266386986
putative O 1 0.9992220401763916
TATA O 1 0.9977541565895081
box O 0 0.028171224519610405
and O 0 0.00212931539863348
predicts O 0 0.07225437462329865
multiple O 0 0.3425426483154297
transcription O 1 0.9994444251060486
factor O 0 0.05910051241517067
binding O 0 0.03667468577623367
sites O 0 0.007554888259619474
. O 0 0.0051533994264900684

The O 0 0.00824893731623888
genomic O 1 0.9974939823150635
structure O 0 0.015192301012575626
was O 0 0.002280842512845993
determined O 0 0.006421527359634638
using O 0 0.009786795824766159
DNA O 1 0.9964088797569275
from O 0 0.0015172563726082444
several O 0 0.0013127195416018367
sources O 0 0.0030875306110829115
including O 0 0.0024320369120687246
multiple O 0 0.0361824706196785
large O 0 0.008228886872529984
- O 0 0.027780598029494286
insert O 1 0.9859029054641724
libaries O 1 0.9296587109565735
and O 0 0.003520023310557008
genomic O 1 0.9998458623886108
DNA O 1 0.9976446032524109
from O 0 0.004348137881606817
Finnish O 1 0.9754021763801575
CLD B-Disease 1 0.9999864101409912
patients O 1 0.9989840388298035
and O 0 0.002837244886904955
controls O 0 0.03411212936043739
. O 0 0.007976674474775791

Exon O 1 0.9952772855758667
- O 0 0.038009610027074814
specific O 0 0.0155299948528409
primers O 1 0.9899544715881348
developed O 0 0.01594303548336029
in O 0 0.001088453340344131
this O 0 0.0010153305483981967
study O 0 0.0039351400919258595
will O 0 0.0013800529995933175
facilitate O 0 0.3221776783466339
mutation O 1 0.9999912977218628
screening O 1 0.9744399785995483
studies O 0 0.00985013134777546
of O 0 0.0020443128887563944
patients O 1 0.9994551539421082
with O 0 0.0033578150905668736
the O 0 0.006442999932914972
disease O 1 0.999990701675415
. O 0 0.008062217384576797

Genomic O 1 0.9908407926559448
sequencing O 0 0.4745405316352844
of O 0 0.003122870344668627
a O 0 0.014989452436566353
BAC O 1 0.9998829364776611
clone O 1 0.9997091889381409
H O 1 0.9974308609962463
_ O 0 0.014090516604483128
RG364P16 O 1 0.9711994528770447
revealed O 0 0.013931570574641228
the O 0 0.0012434129603207111
presence O 0 0.004579994827508926
of O 0 0.000703343830537051
another O 0 0.003911080304533243
, O 0 0.0014713030541315675
highly O 0 0.01509499829262495
homologous O 1 0.999966025352478
gene O 1 0.9997972846031189
3 O 0 0.004715951159596443
of O 0 0.0008828435675241053
the O 0 0.005139654967933893
CLD B-Disease 1 0.9999942779541016
gene O 1 0.9998996257781982
, O 0 0.0017649937653914094
with O 0 0.0014427641872316599
a O 0 0.0039341868832707405
similar O 0 0.010744023136794567
genomic O 1 0.9999020099639893
structure O 0 0.01496855728328228
, O 0 0.0012941602617502213
recently O 0 0.005347099155187607
identified O 0 0.00638948567211628
as O 0 0.0015169912949204445
the O 0 0.006413009017705917
Pendred B-Disease 1 0.9999973773956299
syndrome I-Disease 1 1.0
gene O 1 0.9999855756759644
( O 0 0.013162407092750072
PDS B-Disease 1 0.9999179840087891
) O 0 0.006663067266345024
. O 0 0.002926063956692815
. O 0 0.005439971573650837

The O 0 0.008932432159781456
APCI1307K O 1 0.9989655017852783
allele O 1 0.9999388456344604
and O 0 0.01323254406452179
cancer B-Disease 1 0.9999996423721313
risk O 1 0.9908480644226074
in O 0 0.0014746013330295682
a O 0 0.00446090754121542
community O 0 0.005283541511744261
- O 0 0.013675924390554428
based O 0 0.003624680219218135
study O 0 0.006117673125118017
of O 0 0.0019515631720423698
Ashkenazi O 1 0.9918103814125061
Jews O 0 0.008375374600291252
. O 0 0.005391334183514118

Mutations O 1 0.9996918439865112
in O 0 0.006969630718231201
APC O 1 0.9990717172622681
are O 0 0.0028917526360601187
classically O 1 0.9872692823410034
associated O 0 0.015529921278357506
with O 0 0.013148094527423382
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999997615814209
( O 0 0.02589329518377781
FAP B-Disease 1 0.9999597072601318
) O 0 0.00467331800609827
, O 0 0.00127115985378623
a O 0 0.006008383817970753
highly O 0 0.0899440124630928
penetrant O 1 0.9999903440475464
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9985581040382385
disorder I-Disease 1 0.9999979734420776
characterized O 1 0.6600140333175659
by O 0 0.006247393321245909
multiple O 1 0.9993725419044495
intestinal O 1 0.9999998807907104
polyps B-Disease 1 0.9999974966049194
and O 0 0.0020995887462049723
, O 0 0.0018450649222359061
without O 0 0.00834040716290474
surgical O 1 0.9998249411582947
intervention O 0 0.1089300662279129
, O 0 0.0008509089821018279
the O 0 0.0011416515335440636
development O 0 0.007136224769055843
of O 0 0.020366668701171875
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.018074365332722664
CRC B-Disease 1 0.9998636245727539
) O 0 0.007851660251617432
. O 0 0.005439210683107376

APC B-Disease 1 0.9932007193565369
is O 0 0.008033023215830326
a O 0 0.02768142707645893
tumour O 1 0.9999971389770508
- O 1 0.9768037796020508
suppressor O 1 0.9999921321868896
gene O 1 0.9998201727867126
, O 0 0.0024587649386376143
and O 0 0.0024674220476299524
somatic O 1 0.999884843826294
loss O 1 0.736961841583252
occurs O 0 0.4491720497608185
in O 0 0.006229179911315441
tumours B-Disease 1 0.9999934434890747
. O 0 0.010760830715298653

The O 0 0.017939405515789986
germline O 1 0.9999910593032837
T O 1 0.9998434782028198
- O 0 0.02697598747909069
to O 0 0.0031028029043227434
- O 0 0.017736872658133507
A O 0 0.013702786527574062
transversion O 1 0.9672786593437195
responsible O 0 0.009262524545192719
for O 0 0.0013740492286160588
the O 0 0.0030302945524454117
APC O 1 0.9997839331626892
I1307K O 1 0.9964861869812012
allele O 1 0.9993783235549927
converts O 0 0.04051432013511658
the O 0 0.002544900169596076
wild O 0 0.033528104424476624
- O 0 0.021774590015411377
type O 0 0.09016686677932739
sequence O 0 0.032954346388578415
to O 0 0.0015301898820325732
a O 0 0.008749820291996002
homopolymer O 1 0.9989538192749023
tract O 1 0.9998507499694824
( O 0 0.010404557920992374
A8 O 1 0.9999620914459229
) O 0 0.0040633780881762505
that O 0 0.0010535467881709337
is O 0 0.002520834095776081
genetically O 1 0.9991707801818848
unstable O 1 0.9678672552108765
and O 0 0.002173019340261817
prone O 1 0.6697697043418884
to O 0 0.00568750873208046
somatic O 1 0.999964714050293
mutation O 1 0.9999629259109497
. O 0 0.008967087604105473

The O 0 0.009050186723470688
I1307K O 1 0.9918040037155151
allele O 1 0.9993508458137512
was O 0 0.004383058287203312
found O 0 0.006729584187269211
in O 0 0.002698486438021064
6 O 0 0.013255962170660496
. O 0 0.006428230553865433

1 O 0 0.01162727177143097
% O 0 0.004755285568535328
of O 0 0.0020473271142691374
unselected O 1 0.9931979179382324
Ashkenazi O 1 0.9419059753417969
Jews O 0 0.004390604328364134
and O 0 0.0012089009396731853
higher O 0 0.007503133732825518
proportions O 0 0.1892610788345337
of O 0 0.0019787796773016453
Ashkenazim O 1 0.9981379508972168
with O 0 0.003639548784121871
family O 0 0.008145038038492203
or O 0 0.003609687788411975
personal O 0 0.007727681193500757
histories O 0 0.037014346569776535
of O 0 0.0032394826412200928
CRC B-Disease 1 0.9999372959136963
( O 0 0.010992550291121006
ref O 1 0.9987964630126953
. O 0 0.003694851417094469
2 O 0 0.008519305847585201
) O 0 0.004642726853489876
. O 0 0.004434952512383461

To O 0 0.003938762005418539
evaluate O 0 0.01899923011660576
the O 0 0.0014320106711238623
role O 0 0.004968208260834217
of O 0 0.0017028269357979298
I1307K O 1 0.9995463490486145
in O 0 0.008413748815655708
cancer B-Disease 1 0.9999986886978149
, O 0 0.0019486461533233523
we O 0 0.0017425341065973043
genotyped O 1 0.9894883036613464
5 O 0 0.00983546394854784
, O 0 0.004557255655527115
081 O 1 0.998917818069458
Ashkenazi O 1 0.9875746369361877
volunteers O 0 0.014058577828109264
in O 0 0.0016099187778308988
a O 0 0.0047435518354177475
community O 0 0.004747878294438124
survey O 0 0.009597823955118656
. O 0 0.006238757632672787

Risk O 1 0.5721186995506287
of O 0 0.0038047363050282
developing O 1 0.9951263666152954
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 0.010368963703513145
breast I-Disease 1 0.9999984502792358
and I-Disease 0 0.0016499367775395513
other I-Disease 0 0.0036616413854062557
cancers I-Disease 1 0.9999980926513672
were O 0 0.0011491134064272046
compared O 0 0.006784641183912754
between O 0 0.004862509667873383
genotyped O 1 0.9989616870880127
I1307K O 1 0.9979508519172668
carriers O 1 0.6719297766685486
and O 0 0.002257060259580612
non O 0 0.016863638535141945
- O 0 0.07172893732786179
carriers O 1 0.6915221810340881
and O 0 0.0011238288134336472
their O 0 0.0015371456975117326
first O 0 0.00429559638723731
- O 0 0.022364629432559013
degree O 0 0.01791122928261757
relatives O 0 0.023107893764972687
. O 0 0.007296938449144363

Sperm O 1 0.9983304142951965
DNA O 1 0.9968963861465454
analysis O 0 0.014718569815158844
in O 0 0.0019037557067349553
a O 0 0.015160457231104374
Friedreich B-Disease 1 0.9999668598175049
ataxia I-Disease 1 0.9999932050704956
premutation O 1 0.9986760020256042
carrier O 1 0.7301734685897827
suggests O 0 0.01472377683967352
both O 0 0.003253035480156541
meiotic O 1 0.9997285008430481
and O 0 0.0035540657117962837
mitotic O 1 0.9990155696868896
expansion O 0 0.01356525719165802
in O 0 0.0018551950342953205
the O 0 0.003799856174737215
FRDA B-Disease 1 0.9995361566543579
gene O 1 0.9995383024215698
. O 0 0.010224561206996441

Friedreich B-Disease 1 0.9996830224990845
ataxia I-Disease 1 0.99996018409729
is O 0 0.00900768768042326
usually O 0 0.008500794880092144
caused O 0 0.03966640308499336
by O 0 0.0020662792958319187
an O 0 0.001565452665090561
expansion O 0 0.0065917568281292915
of O 0 0.0009437811095267534
a O 0 0.00860883854329586
GAA O 1 0.8063250780105591
trinucleotide O 1 0.9985944628715515
repeat O 0 0.17630888521671295
in O 0 0.004640850238502026
intron O 1 0.9998730421066284
1 O 0 0.00581060815602541
of O 0 0.0009125793585553765
the O 0 0.004547332879155874
FRDA B-Disease 1 0.9996249675750732
gene O 1 0.9998470544815063
. O 0 0.010006492026150227

Occasionally O 0 0.017072150483727455
, O 0 0.0018336400389671326
a O 0 0.00476511474698782
fully O 0 0.005739330314099789
expanded O 0 0.011470315977931023
allele O 1 0.9999293088912964
has O 0 0.0017902664840221405
been O 0 0.001460763392969966
found O 0 0.0035190314520150423
to O 0 0.0016150790033861995
arise O 0 0.11492690443992615
from O 0 0.0019496100721880794
a O 0 0.00596248172223568
premutation O 1 0.9592352509498596
of O 0 0.0010301561560481787
100 O 0 0.00329810893163085
or O 0 0.003883225843310356
less O 0 0.009153226390480995
triplet O 1 0.9997163414955139
repeats O 1 0.8699792623519897
. O 0 0.007779475301504135

We O 0 0.0028052455745637417
have O 0 0.0015220786444842815
examined O 0 0.015840187668800354
the O 0 0.0028364851605147123
sperm O 1 0.9991469383239746
DNA O 1 0.9940387010574341
of O 0 0.001902685035020113
a O 0 0.011485053226351738
premutation O 1 0.9942909479141235
carrier O 1 0.7447899580001831
. O 0 0.008823727257549763

This O 0 0.006070510018616915
mans O 0 0.3675886392593384
leucocyte O 1 0.9955971837043762
DNA O 1 0.9952698349952698
showed O 0 0.009368599392473698
one O 0 0.00299397436901927
normal O 0 0.14988861978054047
allele O 1 0.9998132586479187
and O 0 0.0018683900125324726
one O 0 0.003044772194698453
allele O 1 0.999128520488739
of O 0 0.001151842763647437
approximately O 0 0.003975702915340662
100 O 0 0.005750300828367472
repeats O 0 0.37884727120399475
. O 0 0.007304344791918993

His O 0 0.014557678252458572
sperm O 1 0.9863991737365723
showed O 0 0.009412478655576706
an O 0 0.002146105282008648
expanded O 0 0.012044117785990238
allele O 1 0.9997205138206482
in O 0 0.0020362769719213247
a O 0 0.006521798204630613
tight O 0 0.02023394964635372
range O 0 0.006139671895653009
centering O 0 0.033301882445812225
on O 0 0.0013566367560997605
a O 0 0.004175886046141386
size O 0 0.00547803845256567
of O 0 0.0011631243396550417
approximately O 0 0.006725136190652847
320 O 0 0.09566709399223328
trinucleotide O 1 0.9986237287521362
repeats O 1 0.6913319230079651
. O 0 0.008605298586189747

His O 0 0.012209190987050533
affected O 0 0.03178183361887932
son O 0 0.026698028668761253
has O 0 0.002823105314746499
repeat O 0 0.10337576270103455
sizes O 0 0.016552073881030083
of O 0 0.002482597716152668
1040 O 1 0.9984656572341919
and O 0 0.003830274101346731
540 O 0 0.32231271266937256
. O 0 0.008256939239799976

These O 0 0.003568838117644191
data O 0 0.004719025455415249
suggest O 0 0.006718090269714594
that O 0 0.0012568627716973424
expansion O 0 0.01228274218738079
occurs O 0 0.03780932351946831
in O 0 0.0011740420013666153
two O 0 0.00200558640062809
stages O 0 0.15426483750343323
, O 0 0.0008812084561213851
the O 0 0.0008615016704425216
first O 0 0.002005642745643854
during O 0 0.004602611064910889
meiosis O 1 0.9995458722114563
followed O 0 0.006669755093753338
by O 0 0.0022244027350097895
a O 0 0.005185313057154417
second O 0 0.010514807887375355
mitotic O 1 0.9989894032478333
expansion O 0 0.025996819138526917
. O 0 0.006754211615771055

We O 0 0.0026382224168628454
also O 0 0.001186223467811942
show O 0 0.0024824454449117184
that O 0 0.0008616589475423098
in O 0 0.0009412240469828248
all O 0 0.001130552846007049
informative O 0 0.07169727981090546
carrier O 1 0.5929710268974304
father O 0 0.00693500554189086
to O 0 0.0020850948058068752
affected O 0 0.05497273802757263
child O 0 0.21116025745868683
transmissions O 1 0.9953752756118774
, O 0 0.0017985445447266102
with O 0 0.001312648761086166
the O 0 0.0008460563840344548
notable O 0 0.003079353366047144
exception O 0 0.004570730496197939
of O 0 0.0007733182283118367
the O 0 0.0025236017536371946
premutation O 1 0.9995368719100952
carrier O 1 0.9237371683120728
, O 0 0.0014805009122937918
the O 0 0.001548275351524353
expansion O 0 0.014891036786139011
size O 0 0.013196318410336971
decreases O 1 0.5270111560821533
. O 0 0.0035250477958470583
. O 0 0.004879475105553865

The O 0 0.00842354167252779
R496H O 1 0.9873737692832947
mutation O 1 0.9998725652694702
of O 0 0.003181873820722103
arylsulfatase O 1 0.9961077570915222
A O 0 0.010580641217529774
does O 0 0.0037078745663166046
not O 0 0.0021048958878964186
cause O 1 0.9971463084220886
metachromatic B-Disease 1 0.9998626708984375
leukodystrophy I-Disease 1 0.9999786615371704
. O 0 0.011625857092440128

Deficiency B-Disease 1 0.999954104423523
of I-Disease 0 0.00417453795671463
arylsulfatase I-Disease 1 0.9895393252372742
A I-Disease 0 0.019606109708547592
( O 0 0.00928166601806879
ARSA O 1 0.9995026588439941
) O 0 0.01209049392491579
enzyme O 1 0.9995089769363403
activity O 0 0.03106694482266903
causes O 1 0.9992294311523438
metachromatic B-Disease 1 0.9998420476913452
leukodystrophy I-Disease 1 0.9999910593032837
( O 0 0.021281220018863678
MLD B-Disease 1 0.9996961355209351
) O 0 0.008923090994358063
. O 0 0.005898467265069485

A O 0 0.012062180787324905
number O 0 0.00258335517719388
of O 0 0.004204820841550827
ARSA O 1 0.999943733215332
gene O 1 0.99996018409729
mutations O 1 0.9999744892120361
responsible O 0 0.016345785930752754
for O 0 0.0038051088340580463
MLD B-Disease 1 0.9998204112052917
have O 0 0.0021274881437420845
been O 0 0.002098131226375699
identified O 0 0.01595412753522396
. O 0 0.005515003576874733

Recently O 0 0.021018508821725845
, O 0 0.0026416676118969917
the O 0 0.004379449877887964
R496H O 1 0.9950594902038574
mutation O 1 0.9998518228530884
of O 0 0.005200063344091177
ARSA O 1 0.9996507167816162
was O 0 0.0034872035030275583
proposed O 0 0.004719892051070929
to O 0 0.000692853587679565
be O 0 0.0007860666373744607
a O 0 0.005402022041380405
cause O 0 0.3779714107513428
of O 0 0.0032024364918470383
MLD B-Disease 1 0.9999485015869141
( O 0 0.011682633310556412
Draghia O 1 0.9990922212600708
et O 1 0.854703962802887
al O 0 0.01979895308613777
. O 0 0.0025028104428201914
, O 0 0.0022182329557836056
1997 O 0 0.014356640167534351
) O 0 0.0050108907744288445
. O 0 0.005149944219738245

We O 0 0.002802092581987381
have O 0 0.001293887384235859
investigated O 0 0.011513330042362213
the O 0 0.003518862184137106
R496H O 1 0.9994000196456909
mutation O 1 0.9999809265136719
and O 0 0.0017022158717736602
found O 0 0.004952786955982447
this O 0 0.003310631262138486
mutation O 1 0.9999876022338867
at O 0 0.002625358523800969
a O 0 0.0042480165138840675
relatively O 0 0.006835407577455044
high O 0 0.00406233873218298
frequency O 0 0.032652027904987335
in O 0 0.0012719627702608705
an O 0 0.0016353079117834568
African O 0 0.008562834933400154
American O 0 0.004427362233400345
population O 0 0.003911028616130352
( O 0 0.006445151753723621
f O 1 0.9286772608757019
= O 0 0.24408070743083954
0 O 0 0.018610084429383278
. O 0 0.0024266426917165518
09 O 0 0.13622404634952545
, O 0 0.0031986923422664404
n O 0 0.23869390785694122
= O 0 0.10194272547960281
61 O 0 0.031113384291529655
subjects O 0 0.012742801569402218
) O 0 0.004786831792443991
. O 0 0.004767243284732103

The O 0 0.013799154199659824
ARSA O 1 0.9991942048072815
enzyme O 1 0.9994082450866699
activity O 0 0.01697423867881298
in O 0 0.001785743865184486
subjects O 0 0.0053499299101531506
with O 0 0.002012254437431693
and O 0 0.0008629629155620933
without O 0 0.002387206070125103
the O 0 0.002012889599427581
R496H O 1 0.9998314380645752
mutation O 1 0.9999934434890747
was O 0 0.0031291695777326822
determined O 0 0.00662256358191371
and O 0 0.0009115018183365464
found O 0 0.003799365134909749
to O 0 0.0012297852663323283
be O 0 0.002118464559316635
normal O 0 0.029414769262075424
. O 0 0.007124038413167

It O 0 0.0037947765085846186
is O 0 0.0020673295948654413
therefore O 0 0.003346578683704138
concluded O 0 0.006867080461233854
that O 0 0.0009435041574761271
the O 0 0.0027016655076295137
R496H O 1 0.9992085099220276
mutation O 1 0.9999306201934814
of O 0 0.005713004153221846
ARSA O 1 0.9998542070388794
does O 0 0.006528567988425493
not O 0 0.00172176375053823
negatively O 0 0.0247307438403368
influence O 0 0.00411651935428381
the O 0 0.0012295664055272937
activity O 0 0.007089944090694189
of O 0 0.0026142969727516174
ARSA O 1 0.9999808073043823
and O 0 0.0018088339129462838
is O 0 0.0013476252788677812
not O 0 0.0012607708340510726
a O 0 0.006227206438779831
cause O 1 0.6258222460746765
of O 0 0.005633570719510317
MLD B-Disease 1 0.9993909597396851

Down O 0 0.034219659864902496
- O 0 0.029459906741976738
regulation O 0 0.032411087304353714
of O 0 0.0029818336479365826
transmembrane O 1 0.9987409710884094
carbonic O 1 0.9991791844367981
anhydrases O 1 0.9901019334793091
in O 0 0.015223207883536816
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9999934434890747
carcinoma I-Disease 1 1.0
cell O 1 0.9986586570739746
lines O 0 0.012637188658118248
by O 0 0.0026404268573969603
wild O 0 0.05466333404183388
- O 0 0.049803514033555984
type O 1 0.981164276599884
von B-Disease 1 0.9964302182197571
Hippel I-Disease 1 0.9997997879981995
- I-Disease 1 0.5241228938102722
Lindau I-Disease 1 0.9993849992752075
transgenes O 1 0.9873413443565369
. O 0 0.013870598748326302

To O 0 0.006316250190138817
discover O 0 0.09461400657892227
genes O 1 0.9973834156990051
involved O 0 0.01094853226095438
in O 0 0.0033749165013432503
von B-Disease 1 0.9980315566062927
Hippel I-Disease 1 0.9999302625656128
- I-Disease 1 0.7422705888748169
Lindau I-Disease 1 0.9997363686561584
( O 0 0.018941229209303856
VHL B-Disease 1 0.9999727010726929
) O 0 0.011416014283895493
- O 0 0.07722610980272293
mediated O 1 0.9996639490127563
carcinogenesis O 1 0.9999730587005615
, O 0 0.0016321229049935937
we O 0 0.0015244879759848118
used O 0 0.015590121038258076
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9999825954437256
carcinoma I-Disease 1 0.9999998807907104
cell O 1 0.9979896545410156
lines O 0 0.028412705287337303
stably O 1 0.9914788603782654
transfected O 1 0.9988665580749512
with O 0 0.006255838554352522
wild O 0 0.07155168801546097
- O 0 0.11974040418863297
type O 1 0.9949719905853271
VHL O 1 0.999951958656311
- O 0 0.04913926497101784
expressing O 0 0.04270913451910019
transgenes O 1 0.985892117023468
. O 0 0.010216973721981049

Large O 0 0.01877179741859436
- O 0 0.02491334266960621
scale O 0 0.03537248820066452
RNA O 1 0.9990423321723938
differential O 0 0.46801209449768066
display O 0 0.0061100241728127
technology O 0 0.008051203563809395
applied O 0 0.0035982888657599688
to O 0 0.0011861053062602878
these O 0 0.0022300092969089746
cell O 1 0.9979522228240967
lines O 0 0.016306865960359573
identified O 0 0.009873681701719761
several O 0 0.003431023331359029
differentially O 1 0.971430242061615
expressed O 0 0.01162573043256998
genes O 1 0.9988048076629639
, O 0 0.001528861466795206
including O 0 0.0018689611461013556
an O 0 0.003052525455132127
alpha O 1 0.9865054488182068
carbonic O 1 0.999750554561615
anhydrase O 1 0.9996483325958252
gene O 1 0.9997267127037048
, O 0 0.006035321392118931
termed O 0 0.4439610242843628
CA12 O 1 0.9886588454246521
. O 0 0.009525795467197895

The O 0 0.005214676260948181
deduced O 0 0.08513911068439484
protein O 1 0.9974193572998047
sequence O 0 0.056513696908950806
was O 0 0.0025558355264365673
classified O 0 0.010572453960776329
as O 0 0.0013794747646898031
a O 0 0.004556173924356699
one O 0 0.003245280124247074
- O 0 0.018170882016420364
pass O 0 0.02749301865696907
transmembrane O 1 0.9984549283981323
CA O 0 0.02065289206802845
possessing O 0 0.014821904711425304
an O 0 0.00199487223289907
apparently O 0 0.014804992824792862
intact O 0 0.04902635142207146
catalytic O 1 0.9948310256004333
domain O 0 0.02781818062067032
in O 0 0.001554323360323906
the O 0 0.003085294971242547
extracellular O 1 0.9986543655395508
CA O 0 0.04620211571455002
module O 1 0.5117248892784119
. O 0 0.007060531992465258

Reintroduced O 1 0.5075317621231079
wild O 0 0.05104878917336464
- O 0 0.04069042205810547
type O 1 0.9177452325820923
VHL B-Disease 1 0.9998227953910828
strongly O 0 0.019672293215990067
inhibited O 1 0.9827123880386353
the O 0 0.0029033576138317585
overexpression O 1 0.9991787075996399
of O 0 0.0012332104379311204
the O 0 0.002745140576735139
CA12 O 1 0.9997907280921936
gene O 1 0.9997692704200745
in O 0 0.001775588491000235
the O 0 0.003380682785063982
parental O 1 0.9999501705169678
renal B-Disease 1 1.0
cell I-Disease 1 0.9999958276748657
carcinoma I-Disease 1 1.0
cell O 1 0.9992988109588623
lines O 0 0.027695853263139725
. O 0 0.006792936008423567

Similar O 0 0.017033081501722336
results O 0 0.008862352930009365
were O 0 0.0009828064357861876
obtained O 0 0.007141856011003256
with O 0 0.0055832709185779095
CA9 O 1 0.9995573163032532
, O 0 0.0034199089277535677
encoding O 1 0.9791436791419983
another O 0 0.011118651367723942
transmembrane O 1 0.9990850687026978
CA O 0 0.019667277112603188
with O 0 0.0020092937629669905
an O 0 0.002089120913296938
intact O 0 0.13187699019908905
catalytic O 1 0.9987778067588806
domain O 0 0.052776239812374115
. O 0 0.0056595648638904095

Although O 0 0.005790001712739468
both O 0 0.0019439435563981533
domains O 0 0.03645894303917885
of O 0 0.0010122382082045078
the O 0 0.0034091088455170393
VHL B-Disease 1 0.9999938011169434
protein O 1 0.9992497563362122
contribute O 0 0.013513472862541676
to O 0 0.0013817599974572659
regulation O 0 0.026608478277921677
of O 0 0.0020850948058068752
CA12 O 1 0.9993651509284973
expression O 0 0.03729726001620293
, O 0 0.0013376991264522076
the O 0 0.0019519793568179011
elongin O 1 0.9937961101531982
binding O 0 0.08819573372602463
domain O 0 0.033567022532224655
alone O 0 0.005027796141803265
could O 0 0.003780314465984702
effectively O 0 0.02624671906232834
regulate O 1 0.8983629941940308
CA9 O 1 0.9991920590400696
expression O 0 0.08196766674518585
. O 0 0.006556570064276457

We O 0 0.006193057633936405
mapped O 0 0.05861678719520569
CA12 O 1 0.9689461588859558
and O 0 0.006637804210186005
CA9 O 1 0.9991076588630676
loci O 1 0.9982602000236511
to O 0 0.009547767229378223
chromosome O 1 0.9999276399612427
bands O 0 0.033153411000967026
15q22 O 1 0.9551721215248108
and O 0 0.003929465543478727
17q21 O 1 0.9735255837440491
. O 0 0.009045923128724098

2 O 0 0.014110992662608624
respectively O 0 0.008098466321825981
, O 0 0.0022029608953744173
regions O 0 0.011136017739772797
prone O 1 0.5715766549110413
to O 0 0.003191059920936823
amplification O 1 0.9944928884506226
in O 0 0.0018570953980088234
some O 0 0.002252408768981695
human O 0 0.31717661023139954
cancers B-Disease 1 0.9999951124191284
. O 0 0.010404631495475769

Additional O 0 0.017974942922592163
experiments O 0 0.026340734213590622
are O 0 0.0010160921374335885
needed O 0 0.0046284133568406105
to O 0 0.0009531352552585304
define O 0 0.008320133201777935
the O 0 0.0010329005308449268
role O 0 0.004772230051457882
of O 0 0.0016135459300130606
CA O 0 0.20448936522006989
IX O 1 0.997718334197998
and O 0 0.002737518632784486
CA O 0 0.03846500813961029
XII O 1 0.9948593378067017
enzymes O 1 0.9966784715652466
in O 0 0.0017067481530830264
the O 0 0.0015646197134628892
regulation O 0 0.028295036405324936
of O 0 0.0019975099712610245
pH O 1 0.9992338418960571
in O 0 0.001371459336951375
the O 0 0.002618360798805952
extracellular O 1 0.9994762539863586
microenvironment O 1 0.9995484948158264
and O 0 0.0013237698003649712
its O 0 0.0015964623307809234
potential O 0 0.01338998880237341
impact O 0 0.012872323393821716
on O 0 0.006888642907142639
cancer B-Disease 1 0.9999995231628418
cell O 1 0.9997778534889221
growth O 0 0.023981057107448578
. O 0 0.005764598958194256

A O 0 0.031209671869874
gene O 1 0.9965129494667053
encoding O 0 0.30828216671943665
a O 0 0.011927496641874313
transmembrane O 1 0.9969494938850403
protein O 1 0.9982498288154602
is O 0 0.004914799705147743
mutated O 1 0.9999183416366577
in O 0 0.005936982110142708
patients O 1 0.9999071359634399
with O 0 0.21344320476055145
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999990463256836
and O 0 0.016680486500263214
optic B-Disease 1 0.9999974966049194
atrophy I-Disease 1 0.9999942779541016
( O 0 0.12524333596229553
Wolfram B-Disease 1 0.9999982118606567
syndrome I-Disease 1 0.9999997615814209
) O 0 0.010302430018782616
. O 0 0.0061544268392026424

Wolfram B-Disease 1 0.9999594688415527
syndrome I-Disease 1 0.9999994039535522
( O 0 0.031280629336833954
WFS B-Disease 1 0.999769389629364
; O 0 0.02281659096479416
OMIM O 1 0.9999592304229736
222300 O 1 0.9964787364006042
) O 0 0.004147305153310299
is O 0 0.002007957547903061
an O 0 0.008350299671292305
autosomal B-Disease 1 1.0
recessive I-Disease 1 0.9999998807907104
neurodegenerative I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999840259552002
defined O 0 0.009996224194765091
by O 0 0.0033058486878871918
young O 0 0.020807618275284767
- O 1 0.7860940098762512
onset O 1 0.9999760389328003
non O 0 0.06709899008274078
- O 1 0.9925395846366882
immune O 1 0.9999983310699463
insulin B-Disease 1 0.9999949932098389
- I-Disease 1 0.8644333481788635
dependent I-Disease 1 0.9965429902076721
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999954700469971
and O 0 0.009877355769276619
progressive O 1 0.9984310269355774
optic B-Disease 1 0.9999899864196777
atrophy I-Disease 1 0.9999074935913086
. O 0 0.013454686850309372

Linkage O 1 0.8326111435890198
to O 0 0.0040471781976521015
markers O 0 0.13583976030349731
on O 0 0.006281073670834303
chromosome O 1 0.9999899864196777
4p O 1 0.9989155530929565
was O 0 0.003992410842329264
confirmed O 0 0.007545380387455225
in O 0 0.0012707040878012776
five O 0 0.0033721497748047113
families O 0 0.007736866362392902
. O 0 0.005087858997285366

On O 0 0.00212680222466588
the O 0 0.0009480791050009429
basis O 0 0.0026391237042844296
of O 0 0.0023113712668418884
meiotic O 1 0.9999710321426392
recombinants O 1 0.9990935325622559
and O 0 0.011589951813220978
disease O 1 0.9999990463256836
- O 0 0.09704089164733887
associated O 0 0.06841212511062622
haplotypes O 1 0.9998880624771118
, O 0 0.00235141534358263
the O 0 0.004562833812087774
WFS B-Disease 1 0.9999693632125854
gene O 1 0.9997934699058533
was O 0 0.005171861033886671
localized O 1 0.9818877577781677
to O 0 0.002456181449815631
a O 0 0.014916197396814823
BAC O 1 0.9999599456787109
/ O 1 0.9840881824493408
P1 O 1 0.9987353682518005
contig O 1 0.8269413709640503
of O 0 0.0018747063586488366
less O 0 0.0033629555255174637
than O 0 0.0019612370524555445
250 O 0 0.01761932298541069
kb O 1 0.9733313918113708
. O 0 0.00888259056955576

Mutations O 1 0.9997729659080505
in O 0 0.002908729948103428
a O 0 0.007244777865707874
novel O 0 0.042260315269231796
gene O 1 0.9998756647109985
( O 0 0.010405239649116993
WFS1 O 1 0.9964162111282349
) O 0 0.0052228826098144054
encoding O 0 0.45969071984291077
a O 0 0.009489571675658226
putative O 1 0.9990434050559998
transmembrane O 1 0.9987879395484924
protein O 1 0.9987183809280396
were O 0 0.0011269678361713886
found O 0 0.002977498574182391
in O 0 0.0008889049640856683
all O 0 0.0009199340711347759
affected O 0 0.012541848234832287
individuals O 0 0.0037956039886921644
in O 0 0.0018570120446383953
six O 0 0.00954208243638277
WFS B-Disease 1 0.9999785423278809
families O 0 0.006295942701399326
, O 0 0.0010244069853797555
and O 0 0.0006301416433416307
these O 0 0.002073063049465418
mutations O 1 0.9999884366989136
were O 0 0.0010679776314646006
associated O 0 0.006239969749003649
with O 0 0.0027219608891755342
the O 0 0.007049815263599157
disease O 1 0.9999985694885254
phenotype O 1 0.9999920129776001
. O 0 0.010593163780868053

WFS1 O 1 0.9897420406341553
appears O 0 0.018758343532681465
to O 0 0.001825332990847528
function O 0 0.016659319400787354
in O 0 0.0018312642350792885
survival O 0 0.1831907480955124
of O 0 0.0030816802754998207
islet O 1 0.9995653033256531
beta O 1 0.9995852112770081
- O 1 0.5009138584136963
cells O 1 0.9998071789741516
and O 0 0.003504254389554262
neurons O 1 0.9993565678596497
. O 0 0.0035262322053313255
. O 0 0.0044344766065478325

Stable O 0 0.08577501773834229
interaction O 0 0.029335075989365578
between O 0 0.0019614133052527905
the O 0 0.0009540406754240394
products O 0 0.004984076134860516
of O 0 0.0008664485649205744
the O 0 0.0047956788912415504
BRCA1 O 1 0.9999995231628418
and O 0 0.019582824781537056
BRCA2 O 1 0.9999998807907104
tumor B-Disease 1 0.9999984502792358
suppressor O 1 0.9999648332595825
genes O 1 0.9974368810653687
in O 0 0.003837225027382374
mitotic O 1 0.9993461966514587
and O 0 0.007434503640979528
meiotic O 1 0.9999690055847168
cells O 1 0.9993026256561279
. O 0 0.008169649168848991

BRCA1 O 1 0.9999454021453857
and O 0 0.014687960036098957
BRCA2 O 1 0.9999932050704956
account O 0 0.005430478136986494
for O 0 0.001054057851433754
most O 0 0.001172529300674796
cases O 0 0.006461502052843571
of O 0 0.0026598384138196707
familial O 1 0.9999958276748657
, O 0 0.002907457761466503
early O 0 0.020953604951500893
onset O 1 0.9999983310699463
breast B-Disease 1 0.9999990463256836
and I-Disease 0 0.003912752959877253
/ I-Disease 1 0.9996198415756226
or I-Disease 1 0.9741032719612122
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 0.002708551473915577
encode O 1 0.9780828952789307
products O 0 0.007973776198923588
that O 0 0.0010822584154084325
each O 0 0.0021456736139953136
interact O 0 0.04978407174348831
with O 0 0.006382427178323269
hRAD51 O 1 0.9909241795539856
. O 0 0.009641329757869244

Results O 0 0.020229090005159378
presented O 0 0.0041075157932937145
here O 0 0.0010388664668425918
show O 0 0.003009168431162834
that O 0 0.0042402478866279125
BRCA1 O 1 0.9999980926513672
and O 0 0.009064330719411373
BRCA2 O 1 0.9999988079071045
coexist O 0 0.3219965696334839
in O 0 0.0017725821817293763
a O 0 0.007791518233716488
biochemical O 1 0.9992921352386475
complex O 0 0.01322989258915186
and O 0 0.001607822603546083
colocalize O 1 0.9869224429130554
in O 0 0.003348178928717971
subnuclear O 1 0.9973924160003662
foci O 1 0.9985412359237671
in O 0 0.00554741732776165
somatic O 1 0.9999752044677734
cells O 1 0.999553382396698
and O 0 0.0010684594744816422
on O 0 0.0008516836096532643
the O 0 0.0017609985079616308
axial O 1 0.9792541265487671
elements O 0 0.006403666455298662
of O 0 0.0016031593549996614
developing O 0 0.03429705277085304
synaptonemal O 1 0.9972905516624451
complexes O 1 0.7295715808868408
. O 0 0.007644285913556814

Like O 0 0.04759223014116287
BRCA1 O 1 0.9999877214431763
and O 0 0.012556834146380424
RAD51 O 1 0.9998863935470581
, O 0 0.01221464853733778
BRCA2 O 1 0.9999817609786987
relocates O 1 0.9454283714294434
to O 0 0.008857796899974346
PCNA O 1 0.9997523427009583
+ O 1 0.9913034439086914
replication O 1 0.9992017149925232
sites O 0 0.005195678677409887
following O 0 0.005177393555641174
exposure O 1 0.6139736175537109
of O 0 0.002142630284652114
S O 1 0.8989827036857605
phase O 0 0.4632308781147003
cells O 1 0.9984725117683411
to O 0 0.004664250649511814
hydroxyurea O 1 0.9998292922973633
or O 0 0.015932071954011917
UV O 1 0.9996902942657471
irradiation O 1 0.9849558472633362
. O 0 0.010879053734242916

Thus O 0 0.017021039500832558
, O 0 0.008320215158164501
BRCA1 O 1 0.9999969005584717
and O 0 0.009102503769099712
BRCA2 O 1 0.9999979734420776
participate O 0 0.006570340599864721
, O 0 0.0012934966944158077
together O 0 0.002292212098836899
, O 0 0.000796948210336268
in O 0 0.0011270177783444524
a O 0 0.008777805604040623
pathway O 1 0.999920129776001
( O 0 0.0065485029481351376
s O 0 0.34504806995391846
) O 0 0.0037631355226039886
associated O 0 0.005317922681570053
with O 0 0.0011195142287760973
the O 0 0.0013194518396630883
activation O 1 0.9958972930908203
of O 0 0.0018328382866457105
double O 0 0.2191532552242279
- O 0 0.07414058595895767
strand O 1 0.9983192086219788
break O 0 0.04212065041065216
repair O 1 0.9949222207069397
and O 0 0.0026881552767008543
/ O 0 0.48133090138435364
or O 0 0.009494228288531303
homologous O 1 0.9998691082000732
recombination O 1 0.9993718266487122
. O 0 0.008897025138139725

Dysfunction O 1 0.9997479319572449
of O 0 0.0018320123199373484
this O 0 0.0028616893105208874
pathway O 1 0.9999151229858398
may O 0 0.0045105526223778725
be O 0 0.0008161865407600999
a O 0 0.0029917778447270393
general O 0 0.0026977164670825005
phenomenon O 0 0.03829556703567505
in O 0 0.0008971149800345302
the O 0 0.0008703918429091573
majority O 0 0.0026667665224522352
of O 0 0.0008020179229788482
cases O 0 0.006579946260899305
of O 0 0.003150921082124114
hereditary B-Disease 1 0.9999986886978149
breast I-Disease 1 0.9999994039535522
and I-Disease 0 0.0062532005831599236
/ I-Disease 1 0.9995661377906799
or I-Disease 1 0.9871348738670349
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.005312162451446056
. O 0 0.0053269146010279655

A O 0 0.021410688757896423
novel O 0 0.034540414810180664
Arg362Ser O 1 0.9974766373634338
mutation O 1 0.9999258518218994
in O 0 0.0022854383569210768
the O 0 0.003191904863342643
sterol O 1 0.999789297580719
27 O 0 0.028155125677585602
- O 0 0.15286125242710114
hydroxylase O 1 0.9997531771659851
gene O 1 0.9999322891235352
( O 0 0.012433676049113274
CYP27 O 1 0.9992082715034485
) O 0 0.0045826612040400505
: O 0 0.0023702324833720922
its O 0 0.002039587590843439
effects O 0 0.030856851488351822
on O 0 0.0019204124109819531
pre O 0 0.039168547838926315
- O 0 0.030599132180213928
mRNA O 1 0.9878320097923279
splicing O 1 0.9976048469543457
and O 0 0.005234505049884319
enzyme O 1 0.9994392991065979
activity O 0 0.0203444454818964
. O 0 0.005661849398165941

A O 0 0.025783149525523186
novel O 0 0.028047477826476097
C O 0 0.09875349700450897
to O 0 0.00192255771253258
A O 0 0.013912913389503956
mutation O 1 0.9999394416809082
in O 0 0.0017742315540090203
the O 0 0.0027886941097676754
sterol O 1 0.9997538924217224
27 O 0 0.025493387132883072
- O 0 0.1020684689283371
hydroxylase O 1 0.9997121691703796
gene O 1 0.9999403953552246
( O 0 0.0114222951233387
CYP27 O 1 0.9990788698196411
) O 0 0.0043790945783257484
was O 0 0.0018771144095808268
identified O 0 0.0090680792927742
by O 0 0.003794473595917225
sequencing O 1 0.9958989024162292
amplified O 1 0.9799985289573669
CYP27 O 1 0.9988810420036316
gene O 1 0.9994224309921265
products O 0 0.012385382317006588
from O 0 0.002507612807676196
a O 0 0.009601354598999023
patient O 1 0.99820876121521
with O 0 0.008677764795720577
cerebrotendinous B-Disease 1 0.9997820258140564
xanthomatosis I-Disease 1 0.9992944002151489
( O 0 0.01873059943318367
CTX B-Disease 1 0.9998880624771118
) O 0 0.010036536492407322
. O 0 0.006171134766191244

The O 0 0.009406224824488163
mutation O 1 0.9997319579124451
changed O 0 0.009213591925799847
the O 0 0.0028000297024846077
adrenodoxin O 1 0.9816263914108276
cofactor O 1 0.9943413734436035
binding O 0 0.07975076884031296
residue O 1 0.9214058518409729
362Arg O 1 0.954939603805542
to O 0 0.004689815454185009
362Ser O 1 0.9610974788665771
( O 0 0.011311348527669907
CGT O 1 0.9848201274871826
362Arg O 1 0.9917112588882446
to O 0 0.008420953527092934
AGT O 1 0.9999803304672241
362Ser O 1 0.9992238283157349
) O 0 0.005156026221811771
, O 0 0.0011407325509935617
and O 0 0.0008125268504954875
was O 0 0.0017343234503641725
responsible O 0 0.009473593905568123
for O 0 0.005163988564163446
deficiency O 1 0.9999961853027344
in O 0 0.00202277023345232
the O 0 0.003625062759965658
sterol O 1 0.9998025298118591
27 O 0 0.02711878903210163
- O 0 0.0592791922390461
hydroxylase O 1 0.9992944002151489
activity O 0 0.017038559541106224
, O 0 0.0014085014117881656
as O 0 0.0014884673291817307
confirmed O 0 0.006915466859936714
by O 0 0.0019026987720280886
expression O 0 0.01577075757086277
of O 0 0.002038954757153988
mutant O 1 0.9989938139915466
cDNA O 1 0.9938687682151794
into O 0 0.01661539077758789
COS O 1 0.9996200799942017
- O 0 0.03930594399571419
1 O 0 0.01985703781247139
cells O 1 0.9980385899543762
. O 0 0.0067091998644173145

Quantitative O 0 0.23533006012439728
analysis O 0 0.015414047986268997
showed O 0 0.004969111178070307
that O 0 0.0007725058239884675
the O 0 0.0010260388953611255
expression O 0 0.018432559445500374
of O 0 0.0021481732837855816
CYP27 O 1 0.9996084570884705
gene O 1 0.9999115467071533
mRNA O 1 0.9872387051582336
in O 0 0.0019340713042765856
the O 0 0.0025026986841112375
patient O 1 0.9958063364028931
represented O 0 0.005696352571249008
52 O 0 0.0213299747556448
. O 0 0.006806112825870514

5 O 0 0.015147179365158081
% O 0 0.004406921099871397
of O 0 0.0009734640480019152
the O 0 0.002005994087085128
normal O 0 0.02751549333333969
level O 0 0.007465093396604061
. O 0 0.005496729165315628

As O 0 0.004280332010239363
the O 0 0.005168191622942686
mutation O 1 0.9998855590820312
occurred O 0 0.017008667811751366
at O 0 0.0019180939998477697
the O 0 0.0019081078935414553
penultimate O 1 0.9898297190666199
nucleotide O 1 0.9959237575531006
of O 0 0.003832377726212144
exon O 1 0.99824059009552
6 O 0 0.01794702187180519
( O 0 0.006889771204441786
- O 0 0.013693354092538357
2 O 0 0.005238262936472893
position O 0 0.0023227513302117586
of O 0 0.001856339629739523
exon O 1 0.9990460276603699
6 O 0 0.023653987795114517
- O 0 0.055441729724407196
intron O 1 0.9997461438179016
6 O 0 0.018164334818720818
splice O 1 0.9991551637649536
site O 0 0.008403316140174866
) O 0 0.0017178929410874844
of O 0 0.0006445327890105546
the O 0 0.0028561672661453485
gene O 1 0.9999746084213257
, O 0 0.0013686689781025052
we O 0 0.0012175935553386807
hypothesized O 1 0.9849117994308472
that O 0 0.0011092610657215118
the O 0 0.0029635203536599874
mutation O 1 0.9999959468841553
may O 0 0.007894347421824932
partially O 0 0.03266723453998566
affect O 0 0.012380193918943405
the O 0 0.0015085218474268913
normal O 0 0.04533049464225769
splicing O 1 0.99951171875
efficiency O 0 0.0272459015250206
in O 0 0.003673831932246685
exon O 1 0.9977442026138306
6 O 0 0.00900525413453579
and O 0 0.001742595573887229
cause O 1 0.8115509748458862
alternative O 0 0.05419253930449486
splicing O 1 0.9998679161071777
elsewhere O 0 0.00878835003823042
, O 0 0.0010706669418141246
which O 0 0.001137603772804141
resulted O 0 0.01078237034380436
in O 0 0.0020997989922761917
decreased O 1 0.6143268346786499
transcript O 1 0.9472054839134216
in O 0 0.002259449567645788
the O 0 0.0033288283739238977
patient O 1 0.9987817406654358
. O 0 0.0069431280717253685

Transfection O 1 0.9938945174217224
of O 0 0.0035996742080897093
constructed O 0 0.015742139890789986
minigenes O 1 0.9892759323120117
, O 0 0.0018142004264518619
with O 0 0.0020069614984095097
or O 0 0.002386601874604821
without O 0 0.0028720349073410034
the O 0 0.0026640286669135094
mutation O 1 0.9999887943267822
, O 0 0.0022386740893125534
into O 0 0.00838721264153719
COS O 1 0.9999374151229858
- O 0 0.03670315071940422
1 O 0 0.016455883160233498
cells O 1 0.9995532631874084
confirmed O 0 0.00739622674882412
that O 0 0.0009081469615921378
the O 0 0.002398053416982293
mutant O 1 0.9996683597564697
minigene O 1 0.9792349338531494
was O 0 0.0026742988266050816
responsible O 0 0.0072421543300151825
for O 0 0.0013529736315831542
a O 0 0.007267231121659279
mRNA O 1 0.9759820699691772
species O 0 0.019057530909776688
alternatively O 1 0.5710357427597046
spliced O 1 0.9971479773521423
at O 0 0.0032841297797858715
an O 0 0.003407115116715431
activated O 1 0.9959270358085632
cryptic O 1 0.9864326119422913
5 O 0 0.011377274058759212
splice O 1 0.9979158043861389
site O 0 0.010601704008877277
88 O 0 0.024287167936563492
bp O 0 0.07554900646209717
upstream O 0 0.038803957402706146
from O 0 0.002187832025811076
the O 0 0.0016059513436630368
3 O 0 0.00689286831766367
end O 0 0.004181812983006239
of O 0 0.0024750896263867617
exon O 1 0.9987937211990356
6 O 0 0.016775263473391533
. O 0 0.006956310011446476

Our O 0 0.005112339276820421
data O 0 0.005214030388742685
suggest O 0 0.00642882427200675
that O 0 0.0010320354485884309
the O 0 0.001709506381303072
C O 0 0.2768571972846985
to O 0 0.0018391902558505535
A O 0 0.015985818579792976
mutation O 1 0.9999223947525024
at O 0 0.00236322870478034
the O 0 0.00196891650557518
penultimate O 1 0.9807883501052856
nucleotide O 1 0.9934048056602478
of O 0 0.0030827850569039583
exon O 1 0.998365581035614
6 O 0 0.00638517364859581
of O 0 0.000995878828689456
the O 0 0.0023975721560418606
CYP27 O 1 0.9997640252113342
gene O 1 0.9999028444290161
not O 0 0.0012185019440948963
only O 0 0.0015389046166092157
causes O 1 0.9876130819320679
the O 0 0.00446480605751276
deficiency B-Disease 1 0.9999980926513672
in I-Disease 0 0.0021845148876309395
the I-Disease 0 0.003625386394560337
sterol I-Disease 1 0.999869704246521
27 I-Disease 0 0.028755247592926025
- I-Disease 0 0.0669666975736618
hydroxylase I-Disease 1 0.999606192111969
activity I-Disease 0 0.016617394983768463
, O 0 0.0013586862478405237
but O 0 0.000985960359685123
also O 0 0.0013492214493453503
partially O 0 0.035340566188097
leads O 0 0.011938774026930332
to O 0 0.001169525901786983
alternative O 0 0.015702513977885246
pre O 0 0.03841599449515343
- O 0 0.027486642822623253
mRNA O 1 0.9840644001960754
splicing O 1 0.9876533150672913
of O 0 0.0017206493066623807
the O 0 0.004455285612493753
gene O 1 0.9996864795684814
. O 0 0.009339781478047371

To O 0 0.0029746771324425936
our O 0 0.0029796611052006483
knowledge O 0 0.0065825022757053375
, O 0 0.0012702812673524022
this O 0 0.0010303800227120519
is O 0 0.0009662179509177804
the O 0 0.0008880688692443073
first O 0 0.0017164943274110556
report O 0 0.002571621211245656
regarding O 0 0.0065367682836949825
effects O 0 0.030827920883893967
on O 0 0.001884368364699185
pre O 0 0.04556187242269516
- O 0 0.029720408841967583
mRNA O 1 0.9860535264015198
splicing O 1 0.9892907738685608
of O 0 0.00161453103646636
a O 0 0.01037437655031681
mutation O 1 0.9999649524688721
at O 0 0.0030420878902077675
the O 0 0.002450036583468318
- O 0 0.015869800001382828
2 O 0 0.006643809378147125
position O 0 0.0018612913554534316
of O 0 0.0009403791627846658
a O 0 0.005234815180301666
5 O 0 0.013107692822813988
splice O 1 0.9988368153572083
site O 0 0.014608020894229412
. O 0 0.007620492484420538

ATM O 1 0.994415283203125
germline O 1 0.9998723268508911
mutations O 1 0.9998078942298889
in O 0 0.005291102919727564
classical O 0 0.25219228863716125
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9988657236099243
telangiectasia I-Disease 1 0.999998927116394
patients O 1 0.9994930028915405
in O 0 0.001984979026019573
the O 0 0.0020282818004488945
Dutch O 0 0.015734998509287834
population O 0 0.004884826019406319
. O 0 0.004941409453749657

Germline O 1 0.9998666048049927
mutations O 1 0.9995260238647461
in O 0 0.0032808149699121714
the O 0 0.003799740457907319
ATM O 1 0.9995238780975342
gene O 1 0.9993168115615845
are O 0 0.0011324206134304404
responsible O 0 0.005330958403646946
for O 0 0.0021966455969959497
the O 0 0.012873366475105286
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9960748553276062
telangiectasia I-Disease 1 0.9999942779541016
( O 0 0.010872540064156055
A B-Disease 1 0.5296736359596252
- I-Disease 1 0.8914012312889099
T I-Disease 1 0.9998815059661865
) O 0 0.009250499308109283
. O 0 0.0065271882340312

In O 0 0.004361133556813002
our O 0 0.0029649424832314253
study O 0 0.007382732816040516
, O 0 0.001302523771300912
we O 0 0.0007748695788905025
have O 0 0.0007058106712065637
determined O 0 0.004508384503424168
the O 0 0.002288134302943945
ATM O 1 0.9997327923774719
mutation O 1 0.9999772310256958
spectrum O 0 0.036691807210445404
in O 0 0.0013935514725744724
19 O 0 0.005262427031993866
classical O 0 0.01109162624925375
A B-Disease 1 0.9389649033546448
- I-Disease 1 0.998728334903717
T I-Disease 1 0.9999969005584717
patients O 1 0.9998688697814941
, O 0 0.0011853318428620696
including O 0 0.0015151109546422958
some O 0 0.0014438808429986238
immigrant O 0 0.03316860273480415
populations O 0 0.035885926336050034
, O 0 0.0012230041902512312
as O 0 0.0011508254101499915
well O 0 0.0012848881306126714
as O 0 0.0011528328759595752
12 O 0 0.0038329274393618107
of O 0 0.0011074735084548593
Dutch O 0 0.014724504202604294
ethnic O 0 0.007163520902395248
origin O 0 0.011606854386627674
. O 0 0.005635807290673256

Both O 0 0.0038023260422050953
the O 0 0.004207812249660492
protein O 1 0.9990100860595703
truncation O 1 0.9971895813941956
test O 0 0.03519967198371887
( O 0 0.006218097172677517
PTT O 1 0.972883939743042
) O 0 0.0034375207033008337
and O 0 0.0008797050686553121
the O 0 0.001994807505980134
restriction O 0 0.25264063477516174
endonuclease O 1 0.9993047714233398
fingerprinting O 1 0.9514498710632324
( O 0 0.01266129408031702
REF O 1 0.9993687272071838
) O 0 0.004234736785292625
method O 0 0.00969349592924118
were O 0 0.0006097424193285406
used O 0 0.0022310225758701563
and O 0 0.0007756821578368545
compared O 0 0.005162521731108427
for O 0 0.0011044564889743924
their O 0 0.0022811724338680506
detection O 1 0.9987550973892212
efficiency O 0 0.026828575879335403
, O 0 0.0021048367489129305
identifying O 0 0.14804522693157196
76 O 0 0.023540109395980835
% O 0 0.00438237190246582
and O 0 0.000845185830257833
60 O 0 0.004149876069277525
% O 0 0.0027417538221925497
of O 0 0.0008063782588578761
the O 0 0.0033125232439488173
mutations O 1 0.999992847442627
, O 0 0.0025617051869630814
respectively O 0 0.006658070720732212
. O 0 0.0060135177336633205

Most O 0 0.011896135285496712
patients O 1 0.9962911605834961
were O 0 0.0010413165437057614
found O 0 0.003613751381635666
to O 0 0.0011456666979938745
be O 0 0.0017765841912478209
compound O 0 0.20960654318332672
heterozygote O 1 0.9993966817855835
. O 0 0.008254830725491047

Seventeen O 0 0.0646824836730957
mutations O 1 0.9999374151229858
were O 0 0.001822429010644555
distinct O 0 0.014762308448553085
, O 0 0.0009566028020344675
of O 0 0.0006193620502017438
which O 0 0.0010402827756479383
10 O 0 0.0022062642965465784
were O 0 0.0006069193477742374
not O 0 0.0013864842476323247
reported O 0 0.008184371516108513
previously O 0 0.005597032606601715
. O 0 0.005675150081515312

Mutations O 1 0.9994499087333679
are O 0 0.002667596098035574
small O 0 0.007400824222713709
deletions O 1 0.9967554211616516
or O 0 0.005183153785765171
point O 0 0.009424414485692978
mutations O 1 0.9999210834503174
frequently O 0 0.0132394814863801
affecting O 0 0.2113637626171112
splice O 1 0.9974353909492493
sites O 0 0.01721525378525257
. O 0 0.008436568081378937

Moreover O 0 0.034938398748636246
, O 0 0.002771420171484351
a O 0 0.008354510180652142
16 O 0 0.012361817993223667
. O 0 0.007003181613981724

7 O 0 0.031660046428442
- O 0 0.038013048470020294
kb O 1 0.9790213108062744
genomic O 1 0.9995081424713135
deletion O 1 0.9976650476455688
of O 0 0.0014413929311558604
the O 0 0.0015958627918735147
3 O 0 0.005658961366862059
end O 0 0.0021414763759821653
of O 0 0.0006879163556732237
the O 0 0.0028148312121629715
gene O 1 0.999993085861206
, O 0 0.0015447402838617563
most O 0 0.001100038061849773
likely O 0 0.0039035791996866465
a O 0 0.0031649498268961906
result O 0 0.005861097481101751
of O 0 0.001722191576845944
recombination O 1 0.9996415376663208
between O 0 0.00278012128546834
two O 0 0.0017829720163717866
LINE O 0 0.009186972863972187
elements O 0 0.004949330817908049
, O 0 0.0012704675318673253
was O 0 0.0024356187786906958
identified O 0 0.018514806404709816
. O 0 0.00517146335914731

The O 0 0.0030631066765636206
most O 0 0.0014768969267606735
frequently O 0 0.005420114379376173
found O 0 0.014963725581765175
mutation O 1 0.9999964237213135
, O 0 0.0020057857036590576
identified O 0 0.006228971295058727
in O 0 0.00077736412640661
three O 0 0.001908443053252995
unrelated O 1 0.5525352954864502
Turkish O 0 0.0158226378262043
A B-Disease 1 0.538222074508667
- I-Disease 1 0.9607124924659729
T I-Disease 1 0.999958872795105
individuals O 0 0.00700667779892683
, O 0 0.001147936680354178
was O 0 0.0016208396991714835
previously O 0 0.0029820320196449757
described O 0 0.0038744118064641953
to O 0 0.0007580847013741732
be O 0 0.000696397852152586
a O 0 0.003599159186705947
Turkish O 0 0.013179189525544643
A B-Disease 0 0.10479753464460373
- I-Disease 1 0.7553380131721497
T I-Disease 1 0.9999040365219116
founder O 1 0.7389882802963257
mutation O 1 0.9999381303787231
. O 0 0.00906074233353138

The O 0 0.003530659945681691
presence O 0 0.006788813043385744
of O 0 0.001079687150195241
a O 0 0.007990742102265358
founder O 0 0.2805996835231781
mutation O 1 0.9999628067016602
among O 0 0.00395639892667532
relatively O 0 0.007180280517786741
small O 0 0.0034973060246556997
ethnic O 0 0.0035796903539448977
population O 0 0.0017691481625661254
groups O 0 0.002005700720474124
in O 0 0.0010230873012915254
Western O 0 0.0036615771241486073
Europe O 0 0.003321846481412649
could O 0 0.001893694163300097
indicate O 0 0.007550470065325499
a O 0 0.005206956062465906
high O 0 0.006725364830344915
carrier O 1 0.9153274297714233
frequency O 0 0.038168661296367645
in O 0 0.0015816823579370975
such O 0 0.0021719238720834255
communities O 0 0.008983390405774117
. O 0 0.005430887918919325

In O 0 0.009800899773836136
patients O 1 0.9883002042770386
of O 0 0.0012668990530073643
Dutch O 0 0.013869712129235268
ethnic O 0 0.004440461751073599
origin O 0 0.007288139313459396
, O 0 0.0011370329884812236
however O 0 0.001769580994732678
, O 0 0.0008002070826478302
no O 0 0.0018706073751673102
significant O 0 0.005766530521214008
founder O 0 0.027115406468510628
effect O 0 0.012365952134132385
could O 0 0.00276849209330976
be O 0 0.0014048891607671976
identified O 0 0.012571143917739391
. O 0 0.004446454346179962

The O 0 0.004633749835193157
observed O 0 0.02310381829738617
genetic O 1 0.9998297691345215
heterogeneity O 1 0.9913382530212402
including O 0 0.0024947053752839565
the O 0 0.0013633875641971827
relative O 0 0.010959473438560963
high O 0 0.004194528795778751
percentage O 0 0.008911586366593838
of O 0 0.002261563902720809
splice O 1 0.9998972415924072
- O 0 0.02950011007487774
site O 0 0.015965068712830544
mutations O 1 0.9999629259109497
had O 0 0.0031192803289741278
no O 0 0.002517160726711154
reflection O 0 0.01440485380589962
on O 0 0.0016055775340646505
the O 0 0.004521122667938471
phenotype O 1 0.9999778270721436
. O 0 0.010096004232764244

All O 0 0.006078297272324562
patients O 1 0.9932578802108765
manifested O 0 0.20708344876766205
classical O 0 0.014384132809937
A B-Disease 0 0.3090403378009796
- I-Disease 1 0.6873757243156433
T I-Disease 1 0.9997113347053528
and O 0 0.002073845127597451
increased O 0 0.01539543829858303
cellular O 1 0.9985294342041016
radioresistant O 1 0.9942264556884766
DNA O 1 0.9982640147209167
synthesis O 1 0.9606807827949524
. O 0 0.006983409635722637

Determination O 0 0.01616499572992325
of O 0 0.0010888619581237435
the O 0 0.002366869244724512
genomic O 1 0.9995539784431458
structure O 0 0.008847799152135849
of O 0 0.0007358575239777565
the O 0 0.002927228808403015
COL4A4 O 1 0.999829888343811
gene O 1 0.9997888207435608
and O 0 0.0011098440736532211
of O 0 0.001283592777326703
novel O 1 0.6410700678825378
mutations O 1 0.9999971389770508
causing O 1 0.999930739402771
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 0.9999985694885254
syndrome I-Disease 1 0.9999973773956299
. O 0 0.013429763726890087

Autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 0.9999970197677612
syndrome I-Disease 1 0.9999978542327881
is O 0 0.004677211865782738
a O 0 0.009402293711900711
progressive O 1 0.8465819954872131
hematuric B-Disease 1 0.9986164569854736
glomerulonephritis I-Disease 1 0.9999008178710938
characterized O 0 0.10597819089889526
by O 0 0.00838692206889391
glomerular B-Disease 1 0.9999823570251465
basement I-Disease 1 0.9898307919502258
membrane I-Disease 1 0.9998914003372192
abnormalities I-Disease 1 0.9999939203262329
and O 0 0.0021094148978590965
associated O 0 0.008380972780287266
with O 0 0.004738334566354752
mutations O 1 0.9999885559082031
in O 0 0.0013174120103940368
either O 0 0.0035818987525999546
the O 0 0.0019903129432350397
COL4A3 O 1 0.9990540146827698
or O 0 0.003469908842816949
the O 0 0.003252750961109996
COL4A4 O 1 0.9999091625213623
gene O 1 0.9999240636825562
, O 0 0.0017076049698516726
which O 0 0.0012961073080077767
encode O 0 0.27301639318466187
the O 0 0.0029673906974494457
alpha3 O 1 0.9589651226997375
and O 0 0.003207325702533126
alpha4 O 1 0.9978710412979126
type O 1 0.9966104626655579
IV O 1 0.9999223947525024
collagen O 1 0.9999938011169434
chains O 1 0.9423191547393799
, O 0 0.003103859256953001
respectively O 0 0.008644063025712967
. O 0 0.006665857508778572

To O 0 0.003177877515554428
date O 0 0.005090540740638971
, O 0 0.0037544111255556345
mutation O 1 0.9999946355819702
screening O 1 0.6637082099914551
in O 0 0.001053143641911447
the O 0 0.0009846949251368642
two O 0 0.0034649528097361326
genes O 1 0.9999011754989624
has O 0 0.002082622842863202
been O 0 0.0024007302708923817
hampered O 1 0.88848876953125
by O 0 0.001613127300515771
the O 0 0.0011653779074549675
lack O 0 0.006974496878683567
of O 0 0.0022187624126672745
genomic O 1 0.9998897314071655
structure O 0 0.02130354940891266
information O 0 0.005839935969561338
. O 0 0.005112802144140005

We O 0 0.003787105204537511
report O 0 0.0021502443123608828
here O 0 0.0009175674058496952
the O 0 0.0011566122993826866
complete O 0 0.01014370284974575
characterization O 0 0.035810187458992004
of O 0 0.0007938195485621691
the O 0 0.0014841892989352345
48 O 0 0.01335245929658413
exons O 1 0.9890339374542236
of O 0 0.0012154127471148968
the O 0 0.003049959661439061
COL4A4 O 1 0.9997232556343079
gene O 1 0.9998897314071655
, O 0 0.0015513121616095304
a O 0 0.00458146445453167
comprehensive O 0 0.2877149283885956
gene O 1 0.9999774694442749
screen O 0 0.02255324274301529
, O 0 0.0009370172629132867
and O 0 0.0005399592919275165
the O 0 0.001161318738013506
subsequent O 0 0.018207324668765068
detection O 1 0.857044517993927
of O 0 0.0010414494900032878
10 O 0 0.0039029952604323626
novel O 0 0.059997569769620895
mutations O 1 0.9999721050262451
in O 0 0.0030087707564234734
eight O 0 0.01317483838647604
patients O 1 0.9999942779541016
diagnosed O 1 0.9999978542327881
with O 0 0.4130735695362091
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 0.9999972581863403
syndrome I-Disease 1 0.9999954700469971
. O 0 0.014485025778412819

Furthermore O 0 0.0376049280166626
, O 0 0.001724045374430716
we O 0 0.0010214039357379079
identified O 0 0.007614721078425646
a O 0 0.006624102592468262
glycine O 1 0.9826435446739197
to O 0 0.0029991683550179005
alanine O 1 0.9886500835418701
substitution O 0 0.1731627881526947
in O 0 0.001539443852379918
the O 0 0.0025071108248084784
collagenous O 1 0.9998685121536255
domain O 0 0.042929746210575104
that O 0 0.0015817185631021857
is O 0 0.0017166530014947057
apparently O 0 0.012358337640762329
silent O 0 0.018745144829154015
in O 0 0.0016486885724589229
the O 0 0.003606211394071579
heterozygous O 1 0.9999467134475708
carriers O 1 0.987036406993866
, O 0 0.002206968842074275
in O 0 0.002038385486230254
11 O 0 0.009425838477909565
. O 0 0.00668087275698781

5 O 0 0.011181807145476341
% O 0 0.0033275268506258726
of O 0 0.0006681646918877959
all O 0 0.0009791238699108362
control O 0 0.018071705475449562
individuals O 0 0.005641411058604717
, O 0 0.0010202229022979736
and O 0 0.0007803982589393854
in O 0 0.0010239655384793878
one O 0 0.0019089289708063006
control O 0 0.014189725741744041
individual O 0 0.008350121788680553
homozygous O 1 0.999470055103302
for O 0 0.001767998212017119
this O 0 0.0021960940212011337
glycine O 1 0.9961557984352112
substitution O 1 0.8542048931121826
. O 0 0.007136511616408825

There O 0 0.0038942103274166584
has O 0 0.0016238015377894044
been O 0 0.0012543685734272003
no O 0 0.00160617392975837
previous O 0 0.0024083000607788563
finding O 0 0.005098567344248295
of O 0 0.0008955106022767723
a O 0 0.006721461191773415
glycine O 1 0.9984727501869202
substitution O 1 0.6864561438560486
that O 0 0.0012287256540730596
is O 0 0.0011211513774469495
not O 0 0.0010616825893521309
associated O 0 0.006184839643537998
with O 0 0.0017897188663482666
any O 0 0.0028607274871319532
obvious O 0 0.23141227662563324
phenotype O 1 0.9999868869781494
in O 0 0.0056262752041220665
homozygous O 1 0.9995132684707642
individuals O 0 0.013477623462677002
. O 0 0.006728359963744879

Founder O 1 0.6822779178619385
BRCA1 O 1 0.9999830722808838
and O 0 0.014988514594733715
BRCA2 O 1 0.999996542930603
mutations O 1 0.9999312162399292
in O 0 0.0033590274397283792
French O 0 0.01586173102259636
Canadian O 1 0.7563991546630859
breast B-Disease 1 0.9999994039535522
and I-Disease 1 0.6292726993560791
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.014491615816950798
. O 0 0.008372302167117596

We O 0 0.002355559030547738
have O 0 0.0012000860879197717
identified O 0 0.0079854940995574
four O 0 0.0043007065542042255
mutations O 1 0.99997878074646
in O 0 0.0009758374653756618
each O 0 0.000830562028568238
of O 0 0.0008285475778393447
the O 0 0.008574112318456173
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
- O 1 0.9564480781555176
susceptibility O 1 0.9999852180480957
genes O 1 0.999819815158844
, O 0 0.006584526505321264
BRCA1 O 1 0.9999996423721313
and O 0 0.0058001005090773106
BRCA2 O 1 0.9999995231628418
, O 0 0.0018438436090946198
in O 0 0.001472185249440372
French O 0 0.017817595973610878
Canadian O 1 0.9707339406013489
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999996423721313
and O 0 0.08684464544057846
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999912977218628
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
families O 0 0.010219091549515724
from O 0 0.004202076233923435
Quebec O 0 0.03736603632569313
. O 0 0.0076307617127895355

To O 0 0.004952403251081705
identify O 0 0.02914646826684475
founder O 0 0.04584040865302086
effects O 0 0.21560722589492798
, O 0 0.0015013894299045205
we O 0 0.001183095620945096
examined O 0 0.019148169085383415
independently O 0 0.011763755232095718
ascertained O 1 0.5362359881401062
French O 0 0.014459346421062946
Canadian O 0 0.3096819221973419
cancer B-Disease 1 0.9999983310699463
families O 0 0.004304391797631979
for O 0 0.0009083268814720213
the O 0 0.000902769563253969
distribution O 0 0.007683320436626673
of O 0 0.0006684461841359735
these O 0 0.0014375628670677543
eight O 0 0.009127323515713215
mutations O 1 0.999990701675415
. O 0 0.007005291525274515

Mutations O 1 0.9997650980949402
were O 0 0.0020360471680760384
found O 0 0.004152152221649885
in O 0 0.0015681470977142453
41 O 0 0.013224302791059017
of O 0 0.0016703431028872728
97 O 0 0.030440593138337135
families O 0 0.010014032945036888
. O 0 0.006852446123957634

Six O 0 0.005999881308525801
of O 0 0.0013466144446283579
eight O 0 0.008864523842930794
mutations O 1 0.9999731779098511
were O 0 0.0017444296972826123
observed O 0 0.009900961071252823
at O 0 0.0025435874704271555
least O 0 0.004371940158307552
twice O 0 0.009462394751608372
. O 0 0.005277207121253014

The O 0 0.014006661251187325
BRCA1 O 1 0.9999971389770508
C4446T O 1 0.9991018772125244
mutation O 1 0.9999394416809082
was O 0 0.0018606102094054222
the O 0 0.000891902600415051
most O 0 0.0014136199606582522
common O 1 0.6098803877830505
mutation O 1 0.9999983310699463
found O 0 0.006088322028517723
, O 0 0.001029623905196786
followed O 0 0.0049466402269899845
by O 0 0.002578518819063902
the O 0 0.006149505265057087
BRCA2 O 1 0.9999988079071045
8765delAG O 1 0.999459445476532
mutation O 1 0.9999425411224365
. O 0 0.009813160635530949

Together O 0 0.008602027781307697
, O 0 0.0016412562690675259
these O 0 0.002628467045724392
mutations O 1 0.9999827146530151
were O 0 0.0010271985083818436
found O 0 0.003274916671216488
in O 0 0.0012394341174513102
28 O 0 0.0047843544743955135
of O 0 0.001215504133142531
41 O 0 0.014874105341732502
families O 0 0.005474547389894724
identified O 0 0.008327496238052845
to O 0 0.000848685042001307
have O 0 0.0014307246310636401
a O 0 0.012662213295698166
mutation O 1 0.9999794960021973
. O 0 0.007911361753940582

The O 0 0.004453505855053663
odds O 0 0.021940190345048904
of O 0 0.0016868927050381899
detection O 1 0.5724842548370361
of O 0 0.0007323023746721447
any O 0 0.0009953049011528492
of O 0 0.0005115402163937688
the O 0 0.0014111350756138563
four O 0 0.011740881018340588
BRCA1 O 1 0.9999998807907104
mutations O 1 0.9999942779541016
was O 0 0.004362851846963167
18 O 0 0.007210344076156616
. O 0 0.005287800449877977

7x O 1 0.9975036978721619
greater O 0 0.011785531416535378
if O 0 0.002827832940965891
one O 0 0.0013491105055436492
or O 0 0.0024122383911162615
more O 0 0.0012836751993745565
cases O 0 0.013603931292891502
of O 0 0.012076593935489655
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
were O 0 0.0012090654345229268
also O 0 0.0008049902389757335
present O 0 0.0019121422665193677
in O 0 0.0011584704043343663
the O 0 0.0019179946975782514
family O 0 0.013483844697475433
. O 0 0.0068466756492853165

The O 0 0.005027290433645248
odds O 0 0.021112356334924698
of O 0 0.001568314153701067
detection O 1 0.6349644660949707
of O 0 0.0006509759114123881
any O 0 0.0010856174631044269
of O 0 0.0005394510226324201
the O 0 0.0015514076221734285
four O 0 0.012124989181756973
BRCA2 O 1 0.9999997615814209
mutations O 1 0.9999885559082031
was O 0 0.004422077909111977
5 O 0 0.009141129441559315
. O 0 0.005042057018727064

3x O 1 0.969031810760498
greater O 0 0.01145213097333908
if O 0 0.002528384793549776
there O 0 0.0006433090893551707
were O 0 0.0004796584544237703
at O 0 0.001234310446307063
least O 0 0.002245998941361904
five O 0 0.002357538789510727
cases O 0 0.009496381506323814
of O 0 0.006632326170802116
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
in O 0 0.002298692474141717
the O 0 0.0022503393702208996
family O 0 0.014734718948602676
. O 0 0.006959658116102219

Interestingly O 0 0.11119463294744492
, O 0 0.001745280111208558
the O 0 0.0011048333253711462
presence O 0 0.0052477032877504826
of O 0 0.0014019273221492767
a O 1 0.6862796545028687
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
case O 0 0.1042126938700676
< O 1 0.9987509250640869
36 O 0 0.011389310471713543
years O 0 0.0015723655233159661
of O 0 0.0007897723116911948
age O 0 0.004246643744409084
was O 0 0.0016463325591757894
strongly O 0 0.00572081608697772
predictive O 1 0.9980341792106628
of O 0 0.0009019097196869552
the O 0 0.0008722507627680898
presence O 0 0.005105812568217516
of O 0 0.0004571792669594288
any O 0 0.0009941136231645942
of O 0 0.0004947392735630274
the O 0 0.0013340202858671546
eight O 0 0.009862024337053299
mutations O 1 0.9999902248382568
screened O 0 0.06643329560756683
. O 0 0.007508726324886084

Carriers O 0 0.07504231482744217
of O 0 0.0010316170519217849
the O 0 0.0012000232236459851
same O 0 0.006510617211461067
mutation O 1 0.9999973773956299
, O 0 0.0017679695738479495
from O 0 0.0012650410644710064
different O 0 0.001663867849856615
families O 0 0.0035519928205758333
, O 0 0.0011581977596506476
shared O 0 0.007296326570212841
similar O 0 0.014050964266061783
haplotypes O 1 0.9999687671661377
, O 0 0.0016890462720766664
indicating O 0 0.014791576191782951
that O 0 0.0009372311760671437
the O 0 0.0020708574447780848
mutant O 1 0.9999231100082397
alleles O 1 0.9999158382415771
were O 0 0.001382248941808939
likely O 0 0.003646369557827711
to O 0 0.000744636810850352
be O 0 0.0009140195325016975
identical O 0 0.015839220955967903
by O 0 0.0020703577902168036
descent O 0 0.014923135749995708
for O 0 0.0016276015667244792
a O 0 0.011425020173192024
mutation O 1 0.9999936819076538
in O 0 0.0019304188899695873
the O 0 0.0019606249406933784
founder O 0 0.022618085145950317
population O 0 0.004594194702804089
. O 0 0.00654625054448843

The O 0 0.003060530638322234
identification O 0 0.015238864347338676
of O 0 0.0015269563300535083
common O 0 0.14411793649196625
BRCA1 O 1 0.9999992847442627
and O 0 0.010042337700724602
BRCA2 O 1 0.9999996423721313
mutations O 1 0.999976634979248
will O 0 0.0022956631146371365
facilitate O 0 0.022040288895368576
carrier O 1 0.6447293162345886
detection O 1 0.8321730494499207
in O 0 0.0017298933817073703
French O 0 0.019281864166259766
Canadian O 1 0.9651259183883667
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
and O 0 0.07609213888645172
breast B-Disease 1 1.0
/ I-Disease 1 0.9999929666519165
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
families O 0 0.015573197975754738
. O 0 0.007238086778670549

Are O 0 0.005477034952491522
Dp71 O 1 0.8809618949890137
and O 0 0.0054021370597183704
Dp140 O 1 0.9992006421089172
brain O 1 0.99992835521698
dystrophin O 1 0.9999468326568604
isoforms O 1 0.9965656399726868
related O 0 0.01397472620010376
to O 0 0.002721293130889535
cognitive B-Disease 1 0.9992885589599609
impairment I-Disease 1 0.9999018907546997
in O 0 0.017853202298283577
Duchenne B-Disease 1 0.9999994039535522
muscular I-Disease 1 0.9999966621398926
dystrophy I-Disease 1 0.9999978542327881
? O 0 0.0770571380853653

Molecular O 1 0.9931093454360962
study O 0 0.011860847473144531
and O 0 0.0030181631445884705
neuropsychological O 1 0.999477207660675
analysis O 0 0.012766108848154545
were O 0 0.0008034390630200505
performed O 0 0.005506040062755346
concurrently O 0 0.007509045302867889
on O 0 0.0020386495161801577
49 O 0 0.041884858161211014
patients O 1 0.999700665473938
with O 0 0.019597221165895462
Duchenne B-Disease 1 0.9999996423721313
muscular I-Disease 1 0.999998927116394
dystrophy I-Disease 1 0.9999998807907104
( O 0 0.09585560113191605
DMD B-Disease 1 0.9999994039535522
) O 0 0.0049474104307591915
in O 0 0.0011771253775805235
order O 0 0.002032896736636758
to O 0 0.001162282656878233
find O 0 0.0049552456475794315
a O 0 0.006557181477546692
molecular O 1 0.9980941414833069
explanation O 0 0.013332158327102661
for O 0 0.0013296505203470588
the O 0 0.0027829196769744158
cognitive B-Disease 1 0.99970942735672
impairment I-Disease 1 0.9998243451118469
observed O 0 0.01503633614629507
in O 0 0.002642025938257575
most O 0 0.010351470671594143
DMD B-Disease 1 0.9999997615814209
patients O 1 0.9996627569198608
. O 0 0.008886273019015789

Complete O 0 0.022809021174907684
analysis O 0 0.010060923174023628
of O 0 0.0009202185901813209
the O 0 0.0042726281099021435
dystrophin O 1 0.9999880790710449
gene O 1 0.9998668432235718
was O 0 0.003602125681936741
performed O 0 0.00492466427385807
to O 0 0.0012449275236576796
define O 0 0.00839272327721119
the O 0 0.001514689764007926
localization O 1 0.7428644895553589
of O 0 0.0020396660547703505
deletions O 1 0.9990717172622681
and O 0 0.0028116407338529825
duplications O 1 0.9991024732589722
in O 0 0.002177720656618476
relation O 0 0.010836772620677948
to O 0 0.000970007386058569
the O 0 0.0017931516049429774
different O 0 0.00876630935817957
DMD B-Disease 1 0.9999948740005493
promoters O 1 0.8771553635597229
. O 0 0.008999723009765148

Qualitative O 0 0.08767499774694443
analysis O 0 0.01160189975053072
of O 0 0.0009375728550367057
the O 0 0.002240094356238842
Dp71 O 1 0.998060405254364
transcript O 1 0.9423461556434631
and O 0 0.0017926977016031742
testing O 0 0.02419794537127018
for O 0 0.0010496455943211913
the O 0 0.000846513663418591
specific O 0 0.004330914001911879
first O 0 0.003006251761689782
exon O 1 0.9985999464988708
of O 0 0.001900800853036344
Dp140 O 1 0.9648816585540771
were O 0 0.0010779512813314795
also O 0 0.0011791980359703302
carried O 0 0.0061057573184370995
out O 0 0.004075785633176565
. O 0 0.006037421524524689

Neuropsychological O 1 0.9937784075737
analysis O 0 0.03102589026093483
assessed O 0 0.02605303004384041
verbal O 0 0.04445096105337143
and O 0 0.004340475425124168
visuospatial O 1 0.9997109770774841
intelligence O 0 0.01830516755580902
, O 0 0.002813468687236309
verbal O 0 0.23037408292293549
memory O 0 0.4653588831424713
, O 0 0.0017728967359289527
and O 0 0.0011991159990429878
reading O 0 0.009814867749810219
skills O 0 0.017521817237138748
. O 0 0.007589729968458414

Comparison O 0 0.01824875921010971
of O 0 0.002230914542451501
molecular O 1 0.9973914623260498
and O 0 0.0032995434012264013
psychometric O 1 0.9963940978050232
findings O 0 0.015233892947435379
demonstrated O 0 0.009887928143143654
that O 0 0.00179103366099298
deletions O 1 0.9978037476539612
and O 0 0.002275430131703615
duplications O 1 0.9991601705551147
that O 0 0.001471513300202787
were O 0 0.0011944409925490618
localized O 1 0.9978975057601929
in O 0 0.0015465418109670281
the O 0 0.002221285831183195
distal O 1 0.9996819496154785
part O 0 0.0028410356026142836
of O 0 0.0008852597675286233
the O 0 0.0027594612911343575
gene O 1 0.999981164932251
seemed O 0 0.00789979100227356
to O 0 0.0009117668378166854
be O 0 0.00131218449678272
preferentially O 1 0.968462347984314
associated O 0 0.011719887144863605
with O 0 0.005952905397862196
cognitive B-Disease 1 0.9993717074394226
impairment I-Disease 1 0.9996836185455322
. O 0 0.009368621744215488

Two O 0 0.008343885652720928
altered O 0 0.13839565217494965
Dp71 O 1 0.9756574630737305
transcripts O 0 0.033040259033441544
and O 0 0.0011926707811653614
two O 0 0.0026173959486186504
deleted O 0 0.3869267702102661
Dp140 O 1 0.9948086738586426
DNA O 1 0.9988073110580444
sequences O 0 0.047429125756025314
were O 0 0.0008678610902279615
found O 0 0.0030587485525757074
in O 0 0.0013771593803539872
four O 0 0.005995289888232946
patients O 1 0.999846339225769
with O 0 0.015052254311740398
severe O 1 0.999954342842102
cerebral B-Disease 1 0.9999979734420776
dysfunction I-Disease 1 0.999995231628418
. O 0 0.011503658257424831

These O 0 0.004069446120411158
findings O 0 0.011829111725091934
suggest O 0 0.006762120872735977
that O 0 0.0010007870150730014
some O 0 0.0012376178056001663
sequences O 0 0.3119191527366638
located O 0 0.002563783200457692
in O 0 0.0010168736334890127
the O 0 0.0025261067785322666
distal O 1 0.99991774559021
part O 0 0.0029790305998176336
of O 0 0.0008417828939855099
the O 0 0.0029041448142379522
gene O 1 0.9999902248382568
and O 0 0.0012556082801893353
, O 0 0.0009523278567939997
in O 0 0.0010518282651901245
particular O 0 0.0036758920177817345
, O 0 0.0015367608284577727
some O 0 0.0045419358648359776
DMD B-Disease 1 0.999997615814209
isoforms O 1 0.994099497795105
expressed O 0 0.004667301662266254
in O 0 0.0015345965512096882
the O 0 0.0036703289952129126
brain O 1 0.9999940395355225
may O 0 0.006213244050741196
be O 0 0.0011145396856591105
related O 0 0.005445211194455624
to O 0 0.0009639178751967847
the O 0 0.002600134117528796
cognitive B-Disease 1 0.9997468590736389
impairment I-Disease 1 0.9999513626098633
associated O 0 0.029240161180496216
with O 0 0.011367891915142536
DMD B-Disease 1 0.9999986886978149
. O 0 0.0057501476258039474
. O 0 0.005436149425804615

I1307K O 1 0.9601322412490845
APC O 1 0.995564341545105
and O 0 0.00685885502025485
hMLH1 O 1 0.999051034450531
mutations O 1 0.9998674392700195
in O 0 0.002644785214215517
a O 0 0.005314186215400696
non O 0 0.009185553528368473
- O 0 0.01235906407237053
Jewish O 0 0.00739299925044179
family O 0 0.008093542419373989
with O 0 0.005584808997809887
hereditary B-Disease 1 0.9999594688415527
non I-Disease 1 0.8225041627883911
- I-Disease 1 0.9996761083602905
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999964237213135
. O 0 0.014959306456148624

We O 0 0.003037550952285528
describe O 0 0.008771112188696861
a O 0 0.005091729108244181
French O 0 0.009967719204723835
Canadian O 0 0.020950045436620712
hereditary B-Disease 1 0.9998759031295776
non I-Disease 1 0.5393596887588501
- I-Disease 1 0.9996528625488281
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
( O 0 0.03415803611278534
HNPCC B-Disease 1 0.9999959468841553
) O 0 0.012232492677867413
kindred O 1 0.995995044708252
which O 0 0.0020389265846461058
carries O 0 0.013309670612215996
a O 0 0.007198850158601999
novel O 0 0.027913663536310196
truncating O 1 0.9995966553688049
mutation O 1 0.9999626874923706
in O 0 0.007101718336343765
hMLH1 O 1 0.9920865893363953
. O 0 0.008816232904791832

Interestingly O 0 0.08503643423318863
, O 0 0.002584085101261735
the O 0 0.0037376158870756626
I1307K O 1 0.9972326159477234
APC O 1 0.9998527765274048
polymorphism O 1 0.9995312690734863
, O 0 0.0029609501361846924
associated O 0 0.007017235737293959
with O 0 0.0013025945518165827
an O 0 0.0014207344502210617
increased O 0 0.012093239463865757
risk O 1 0.999110758304596
of O 0 0.022186966612935066
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.002515579806640744
is O 0 0.0013956251787021756
also O 0 0.0009054391412064433
present O 0 0.0020751135889440775
in O 0 0.0010077260667458177
this O 0 0.0017764962976798415
family O 0 0.013422318734228611
. O 0 0.005890258587896824

The O 0 0.008506245911121368
I1307K O 1 0.9921261072158813
polymorphism O 1 0.9981874823570251
has O 0 0.0024160738103091717
previously O 0 0.0021824154537171125
only O 0 0.0009312473121099174
been O 0 0.0013607763685286045
identified O 0 0.007562404498457909
in O 0 0.0010742433369159698
individuals O 0 0.0033413912169635296
of O 0 0.0016939127817749977
self O 0 0.026295045390725136
- O 0 0.028306856751441956
reported O 0 0.01938002184033394
Ashkenazi O 1 0.9760934710502625
Jewish O 0 0.012445076368749142
origins O 0 0.0396922305226326
. O 0 0.005504606757313013

In O 0 0.0058204722590744495
addition O 0 0.006090803537517786
, O 0 0.001450893236324191
in O 0 0.0010258050169795752
this O 0 0.0014717269223183393
family O 0 0.009000642225146294
, O 0 0.0013892414281144738
there O 0 0.0012034447863698006
appears O 0 0.007190859876573086
to O 0 0.0008208185900002718
be O 0 0.0008071262273006141
no O 0 0.0018791507463902235
relationship O 0 0.0094361063092947
between O 0 0.002023076405748725
the O 0 0.0022679122630506754
I1307K O 1 0.9993014335632324
polymorphism O 1 0.9990598559379578
and O 0 0.0010933360317721963
the O 0 0.0012550511164590716
presence O 0 0.008260142058134079
or O 0 0.004110661335289478
absence O 0 0.022281022742390633
of O 0 0.0047910637222230434
cancer B-Disease 1 0.999998927116394
. O 0 0.004730844870209694
. O 0 0.005819049198180437

Identification O 0 0.029822003096342087
of O 0 0.00127122038975358
a O 0 0.005703581031411886
novel O 0 0.02839919552206993
mutation O 1 0.9998736381530762
of O 0 0.0012520815944299102
the O 0 0.0021448435727506876
CPO O 1 0.99812251329422
gene O 1 0.9996210336685181
in O 0 0.0020956823136657476
a O 0 0.006761429365724325
Japanese O 0 0.014311554841697216
hereditary B-Disease 1 0.9999140501022339
coproporphyria I-Disease 1 0.9976644515991211
family O 0 0.024162881076335907
. O 0 0.007325887680053711

Hereditary B-Disease 1 0.9994713664054871
coproporphyria I-Disease 1 0.9967065453529358
( O 0 0.01765470765531063
HCP B-Disease 1 0.9999531507492065
) O 0 0.004736712668091059
is O 0 0.002139072399586439
an O 0 0.006508483085781336
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9992221593856812
disease I-Disease 1 0.9999955892562866
characterized O 0 0.4076801538467407
by O 0 0.002671337453648448
a O 0 0.014961387030780315
deficiency B-Disease 1 0.9999953508377075
of I-Disease 0 0.0041896142065525055
coproporphyrinogen I-Disease 1 0.9996115565299988
oxidase I-Disease 1 0.99996018409729
( O 0 0.009868662804365158
CPO O 1 0.9919708967208862
) O 0 0.0056107547134160995
caused O 0 0.029785921797156334
by O 0 0.002186238532885909
a O 0 0.008782046847045422
mutation O 1 0.9999611377716064
in O 0 0.002058928832411766
the O 0 0.0030240544583648443
CPO O 1 0.9962952733039856
gene O 1 0.9997400641441345
. O 0 0.008620566688477993

Only O 0 0.003937278874218464
11 O 0 0.01081794872879982
mutations O 1 0.9997931122779846
of O 0 0.00116051419172436
the O 0 0.002368251094594598
gene O 1 0.9999613761901855
have O 0 0.001437450642697513
been O 0 0.00172216456849128
reported O 0 0.00895330123603344
in O 0 0.006182802841067314
HCP B-Disease 1 0.9999905824661255
patients O 1 0.999656081199646
. O 0 0.008177148178219795

We O 0 0.0032364525832235813
report O 0 0.0033482646103948355
another O 0 0.012222366407513618
mutation O 1 0.9999790191650391
in O 0 0.0019274079240858555
a O 0 0.005027280654758215
Japanese O 0 0.00805587787181139
family O 0 0.013907243497669697
. O 0 0.006680390797555447

Polymerase O 1 0.9983125925064087
chain O 1 0.9571326375007629
reaction O 0 0.22032742202281952
- O 0 0.016756147146224976
single O 0 0.016639873385429382
strand O 1 0.9968054294586182
conformational O 1 0.9992018342018127
polymorphism O 1 0.9963552951812744
and O 0 0.0017356498865410686
direct O 0 0.007111839484423399
sequence O 0 0.04489421099424362
analyses O 0 0.022871343418955803
demonstrated O 0 0.01034725084900856
a O 0 0.008262376300990582
C O 1 0.6605870127677917
to O 0 0.0035780456382781267
T O 1 0.9991544485092163
substitution O 0 0.42078468203544617
in O 0 0.00338027928955853
exon O 1 0.9986323714256287
1 O 0 0.0042452458292245865
of O 0 0.0007276955293491483
the O 0 0.002140157390385866
CPO O 1 0.9951475262641907
gene O 1 0.9996460676193237
at O 0 0.006551514845341444
nucleotide O 1 0.9975141286849976
position O 0 0.005171718541532755
85 O 0 0.012195121496915817
, O 0 0.0011908510932698846
which O 0 0.0009345203870907426
lies O 0 0.003339915070682764
in O 0 0.0010072427103295922
the O 0 0.002264113165438175
putative O 1 0.9994502663612366
presequence O 1 0.9927026033401489
for O 0 0.0020032189786434174
targeting O 0 0.022187519818544388
to O 0 0.0036090980283915997
mitochondria O 1 0.9996185302734375
. O 0 0.00849849171936512

This O 0 0.008619393222033978
mutation O 1 0.9996863603591919
changes O 0 0.009391062892973423
the O 0 0.0021006313618272543
codon O 1 0.9877654314041138
for O 0 0.0030283734668046236
glutamine O 1 0.9917165637016296
to O 0 0.0021379669196903706
a O 0 0.008778751827776432
termination O 1 0.9868944883346558
codon O 1 0.974291980266571
at O 0 0.005680754780769348
amino O 1 0.9941030144691467
acid O 1 0.995309054851532
position O 0 0.0073037948459386826
29 O 0 0.014974123798310757
. O 0 0.00627959193661809

MaeI O 1 0.9447817206382751
restriction O 0 0.05498095229268074
analysis O 0 0.01590133272111416
showed O 0 0.006021073088049889
two O 0 0.0018799728713929653
other O 0 0.00197562831453979
carriers O 1 0.7287241816520691
in O 0 0.0018221751088276505
the O 0 0.002096592215821147
family O 0 0.015441058203577995
. O 0 0.005985819734632969

The O 0 0.011705922894179821
C O 1 0.9956529140472412
- O 1 0.8879699110984802
T O 1 0.9999357461929321
mutation O 1 0.9999532699584961
is O 0 0.0027189026586711407
located O 0 0.002554815961048007
within O 0 0.0022505715023726225
a O 0 0.004257424268871546
recently O 0 0.0071457987651228905
proposed O 0 0.010723602026700974
putative O 1 0.9826846718788147
alternative O 0 0.020732706412672997
translation O 0 0.023706892505288124
initiation O 1 0.9716055393218994
codon O 1 0.997154951095581
( O 0 0.01971081644296646
TIC O 1 0.9999809265136719
- O 0 0.0314951166510582
1 O 0 0.009612235240638256
) O 0 0.0030001895502209663
, O 0 0.00122620549518615
supporting O 0 0.0077456827275455
that O 0 0.005144162569195032
TIC O 1 0.9999845027923584
- O 0 0.02519366890192032
1 O 0 0.005779432598501444
is O 0 0.0012682622764259577
the O 0 0.0015105889178812504
real O 0 0.014540108852088451
TIC O 1 0.9994935989379883
rather O 0 0.006905983202159405
than O 0 0.006636068690568209
TIC O 1 0.9999802112579346
- O 0 0.03798307478427887
2 O 0 0.011977282352745533
. O 0 0.0036822857800871134
. O 0 0.00550286378711462

Human B-Disease 0 0.02781721204519272
complement I-Disease 0 0.3645161986351013
factor I-Disease 1 0.9729324579238892
H I-Disease 1 0.9999058246612549
deficiency I-Disease 1 0.9999986886978149
associated O 0 0.042378295212984085
with O 0 0.2708319425582886
hemolytic B-Disease 1 1.0
uremic I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999982118606567
. O 0 0.01340953167527914

This O 0 0.0035278259310871363
study O 0 0.00570344366133213
reports O 0 0.002363551175221801
on O 0 0.0007209868053905666
six O 0 0.0028691987972706556
cases O 0 0.00848307739943266
of O 0 0.0027348718140274286
deficiency B-Disease 1 0.9999995231628418
in I-Disease 0 0.001358336303383112
the I-Disease 0 0.0010808890219777822
human I-Disease 0 0.007935486733913422
complement I-Disease 1 0.6846436262130737
regulatory I-Disease 1 0.9823577404022217
protein I-Disease 1 0.9997121691703796
Factor I-Disease 1 0.9833266139030457
H I-Disease 1 0.9997028708457947
( O 0 0.011644353158771992
FH O 1 0.9999803304672241
) O 0 0.003397428896278143
in O 0 0.0006883764290250838
the O 0 0.0007705640746280551
context O 0 0.004488632082939148
of O 0 0.0012389281764626503
an O 0 0.014639807865023613
acute B-Disease 1 0.9999997615814209
renal I-Disease 1 1.0
disease I-Disease 1 0.9999991655349731
. O 0 0.011123004369437695

Five O 0 0.004546858370304108
of O 0 0.0007899141637608409
the O 0 0.0017776788445189595
cases O 0 0.00696745328605175
were O 0 0.0010563612449914217
observed O 0 0.007974747568368912
in O 0 0.0014980784617364407
children O 0 0.006970234680920839
presenting O 0 0.03738531097769737
with O 0 0.26768460869789124
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 0 0.026775851845741272
HUS B-Disease 1 0.9999736547470093
) O 0 0.010397709906101227
. O 0 0.007253161631524563

Two O 0 0.0027741084340959787
of O 0 0.0007308086496777833
the O 0 0.0013510583667084575
children O 0 0.004857247229665518
exhibited O 0 0.012006836012005806
a O 0 0.02271033637225628
homozygous O 1 0.9999964237213135
deficiency O 1 0.9999994039535522
characterized O 0 0.30205851793289185
by O 0 0.0019696878734976053
the O 0 0.001350288512185216
absence O 0 0.009905081242322922
of O 0 0.0007731926161795855
the O 0 0.0015680381329730153
150 O 0 0.013196652755141258
- O 0 0.034478966146707535
kD O 1 0.9959659576416016
form O 0 0.010537310503423214
of O 0 0.001972762867808342
Factor O 1 0.9891252517700195
H O 1 0.9990774393081665
and O 0 0.000949595239944756
the O 0 0.001363674527965486
presence O 0 0.008763380348682404
, O 0 0.0012213937006890774
upon O 0 0.004297375679016113
immunoblotting O 1 0.9932328462600708
, O 0 0.0012331600300967693
of O 0 0.0006904341280460358
the O 0 0.0018731706077232957
42 O 0 0.02744409069418907
- O 0 0.05161796137690544
kD O 1 0.9982175230979919
Factor O 1 0.8123682737350464
H O 1 0.9978499412536621
- O 0 0.023616066202521324
like O 0 0.012913540937006474
protein O 1 0.9988095760345459
1 O 0 0.012483402155339718
( O 0 0.009091829881072044
FHL O 1 0.9999343156814575
- O 0 0.024941185489296913
1 O 0 0.007608497049659491
) O 0 0.0026444760151207447
and O 0 0.0011052312329411507
other O 0 0.0028326050378382206
FH O 1 0.9999717473983765
- O 0 0.040919363498687744
related O 0 0.037072695791721344
protein O 1 0.9997655749320984
( O 0 0.01054257620126009
FHR O 1 0.9990949630737305
) O 0 0.006334033794701099
bands O 0 0.017201988026499748
. O 0 0.004914517048746347

Southern O 0 0.023227423429489136
blot O 1 0.9485247731208801
and O 0 0.004723286721855402
PCR O 1 0.9982466697692871
analysis O 0 0.011853842064738274
of O 0 0.0013512634905055165
DNA O 1 0.9987624883651733
of O 0 0.001076900283806026
one O 0 0.0032007149420678616
patient O 1 0.9987449645996094
with O 0 0.01070223655551672
homozygous O 1 0.9999959468841553
deficiency O 1 0.9999997615814209
ruled O 0 0.01490034256130457
out O 0 0.0015827799215912819
the O 0 0.0010479214834049344
presence O 0 0.004798817913979292
of O 0 0.0006925931666046381
a O 0 0.0036074125673621893
large O 0 0.004851957317441702
deletion O 1 0.9992061257362366
of O 0 0.0012775077484548092
the O 0 0.004497741814702749
FH O 1 0.999993085861206
gene O 1 0.9997839331626892
as O 0 0.0013073362642899156
the O 0 0.0013610367896035314
underlying O 1 0.9617784023284912
defect O 1 0.9997809529304504
for O 0 0.002338759135454893
the O 0 0.006635264493525028
deficiency O 1 0.999998927116394
. O 0 0.010347988456487656

The O 0 0.0034166034311056137
other O 0 0.0012070442317053676
four O 0 0.002205390017479658
children O 0 0.004624234512448311
presented O 0 0.0047147562727332115
with O 0 0.007678740657866001
heterozygous O 1 0.9999969005584717
deficiency O 1 0.9999990463256836
and O 0 0.001872653723694384
exhibited O 0 0.00902820285409689
a O 0 0.0056022098287940025
normal O 0 0.03444454073905945
immunoblotting O 1 0.9912915229797363
pattern O 0 0.036631468683481216
of O 0 0.0017939020181074739
proteins O 1 0.9865766763687134
of O 0 0.001405092654749751
the O 0 0.004029468167573214
FH O 1 0.99992835521698
family O 0 0.02750023454427719
. O 0 0.007984081283211708

Factor B-Disease 1 0.9815561771392822
H I-Disease 1 0.999890923500061
deficiency I-Disease 1 0.9999966621398926
is O 0 0.0024607316590845585
the O 0 0.0016819791635498405
only O 0 0.003923166077584028
complement B-Disease 1 0.999518871307373
deficiency I-Disease 1 0.9999997615814209
associated O 0 0.02639644779264927
with O 0 0.008641873486340046
HUS B-Disease 1 0.9999619722366333
. O 0 0.012386222369968891

These O 0 0.003423035843297839
observations O 0 0.008580029010772705
suggest O 0 0.007743774447590113
a O 0 0.00491316756233573
role O 0 0.007485414855182171
for O 0 0.004472011234611273
FH O 1 0.9999802112579346
and O 0 0.0036926493048667908
/ O 1 0.7759534120559692
or O 0 0.011120225302875042
FH O 1 0.9999485015869141
receptors O 1 0.9981397390365601
in O 0 0.001640183967538178
the O 0 0.0034358548000454903
pathogenesis O 1 0.9999867677688599
of O 0 0.008647692389786243
idiopathic O 1 0.9999992847442627
HUS B-Disease 1 0.9999879598617554
. O 0 0.006768145132809877
. O 0 0.005479841027408838

Further O 0 0.007640806958079338
evidence O 0 0.003141672583296895
for O 0 0.0009898890275508165
a O 0 0.0035433468874543905
major O 0 0.00597607996314764
ancient O 0 0.011673127301037312
mutation O 1 0.9999943971633911
underlying O 1 0.9994366765022278
myotonic B-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999974966049194
from O 0 0.01167712826281786
linkage O 1 0.9994685053825378
disequilibrium O 1 0.9997716546058655
studies O 0 0.012967418879270554
in O 0 0.0011489279568195343
the O 0 0.001161901280283928
Japanese O 0 0.006146504543721676
population O 0 0.0054190633818507195
. O 0 0.00534370681270957

The O 0 0.031098010018467903
myotonic B-Disease 1 0.9999969005584717
dystrophy I-Disease 1 0.9999994039535522
( O 0 0.03563905134797096
DM B-Disease 1 0.9999884366989136
) O 0 0.01481799129396677
mutation O 1 0.9999688863754272
is O 0 0.0024961140006780624
an O 0 0.0030522963497787714
unstable O 1 0.9943082928657532
( O 0 0.009329221211373806
CTG O 1 0.9991616010665894
) O 0 0.008387256413698196
n O 0 0.3374934494495392
repeat O 0 0.4115754961967468
, O 0 0.0015315089840441942
present O 0 0.002057071076706052
at O 0 0.0015268224524334073
a O 0 0.0044046565890312195
copy O 0 0.015614246018230915
number O 0 0.001390312914736569
of O 0 0.0010500152129679918
5 O 0 0.010946322232484818
- O 0 0.017084188759326935
37 O 0 0.018484657630324364
repeats O 0 0.055378638207912445
on O 0 0.0025465795770287514
normal O 0 0.04210828244686127
chromosomes O 1 0.9977566599845886
but O 0 0.0029003333766013384
amplified O 0 0.19374831020832062
to O 0 0.0021885400637984276
50 O 0 0.0066729276441037655
- O 0 0.016813181340694427
3000 O 0 0.055929116904735565
copies O 0 0.010488249361515045
on O 0 0.005343261174857616
DM B-Disease 1 0.9999586343765259
chromosomes O 1 0.9959679841995239
. O 0 0.010816672816872597

Previous O 0 0.010489555075764656
findings O 0 0.013574682176113129
in O 0 0.002985006431117654
Caucasian O 1 0.9973767995834351
populations O 0 0.020554430782794952
of O 0 0.0016381604364141822
a O 0 0.018473805859684944
DM B-Disease 1 0.999984860420227
founder O 1 0.781499981880188
chromosome O 1 0.999964714050293
raise O 0 0.012272021733224392
a O 0 0.003669533645734191
question O 0 0.0018698996864259243
about O 0 0.00083251012256369
the O 0 0.0021066765766590834
molecular O 1 0.9994412064552307
events O 0 0.004145408980548382
involved O 0 0.004583308938890696
in O 0 0.0009460340952500701
the O 0 0.0019958680495619774
expansion O 0 0.04333358630537987
mutation O 1 0.9999603033065796
. O 0 0.009447313845157623

To O 0 0.0031570917926728725
investigate O 0 0.010252888314425945
whether O 0 0.003771167015656829
a O 0 0.007001073099672794
founder O 0 0.09550195932388306
chromosome O 1 0.9998806715011597
for O 0 0.0023963660933077335
the O 0 0.005344201810657978
DM B-Disease 1 0.9999945163726807
mutation O 1 0.9999914169311523
exists O 0 0.015197551809251308
in O 0 0.0010771648958325386
the O 0 0.001121724140830338
Japanese O 0 0.005006914958357811
population O 0 0.002530309371650219
, O 0 0.001307146972976625
we O 0 0.0014909172896295786
genotyped O 1 0.9360188245773315
families O 0 0.00533125689253211
using O 0 0.012167517095804214
polymorphic O 1 0.9997077584266663
markers O 1 0.6707116365432739
near O 0 0.00672108493745327
the O 0 0.0025957452598959208
( O 0 0.008850532583892345
CTG O 1 0.9997186064720154
) O 0 0.007244122214615345
n O 0 0.063387431204319
repeat O 0 0.06457039713859558
region O 0 0.004559765569865704
and O 0 0.001507413457147777
constructed O 0 0.02046888694167137
haplotypes O 1 0.9996569156646729
. O 0 0.009215062484145164

Six O 0 0.007992276921868324
different O 0 0.0049186283722519875
haplotypes O 1 0.9994899034500122
were O 0 0.0012017854023724794
found O 0 0.005431499797850847
and O 0 0.004185307305306196
DM B-Disease 1 0.9999959468841553
alleles O 1 0.9997159838676453
were O 0 0.002247826661914587
always O 0 0.007198394276201725
haplotype O 1 0.9998190999031067
A O 0 0.01717638596892357
. O 0 0.006435571704059839

To O 0 0.0036174189299345016
find O 0 0.00540149724110961
an O 0 0.001271475339308381
origin O 0 0.00395005289465189
of O 0 0.0008857242064550519
the O 0 0.0017518621170893312
( O 0 0.007714907173067331
CTG O 1 0.9994409680366516
) O 0 0.006796521600335836
n O 0 0.1762470006942749
repeat O 1 0.992057740688324
mutation O 1 0.9999855756759644
and O 0 0.001070474274456501
to O 0 0.0008214010740630329
investigate O 0 0.005950996186584234
the O 0 0.001219293219037354
mechanism O 0 0.029283011332154274
of O 0 0.0006595771992579103
the O 0 0.0015465784817934036
expansion O 0 0.029977768659591675
mutation O 1 0.9999889135360718
in O 0 0.001736592035740614
the O 0 0.0011172512313351035
Japanese O 0 0.004009589087218046
population O 0 0.0018105675699189305
we O 0 0.0006917844293639064
have O 0 0.0008940838743001223
studied O 0 0.005489235743880272
90 O 0 0.007792660500854254
Japanese O 0 0.01414942555129528
DM B-Disease 1 0.9998923540115356
families O 0 0.009897531010210514
comprising O 0 0.007892117835581303
190 O 0 0.022358780726790428
affected O 0 0.01648087054491043
and O 0 0.002047484740614891
130 O 0 0.019887501373887062
unaffected O 0 0.49431249499320984
members O 0 0.004612960387021303
. O 0 0.00587688572704792

The O 0 0.004779488779604435
results O 0 0.010070111602544785
suggest O 0 0.006925032939761877
that O 0 0.0008900502580218017
a O 0 0.0030570770613849163
few O 0 0.0019316190155223012
common O 0 0.013472558930516243
ancestral O 1 0.9824671149253845
mutations O 1 0.9999933242797852
in O 0 0.0015805915463715792
both O 0 0.0027268219273537397
Caucasian O 1 0.998688280582428
and O 0 0.0015570325776934624
Japanese O 0 0.005898881237953901
populations O 0 0.01950863003730774
have O 0 0.0014774821465834975
originated O 0 0.01288527250289917
by O 0 0.0015125025529414415
expansion O 0 0.006659287493675947
of O 0 0.0008986656321212649
an O 0 0.0024071051739156246
ancestral O 0 0.36998695135116577
n O 1 0.5459903478622437
= O 0 0.08631887286901474
5 O 0 0.008084062486886978
repeat O 0 0.03988814353942871
to O 0 0.0025766873732209206
n O 0 0.15530264377593994
= O 0 0.23840315639972687
19 O 0 0.01619626022875309
- O 0 0.018937215209007263
37 O 0 0.016217585653066635
copies O 0 0.015282182022929192
. O 0 0.006586550734937191

These O 0 0.002881778171285987
data O 0 0.005108074750751257
support O 0 0.004208574071526527
multistep O 1 0.9819648861885071
models O 0 0.012630912475287914
of O 0 0.002911721356213093
triplet O 1 0.9998542070388794
repeat O 1 0.793586254119873
expansion O 0 0.01243045087903738
that O 0 0.0011319579789415002
have O 0 0.0006861452711746097
been O 0 0.0010142959654331207
proposed O 0 0.004161050543189049
for O 0 0.0013330981601029634
both O 0 0.005057225935161114
DM B-Disease 1 0.999983549118042
and O 0 0.007949918508529663
Friedreichs B-Disease 1 0.9998152852058411
ataxia I-Disease 1 0.9999927282333374
. O 0 0.005483651999384165
. O 0 0.005854221526533365

The O 0 0.005255694035440683
molecular O 1 0.9692713022232056
basis O 0 0.00482476269826293
of O 0 0.0046061561442911625
C6 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999995231628418
in O 0 0.001988536911085248
the O 0 0.0014564200537279248
western O 0 0.0051445188000798225
Cape O 0 0.027169987559318542
, O 0 0.002016978105530143
South O 0 0.0034548661205917597
Africa O 0 0.0105591444298625
. O 0 0.006244998890906572

Deficiency B-Disease 1 0.9999681711196899
of I-Disease 0 0.0017458018846809864
the I-Disease 0 0.0013069777050986886
sixth I-Disease 0 0.011637067422270775
component I-Disease 0 0.02101881243288517
of I-Disease 0 0.0010422032792121172
human I-Disease 0 0.011655306443572044
complement I-Disease 1 0.9587973356246948
( O 0 0.010145613923668861
C6 O 1 0.9999943971633911
) O 0 0.004058637656271458
has O 0 0.0011843678075820208
been O 0 0.0014143295120447874
reported O 0 0.005290223751217127
in O 0 0.0011615051189437509
a O 0 0.0027773939073085785
number O 0 0.0009482638561166823
of O 0 0.0007693183142691851
families O 0 0.004023905377835035
from O 0 0.0013521629152819514
the O 0 0.0013679842231795192
western O 0 0.005254650022834539
Cape O 0 0.032291579991579056
, O 0 0.0020774928852915764
South O 0 0.004376527853310108
Africa O 0 0.010666993446648121
. O 0 0.006286630406975746

Meningococcal B-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999902248382568
is O 0 0.005599528551101685
endemic O 1 0.9452776908874512
in O 0 0.0016027367673814297
the O 0 0.0017678112490102649
Cape O 0 0.01910821907222271
and O 0 0.0009714303305372596
almost O 0 0.0016132793389260769
all O 0 0.0009927975479513407
pedigrees O 1 0.9064180254936218
of O 0 0.0015012036310508847
total O 0 0.01586192287504673
C6 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
( O 0 0.011544287204742432
C6Q0 O 1 0.9996910095214844
) O 0 0.0034114704467356205
have O 0 0.0008936026715673506
been O 0 0.0014670435339212418
ascertained O 0 0.4825010299682617
because O 0 0.003409719793125987
of O 0 0.003428542986512184
recurrent O 1 0.9999902248382568
disease O 1 0.999994158744812
. O 0 0.009926178492605686

We O 0 0.0038662308361381292
have O 0 0.0019149291329085827
sequenced O 1 0.7721421718597412
the O 0 0.002038717269897461
expressed O 0 0.005018865689635277
exons O 1 0.942859947681427
of O 0 0.0017011798918247223
the O 0 0.004459945484995842
C6 O 1 0.9999898672103882
gene O 1 0.9996873140335083
from O 0 0.002120123477652669
selected O 0 0.0037314954679459333
cases O 0 0.0051094465889036655
and O 0 0.0006545699434354901
have O 0 0.0007896925089880824
found O 0 0.0033300186041742563
three O 0 0.003673744620755315
molecular O 1 0.999962329864502
defects O 1 0.9999555349349976
leading O 0 0.006058684550225735
to O 0 0.0016322830924764276
total O 0 0.013603906147181988
deficiency O 1 0.9999998807907104
879delG O 1 0.9993224143981934
, O 0 0.0014788854168727994
which O 0 0.0008600757573731244
is O 0 0.0009144568466581404
the O 0 0.0016116335755214095
common O 0 0.09094127267599106
defect O 1 0.9999051094055176
in O 0 0.0014010639861226082
the O 0 0.0015878675039857626
Cape O 0 0.01914304867386818
and O 0 0.0015969921369105577
hitherto O 0 0.43980672955513
unreported O 0 0.4435631334781647
, O 0 0.0017599929124116898
and O 0 0.0018824995495378971
1195delC O 1 0.9992148876190186
and O 0 0.003198873484507203
1936delG O 1 0.9990736246109009
, O 0 0.0016285426681861281
which O 0 0.001089368830434978
have O 0 0.0009055245900526643
been O 0 0.0016217607771977782
previously O 0 0.003565720049664378
reported O 0 0.006738182622939348
in O 0 0.002268707612529397
African O 0 0.020117677748203278
- O 0 0.021800484508275986
Americans O 0 0.0105244480073452
. O 0 0.006451766472309828

We O 0 0.0025739218108356
also O 0 0.0012042232556268573
show O 0 0.002009615069255233
that O 0 0.0009462936432100832
the O 0 0.0021286276169121265
879delG O 1 0.995954155921936
and O 0 0.003888726467266679
1195delC O 1 0.9998238682746887
defects O 1 0.9999161958694458
are O 0 0.0018641637871041894
associated O 0 0.007132789585739374
with O 0 0.003900643438100815
characteristic O 1 0.9897382855415344
C6 O 1 0.9999836683273315
/ O 1 0.9898576736450195
C7 O 1 0.9997407793998718
region O 0 0.01776311732828617
DNA O 1 0.9994860887527466
marker O 1 0.9928340911865234
haplotypes O 1 0.9998766183853149
, O 0 0.0025045801885426044
although O 0 0.00249110022559762
small O 0 0.004868466407060623
variations O 0 0.023117760196328163
were O 0 0.0013632960617542267
observed O 0 0.016589567065238953
. O 0 0.006280333269387484

The O 0 0.01013401709496975
1936delG O 1 0.9982722997665405
defect O 1 0.9993770718574524
was O 0 0.003950262907892466
observed O 0 0.008021747693419456
only O 0 0.0009684943361207843
once O 0 0.002128358231857419
in O 0 0.0009168281103484333
the O 0 0.0018587992526590824
Cape O 0 0.07792015373706818
, O 0 0.0012000197311863303
but O 0 0.0012758078519254923
its O 0 0.002474981127306819
associated O 0 0.03350836783647537
haplotype O 1 0.9999563694000244
could O 0 0.003579628886654973
be O 0 0.0016615818021818995
deduced O 0 0.051975175738334656
. O 0 0.005928432568907738

The O 0 0.0034959272015839815
data O 0 0.005264252424240112
from O 0 0.001722258049994707
the O 0 0.002904650289565325
haplotypes O 1 0.9999020099639893
indicate O 0 0.010761273093521595
that O 0 0.0007611974142491817
these O 0 0.0009534939890727401
three O 0 0.003171456977725029
molecular O 1 0.9999604225158691
defects O 1 0.99996018409729
account O 0 0.0025500718038529158
for O 0 0.0008798589697107673
the O 0 0.0021706614643335342
defects O 1 0.999984622001648
in O 0 0.001014011912047863
all O 0 0.0005380610236898065
the O 0 0.0015521352179348469
38 O 0 0.020541109144687653
unrelated O 1 0.9908990859985352
C6Q0 O 1 0.9995276927947998
individuals O 0 0.005826347507536411
we O 0 0.0010684075532481074
have O 0 0.0008707394008524716
studied O 0 0.004514860454946756
from O 0 0.0015959342708811164
the O 0 0.002332291565835476
Cape O 0 0.03943139314651489
. O 0 0.007301917299628258

We O 0 0.0031172274611890316
have O 0 0.0010715174721553922
also O 0 0.0011289073154330254
observed O 0 0.007070452906191349
the O 0 0.00279032438993454
879delG O 1 0.9978204965591431
defect O 1 0.9983647465705872
in O 0 0.001820600708015263
two O 0 0.0037064128555357456
Dutch O 1 0.7111917734146118
C6 B-Disease 1 0.9999945163726807
- I-Disease 1 0.9436521530151367
deficient I-Disease 1 0.9999358654022217
kindreds O 1 0.998917818069458
, O 0 0.0023347893729805946
but O 0 0.0012894375249743462
the O 0 0.0025166987907141447
879delG O 1 0.9996594190597534
defect O 1 0.9996751546859741
in O 0 0.002110027940943837
the O 0 0.0023178327828645706
Cape O 0 0.03125922009348869
probably O 0 0.0068545229732990265
did O 0 0.0021660968195647
not O 0 0.0010361395543441176
come O 0 0.0015438933623954654
from O 0 0.0011857800418511033
The O 0 0.0020841010846197605
Netherlands O 0 0.0095653235912323
. O 0 0.0031256151851266623
. O 0 0.005729018710553646

Complement B-Disease 1 0.9907666444778442
C7 I-Disease 1 0.9999903440475464
deficiency I-Disease 1 0.9999983310699463
: O 0 0.0059626176953315735
seven O 0 0.0031557022593915462
further O 0 0.005886598955839872
molecular O 1 0.9999517202377319
defects O 1 0.999935507774353
and O 0 0.0012689122231677175
their O 0 0.002134651178494096
associated O 0 0.017769891768693924
marker O 1 0.9919062852859497
haplotypes O 1 0.9996168613433838
. O 0 0.009767849929630756

Seven O 0 0.007370149716734886
further O 0 0.006743520498275757
molecular O 1 0.9328925609588623
bases O 0 0.013967315666377544
of O 0 0.006847398355603218
C7 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999994039535522
are O 0 0.0030276882462203503
described O 0 0.012624579481780529
. O 0 0.0057948678731918335

All O 0 0.001864743186160922
these O 0 0.001133220735937357
new O 0 0.003998924046754837
molecular O 1 0.9997746348381042
defects O 1 0.9998300075531006
involve O 0 0.022164098918437958
single O 0 0.013538796454668045
- O 0 0.025072641670703888
nucleotide O 1 0.99733966588974
events O 0 0.00574701139703393
, O 0 0.0025020656175911427
deletions O 1 0.9989546537399292
and O 0 0.002118590520694852
substitutions O 0 0.34919315576553345
, O 0 0.0009245529072359204
some O 0 0.0005361192161217332
of O 0 0.0005686628865078092
which O 0 0.0016316265100613236
alter O 1 0.9644968509674072
splice O 1 0.9995375871658325
sites O 0 0.0068296645767986774
, O 0 0.0012292348546907306
and O 0 0.00131664564833045
others O 0 0.007067030295729637
codons O 1 0.995177149772644
. O 0 0.009108983911573887

They O 0 0.002317870268598199
are O 0 0.0008331041317433119
distributed O 0 0.005584785249084234
along O 0 0.0033249107655137777
the O 0 0.005515895783901215
C7 O 1 0.9999967813491821
gene O 1 0.9999561309814453
, O 0 0.002215320710092783
but O 0 0.0011057198280468583
predominantly O 0 0.003972098231315613
towards O 0 0.003153235651552677
the O 0 0.0019331473158672452
3 O 0 0.009601210243999958
end O 0 0.0076066069304943085
. O 0 0.006140305660665035

All O 0 0.0021183285862207413
were O 0 0.00105068099219352
found O 0 0.004809685982763767
in O 0 0.0025913738645613194
compound O 0 0.18875904381275177
heterozygous O 1 0.9990730285644531
individuals O 0 0.013519346714019775
. O 0 0.007156239356845617

The O 0 0.01685076765716076
C6 O 1 0.9998162388801575
/ O 1 0.967025876045227
C7 O 1 0.9998024106025696
marker O 1 0.9818062782287598
haplotypes O 1 0.9996896982192993
associated O 0 0.013829763978719711
with O 0 0.0027578098233789206
most O 0 0.003958271350711584
C7 B-Disease 1 0.9999954700469971
defects I-Disease 1 0.9999434947967529
are O 0 0.0017424703110009432
tabulated O 0 0.013830256648361683
. O 0 0.0026395590975880623
. O 0 0.004383362829685211

A O 0 0.04740101844072342
genome O 1 0.9984764456748962
- O 0 0.020406093448400497
wide O 0 0.009472175501286983
search O 0 0.013508611358702183
for O 0 0.005586936138570309
chromosomal O 1 0.9999903440475464
loci O 1 0.9998695850372314
linked O 1 0.5453353524208069
to O 0 0.0037194902542978525
mental O 1 0.9988553524017334
health O 1 0.9324694275856018
wellness O 1 0.997962474822998
in O 0 0.0021689131390303373
relatives O 0 0.0126408776268363
at O 0 0.0022182560060173273
high O 0 0.007076428271830082
risk O 1 0.9976338148117065
for O 0 0.012340511195361614
bipolar B-Disease 1 0.9999998807907104
affective I-Disease 1 0.9999940395355225
disorder I-Disease 1 0.9999866485595703
among O 0 0.0031561164651066065
the O 0 0.001650250400416553
Old O 0 0.010319815948605537
Order O 0 0.008641905151307583
Amish O 0 0.213882178068161
. O 0 0.009389445185661316

Bipolar B-Disease 1 0.9999927282333374
affective I-Disease 1 0.9999523162841797
disorder I-Disease 1 0.9999915361404419
( O 0 0.01594136282801628
BPAD B-Disease 1 0.9998822212219238
; O 0 0.0742328092455864
manic B-Disease 1 0.9999973773956299
- I-Disease 1 0.999426007270813
depressive I-Disease 1 0.9999995231628418
illness I-Disease 1 0.999988317489624
) O 0 0.004915446043014526
is O 0 0.0018135709688067436
characterized O 0 0.06254242360591888
by O 0 0.002016680547967553
episodes O 0 0.018593644723296165
of O 0 0.002996274270117283
mania B-Disease 1 0.9999369382858276
and O 0 0.0037748878821730614
/ O 1 0.9857770800590515
or O 0 0.013413934968411922
hypomania B-Disease 1 0.9999796152114868
interspersed O 0 0.1214960590004921
with O 0 0.0038291935343295336
periods O 0 0.009559353813529015
of O 0 0.003106291638687253
depression B-Disease 1 0.9984392523765564
. O 0 0.009221978485584259

Compelling O 0 0.02143280580639839
evidence O 0 0.004314280115067959
supports O 0 0.008198564872145653
a O 0 0.0035013218875974417
significant O 0 0.008407087996602058
genetic O 1 0.9999047517776489
component O 0 0.026408080011606216
in O 0 0.0011674577835947275
the O 0 0.0026092450134456158
susceptibility O 1 0.9999001026153564
to O 0 0.004840335343033075
develop O 1 0.7389358878135681
BPAD B-Disease 1 0.9989871382713318
. O 0 0.01031142845749855

To O 0 0.0037038165610283613
date O 0 0.004451183136552572
, O 0 0.0012034022947773337
however O 0 0.001964102266356349
, O 0 0.0020394991151988506
linkage O 1 0.9994248151779175
studies O 0 0.007141378708183765
have O 0 0.0010231520282104611
attempted O 0 0.007559655699878931
only O 0 0.0007314802496694028
to O 0 0.0014705418143421412
identify O 0 0.14574559032917023
chromosomal O 1 0.9999973773956299
loci O 1 0.9996176958084106
that O 0 0.0034464411437511444
cause O 1 0.9288282990455627
or O 0 0.0031636024359613657
increase O 0 0.004747107159346342
the O 0 0.002042131032794714
risk O 1 0.9095864295959473
of O 0 0.0023282275069504976
developing O 0 0.36763182282447815
BPAD B-Disease 1 0.9988937973976135
. O 0 0.009316380135715008

To O 0 0.0032684728503227234
determine O 0 0.006885710172355175
whether O 0 0.0022314474917948246
there O 0 0.0010047670220956206
could O 0 0.0018310254672542214
be O 0 0.001657762099057436
protective O 1 0.9927896857261658
alleles O 1 0.9999693632125854
that O 0 0.0027492400258779526
prevent O 0 0.13743434846401215
or O 0 0.0033400740940123796
reduce O 0 0.01674700155854225
the O 0 0.002041266532614827
risk O 1 0.9511110186576843
of O 0 0.0016380862798541784
developing O 1 0.6622257232666016
BPAD B-Disease 1 0.9999375343322754
, O 0 0.0018360784742981195
similar O 0 0.004180697724223137
to O 0 0.0006440823781304061
what O 0 0.0009149086545221508
is O 0 0.0008693201816640794
observed O 0 0.00552807142958045
in O 0 0.0011984867742285132
other O 0 0.00481754494830966
genetic B-Disease 1 0.9999998807907104
disorders I-Disease 1 0.9999997615814209
, O 0 0.0013930763816460967
we O 0 0.0010553246829658747
used O 0 0.0060631288215518
mental O 1 0.9997060894966125
health O 1 0.9917948842048645
wellness O 1 0.9996559619903564
( O 0 0.003627009689807892
absence O 0 0.008878268301486969
of O 0 0.0010280032875016332
any O 0 0.009179922752082348
psychiatric B-Disease 1 0.9999969005584717
disorder I-Disease 1 0.9999991655349731
) O 0 0.002940279897302389
as O 0 0.0009594644070602953
the O 0 0.0028461504261940718
phenotype O 1 0.9999760389328003
in O 0 0.0023833876475691795
our O 0 0.0060524484142661095
genome O 1 0.9998559951782227
- O 0 0.02695419080555439
wide O 0 0.020113371312618256
linkage O 1 0.9962877035140991
scan O 1 0.5823816657066345
of O 0 0.0011027025757357478
several O 0 0.001837434247136116
large O 0 0.0055356742814183235
multigeneration O 1 0.9956831932067871
Old O 0 0.012593436054885387
Order O 0 0.007822100073099136
Amish O 0 0.2924758791923523
pedigrees O 1 0.9844563007354736
exhibiting O 0 0.04663354530930519
an O 0 0.002206976991146803
extremely O 0 0.012941859662532806
high O 0 0.010730150155723095
incidence O 1 0.9994014501571655
of O 0 0.004748218692839146
BPAD B-Disease 1 0.9993175268173218
. O 0 0.009458843618631363

We O 0 0.002966573927551508
have O 0 0.0011729655088856816
found O 0 0.003530423389747739
strong O 0 0.0031444362830370665
evidence O 0 0.002403983613476157
for O 0 0.0013385000638663769
a O 0 0.008053400553762913
locus O 1 0.9987521171569824
on O 0 0.008250841870903969
chromosome O 1 0.9999690055847168
4p O 1 0.9976058006286621
at O 0 0.00882639642804861
D4S2949 O 1 0.9818748831748962
( O 0 0.00541320163756609
maximum O 0 0.01755443587899208
GENEHUNTER O 1 0.9974334836006165
- O 0 0.024986237287521362
PLUS O 0 0.02970259264111519
nonparametric O 1 0.9671063423156738
linkage O 1 0.9598053097724915
score O 0 0.01652795821428299
= O 0 0.06588789075613022
4 O 0 0.01000405102968216
. O 0 0.002645694650709629
05 O 0 0.42336106300354004
, O 0 0.004690968431532383
P O 1 0.9940220713615417
= O 0 0.16639062762260437
5 O 0 0.0067960480228066444
. O 0 0.0018286355771124363
22 O 0 0.008587575517594814
x O 0 0.14995937049388885
10 O 0 0.005951331928372383
( O 0 0.005543446633964777
- O 0 0.01822434924542904
4 O 0 0.010987159796059132
) O 0 0.004839126951992512
; O 0 0.005454089026898146
SIBPAL O 1 0.9956260919570923
Pempirical O 1 0.9860521554946899
value O 0 0.009401419200003147
< O 1 0.989011287689209
3 O 0 0.013903968036174774
x O 0 0.11215829104185104
10 O 0 0.005684573203325272
( O 0 0.005637119058519602
- O 0 0.018166519701480865
5 O 0 0.011415340006351471
) O 0 0.00399672519415617
) O 0 0.0022404033225029707
and O 0 0.0010618009837344289
suggestive O 1 0.9580259323120117
evidence O 0 0.0036138284485787153
for O 0 0.0012419192353263497
a O 0 0.00677222665399313
locus O 1 0.9992734789848328
on O 0 0.006448124069720507
chromosome O 1 0.9999943971633911
4q O 1 0.9993719458580017
at O 0 0.00896721426397562
D4S397 O 1 0.9802699089050293
( O 0 0.006871628575026989
maximum O 0 0.02100026234984398
GENEHUNTER O 1 0.9961579442024231
- O 0 0.03008337691426277
PLUS O 0 0.030930891633033752
nonparametric O 1 0.9791421890258789
linkage O 1 0.9751906991004944
score O 0 0.014712775126099586
= O 0 0.13299047946929932
3 O 0 0.00825283583253622
. O 0 0.001976330066099763
29 O 0 0.008027561940252781
, O 0 0.003057056339457631
P O 1 0.9935107827186584
= O 0 0.16217809915542603
2 O 0 0.007413522340357304
. O 0 0.0018214959418401122
57 O 0 0.018164077773690224
x O 0 0.2618566155433655
10 O 0 0.007115800864994526
( O 0 0.006685947068035603
- O 0 0.018250901252031326
3 O 0 0.011652735993266106
) O 0 0.003804747248068452
; O 0 0.006862519774585962
SIBPAL O 1 0.9952778816223145
Pempirical O 1 0.9834312796592712
value O 0 0.009139591827988625
< O 1 0.9872117638587952
1 O 0 0.01184406504034996
x O 0 0.058284956961870193
10 O 0 0.005648038350045681
( O 0 0.005584572907537222
- O 0 0.01999950222671032
3 O 0 0.010530884377658367
) O 0 0.004020399879664183
) O 0 0.001642395043745637
that O 0 0.0006079168524593115
are O 0 0.0008270578691735864
linked O 0 0.33320799469947815
to O 0 0.0034080243203788996
mental O 1 0.9995136260986328
health O 1 0.9743971824645996
wellness O 1 0.9967843294143677
. O 0 0.009466833434998989

These O 0 0.003981734625995159
findings O 0 0.008548613637685776
are O 0 0.0008891264442354441
consistent O 0 0.008438331075012684
with O 0 0.0013078020419925451
the O 0 0.0011812127195298672
hypothesis O 1 0.51678866147995
that O 0 0.0012794975191354752
certain O 0 0.006459369789808989
alleles O 1 0.9999767541885376
could O 0 0.00492334458976984
prevent O 0 0.08423575758934021
or O 0 0.0040893880650401115
modify O 0 0.1218775287270546
the O 0 0.003460146486759186
clinical O 1 0.9995730519294739
manifestations O 1 0.6623433828353882
of O 0 0.0025175786577165127
BPAD B-Disease 1 0.9998656511306763
and O 0 0.0015674976166337729
perhaps O 0 0.006050890311598778
other O 0 0.0023468739818781614
related O 1 0.6554304361343384
affective B-Disease 1 0.9999938011169434
disorders I-Disease 1 0.9999971389770508
. O 0 0.009099176153540611

Segregation O 0 0.16855394840240479
distortion O 1 0.8157221078872681
in O 0 0.02230323664844036
myotonic B-Disease 1 0.9999985694885254
dystrophy I-Disease 1 0.9999984502792358
. O 0 0.018208853900432587

Myotonic B-Disease 1 0.9999980926513672
dystrophy I-Disease 1 0.9999995231628418
( O 0 0.04021516814827919
DM B-Disease 1 0.9999765157699585
) O 0 0.0055039627477526665
is O 0 0.0021227700635790825
an O 0 0.005311618093401194
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9996874332427979
disease I-Disease 1 0.9999973773956299
which O 0 0.0016065798699855804
, O 0 0.0008509613107889891
in O 0 0.0008128148620016873
the O 0 0.001483546569943428
typical O 0 0.1574179083108902
pedigree O 1 0.9979507327079773
, O 0 0.0015210455749183893
shows O 0 0.0035034320317208767
a O 0 0.004470617976039648
three O 0 0.0028516417369246483
generation O 0 0.031478703022003174
anticipation O 0 0.05738634243607521
cascade O 1 0.994265615940094
. O 0 0.00992570910602808

This O 0 0.003683321410790086
results O 0 0.012162880040705204
in O 0 0.006947489455342293
infertility B-Disease 1 0.9999972581863403
and O 0 0.06300245970487595
congenital B-Disease 1 1.0
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999997615814209
( O 0 0.02342747151851654
CDM B-Disease 1 0.9997460246086121
) O 0 0.004369387868791819
with O 0 0.00149242440238595
the O 0 0.0013582981191575527
disappearance O 0 0.30670449137687683
of O 0 0.003516231896355748
DM B-Disease 1 0.9999822378158569
in O 0 0.0032486889977008104
that O 0 0.0034018412698060274
pedigree O 1 0.990902841091156
. O 0 0.007261244580149651

The O 0 0.0033555703703314066
concept O 0 0.00795543659478426
of O 0 0.0016062724171206355
segregation O 1 0.6889206171035767
distortion O 1 0.9897816181182861
, O 0 0.0015526415081694722
where O 0 0.0012324637500569224
there O 0 0.0009866971522569656
is O 0 0.0015544823836535215
preferential O 0 0.2155928760766983
transmission O 1 0.9557815790176392
of O 0 0.0008024922572076321
the O 0 0.0012442521983757615
larger O 0 0.013327768072485924
allele O 1 0.9997966885566711
at O 0 0.0029278856236487627
the O 0 0.0058836727403104305
DM B-Disease 1 0.9999984502792358
locus O 1 0.9999233484268188
, O 0 0.0021832669153809547
has O 0 0.0012260741787031293
been O 0 0.001311641652137041
put O 0 0.0035087380092591047
forward O 0 0.0030646983068436384
to O 0 0.0010606707073748112
explain O 0 0.0085876090452075
partially O 0 0.016603123396635056
the O 0 0.0016136986669152975
maintenance O 0 0.0384778268635273
of O 0 0.003492096671834588
DM B-Disease 1 0.9999861717224121
in O 0 0.0018307049758732319
the O 0 0.0016820335295051336
population O 0 0.004082472994923592
. O 0 0.005397246219217777

In O 0 0.004681926686316729
a O 0 0.0051011634059250355
survey O 0 0.00725221773609519
of O 0 0.0031934562139213085
DM B-Disease 1 0.9999392032623291
in O 0 0.00398466270416975
Northern O 0 0.005654599983245134
Ireland O 0 0.007749529089778662
, O 0 0.00210047559812665
59 O 0 0.02468070574104786
pedigrees O 1 0.912531852722168
were O 0 0.0022806755732744932
ascertained O 0 0.4899193346500397
. O 0 0.007605663500726223

Sibships O 1 0.9694784283638
where O 0 0.0025724556762725115
the O 0 0.001047485857270658
status O 0 0.003096256870776415
of O 0 0.00042821920942515135
all O 0 0.00045469586621038616
the O 0 0.0007880184566602111
members O 0 0.0012942423345521092
had O 0 0.0014980563428252935
been O 0 0.0015072111273184419
identified O 0 0.007121954578906298
were O 0 0.0008610101067461073
examined O 0 0.014014954678714275
to O 0 0.0008537409012205899
determine O 0 0.004228954203426838
the O 0 0.0013786808121949434
transmission O 1 0.994053304195404
of O 0 0.0009764410788193345
the O 0 0.004066150169819593
DM B-Disease 1 0.9999895095825195
expansion O 0 0.018796779215335846
from O 0 0.0023994208313524723
affected O 0 0.01807384565472603
parents O 0 0.008238662034273148
to O 0 0.0015280639054253697
their O 0 0.0036139918956905603
offspring O 1 0.9909706115722656
. O 0 0.007628317456692457

Where O 0 0.00554521381855011
the O 0 0.004330973606556654
transmitting O 1 0.9953747391700745
parent O 1 0.8738633990287781
was O 0 0.005128967110067606
male O 0 0.040557101368904114
, O 0 0.00308359251357615
58 O 0 0.025573162361979485
. O 0 0.007107076700776815

3 O 0 0.014017552137374878
% O 0 0.0037010337691754103
of O 0 0.0008705648360773921
the O 0 0.001979049062356353
offspring O 1 0.9969682097434998
were O 0 0.001190577750094235
affected O 0 0.017862068489193916
, O 0 0.00126085861120373
and O 0 0.0006592152058146894
in O 0 0.0008632235112600029
the O 0 0.0009552722331136465
case O 0 0.0037466022185981274
of O 0 0.0008613658137619495
a O 0 0.006395404227077961
female O 0 0.04455864429473877
transmitting O 1 0.9985926747322083
parent O 1 0.9309737682342529
, O 0 0.003432480152696371
68 O 0 0.03130737319588661
. O 0 0.007394672371447086

7 O 0 0.01834620162844658
% O 0 0.006660499610006809
were O 0 0.001632055384106934
affected O 0 0.020481226965785027
. O 0 0.006459586322307587

Studies O 0 0.020303351804614067
on O 0 0.0032175714150071144
meiotic O 1 0.9997115731239319
drive O 0 0.031082093715667725
in O 0 0.005527007393538952
DM B-Disease 1 0.9999297857284546
have O 0 0.0021747155115008354
shown O 0 0.0056458632461726665
increased O 0 0.007753922138363123
transmission O 1 0.8066698312759399
of O 0 0.0007528995629400015
the O 0 0.0014692259719595313
larger O 0 0.013678510673344135
allele O 1 0.9997486472129822
at O 0 0.0030220523476600647
the O 0 0.00460809376090765
DM B-Disease 1 0.999984860420227
locus O 1 0.9994276165962219
in O 0 0.004544989671558142
non O 0 0.023075466975569725
- O 1 0.7464823126792908
DM O 1 0.9999513626098633
heterozygotes O 1 0.997154951095581
for O 0 0.0062274448573589325
CTGn O 1 0.9763892292976379
. O 0 0.009066695347428322

This O 0 0.0036420635879039764
study O 0 0.00711851567029953
provides O 0 0.005586461629718542
further O 0 0.0026612074580043554
evidence O 0 0.0023981223348528147
that O 0 0.0010665475856512785
the O 0 0.0037501133047044277
DM B-Disease 1 0.9999663829803467
expansion O 0 0.024951331317424774
tends O 0 0.016290126368403435
to O 0 0.0013194386847317219
be O 0 0.0024494866374880075
transmitted O 1 0.9885822534561157
preferentially O 1 0.9001444578170776
. O 0 0.007751306984573603

Diagnosis O 1 0.9994397759437561
of O 0 0.012259254232048988
hemochromatosis B-Disease 1 0.9999794960021973
. O 0 0.01576550491154194

If O 0 0.016161704435944557
untreated O 1 0.9997028708457947
, O 0 0.007795123849064112
hemochromatosis B-Disease 1 0.9999992847442627
can O 0 0.013978998176753521
cause O 1 0.999657154083252
serious O 1 0.9974443912506104
illness O 1 0.9999511241912842
and O 0 0.0016025587683543563
early B-Disease 0 0.0063166567124426365
death I-Disease 0 0.04846493899822235
, O 0 0.0012998502934351563
but O 0 0.0014166812179610133
the O 0 0.0035056814085692167
disease O 1 0.9999985694885254
is O 0 0.002026303205639124
still O 0 0.002076538046821952
substantially O 0 0.08133543282747269
under O 0 0.007347791455686092
- O 1 0.974220335483551
diagnosed O 1 0.9999688863754272
. O 0 0.011964220553636551

The O 0 0.004937064368277788
cornerstone O 0 0.04106484353542328
of O 0 0.002515377476811409
screening O 1 0.8690946102142334
and O 0 0.0016984198009595275
case O 0 0.010418392717838287
detection O 1 0.9832792282104492
is O 0 0.001524487161077559
the O 0 0.0015246790135279298
measurement O 0 0.02938261069357395
of O 0 0.002535997424274683
serum O 1 0.9997058510780334
transferrin O 1 0.9989863038063049
saturation O 1 0.8126487135887146
and O 0 0.0017163752345368266
the O 0 0.0039011731278151274
serum O 1 0.9996352195739746
ferritin O 1 0.9971098303794861
level O 0 0.012484448961913586
. O 0 0.006779626477509737

Once O 0 0.01291204709559679
the O 0 0.00599301140755415
diagnosis O 1 0.9999809265136719
is O 0 0.003680578898638487
suspected O 0 0.03888928145170212
, O 0 0.0027350373566150665
physicians O 0 0.11118023842573166
must O 0 0.002240397036075592
use O 0 0.008313879370689392
serum O 1 0.9992421865463257
ferritin O 1 0.9977253079414368
levels O 0 0.019927814602851868
and O 0 0.0039025337900966406
hepatic O 1 0.9999955892562866
iron O 0 0.06912735849618912
stores O 0 0.014417857863008976
on O 0 0.006302306894212961
liver O 1 0.9999997615814209
biopsy O 1 0.9999865293502808
specimens O 0 0.03053699992597103
to O 0 0.0026850176509469748
assess O 0 0.3565380871295929
patients O 1 0.9987188577651978
for O 0 0.0011075421934947371
the O 0 0.000997245078906417
presence O 0 0.006979132071137428
of O 0 0.0020243744365870953
iron B-Disease 1 0.8934403657913208
overload I-Disease 1 0.9989238381385803
. O 0 0.010596487671136856

Liver O 1 0.9999990463256836
biopsy O 1 0.9999608993530273
is O 0 0.0028621135279536247
also O 0 0.001007398241199553
used O 0 0.0017751912819221616
to O 0 0.0007146000862121582
establish O 0 0.00402905885130167
the O 0 0.0008919400861486793
presence O 0 0.006817959249019623
or O 0 0.0029726868961006403
absence O 0 0.015881257131695747
of O 0 0.0030772064346820116
cirrhosis B-Disease 1 0.9999997615814209
, O 0 0.0019884309731423855
which O 0 0.0014457658398896456
can O 0 0.004823796451091766
affect O 1 0.8732022047042847
prognosis O 1 0.9999687671661377
and O 0 0.0030781810637563467
management O 0 0.032548800110816956
. O 0 0.006349253002554178

A O 0 0.04039856791496277
DNA O 1 0.9994041919708252
- O 0 0.02258332632482052
based O 0 0.0036943021696060896
test O 0 0.008114244788885117
for O 0 0.00130854279268533
the O 0 0.003860307391732931
HFE O 1 0.9999933242797852
gene O 1 0.999923586845398
is O 0 0.0027820358518511057
commercially O 0 0.01861671544611454
available O 0 0.0030664619989693165
, O 0 0.0008571440703235567
but O 0 0.0007640448166057467
its O 0 0.0011390156578272581
place O 0 0.001267396379262209
in O 0 0.0010551759041845798
the O 0 0.0027324517723172903
diagnosis O 1 0.9999915361404419
of O 0 0.004277694504708052
hemochromatosis B-Disease 1 0.9999997615814209
is O 0 0.0033421760890632868
still O 0 0.0022105900570750237
being O 0 0.003030274296179414
evaluated O 0 0.0545758493244648
. O 0 0.0060516768135130405

Currently O 0 0.006552989594638348
, O 0 0.0012921292800456285
the O 0 0.0010523308301344514
most O 0 0.0012549912789836526
useful O 0 0.009112492203712463
role O 0 0.005696700420230627
for O 0 0.0009342732955701649
this O 0 0.0011167990742251277
test O 0 0.01044840831309557
is O 0 0.000988122308626771
in O 0 0.0007601567776873708
the O 0 0.0014397831400856376
detection O 1 0.9914621710777283
of O 0 0.002977865282446146
hemochromatosis B-Disease 1 0.999998927116394
in O 0 0.0019117392366752028
the O 0 0.0013881371123716235
family O 0 0.005283528473228216
members O 0 0.001463778899051249
of O 0 0.0017449776642024517
patients O 1 0.9998756647109985
with O 0 0.002748108236119151
a O 0 0.005133833270519972
proven O 0 0.03177714720368385
case O 0 0.004684916231781244
of O 0 0.001092642662115395
the O 0 0.006468437146395445
disease O 1 0.9999935626983643
. O 0 0.010084348730742931

It O 0 0.0036385839339345694
is O 0 0.0019614105112850666
crucial O 0 0.009847307577729225
to O 0 0.005816533695906401
diagnose O 1 0.9999852180480957
hemochromatosis B-Disease 1 0.9999959468841553
before O 0 0.19984108209609985
hepatic B-Disease 1 0.9999997615814209
cirrhosis I-Disease 1 0.9999992847442627
develops O 1 0.998719334602356
because O 0 0.015010968782007694
phlebotomy O 1 0.9999068975448608
therapy O 1 0.9997760653495789
can O 0 0.009788681752979755
avert O 1 0.9994366765022278
serious O 1 0.9997209906578064
chronic O 1 0.9999998807907104
disease O 1 0.9999992847442627
and O 0 0.001569558633491397
can O 0 0.002685317536816001
even O 0 0.002329109236598015
lead O 0 0.012293297797441483
to O 0 0.0017334965523332357
normal O 0 0.05406484007835388
life O 0 0.008761060424149036
expectancy O 1 0.7165311574935913
. O 0 0.003991971258074045
. O 0 0.005194836296141148

Prevalence O 1 0.9487528204917908
of O 0 0.0019039786420762539
the O 0 0.0036197726149111986
I1307K O 1 0.9987055063247681
APC B-Disease 1 0.9999039173126221
gene O 1 0.9999293088912964
variant O 1 0.9983718991279602
in O 0 0.0022769940551370382
Israeli O 0 0.0038521364331245422
Jews O 0 0.0020330671686679125
of O 0 0.0005946652963757515
differing O 0 0.007664097007364035
ethnic O 0 0.003858208656311035
origin O 0 0.006161748897284269
and O 0 0.001997011248022318
risk O 1 0.9993336796760559
for O 0 0.1984383910894394
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.010824074037373066

BACKGROUND O 0 0.05931679531931877
& O 0 0.04052865505218506
AIMS O 0 0.024645138531923294
Israeli O 0 0.00469357380643487
Jews O 0 0.0022816346026957035
of O 0 0.000851523014716804
European O 0 0.005641651805490255
birth O 1 0.9634388089179993
, O 0 0.0017679105512797832
i O 0 0.0031022324692457914
. O 0 0.0025115422904491425
e O 0 0.10777925699949265
. O 0 0.0016321237199008465
, O 0 0.002017589285969734
Ashkenazim O 1 0.9942203760147095
, O 0 0.0010342351160943508
have O 0 0.000736905902158469
the O 0 0.0021978667937219143
highest O 1 0.8676510453224182
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9998083710670471
of O 0 0.0011764975497499108
any O 0 0.0018869718769565225
Israeli O 0 0.004520873539149761
ethnic O 0 0.00627563614398241
group O 0 0.009485582821071148
. O 0 0.005710562225431204

The O 0 0.00934320967644453
I1307K O 1 0.9956478476524353
APC B-Disease 1 0.9997952580451965
gene O 1 0.9998718500137329
variant O 1 0.9971057772636414
was O 0 0.004277121741324663
found O 0 0.00553607614710927
in O 0 0.002314377576112747
6 O 0 0.01283510122448206
. O 0 0.006482785567641258

1 O 0 0.011632164940237999
% O 0 0.0046259211376309395
of O 0 0.0008291596896015108
American O 0 0.003143760608509183
Jews O 0 0.0032280245795845985
, O 0 0.001184590277262032
28 O 0 0.004380830563604832
% O 0 0.0020895246416330338
of O 0 0.0008779637282714248
their O 0 0.011522499844431877
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.34378543496131897
, O 0 0.0013929986162111163
but O 0 0.0011778537882491946
not O 0 0.0009968888480216265
in O 0 0.0015857508406043053
non O 0 0.011499721556901932
- O 0 0.01575283706188202
Jews O 0 0.00677529675886035
. O 0 0.005196494050323963

We O 0 0.003989569377154112
assessed O 0 0.015493337996304035
the O 0 0.0032945461571216583
I1307K O 1 0.9989909529685974
prevalence O 1 0.999056875705719
in O 0 0.0018600099720060825
Israeli O 0 0.004261032212525606
Jews O 0 0.0022981404326856136
of O 0 0.0008138565463013947
differing O 0 0.007923671044409275
ethnic O 0 0.003915887791663408
origin O 0 0.006105323322117329
and O 0 0.002238572807982564
risk O 1 0.9994537234306335
for O 0 0.06504900008440018
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
. O 0 0.00936797633767128

METHODS O 0 0.05212718993425369
DNA O 1 0.9893605709075928
samples O 0 0.03202567994594574
from O 0 0.0026896619237959385
500 O 0 0.010172969661653042
unrelated O 0 0.05056546628475189
Jews O 0 0.0025984428357332945
of O 0 0.0008245017379522324
European O 0 0.0042507946491241455
or O 0 0.00491755735129118
non O 0 0.009784014895558357
- O 0 0.012557520531117916
European O 0 0.004525354597717524
origin O 0 0.006731859408318996
, O 0 0.0010703575098887086
with O 0 0.0020353852305561304
or O 0 0.0026443046517670155
without O 0 0.0030466991011053324
a O 0 0.0039277453906834126
personal O 0 0.006581838708370924
and O 0 0.002268396783620119
/ O 1 0.9486134648323059
or O 0 0.003051184816285968
family O 0 0.006473200861364603
history O 0 0.002677608747035265
of O 0 0.0032161755952984095
neoplasia B-Disease 1 0.999996542930603
, O 0 0.0019856924191117287
were O 0 0.0007705482421442866
examined O 0 0.015227734111249447
for O 0 0.0011266667861491442
the O 0 0.002219641115516424
I1307K O 1 0.9967381358146667
variant O 1 0.9969015121459961
by O 0 0.0028709862381219864
the O 0 0.003998319618403912
allele O 1 0.9999589920043945
- O 0 0.029088156297802925
specific O 0 0.019300242885947227
oligonucleotide O 1 0.9993171691894531
( O 0 0.011794148944318295
ASO O 1 0.9907717704772949
) O 0 0.006566541735082865
method O 0 0.027711544185876846
. O 0 0.00690517807379365

RESULTS O 0 0.031239429488778114
In O 0 0.0023331306874752045
persons O 0 0.0036722300574183464
at O 0 0.0026192101649940014
average O 0 0.011981560848653316
risk O 1 0.9993583559989929
for O 0 0.13382230699062347
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 0.004715127870440483
I1307K O 1 0.9947819113731384
was O 0 0.0030677481554448605
found O 0 0.005015859846025705
in O 0 0.0021613696590065956
5 O 0 0.011035671457648277
. O 0 0.006737314164638519

0 O 0 0.030046243220567703
% O 0 0.004358569160103798
of O 0 0.0010136999189853668
120 O 0 0.006107410416007042
European O 0 0.004734132904559374
and O 0 0.0014869197038933635
1 O 0 0.009625638835132122
. O 0 0.005322853568941355

6 O 0 0.01446359883993864
% O 0 0.005340324714779854
of O 0 0.0017530416371300817
188 O 0 0.045032188296318054
non O 0 0.011755802668631077
- O 0 0.013539216481149197
European O 0 0.005335496738553047
Jews O 0 0.005366988480091095
( O 0 0.007545622065663338
P O 1 0.9977959394454956
= O 1 0.7210676074028015
0 O 0 0.020630212500691414
. O 0 0.0030461763963103294
08 O 0 0.2131689488887787
) O 0 0.006074849516153336
. O 0 0.006134954281151295

It O 0 0.005413091275840998
occurred O 0 0.015202092938125134
in O 0 0.002599742030724883
15 O 0 0.008334414102137089
. O 0 0.005361688323318958

4 O 0 0.013975316658616066
% O 0 0.004771221894770861
of O 0 0.001221271581016481
52 O 0 0.022635264322161674
Ashkenazi O 1 0.9402444362640381
Israelis O 0 0.017295783385634422
with O 0 0.012680956162512302
familial O 1 0.9999996423721313
cancer B-Disease 1 0.999998927116394
( O 0 0.013130584731698036
P O 1 0.9984416365623474
= O 1 0.6859567165374756
0 O 0 0.022264141589403152
. O 0 0.0036591754760593176
02 O 1 0.9970878958702087
) O 0 0.0032309500966221094
and O 0 0.0007432734128087759
was O 0 0.0012997275916859508
not O 0 0.001376022002659738
detected O 1 0.6406530737876892
in O 0 0.0016328596975654364
51 O 0 0.015278737992048264
non O 0 0.008589963428676128
- O 0 0.009349369443953037
European O 0 0.0036142219323664904
Jews O 0 0.003480536863207817
at O 0 0.003906775265932083
increased O 1 0.7698707580566406
cancer B-Disease 1 0.999998927116394
risk O 1 0.9969182014465332
. O 0 0.005544314626604319

Colorectal B-Disease 1 0.9999986886978149
neoplasia I-Disease 1 0.999983549118042
occurred O 0 0.03768089786171913
personally O 0 0.013161887414753437
or O 0 0.0030368762090802193
in O 0 0.0008842051611281931
the O 0 0.0010721039725467563
families O 0 0.0034673588816076517
of O 0 0.0008080116240307689
13 O 0 0.0040550269186496735
of O 0 0.0011061877012252808
20 O 0 0.00902733113616705
Ashkenazi O 1 0.9984575510025024
I1307K O 1 0.9989792108535767
carriers O 1 0.9596080780029297
, O 0 0.002235276624560356
8 O 0 0.0050569381564855576
of O 0 0.0008094565710052848
whom O 0 0.0027350569143891335
also O 0 0.0010183966951444745
had O 0 0.0014561301795765758
a O 0 0.00396439153701067
personal O 0 0.006351211573928595
or O 0 0.0031340597197413445
family O 0 0.006055567879229784
history O 0 0.0033804592676460743
of O 0 0.003186918795108795
noncolonic O 1 0.9994426369667053
neoplasia B-Disease 1 0.9999526739120483
. O 0 0.011964907869696617

CONCLUSIONS O 0 0.02879890613257885
The O 0 0.006419200915843248
I1307K O 1 0.9965686798095703
APC O 1 0.9998335838317871
variant O 1 0.9982726573944092
may O 0 0.0035575004294514656
represent O 0 0.002678844379261136
a O 0 0.008876006118953228
susceptibility O 1 0.9999912977218628
gene O 1 0.999977707862854
for O 0 0.008656752295792103
colorectal B-Disease 1 0.9999997615814209
, I-Disease 0 0.002580802422016859
or I-Disease 0 0.0027834647335112095
other I-Disease 0 0.0017596285324543715
, I-Disease 0 0.004020705819129944
cancers I-Disease 1 0.9999986886978149
in O 0 0.0033255997113883495
Ashkenazi O 1 0.9980631470680237
Jews O 0 0.004063671920448542
, O 0 0.001145667745731771
and O 0 0.00121403019875288
partially O 0 0.029488615691661835
explains O 0 0.012313607148826122
the O 0 0.0014691350515931845
higher O 0 0.009919878095388412
incidence O 1 0.999850869178772
of O 0 0.017097724601626396
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
in O 0 0.0040774038061499596
European O 0 0.007303158286958933
Israelis O 0 0.019361456856131554
. O 0 0.005314561538398266

Systematic O 0 0.07498331367969513
analysis O 0 0.013279540464282036
of O 0 0.0023933870252221823
coproporphyrinogen O 1 0.9989111423492432
oxidase O 1 0.9999735355377197
gene O 1 0.9999836683273315
defects O 1 0.999913215637207
in O 0 0.004705296829342842
hereditary B-Disease 1 0.9999144077301025
coproporphyria I-Disease 1 0.9976435303688049
and O 0 0.007644119206815958
mutation O 1 0.9999754428863525
update O 0 0.3600587844848633
. O 0 0.006971110124140978

Hereditary B-Disease 1 0.9993093013763428
coproporphyria I-Disease 1 0.9941328167915344
( O 0 0.015173292718827724
HC B-Disease 1 0.9973273277282715
) O 0 0.005347568076103926
is O 0 0.0022197552025318146
an O 0 0.0060361516661942005
acute O 1 0.9999889135360718
hepatic B-Disease 1 0.9999996423721313
porphyria I-Disease 1 0.9999949932098389
with O 0 0.020052552223205566
autosomal O 1 0.999998927116394
dominant O 1 0.7395386099815369
inheritance O 1 0.9976945519447327
caused O 0 0.33491015434265137
by O 0 0.005238699726760387
deficient B-Disease 1 0.9985578656196594
activity I-Disease 0 0.01127528678625822
of I-Disease 0 0.0027677009347826242
coproporphyrinogen I-Disease 1 0.9993442893028259
III I-Disease 1 0.9989296793937683
oxidase I-Disease 1 0.9998742341995239
( O 0 0.01146725658327341
CPO O 1 0.9606633186340332
) O 0 0.00771730300039053
. O 0 0.0066519551910459995

Clinical O 1 0.9962722063064575
manifestations O 0 0.053017739206552505
of O 0 0.001472946722060442
the O 0 0.005171801894903183
disease O 1 0.999995231628418
are O 0 0.0021244871895760298
characterized O 1 0.7885226011276245
by O 0 0.005973335355520248
acute O 1 0.9999330043792725
attacks O 0 0.02858722396194935
of O 0 0.005794175434857607
neurological B-Disease 1 0.9999997615814209
dysfunction I-Disease 1 0.9999966621398926
often O 0 0.008710862137377262
precipitated O 1 0.998649537563324
by O 0 0.00616479804739356
drugs O 1 0.9543806314468384
, O 0 0.002745315432548523
fasting O 1 0.6710665225982666
, O 0 0.0040512243285775185
cyclical O 1 0.9994159936904907
hormonal O 1 0.9999674558639526
changes O 0 0.015869546681642532
, O 0 0.003133669262751937
or O 0 0.08349187672138214
infectious B-Disease 1 0.9999983310699463
diseases I-Disease 1 0.9999896287918091
. O 0 0.010404440574347973

Skin O 1 0.9999873638153076
photosensitivity O 1 0.9999655485153198
may O 0 0.009340278804302216
also O 0 0.0013279528357088566
be O 0 0.001208192901685834
present O 0 0.0034623672254383564
. O 0 0.004632617346942425

The O 0 0.0038235282991081476
seven O 0 0.006224400829523802
exons O 1 0.9952345490455627
, O 0 0.0020482654217630625
the O 0 0.003155562561005354
exon O 1 0.9997332692146301
/ O 1 0.9540936350822449
intron O 1 0.9990047812461853
boundaries O 0 0.005555989686399698
and O 0 0.0008233143016695976
part O 0 0.001435537007637322
of O 0 0.0009395185625180602
3 O 0 0.012641365639865398
noncoding O 1 0.9990724325180054
sequence O 0 0.031901195645332336
of O 0 0.0008331690914928913
the O 0 0.002084729727357626
CPO O 1 0.9967663288116455
gene O 1 0.9993433356285095
were O 0 0.0019089945126324892
systematically O 0 0.021395696327090263
analyzed O 0 0.01990354061126709
by O 0 0.0019193125190213323
an O 0 0.0038583457935601473
exon O 1 0.9996552467346191
- O 0 0.023296140134334564
by O 0 0.005752790719270706
- O 0 0.03886103257536888
exon O 1 0.9941336512565613
denaturing O 1 0.9966245889663696
gradient O 1 0.992694616317749
gel O 1 0.9997794032096863
electrophoresis O 1 0.9996695518493652
( O 0 0.015352108515799046
DGGE O 1 0.998297393321991
) O 0 0.005314962472766638
strategy O 0 0.015574468299746513
followed O 0 0.004057948011904955
by O 0 0.0018176602898165584
direct O 0 0.009375430643558502
sequencing O 1 0.9928552508354187
in O 0 0.001636399538256228
seven O 0 0.004532541148364544
unrelated O 1 0.9920921325683594
heterozygous O 1 0.9999579191207886
HC B-Disease 1 0.9998445510864258
patients O 1 0.9995230436325073
from O 0 0.0036628416273742914
France O 0 0.008173584006726742
, O 0 0.0028363007586449385
Holland O 0 0.1448739618062973
, O 0 0.0018026920733973384
and O 0 0.001252270070835948
Czech O 0 0.013140525668859482
Republic O 0 0.005374206695705652
. O 0 0.006502349860966206

Seven O 0 0.014659480191767216
novel O 0 0.04661349207162857
mutations O 1 0.9999470710754395
and O 0 0.0016445370856672525
two O 0 0.0017799632623791695
new O 0 0.0048610744997859
polymorphisms O 1 0.9997352957725525
were O 0 0.003310621716082096
detected O 1 0.9129447937011719
. O 0 0.007153455633670092

Among O 0 0.006159693468362093
these O 0 0.003577457508072257
mutations O 1 0.999889612197876
two O 0 0.002436381531879306
are O 0 0.002661632839590311
missense O 1 0.9998955726623535
( O 0 0.008671351708471775
G197W O 1 0.997706413269043
, O 0 0.004294306039810181
W427R O 1 0.9973576664924622
) O 0 0.004855002276599407
, O 0 0.0010871740523725748
two O 0 0.001479132566601038
are O 0 0.0011394514003768563
nonsense O 0 0.30403459072113037
( O 0 0.007057286333292723
Q306X O 1 0.9969443678855896
, O 0 0.003999580629169941
Q385X O 1 0.9986353516578674
) O 0 0.003603943856433034
, O 0 0.0009752491605468094
two O 0 0.0011294010328128934
are O 0 0.0008380045183002949
small O 0 0.006279146298766136
deletions O 1 0.9991631507873535
( O 0 0.008005194365978241
662de14bp O 1 0.9958962202072144
; O 0 0.007338729687035084
1168del3bp O 1 0.9740227460861206
removing O 0 0.03499537706375122
a O 0 0.008817999623715878
glycine O 1 0.9922145009040833
at O 0 0.0037251103203743696
position O 0 0.004786697681993246
390 O 1 0.6599915027618408
) O 0 0.003751405281946063
, O 0 0.0010321425506845117
and O 0 0.0006325400318019092
one O 0 0.0011258089216426015
is O 0 0.001480995211750269
a O 0 0.009989047423005104
splicing O 1 0.9999192953109741
mutation O 1 0.99991774559021
( O 0 0.011016148142516613
IVS1 O 1 0.9989797472953796
- O 0 0.07096808403730392
15c O 1 0.9973722696304321
- O 0 0.3939143419265747
- O 1 0.5179038047790527
> O 1 0.9997491240501404
g O 1 0.9927461743354797
) O 0 0.0030815601348876953
which O 0 0.001165445544756949
creates O 0 0.017189020290970802
a O 0 0.00491701066493988
new O 0 0.005208352115005255
acceptor O 1 0.9994971752166748
splice O 1 0.998073935508728
site O 0 0.016750896349549294
. O 0 0.007165017072111368

The O 0 0.007581670302897692
pathological O 1 0.848863959312439
significance O 0 0.006431038491427898
of O 0 0.0007663738215342164
the O 0 0.0012892041122540832
point O 0 0.007822495885193348
mutations O 1 0.9999951124191284
G197W O 1 0.9985477328300476
, O 0 0.004368857480585575
W427R O 1 0.997809112071991
, O 0 0.0016180860111489892
and O 0 0.0006297376239672303
the O 0 0.00129454315174371
in O 0 0.002479991875588894
- O 0 0.027350541204214096
frame O 1 0.5204102396965027
deletion O 1 0.9998910427093506
390delGly O 1 0.9904198050498962
were O 0 0.0014362656511366367
assessed O 0 0.011262270621955395
by O 0 0.0012402950087562203
their O 0 0.0012805459555238485
respective O 0 0.008039182052016258
expression O 0 0.02003081701695919
in O 0 0.0014296963345259428
a O 0 0.006708255968987942
prokaryotic O 1 0.9959022402763367
system O 0 0.012058038264513016
using O 0 0.005916759371757507
site O 0 0.0075382450595498085
- O 0 0.017730941995978355
directed O 0 0.01741979829967022
mutagenesis O 1 0.9878338575363159
. O 0 0.009884712286293507

These O 0 0.010966023430228233
mutations O 1 0.9999502897262573
resulted O 0 0.02336098626255989
in O 0 0.0014001574600115418
the O 0 0.0014456764329224825
absence O 0 0.017957402393221855
or O 0 0.003431488061323762
a O 0 0.0053890845738351345
dramatic O 0 0.019459938630461693
decrease O 0 0.02819904498755932
of O 0 0.001945714931935072
CPO O 1 0.9653043746948242
activity O 0 0.026245348155498505
. O 0 0.006253692787140608

The O 0 0.0035439380444586277
two O 0 0.004276792984455824
polymorphisms O 1 0.9992673993110657
were O 0 0.0026863357052206993
localized O 1 0.9978203773498535
in O 0 0.0035282988101243973
noncoding O 1 0.9992709755897522
part O 0 0.00213035405613482
of O 0 0.0007799719460308552
the O 0 0.002748283091932535
gene O 1 0.9999469518661499
1 O 0 0.007869063876569271
) O 0 0.0033724328968673944
a O 0 0.010188004933297634
C O 1 0.9985955357551575
/ O 1 0.9631351828575134
G O 1 0.9986833930015564
polymorphism O 1 0.9958970546722412
in O 0 0.0020692823454737663
the O 0 0.002751890104264021
promotor O 1 0.9994207620620728
region O 0 0.006086965557187796
, O 0 0.0020080492831766605
142 O 0 0.04383896663784981
bp O 0 0.07342048734426498
upstream O 0 0.03404802456498146
from O 0 0.0016935300081968307
the O 0 0.002435757778584957
transcriptional O 1 0.996727705001831
initiation O 1 0.9067354798316956
site O 0 0.010561246424913406
( O 0 0.007432976737618446
- O 0 0.1984333097934723
142C O 1 0.9997593760490417
/ O 1 0.9972584247589111
G O 1 0.9995157718658447
) O 0 0.0044174701906740665
, O 0 0.0012856789398938417
and O 0 0.0011944255093112588
2 O 0 0.006766779348254204
) O 0 0.0030501005239784718
a O 0 0.00522565096616745
6 O 0 0.012539989314973354
bp O 0 0.3882160484790802
deletion O 1 0.9989822506904602
polymorphism O 1 0.994515061378479
in O 0 0.001617848058231175
the O 0 0.0017123462166637182
3 O 0 0.011767768301069736
noncoding O 1 0.9989550113677979
part O 0 0.002015460981056094
of O 0 0.0007400582544505596
the O 0 0.0023716615978628397
CPO O 1 0.9974683523178101
gene O 1 0.999806821346283
, O 0 0.004127547610551119
574 O 1 0.812999427318573
bp O 0 0.10950939357280731
downstream O 0 0.03671873360872269
of O 0 0.0010230022016912699
the O 0 0.0010899854823946953
last O 0 0.002397596137598157
base O 0 0.003739373991265893
of O 0 0.0007753935060463846
the O 0 0.002044869353994727
normal O 0 0.06936150044202805
termination O 1 0.9974240064620972
codon O 1 0.9951311349868774
( O 0 0.011623704805970192
+ O 1 0.9777489900588989
574 O 1 0.9657834768295288
delATTCTT O 1 0.9896165132522583
) O 0 0.00895821861922741
. O 0 0.006287771742790937

Five O 0 0.02057916298508644
intragenic O 1 0.9917799830436707
dimorphisms O 1 0.9656874537467957
are O 0 0.001712715602479875
now O 0 0.002363374689593911
well O 0 0.0023089840542525053
characterized O 0 0.037004172801971436
and O 0 0.0010061584180220962
the O 0 0.0013459359761327505
high O 0 0.004574887454509735
degree O 0 0.007741143461316824
of O 0 0.0020816936157643795
allelic O 1 0.9997754693031311
heterogeneity O 1 0.9987592697143555
in O 0 0.004571729805320501
HC B-Disease 1 0.9950127005577087
is O 0 0.002446275670081377
demonstrated O 0 0.00892544910311699
with O 0 0.0016422165790572762
seven O 0 0.0018064238829538226
new O 0 0.0019003446213901043
different O 0 0.0035898922942578793
mutations O 1 0.999987006187439
making O 0 0.003391169011592865
a O 0 0.002717374823987484
total O 0 0.0017048799199983478
of O 0 0.001315825735218823
nineteen O 0 0.032579660415649414
CPO O 1 0.9981922507286072
gene B-Disease 1 0.9999873638153076
defects I-Disease 1 0.9999486207962036
reported O 0 0.014019371010363102
so O 0 0.0027483850717544556
far O 0 0.0030233843717724085
. O 0 0.0024258324410766363
. O 0 0.004971849266439676

Coincidence O 0 0.051042862236499786
of O 0 0.0016248564934358
two O 0 0.0026419402565807104
novel O 0 0.023419126868247986
arylsulfatase O 1 0.9735755324363708
A O 0 0.020394859835505486
alleles O 1 0.9996589422225952
and O 0 0.0057956865057349205
mutation O 1 0.9999688863754272
459 O 1 0.9865825772285461
+ O 1 0.9969895482063293
1G O 1 0.9995933175086975
> O 1 0.9914105534553528
A O 0 0.00915184710174799
within O 0 0.002245516050606966
a O 0 0.004667653702199459
family O 0 0.009013640694320202
with O 0 0.007415845990180969
metachromatic B-Disease 1 0.9999524354934692
leukodystrophy I-Disease 1 0.9999918937683105
: O 0 0.008836125954985619
molecular O 1 0.985129714012146
basis O 0 0.0033228856045752764
of O 0 0.0017166627803817391
phenotypic O 1 0.9989618062973022
heterogeneity O 1 0.9960638880729675
. O 0 0.008624056354165077

In O 0 0.005299599375575781
a O 0 0.0078115565702319145
family O 0 0.01032400131225586
with O 0 0.003100759582594037
three O 0 0.004139755852520466
siblings O 1 0.9660539627075195
, O 0 0.0015215033199638128
one O 0 0.0019463688367977738
developed O 0 0.013086036778986454
classical O 0 0.012573612853884697
late O 0 0.0177106074988842
infantile O 1 0.999985933303833
metachromatic B-Disease 1 0.9999237060546875
leukodystrophy I-Disease 1 0.9999895095825195
( O 0 0.022846676409244537
MLD B-Disease 1 0.9999582767486572
) O 0 0.00760418176651001
, O 0 0.003774279961362481
fatal O 1 0.9998809099197388
at O 0 0.0038830190896987915
age O 0 0.0066032917238771915
5 O 0 0.006343265995383263
years O 0 0.001986062852665782
, O 0 0.0013195894425734878
with O 0 0.004345630295574665
deficient O 1 0.9998958110809326
arylsulfatase O 1 0.9977455735206604
A O 0 0.018691854551434517
( O 0 0.01091539952903986
ARSA O 1 0.9998370409011841
) O 0 0.005322661250829697
activity O 0 0.006781762465834618
and O 0 0.0012399229453876615
increased O 0 0.013209576718509197
galactosylsulfatide O 1 0.9983243346214294
( O 0 0.014605756849050522
GS O 1 0.9999511241912842
) O 0 0.01357108261436224
excretion O 1 0.998806357383728
. O 0 0.009565059095621109

The O 0 0.0032603382132947445
two O 0 0.0021715103648602962
other O 0 0.0020299232564866543
siblings O 1 0.9197726249694824
, O 0 0.0024857453536242247
apparently O 0 0.014298618771135807
healthy O 1 0.8320418000221252
at O 0 0.003296687500551343
12 O 0 0.006267903372645378
( O 0 0.004750533029437065
1 O 0 0.01309721264988184
/ O 1 0.8044838905334473
2 O 0 0.009734163992106915
) O 0 0.0027746111154556274
and O 0 0.0009627618128433824
15 O 0 0.003965169191360474
years O 0 0.0021600481122732162
, O 0 0.0012655267491936684
respectively O 0 0.004142142832279205
, O 0 0.0010782773606479168
and O 0 0.0007637543021701276
their O 0 0.0017974268412217498
father O 0 0.009779579937458038
, O 0 0.002170564141124487
apparently O 0 0.01741069182753563
healthy O 1 0.9522168636322021
as O 0 0.0013869927497580647
well O 0 0.0015117847360670567
, O 0 0.0013864870416000485
presented O 0 0.009183309972286224
ARSA O 1 0.9998537302017212
and O 0 0.004733355715870857
GS O 1 0.9998961687088013
values O 0 0.004999935626983643
within O 0 0.001548830303363502
the O 0 0.0007987432181835175
range O 0 0.004062949679791927
of O 0 0.0038459307979792356
MLD B-Disease 1 0.9999823570251465
patients O 1 0.999549925327301
. O 0 0.009208687581121922

Mutation O 1 0.9998834133148193
screening O 0 0.2912137508392334
and O 0 0.002792773302644491
sequence O 0 0.09382932633161545
analysis O 0 0.015557581558823586
disclosed O 0 0.014834838919341564
the O 0 0.001266972627490759
involvement O 0 0.010518113151192665
of O 0 0.0007309563225135207
three O 0 0.0024652034044265747
different O 0 0.0065146032720804214
ARSA O 1 0.9999701976776123
mutations O 1 0.9999232292175293
being O 0 0.002469263970851898
the O 0 0.0016818060539662838
molecular O 1 0.9926621913909912
basis O 0 0.0033208047971129417
of O 0 0.001787371700629592
intrafamilial O 1 0.9925863146781921
phenotypic O 1 0.9984363913536072
heterogeneity O 1 0.9968072175979614
. O 0 0.007943158969283104

The O 0 0.007784675341099501
late O 0 0.02671624906361103
infantile O 1 0.9999966621398926
patient O 1 0.9998514652252197
inherited O 1 0.9981897473335266
from O 0 0.0020632315427064896
his O 0 0.0029422701336443424
mother O 0 0.01162273995578289
the O 0 0.002500537782907486
frequent O 0 0.09640991687774658
0 O 0 0.03587501868605614
- O 0 0.029231367632746696
type O 1 0.9181385636329651
mutation O 1 0.9999234676361084
459 O 1 0.9830601811408997
+ O 1 0.9955472946166992
1G O 1 0.9990957975387573
> O 1 0.9963380098342896
A O 0 0.015633489936590195
, O 0 0.0018187144305557013
and O 0 0.0009420072310604155
from O 0 0.0017246430506929755
his O 0 0.0030032650101929903
father O 0 0.0077410670928657055
a O 0 0.006465856451541185
novel O 0 0.015339643694460392
, O 0 0.0014788939151912928
single O 0 0.01158176176249981
basepair O 1 0.985514760017395
microdeletion O 1 0.8315140604972839
of O 0 0.0024501169100403786
guanine O 1 0.987770676612854
at O 0 0.005290081724524498
nucleotide O 1 0.9974066615104675
7 O 0 0.01005904283374548
in O 0 0.003734456840902567
exon O 1 0.9987138509750366
1 O 0 0.014972514472901821
( O 0 0.008279310539364815
7delG O 1 0.9940773248672485
) O 0 0.006647249683737755
. O 0 0.005583885125815868

The O 0 0.0035761489998549223
two O 0 0.00557326665148139
clinically O 1 0.9987371563911438
unaffected O 1 0.9622644782066345
siblings O 0 0.04729444906115532
carried O 0 0.005390899255871773
the O 0 0.0033058205153793097
maternal O 1 0.9993069171905518
mutation O 1 0.9999808073043823
459 O 1 0.9958343505859375
+ O 1 0.9983781576156616
1G O 1 0.9997156262397766
> O 1 0.9975060820579529
A O 0 0.009695817716419697
and O 0 0.0010111525189131498
, O 0 0.0008947414462454617
on O 0 0.0009951057145372033
their O 0 0.0028967971447855234
paternal O 1 0.9987653493881226
allele O 1 0.9998557567596436
, O 0 0.002032846910879016
a O 0 0.005648535676300526
novel O 0 0.022960804402828217
cytosine O 1 0.9961028099060059
to O 0 0.0041288952343165874
thymidine O 1 0.997936487197876
transition O 0 0.02282935008406639
at O 0 0.0051209270022809505
nucleotide O 1 0.9980283379554749
2435 O 1 0.9958078861236572
in O 0 0.006486376281827688
exon O 1 0.9989703893661499
8 O 0 0.010793589986860752
, O 0 0.0016799498116597533
resulting O 0 0.023924101144075394
in O 0 0.0018861818825826049
substitution O 0 0.16019245982170105
of O 0 0.0025990286376327276
alanine O 1 0.9971914887428284
464 O 1 0.916986882686615
by O 0 0.008857546374201775
valine O 1 0.9983059167861938
( O 0 0.010683240368962288
A464V O 1 0.9951646327972412
) O 0 0.00808661337941885
. O 0 0.005628522019833326

The O 0 0.006535721942782402
fathers O 0 0.05900222063064575
genotype O 1 0.9994531273841858
thus O 0 0.010423806495964527
was O 0 0.0057977610267698765
7delG O 1 0.9985744953155518
/ O 1 0.9155116677284241
A464V O 1 0.9533246755599976
. O 0 0.010129551403224468

Mutation O 1 0.9999812841415405
A464V O 1 0.991229772567749
was O 0 0.0027827213052660227
not O 0 0.0010231477208435535
found O 0 0.0030285478569567204
in O 0 0.0016513388836756349
18 O 0 0.009628716856241226
unrelated O 1 0.9993414282798767
MLD B-Disease 1 0.9999881982803345
patients O 1 0.9993566870689392
and O 0 0.002000849461182952
50 O 0 0.006509645376354456
controls O 0 0.030532848089933395
. O 0 0.006640773266553879

A464V O 1 0.9366641640663147
, O 0 0.0032616136595606804
although O 0 0.003171037882566452
clearly O 0 0.008642793633043766
modifying O 1 0.9934024214744568
ARSA O 1 0.999736487865448
and O 0 0.007408166769891977
GS O 1 0.9999639987945557
levels O 0 0.025134099647402763
, O 0 0.0016938757617026567
apparently O 0 0.010633912868797779
bears O 0 0.011388606391847134
little O 0 0.0051000770181417465
significance O 0 0.006354131270200014
for O 0 0.0031991559080779552
clinical O 1 0.998848557472229
manifestation O 1 0.8676780462265015
of O 0 0.004366022534668446
MLD B-Disease 1 0.9999206066131592
, O 0 0.004602025728672743
mimicking O 1 0.943045437335968
the O 0 0.0039478568360209465
frequent O 0 0.29595109820365906
ARSA O 1 0.9994775652885437
pseudodeficiency O 1 0.9949659705162048
allele O 1 0.9992544054985046
. O 0 0.01048380695283413

Our O 0 0.007507482077926397
results O 0 0.009313183836638927
demonstrate O 0 0.006568715441972017
that O 0 0.0008556992397643626
in O 0 0.0010209584143012762
certain O 0 0.0065335859544575214
genetic O 1 0.9999799728393555
conditions O 0 0.1942361295223236
MLD B-Disease 1 0.9999693632125854
- O 0 0.03671421855688095
like O 0 0.015884490683674812
ARSA O 1 0.9998841285705566
and O 0 0.0049863276071846485
GS O 1 0.9999312162399292
values O 0 0.006458802614361048
need O 0 0.00285263336263597
not O 0 0.000723091303370893
be O 0 0.0012153161223977804
paralleled O 1 0.7300422787666321
by O 0 0.00946749560534954
clinical O 1 0.9999924898147583
disease O 1 0.9999954700469971
, O 0 0.0018731190357357264
a O 0 0.004331243224442005
finding O 0 0.009122653864324093
with O 0 0.003577530849725008
serious O 1 0.7883135676383972
diagnostic O 1 0.9995239973068237
and O 0 0.004650142043828964
prognostic O 1 0.9998733997344971
implications O 0 0.34550899267196655
. O 0 0.008039972744882107

Moreover O 0 0.03050536848604679
, O 0 0.002854321151971817
further O 0 0.010570437647402287
ARSA O 1 0.9996849298477173
alleles O 1 0.9999085664749146
functionally O 1 0.9917523264884949
similar O 0 0.008146687410771847
to O 0 0.002422093413770199
A464V O 1 0.9954683780670166
might O 0 0.0059563941322267056
exist O 0 0.0033568430226296186
which O 0 0.0008153788512572646
, O 0 0.0006708333385176957
together O 0 0.002370799658820033
with O 0 0.0029480597004294395
0 O 0 0.20920702815055847
- O 0 0.2155379354953766
type O 1 0.9983651041984558
mutations O 1 0.9999947547912598
, O 0 0.002778676338493824
may O 0 0.008387217298150063
cause O 1 0.9962013363838196
pathological O 1 0.9997966885566711
ARSA O 1 0.9998070597648621
and O 0 0.00749222282320261
GS O 1 0.9999730587005615
levels O 0 0.019820252433419228
, O 0 0.001155406585894525
but O 0 0.001270016422495246
not O 0 0.00233101355843246
clinical O 1 0.9998897314071655
outbreak O 1 0.9985333681106567
of O 0 0.0016129346331581473
the O 0 0.005646564997732639
disease O 1 0.9999963045120239
. O 0 0.004110969603061676
. O 0 0.0050073182210326195

Human O 0 0.09783149510622025
MLH1 O 1 0.9997963309288025
deficiency O 1 0.9999969005584717
predisposes O 1 0.9986826777458191
to O 0 0.012849779799580574
hematological B-Disease 1 0.999961256980896
malignancy I-Disease 1 0.9999912977218628
and O 0 0.010820305906236172
neurofibromatosis B-Disease 1 0.9999982118606567
type I-Disease 1 0.9177424907684326
1 I-Disease 0 0.012052909471094608
. O 0 0.0054982127621769905

Heterozygous O 1 0.9991201758384705
germ O 1 0.9987329840660095
- O 0 0.03399261087179184
line O 0 0.018752817064523697
mutations O 1 0.9999499320983887
in O 0 0.0015235119499266148
the O 0 0.002661782316863537
DNA O 1 0.9998094439506531
mismatch O 1 0.9996259212493896
repair O 1 0.9968716502189636
genes O 1 0.9984057545661926
lead O 0 0.014970776624977589
to O 0 0.005184169393032789
hereditary B-Disease 1 0.9999814033508301
nonpolyposis I-Disease 1 0.999994158744812
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
. O 0 0.00977136380970478

The O 0 0.018386760726571083
disease O 1 0.9999940395355225
susceptibility O 1 0.9999538660049438
of O 0 0.0018238392658531666
individuals O 0 0.004408984910696745
who O 0 0.0018299206858500838
constitutionally O 0 0.02531125210225582
lack O 0 0.008276719599962234
both O 0 0.002639773767441511
wild O 0 0.15695984661579132
- O 0 0.18640080094337463
type O 1 0.9958012700080872
alleles O 1 0.9999446868896484
is O 0 0.003611986991018057
unknown O 0 0.018162304535508156
. O 0 0.006274374667555094

We O 0 0.0026675285771489143
have O 0 0.0012660276843234897
identified O 0 0.0062615592032670975
three O 0 0.0025627180002629757
offspring O 1 0.8451706767082214
in O 0 0.0017748448299244046
a O 0 0.01203292328864336
hereditary B-Disease 1 0.9999939203262329
nonpolyposis I-Disease 1 0.9999963045120239
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
family O 0 0.01840651035308838
who O 0 0.004115896299481392
developed O 1 0.850074052810669
hematological B-Disease 1 0.9999958276748657
malignancy I-Disease 1 0.9999958276748657
at O 0 0.003021766897290945
a O 0 0.004092568531632423
very O 0 0.0026773579884320498
early O 0 0.004696144722402096
age O 0 0.005860577803105116
, O 0 0.0011968360049650073
and O 0 0.0008751540444791317
at O 0 0.0019584144465625286
least O 0 0.002523797331377864
two O 0 0.0010949794668704271
of O 0 0.0006365478620864451
them O 0 0.0008854260086081922
displayed O 0 0.003963009919971228
signs O 0 0.012804640457034111
of O 0 0.0037951262202113867
neurofibromatosis B-Disease 1 0.9999986886978149
type I-Disease 1 0.9293578863143921
1 I-Disease 0 0.012166456319391727
( O 0 0.012632398866117
NF1 B-Disease 1 0.9999493360519409
) O 0 0.008174290880560875
. O 0 0.0047910092398524284

DNA O 1 0.985151469707489
sequence O 0 0.06472422927618027
analysis O 0 0.017435196787118912
and O 0 0.0038603772409260273
allele O 1 0.9999489784240723
- O 0 0.01941569149494171
specific O 0 0.01147015392780304
amplification O 1 0.9958204030990601
in O 0 0.0014932651538401842
two O 0 0.0020191899966448545
siblings O 0 0.4607942998409271
revealed O 0 0.015486437827348709
a O 0 0.013238509185612202
homozygous O 1 0.9997789263725281
MLH1 O 1 0.9998946189880371
mutation O 1 0.9999121427536011
( O 0 0.01257326826453209
C676T O 1 0.9985862970352173
- O 0 0.2908225655555725
- O 0 0.1454034447669983
> O 1 0.998434841632843
Arg226Stop O 1 0.9949308037757874
) O 0 0.008380782790482044
. O 0 0.00601059477776289

Thus O 0 0.01263346429914236
, O 0 0.002816760679706931
a O 0 0.013351215980947018
homozygous O 1 0.9998006224632263
germ O 1 0.9995470643043518
- O 0 0.03547215089201927
line O 0 0.02419247478246689
MLH1 O 1 0.9998705387115479
mutation O 1 0.9999531507492065
and O 0 0.00335606443695724
consequent O 1 0.9984123706817627
mismatch O 1 0.9999656677246094
repair O 1 0.9999347925186157
deficiency O 1 0.9999977350234985
results O 0 0.011356793344020844
in O 0 0.0018570449901744723
a O 0 0.01567510887980461
mutator O 1 0.9999773502349854
phenotype O 1 0.9999918937683105
characterized O 1 0.9354983568191528
by O 0 0.0158182792365551
leukemia B-Disease 1 0.9999997615814209
and O 0 0.00521383760496974
/ O 1 0.9980114698410034
or O 0 0.1950935274362564
lymphoma B-Disease 1 0.9999998807907104
associated O 0 0.03767768666148186
with O 0 0.012866229750216007
neurofibromatosis B-Disease 1 0.9999994039535522
type I-Disease 1 0.9740013480186462
1 I-Disease 0 0.008279873989522457
. O 0 0.002541734604164958
. O 0 0.004188846331089735

Missense O 1 0.9996517896652222
mutations O 1 0.9998916387557983
in O 0 0.002079142490401864
the O 0 0.001018555834889412
most O 0 0.0009224279783666134
ancient O 0 0.003723271656781435
residues O 0 0.20961099863052368
of O 0 0.0009010435896925628
the O 0 0.003006097162142396
PAX6 O 1 0.9999226331710815
paired O 1 0.8442314863204956
domain O 0 0.07434485852718353
underlie O 1 0.9632657170295715
a O 0 0.006224085111171007
spectrum O 0 0.026533640921115875
of O 0 0.0023950280155986547
human O 1 0.9916919469833374
congenital B-Disease 1 1.0
eye I-Disease 1 0.9997667670249939
malformations I-Disease 1 0.9999760389328003
. O 0 0.010772746987640858

Mutations O 1 0.9988982677459717
of O 0 0.0015781914116814733
the O 0 0.0019108825363218784
human O 0 0.02634745091199875
PAX6 O 1 0.9999765157699585
gene O 1 0.9999417066574097
underlie O 1 0.9991006851196289
aniridia B-Disease 1 0.9995169639587402
( O 0 0.02295495942234993
congenital B-Disease 1 0.9999997615814209
absence I-Disease 0 0.022503472864627838
of I-Disease 0 0.0010356983402743936
the I-Disease 0 0.0029568832833319902
iris I-Disease 1 0.9999067783355713
) O 0 0.004531450569629669
, O 0 0.0012180053163319826
a O 0 0.004622957669198513
rare O 0 0.05397430434823036
dominant O 1 0.9750858545303345
malformation B-Disease 1 0.999984622001648
of I-Disease 0 0.0020078534726053476
the I-Disease 0 0.003953604027628899
eye I-Disease 1 0.991278350353241
. O 0 0.00706679280847311

The O 0 0.0044840662740170956
spectrum O 0 0.03288470581173897
of O 0 0.004185518249869347
PAX6 O 1 0.9999696016311646
mutations O 1 0.9999871253967285
in O 0 0.007074291817843914
aniridia B-Disease 1 0.9999511241912842
patients O 1 0.9997351765632629
is O 0 0.002568405121564865
highly O 0 0.01019733864814043
biased O 0 0.029248706996440887
, O 0 0.001453540869988501
with O 0 0.0021515092812478542
92 O 0 0.019052177667617798
% O 0 0.002684680512174964
of O 0 0.0006053849356248975
all O 0 0.0009029381908476353
reported O 0 0.015568936243653297
mutations O 1 0.999992847442627
leading O 0 0.008818179368972778
to O 0 0.0027953865937888622
premature O 1 0.9982605576515198
truncation O 1 0.9939916729927063
of O 0 0.0012573172571137547
the O 0 0.0027359556406736374
protein O 1 0.9997838139533997
( O 0 0.005367978475987911
nonsense O 0 0.16443176567554474
, O 0 0.002835101680830121
splicing O 1 0.9994624257087708
, O 0 0.003969789482653141
insertions O 1 0.9983362555503845
and O 0 0.0034320950508117676
deletions O 1 0.9997077584266663
) O 0 0.004168907646089792
and O 0 0.0011940475087612867
just O 0 0.002509851474314928
2 O 0 0.005744399037212133
% O 0 0.0042740097269415855
leading O 0 0.004825958050787449
to O 0 0.001086242264136672
substitution O 0 0.04223864525556564
of O 0 0.0007914885645732284
one O 0 0.0023553117644041777
amino O 1 0.9985883831977844
acid O 1 0.997868537902832
by O 0 0.002640611259266734
another O 0 0.008825571276247501
( O 0 0.009238327853381634
missense O 1 0.9997590184211731
) O 0 0.008713316172361374
. O 0 0.006496124435216188

The O 0 0.004492750391364098
extraordinary O 0 0.009623866528272629
conservation O 0 0.008635837584733963
of O 0 0.0011680283350870013
the O 0 0.0041965944692492485
PAX6 O 1 0.9999423027038574
protein O 1 0.9979069232940674
at O 0 0.002555694431066513
the O 0 0.002220391295850277
amino O 1 0.9936537742614746
acid O 1 0.9952836632728577
level O 0 0.005517499055713415
amongst O 0 0.009672097861766815
vertebrates O 1 0.9447435140609741
predicts O 0 0.08983615785837173
that O 0 0.0037700205575674772
pathological O 1 0.9997754693031311
missense O 1 0.9999771118164062
mutations O 1 0.9999833106994629
should O 0 0.002315392717719078
in O 0 0.0009664328536018729
fact O 0 0.0023146988824009895
be O 0 0.0012438518460839987
common O 0 0.012845920398831367
even O 0 0.0025065382942557335
though O 0 0.0022769940551370382
they O 0 0.000667656073346734
are O 0 0.0006397191900759935
hardly O 0 0.007959660142660141
ever O 0 0.0027669903356581926
seen O 0 0.004985405597835779
in O 0 0.005030210595577955
aniridia B-Disease 1 0.9999154806137085
patients O 1 0.9991099238395691
. O 0 0.00906846858561039

This O 0 0.0038980338722467422
indicates O 0 0.013855814933776855
that O 0 0.0010907889809459448
there O 0 0.0009813000215217471
is O 0 0.001405218499712646
a O 0 0.004796953406184912
heavy O 0 0.024105137214064598
ascertainment O 1 0.9992098808288574
bias O 0 0.0948251485824585
in O 0 0.0011862193932756782
the O 0 0.0010753318201750517
selection O 0 0.007254050113260746
of O 0 0.0017670062370598316
patients O 1 0.9998177886009216
for O 0 0.007091735489666462
PAX6 O 1 0.9999957084655762
mutation O 1 0.9999939203262329
analysis O 0 0.01552808377891779
and O 0 0.0005991419311612844
that O 0 0.0007401377079077065
the O 0 0.0020509350579231977
missing O 0 0.11228519678115845
PAX6 O 1 0.9999797344207764
missense O 1 0.9999408721923828
mutations O 1 0.9999535083770752
frequently O 0 0.010768890380859375
may O 0 0.010106636211276054
underlie O 1 0.9989431500434875
phenotypes O 1 0.9998146891593933
distinct O 0 0.023437509313225746
from O 0 0.0042036049999296665
textbook O 1 0.8858938813209534
aniridia B-Disease 1 0.9941364526748657
. O 0 0.011107385158538818

Here O 0 0.0029831037390977144
we O 0 0.0009840488201007247
present O 0 0.0018990897806361318
four O 0 0.0030868614558130503
novel O 0 0.09636954218149185
PAX6 O 1 0.9999797344207764
missense O 1 0.9999755620956421
mutations O 1 0.9999860525131226
, O 0 0.002033721189945936
two O 0 0.0016054483130574226
in O 0 0.0013178098015487194
association O 0 0.006190167274326086
with O 0 0.007364026736468077
atypical O 1 0.9999358654022217
phenotypes O 1 0.9999630451202393
ectopia B-Disease 1 0.9986478686332703
pupillae I-Disease 1 0.9953206181526184
( O 0 0.006094158627092838
displaced B-Disease 0 0.025300538167357445
pupils I-Disease 0 0.020373817533254623
) O 0 0.005009357817471027
and O 0 0.0067779384553432465
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999722242355347
( O 0 0.006821705028414726
searching B-Disease 0 0.028196880593895912
gaze I-Disease 1 0.9185118675231934
) O 0 0.003955948166549206
, O 0 0.001057427958585322
and O 0 0.000684242753777653
two O 0 0.0014317379100248218
in O 0 0.0013360640732571483
association O 0 0.004049756098538637
with O 0 0.0017626498593017459
more O 0 0.0022871994879096746
recognizable O 1 0.9512539505958557
aniridia B-Disease 1 0.9994681477546692
phenotypes O 1 0.9998149275779724
. O 0 0.01016264222562313

Strikingly O 0 0.10330307483673096
, O 0 0.002129475586116314
all O 0 0.0010423840722069144
four O 0 0.005037229508161545
mutations O 1 0.9999765157699585
are O 0 0.0010459242621436715
located O 0 0.002388704102486372
within O 0 0.0023972908966243267
the O 0 0.003772589610889554
PAX6 O 1 0.9999207258224487
paired O 1 0.8728804588317871
domain O 0 0.029560694471001625
and O 0 0.001559721538797021
affect O 0 0.03261548653244972
amino O 1 0.9974095225334167
acids O 1 0.991913914680481
which O 0 0.0011024499544873834
are O 0 0.0006106927176006138
highly O 0 0.007621833588927984
conserved O 0 0.2123073935508728
in O 0 0.0009631660068407655
all O 0 0.0007918020128272474
known O 0 0.007759522646665573
paired O 1 0.9348910450935364
domain O 0 0.33906036615371704
proteins O 1 0.9921980500221252
. O 0 0.008194785565137863

Our O 0 0.00652575958520174
results O 0 0.009862643666565418
support O 0 0.0027171229012310505
the O 0 0.001627350808121264
hypothesis O 1 0.7100867033004761
that O 0 0.0009500449523329735
the O 0 0.001031125313602388
under O 0 0.002010595751926303
- O 0 0.007407556753605604
representation O 0 0.00513267470523715
of O 0 0.0026560768019407988
missense O 1 0.9999849796295166
mutations O 1 0.9999868869781494
is O 0 0.002879692241549492
caused O 0 0.08305789530277252
by O 0 0.004365856759250164
ascertainment O 1 0.9998372793197632
bias O 1 0.532953143119812
and O 0 0.0012567783705890179
suggest O 0 0.00630991393700242
that O 0 0.0008265126962214708
a O 0 0.0034194071777164936
substantial O 0 0.00991917122155428
burden O 0 0.03016001731157303
of O 0 0.004957416094839573
PAX6 B-Disease 1 0.9999972581863403
- I-Disease 1 0.9273710250854492
related I-Disease 1 0.9446737170219421
disease I-Disease 1 0.9999932050704956
remains O 0 0.0056421756744384766
to O 0 0.001197999226860702
be O 0 0.0014714732533320785
uncovered O 0 0.028520597144961357
. O 0 0.003244769526645541
. O 0 0.0056835561990737915

The O 0 0.006943377200514078
chromosomal O 1 0.9999306201934814
order O 0 0.0048139700666069984
of O 0 0.001876693801023066
genes O 1 0.9996199607849121
controlling O 0 0.3205067217350006
the O 0 0.0023452364839613438
major O 0 0.015072314999997616
histocompatibility O 1 0.9999653100967407
complex O 0 0.020302342250943184
, O 0 0.003494510194286704
properdin O 1 0.9982336759567261
factor O 1 0.924281895160675
B O 1 0.9800612926483154
, O 0 0.0023635432589799166
and O 0 0.0033530485816299915
deficiency B-Disease 1 0.9999982118606567
of I-Disease 0 0.0010420484468340874
the I-Disease 0 0.001250710804015398
second I-Disease 0 0.005615526810288429
component I-Disease 0 0.027123605832457542
of I-Disease 0 0.0024037982802838087
complement I-Disease 0 0.24649596214294434
. O 0 0.006431725341826677

The O 0 0.004534413106739521
relationship O 0 0.009702582843601704
of O 0 0.0007090065628290176
the O 0 0.0023850391153246164
genes O 1 0.9998462200164795
coding O 1 0.9993661046028137
for O 0 0.004542470443993807
HLA O 1 0.9999551773071289
to O 0 0.0018906558398157358
those O 0 0.0019534050952643156
coding O 1 0.9972624778747559
for O 0 0.003290119580924511
properdin O 1 0.9983009696006775
Factor O 1 0.9117835164070129
B O 1 0.9936022162437439
allotypes O 1 0.9841317534446716
and O 0 0.0014596517430618405
for O 0 0.004226266406476498
deficiency B-Disease 1 0.9999974966049194
of I-Disease 0 0.0009927189676091075
the I-Disease 0 0.0009214740130119026
second I-Disease 0 0.0032470035366714
component I-Disease 0 0.020376216620206833
of I-Disease 0 0.0013456251472234726
complement I-Disease 1 0.9008041620254517
( O 0 0.009150809608399868
C2 O 1 0.999982476234436
) O 0 0.004336065147072077
was O 0 0.001559606404043734
studied O 0 0.003387071657925844
in O 0 0.0010649946052581072
families O 0 0.0036649724934250116
of O 0 0.0020903171971440315
patients O 1 0.9998539686203003
with O 0 0.027801664546132088
connective O 1 0.9999997615814209
tissue O 1 0.9999988079071045
disorders O 1 0.9999916553497314
. O 0 0.009406394325196743

Patients O 1 0.9946362376213074
were O 0 0.0015531249810010195
selected O 0 0.003101266687735915
because O 0 0.0022543224040418863
they O 0 0.0007528336136601865
were O 0 0.0015329483430832624
heterozygous O 1 0.9995576739311218
or O 0 0.010358194820582867
homozygous O 1 0.9997044205665588
for O 0 0.017762843519449234
C2 B-Disease 1 0.999998927116394
deficiency I-Disease 1 0.9999985694885254
. O 0 0.017255589365959167

12 O 0 0.014325922355055809
families O 0 0.0076225511729717255
with O 0 0.0034899681340903044
15 O 0 0.009490813128650188
matings O 1 0.9921531081199646
informative O 0 0.0476393848657608
for O 0 0.009750845842063427
C2 B-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.999998927116394
were O 0 0.0023461540695279837
found O 0 0.008738107979297638
. O 0 0.005526071880012751

Of O 0 0.004336926154792309
57 O 0 0.02398763783276081
informative O 0 0.05194026976823807
meioses O 1 0.9869217872619629
, O 0 0.0020571895875036716
two O 0 0.002193666994571686
crossovers O 0 0.09393656998872757
were O 0 0.0009995949221774936
noted O 0 0.002297214465215802
between O 0 0.002719664480537176
the O 0 0.006487780250608921
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
gene O 1 0.9999022483825684
and O 0 0.0016978136263787746
the O 0 0.004240840207785368
HLA O 1 0.9999983310699463
- O 1 0.9431933760643005
B O 1 0.9992944002151489
gene O 1 0.9998682737350464
, O 0 0.0019165538251399994
with O 0 0.0020752816926687956
a O 0 0.008945979177951813
recombinant O 1 0.9993698000907898
fraction O 0 0.023223960772156715
of O 0 0.0017135816160589457
0 O 0 0.02341759204864502
. O 0 0.004795260261744261

035 O 1 0.9499546885490417
. O 0 0.02128004841506481

A O 0 0.030122309923171997
lod O 1 0.7608274221420288
score O 0 0.006335564889013767
of O 0 0.001250331406481564
13 O 0 0.0043893782421946526
was O 0 0.0013903981307521462
calculated O 0 0.008482342585921288
for O 0 0.002096472540870309
linkage O 1 0.9971101880073547
between O 0 0.016237379983067513
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999998807907104
and O 0 0.010020124725997448
HLA O 1 0.999997615814209
- O 1 0.5384639501571655
B O 1 0.9343661069869995
at O 0 0.002789281541481614
a O 0 0.0046189893037080765
maximum O 0 0.006815919186919928
likelihood O 0 0.028899885714054108
value O 0 0.0019973227754235268
of O 0 0.0006196903414092958
the O 0 0.002684376435354352
recombinant O 1 0.9991366267204285
fraction O 0 0.02715376578271389
of O 0 0.0020006343256682158
0 O 0 0.026176389306783676
. O 0 0.006168439518660307

04 O 0 0.24981555342674255
. O 0 0.014885762706398964

18 O 0 0.011962694115936756
families O 0 0.007166600786149502
with O 0 0.0031438057776540518
21 O 0 0.010565392673015594
informative O 0 0.042851921170949936
matings O 1 0.9832181930541992
for O 0 0.0020604783203452826
both O 0 0.002993726870045066
properdin O 1 0.9967435598373413
Factor O 1 0.882326602935791
B O 1 0.9950738549232483
allotype O 1 0.998329222202301
and O 0 0.006798992399126291
HLA O 1 0.9999972581863403
- O 0 0.37782880663871765
B O 1 0.5422999262809753
were O 0 0.0015626073582097888
found O 0 0.008688827976584435
. O 0 0.006359172984957695

Of O 0 0.003908692393451929
72 O 0 0.026408974081277847
informative O 0 0.052068695425987244
meioses O 1 0.9868261218070984
, O 0 0.002242317656055093
three O 0 0.0032217949628829956
recombinants O 1 0.9334552884101868
were O 0 0.0011519799008965492
found O 0 0.004559527616947889
, O 0 0.0011729885591194034
giving O 0 0.005761333275586367
a O 0 0.009246539324522018
recombinant O 1 0.9992563128471375
fraction O 0 0.02587210200726986
of O 0 0.0022582027595490217
0 O 0 0.025067893788218498
. O 0 0.00570589629933238

042 O 1 0.8121780157089233
. O 0 0.014615326188504696

A O 0 0.032442573457956314
lod O 0 0.47878652811050415
score O 0 0.004604792222380638
of O 0 0.000920963182579726
16 O 0 0.006894618272781372
between O 0 0.00943586602807045
HLA O 1 0.999998927116394
- O 0 0.24077746272087097
B O 1 0.917804479598999
and O 0 0.0028544554952532053
Factor O 1 0.8598608374595642
B O 1 0.9967260360717773
allotypes O 1 0.9940060377120972
was O 0 0.002502545015886426
calculated O 0 0.009134446270763874
at O 0 0.0018330493476241827
a O 0 0.0034769384656101465
maximum O 0 0.006618671119213104
likelihood O 0 0.030312981456518173
value O 0 0.0018519422737881541
of O 0 0.00083570322021842
the O 0 0.0026013485621660948
recombinant O 1 0.999563992023468
fraction O 0 0.02671264111995697
of O 0 0.002056767698377371
0 O 0 0.025212815031409264
. O 0 0.0061226096004247665

04 O 0 0.2385711967945099
. O 0 0.018457548692822456

A O 0 0.023070432245731354
crossover O 0 0.0690794363617897
was O 0 0.0029304868075996637
shown O 0 0.004887383431196213
to O 0 0.000983571633696556
have O 0 0.0011805761605501175
occurred O 0 0.008250471204519272
between O 0 0.004074451979249716
genes O 1 0.9992573857307434
for O 0 0.002581051317974925
Factor O 1 0.7150626182556152
B O 1 0.9805583357810974
and O 0 0.0061189779080450535
HLA O 1 0.9999985694885254
- O 1 0.8786329030990601
D O 1 0.9879492521286011
, O 0 0.001494161318987608
in O 0 0.0013070959830656648
which O 0 0.004657370038330555
HLA O 1 0.999997615814209
- O 1 0.6018297672271729
D O 1 0.9962506890296936
segregared O 1 0.9949783682823181
with O 0 0.014478751458227634
HLA O 1 0.9999819993972778
- O 0 0.0295418631285429
A O 0 0.01461129542440176
and O 0 0.0030260104686021805
B O 1 0.9522901773452759
. O 0 0.006723332684487104

These O 0 0.0038922184612601995
studies O 0 0.008573373779654503
suggest O 0 0.006022006273269653
that O 0 0.0007632754859514534
the O 0 0.001548370230011642
genes O 1 0.9990594983100891
for O 0 0.002103933598846197
Factor O 1 0.9476755857467651
B O 1 0.998267412185669
and O 0 0.008626151829957962
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999992847442627
are O 0 0.0013693422079086304
located O 0 0.0019295902457088232
outside O 0 0.0016625109128654003
those O 0 0.0011197403073310852
for O 0 0.003363048192113638
HLA O 1 0.9999953508377075
, O 0 0.0014781878562644124
that O 0 0.0007125477422960103
the O 0 0.0006728762527927756
order O 0 0.0020413128659129143
of O 0 0.0012919341679662466
genese O 1 0.9992638230323792
is O 0 0.008137969300150871
HLA O 1 0.9999957084655762
- O 0 0.030871165916323662
A O 0 0.014722402207553387
, O 0 0.003848469350486994
- O 0 0.12455688416957855
B O 1 0.9969146251678467
, O 0 0.00544667849317193
- O 0 0.1853892058134079
D O 1 0.9935566782951355
, O 0 0.0034239012748003006
Factor O 1 0.7813778519630432
B O 1 0.9950839877128601
allotype O 1 0.9976995587348938
, O 0 0.01274306420236826
C2 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999995231628418
, O 0 0.0022284663282334805
that O 0 0.0008482193807139993
the O 0 0.001912249717861414
genes O 1 0.9997537732124329
coding O 1 0.9992703795433044
for O 0 0.011288711801171303
C2 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999997615814209
and O 0 0.0038739261217415333
Factor O 1 0.9316596984863281
B O 1 0.9964680671691895
allotypes O 1 0.9766090512275696
are O 0 0.0010575513588264585
approximately O 0 0.004197740461677313
3 O 0 0.012340759858489037
- O 0 0.022434255108237267
- O 0 0.017211206257343292
5 O 0 0.009717104025185108
centimorgans O 1 0.9728214144706726
from O 0 0.0022956468164920807
the O 0 0.0042103552259504795
HLA O 1 0.9999904632568359
- O 0 0.02452179789543152
A O 0 0.013462530449032784
and O 0 0.004998018965125084
HLA O 1 0.9999972581863403
- O 1 0.8190970420837402
B O 1 0.9992756247520447
loci O 1 0.999714195728302
, O 0 0.0020327141974121332
and O 0 0.0007139010704122484
that O 0 0.000743379641789943
the O 0 0.0012523791519924998
apparent O 0 0.07968124747276306
lack O 0 0.008951020427048206
of O 0 0.0014669360825791955
recombinants O 1 0.990872859954834
between O 0 0.0017705532955005765
the O 0 0.001971620600670576
Factor O 1 0.9723581671714783
B O 1 0.9992157220840454
gene O 1 0.9999748468399048
and O 0 0.010552719235420227
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
gene O 1 0.9999724626541138
suggests O 0 0.0124635836109519
that O 0 0.0009041976882144809
these O 0 0.0008425632258877158
two O 0 0.0023779449984431267
genes O 1 0.9997368454933167
lie O 0 0.010141353122889996
in O 0 0.001302847871556878
close O 0 0.0044826362282037735
proximity O 0 0.021045321598649025
to O 0 0.0012475852854549885
one O 0 0.0022095502354204655
another O 0 0.0073498017154634
. O 0 0.0050820522010326385

Distribution O 0 0.025292454287409782
of O 0 0.0030803647823631763
emerin O 1 0.9277300238609314
and O 0 0.00280607002787292
lamins O 1 0.9974175691604614
in O 0 0.001699006068520248
the O 0 0.002358902944251895
heart O 1 0.9990973472595215
and O 0 0.0017423764802515507
implications O 0 0.2455737143754959
for O 0 0.004929461982101202
Emery B-Disease 1 0.9996811151504517
- I-Disease 1 0.9656798839569092
Dreifuss I-Disease 1 0.9998507499694824
muscular I-Disease 1 0.9999853372573853
dystrophy I-Disease 1 0.9999943971633911
. O 0 0.01400370616465807

Emerin O 1 0.8275683522224426
is O 0 0.003755012294277549
a O 0 0.00608312152326107
nuclear O 0 0.020695555955171585
membrane O 1 0.9985272884368896
protein O 1 0.9974185228347778
which O 0 0.0015455716056749225
is O 0 0.0015001139836385846
missing O 0 0.013579818420112133
or O 0 0.005567846819758415
defective O 1 0.9995474219322205
in O 0 0.005423927679657936
Emery B-Disease 1 0.9993914365768433
- I-Disease 1 0.9397646188735962
Dreifuss I-Disease 1 0.9999040365219116
muscular I-Disease 1 0.9999960660934448
dystrophy I-Disease 1 0.9999994039535522
( O 0 0.026649685576558113
EDMD B-Disease 1 0.9996402263641357
) O 0 0.009082740172743797
. O 0 0.006991340313106775

It O 0 0.002968289190903306
is O 0 0.0014763267245143652
one O 0 0.0010682365391403437
member O 0 0.0014795629540458322
of O 0 0.0007422146154567599
a O 0 0.004696356598287821
family O 0 0.0077421218156814575
of O 0 0.0027747589629143476
lamina O 1 0.9999566078186035
- O 0 0.03606480360031128
associated O 0 0.019167529419064522
proteins O 1 0.9966713786125183
which O 0 0.001698004431091249
includes O 0 0.004795731510967016
LAP1 O 1 0.99820876121521
, O 0 0.0032737632282078266
LAP2 O 1 0.9980396628379822
and O 0 0.005026513710618019
lamin O 1 0.9999196529388428
B O 1 0.9990420937538147
receptor O 1 0.9998635053634644
( O 0 0.013887841254472733
LBR O 1 0.9993707537651062
) O 0 0.008765840902924538
. O 0 0.0057038539089262486

A O 0 0.014789157547056675
panel O 0 0.00940120592713356
of O 0 0.0019215763313695788
16 O 0 0.016265418380498886
monoclonal O 1 0.9999186992645264
antibodies O 1 0.9999334812164307
( O 0 0.011697265319526196
mAbs O 1 0.9996159076690674
) O 0 0.00381533638574183
has O 0 0.0010850675171241164
been O 0 0.0013142932439222932
mapped O 0 0.014878003858029842
to O 0 0.0011094697983935475
six O 0 0.0021785327699035406
specific O 0 0.003384214360266924
sites O 0 0.002369901165366173
throughout O 0 0.0014522623969241977
the O 0 0.002215471351519227
emerin O 1 0.9974172115325928
molecule O 1 0.9966902732849121
using O 0 0.020821183919906616
phage O 1 0.9996674060821533
- O 0 0.02369186468422413
displayed O 0 0.014393843710422516
peptide O 1 0.9992092847824097
libraries O 0 0.016453314572572708
and O 0 0.000924168445635587
has O 0 0.0011864297557622194
been O 0 0.001329381950199604
used O 0 0.003187100635841489
to O 0 0.003132486715912819
localize O 1 0.9986252784729004
emerin O 1 0.974521815776825
in O 0 0.0033010474871844053
human O 0 0.01139399316161871
and O 0 0.004084768705070019
rabbit O 1 0.9998917579650879
heart O 1 0.9978448152542114
. O 0 0.007605009246617556

Several O 0 0.013246534392237663
mAbs O 1 0.9647337794303894
against O 0 0.004672643728554249
different O 0 0.0046828798949718475
emerin O 1 0.9976485371589661
epitopes O 1 0.996945321559906
did O 0 0.004189757164567709
not O 0 0.0020045978017151356
recognize O 0 0.019917378202080727
intercalated O 1 0.9978649020195007
discs O 0 0.03428959101438522
in O 0 0.0020672755781561136
the O 0 0.003361737821251154
heart O 1 0.9995481371879578
, O 0 0.001800231751985848
though O 0 0.00221628206782043
they O 0 0.0011507733725011349
recognized O 0 0.010370265692472458
cardiomyocyte O 1 0.9975971579551697
nuclei O 1 0.9912276864051819
strongly O 0 0.008260887116193771
, O 0 0.001176186720840633
both O 0 0.0010726801119744778
at O 0 0.0012443914311006665
the O 0 0.0013833616394549608
rim O 0 0.09817098081111908
and O 0 0.0011760343331843615
in O 0 0.0026186397299170494
intranuclear O 1 0.9985711574554443
spots O 0 0.02787609025835991
or O 0 0.007188423536717892
channels O 0 0.03350533917546272
. O 0 0.0051244511269032955

A O 0 0.05340159311890602
polyclonal O 1 0.9969498515129089
rabbit O 1 0.9971179962158203
antiserum O 1 0.9963739514350891
against O 0 0.011129855178296566
emerin O 1 0.9570754170417786
did O 0 0.004155570641160011
recognize O 0 0.008936244063079357
both O 0 0.0018912263913080096
nuclear O 0 0.01511838287115097
membrane O 1 0.9985488057136536
and O 0 0.0027210719417780638
intercalated O 1 0.999404788017273
discs O 0 0.065786212682724
but O 0 0.001713906298391521
, O 0 0.0011692250845953822
after O 0 0.005878448020666838
affinity O 1 0.9613364934921265
purification O 1 0.9166630506515503
against O 0 0.0038114218041300774
a O 0 0.0069152177311480045
pure O 0 0.04027858376502991
- O 0 0.02936960756778717
emerin O 1 0.9713233709335327
band O 0 0.01158621534705162
on O 0 0.0011478689266368747
a O 0 0.0038966548163443804
western O 0 0.006099296268075705
blot O 1 0.998415470123291
, O 0 0.0019420256139710546
it O 0 0.0019178623333573341
stained O 1 0.8751076459884644
only O 0 0.0011827434645965695
the O 0 0.0018567637307569385
nuclear O 0 0.02247697114944458
membrane O 1 0.9905657172203064
. O 0 0.006893903482705355

These O 0 0.004065990447998047
results O 0 0.010795336216688156
would O 0 0.00108806521166116
not O 0 0.0009236816549673676
be O 0 0.0007998247747309506
expected O 0 0.002242910908535123
if O 0 0.0036516760010272264
immunostaining O 1 0.9916936755180359
at O 0 0.0049158865585923195
intercalated O 1 0.9991422891616821
discs O 0 0.02706761844456196
were O 0 0.0008311569690704346
due O 0 0.0032875859178602695
to O 0 0.0006781067349947989
a O 0 0.002789143705740571
product O 0 0.005241462029516697
of O 0 0.000664074148517102
the O 0 0.0028695862274616957
emerin O 1 0.9999309778213501
gene O 1 0.9999833106994629
and O 0 0.0017966500017791986
, O 0 0.0013477933825924993
therefore O 0 0.0031684748828411102
, O 0 0.0010098133934661746
cast O 0 0.004456517286598682
some O 0 0.0009768515592440963
doubt O 0 0.004509426653385162
upon O 0 0.0016687940806150436
the O 0 0.0015663712983950973
hypothesis O 1 0.9762168526649475
that O 0 0.007985607720911503
cardiac B-Disease 1 0.9999996423721313
defects I-Disease 1 0.9999663829803467
in O 0 0.004515332169830799
EDMD B-Disease 1 0.9998227953910828
are O 0 0.0018423594301566482
caused O 0 0.04489601030945778
by O 0 0.002255332889035344
absence O 0 0.012798384763300419
of O 0 0.0017028562724590302
emerin O 1 0.997253954410553
from O 0 0.0055968365631997585
intercalated O 1 0.998678982257843
discs O 0 0.0692843422293663
. O 0 0.007148221600800753

Although O 0 0.01703523099422455
emerin O 1 0.7840243577957153
was O 0 0.0030706922989338636
abundant O 0 0.008113479241728783
in O 0 0.0010239186231046915
the O 0 0.0019828046206384897
membranes O 1 0.9994499087333679
of O 0 0.003001597709953785
cardiomyocyte O 1 0.9989290833473206
nuclei O 1 0.9952713847160339
, O 0 0.0017301676562055945
it O 0 0.0011891843751072884
was O 0 0.0016806304920464754
absent O 0 0.014710288494825363
from O 0 0.0013609305024147034
many O 0 0.0015206410316750407
non O 0 0.01234346255660057
- O 1 0.5514329671859741
myocyte O 1 0.9999749660491943
cells O 1 0.9991647005081177
in O 0 0.0022578753996640444
the O 0 0.0034813620150089264
heart O 1 0.9986459612846375
. O 0 0.008924153633415699

This O 0 0.0030860514380037785
distribution O 0 0.010961711406707764
of O 0 0.0018214500742033124
emerin O 1 0.9960675239562988
was O 0 0.002549807308241725
similar O 0 0.004827086813747883
to O 0 0.001070697559043765
that O 0 0.0009001541184261441
of O 0 0.0016376872081309557
lamin O 1 0.9998829364776611
A O 0 0.010426679626107216
, O 0 0.001351436018012464
a O 0 0.0045217410661280155
candidate O 0 0.0182165689766407
gene O 1 0.9998772144317627
for O 0 0.0022498650941997766
an O 0 0.005342414602637291
autosomal O 1 0.9999992847442627
form O 0 0.013793845660984516
of O 0 0.0027669696137309074
EDMD B-Disease 1 0.9993661046028137
. O 0 0.010069431737065315

In O 0 0.006352045573294163
contrast O 0 0.017982909455895424
, O 0 0.0075751254335045815
lamin O 1 0.9997772574424744
B1 O 1 0.9997197985649109
was O 0 0.006339372135698795
absent O 0 0.025521233677864075
from O 0 0.004763285629451275
cardiomyocyte O 1 0.9974228143692017
nuclei O 1 0.9861755967140198
, O 0 0.002017602091655135
showing O 0 0.008638625033199787
that O 0 0.004089465364813805
lamin O 1 0.9999284744262695
B1 O 1 0.9999029636383057
is O 0 0.0026665052864700556
not O 0 0.00108784856274724
essential O 0 0.006247481796890497
for O 0 0.0014388544950634241
localization O 1 0.919198751449585
of O 0 0.001550392946228385
emerin O 1 0.9881396293640137
to O 0 0.0015266342088580132
the O 0 0.002260400913655758
nuclear O 0 0.029087373986840248
lamina O 1 0.998164713382721
. O 0 0.0100979283452034

Lamin O 1 0.9997197985649109
B1 O 1 0.9997362494468689
is O 0 0.004252991639077663
also O 0 0.0012882199371233582
almost O 0 0.0027743251994252205
completely O 0 0.010549542494118214
absent O 0 0.02751392312347889
from O 0 0.006544752977788448
skeletal O 1 0.9999583959579468
muscle O 1 0.9999444484710693
nuclei O 1 0.987015962600708
. O 0 0.01023527979850769

In O 0 0.009369265288114548
EDMD B-Disease 1 0.996679425239563
, O 0 0.002133788075298071
the O 0 0.0011839360231533647
additional O 0 0.00495095644146204
absence O 0 0.012733823619782925
of O 0 0.003252763533964753
lamin O 1 0.9998681545257568
B1 O 1 0.9998730421066284
from O 0 0.007023761048913002
heart O 1 0.9983483552932739
and O 0 0.004143251571804285
skeletal O 1 0.9999904632568359
muscle O 1 0.9999796152114868
nuclei O 1 0.988947868347168
which O 0 0.0016033845022320747
already O 0 0.004278186243027449
lack O 0 0.01500314474105835
emerin O 1 0.9992015957832336
may O 0 0.0067305718548595905
offer O 0 0.004379437305033207
an O 0 0.0014357351465150714
alternative O 0 0.011899246834218502
explanation O 0 0.008820759132504463
of O 0 0.0009801320265978575
why O 0 0.004516909830272198
these O 0 0.001980337779968977
tissues O 1 0.9998766183853149
are O 0 0.0016758162528276443
particularly O 0 0.006292111240327358
affected O 0 0.02442166954278946
. O 0 0.0029761455953121185
. O 0 0.004840999376028776

Genetic O 1 0.9965432286262512
mapping O 0 0.0370161347091198
of O 0 0.0009743265109136701
the O 0 0.0020388667471706867
copper B-Disease 1 0.6502132415771484
toxicosis I-Disease 1 0.9998400211334229
locus O 1 0.9989455342292786
in O 0 0.007200588472187519
Bedlington O 1 0.9989987015724182
terriers O 1 0.9977415800094604
to O 0 0.00635787146165967
dog O 1 0.9964534044265747
chromosome O 1 0.9999814033508301
10 O 0 0.005725828465074301
, O 0 0.001248963293619454
in O 0 0.0011057573137804866
a O 0 0.004384767264127731
region O 0 0.004221993964165449
syntenic O 1 0.9681353569030762
to O 0 0.0024252994917333126
human O 0 0.023705005645751953
chromosome O 1 0.9999779462814331
region O 0 0.015012238174676895
2p13 O 1 0.9976153373718262
- O 0 0.23657776415348053
p16 O 1 0.9990172386169434
. O 0 0.013974042609333992

Abnormal O 1 0.9998496770858765
hepatic B-Disease 1 0.9999935626983643
copper I-Disease 1 0.5122070908546448
accumulation I-Disease 1 0.9792800545692444
is O 0 0.002160363830626011
recognized O 0 0.004267746116966009
as O 0 0.001565968501381576
an O 0 0.004919848404824734
inherited B-Disease 1 0.9999955892562866
disorder I-Disease 1 0.9999990463256836
in O 0 0.0025934188161045313
man O 0 0.011269276030361652
, O 0 0.003594673238694668
mouse O 1 0.9999128580093384
, O 0 0.007388116326183081
rat O 1 0.9995055198669434
and O 0 0.004645570646971464
dog O 1 0.9708102345466614
. O 0 0.008035395294427872

The O 0 0.003937117755413055
major O 0 0.008291821926832199
cause O 0 0.12746813893318176
of O 0 0.004145230166614056
hepatic B-Disease 1 0.9999986886978149
copper I-Disease 1 0.6214075684547424
accumulation I-Disease 1 0.9894859790802002
in O 0 0.0017208695644512773
man O 0 0.0051698884926736355
is O 0 0.0014776487369090319
a O 0 0.0084612425416708
dysfunctional O 1 0.9995517134666443
ATP7B O 1 0.999840259552002
gene O 1 0.9999152421951294
, O 0 0.005189983639866114
causing O 1 0.9981434345245361
Wilson B-Disease 1 0.9983817338943481
disease I-Disease 1 0.9999972581863403
( O 0 0.018877597525715828
WD B-Disease 1 0.9999803304672241
) O 0 0.008245950564742088
. O 0 0.0057421112433075905

Mutations O 1 0.9998007416725159
in O 0 0.002744972240179777
the O 0 0.003209860762581229
ATP7B O 1 0.9998325109481812
genes O 1 0.9994577765464783
have O 0 0.001461575971916318
also O 0 0.0009174848673865199
been O 0 0.0013935586903244257
demonstrated O 0 0.010412145406007767
in O 0 0.0030835208017379045
mouse O 1 0.9998247027397156
and O 0 0.00597384525462985
rat O 1 0.9993218183517456
. O 0 0.010760587640106678

The O 0 0.010219795629382133
ATP7B O 1 0.999300479888916
gene O 1 0.9999088048934937
has O 0 0.0026490979362279177
been O 0 0.0014896810753270984
excluded O 0 0.00908331573009491
in O 0 0.000979868695139885
the O 0 0.0011962872231379151
much O 0 0.004065538756549358
rarer O 1 0.9971029162406921
human O 0 0.02097955532371998
copper B-Disease 1 0.9913778305053711
overload I-Disease 1 0.9999788999557495
disease O 1 0.999990701675415
non B-Disease 0 0.016685526818037033
- I-Disease 0 0.021314701065421104
Indian I-Disease 0 0.016590392217040062
childhood I-Disease 1 0.999065101146698
cirrhosis I-Disease 1 0.999997615814209
, O 0 0.004514796193689108
indicating O 0 0.4760866165161133
genetic O 1 0.999904990196228
heterogeneity O 1 0.9981523156166077
. O 0 0.006811088416725397

By O 0 0.006629320327192545
investigating O 0 0.012548760510981083
the O 0 0.0031300040427595377
common O 1 0.6719700694084167
autosomal O 1 0.9999997615814209
recessive O 1 0.9999984502792358
copper B-Disease 1 0.9833969473838806
toxicosis I-Disease 1 0.9999222755432129
( O 0 0.02107715606689453
CT B-Disease 1 0.9999773502349854
) O 0 0.005965342745184898
in O 0 0.0043830606155097485
Bedlington O 1 0.9999290704727173
terriers O 1 0.9997140765190125
, O 0 0.002109838416799903
we O 0 0.0008305897936224937
have O 0 0.0009120703325606883
identified O 0 0.006568121258169413
a O 0 0.003913728520274162
new O 0 0.004030122887343168
locus O 1 0.9994971752166748
involved O 0 0.011200151406228542
in O 0 0.005775137804448605
progressive O 1 0.9998537302017212
liver B-Disease 1 1.0
disease I-Disease 1 0.9999980926513672
. O 0 0.010511166416108608

We O 0 0.003819683101028204
examined O 0 0.018785949796438217
whether O 0 0.0037682373076677322
the O 0 0.005720094777643681
WD B-Disease 1 0.999994158744812
gene O 1 0.999911904335022
ATP7B O 1 0.99539715051651
was O 0 0.0031929246615618467
also O 0 0.0026897320058196783
causative O 1 0.9992345571517944
for O 0 0.004918077029287815
CT B-Disease 1 0.9999204874038696
by O 0 0.0025263074785470963
investigating O 0 0.01004832610487938
the O 0 0.005194313358515501
chromosomal O 1 0.9999942779541016
co O 1 0.6603913903236389
- O 0 0.027147777378559113
localization O 1 0.753838062286377
of O 0 0.003294712398201227
ATP7B O 1 0.997359573841095
and O 0 0.0032693149987608194
C04107 O 1 0.9748387336730957
, O 0 0.0022566262632608414
using O 0 0.010069608688354492
fluorescence O 1 0.9884267449378967
in O 0 0.00418408727273345
situ O 1 0.9984689354896545
hybridization O 1 0.9990302324295044
( O 0 0.008033160120248795
FISH O 0 0.03145446255803108
) O 0 0.006357342004776001
. O 0 0.006079965271055698

C04107 O 1 0.8812532424926758
is O 0 0.0035491816233843565
an O 0 0.0030569694936275482
anonymous O 0 0.08667221665382385
microsatellite O 1 0.9994809031486511
marker O 1 0.616036593914032
closely O 0 0.0156556349247694
linked O 0 0.17592863738536835
to O 0 0.0062788100913167
CT B-Disease 1 0.9998784065246582
. O 0 0.009462198242545128

However O 0 0.007241163868457079
, O 0 0.004981834441423416
BAC O 1 0.9997016787528992
clones O 1 0.9938972592353821
containing O 0 0.031287435442209244
ATP7B O 1 0.9955169558525085
and O 0 0.0033131830859929323
C04107 O 1 0.9242978096008301
mapped O 0 0.020954709500074387
to O 0 0.0015753245679661632
the O 0 0.003708055941388011
canine O 1 0.9999642372131348
chromosome O 1 0.9999878406524658
regions O 0 0.021336272358894348
CFA22q11 O 1 0.9966562986373901
and O 0 0.0030282523948699236
CFA10q26 O 1 0.9988783001899719
, O 0 0.0019875764846801758
respectively O 0 0.0033790171146392822
, O 0 0.0011398764327168465
demonstrating O 0 0.011906009167432785
that O 0 0.0035523888655006886
WD B-Disease 1 0.9999793767929077
cannot O 0 0.0052648140117526054
be O 0 0.0020949705503880978
homologous O 1 0.9996284246444702
to O 0 0.006416060496121645
CT B-Disease 1 0.9998950958251953
. O 0 0.010006443597376347

The O 0 0.007004319224506617
copper O 0 0.039416614919900894
transport O 0 0.03898591175675392
genes O 1 0.9992074370384216
CTR1 O 1 0.9965305924415588
and O 0 0.003907137084752321
CTR2 O 1 0.9936376214027405
were O 0 0.0009546306682750583
also O 0 0.0012249198043718934
excluded O 0 0.008936497382819653
as O 0 0.0015855610836297274
candidate O 0 0.015443493612110615
genes O 1 0.9996476173400879
for O 0 0.0065317354165017605
CT B-Disease 1 0.9999650716781616
since O 0 0.003471734933555126
they O 0 0.0007050163694657385
both O 0 0.0014155153185129166
mapped O 0 0.025283461436629295
to O 0 0.005295761860907078
canine O 1 0.9999394416809082
chromosome O 1 0.9999643564224243
region O 0 0.016269734129309654
CFA11q22 O 1 0.9846270680427551
. O 0 0.00832652859389782

2 O 0 0.03271733224391937
- O 0 0.030864328145980835
22 O 0 0.016446569934487343
. O 0 0.008143690414726734

5 O 0 0.02860426902770996
. O 0 0.008743788115680218

A O 0 0.024267975240945816
transcribed O 0 0.37972292304039
sequence O 0 0.06593041867017746
identified O 0 0.01050657220184803
from O 0 0.0014440701343119144
the O 0 0.0026230793446302414
C04107 O 1 0.9982132911682129
- O 0 0.02549697458744049
containing O 0 0.039759743958711624
BAC O 1 0.9996520280838013
was O 0 0.0023203922901302576
found O 0 0.0033726224210113287
to O 0 0.0008685642969794571
be O 0 0.0014414842007681727
homologous O 1 0.9996945858001709
to O 0 0.0014585311291739345
a O 0 0.007751024328172207
gene O 1 0.99960857629776
expressed O 0 0.00433929031714797
from O 0 0.0021556303836405277
human O 0 0.030603038147091866
chromosome O 1 0.999992847442627
2p13 O 1 0.999426007270813
- O 0 0.4046647250652313
p16 O 1 0.999805748462677
, O 0 0.002836567349731922
a O 0 0.004433020483702421
region O 0 0.003829791909083724
devoid O 0 0.01711370423436165
of O 0 0.0008732628193683922
any O 0 0.0032872874289751053
positional O 1 0.9900944828987122
candidate O 0 0.02735038474202156
genes O 1 0.9987816214561462
. O 0 0.00774715282022953

Molecular O 1 0.9877647757530212
analysis O 0 0.012002554722130299
of O 0 0.0009600560297258198
the O 0 0.003498589154332876
APC B-Disease 1 0.9999594688415527
gene O 1 0.9998733997344971
in O 0 0.0025139159988611937
205 O 0 0.07607343047857285
families O 0 0.006353312637656927
: O 0 0.004419551230967045
extended O 0 0.01806812547147274
genotype O 1 0.9999760389328003
- O 1 0.6706854104995728
phenotype O 1 0.999976634979248
correlations O 1 0.9959034323692322
in O 0 0.00547986663877964
FAP B-Disease 1 0.9999692440032959
and O 0 0.0014336188323795795
evidence O 0 0.0025126226246356964
for O 0 0.0007997935172170401
the O 0 0.0010675478260964155
role O 0 0.004865200724452734
of O 0 0.0023398196790367365
APC B-Disease 1 0.9997484087944031
amino O 1 0.9976510405540466
acid O 1 0.9980297684669495
changes O 0 0.018856462091207504
in O 0 0.040301669389009476
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
predisposition O 1 0.9999563694000244
. O 0 0.010179906152188778

BACKGROUND O 0 0.058239273726940155
/ O 0 0.09326411783695221
AIMS O 0 0.016277948394417763
The O 0 0.0018765953136608005
development O 0 0.005366112571209669
of O 0 0.010168869979679585
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
and O 0 0.0020975221414119005
a O 0 0.00666187796741724
variable O 0 0.1774464249610901
range O 0 0.00368018657900393
of O 0 0.0012616219464689493
extracolonic O 1 0.9979155659675598
manifestations O 1 0.9388806223869324
in O 0 0.01117466390132904
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999997615814209
( O 0 0.02824382670223713
FAP B-Disease 1 0.9999912977218628
) O 0 0.005070280749350786
is O 0 0.0012097049038857222
the O 0 0.0008745001978240907
result O 0 0.003925093915313482
of O 0 0.000574490986764431
the O 0 0.0015632743015885353
dominant O 0 0.11471503227949142
inheritance O 1 0.9887391328811646
of O 0 0.012071844190359116
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999954700469971
( O 0 0.019157731905579567
APC B-Disease 1 0.999779999256134
) O 0 0.02306583896279335
gene O 1 0.9999414682388306
mutations O 1 0.9998842477798462
. O 0 0.00971926562488079

In O 0 0.003121785819530487
this O 0 0.0015641876962035894
study O 0 0.0050556715577840805
, O 0 0.0015892543597146869
direct O 0 0.018661508336663246
mutation O 1 0.9999425411224365
analysis O 0 0.008984159678220749
of O 0 0.0007608974701724946
the O 0 0.0032309347297996283
APC B-Disease 1 0.9999737739562988
gene O 1 0.999854564666748
was O 0 0.0025395972188562155
performed O 0 0.004883813671767712
to O 0 0.0018561073811724782
determine O 0 0.02597758173942566
genotype O 1 0.9999755620956421
- O 1 0.8072786927223206
phenotype O 1 0.999987006187439
correlations O 1 0.9791208505630493
for O 0 0.0022410175297409296
nine O 0 0.007350103929638863
extracolonic O 1 0.9981990456581116
manifestations O 1 0.6204920411109924
and O 0 0.0008988548070192337
to O 0 0.0011425436241552234
investigate O 0 0.007791233714669943
the O 0 0.0024563416372984648
incidence O 1 0.9985924363136292
of O 0 0.00336517789401114
APC B-Disease 1 0.9999547004699707
mutations O 1 0.9999750852584839
in O 0 0.004428731743246317
non O 0 0.06251529604196548
- O 1 0.9986257553100586
FAP O 1 0.9999990463256836
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
. O 0 0.013441033661365509

METHODS O 0 0.030639126896858215
The O 0 0.006701828446239233
APC B-Disease 1 0.999824583530426
gene O 1 0.9993845224380493
was O 0 0.003992532379925251
analysed O 0 0.04111025482416153
in O 0 0.0026401393115520477
190 O 0 0.03000173158943653
unrelated O 1 0.9874874353408813
FAP B-Disease 1 0.9998468160629272
and O 0 0.0023295015562325716
15 O 0 0.00798969529569149
non O 0 0.07358277589082718
- O 1 0.9983275532722473
FAP O 1 0.9999992847442627
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
patients O 1 0.998602569103241
using O 0 0.01980406977236271
denaturing O 1 0.9986168146133423
gradient O 1 0.9974169731140137
gel O 1 0.999736487865448
electrophoresis O 1 0.9992949962615967
, O 0 0.0026494860649108887
the O 0 0.003171795979142189
protein O 1 0.9996399879455566
truncation O 1 0.997947633266449
test O 0 0.018913330510258675
, O 0 0.0013503424124792218
and O 0 0.001370179932564497
direct O 0 0.018042638897895813
sequencing O 1 0.9938148260116577
. O 0 0.008189091458916664

RESULTS O 0 0.06831453740596771
Chain O 1 0.9603335857391357
terminating O 1 0.9056814312934875
signals O 0 0.02529553510248661
were O 0 0.000720035401172936
only O 0 0.0011902450351044536
identified O 0 0.009294521994888783
in O 0 0.002475508488714695
patients O 1 0.9995878338813782
belonging O 0 0.011768079362809658
to O 0 0.001069696736522019
the O 0 0.0030236246529966593
FAP B-Disease 1 0.9999687671661377
group O 0 0.01599752902984619
( O 0 0.006695365533232689
105 O 0 0.16635797917842865
patients O 1 0.9998537302017212
) O 0 0.005946855992078781
. O 0 0.005389337427914143

Amino O 1 0.9886428713798523
acid O 1 0.9963722229003906
changes O 0 0.006984686013311148
were O 0 0.0007154832710511982
identified O 0 0.007041239179670811
in O 0 0.0015426699537783861
four O 0 0.005324020050466061
patients O 1 0.9998506307601929
, O 0 0.0012551622930914164
three O 0 0.0011229421943426132
of O 0 0.0007100474904291332
whom O 0 0.003084458876401186
belonged O 0 0.007193440571427345
to O 0 0.0007556683849543333
the O 0 0.001716525643132627
non O 0 0.015100707300007343
- O 0 0.31411316990852356
FAP O 1 0.9999167919158936
group O 0 0.0224326029419899
of O 0 0.02150930091738701
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 1 0.9998778104782104
. O 0 0.008987794630229473

Genotype O 1 0.9997655749320984
- O 1 0.8095381855964661
phenotype O 1 0.9999600648880005
correlations O 1 0.9963544607162476
identified O 0 0.014164053834974766
significant O 0 0.004951184615492821
differences O 0 0.006798381917178631
in O 0 0.0007486726390197873
the O 0 0.0008616161649115384
nature O 0 0.0034062701743096113
of O 0 0.0009364407160319388
certain O 0 0.006311122328042984
extracolonic O 1 0.9990049004554749
manifestations O 1 0.9087786078453064
in O 0 0.006970683578401804
FAP B-Disease 1 0.9999958276748657
patients O 1 0.9993858337402344
belonging O 0 0.013933169655501842
to O 0 0.0017035908531397581
three O 0 0.005735062062740326
mutation O 1 0.9999841451644897
subgroups O 1 0.9773274660110474
. O 0 0.00793049018830061

CONCLUSIONS O 0 0.04388048127293587
Extended O 0 0.03799700364470482
genotype O 1 0.9999352693557739
- O 1 0.8811848163604736
phenotype O 1 0.9999816417694092
correlations O 1 0.9838892221450806
made O 0 0.00230810116045177
in O 0 0.00094458123203367
this O 0 0.0012870688224211335
study O 0 0.006245649419724941
may O 0 0.0035978597588837147
have O 0 0.0007577575161121786
the O 0 0.0011433613253757358
potential O 0 0.008755194954574108
to O 0 0.0009787899907678366
determine O 0 0.004226539749652147
the O 0 0.000858841638546437
most O 0 0.0010329377837479115
appropriate O 0 0.007240176200866699
surveillance O 0 0.034114912152290344
and O 0 0.0027768523432314396
prophylactic O 1 0.9999608993530273
treatment O 1 0.9994875192642212
regimens O 1 0.9998451471328735
for O 0 0.0019942685030400753
those O 0 0.0031969610136002302
patients O 1 0.9998865127563477
with O 0 0.008784658275544643
mutations O 1 0.9999986886978149
associated O 0 0.012084992602467537
with O 0 0.002892605261877179
life O 0 0.010879521258175373
threatening O 1 0.9821802377700806
conditions O 0 0.018461957573890686
. O 0 0.006149697583168745

This O 0 0.004221723414957523
study O 0 0.006433156784623861
also O 0 0.0009690781589597464
provided O 0 0.0022410207893699408
evidence O 0 0.0023180621210485697
for O 0 0.0007727782358415425
the O 0 0.0017497220542281866
pathological O 1 0.997260570526123
nature O 0 0.00518066855147481
of O 0 0.001573488232679665
amino O 1 0.9991685152053833
acid O 1 0.9991912245750427
changes O 0 0.009335591457784176
in O 0 0.0028278599493205547
APC O 1 0.9999303817749023
associated O 0 0.010518365539610386
with O 0 0.0020194118842482567
both O 0 0.0033895450178533792
FAP B-Disease 1 0.9999442100524902
and O 0 0.0031797648407518864
non O 0 0.33391886949539185
- O 1 0.999584972858429
FAP O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9998993873596191
. O 0 0.004847553092986345
. O 0 0.006775220390409231

Inherited B-Disease 1 0.9999322891235352
colorectal I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999995231628418
and O 0 0.019221844151616096
cancer B-Disease 1 0.9999991655349731
risk O 1 0.9119499325752258
of O 0 0.001044239616021514
the O 0 0.003786579705774784
APC O 1 0.999779999256134
I1307K O 1 0.9967145919799805
polymorphism O 1 0.9974905252456665
. O 0 0.009766913950443268

Germ O 1 0.9983704686164856
- O 0 0.030373532325029373
line O 0 0.010477209463715553
and O 0 0.0031285968143492937
somatic O 1 0.9995366334915161
truncating O 1 0.9988699555397034
mutations O 1 0.9996968507766724
of O 0 0.0012092278338968754
the O 0 0.003414891194552183
APC B-Disease 1 0.9999812841415405
gene O 1 0.9998854398727417
are O 0 0.0010727987391874194
thought O 0 0.004226906690746546
to O 0 0.002532481448724866
initiate O 1 0.9995899796485901
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999922513961792
formation O 0 0.3721800446510315
in O 0 0.015469296835362911
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
and O 0 0.008828500285744667
sporadic O 1 0.9995538592338562
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.9999735355377197
, O 0 0.004977180622518063
respectively O 0 0.008426185697317123
. O 0 0.005876024719327688

Recently O 0 0.01890682242810726
, O 0 0.0023283851332962513
an O 0 0.004732551518827677
isoleucine O 1 0.9996247291564941
- O 0 0.10364704579114914
- O 0 0.05115325748920441
> O 1 0.9955857992172241
lysine O 1 0.995387613773346
polymorphism O 1 0.9865354895591736
at O 0 0.009760874323546886
codon O 1 0.9959328770637512
1307 O 1 0.9948222637176514
( O 0 0.009756676852703094
I1307K O 1 0.9875316023826599
) O 0 0.002523974981158972
of O 0 0.0007131212041713297
the O 0 0.002887456212192774
APC B-Disease 1 0.9999771118164062
gene O 1 0.9999368190765381
has O 0 0.0020439354702830315
been O 0 0.0015935517149046063
identified O 0 0.0077104270458221436
in O 0 0.0015920200385153294
6 O 0 0.007622662931680679
% O 0 0.009100413881242275
- O 0 0.014036042615771294
7 O 0 0.007751237601041794
% O 0 0.003200272563844919
of O 0 0.0006458227871917188
the O 0 0.0022011830005794764
Ashkenazi O 1 0.9938473105430603
Jewish O 0 0.009792116470634937
population O 0 0.004307975992560387
. O 0 0.005534083116799593

To O 0 0.004574895836412907
assess O 0 0.017881961539387703
the O 0 0.002460010815411806
risk O 0 0.3216383457183838
of O 0 0.0007796888239681721
this O 0 0.0014811354922130704
common O 0 0.021108318120241165
APC B-Disease 1 0.9999270439147949
allelic O 1 0.9997335076332092
variant O 1 0.999805748462677
in O 0 0.019706817343831062
colorectal O 1 1.0
carcinogenesis O 1 0.9999877214431763
, O 0 0.0021743939723819494
we O 0 0.0007424487848766148
have O 0 0.0008211420499719679
analyzed O 0 0.014824919402599335
a O 0 0.00411849282681942
large O 0 0.004565738607198
cohort O 1 0.848775327205658
of O 0 0.001966167474165559
unselected O 1 0.9935320615768433
Ashkenazi O 1 0.9590920209884644
Jewish O 0 0.007503116503357887
subjects O 0 0.008798329159617424
with O 0 0.011722139082849026
adenomatous B-Disease 1 0.9999998807907104
polyps I-Disease 1 0.9999904632568359
and O 0 0.0025352512020617723
. O 0 0.004070806782692671
or O 1 0.9813364148139954
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, I-Disease 0 0.0020626757759600878
for O 0 0.0014739190228283405
the O 0 0.0040311445482075214
APC O 1 0.9998810291290283
I1307K O 1 0.9969909191131592
polymorphism O 1 0.9971693158149719
. O 0 0.010407179594039917

The O 0 0.013714906759560108
APC O 1 0.9987058639526367
I1307K O 1 0.9944359064102173
allele O 1 0.9992510676383972
was O 0 0.004750869236886501
identified O 0 0.012092414312064648
in O 0 0.0020239679142832756
48 O 0 0.01310063898563385
( O 0 0.0033943564631044865
10 O 0 0.0037236963398754597
. O 0 0.0017295880243182182
1 O 0 0.0060448660515248775
% O 0 0.004654802847653627
) O 0 0.0030739870853722095
of O 0 0.002735487185418606
476 O 1 0.9983945488929749
patients O 1 0.9989855885505676
. O 0 0.008983047679066658

Compared O 0 0.017585216090083122
with O 0 0.0031012489926069975
the O 0 0.0021263225935399532
frequency O 0 0.0265438761562109
in O 0 0.0013567439746111631
two O 0 0.0017321486957371235
separate O 0 0.006362087093293667
population O 0 0.0034591141156852245
control O 0 0.011238857172429562
groups O 0 0.002527381991967559
, O 0 0.00107146380469203
the O 0 0.0033899620175361633
APC O 1 0.9998948574066162
I1307K O 1 0.9993457198143005
allele O 1 0.9999103546142578
is O 0 0.0034383698366582394
associated O 0 0.006967928260564804
with O 0 0.0018570545362308621
an O 0 0.001495057251304388
estimated O 0 0.007120140828192234
relative O 0 0.020680641755461693
risk O 1 0.9152182936668396
of O 0 0.0013836885336786509
1 O 0 0.00869567971676588
. O 0 0.005813079420477152

5 O 0 0.036310698837041855
- O 0 0.0269074235111475
1 O 0 0.014429857023060322
. O 0 0.006381136365234852

7 O 0 0.029361287131905556
for O 0 0.018483731895685196
colorectal B-Disease 1 0.9999990463256836
neoplasia I-Disease 1 0.9999600648880005
( O 0 0.007930967025458813
both O 0 0.005031031556427479
P O 1 0.9981854557991028
= O 1 0.787697434425354
. O 0 0.005619732663035393
01 O 1 0.9974700212478638
) O 0 0.007475908845663071
. O 0 0.005764754023402929

Furthermore O 0 0.03525924310088158
, O 0 0.0022394314873963594
compared O 0 0.01008608192205429
with O 0 0.005831638816744089
noncarriers O 1 0.9908124804496765
, O 0 0.00668214401230216
APC O 1 0.999762237071991
I1307K O 1 0.998498797416687
carriers O 0 0.3122994601726532
had O 0 0.002392331836745143
increased O 0 0.005014227237552404
numbers O 0 0.003119058208540082
of O 0 0.0025004001799970865
adenomas B-Disease 1 0.999994158744812
and O 0 0.018995637074112892
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999971389770508
per O 0 0.012541570700705051
patient O 1 0.9995728135108948
( O 0 0.008513049222528934
P O 1 0.9991666078567505
= O 1 0.8008605241775513
. O 0 0.0043422929011285305
03 O 1 0.9990047812461853
) O 0 0.0037796739488840103
, O 0 0.0009287901339121163
as O 0 0.0010490742279216647
well O 0 0.0010329550132155418
as O 0 0.001146858325228095
a O 0 0.006462978199124336
younger O 0 0.04372769594192505
age O 0 0.008401061408221722
at O 0 0.0073919110000133514
diagnosis O 1 0.9999704360961914
. O 0 0.0070880199782550335

We O 0 0.0037009213119745255
conclude O 0 0.013017439283430576
that O 0 0.0012369704199954867
the O 0 0.0031698821112513542
APC O 1 0.9997649788856506
I1307K O 1 0.9971078038215637
variant O 1 0.9976129531860352
leads O 0 0.019921062514185905
to O 0 0.0020925812423229218
increased O 0 0.031917475163936615
adenoma B-Disease 1 0.999993085861206
formation O 0 0.06527581810951233
and O 0 0.0011614724062383175
directly O 0 0.004352346528321505
contributes O 0 0.030033335089683533
to O 0 0.001604224438779056
3 O 0 0.009095616638660431
% O 0 0.007237973622977734
- O 0 0.013771271333098412
4 O 0 0.0061547765508294106
% O 0 0.0025040109176188707
of O 0 0.000701475131791085
all O 0 0.0020090884063392878
Ashkenazi O 1 0.9993126392364502
Jewish O 1 0.9861268997192383
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
. O 0 0.012226931750774384

The O 0 0.003860336961224675
estimated O 0 0.007401906419545412
relative O 0 0.02099788561463356
risk O 1 0.8837277293205261
for O 0 0.002963631646707654
carriers O 1 0.9563984274864197
may O 0 0.004869196098297834
justify O 0 0.016021687537431717
specific O 0 0.011764779686927795
clinical O 1 0.9996829032897949
screening O 1 0.781639039516449
for O 0 0.0013789060758426785
the O 0 0.0015485627809539437
360 O 0 0.024991843849420547
, O 0 0.0015634788433089852
000 O 0 0.012707826681435108
Americans O 0 0.0032219435088336468
expected O 0 0.0015994977438822389
to O 0 0.0011624796316027641
harbor O 0 0.011205391027033329
this O 0 0.0026255957782268524
allele O 1 0.999953031539917
, O 0 0.0020533252973109484
and O 0 0.002203779760748148
genetic O 1 0.9999649524688721
testing O 0 0.032472606748342514
in O 0 0.0009184114751406014
the O 0 0.0010132798925042152
setting O 0 0.005678363144397736
of O 0 0.001416719052940607
long O 0 0.016364412382245064
- O 0 0.04554809257388115
term O 0 0.0219818577170372
- O 0 0.0195775143802166
outcome O 0 0.01946215145289898
studies O 0 0.00915191974490881
may O 0 0.0035788994282484055
impact O 0 0.011144150979816914
significantly O 1 0.5190614461898804
on O 0 0.05890193209052086
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9994402527809143
in O 0 0.002106024883687496
this O 0 0.0016762709710747004
population O 0 0.004007705952972174
. O 0 0.006199531722813845

Localization O 0 0.25021693110466003
of O 0 0.0028619992081075907
human O 0 0.03234275057911873
BRCA1 O 1 0.9999986886978149
and O 0 0.002004687674343586
its O 0 0.002261553192511201
loss O 0 0.03850940987467766
in O 0 0.0016249733744189143
high O 0 0.007793703582137823
- O 0 0.020130008459091187
grade O 0 0.03277690336108208
, O 0 0.002585398033261299
non B-Disease 0 0.021967189386487007
- I-Disease 1 0.9456030130386353
inherited I-Disease 1 0.9999635219573975
breast I-Disease 1 0.9999991655349731
carcinomas I-Disease 1 0.9999908208847046
. O 0 0.01684052310883999

Although O 0 0.004125649109482765
the O 0 0.0018975865095853806
link O 0 0.02538338676095009
between O 0 0.003096586326137185
the O 0 0.006586588453501463
BRCA1 O 1 0.9999998807907104
tumour B-Disease 1 0.999998927116394
- O 1 0.9226101040840149
suppressor O 1 0.9999868869781494
gene O 1 0.9998242259025574
and O 0 0.008920535445213318
hereditary B-Disease 1 0.9999940395355225
breast I-Disease 1 0.9999994039535522
and I-Disease 1 0.6902956962585449
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
is O 0 0.0029326220974326134
established O 0 0.00332806003279984
, O 0 0.0009638352203182876
the O 0 0.0014945926377549767
role O 0 0.007818666286766529
, O 0 0.0011306868400424719
if O 0 0.001766056870110333
any O 0 0.001258174772374332
, O 0 0.0008706588996574283
of O 0 0.0020785965025424957
BRCA1 O 1 0.9999996423721313
in O 0 0.004185201600193977
non B-Disease 0 0.052780479192733765
- I-Disease 1 0.998027503490448
familial I-Disease 1 0.9999995231628418
cancers I-Disease 1 0.9999988079071045
is O 0 0.004559575114399195
unclear O 0 0.018232107162475586
. O 0 0.004651324823498726

BRCA1 O 1 0.9999977350234985
mutations O 1 0.9999202489852905
are O 0 0.002028471790254116
rare O 0 0.01556710246950388
in O 0 0.003024281933903694
sporadic B-Disease 1 0.998953104019165
cancers I-Disease 1 0.9999985694885254
, O 0 0.002214403823018074
but O 0 0.0020037032663822174
loss O 0 0.0281866155564785
of O 0 0.004193949047476053
BRCA1 O 1 0.9999995231628418
resulting O 0 0.14871615171432495
from O 0 0.0035137832164764404
reduced O 0 0.02113204635679722
expression O 0 0.030725747346878052
or O 0 0.004805990494787693
incorrect O 0 0.051033228635787964
subcellular O 1 0.9961341619491577
localization O 1 0.9681575894355774
is O 0 0.0026533331256359816
postulated O 0 0.37301382422447205
to O 0 0.0008991790236905217
be O 0 0.0005752580473199487
important O 0 0.0012018013512715697
in O 0 0.001713940524496138
non B-Disease 0 0.025717271491885185
- I-Disease 1 0.9940646290779114
familial I-Disease 1 0.9999992847442627
breast I-Disease 1 0.9999986886978149
and I-Disease 0 0.3956085443496704
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999991655349731
. O 0 0.010491971857845783

Epigenetic O 1 0.9998226761817932
loss O 1 0.674087643623352
, O 0 0.002168043749406934
however O 0 0.002249092562124133
, O 0 0.0010813083499670029
has O 0 0.001185539411380887
not O 0 0.001099113840609789
received O 0 0.004103631712496281
general O 0 0.003159145126119256
acceptance O 0 0.045882321894168854
due O 0 0.004869787488132715
to O 0 0.00123139179777354
controversy O 0 0.008388271555304527
regarding O 0 0.0032302069012075663
the O 0 0.0016757292905822396
subcellular O 1 0.9881672263145447
localization O 1 0.7934913635253906
of O 0 0.004926305264234543
BRCA1 O 1 0.9999997615814209
proteins O 1 0.9990948438644409
, O 0 0.0014824760146439075
reports O 0 0.0024616087321192026
of O 0 0.0006392373470589519
which O 0 0.000857068516779691
have O 0 0.0009507603244856
ranged O 0 0.010796334594488144
from O 0 0.0016394617268815637
exclusively O 0 0.005751900840550661
nuclear O 0 0.008655163459479809
, O 0 0.0008956104866228998
to O 0 0.0013600339880213141
conditionally O 1 0.8690879344940186
nuclear O 0 0.009480279870331287
, O 0 0.000917348894290626
to O 0 0.0008871880127117038
the O 0 0.003671493614092469
ER O 1 0.9999531507492065
/ O 1 0.9909798502922058
golgi O 1 0.9995392560958862
, O 0 0.0029421199578791857
to O 0 0.0030914610251784325
cytoplasmic O 1 0.998964786529541
invaginations O 1 0.7625454068183899
into O 0 0.0042617442086339
the O 0 0.0030626931693404913
nucleus O 1 0.9821052551269531
. O 0 0.0072016934864223

In O 0 0.003653217339888215
an O 0 0.0021274166647344828
attempt O 0 0.011329114437103271
to O 0 0.0017972958739846945
resolve O 0 0.014721743762493134
this O 0 0.0014824928948655725
issue O 0 0.002537637483328581
, O 0 0.0007790356758050621
we O 0 0.0006681251688860357
have O 0 0.0010667904280126095
comprehensively O 0 0.045616261661052704
characterized O 0 0.055345568805933
19 O 0 0.014241524040699005
anti O 0 0.16352811455726624
- O 1 0.9855988025665283
BRCA1 O 1 0.9999992847442627
antibodies O 1 0.9995813965797424
. O 0 0.012521255761384964

These O 0 0.006599393207579851
reagents O 1 0.8577524423599243
detect O 0 0.24467746913433075
a O 0 0.00728679308667779
220 O 0 0.033980198204517365
- O 0 0.04848510026931763
kD O 1 0.9981853365898132
protein O 1 0.9989109039306641
localized O 1 0.9844931364059448
in O 0 0.0027762765530496836
discrete O 0 0.104561448097229
nuclear O 0 0.0185268372297287
foci O 1 0.989477813243866
in O 0 0.0015770939644426107
all O 0 0.002637147670611739
epithelial O 1 0.9999947547912598
cell O 1 0.9996697902679443
lines O 0 0.015592626295983791
, O 0 0.0014683852205052972
including O 0 0.0013200355460867286
those O 0 0.0012371541233733296
derived O 0 0.03699013218283653
from O 0 0.009490769356489182
breast B-Disease 1 0.9999986886978149
malignancies I-Disease 1 0.9999576807022095
. O 0 0.009963982738554478

Immunohistochemical O 1 0.9957895874977112
staining O 1 0.9823743104934692
of O 0 0.004350803326815367
human O 0 0.07965890318155289
breast O 1 0.9999921321868896
specimens O 0 0.02897743694484234
also O 0 0.00253667333163321
revealed O 0 0.10057640075683594
BRCA1 O 1 0.9999979734420776
nuclear O 0 0.037230949848890305
foci O 1 0.9982346296310425
in O 0 0.006544979754835367
benign O 1 0.9999909400939941
breast O 1 0.9999988079071045
, O 0 0.01039894763380289
invasive B-Disease 1 0.9999945163726807
lobular I-Disease 1 0.999998927116394
cancers I-Disease 1 0.999997615814209
and O 0 0.004102942068129778
low B-Disease 0 0.030320266261696815
- I-Disease 0 0.11110939085483551
grade I-Disease 1 0.9938637018203735
ductal I-Disease 1 0.9999982118606567
carcinomas I-Disease 1 0.9999872446060181
. O 0 0.013478555716574192

Conversely O 0 0.18359971046447754
, O 0 0.011280445381999016
BRCA1 O 1 0.999988317489624
expression O 0 0.04569101333618164
was O 0 0.0027227222453802824
reduced O 0 0.020846115425229073
or O 0 0.006947902962565422
undetectable O 1 0.9990875720977783
in O 0 0.001420438289642334
the O 0 0.0009807682363316417
majority O 0 0.003347551915794611
of O 0 0.0011486848816275597
high O 0 0.0072790225967764854
- O 0 0.027138635516166687
grade O 0 0.49121519923210144
, O 0 0.008749870583415031
ductal B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 0.9999990463256836
, O 0 0.0029958467930555344
suggesting O 0 0.011750107631087303
that O 0 0.001085026073269546
absence O 0 0.013232617639005184
of O 0 0.0034131244756281376
BRCA1 O 1 0.9999997615814209
may O 0 0.007995238527655602
contribute O 0 0.008424258790910244
to O 0 0.000862301152665168
the O 0 0.00225962046533823
pathogenesis O 1 0.9999746084213257
of O 0 0.0011299450416117907
a O 0 0.003115039551630616
significant O 0 0.0036851102486252785
percentage O 0 0.007326505612581968
of O 0 0.002772417850792408
sporadic B-Disease 1 0.9998049139976501
breast I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999986886978149
. O 0 0.0054330406710505486
. O 0 0.006510432343930006

